Reporting Country  â†‘,Date Received,Accession #,Request Type,Account: Account Name,Contact: Full Name,Test Ordered,Sample Gene Panel,LIMS Project ID,Billing Type,Cancer Type,Final Report Date,Latest Report Date,Reporting Country,Type,Cancer Type_mapped,Reporting Country_mapped,Product,AE_supported,Currency,Sub_region,Month,Year,Quarter,Sales,Year_Month,Month_to_match,new LIMS Project ID,Quarter_Year,adv_Sub_region,FOC,Invoiced Ammount,Revenue(Local_Curr),Date,Value,Revenue (USD),price_segment
ES,2020-01-02,A0223879,Clinical,Hospital Quiron Barcelona,Jesus Soberino Garcia,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/7/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-01,1.109846,2555.975338,2000-3000$ 
GB,2020-01-02,A0223865,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),1/14/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,"GBP 2,490.00",2490.0,2020-01,1.307485,3255.63765,3000+ $
TR,2020-01-02,A0223841,Clinical,Iontek,Cengiz Yakicier,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,1/8/2020,9/28/2020,TURKEY,Commercial,Other,TURKEY,1,AE,USD,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2100,2100.0,2020-01,1.0,2100.0,2000-3000$ 
TR,2020-01-02,A0223827,Clinical,Iontek,Cengiz Yakicier,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/7/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2100,2100.0,2020-01,1.0,2100.0,2000-3000$ 
GB,2020-01-02,A0223852,Clinical,University Hospitals Of Leicester,Manar Almusarhed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/9/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Free,0,0.0,2020-01,1.307485,0.0,0 $
GB,2020-01-02,A0223877,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/7/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Free,0,0.0,2020-01,1.307485,0.0,0 $
ES,2020-01-03,A0224029,Clinical,Clinica Universidad de Navarra-Madrid,Luisa Sanchez Lorenzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/9/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-01,1.109846,2774.6150000000002,2000-3000$ 
CH,2020-01-06,A0224457,Clinical,Hopitaux Universitaires de Genevu,Eugenio Fernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Renal Cell Carcinoma,1/11/2020,9/28/2020,SWITZERLAND,Commercial,Kidney,SWITZERLAND,1,non_AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Free,0,0.0,2020-01,1.109846,0.0,0 $
ES,2020-01-06,A0224458,Clinical,Hospital Quiron Barcelona,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/11/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-01,1.109846,2555.975338,2000-3000$ 
GB,2020-01-08,A0224940,Clinical,Mount Alverina Hospital,Anthony Neal,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/15/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2300,2300.0,2020-01,1.307485,3007.2155,3000+ $
GB,2020-01-10,A0225590,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,1/16/2020,1/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2300,2300.0,2020-01,1.307485,3007.2155,3000+ $
GB,2020-01-10,A0225583,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/14/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,"GBP 2,490.00",2490.0,2020-01,1.307485,3255.63765,3000+ $
GB,2020-01-11,A0226032,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,1/17/2020,9/28/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.307485,3255.63765,3000+ $
ES,2020-01-11,A0226023,Clinical,Clinica Universidad de Navarra,Amaia Urrizola Martinez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/18/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-01,1.109846,2774.6150000000002,2000-3000$ 
ES,2020-01-11,A0226098,Clinical,Complejo Hospitalario Ruber Juan Bravo,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/20/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-01,1.109846,2555.975338,2000-3000$ 
IT,2020-01-13,A0226155,Clinical,Istituto Tumori della Romagna IRST,Alesandro Passardi,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,,1/15/2020,9/28/2020,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,0,0.0,2020-01,1.109846,0.0,0 $
IT,2020-01-13,A0226164,Clinical,San Giovanni-Addolorata Hospital,Antonio Burza,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/19/2020,9/28/2020,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.109846,2763.51654,2000-3000$ 
CL,2020-01-13,A0226165,Clinical,Clinica Las Condes,Laura Itriago,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,1/19/2020,9/28/2020,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,South America,Free,0,0.0,2020-01,1.0,0.0,0 $
GB,2020-01-13,A0226153,Clinical,Genesis Care Nottingham,Sarah Khan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/21/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Free,0,0.0,2020-01,1.307485,0.0,0 $
ES,2020-01-13,A0226161,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,1/21/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-01,1.109846,2555.975338,2000-3000$ 
ES,2020-01-13,A0226162,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,1/21/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-01,1.109846,2555.975338,2000-3000$ 
ES,2020-01-15,A0226466,Clinical,Hospital Clinico Provincial de Barcelona,Lydia Gaba Garcia,Guardant 360,2.11,GHI_01,Distributors : ROW,Endometrial carcinoma,1/20/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2200,2200.0,2020-01,1.109846,2441.6612000000005,2000-3000$ 
TR,2020-01-16,A0226899,Clinical,Iontek,Atakan Demir,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,1/22/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2100,2100.0,2020-01,1.0,2100.0,2000-3000$ 
GB,2020-01-16,A0227438,Clinical,The Royal Marsden Hospital,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/25/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.307485,3255.63765,3000+ $
GB,2020-01-16,A0226892,Validation,The Royal Marsden Hospital,Stephen Johnston,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,,1/18/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,0,0.0,2020-01,1.307485,0.0,0 $
BR,2020-01-17,A0227413,Clinical,Hospital Israelita Albert Einstein,Nise Yamaguchi,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,1/24/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,South America,Paid,0,0.0,2020-01,1.0,0.0,0 $
ES,2020-01-17,A0227135,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/23/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-01,1.109846,2774.6150000000002,2000-3000$ 
UA,2020-01-17,A0227305,Clinical,Boris Clinic,Tatiana Dehtyar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/24/2020,9/28/2020,UKRAINE,Commercial,,UKRAINE,1,non_AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,1500,1500.0,2020-01,1.109846,1664.7690000000002,1500-2000$ 
ES,2020-01-17,A0227389,Clinical,Clinica Universidad de Navarra,Jaime Espinos Jimenez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/22/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-01,1.109846,2774.6150000000002,2000-3000$ 
ES,2020-01-17,A0227156,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/22/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-01,1.109846,2774.6150000000002,2000-3000$ 
CA,2020-01-17,A0227331,Clinical,Princess Margaret Hospital,Eric Chen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,1/22/2020,9/28/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Canada,Paid,3490,3490.0,2020-01,1.0,3490.0,3000+ $
GB,2020-01-18,A0227500,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric Carcinoma,1/26/2020,9/28/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.307485,3255.63765,3000+ $
GB,2020-01-18,A0227485,Clinical,HCA Laboratories,Peter Harper,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/24/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.307485,3255.63765,3000+ $
GB,2020-01-18,A0227571,Clinical,HCA Laboratories,Debashis Sarker,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,1/25/2020,9/28/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.307485,3255.63765,3000+ $
ES,2020-01-20,A0227668,Clinical,Clinica Corachan,Joaquin Bellmunt Molins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Renal pelvis urothelial carcinoma,1/28/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.109846,2763.51654,2000-3000$ 
GB,2020-01-20,A0227680,Clinical,University College London Hospitals,Dionysis Papadatos-Pastos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/25/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.307485,3255.63765,3000+ $
GB,2020-01-20,A0227679,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/26/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.307485,3255.63765,3000+ $
GB,2020-01-20,A0227684,Clinical,The Holly Private Hospital,Sherif Raouf,Guardant 360,2.11,GHI_01,Distributors : ROW,Esophageal squamous cell carcinoma,1/29/2020,9/28/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.307485,3255.63765,3000+ $
ES,2020-01-20,A0227671,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/31/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.109846,2763.51654,2000-3000$ 
MX,2020-01-22,A0228141,Clinical,Labopat,Oscar Arrieta Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/28/2020,9/28/2020,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,South America,Paid,3200,3200.0,2020-01,1.109846,3551.5072000000005,3000+ $
GB,2020-01-22,A0228138,Clinical,HCA Laboratories,Paul Ross,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,1/28/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.307485,3255.63765,3000+ $
ES,2020-01-22,A0228283,Clinical,Hospital Clinico Provincial de Barcelona,Tamara Sauri,Guardant 360,2.11,GHI_01,Distributors : ROW,GIST (Gastrointestinal stromal tumor),1/28/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2200,2200.0,2020-01,1.109846,2441.6612000000005,2000-3000$ 
GB,2020-01-22,A0228140,Clinical,HCA Laboratories,Maurice Slevin,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),1/28/2020,9/28/2020,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.307485,3255.63765,3000+ $
ES,2020-01-22,A0228134,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/28/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-01,1.109846,2774.6150000000002,2000-3000$ 
GB,2020-01-23,A0228575,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/29/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-01,1.307485,3255.63765,3000+ $
GB,2020-01-23,A0228719,Clinical,HCA at The Christie Clinic,David Woolf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/30/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,3113,3113.0,2020-01,1.307485,4070.200805,3000+ $
IT,2020-01-24,A0228908,Clinical,Istituto Tumori della Romagna IRST,Alesandro Passardi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/2/2020,9/28/2020,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,1500,1500.0,2020-01,1.109846,1664.7690000000002,1500-2000$ 
ES,2020-01-24,A0229048,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,1/30/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-01,1.109846,2555.975338,2000-3000$ 
BR,2020-01-24,A0229022,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,1/31/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,South America,Paid,2500,2500.0,2020-01,1.0,2500.0,2000-3000$ 
GB,2020-01-24,A0228974,Clinical,Southampton General Hospital,Charles Hamilton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/31/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,3113,3113.0,2020-01,1.307485,4070.200805,3000+ $
BR,2020-01-24,A0229123,Clinical,Synlab - Brasil,Nise Yamaguchi,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/2/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,South America,Paid,2800,2800.0,2020-01,1.0,2800.0,2000-3000$ 
CA,2020-01-24,A0228920,Clinical,London Health Sciences Centre,Mark Vincent,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/4/2020,9/28/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Canada,Paid,3490,3490.0,2020-01,1.0,3490.0,3000+ $
ES,2020-01-25,A0229290,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/31/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-01,1.109846,2774.6150000000002,2000-3000$ 
ES,2020-01-25,A0229281,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,1/31/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-01,1.109846,2774.6150000000002,2000-3000$ 
ES,2020-01-27,A0229678,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/1/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Free,0,0.0,2020-01,1.109846,0.0,0 $
CA,2020-01-28,A0229829,Clinical,RCM Health Consultancy,Raymond Rupert,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,2/4/2020,9/28/2020,CANADA,Commercial,Other,CANADA,1,AE,USD,Americas,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Canada,Paid,3800,3800.0,2020-01,1.0,3800.0,3000+ $
ES,2020-01-29,A0230144,Clinical,Clinica Universidad de Navarra,Jaime Espinos Jimenez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/4/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-01,1.109846,2774.6150000000002,2000-3000$ 
CL,2020-01-30,A0230710,Clinical,Fundacion Arturo Lopez Perez,Carolina Selman,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,2/6/2020,9/28/2020,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,South America,Free,0,0.0,2020-01,1.0,0.0,0 $
ES,2020-01-30,A0230528,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/7/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-01,1.109846,2555.975338,2000-3000$ 
BR,2020-01-31,A0230911,Clinical,Hospital Sirio Libanes,Artur Katz,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/6/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2020,1,1,2020-01-01,2020-01,G360 CDx,2020Q1,South America,Paid,2500,2500.0,2020-01,1.0,2500.0,2000-3000$ 
TR,2020-02-01,A0231390,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,2/7/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2100,2100.0,2020-02,1.0,2100.0,2000-3000$ 
GB,2020-02-01,A0231355,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/7/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.296937,3229.37313,3000+ $
ES,2020-02-03,A0231506,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/8/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-02,1.091708,2514.2035239999996,2000-3000$ 
GB,2020-02-03,A0231508,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/8/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.296937,3229.37313,3000+ $
DE,2020-02-03,A0231498,Clinical,Rainer Musselmann,Rainer Musselmann,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,2/6/2020,9/28/2020,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,0,0.0,2020-02,1.091708,0.0,0 $
IE,2020-02-03,A0231512,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,2/4/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,0,0.0,2020-02,1.091708,0.0,0 $
ES,2020-02-03,A0231500,Clinical,Hospital Clinico Provincial de Barcelona,Aleix Prat,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/8/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2200,2200.0,2020-02,1.091708,2401.7576,2000-3000$ 
GB,2020-02-04,A0231552,Clinical,HCA Laboratories,Stephen Morris,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,2/9/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.296937,3229.37313,3000+ $
GB,2020-02-05,A0231962,Clinical,Cheltenham General Hospital,David Farrugia,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/10/2020,6/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.296937,3229.37313,3000+ $
BR,2020-02-05,A0231932,Clinical,Hospital de Cancer de Barretos,Pedro De Marchi,Guardant 360,2.11,GHI_01,Do Not Bill - ROW,Lung adenocarcinoma,2/18/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,South America,Paid,0,0.0,2020-02,1.0,0.0,0 $
ES,2020-02-05,A0232052,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/14/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-02,1.091708,2729.2699999999995,2000-3000$ 
ES,2020-02-05,A0231814,Clinical,Hospital Quiron Barcelona,Jose Manuel Perez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/12/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-02,1.091708,2514.2035239999996,2000-3000$ 
BR,2020-02-05,A0231870,Clinical,Grupo CSB,Raphael Pereira Paschoalin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/13/2020,9/28/2020,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,South America,Paid,2500,2500.0,2020-02,1.0,2500.0,2000-3000$ 
TR,2020-02-06,A0232380,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,2/14/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2100,2100.0,2020-02,1.0,2100.0,2000-3000$ 
ES,2020-02-06,A0232294,Clinical,Clinica Corachan,Joaquin Bellmunt Molins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Bladder carcinoma,2/13/2020,9/28/2020,SPAIN,Commercial,Bladder,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,1745,1745.0,2020-02,1.091708,1905.0304599999997,1500-2000$ 
GB,2020-02-07,A0232725,Clinical,HCA Laboratories,Paul Ross,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,2/14/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-02,1.296937,2986.845911,2000-3000$ 
GB,2020-02-07,A0232750,Clinical,BMI Bishops Wood Hospital,Andreas Makris,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/15/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.296937,3229.37313,3000+ $
GB,2020-02-07,A0232766,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,2/19/2020,9/28/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.296937,3229.37313,3000+ $
ES,2020-02-10,A0233176,Clinical,Hospital Clinico Provincial de Barcelona,Aleix Prat,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/19/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2200,2200.0,2020-02,1.091708,2401.7576,2000-3000$ 
TR,2020-02-10,A0233177,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,2/22/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-02,1.0,2500.0,2000-3000$ 
TR,2020-02-10,A0233173,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Sarcoma,2/23/2020,9/28/2020,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-02,1.0,2500.0,2000-3000$ 
ES,2020-02-10,A0233168,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/15/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-02,1.091708,2514.2035239999996,2000-3000$ 
TR,2020-02-10,A0233175,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,2/23/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-02,1.0,2500.0,2000-3000$ 
GB,2020-02-13,A0234118,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/19/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.296937,3229.37313,3000+ $
ES,2020-02-13,A0234054,Clinical,Clinica Universidad de Navarra,Javier Blanco Avila,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/19/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-02,1.091708,2729.2699999999995,2000-3000$ 
ES,2020-02-13,A0234132,Clinical,Hospital Quiron Barcelona,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/21/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-02,1.091708,2514.2035239999996,2000-3000$ 
IE,2020-02-13,A0234089,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/19/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2990,2990.0,2020-02,1.091708,3264.2069199999996,3000+ $
CA,2020-02-14,A0234582,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/19/2020,9/28/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Canada,Paid,3490,3490.0,2020-02,1.0,3490.0,3000+ $
GB,2020-02-15,A0234888,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/21/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-02,1.296937,2986.845911,2000-3000$ 
TR,2020-02-15,A0234823,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/22/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2100,2100.0,2020-02,1.0,2100.0,2000-3000$ 
GB,2020-02-17,A0235002,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,2/23/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.296937,3229.37313,3000+ $
ES,2020-02-17,A0234994,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/22/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-02,1.091708,2729.2699999999995,2000-3000$ 
ES,2020-02-17,A0234996,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/24/2020,11/13/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.091708,2718.35292,2000-3000$ 
ES,2020-02-17,A0234991,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,2/22/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-02,1.091708,2514.2035239999996,2000-3000$ 
GB,2020-02-17,A0235000,Clinical,Genesis Care Nottingham,Santhanam Sundar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,2/23/2020,1/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2300,2300.0,2020-02,1.296937,2982.9551,2000-3000$ 
IT,2020-02-18,A0235051,Clinical,San Giovanni-Addolorata Hospital,Antonio Burza,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/25/2020,9/28/2020,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,1745,1745.0,2020-02,1.091708,1905.0304599999997,1500-2000$ 
GB,2020-02-18,A0235039,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,2/23/2020,9/28/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-02,1.296937,2986.845911,2000-3000$ 
GB,2020-02-19,A0235488,Clinical,Clatterbridge Cancer Centre,Rajaram Sripadam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/25/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.296937,3229.37313,3000+ $
ES,2020-02-19,A0235500,Clinical,Clinica Universidad de Navarra-Madrid,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/24/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-02,1.091708,2729.2699999999995,2000-3000$ 
ES,2020-02-19,A0235465,Clinical,Clinica Universidad de Navarra-Madrid,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,2/25/2020,9/28/2020,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-02,1.091708,2729.2699999999995,2000-3000$ 
GB,2020-02-19,A0235245,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/25/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-02,1.296937,2986.845911,2000-3000$ 
ES,2020-02-20,A0235812,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/26/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-02,1.091708,2729.2699999999995,2000-3000$ 
GB,2020-02-21,A0236199,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/26/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-02,1.296937,2986.845911,2000-3000$ 
GB,2020-02-21,A0236159,Clinical,Queen Alexandra Hospital,Sethupathi Ramalingam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/26/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.296937,3229.37313,3000+ $
CA,2020-02-21,A0236132,Clinical,Brampton Civic Hosptial,Parneet Cheema,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/26/2020,9/28/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Canada,Paid,3490,3490.0,2020-02,1.0,3490.0,3000+ $
GB,2020-02-21,A0236225,Clinical,Southampton General Hospital,Sanjay Raj,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/27/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2300,2300.0,2020-02,1.296937,2982.9551,2000-3000$ 
GB,2020-02-22,A0236502,Clinical,Clatterbridge Cancer Centre,Amir Montazeri,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/28/2020,1/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2300,2300.0,2020-02,1.296937,2982.9551,2000-3000$ 
ES,2020-02-24,A0236922,Clinical,Clinica Universidad de Navarra,Lucia Ceniceros Paredes,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/29/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-02,1.091708,2729.2699999999995,2000-3000$ 
GB,2020-02-24,A0236768,Clinical,HCA at The Christie Clinic,David Woolf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/3/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-02,1.296937,3229.37313,3000+ $
GB,2020-02-25,A0236984,Clinical,HCA Laboratories,Debashis Sarker,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,2/29/2020,9/28/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-02,1.296937,2986.845911,2000-3000$ 
GB,2020-02-25,A0237016,Clinical,University Hospitals Of Leicester,Mohamed Mahgoub,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/29/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Free,0,0.0,2020-02,1.296937,0.0,0 $
GB,2020-02-26,A0237398,Clinical,Elstree Cancer Centre,Richard Ashford,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/9/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2300,2300.0,2020-02,1.296937,2982.9551,2000-3000$ 
GB,2020-02-26,A0237316,Clinical,HCA Laboratories,Debashis Sarker,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/1/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-02,1.296937,2986.845911,2000-3000$ 
ES,2020-02-27,A0238056,Clinical,Hospital Quiron Barcelona,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/4/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-02,1.091708,2514.2035239999996,2000-3000$ 
GB,2020-02-27,A0237941,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/3/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-02,1.296937,2986.845911,2000-3000$ 
GB,2020-02-28,A0238521,Clinical,Southampton General Hospital,Luke Nolan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/5/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,1744,1744.0,2020-02,1.296937,2261.858128,2000-3000$ 
BR,2020-02-28,A0238479,Clinical,Hospital Sirio Libanes,Artur Katz,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/4/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,South America,Paid,2500,2500.0,2020-02,1.0,2500.0,2000-3000$ 
ES,2020-02-29,A0238794,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/4/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2020,1,1,2020-02-01,2020-02,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-02,1.091708,2729.2699999999995,2000-3000$ 
ES,2020-03-02,A0238986,Clinical,Clinica Universidad de Navarra-Madrid,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/7/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-03,1.105525,2763.8125,2000-3000$ 
ES,2020-03-02,A0238988,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Esophageal squamous cell carcinoma,3/6/2020,9/28/2020,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-03,1.105525,2763.8125,2000-3000$ 
GB,2020-03-02,A0238969,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,3/10/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-03,1.237096,3080.36904,3000+ $
ES,2020-03-02,A0238974,Clinical,Hospital Quironsalud Sagrado Corazon,Juan Carlos Quero Guillen,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/6/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Free,0,0.0,2020-03,1.105525,0.0,0 $
ES,2020-03-04,A0239728,Clinical,Clinica Corachan,Joaquin Bellmunt Molins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Bladder carcinoma,3/9/2020,9/28/2020,SPAIN,Commercial,Bladder,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-03,1.105525,2752.75725,2000-3000$ 
GB,2020-03-05,A0240093,Clinical,Charing Cross Hospital Medical Oncology Department,Laura Kenny,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/12/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-03,1.237096,3080.36904,3000+ $
CL,2020-03-05,A0240155,Clinical,Fundacion Arturo Lopez Perez,Carolina Selman,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/10/2020,9/28/2020,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Free,0,0.0,2020-03,1.0,0.0,0 $
ES,2020-03-06,A0240436,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,3/13/2020,9/28/2020,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-03,1.105525,2763.8125,2000-3000$ 
TR,2020-03-06,A0240466,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/10/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2100,2100.0,2020-03,1.0,2100.0,2000-3000$ 
GB,2020-03-06,A0240422,Clinical,HCA Laboratories,Paul Ross,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/10/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-03,1.237096,2849.032088,2000-3000$ 
GB,2020-03-06,A0240367,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/16/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-03,1.237096,2849.032088,2000-3000$ 
ES,2020-03-06,A0240468,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,3/10/2020,9/28/2020,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-03,1.105525,2763.8125,2000-3000$ 
BE,2020-03-09,A0240907,Clinical,University Hospital Antwerp,Jan Van Den Brande,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,3/19/2020,9/28/2020,BELGIUM,Commercial,,BELGIUM,1,non_AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-03,1.105525,2763.8125,2000-3000$ 
GB,2020-03-09,A0240916,Clinical,Bupa Cromwell Hospital,Nick Plowman,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,,3/31/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,0,0.0,2020-03,1.237096,0.0,0 $
GB,2020-03-10,A0241187,Clinical,HCA Laboratories,Debashis Sarker,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,3/21/2020,9/28/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-03,1.237096,2849.032088,2000-3000$ 
ES,2020-03-11,A0241254,Clinical,Hospital Quiron Barcelona,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/16/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-03,1.105525,2546.0240750000003,2000-3000$ 
GB,2020-03-11,A0241271,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,3/17/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-03,1.237096,3080.36904,3000+ $
GB,2020-03-11,A0241430,Clinical,Hammersmith Hospital,Harpreet Wasan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/17/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-03,1.237096,3080.36904,3000+ $
GB,2020-03-12,A0241722,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Sarcoma,3/17/2020,9/28/2020,UNITED KINGDOM,Commercial,Soft Tissue/Bone,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-03,1.237096,2849.032088,2000-3000$ 
GB,2020-03-12,A0241896,Clinical,"Primrose Unit, Bedford Hospital",Venkata Bulusu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/17/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Free,0,0.0,2020-03,1.237096,0.0,0 $
ES,2020-03-12,A0241692,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/16/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2200,2200.0,2020-03,1.105525,2432.155,2000-3000$ 
ES,2020-03-12,A0241687,Clinical,Hospital Clinico Provincial de Barcelona,Aleix Prat,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/16/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2200,2200.0,2020-03,1.105525,2432.155,2000-3000$ 
TR,2020-03-12,A0241859,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,3/18/2020,9/28/2020,TURKEY,Commercial,Other,TURKEY,1,AE,USD,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2100,2100.0,2020-03,1.0,2100.0,2000-3000$ 
CL,2020-03-12,A0241660,Clinical,Clinica Santa Maria,Cristian Carvallo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/26/2020,9/28/2020,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,3490,3490.0,2020-03,1.0,3490.0,3000+ $
GB,2020-03-13,A0242135,Clinical,University Hospitals Of Leicester,Mohamed Mahgoub,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/18/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Free,0,0.0,2020-03,1.237096,0.0,0 $
ES,2020-03-13,A0242567,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/18/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-03,1.105525,2763.8125,2000-3000$ 
MX,2020-03-13,A0241992,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic neuroendocrine tumor,3/21/2020,9/28/2020,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,4000,4000.0,2020-03,1.105525,4422.1,3000+ $
ES,2020-03-13,A0242568,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/18/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Free,0,0.0,2020-03,1.105525,0.0,0 $
AT,2020-03-16,A0242841,Clinical,Naturheilpraxis Dr. med. Baumert,Stefan Baumert,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/21/2020,9/28/2020,AUSTRIA,Commercial,,AUSTRIA,1,non_AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,1750,1750.0,2020-03,1.105525,1934.6687500000003,1500-2000$ 
ES,2020-03-16,A0242843,Clinical,Clinica Universidad de Navarra-Madrid,Antonio Gonzalez Martin,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/20/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-03,1.105525,2763.8125,2000-3000$ 
GB,2020-03-16,A0242847,Clinical,Genesis Care Nottingham,Santhanam Sundar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,3/20/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,1744,1744.0,2020-03,1.237096,2157.4954239999997,2000-3000$ 
GB,2020-03-16,A0242871,Clinical,HCA Laboratories,Maurice Slevin,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/23/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-03,1.237096,2849.032088,2000-3000$ 
GB,2020-03-16,A0242848,Clinical,Clatterbridge Cancer Centre,Rajaram Sripadam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/21/2020,1/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2300,2300.0,2020-03,1.237096,2845.3208,2000-3000$ 
BR,2020-03-16,A0242854,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/20/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,2500,2500.0,2020-03,1.0,2500.0,2000-3000$ 
BR,2020-03-16,A0242850,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/20/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,2500,2500.0,2020-03,1.0,2500.0,2000-3000$ 
BR,2020-03-16,A0242864,Clinical,Hospital Sirio Libanes,Karime Kalil Machado,Guardant 360,2.11,GHI_01,Self-Pay Patient,Bladder carcinoma,3/20/2020,9/28/2020,BRAZIL,Commercial,Bladder,BRAZIL,1,AE,USD,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,2500,2500.0,2020-03,1.0,2500.0,2000-3000$ 
BR,2020-03-16,A0242935,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/22/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,2000,2000.0,2020-03,1.0,2000.0,1500-2000$ 
TR,2020-03-16,A0242855,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Melanoma,3/21/2020,9/28/2020,TURKEY,Commercial,Skin,TURKEY,1,AE,USD,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2100,2100.0,2020-03,1.0,2100.0,2000-3000$ 
GB,2020-03-16,A0242865,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,3/17/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,0,0.0,2020-03,1.237096,0.0,0 $
DE,2020-03-18,A0243344,Clinical,Essen University Hospital,Sebastian Bauer,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,GIST (Gastrointestinal stromal tumor),3/24/2020,9/28/2020,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,3490,3490.0,2020-03,1.105525,3858.28225,3000+ $
CL,2020-03-18,A0243379,Clinical,Clinica Alemana,Conrado Vogel,Guardant 360,2.11,GHI_01,Self-Pay Patient,Bladder carcinoma,3/24/2020,9/28/2020,CHILE,Commercial,Bladder,CHILE,1,non_AE,USD,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,3490,3490.0,2020-03,1.0,3490.0,3000+ $
GB,2020-03-18,A0243407,Clinical,HCA Laboratories,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/22/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-03,1.237096,2849.032088,2000-3000$ 
GB,2020-03-20,A0244123,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/26/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-03,1.237096,2849.032088,2000-3000$ 
GB,2020-03-20,A0243949,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/25/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2303.25,2303.0,2020-03,1.237096,2849.032088,2000-3000$ 
GB,2020-03-20,A0244015,Clinical,Coventry University Hospitals,Nawaz Walji,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/24/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2300,2300.0,2020-03,1.237096,2845.3208,2000-3000$ 
GB,2020-03-20,A0244099,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/26/2020,8/23/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2300,2300.0,2020-03,1.237096,2845.3208,2000-3000$ 
ES,2020-03-20,A0244079,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/26/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2303,2303.0,2020-03,1.105525,2546.0240750000003,2000-3000$ 
TR,2020-03-20,A0243952,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,3/27/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2100,2100.0,2020-03,1.0,2100.0,2000-3000$ 
BR,2020-03-20,A0244138,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/26/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,2500,2500.0,2020-03,1.0,2500.0,2000-3000$ 
GB,2020-03-20,A0244095,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/25/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2300,2300.0,2020-03,1.237096,2845.3208,2000-3000$ 
ES,2020-03-20,A0244057,Clinical,Clinica Universidad de Navarra-Madrid,Eduardo Castanov,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/25/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2500,2500.0,2020-03,1.105525,2763.8125,2000-3000$ 
BR,2020-03-23,A0244509,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/28/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,2000,2000.0,2020-03,1.0,2000.0,1500-2000$ 
BR,2020-03-23,A0244398,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/28/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,2000,2000.0,2020-03,1.0,2000.0,1500-2000$ 
HU,2020-03-25,A0244768,Clinical,Semmelweis University,Kalocsai Tamas,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),3/31/2020,9/28/2020,HUNGARY,Commercial,CUP,HUNGARY,1,non_AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-03,1.105525,2752.75725,2000-3000$ 
MX,2020-03-26,A0245057,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,4/1/2020,9/28/2020,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,4000,4000.0,2020-03,1.105525,4422.1,3000+ $
BR,2020-03-30,A0245542,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/3/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,South America,Paid,2500,2500.0,2020-03,1.0,2500.0,2000-3000$ 
IE,2020-03-30,A0245535,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/3/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2990,2990.0,2020-03,1.105525,3305.5197500000004,3000+ $
ES,2020-03-30,A0245537,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/4/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2200,2200.0,2020-03,1.105525,2432.155,2000-3000$ 
ES,2020-03-30,A0245545,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/4/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2200,2200.0,2020-03,1.105525,2432.155,2000-3000$ 
GB,2020-03-30,A0245540,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/3/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2020,1,1,2020-03-01,2020-03,G360 CDx,2020Q1,Europe,Paid,2490,2490.0,2020-03,1.237096,3080.36904,3000+ $
GB,2020-04-03,A0246401,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/7/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2154.01,2154.0,2020-04,1.242199,2675.6966460000003,2000-3000$ 
TR,2020-04-04,A0246546,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,4/13/2020,9/28/2020,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,0,0.0,2020-04,1.0,0.0,0 $
GB,2020-04-04,A0246573,Clinical,Coventry University Hospitals,Peter Correa,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/9/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-04,1.242199,3093.07551,3000+ $
ES,2020-04-06,A0246649,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,4/14/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-04,1.086721,2716.8025000000002,2000-3000$ 
ES,2020-04-07,A0246708,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/13/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-04,1.086721,2716.8025000000002,2000-3000$ 
TR,2020-04-07,A0246700,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Leiomyosarcoma,4/11/2020,9/28/2020,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-04,1.0,2100.0,2000-3000$ 
ES,2020-04-08,A0247024,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/14/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2200,2200.0,2020-04,1.086721,2390.7862,2000-3000$ 
ES,2020-04-08,A0247050,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,4/13/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-04,1.086721,2716.8025000000002,2000-3000$ 
GB,2020-04-08,A0246941,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,4/14/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.242199,0.0,0 $
CA,2020-04-09,A0247369,Clinical,Princess Margaret Cancer Centre,Penelope Bradbury,Guardant 360,2.11,GHI_01,Self-Pay Patient,Sarcomatoid Lung Carcinoma,4/13/2020,9/28/2020,CANADA,Commercial,Lung,CANADA,1,AE,USD,Americas,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Canada,Paid,3490,3490.0,2020-04,1.0,3490.0,3000+ $
ES,2020-04-10,A0247683,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,4/18/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-04,1.086721,2716.8025000000002,2000-3000$ 
ES,2020-04-10,A0247676,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/14/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-04,1.086721,2716.8025000000002,2000-3000$ 
ES,2020-04-10,A0247704,Clinical,Vall D'Hebron University Hospital,Nuria Pardo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),4/16/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.086721,0.0,0 $
TR,2020-04-10,A0247726,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,4/17/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-04,1.0,2100.0,2000-3000$ 
ES,2020-04-10,A0247708,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,4/15/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-04,1.086721,2716.8025000000002,2000-3000$ 
GB,2020-04-10,A0247700,Clinical,The Royal Marsden Hospital,Kazimierz Mochlinski,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,4/15/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-04,1.242199,3093.07551,3000+ $
GB,2020-04-10,A0247690,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,4/16/2020,11/11/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,1750,1750.0,2020-04,1.242199,2173.84825,2000-3000$ 
GB,2020-04-10,A0247623,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,4/22/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.242199,0.0,0 $
GB,2020-04-10,A0247558,Clinical,Genesis Care Nottingham,Sarah Khan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,4/15/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.242199,0.0,0 $
ES,2020-04-13,A0247944,Clinical,Hospital Ruber Internacional,Francisco Javier Roman Garcia,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/19/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2303,2303.0,2020-04,1.086721,2502.718463,2000-3000$ 
ES,2020-04-15,A0248333,Clinical,Hospital Ruber Internacional,Francisco Javier Roman Garcia,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,4/19/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2303,2303.0,2020-04,1.086721,2502.718463,2000-3000$ 
TR,2020-04-15,A0248256,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,4/21/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-04,1.0,2100.0,2000-3000$ 
TR,2020-04-16,A0248614,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,4/22/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-04,1.0,2100.0,2000-3000$ 
TR,2020-04-17,A0248869,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/24/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-04,1.0,2100.0,2000-3000$ 
GB,2020-04-20,A0249381,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,4/24/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-04,1.242199,2860.784297,2000-3000$ 
ES,2020-04-20,A0249366,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,4/24/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-04,1.086721,2716.8025000000002,2000-3000$ 
BR,2020-04-20,A0249367,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/24/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,South America,Paid,2500,2500.0,2020-04,1.0,2500.0,2000-3000$ 
GB,2020-04-20,A0249379,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),4/24/2020,9/28/2020,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-04,1.242199,3093.07551,3000+ $
BR,2020-04-20,A0249364,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,4/24/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,South America,Paid,2000,2000.0,2020-04,1.0,2000.0,1500-2000$ 
GB,2020-04-21,A0249406,Clinical,HCA Laboratories,Maurice Slevin,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/25/2020,1/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-04,1.242199,2860.784297,2000-3000$ 
GB,2020-04-21,A0249421,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,5/2/2020,1/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2300,2300.0,2020-04,1.242199,2857.0577000000003,2000-3000$ 
GB,2020-04-21,A0249483,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,4/25/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.242199,0.0,0 $
GB,2020-04-23,A0250017,Clinical,Southampton General Hospital,Luke Nolan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/27/2020,1/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2300,2300.0,2020-04,1.242199,2857.0577000000003,2000-3000$ 
ES,2020-04-23,A0249992,Clinical,Vall D'Hebron University Hospital,Iosune Baraibar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/28/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.086721,0.0,0 $
TR,2020-04-24,A0250350,Clinical,Iontek,Gurbuz Gorumlu,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/1/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-04,1.0,2100.0,2000-3000$ 
ES,2020-04-27,A0250979,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,5/1/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2303,2303.0,2020-04,1.086721,2502.718463,2000-3000$ 
ES,2020-04-27,A0250980,Clinical,Vall D'Hebron University Hospital,Nuria Pardo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/5/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.086721,0.0,0 $
ES,2020-04-27,A0250971,Clinical,Vall D'Hebron University Hospital,Iosune Baraibar,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/1/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.086721,0.0,0 $
ES,2020-04-27,A0250985,Clinical,Vall D'Hebron University Hospital,Patricia Iranzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/6/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.086721,0.0,0 $
ES,2020-04-27,A0250974,Clinical,Vall D'Hebron University Hospital,Patricia Iranzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung carcinoid,5/2/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.086721,0.0,0 $
GB,2020-04-29,A0251427,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/6/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.242199,0.0,0 $
GB,2020-04-29,A0251431,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,5/6/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-04,1.242199,0.0,0 $
GB,2020-04-30,A0251761,Clinical,Hammersmith Hospital,Harpreet Wasan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/6/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-04,1.242199,3093.07551,3000+ $
ES,2020-04-30,A0251749,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/4/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2200,2200.0,2020-04,1.086721,2390.7862,2000-3000$ 
IT,2020-04-30,A0251817,Clinical,San Giovanni-Addolorata Hospital,Antonio Burza,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/5/2020,9/28/2020,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,1750,1750.0,2020-04,1.086721,1901.7617500000001,1500-2000$ 
TR,2020-04-30,A0251775,Clinical,Iontek,Gurbuz Gorumlu,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/6/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-04,1.0,2100.0,2000-3000$ 
TR,2020-04-30,A0251769,Clinical,Iontek,Ahmet Ozveren,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/6/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2020,2,1,2020-04-01,2020-04,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-04,1.0,2100.0,2000-3000$ 
GB,2020-05-02,A0252532,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/7/2020,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.231081,0.0,0 $
ES,2020-05-04,A0253000,Clinical,Vall D'Hebron University Hospital,Patricia Iranzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/9/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
BR,2020-05-04,A0253004,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/8/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,South America,Paid,2500,2500.0,2020-05,1.0,2500.0,2000-3000$ 
ES,2020-05-04,A0252999,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Bladder carcinoma,5/11/2020,9/28/2020,SPAIN,Commercial,Bladder,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-05,1.093466,2733.665,2000-3000$ 
ES,2020-05-04,A0252998,Clinical,Vall D'Hebron University Hospital,Alex Martinez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/8/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
FI,2020-05-05,A0253234,Clinical,Turku University Hospital,Veli Kairisto,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/11/2020,9/28/2020,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
GB,2020-05-05,A0253250,Clinical,HCA Laboratories,Debashis Sarker,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,5/9/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-05,1.231081,2835.179543,2000-3000$ 
GB,2020-05-05,A0253315,Clinical,BMI The Ridgeway Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/11/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2300,2300.0,2020-05,1.231081,2831.4863,2000-3000$ 
GB,2020-05-05,A0253302,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,5/11/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-05,1.231081,3065.3916900000004,3000+ $
GB,2020-05-06,A0253588,Clinical,BMI The Ridgeway Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/13/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,1744,1744.0,2020-05,1.231081,2147.0052640000004,2000-3000$ 
GB,2020-05-06,A0253500,Clinical,Hammersmith Hospital,Harpreet Wasan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/10/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-05,1.231081,3065.3916900000004,3000+ $
GB,2020-05-06,A0253466,Clinical,University Hospitals Of Leicester,Mohamed Mahgoub,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/10/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,1744,1744.0,2020-05,1.231081,2147.0052640000004,2000-3000$ 
ES,2020-05-06,A0253572,Clinical,Hospital Quironsalud Sagrado Corazon,Juan Carlos Quero Guillen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/12/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-05,1.093466,2722.73034,2000-3000$ 
TR,2020-05-07,A0253750,Clinical,Iontek,Hakan Karagol,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,5/13/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-05,1.0,2100.0,2000-3000$ 
ES,2020-05-07,A0253817,Clinical,Vall D'Hebron University Hospital,Alejandro Navarro Mendivil,Guardant 360,2.11,GHI_01,Distributors : ROW,Small cell lung carcinoma,5/13/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
GB,2020-05-07,A0253734,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/12/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-05,1.231081,1532.6958450000002,1500-2000$ 
IE,2020-05-08,A0254108,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Colorectal adenocarcinoma,5/11/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,0,0.0,2020-05,1.093466,0.0,0 $
IE,2020-05-08,A0254166,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Colorectal adenocarcinoma,5/11/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,0,0.0,2020-05,1.093466,0.0,0 $
GB,2020-05-08,A0254146,Clinical,Southampton General Hospital,Peter Simmonds,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/12/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2300,2300.0,2020-05,1.231081,2831.4863,2000-3000$ 
GB,2020-05-08,A0254025,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/13/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-05,1.231081,2835.179543,2000-3000$ 
ES,2020-05-09,A0254308,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,5/13/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-05,1.093466,2733.665,2000-3000$ 
GB,2020-05-09,A0254303,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,5/15/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.231081,0.0,0 $
GB,2020-05-09,A0254318,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/14/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-05,1.231081,3065.3916900000004,3000+ $
BR,2020-05-11,A0254458,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Renal Cell Carcinoma,5/16/2020,9/28/2020,BRAZIL,Commercial,Kidney,BRAZIL,1,AE,USD,Americas,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,South America,Paid,2000,2000.0,2020-05,1.0,2000.0,1500-2000$ 
ES,2020-05-11,A0254455,Clinical,Vall D'Hebron University Hospital,Nuria Pardo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/19/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
TR,2020-05-11,A0254451,Clinical,Iontek,Gurbuz Gorumlu,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/18/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-05,1.0,2100.0,2000-3000$ 
DE,2020-05-11,A0254456,Clinical,Praxis Prof. Dr. Renz,Wolfgang Renz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/15/2020,9/28/2020,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,3490,3490.0,2020-05,1.093466,3816.19634,3000+ $
ES,2020-05-12,A0254500,Clinical,Vall D'Hebron University Hospital,Nuria Pardo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/16/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
ES,2020-05-12,A0254527,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,5/18/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-05,1.093466,2733.665,2000-3000$ 
ES,2020-05-12,A0254558,Clinical,Vall D'Hebron University Hospital,Alejandro Navarro Mendivil,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/16/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
GB,2020-05-12,A0254647,Clinical,The Royal Marsden NHS Foundation Trust,Maria Ifijen,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,5/18/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-05,1.231081,3065.3916900000004,3000+ $
ES,2020-05-14,A0255281,Clinical,Vall D'Hebron University Hospital,Susana Cedres,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/20/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
TR,2020-05-14,A0255279,Clinical,Iontek,Gurbuz Gorumlu,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,5/20/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-05,1.0,2100.0,2000-3000$ 
ES,2020-05-14,A0255311,Clinical,Vall D'Hebron University Hospital,Nuria Pardo,Guardant 360,2.11,GHI_01,Distributors : ROW,Large cell lung carcinoma,5/20/2020,9/28/2020,SPAIN,Commercial,Lung,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
GB,2020-05-14,A0255335,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/20/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-05,1.231081,3065.3916900000004,3000+ $
GB,2020-05-15,A0255621,Clinical,BMI The Ridgeway Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/19/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2300,2300.0,2020-05,1.231081,2831.4863,2000-3000$ 
IE,2020-05-15,A0255523,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/20/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-05,1.093466,1361.36517,0-1500$ 
ES,2020-05-15,A0255677,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/21/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2303,2303.0,2020-05,1.093466,2518.252198,2000-3000$ 
ES,2020-05-15,A0255544,Clinical,Vall D'Hebron University Hospital,Nuria Pardo,Guardant 360,2.11,GHI_01,Distributors : ROW,Large cell lung carcinoma,5/20/2020,9/28/2020,SPAIN,Commercial,Lung,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
GB,2020-05-15,A0255723,Clinical,GenesisCare Milton Keynes,Craig Macmillan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/21/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2300,2300.0,2020-05,1.231081,2831.4863,2000-3000$ 
ES,2020-05-16,A0255843,Clinical,Vall D'Hebron University Hospital,Alejandro Navarro Mendivil,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/23/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
GB,2020-05-18,A0256043,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/23/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-05,1.231081,3065.3916900000004,3000+ $
ES,2020-05-19,A0256233,Clinical,Vall D'Hebron University Hospital,Alex Martinez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/24/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
GB,2020-05-19,A0256122,Clinical,HCA Laboratories,Stephen Morris,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,5/23/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-05,1.231081,2835.179543,2000-3000$ 
BR,2020-05-19,A0256204,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/24/2020,9/28/2020,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,South America,Paid,2500,2500.0,2020-05,1.0,2500.0,2000-3000$ 
ES,2020-05-20,A0256428,Clinical,Vall D'Hebron University Hospital,Francisco Javier Ros Montana,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/27/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
ES,2020-05-20,A0256363,Clinical,Hospital Clinico Provincial de Barcelona,Nuria Chic Ruche,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/27/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2200,2200.0,2020-05,1.093466,2405.6252,2000-3000$ 
BR,2020-05-20,A0256379,Clinical,Hospital Sirio Libanes,Max S. Mano,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/26/2020,9/28/2020,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,South America,Paid,2500,2500.0,2020-05,1.0,2500.0,2000-3000$ 
ES,2020-05-21,A0256592,Clinical,Vall D'Hebron University Hospital,Ana Callejo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/27/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
GB,2020-05-21,A0256647,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/27/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-05,1.231081,2835.179543,2000-3000$ 
GB,2020-05-21,A0256725,Clinical,BMI The Ridgeway Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/29/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2300,2300.0,2020-05,1.231081,2831.4863,2000-3000$ 
ES,2020-05-21,A0256711,Clinical,Hospital Quiron Barcelona,Enriqueta Felip,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/27/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2303,2303.0,2020-05,1.093466,2518.252198,2000-3000$ 
ES,2020-05-21,A0256735,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,5/27/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
IE,2020-05-21,A0256697,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/27/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-05,1.093466,1361.36517,0-1500$ 
ES,2020-05-21,A0256596,Clinical,Vall D'Hebron University Hospital,Ana Callejo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/27/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
GB,2020-05-21,A0256663,Clinical,HCA at The Christie Clinic,David Woolf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/29/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.231081,0.0,0 $
ES,2020-05-21,A0256559,Clinical,Vall D'Hebron University Hospital,Ana Callejo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/26/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
ES,2020-05-22,A0256994,Clinical,Hospital Universitario de Guadalajara,Isabel Fernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,5/28/2020,9/28/2020,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-05,1.093466,1361.36517,0-1500$ 
GB,2020-05-22,A0257001,Clinical,GenesisCare Milton Keynes,Craig Macmillan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/27/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2300,2300.0,2020-05,1.231081,2831.4863,2000-3000$ 
CA,2020-05-22,A0256952,Clinical,London Health Sciences Centre,Mark Vincent,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/27/2020,9/28/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Canada,Paid,2500,2500.0,2020-05,1.0,2500.0,2000-3000$ 
ES,2020-05-26,A0257837,Clinical,Vall D'Hebron University Hospital,Alex Martinez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/31/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
ES,2020-05-26,A0257828,Clinical,Vall D'Hebron University Hospital,Patricia Iranzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,5/31/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
ES,2020-05-26,A0257819,Clinical,Vall D'Hebron University Hospital,Francesc Salva Ballabrera,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/1/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
ES,2020-05-26,A0257827,Clinical,Vall D'Hebron University Hospital,Nuria Pardo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,5/31/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
ES,2020-05-26,A0257831,Clinical,Vall D'Hebron University Hospital,Alex Martinez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung carcinoid,5/31/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
ES,2020-05-26,A0257817,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,5/31/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-05,1.093466,2733.665,2000-3000$ 
ES,2020-05-26,A0257834,Clinical,Vall D'Hebron University Hospital,Nuria Pardo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,6/9/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,0,0.0,2020-05,1.093466,0.0,0 $
ES,2020-05-26,A0257821,Clinical,Vall D'Hebron University Hospital,Patricia Iranzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/31/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-05,1.093466,0.0,0 $
ES,2020-05-26,A0257832,Clinical,Clinica Universidad de Navarra,Lucia Ceniceros Paredes,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/31/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-05,1.093466,2733.665,2000-3000$ 
ES,2020-05-26,A0257823,Clinical,Hospital A Coruna,Maria Rosario Garcia Campelo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/31/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-05,1.093466,1361.36517,0-1500$ 
TR,2020-05-27,A0258139,Clinical,Iontek,Goker Erdem,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/31/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-05,1.0,2100.0,2000-3000$ 
GB,2020-05-27,A0258112,Clinical,Genesis Care Nottingham,Sarah Khan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/1/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-05,1.231081,3065.3916900000004,3000+ $
ES,2020-05-27,A0258147,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastroesophageal junction carcinoma,6/6/2020,9/28/2020,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-05,1.093466,2733.665,2000-3000$ 
GB,2020-05-28,A0258413,Clinical,The Nuffield Hospital Guildford,Robert Laing,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/4/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-05,1.231081,3065.3916900000004,3000+ $
GB,2020-05-28,A0258421,Clinical,HCA Laboratories,Siow-Ming Lee,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/3/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-05,1.231081,2835.179543,2000-3000$ 
IE,2020-05-29,A0258577,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,6/4/2020,9/28/2020,IRELAND,Commercial,Other,IRELAND,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-05,1.093466,1361.36517,0-1500$ 
IE,2020-05-29,A0258608,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/3/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-05,1.093466,1361.36517,0-1500$ 
ES,2020-05-29,A0258620,Clinical,Fundacion Jimenez Diaz,Cristina Carames Sanchez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,6/8/2020,9/28/2020,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,"EUR 1,245.00",1245.0,2020-05,1.093466,1361.36517,0-1500$ 
GB,2020-05-29,A0258794,Clinical,HCA Laboratories,Kai-Keen Shiu,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/4/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-05,1.231081,2835.179543,2000-3000$ 
ES,2020-05-29,A0258626,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,6/3/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-05,1.093466,2733.665,2000-3000$ 
ES,2020-05-29,A0258749,Clinical,Centro Diagnostico de las Afecciones Mamarias,Miguel Prats de Puig,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),6/4/2020,9/28/2020,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-05,1.093466,2722.73034,2000-3000$ 
GB,2020-05-29,A0258691,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,6/4/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,"GBP 2,300.00",2300.0,2020-05,1.231081,2831.4863,2000-3000$ 
ES,2020-05-29,A0258632,Clinical,Clinica Universidad de Navarra,Jaime Espinos Jimenez,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,6/3/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-05,1.093466,2733.665,2000-3000$ 
GB,2020-05-29,A0258773,Clinical,University Hospital Southampton,Sanjay Raj,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/4/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2300,2300.0,2020-05,1.231081,2831.4863,2000-3000$ 
GB,2020-05-30,A0259123,Clinical,HCA Laboratories,Maurice Slevin,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/6/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2020,2,1,2020-05-01,2020-05,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-05,1.231081,2835.179543,2000-3000$ 
TR,2020-06-01,A0259247,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/8/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-06,1.0,2100.0,2000-3000$ 
ES,2020-06-01,A0259254,Clinical,Hospital Clinico Provincial de Barcelona,Nuria Chic Ruche,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/7/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2200,2200.0,2020-06,1.125411,2475.9042,2000-3000$ 
ES,2020-06-01,A0259292,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/8/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-06,1.125411,2813.5274999999997,2000-3000$ 
ES,2020-06-01,A0259250,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/7/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2200,2200.0,2020-06,1.125411,2475.9042,2000-3000$ 
GB,2020-06-03,A0260427,Clinical,BMI The Ridgeway Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/9/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.251097,0.0,0 $
GB,2020-06-04,A0260690,Clinical,BMI The Chaucer Hospital,Carys Thomas,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/9/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2300,2300.0,2020-06,1.251097,2877.5231,2000-3000$ 
ES,2020-06-04,A0260582,Clinical,Vall D'Hebron University Hospital,Patricia Iranzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/16/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
BR,2020-06-04,A0260624,Clinical,VeritasBio S.A.,Luis Carvalho,Guardant 360,2.11,GHI_01,Do Not Bill - ROW,Breast Carcinoma,6/12/2020,9/28/2020,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,South America,Paid,0,0.0,2020-06,1.0,0.0,0 $
GB,2020-06-04,A0260730,Clinical,Queen Alexandra Hospital,Caroline Archer,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/9/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2300,2300.0,2020-06,1.251097,2877.5231,2000-3000$ 
GB,2020-06-04,A0260742,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/11/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-06,1.251097,2881.276391,2000-3000$ 
GB,2020-06-05,A0260961,Clinical,HCA Laboratories,Stephen Mackinnon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/18/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-06,1.251097,2881.276391,2000-3000$ 
GB,2020-06-05,A0261037,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/13/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
GB,2020-06-05,A0260935,Clinical,HCA Laboratories,Stephen Morris,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,6/10/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-06,1.251097,2881.276391,2000-3000$ 
TR,2020-06-05,A0260927,Clinical,Iontek,Dilek Erdem,Guardant 360,2.11,GHI_01,Distributors : ROW,Cervical Squamous Cell Carcinoma,6/10/2020,9/28/2020,TURKEY,Commercial,Cervical,TURKEY,1,AE,USD,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-06,1.0,2100.0,2000-3000$ 
GB,2020-06-06,A0261467,Clinical,The Royal Marsden Hospital,Ian Smith,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/12/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-06,1.251097,3115.2315299999996,3000+ $
ES,2020-06-08,A0261520,Clinical,Hospital Clinico Provincial de Barcelona,Olga Martinez Saez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/12/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2200,2200.0,2020-06,1.125411,2475.9042,2000-3000$ 
ES,2020-06-08,A0261540,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/12/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-06,1.125411,2813.5274999999997,2000-3000$ 
TR,2020-06-08,A0261526,Clinical,Iontek,Cengiz Yakicier,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/12/2020,9/28/2020,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-06,1.0,2100.0,2000-3000$ 
TR,2020-06-08,A0261530,Clinical,Iontek,Cengiz Yakicier,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,6/12/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-06,1.0,2100.0,2000-3000$ 
ES,2020-06-08,A0261545,Clinical,Hospital Clinico Provincial de Barcelona,Aleix Prat,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/16/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1745,1745.0,2020-06,1.125411,1963.842195,1500-2000$ 
ES,2020-06-08,A0261549,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/12/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-06,1.125411,2813.5274999999997,2000-3000$ 
GB,2020-06-08,A0261550,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/12/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
ES,2020-06-08,A0261535,Clinical,Vall D'Hebron University Hospital,Nuria Pardo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung carcinoid,6/12/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
GB,2020-06-08,A0261538,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/12/2020,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
IE,2020-06-08,A0261544,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,6/12/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,"EUR 1,245.00",1245.0,2020-06,1.125411,1401.136695,0-1500$ 
ES,2020-06-08,A0261528,Clinical,Vall D'Hebron University Hospital,Patricia Iranzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/15/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
GB,2020-06-08,A0261548,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/12/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
BR,2020-06-11,A0262595,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/17/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,South America,Paid,2000,2000.0,2020-06,1.0,2000.0,1500-2000$ 
GB,2020-06-12,A0262781,Clinical,HCA Laboratories,Paul Ross,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/22/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-06,1.251097,2881.276391,2000-3000$ 
GB,2020-06-12,A0262810,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/18/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.251097,0.0,0 $
GR,2020-06-12,A0262842,Clinical,EuroMedica General Clinic,Athanasios Pouptsis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/17/2020,9/28/2020,GREECE,Commercial,,GREECE,1,non_AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2228.63,2228.0,2020-06,1.125411,2507.415708,2000-3000$ 
GB,2020-06-12,A0262805,Clinical,Coventry University Hospitals,Nawaz Walji,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/18/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-06,1.251097,3115.2315299999996,3000+ $
GB,2020-06-13,A0263211,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/19/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
TR,2020-06-13,A0263281,Clinical,Iontek,Gurbuz Gorumlu,Guardant 360,2.11,GHI_01,Distributors : ROW,Small cell lung carcinoma,6/22/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-06,1.0,2100.0,2000-3000$ 
GB,2020-06-13,A0263184,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/18/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-06,1.251097,2881.276391,2000-3000$ 
ES,2020-06-15,A0263396,Clinical,Vall D'Hebron University Hospital,Iosune Baraibar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/19/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
ES,2020-06-15,A0263393,Clinical,Vall D'Hebron University Hospital,Nuria Pardo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/20/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
ES,2020-06-15,A0263398,Clinical,Vall D'Hebron University Hospital,Patricia Iranzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,6/21/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
ES,2020-06-16,A0263544,Clinical,Vall D'Hebron University Hospital,Patricia Iranzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/21/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
GB,2020-06-18,A0264403,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,6/23/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
ES,2020-06-18,A0264293,Clinical,Vall D'Hebron University Hospital,Alberto Hernando,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/23/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
GB,2020-06-18,A0264323,Clinical,BMI The Ridgeway Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/23/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.251097,0.0,0 $
ES,2020-06-18,A0264335,Clinical,Clinica Corachan,Joaquin Bellmunt Molins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Bladder carcinoma,6/24/2020,9/28/2020,SPAIN,Commercial,Bladder,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1745,1745.0,2020-06,1.125411,1963.842195,1500-2000$ 
IE,2020-06-18,A0264536,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/23/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,"EUR 1,245.00",1245.0,2020-06,1.125411,1401.136695,0-1500$ 
IE,2020-06-18,A0264484,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cervical Squamous Cell Carcinoma,6/24/2020,9/28/2020,IRELAND,Commercial,Cervical,IRELAND,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,"EUR 1,245.00",1245.0,2020-06,1.125411,1401.136695,0-1500$ 
ES,2020-06-19,A0264601,Clinical,Vall D'Hebron University Hospital,Maria Vieito,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/25/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
TR,2020-06-19,A0264709,Clinical,Iontek,Dilek Erdem,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic neuroendocrine tumor,6/24/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-06,1.0,2100.0,2000-3000$ 
ES,2020-06-19,A0264657,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/23/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2303,2303.0,2020-06,1.125411,2591.821533,2000-3000$ 
TR,2020-06-19,A0264704,Clinical,Iontek,Dilek Erdem,Guardant 360,2.11,GHI_01,Distributors : ROW,Small cell lung carcinoma,6/26/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-06,1.0,2100.0,2000-3000$ 
IE,2020-06-22,A0265279,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/29/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,"EUR 1,245.00",1245.0,2020-06,1.125411,1401.136695,0-1500$ 
TR,2020-06-22,A0265326,Clinical,Iontek,Kerim Kaban,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/29/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-06,1.0,2100.0,2000-3000$ 
GB,2020-06-23,A0265541,Clinical,University Hospitals Of Leicester,Mohamed Mahgoub,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/30/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
GB,2020-06-23,A0265537,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/30/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
GB,2020-06-23,A0265522,Clinical,University Hospitals Of Leicester,Mohamed Mahgoub,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/28/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
TR,2020-06-24,A0265826,Clinical,Iontek,Pinar Dal Konak,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/30/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2100,2100.0,2020-06,1.0,2100.0,2000-3000$ 
GB,2020-06-24,A0265720,Clinical,The Royal Marsden Hospital,James Dobbyn,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/29/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
ES,2020-06-24,A0265804,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,6/30/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-06,1.125411,2813.5274999999997,2000-3000$ 
GB,2020-06-24,A0265739,Clinical,HCA Laboratories,Mark Harries,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/29/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-06,1.251097,2881.276391,2000-3000$ 
FR,2020-06-24,A0265851,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,6/29/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
ES,2020-06-25,A0266127,Clinical,Vall D'Hebron University Hospital,Alex Martinez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/3/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
IE,2020-06-25,A0266098,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/30/2020,9/28/2020,IRELAND,Commercial,Breast,IRELAND,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,"EUR 1,245.00",1245.0,2020-06,1.125411,1401.136695,0-1500$ 
BR,2020-06-25,A0266065,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,6/30/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,South America,Paid,2000,2000.0,2020-06,1.0,2000.0,1500-2000$ 
ES,2020-06-25,A0266184,Clinical,Hospital Universitario de Guadalajara,Luis Enrique Chara Velarde,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/1/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.125411,1401.136695,0-1500$ 
GB,2020-06-25,A0266187,Clinical,The Royal Marsden Hospital,James Dobbyn,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/30/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
ES,2020-06-25,A0266055,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/2/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2200,2200.0,2020-06,1.125411,2475.9042,2000-3000$ 
SI,2020-06-25,A0266102,Clinical,ZTM Ljubljana,Primoz Rozman,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/1/2020,9/28/2020,SLOVENIA,Commercial,Breast,SLOVENIA,1,non_AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2450,2450.0,2020-06,1.125411,2757.25695,2000-3000$ 
IE,2020-06-25,A0266103,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,7/1/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,"EUR 1,245.00",1245.0,2020-06,1.125411,1401.136695,0-1500$ 
GB,2020-06-26,A0266435,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/2/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2303.25,2303.0,2020-06,1.251097,2881.276391,2000-3000$ 
FR,2020-06-26,A0266450,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,7/2/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
FR,2020-06-26,A0266454,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,7/2/2020,9/28/2020,FRANCE,Commercial,GI,FRANCE,1,non_AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
FR,2020-06-26,A0266459,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,7/2/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
GB,2020-06-27,A0266894,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,7/4/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,1245,1245.0,2020-06,1.251097,1557.6157649999998,1500-2000$ 
ES,2020-06-27,A0267028,Clinical,Vall D'Hebron University Hospital,Patricia Iranzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/4/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Free,0,0.0,2020-06,1.125411,0.0,0 $
ES,2020-06-29,A0267048,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Small cell lung carcinoma,7/5/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2500,2500.0,2020-06,1.125411,2813.5274999999997,2000-3000$ 
GB,2020-06-29,A0267041,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/6/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-06,1.251097,3115.2315299999996,3000+ $
GB,2020-06-30,A0267126,Clinical,The Royal Marsden NHS Foundation Trust,Kazimierz Mochlinski,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,7/7/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-06,1.251097,3115.2315299999996,3000+ $
GB,2020-06-30,A0267263,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/5/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,2490,2490.0,2020-06,1.251097,3115.2315299999996,3000+ $
IE,2020-06-30,A0267261,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/5/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2020,2,1,2020-06-01,2020-06,G360 CDx,2020Q2,Europe,Paid,"EUR 1,245.00",1245.0,2020-06,1.125411,1401.136695,0-1500$ 
ES,2020-07-01,A0267582,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Thymic carcinoma,7/8/2020,9/28/2020,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-07,1.144634,2861.585,2000-3000$ 
GB,2020-07-01,A0267578,Clinical,Grizedale Oncology Unit,David Eaton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/6/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.265492,1575.53754,1500-2000$ 
GB,2020-07-01,A0267624,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/9/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.265492,1575.53754,1500-2000$ 
GB,2020-07-02,A0267879,Clinical,BMI The Ridgeway Hospital,Nicky Levitt,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/10/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1744,1744.0,2020-07,1.265492,2207.018048,2000-3000$ 
IE,2020-07-02,A0267814,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/9/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.144634,1425.0693299999998,0-1500$ 
IE,2020-07-02,A0268053,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,7/9/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.144634,1425.0693299999998,0-1500$ 
ES,2020-07-02,A0267753,Clinical,Hospital Clinico Provincial de Barcelona,Aleix Prat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/9/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2200,2200.0,2020-07,1.144634,2518.1947999999998,2000-3000$ 
GB,2020-07-02,A0267891,Clinical,HCA Laboratories,Peter Harper,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,7/9/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-07,1.265492,2914.428076,2000-3000$ 
ES,2020-07-02,A0267743,Clinical,Hospital Quiron Barcelona,Jesus Soberino Garcia,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/9/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2303,2303.0,2020-07,1.144634,2636.0921019999996,2000-3000$ 
GB,2020-07-02,A0267957,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/9/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-07,1.265492,2914.428076,2000-3000$ 
ES,2020-07-02,A0267761,Clinical,Clinica Universidad de Navarra-Madrid,Jesus Corral,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/9/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-07,1.144634,2861.585,2000-3000$ 
GB,2020-07-02,A0267871,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,7/10/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-07,1.265492,2914.428076,2000-3000$ 
TR,2020-07-03,A0268242,Clinical,Iontek,Gurbuz Gorumlu,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,7/10/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-07,1.0,2100.0,2000-3000$ 
FR,2020-07-03,A0268355,Clinical,Gustave Roussy Cancer Campus,Christophe Massard,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Renal pelvis urothelial carcinoma,7/10/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
FR,2020-07-03,A0268399,Clinical,Gustave Roussy Cancer Campus,Capucine Baldini,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Renal Cell Carcinoma,7/10/2020,9/28/2020,FRANCE,Commercial,Kidney,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
GB,2020-07-03,A0268315,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/10/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.265492,1575.53754,1500-2000$ 
GB,2020-07-03,A0268390,Clinical,HCA Laboratories,Paul Ross,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,7/10/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-07,1.265492,2914.428076,2000-3000$ 
FR,2020-07-03,A0268294,Clinical,Gustave Roussy Cancer Campus,Anas Gazzah,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Thyroid carcinoma,7/10/2020,9/28/2020,FRANCE,Commercial,Thyroid,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
FR,2020-07-03,A0268359,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,7/9/2020,9/28/2020,FRANCE,Commercial,GI,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
FR,2020-07-03,A0268202,Clinical,Gustave Roussy Cancer Campus,Andrea Varga,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,7/9/2020,9/28/2020,FRANCE,Commercial,Breast,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
FR,2020-07-03,A0268356,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,7/10/2020,9/28/2020,FRANCE,Commercial,GI,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
GB,2020-07-03,A0268407,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/11/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-07,1.265492,3151.07508,3000+ $
MX,2020-07-03,A0268273,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/9/2020,9/28/2020,MEXICO,Commercial,Breast,MEXICO,1,non_AE,EUR,Americas,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,South America,Paid,4000,4000.0,2020-07,1.144634,4578.536,3000+ $
ES,2020-07-03,A0268295,Clinical,Vall D'Hebron University Hospital,Juan David Assaf Pastrana,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,7/10/2020,9/28/2020,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
FR,2020-07-06,A0268550,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,7/10/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
GB,2020-07-06,A0268557,Clinical,BMI The Chaucer Hospital,Carys Thomas,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/11/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2300,2300.0,2020-07,1.265492,2910.6316,2000-3000$ 
ES,2020-07-06,A0268545,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,7/11/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-07,1.144634,2861.585,2000-3000$ 
GB,2020-07-07,A0268774,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/13/2020,1/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2300,2300.0,2020-07,1.265492,2910.6316,2000-3000$ 
IE,2020-07-07,A0268738,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/12/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.144634,1425.0693299999998,0-1500$ 
GB,2020-07-07,A0268711,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,7/14/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.265492,1575.53754,1500-2000$ 
FR,2020-07-08,A0269054,Clinical,Gustave Roussy Cancer Campus,Andrea Varga,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Non-small cell lung carcinoma (NSCLC),7/13/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
MX,2020-07-08,A0268995,Clinical,ABC Hospital,Christian Patricio Camacho Limas,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/14/2020,9/28/2020,MEXICO,Commercial,Breast,MEXICO,1,non_AE,EUR,Americas,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,South America,Paid,4000,4000.0,2020-07,1.144634,4578.536,3000+ $
FR,2020-07-08,A0269058,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,7/14/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
GB,2020-07-09,A0269483,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,7/16/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.265492,1575.53754,1500-2000$ 
GB,2020-07-09,A0269329,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/14/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-07,1.265492,3151.07508,3000+ $
TR,2020-07-09,A0269537,Clinical,Iontek,Umut Disel,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,7/16/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-07,1.0,2100.0,2000-3000$ 
GB,2020-07-10,A0269703,Clinical,HCA Laboratories,Peter Harper,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,7/18/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-07,1.265492,2914.428076,2000-3000$ 
BR,2020-07-10,A0269844,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/16/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,South America,Paid,2000,2000.0,2020-07,1.0,2000.0,1500-2000$ 
GB,2020-07-10,A0269978,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/15/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.265492,1575.53754,1500-2000$ 
IE,2020-07-10,A0269967,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/15/2020,9/28/2020,IRELAND,Commercial,Breast,IRELAND,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.144634,1425.0693299999998,0-1500$ 
GB,2020-07-10,A0269925,Clinical,Royal Free London NHS Foundation Trust,Roopinder Gillmore,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic neuroendocrine tumor,7/20/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.265492,0.0,0 $
GB,2020-07-11,A0270070,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/18/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.265492,1575.53754,1500-2000$ 
TR,2020-07-13,A0270309,Clinical,Iontek,Metin Kanitez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/21/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-07,1.0,2100.0,2000-3000$ 
FR,2020-07-13,A0270303,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,7/21/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
TR,2020-07-13,A0270313,Clinical,Iontek,Dilek Erdem,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic neuroendocrine tumor,7/28/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.0,0.0,0 $
FR,2020-07-13,A0270307,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Thyroid carcinoma,7/19/2020,9/28/2020,FRANCE,Commercial,Thyroid,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
ES,2020-07-13,A0270286,Clinical,Hospital Quiron Barcelona,Carolina Ortio Velez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/21/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2303,2303.0,2020-07,1.144634,2636.0921019999996,2000-3000$ 
GB,2020-07-13,A0270300,Clinical,BMI Harbour Hospital,Mike Bayne,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,7/20/2020,1/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2300,2300.0,2020-07,1.265492,2910.6316,2000-3000$ 
GB,2020-07-14,A0270512,Clinical,HCA Laboratories,Debashis Sarker,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,7/21/2020,9/28/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-07,1.265492,2914.428076,2000-3000$ 
GB,2020-07-15,A0270756,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,7/22/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.265492,1575.53754,1500-2000$ 
FR,2020-07-15,A0270653,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,7/20/2020,9/28/2020,FRANCE,Commercial,GI,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
GB,2020-07-15,A0270833,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,7/21/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.265492,1575.53754,1500-2000$ 
ES,2020-07-16,A0271059,Clinical,Clinica Universidad de Navarra-Madrid,Jaime Espinos,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,7/21/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-07,1.144634,2861.585,2000-3000$ 
TR,2020-07-16,A0271054,Clinical,Iontek,Alper Sevinc,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic neuroendocrine tumor,7/22/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-07,1.0,2100.0,2000-3000$ 
BR,2020-07-16,A0271136,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,7/23/2020,9/28/2020,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,South America,Paid,1550,1550.0,2020-07,1.0,1550.0,1500-2000$ 
BR,2020-07-16,A0271130,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gallbladder carcinoma,7/22/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,South America,Paid,1700,1700.0,2020-07,1.0,1700.0,1500-2000$ 
BR,2020-07-17,A0271789,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,7/26/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,South America,Free,0,0.0,2020-07,1.0,0.0,0 $
GB,2020-07-17,A0271573,Clinical,Southampton General Hospital,Peter Simmonds,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/24/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2300,2300.0,2020-07,1.265492,2910.6316,2000-3000$ 
IE,2020-07-17,A0271658,Clinical,Bon Secours Hospital,Conleth Murphy,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/24/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1247,1247.0,2020-07,1.144634,1427.3585979999998,0-1500$ 
GB,2020-07-17,A0271531,Clinical,HCA Laboratories,Kai-Keen Shiu,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,7/24/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-07,1.265492,2914.428076,2000-3000$ 
ES,2020-07-17,A0271539,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,7/23/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2303,2303.0,2020-07,1.144634,2636.0921019999996,2000-3000$ 
BR,2020-07-20,A0272146,Clinical,Synlab - Brasil,Andrey Soares,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,7/28/2020,9/28/2020,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,South America,Paid,2800,2800.0,2020-07,1.0,2800.0,2000-3000$ 
IE,2020-07-20,A0272155,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Appendix adenocarcinoma,7/28/2020,9/28/2020,IRELAND,Commercial,GI,IRELAND,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.144634,1425.0693299999998,0-1500$ 
IE,2020-07-20,A0272158,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,7/29/2020,9/28/2020,IRELAND,Commercial,Other,IRELAND,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1246,1246.0,2020-07,1.144634,1426.2139639999998,0-1500$ 
FR,2020-07-20,A0272147,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Other,7/27/2020,9/28/2020,FRANCE,Commercial,Other,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
ES,2020-07-20,A0272156,Clinical,Hospital Duran i Reynals-ICO Hospitalet,Ernest Nadal,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/28/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-07,1.144634,2850.1386599999996,2000-3000$ 
IE,2020-07-22,A0272886,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,7/30/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.144634,1425.0693299999998,0-1500$ 
GB,2020-07-22,A0272830,Clinical,Charing Cross Hospital Medical Oncology Department,Joanne Evans,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/30/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.265492,0.0,0 $
ES,2020-07-22,A0272617,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/29/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-07,1.144634,2861.585,2000-3000$ 
FR,2020-07-22,A0272833,Clinical,Institut de Cancerologie des Hospices Civils de Lyon,Michael Duruisseaux,Guardant 360,2.11,GHI_01,Self-Pay Patient,Small cell lung carcinoma,7/31/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
FR,2020-07-22,A0272605,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),7/30/2020,9/28/2020,FRANCE,Commercial,CUP,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
GB,2020-07-23,A0273261,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/1/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1744,1744.0,2020-07,1.265492,2207.018048,2000-3000$ 
ES,2020-07-24,A0273745,Clinical,INITIA Oncologia,Angel Luis Guerrero Zotano,Guardant 360,2.11,GHI_01,Distributors : ROW,Endometrial carcinoma,8/3/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
ES,2020-07-24,A0273715,Clinical,INITIA Oncologia,Angel Luis Guerrero Zotano,Guardant 360,2.11,GHI_01,Distributors : ROW,Hepatocellular carcinoma,8/1/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
ES,2020-07-25,A0274099,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung carcinoid,8/3/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-07,1.144634,2861.585,2000-3000$ 
GB,2020-07-27,A0274126,Clinical,Bupa Cromwell Hospital,Robert Leonard,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/4/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-07,1.265492,3151.07508,3000+ $
BR,2020-07-27,A0274180,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,8/4/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,South America,Paid,2000,2000.0,2020-07,1.0,2000.0,1500-2000$ 
BR,2020-07-27,A0274130,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,8/4/2020,9/28/2020,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,South America,Paid,1550,1550.0,2020-07,1.0,1550.0,1500-2000$ 
GB,2020-07-27,A0274122,Clinical,Velindre Cancer Centre,Richard Adams,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/7/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,0,0.0,2020-07,1.265492,0.0,0 $
BR,2020-07-27,A0274129,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/2/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,South America,Paid,1700,1700.0,2020-07,1.0,1700.0,1500-2000$ 
GB,2020-07-27,A0274132,Clinical,Bupa Cromwell Hospital,Robert Leonard,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/4/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2300,2300.0,2020-07,1.265492,2910.6316,2000-3000$ 
TR,2020-07-28,A0274329,Clinical,Iontek,Gurbuz Gorumlu,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/4/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-07,1.0,2100.0,2000-3000$ 
GB,2020-07-29,A0274473,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,8/4/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-07,1.265492,2914.428076,2000-3000$ 
IE,2020-07-30,A0275076,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,8/5/2020,9/28/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.144634,1425.0693299999998,0-1500$ 
FR,2020-07-30,A0274884,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,8/6/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
GB,2020-07-30,A0275121,Clinical,Spire Harpenden Hospital,Nihal Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/5/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,2300,2300.0,2020-07,1.265492,2910.6316,2000-3000$ 
GB,2020-07-31,A0275573,Clinical,North Middlesex University Hospital,Sasa Badzek,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/8/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-07,1.265492,1575.53754,1500-2000$ 
FR,2020-07-31,A0275412,Clinical,Gustave Roussy Cancer Campus,Patricia Martin-Romano,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,8/7/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.144634,0.0,0 $
GB,2020-07-31,A0275304,Clinical,Charing Cross Hospital Medical Oncology Department,Jonathan Krell,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,8/7/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2020,3,1,2020-07-01,2020-07,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-07,1.265492,0.0,0 $
TR,2020-08-01,A0275816,Clinical,Iontek,Esat Namal,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,8/8/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-08,1.0,2100.0,2000-3000$ 
GB,2020-08-03,A0275929,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/8/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-08,1.313673,3271.04577,3000+ $
GB,2020-08-03,A0275918,Clinical,St Bartholomews Hospital,Melissa Phillips,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/10/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-08,1.313673,1635.522885,1500-2000$ 
GB,2020-08-03,A0275927,Clinical,Bupa Cromwell Hospital,Robert Leonard,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/13/2020,10/1/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-08,1.313673,3271.04577,3000+ $
GB,2020-08-04,A0276237,Clinical,University Hospitals Of Leicester,Mohamed Mahgoub,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/15/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.313673,0.0,0 $
GB,2020-08-04,A0276235,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/10/2020,10/26/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-08,1.313673,1635.522885,1500-2000$ 
GB,2020-08-05,A0276584,Clinical,Southampton General Hospital,Jennifer Marshall,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/10/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.313673,0.0,0 $
CA,2020-08-05,A0276547,Clinical,Michael Garron Hospital,James Bin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/9/2020,10/19/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Canada,Paid,3150,3150.0,2020-08,1.0,3150.0,3000+ $
TR,2020-08-06,A0276998,Clinical,Iontek,Gurbuz Gorumlu,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/13/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-08,1.0,2100.0,2000-3000$ 
CL,2020-08-06,A0276878,Clinical,Clinica Santa Maria,Cristian Carvallo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/12/2020,9/28/2020,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,South America,Paid,"$1.550,00",1.0,2020-08,1.0,1.0,0-1500$ 
GB,2020-08-06,A0276993,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,8/13/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-08,1.313673,1635.522885,1500-2000$ 
GB,2020-08-06,A0276808,Clinical,Cheltenham General Hospital,David Farrugia,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/12/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-08,1.313673,3271.04577,3000+ $
BR,2020-08-06,A0276831,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/15/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,South America,Paid,1550,1550.0,2020-08,1.0,1550.0,1500-2000$ 
GB,2020-08-06,A0276815,Clinical,Cheltenham General Hospital,David Farrugia,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/12/2020,10/1/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-08,1.313673,3271.04577,3000+ $
GB,2020-08-06,A0276969,Clinical,HCA Laboratories,Paul Ross,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,8/13/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-08,1.313673,3025.388919,3000+ $
GB,2020-08-06,A0277065,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,8/13/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-08,1.313673,3025.388919,3000+ $
ES,2020-08-07,A0277393,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,8/15/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2303,2303.0,2020-08,1.183038,2724.536514,2000-3000$ 
GB,2020-08-07,A0277368,Clinical,Queen Alexandra Hospital,Caroline Archer,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/15/2020,10/6/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-08,1.313673,3271.04577,3000+ $
GB,2020-08-07,A0277210,Clinical,The Royal Marsden Hospital,Merina Ahmed,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,8/13/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-08,1.313673,1635.522885,1500-2000$ 
CA,2020-08-08,A0277705,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/14/2020,9/28/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Canada,Paid,1750,1750.0,2020-08,1.0,1750.0,1500-2000$ 
GB,2020-08-08,A0277593,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,8/15/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-08,1.313673,3025.388919,3000+ $
FR,2020-08-10,A0277776,Clinical,Gustave Roussy Cancer Campus,Patricia Martin-Romano,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Other,8/17/2020,9/28/2020,FRANCE,Commercial,Other,FRANCE,1,non_AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.183038,0.0,0 $
BR,2020-08-11,A0277915,Clinical,Hospital Sirio Libanes,Marcelo Rocha de Souza Cruz,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/18/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,South America,Paid,2500,2500.0,2020-08,1.0,2500.0,2000-3000$ 
CA,2020-08-11,A0278053,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/17/2020,9/28/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Canada,Paid,1750,1750.0,2020-08,1.0,1750.0,1500-2000$ 
BR,2020-08-12,A0278278,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,8/19/2020,9/28/2020,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,South America,Paid,2000,2000.0,2020-08,1.0,2000.0,1500-2000$ 
BR,2020-08-13,A0278804,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,8/20/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,South America,Paid,2000,2000.0,2020-08,1.0,2000.0,1500-2000$ 
ES,2020-08-13,A0278917,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,GIST (Gastrointestinal stromal tumor),8/20/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-08,1.183038,2957.5950000000003,2000-3000$ 
ES,2020-08-13,A0278919,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,8/20/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-08,1.183038,2957.5950000000003,2000-3000$ 
FR,2020-08-13,A0278814,Clinical,Institut de Cancerologie des Hospices Civils de Lyon,Michael Duruisseaux,Guardant 360,2.11,GHI_01,Self-Pay Patient,Small cell lung carcinoma,8/21/2020,5/5/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.183038,0.0,0 $
GB,2020-08-13,A0278772,Clinical,Charing Cross Hospital Medical Oncology Department,Jonathan Krell,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,8/18/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.313673,0.0,0 $
GB,2020-08-14,A0279160,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,8/22/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-08,1.313673,3271.04577,3000+ $
GB,2020-08-14,A0279258,Clinical,Charing Cross Hospital Medical Oncology Department,Jonathan Krell,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,8/20/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-08,1.313673,1635.522885,1500-2000$ 
IE,2020-08-14,A0279269,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),8/24/2020,9/28/2020,IRELAND,Commercial,CUP,IRELAND,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-08,1.183038,1472.88231,0-1500$ 
SI,2020-08-14,A0279270,Clinical,Luka Hauptman MD,Luka Hauptman,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/20/2020,9/28/2020,SLOVENIA,Commercial,,SLOVENIA,1,non_AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-08,1.183038,2945.76462,2000-3000$ 
ES,2020-08-14,A0279272,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,8/22/2020,9/28/2020,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-08,1.183038,2957.5950000000003,2000-3000$ 
ES,2020-08-15,A0279577,Clinical,Clinica Universidad de Navarra-Madrid,Antonio Gonzalez Martin,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,8/24/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-08,1.183038,2957.5950000000003,2000-3000$ 
CA,2020-08-15,A0279550,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/21/2020,9/28/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Canada,Paid,1750,1750.0,2020-08,1.0,1750.0,1500-2000$ 
ES,2020-08-17,A0279631,Clinical,Fundacion Jimenez Diaz,Cristina Carames Sanchez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,8/24/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-08,1.183038,1472.88231,0-1500$ 
TR,2020-08-17,A0279643,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Osteosarcoma,8/24/2020,9/28/2020,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-08,1.0,2100.0,2000-3000$ 
GB,2020-08-18,A0279935,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/25/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.313673,0.0,0 $
BR,2020-08-19,A0280447,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/25/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,South America,Free,0,0.0,2020-08,1.0,0.0,0 $
TR,2020-08-19,A0280353,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Sarcoma,8/25/2020,9/28/2020,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-08,1.0,2100.0,2000-3000$ 
CA,2020-08-19,A0280317,Clinical,Dr. Paul Klimo,Paul Klimo,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,8/20/2020,9/28/2020,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Canada,Paid,0,0.0,2020-08,1.0,0.0,0 $
CA,2020-08-19,A0280377,Clinical,Dr. Paul Klimo,Paul Klimo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/25/2020,9/28/2020,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Canada,Paid,3150,3150.0,2020-08,1.0,3150.0,3000+ $
ES,2020-08-20,A0280582,Clinical,Clinica Universidad de Navarra,Lucia Ceniceros Paredes,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,8/27/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-08,1.183038,2957.5950000000003,2000-3000$ 
CL,2020-08-20,A0280816,Clinical,Clinica Santa Maria,Cristian Carvallo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/28/2020,9/28/2020,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,South America,Paid,"$1.550,00",1.0,2020-08,1.0,1.0,0-1500$ 
BR,2020-08-21,A0281177,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/29/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,South America,Paid,2000,2000.0,2020-08,1.0,2000.0,1500-2000$ 
FR,2020-08-21,A0281167,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,8/29/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.183038,0.0,0 $
TR,2020-08-24,A0281540,Clinical,Iontek,Gurbuz Gorumlu,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/5/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-08,1.0,2100.0,2000-3000$ 
TR,2020-08-24,A0281543,Clinical,Iontek,Bulent Karabulut,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/5/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-08,1.0,2100.0,2000-3000$ 
MX,2020-08-25,A0281767,Clinical,ABC Hospital,Christian Patricio Camacho Limas,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,9/2/2020,9/28/2020,MEXICO,Commercial,Other,MEXICO,1,non_AE,EUR,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,South America,Paid,74240,74240.0,2020-08,1.183038,87828.74112,3000+ $
GB,2020-08-25,A0281745,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/1/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-08,1.313673,3271.04577,3000+ $
CA,2020-08-25,A0281809,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/1/2020,9/28/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Canada,Paid,1750,1750.0,2020-08,1.0,1750.0,1500-2000$ 
GB,2020-08-26,A0282012,Clinical,Charing Cross Hospital Medical Oncology Department,Jonathan Krell,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,8/31/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-08,1.313673,1635.522885,1500-2000$ 
TR,2020-08-26,A0281988,Clinical,Iontek,Bulent Karabulut,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/2/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-08,1.0,2100.0,2000-3000$ 
TR,2020-08-26,A0281983,Clinical,Iontek,Bulent Karabulut,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/2/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-08,1.0,2100.0,2000-3000$ 
GB,2020-08-26,A0282134,Clinical,Charing Cross Hospital Medical Oncology Department,Danielle Power,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/1/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.313673,0.0,0 $
GB,2020-08-26,A0282013,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/2/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-08,1.313673,1635.522885,1500-2000$ 
ES,2020-08-27,A0282355,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Esophageal/Gastroesophageal junction Adenocarcinoma,9/2/2020,9/28/2020,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-08,1.183038,2957.5950000000003,2000-3000$ 
ES,2020-08-27,A0282298,Clinical,Hospital Quironsalud Sagrado Corazon,Juan Carlos Quero Guillen,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/4/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.183038,0.0,0 $
BR,2020-08-27,A0282309,Clinical,Hospital Sirio Libanes,Marcelo Rocha de Souza Cruz,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/3/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,South America,Paid,2500,2500.0,2020-08,1.0,2500.0,2000-3000$ 
GB,2020-08-27,A0282263,Clinical,University Hospital Southampton,Sanjay Raj,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/10/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2300,2300.0,2020-08,1.313673,3021.4479,3000+ $
BR,2020-08-27,A0282304,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),9/2/2020,9/28/2020,BRAZIL,Commercial,CUP,BRAZIL,1,AE,USD,Americas,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,South America,Paid,2000,2000.0,2020-08,1.0,2000.0,1500-2000$ 
FI,2020-08-28,A0282684,Clinical,Turku University Hospital,Eeva-Liisa Junnila,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/5/2020,10/19/2020,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-08,1.183038,2945.76462,2000-3000$ 
GB,2020-08-28,A0282711,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,9/6/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-08,1.313673,1635.522885,1500-2000$ 
IE,2020-08-28,A0282847,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/7/2020,11/11/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-08,1.183038,1472.88231,0-1500$ 
FR,2020-08-28,A0282855,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/6/2020,9/28/2020,FRANCE,Commercial,Breast,FRANCE,1,non_AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.183038,0.0,0 $
GB,2020-08-28,A0282724,Clinical,HCA Laboratories,Paul Ross,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/6/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-08,1.313673,3025.388919,3000+ $
ES,2020-08-28,A0282678,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Head and neck carcinoma,9/5/2020,9/28/2020,SPAIN,Commercial,Head and neck carcinoma,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2200,2200.0,2020-08,1.183038,2602.6836000000003,2000-3000$ 
FR,2020-08-31,A0283230,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Small cell lung carcinoma,9/6/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.183038,0.0,0 $
FR,2020-08-31,A0283220,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Other,9/6/2020,9/28/2020,FRANCE,Commercial,Other,FRANCE,1,non_AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-08,1.183038,0.0,0 $
ES,2020-08-31,A0283227,Clinical,Centro Diagnostico de las Afecciones Mamarias,Miguel Prats de Puig,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,9/5/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,1745,1745.0,2020-08,1.183038,2064.40131,2000-3000$ 
ES,2020-08-31,A0283229,Clinical,Hospital Clinico Provincial de Barcelona,Aleix Prat,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/6/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,8,2020,3,1,2020-08-01,2020-08,G360 CDx,2020Q3,Europe,Paid,2200,2200.0,2020-08,1.183038,2602.6836000000003,2000-3000$ 
CA,2020-09-01,A0283478,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/9/2020,9/28/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Canada,Paid,1750,1750.0,2020-09,1.0,1750.0,1500-2000$ 
ES,2020-09-03,A0284248,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/10/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-09,1.178781,2946.9525000000003,2000-3000$ 
ES,2020-09-03,A0284394,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/10/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-09,1.178781,2946.9525000000003,2000-3000$ 
BR,2020-09-03,A0284402,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/11/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Free,0,0.0,2020-09,1.0,0.0,0 $
GB,2020-09-04,A0284690,Clinical,Charing Cross Hospital Medical Oncology Department,Jonathan Krell,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,9/11/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.295021,1612.301145,1500-2000$ 
GB,2020-09-04,A0284652,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/11/2020,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.295021,1612.301145,1500-2000$ 
AR,2020-09-04,A0284730,Clinical,Laboratorio Genia,Gonzalo Recondo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/11/2020,10/6/2020,ARGENTINA,Commercial,,ARGENTINA,1,non_AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,2000,2000.0,2020-09,1.0,2000.0,1500-2000$ 
FR,2020-09-04,A0284461,Clinical,Gustave Roussy Cancer Campus,Patricia Martin-Romano,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/10/2020,9/28/2020,FRANCE,Commercial,Breast,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
BR,2020-09-04,A0284728,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/11/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,2000,2000.0,2020-09,1.0,2000.0,1500-2000$ 
TR,2020-09-05,A0284905,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/15/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-09,1.0,2100.0,2000-3000$ 
ES,2020-09-08,A0285127,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung carcinoid,9/17/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-09,1.178781,2946.9525000000003,2000-3000$ 
BR,2020-09-08,A0285129,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Anaplastic thyroid carcinoma,9/18/2020,9/28/2020,BRAZIL,Commercial,Thyroid,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,2000,2000.0,2020-09,1.0,2000.0,1500-2000$ 
FR,2020-09-08,A0285128,Clinical,Gustave Roussy Cancer Campus,Jean Charles Soria,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/17/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
BR,2020-09-08,A0285232,Clinical,Synlab - Brasil,Nise Yamaguchi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/15/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,2800,2800.0,2020-09,1.0,2800.0,2000-3000$ 
BR,2020-09-08,A0285134,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/15/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Free,0,0.0,2020-09,1.0,0.0,0 $
FR,2020-09-08,A0285124,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Renal Cell Carcinoma,9/14/2020,9/28/2020,FRANCE,Commercial,Kidney,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
DE,2020-09-09,A0285743,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/15/2020,9/28/2020,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
CL,2020-09-09,A0285731,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/15/2020,9/30/2020,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,1550,1550.0,2020-09,1.0,1550.0,1500-2000$ 
GB,2020-09-09,A0285696,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/15/2020,5/6/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2300,2300.0,2020-09,1.295021,2978.5483,2000-3000$ 
GB,2020-09-09,A0285805,Clinical,North Middlesex University Hospital,Sasa Badzek,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/14/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.295021,1612.301145,1500-2000$ 
DE,2020-09-10,A0286302,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Ovarian carcinoma,9/14/2020,9/28/2020,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,0,0.0,2020-09,1.178781,0.0,0 $
GB,2020-09-10,A0286211,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/17/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1745,1745.0,2020-09,1.295021,2259.8116449999998,2000-3000$ 
GB,2020-09-10,A0286298,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/16/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1745,1745.0,2020-09,1.295021,2259.8116449999998,2000-3000$ 
FR,2020-09-10,A0286060,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/15/2020,9/28/2020,FRANCE,Commercial,Breast,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
LT,2020-09-10,A0286075,Clinical,Genomika,Mantas Simutis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/14/2020,9/28/2020,LITHUANIA,Commercial,Breast,LITHUANIA,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-09,1.178781,2475.4401000000003,2000-3000$ 
DE,2020-09-10,A0286306,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/16/2020,9/28/2020,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
FR,2020-09-11,A0286403,Clinical,Gustave Roussy Cancer Campus,Anas Gazzah,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/18/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
GB,2020-09-11,A0286681,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/17/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-09,1.295021,2982.433363,2000-3000$ 
GB,2020-09-11,A0286691,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/16/2020,9/29/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.295021,1612.301145,1500-2000$ 
GB,2020-09-14,A0287218,Clinical,HCA Laboratories,Kai-Keen Shiu,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),9/21/2020,9/28/2020,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-09,1.295021,2982.433363,2000-3000$ 
GB,2020-09-14,A0287223,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/21/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-09,1.295021,3224.60229,3000+ $
ES,2020-09-14,A0287242,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/22/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2200,2200.0,2020-09,1.178781,2593.3182,2000-3000$ 
BR,2020-09-14,A0287229,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/22/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Free,0,0.0,2020-09,1.0,0.0,0 $
BR,2020-09-14,A0287230,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/21/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,2000,2000.0,2020-09,1.0,2000.0,1500-2000$ 
TR,2020-09-14,A0287217,Clinical,Iontek,Mehmet Metin Seker,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,9/23/2020,9/28/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-09,1.0,2100.0,2000-3000$ 
BR,2020-09-14,A0287232,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/21/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,2000,2000.0,2020-09,1.0,2000.0,1500-2000$ 
FR,2020-09-14,A0287236,Clinical,Institut de Cancerologie des Hospices Civils de Lyon,Michael Duruisseaux,Guardant 360,2.11,GHI_01,Self-Pay Patient,Small cell lung carcinoma,9/22/2020,5/5/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
FR,2020-09-16,A0287847,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,9/22/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
FR,2020-09-16,A0287804,Clinical,Gustave Roussy Cancer Campus,Loic Verlingue,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,9/22/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
GB,2020-09-16,A0287857,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,9/22/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.295021,1612.301145,1500-2000$ 
GB,2020-09-16,A0287735,Clinical,The Royal Marsden NHS Foundation Trust,Wanyuan Cui,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/22/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-09,1.295021,3224.60229,3000+ $
GB,2020-09-16,A0287860,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,9/22/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.295021,1612.301145,1500-2000$ 
ES,2020-09-16,A0287760,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Esophageal squamous cell carcinoma,9/22/2020,9/28/2020,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-09,1.178781,2946.9525000000003,2000-3000$ 
GB,2020-09-17,A0287965,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,9/22/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.295021,1612.301145,1500-2000$ 
ES,2020-09-17,A0288183,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/23/2020,9/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2200,2200.0,2020-09,1.178781,2593.3182,2000-3000$ 
GB,2020-09-17,A0288091,Clinical,HCA Laboratories,Kefah Mokbel,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/23/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-09,1.295021,2982.433363,2000-3000$ 
GB,2020-09-17,A0288020,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/23/2020,10/6/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.295021,1612.301145,1500-2000$ 
BR,2020-09-18,A0288536,Clinical,Synlab - Brasil,Rui Fernando Weschendfelder,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/25/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,2800,2800.0,2020-09,1.0,2800.0,2000-3000$ 
FR,2020-09-18,A0288391,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,9/27/2020,9/29/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
FR,2020-09-18,A0288374,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/25/2020,9/28/2020,FRANCE,Commercial,Breast,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
GB,2020-09-18,A0288595,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,9/23/2020,10/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.295021,0.0,0 $
GB,2020-09-18,A0288538,Clinical,HCA Laboratories,John Conibear,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/23/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.295021,1612.301145,1500-2000$ 
ES,2020-09-18,A0288467,Clinical,Clinica Universidad de Navarra-Madrid,Luisa Sanchez Lorenzo,Guardant 360,2.11,GHI_01,Distributors : ROW,Cervical Squamous Cell Carcinoma,9/23/2020,9/28/2020,SPAIN,Commercial,Cervical,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-09,1.178781,2946.9525000000003,2000-3000$ 
FR,2020-09-18,A0288395,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung squamous cell carcinoma,9/25/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
FR,2020-09-19,A0289012,Clinical,Gustave Roussy Cancer Campus,Loic Verlingue,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Prostate adenocarcinoma,9/25/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
GB,2020-09-19,A0288797,Clinical,University Hospitals Of Leicester,Kiran Kancherla,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,9/22/2020,9/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,0,0.0,2020-09,1.295021,0.0,0 $
FR,2020-09-19,A0289013,Clinical,Gustave Roussy Cancer Campus,Christophe Massard,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Prostate adenocarcinoma,9/25/2020,9/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
FR,2020-09-19,A0289002,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Bladder carcinoma,9/24/2020,9/28/2020,FRANCE,Commercial,Bladder,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
ES,2020-09-21,A0289081,Clinical,Hospital Universitario HM Sanchinarro,Antonio Cubillo Gracian,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/28/2020,9/28/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-09,1.178781,2946.9525000000003,2000-3000$ 
GB,2020-09-21,A0289066,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/27/2020,10/30/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-09,1.295021,3224.60229,3000+ $
GB,2020-09-21,A0289042,Clinical,HCA Laboratories,Paul Ross,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/26/2020,9/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-09,1.295021,2982.433363,2000-3000$ 
IE,2020-09-21,A0289036,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/28/2020,10/13/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.178781,1467.582345,0-1500$ 
BR,2020-09-21,A0289084,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/26/2020,9/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,1700,1700.0,2020-09,1.0,1700.0,1500-2000$ 
GB,2020-09-21,A0289083,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/26/2020,10/26/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.295021,0.0,0 $
ES,2020-09-22,A0289150,Clinical,Hospital Universitario Ramon y Cajal,Elena Corral de la Fuente,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/28/2020,9/30/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.178781,1467.582345,0-1500$ 
ES,2020-09-22,A0289283,Clinical,Hospital Universitario HM Sanchinarro,Antonio Cubillo Gracian,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/29/2020,9/29/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-09,1.178781,2946.9525000000003,2000-3000$ 
BE,2020-09-22,A0289112,Clinical,University Hospital Antwerp,Marika Rasschaert,Guardant 360,2.11,GHI_01,Distributors : ROW,Bladder carcinoma,9/29/2020,9/29/2020,BELGIUM,Commercial,Bladder,BELGIUM,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2500,2500.0,2020-09,1.178781,2946.9525000000003,2000-3000$ 
TR,2020-09-22,A0289116,Clinical,Iontek,Kubra Aydin,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,9/24/2020,9/28/2020,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,0,0.0,2020-09,1.0,0.0,0 $
MX,2020-09-23,A0289608,Clinical,Labopat,Oscar Arrieta Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/30/2020,9/30/2020,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,3200,3200.0,2020-09,1.178781,3772.0992,3000+ $
IE,2020-09-23,A0289524,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/30/2020,10/29/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.178781,1467.582345,0-1500$ 
GB,2020-09-23,A0289561,Clinical,The Royal Marsden Hospital,Alistair Ring,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/29/2020,11/13/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-09,1.295021,3224.60229,3000+ $
GB,2020-09-23,A0289576,Clinical,The Royal Marsden Hospital,Naureen Starling,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/29/2020,9/29/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.295021,1612.301145,1500-2000$ 
IE,2020-09-24,A0289823,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/29/2020,10/13/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.178781,1467.582345,0-1500$ 
PE,2020-09-24,A0289644,Clinical,Oncosalud â€“ Oncocenter,Luis Mas,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/30/2020,9/30/2020,PERU,Commercial,,PERU,1,non_AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,2500,2500.0,2020-09,1.0,2500.0,2000-3000$ 
BR,2020-09-24,A0289687,Clinical,Hospital Sirio Libanes,Marcelo Rocha de Souza Cruz,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/30/2020,9/30/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,2500,2500.0,2020-09,1.0,2500.0,2000-3000$ 
CA,2020-09-24,A0289684,Clinical,Princess Margaret Cancer Centre,Penelope Bradbury,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/30/2020,9/30/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Canada,Paid,1750,1750.0,2020-09,1.0,1750.0,1500-2000$ 
GB,2020-09-24,A0289832,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/29/2020,9/29/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-09,1.295021,2982.433363,2000-3000$ 
ES,2020-09-24,A0289843,Clinical,Fundacion Jimenez Diaz,Cristina Carames Sanchez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/30/2020,9/30/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.178781,1467.582345,0-1500$ 
BR,2020-09-24,A0289974,Clinical,Synlab - Brasil,Nise Yamaguchi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),10/7/2020,10/7/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,2800,2800.0,2020-09,1.0,2800.0,2000-3000$ 
GB,2020-09-25,A0290059,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/30/2020,9/30/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-09,1.295021,2982.433363,2000-3000$ 
GB,2020-09-25,A0290199,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/1/2020,10/1/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.295021,0.0,0 $
TR,2020-09-25,A0290149,Clinical,Iontek,Esat Namal,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,10/3/2020,10/3/2020,TURKEY,Commercial,Other,TURKEY,1,AE,USD,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2100,2100.0,2020-09,1.0,2100.0,2000-3000$ 
GB,2020-09-25,A0290202,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/1/2020,10/1/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.295021,1612.301145,1500-2000$ 
FR,2020-09-25,A0290006,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,10/1/2020,10/1/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
GB,2020-09-25,A0290228,Clinical,University Hospitals Of Leicester,Kiran Kancherla,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/30/2020,1/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2300,2300.0,2020-09,1.295021,2978.5483,2000-3000$ 
GB,2020-09-28,A0290660,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/2/2020,10/2/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-09,1.295021,2982.433363,2000-3000$ 
GB,2020-09-28,A0290662,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/2/2020,10/2/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2490,2490.0,2020-09,1.295021,3224.60229,3000+ $
ES,2020-09-28,A0290686,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/3/2020,10/23/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1245,1245.0,2020-09,1.178781,1467.582345,0-1500$ 
BR,2020-09-28,A0290681,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,10/2/2020,10/2/2020,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,1700,1700.0,2020-09,1.0,1700.0,1500-2000$ 
BR,2020-09-28,A0290674,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/3/2020,10/3/2020,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,South America,Paid,1700,1700.0,2020-09,1.0,1700.0,1500-2000$ 
GB,2020-09-28,A0290666,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/5/2020,10/27/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,1745,1745.0,2020-09,1.295021,2259.8116449999998,2000-3000$ 
FR,2020-09-28,A0290676,Clinical,Gustave Roussy Cancer Campus,Jean Charles Soria,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/4/2020,10/4/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.178781,0.0,0 $
GB,2020-09-29,A0290741,Clinical,Peterborough City Hospital Dept of Oncology 18,Abigail Hollingdale,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,10/3/2020,10/23/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.295021,0.0,0 $
TR,2020-09-30,A0291112,Clinical,Iontek,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/5/2020,10/5/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.0,0.0,0 $
GB,2020-09-30,A0291136,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,10/5/2020,10/23/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Free,0,0.0,2020-09,1.295021,0.0,0 $
GB,2020-09-30,A0291242,Clinical,HCA Laboratories,Mark Nathan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/5/2020,10/6/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2020,3,1,2020-09-01,2020-09,G360 CDx,2020Q3,Europe,Paid,2303.25,2303.0,2020-09,1.295021,2982.433363,2000-3000$ 
GB,2020-10-01,A0291617,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,10/7/2020,10/7/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
GB,2020-10-01,A0291716,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/8/2020,10/23/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-10,1.298405,3233.0284500000002,3000+ $
GB,2020-10-01,A0291550,Clinical,HCA Laboratories,Peter Harper,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,10/13/2020,10/13/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-10,1.298405,2990.2267150000002,2000-3000$ 
TR,2020-10-02,A0291920,Clinical,Iontek,Kubra Aydin,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/7/2020,10/7/2020,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-10,1.0,0.0,0 $
GB,2020-10-02,A0291809,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,10/8/2020,10/8/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
GB,2020-10-02,A0292054,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/11/2020,10/11/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-10,1.298405,2990.2267150000002,2000-3000$ 
TR,2020-10-02,A0291926,Clinical,Iontek,Kubra Aydin,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/8/2020,10/8/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-10,1.0,2100.0,2000-3000$ 
BR,2020-10-02,A0291923,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/7/2020,10/7/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,South America,Paid,2000,2000.0,2020-10,1.0,2000.0,1500-2000$ 
ES,2020-10-02,A0291914,Clinical,Clinica Universidad de Navarra-Madrid,Antonio Gonzalez Martin,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/7/2020,10/7/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-10,1.177,2942.5,2000-3000$ 
GB,2020-10-02,A0292041,Clinical,HCA Laboratories,Paul Ross,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,10/7/2020,10/7/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-10,1.298405,2990.2267150000002,2000-3000$ 
GB,2020-10-02,A0291817,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,10/8/2020,10/8/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-10,1.298405,3233.0284500000002,3000+ $
GB,2020-10-03,A0292387,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,10/8/2020,10/8/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
ES,2020-10-05,A0292435,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,10/12/2020,10/12/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303,2303.0,2020-10,1.177,2710.6310000000003,2000-3000$ 
GB,2020-10-05,A0292457,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,10/16/2020,10/16/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-10,1.298405,0.0,0 $
ES,2020-10-05,A0292453,Clinical,Hospital Quiron Barcelona,Jesus Soberino Garcia,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/14/2020,10/14/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303,2303.0,2020-10,1.177,2710.6310000000003,2000-3000$ 
GB,2020-10-05,A0292465,Clinical,Southampton General Hospital,Hugo De La Pena,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,10/14/2020,10/23/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-10,1.298405,0.0,0 $
GB,2020-10-05,A0292448,Clinical,BMI The Chaucer Hospital,Carys Thomas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,10/14/2020,10/23/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-10,1.298405,3233.0284500000002,3000+ $
GB,2020-10-05,A0292462,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/15/2020,10/15/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-10,1.298405,3233.0284500000002,3000+ $
GB,2020-10-06,A0292692,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,10/11/2020,10/11/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
MX,2020-10-06,A0292718,Clinical,MileniaLabs,Guadalupe Evaristo Cedillo Salazar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal adenocarcinoma,10/12/2020,10/23/2020,MEXICO,Commercial,GI,MEXICO,1,non_AE,EUR,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,South America,Paid,2500,2500.0,2020-10,1.177,2942.5,2000-3000$ 
GB,2020-10-07,A0293064,Clinical,Genesis Care Nottingham,Jamie Mills,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,10/14/2020,10/23/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
GB,2020-10-07,A0292836,Clinical,The Royal Marsden NHS Foundation Trust,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,10/12/2020,10/12/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
GB,2020-10-08,A0293164,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung carcinoid,10/14/2020,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
GB,2020-10-08,A0293388,Clinical,HCA Laboratories,Mark Harries,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/15/2020,10/15/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-10,1.298405,2990.2267150000002,2000-3000$ 
GB,2020-10-08,A0293160,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/14/2020,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
FI,2020-10-08,A0293188,Clinical,Turku University Hospital,Eija Korkeila,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/14/2020,10/19/2020,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-10,1.177,2930.73,2000-3000$ 
BR,2020-10-08,A0293209,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/14/2020,11/4/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,South America,Paid,1700,1700.0,2020-10,1.0,1700.0,1500-2000$ 
CA,2020-10-08,A0293383,Clinical,Dr. Sabah Yusuf,Sabah Yusuf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/27/2020,10/27/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Canada,Paid,2000,2000.0,2020-10,1.0,2000.0,1500-2000$ 
LT,2020-10-08,A0293123,Clinical,Genomika,Mantas Simutis,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,10/14/2020,11/3/2020,LITHUANIA,Commercial,Breast,LITHUANIA,1,non_AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-10,1.177,2471.7000000000003,2000-3000$ 
GB,2020-10-09,A0293682,Clinical,HCA Laboratories,Andrew Tutt,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/17/2020,11/7/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-10,1.298405,2990.2267150000002,2000-3000$ 
GB,2020-10-09,A0293518,Clinical,HCA at The Christie Clinic,Jurjees Hasan,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Endometrial carcinoma,10/15/2020,10/23/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-10,1.298405,3233.0284500000002,3000+ $
ES,2020-10-09,A0293751,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,10/16/2020,10/16/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-10,1.177,2942.5,2000-3000$ 
ES,2020-10-12,A0294207,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,10/18/2020,11/13/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1735,1735.0,2020-10,1.177,2042.095,2000-3000$ 
DE,2020-10-12,A0294196,Clinical,Onkologie im Elisenhof,Christof Fischer,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Clear cell renal cell carcinoma,10/18/2020,10/23/2020,GERMANY,Commercial,Kidney,GERMANY,1,non_AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,3490,3490.0,2020-10,1.177,4107.7300000000005,3000+ $
BR,2020-10-12,A0294184,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/18/2020,10/19/2020,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,South America,Paid,2000,2000.0,2020-10,1.0,2000.0,1500-2000$ 
ES,2020-10-12,A0294215,Clinical,Hospital Universitario HM Sanchinarro,Antonio Cubillo Gracian,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/18/2020,10/18/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-10,1.177,2942.5,2000-3000$ 
GB,2020-10-13,A0294261,Clinical,The Royal Marsden NHS Foundation Trust,Nicholas Turner,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,10/20/2020,10/20/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
MX,2020-10-14,A0294730,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/19/2020,10/19/2020,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,South America,Paid,74240,74240.0,2020-10,1.177,87380.48000000001,3000+ $
GB,2020-10-14,A0294751,Clinical,HCA Laboratories,Peter Harper,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,10/19/2020,10/19/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-10,1.298405,2990.2267150000002,2000-3000$ 
GB,2020-10-14,A0294739,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,10/19/2020,10/19/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-10,1.298405,2990.2267150000002,2000-3000$ 
GB,2020-10-14,A0294546,Clinical,Western General Hospital - Edinburgh Cancer Centre,Alan Christie,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,10/18/2020,11/5/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-10,1.298405,3233.0284500000002,3000+ $
GB,2020-10-14,A0294710,Clinical,St Bartholomews Hospital,Sherif Raouf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,10/20/2020,11/16/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
ES,2020-10-14,A0294692,Validation,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Distributors : ROW,,,10/15/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,0,0.0,2020-10,1.177,0.0,0 $
ES,2020-10-15,A0295049,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/21/2020,10/21/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303,2303.0,2020-10,1.177,2710.6310000000003,2000-3000$ 
FR,2020-10-15,A0294850,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Thyroid carcinoma,10/22/2020,10/22/2020,FRANCE,Commercial,Thyroid,FRANCE,1,non_AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-10,1.177,0.0,0 $
ES,2020-10-15,A0295173,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Other,10/22/2020,11/4/2020,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.177,1465.365,0-1500$ 
MX,2020-10-16,A0295443,Clinical,MileniaLabs,Christian Patricio Camacho Limas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/22/2020,11/3/2020,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,South America,Paid,2500,2500.0,2020-10,1.177,2942.5,2000-3000$ 
ES,2020-10-17,A0295829,Clinical,Synlab - Barcelona,Federico Cassab Lopez,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Colorectal adenocarcinoma,10/24/2020,10/24/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,0,0.0,2020-10,1.177,0.0,0 $
DE,2020-10-19,A0295832,Clinical,Universitaetsmedizin Goettingen Klinik fur Urologie,Lutz Trojan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,10/24/2020,11/18/2020,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,3490,3490.0,2020-10,1.177,4107.7300000000005,3000+ $
IE,2020-10-19,A0295838,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,10/25/2020,11/11/2020,IRELAND,Commercial,GI,IRELAND,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.177,1465.365,0-1500$ 
FR,2020-10-19,A0295851,Clinical,Gustave Roussy Cancer Campus,Antoine Italiano,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Sarcoma,10/25/2020,10/25/2020,FRANCE,Commercial,Soft Tissue/Bone,FRANCE,1,non_AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-10,1.177,0.0,0 $
GB,2020-10-19,A0295849,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,10/24/2020,10/24/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
GB,2020-10-19,A0295905,Clinical,Cheltenham General Hospital,Marios Decatris,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/25/2020,11/7/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
GB,2020-10-19,A0295834,Clinical,Queen Alexandra Hospital,Sethupathi Ramalingam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/24/2020,10/24/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
BR,2020-10-20,A0295924,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/24/2020,10/24/2020,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,South America,Free,0,0.0,2020-10,1.0,0.0,0 $
GB,2020-10-20,A0295969,Clinical,Maidstone and Tunbridge Wells NHS Trust,Charlotte Abson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/24/2020,10/24/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
ES,2020-10-21,A0296168,Clinical,Hospital Quiron Barcelona,Aleix Prat,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/25/2020,10/25/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303,2303.0,2020-10,1.177,2710.6310000000003,2000-3000$ 
ES,2020-10-21,A0296173,Clinical,Hospital Quiron Barcelona,Teresa Macarulla,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),10/28/2020,10/28/2020,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303,2303.0,2020-10,1.177,2710.6310000000003,2000-3000$ 
CA,2020-10-22,A0296505,Clinical,Centre for Natural Medicine,Sara Korsunsky,Guardant 360,2.11,GHI_01,Self-Pay Patient,Renal Cell Carcinoma,10/29/2020,10/29/2020,CANADA,Commercial,Kidney,CANADA,1,AE,USD,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Canada,Paid,3150,3150.0,2020-10,1.0,3150.0,3000+ $
GB,2020-10-22,A0296512,Clinical,HCA Laboratories,Andrew Tutt,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/28/2020,10/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-10,1.298405,0.0,0 $
GB,2020-10-22,A0296480,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/28/2020,11/16/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
GB,2020-10-22,A0296501,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung cancer,10/29/2020,10/29/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
BR,2020-10-23,A0297168,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Small cell lung carcinoma,10/29/2020,10/29/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,South America,Paid,1350,1350.0,2020-10,1.0,1350.0,0-1500$ 
FI,2020-10-23,A0297433,Clinical,Turku University Hospital,Taneli Saariaho,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/30/2020,11/3/2020,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-10,1.177,2930.73,2000-3000$ 
ES,2020-10-23,A0297557,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,10/30/2020,10/30/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-10,1.177,2942.5,2000-3000$ 
FI,2020-10-23,A0297171,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/29/2020,11/3/2020,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-10,1.177,2930.73,2000-3000$ 
ES,2020-10-24,A0297820,Clinical,Hospital Quironsalud Sagrado Corazon,Juan Antonio Virizuela,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,10/31/2020,10/31/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-10,1.177,2930.73,2000-3000$ 
BR,2020-10-26,A0297832,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,11/2/2020,12/1/2020,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,South America,Paid,1350,1350.0,2020-10,1.0,1350.0,0-1500$ 
ES,2020-10-26,A0297847,Clinical,Hospital Ruber Internacional,Maria Gion,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/3/2020,11/3/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303,2303.0,2020-10,1.177,2710.6310000000003,2000-3000$ 
GB,2020-10-26,A0297834,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/4/2020,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Free,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
CA,2020-10-26,A0297853,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,11/1/2020,11/4/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Canada,Paid,1750,1750.0,2020-10,1.0,1750.0,1500-2000$ 
ES,2020-10-26,A0297836,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/1/2020,11/1/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303,2303.0,2020-10,1.177,2710.6310000000003,2000-3000$ 
ES,2020-10-26,A0297862,Clinical,Fundacion Jimenez Diaz,Cristina Carames Sanchez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,11/1/2020,11/5/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.177,1465.365,0-1500$ 
ES,2020-10-26,A0297835,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/31/2020,10/31/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2200,2200.0,2020-10,1.177,2589.4,2000-3000$ 
ES,2020-10-26,A0297858,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/3/2020,11/16/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.177,1465.365,0-1500$ 
CA,2020-10-28,A0298340,Clinical,Centre for Natural Medicine,Sara Korsunsky,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,11/3/2020,11/5/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Canada,Paid,3150,3150.0,2020-10,1.0,3150.0,3000+ $
DE,2020-10-28,A0298398,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,11/4/2020,12/9/2020,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2990,2990.0,2020-10,1.177,3519.23,3000+ $
TR,2020-10-29,A0298618,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/5/2020,11/5/2020,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-10,1.0,2100.0,2000-3000$ 
CL,2020-10-29,A0298818,Clinical,Clinica Las Condes,Laura Itriago,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/6/2020,11/6/2020,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,South America,Paid,1550,1550.0,2020-10,1.0,1550.0,1500-2000$ 
GB,2020-10-29,A0298585,Clinical,HCA Laboratories,Kai-Keen Shiu,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/5/2020,11/5/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-10,1.298405,2990.2267150000002,2000-3000$ 
ES,2020-10-29,A0298596,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,11/5/2020,11/5/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-10,1.177,2942.5,2000-3000$ 
GB,2020-10-29,A0298577,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Mesothelioma,11/5/2020,12/21/2020,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-10,1.298405,3233.0284500000002,3000+ $
GB,2020-10-29,A0298580,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/5/2020,11/5/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-10,1.298405,1616.5142250000001,1500-2000$ 
DE,2020-10-30,A0298955,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Melanoma,11/6/2020,11/6/2020,GERMANY,Commercial,Skin,GERMANY,1,non_AE,EUR,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Paid,2990,2990.0,2020-10,1.177,3519.23,3000+ $
GB,2020-10-30,A0298901,Clinical,Southampton General Hospital,Andrew Bates,Guardant 360,2.11,GHI_01,Self-Pay Patient,Thymic carcinoma,11/11/2020,11/11/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,10,2020,4,1,2020-10-01,2020-10,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-10,1.298405,0.0,0 $
FR,2020-11-02,A0299832,Clinical,Gustave Roussy Cancer Campus,Christophe Massard,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,11/8/2020,12/2/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.184064,0.0,0 $
ES,2020-11-02,A0299842,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Follicular thyroid carcinoma,11/9/2020,12/2/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.184064,1474.15968,0-1500$ 
CH,2020-11-02,A0299852,Clinical,Hopitaux Universitaires de Genevu,Alfredo Addeo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/9/2020,12/2/2020,SWITZERLAND,Commercial,,SWITZERLAND,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,3490,3490.0,2020-11,1.184064,4132.38336,3000+ $
TR,2020-11-02,A0300676,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/11/2020,11/11/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-11,1.0,2100.0,2000-3000$ 
GB,2020-11-02,A0299833,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/8/2020,12/2/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.320811,1644.409695,1500-2000$ 
ES,2020-11-02,A0299875,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/10/2020,11/10/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.184064,2948.31936,2000-3000$ 
DE,2020-11-03,A0300175,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/9/2020,12/2/2020,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2990,2990.0,2020-11,1.184064,3540.35136,3000+ $
GB,2020-11-03,A0300162,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/11/2020,11/11/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.320811,1644.409695,1500-2000$ 
CH,2020-11-04,A0300338,Clinical,Hopitaux Universitaires de Genevu,Alfredo Addeo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/9/2020,12/29/2020,SWITZERLAND,Commercial,,SWITZERLAND,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,3490,3490.0,2020-11,1.184064,4132.38336,3000+ $
GB,2020-11-04,A0300493,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/11/2020,11/13/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-11,1.320811,3041.827733,3000+ $
GB,2020-11-05,A0300747,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/11/2020,11/11/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.320811,1644.409695,1500-2000$ 
CL,2020-11-05,A0300855,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/12/2020,12/4/2020,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,South America,Paid,1550,1550.0,2020-11,1.0,1550.0,1500-2000$ 
ES,2020-11-06,A0301304,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/16/2020,11/16/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-11,1.184064,2960.16,2000-3000$ 
GB,2020-11-06,A0301028,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/17/2020,11/17/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.320811,3288.81939,3000+ $
GB,2020-11-06,A0301021,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/16/2020,11/18/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.320811,1644.409695,1500-2000$ 
GB,2020-11-06,A0301091,Clinical,BMI Harbour Hospital,Mike Bayne,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/12/2020,11/12/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-06,A0301092,Clinical,Synthesis Clinic,Nina Fuller-Shavel,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),11/16/2020,11/16/2020,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-06,A0301205,Clinical,The Royal Marsden Hospital,David Watkins,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,11/13/2020,11/13/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-07,A0301730,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,11/18/2020,11/18/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2300,2300.0,2020-11,1.320811,3037.8653,3000+ $
DE,2020-11-09,A0301752,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Hepatocellular carcinoma,11/16/2020,11/16/2020,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2990,2990.0,2020-11,1.184064,3540.35136,3000+ $
ES,2020-11-09,A0301778,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Melanoma,11/12/2020,11/12/2020,SPAIN,Commercial,Skin,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303,2303.0,2020-11,1.184064,2726.899392,2000-3000$ 
FR,2020-11-09,A0301753,Clinical,Gustave Roussy Cancer Campus,Jean Charles Soria,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/17/2020,11/17/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.184064,0.0,0 $
MX,2020-11-09,A0301769,Clinical,ABC Hospital,Raquel Gerson,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,11/19/2020,11/20/2020,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,South America,Paid,1700,1700.0,2020-11,1.184064,2012.9088,2000-3000$ 
GB,2020-11-09,A0301756,Clinical,"NHS Highland, Raigmore Hospital, Inverness",Walter Mmeka,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,11/17/2020,11/17/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-09,A0301765,Clinical,"NHS Highland, Raigmore Hospital, Inverness",Walter Mmeka,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/16/2020,11/16/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-09,A0301762,Clinical,The Holly Private Hospital,Sherif Raouf,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/17/2020,11/17/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2300,2300.0,2020-11,1.320811,3037.8653,3000+ $
GB,2020-11-09,A0301804,Clinical,Bupa Cromwell Hospital,Robert Leonard,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/16/2020,11/16/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.320811,3288.81939,3000+ $
FR,2020-11-09,A0301755,Clinical,Gustave Roussy Cancer Campus,Jean Charles Soria,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/17/2020,11/17/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.184064,0.0,0 $
ES,2020-11-09,A0301739,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,11/19/2020,11/19/2020,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-11,1.184064,2960.16,2000-3000$ 
GB,2020-11-09,A0301766,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/17/2020,11/17/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1750,1750.0,2020-11,1.320811,2311.41925,2000-3000$ 
GB,2020-11-10,A0301874,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/21/2020,11/21/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-10,A0301909,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/18/2020,11/18/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-11,A0302121,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/18/2020,11/18/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-11,1.320811,3041.827733,3000+ $
GB,2020-11-11,A0302392,Clinical,The Royal Marsden Hospital,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,11/22/2020,11/22/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.320811,1644.409695,1500-2000$ 
CL,2020-11-11,A0302373,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/19/2020,12/4/2020,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,South America,Paid,1550,1550.0,2020-11,1.0,1550.0,1500-2000$ 
CL,2020-11-11,A0302386,Clinical,Clinica Las Condes,Jose Miguel Reyes,UNKNOWN,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,11/19/2020,12/4/2020,CHILE,Commercial,GI,CHILE,1,non_AE,USD,Americas,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,South America,Paid,1550,1550.0,2020-11,1.0,1550.0,1500-2000$ 
FR,2020-11-11,A0302112,Clinical,Gustave Roussy Cancer Campus,Jean Charles Soria,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Esophageal/Gastroesophageal junction Adenocarcinoma,11/18/2020,11/18/2020,FRANCE,Commercial,GI,FRANCE,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.184064,0.0,0 $
ES,2020-11-12,A0302735,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/20/2020,11/30/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.184064,1474.15968,0-1500$ 
GB,2020-11-12,A0302585,Clinical,The Christie Hospital,Louise Carter,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,11/21/2020,11/21/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-12,A0302841,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,11/19/2020,11/19/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.320811,3288.81939,3000+ $
GB,2020-11-12,A0302854,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/20/2020,11/20/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-11,1.320811,3041.827733,3000+ $
GB,2020-11-12,A0302641,Clinical,The Christie Hospital,Matthew Krebs,Guardant 360,2.11,GHI_01,Distributors : ROW,Cervical adenocarcinoma,11/19/2020,11/19/2020,UNITED KINGDOM,Commercial,Cervical,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
CA,2020-11-13,A0302960,Clinical,Ottawa Hospital Cancer Centre,Paul Wheatley-Price,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/21/2020,12/22/2020,CANADA,Commercial,,CANADA,1,AE,USD,Americas,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Canada,Paid,3150,3150.0,2020-11,1.0,3150.0,3000+ $
GB,2020-11-13,A0303007,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/21/2020,11/21/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-11,1.320811,3041.827733,3000+ $
LT,2020-11-13,A0302912,Clinical,Genomika,Mantas Simutis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/23/2020,12/3/2020,LITHUANIA,Commercial,Breast,LITHUANIA,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-11,1.184064,2486.5344,2000-3000$ 
GB,2020-11-13,A0302982,Clinical,University College London Hospitals,Siow Ming Lee,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/21/2020,11/21/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.320811,3288.81939,3000+ $
GB,2020-11-14,A0303601,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,11/23/2020,11/23/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-11,1.320811,3041.827733,3000+ $
ES,2020-11-16,A0303774,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/24/2020,12/2/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.184064,1474.15968,0-1500$ 
ES,2020-11-16,A0303765,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/20/2020,11/20/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303,2303.0,2020-11,1.184064,2726.899392,2000-3000$ 
BR,2020-11-16,A0303809,Clinical,Synlab - Brasil,Nise Yamaguchi,Guardant 360,2.11,GHI_01,Distributors : ROW,Melanoma,12/1/2020,12/9/2020,BRAZIL,Commercial,Skin,BRAZIL,1,AE,USD,Americas,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,South America,Paid,2800,2800.0,2020-11,1.0,2800.0,2000-3000$ 
IE,2020-11-16,A0303781,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/24/2020,3/11/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.184064,1474.15968,0-1500$ 
GB,2020-11-16,A0303783,Clinical,"NHS Highland, Raigmore Hospital, Inverness",Ute MacGregor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/24/2020,12/3/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-16,A0303760,Clinical,Synthesis Clinic,Nina Fuller-Shavel,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,11/22/2020,11/30/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1744,1744.0,2020-11,1.320811,2303.494384,2000-3000$ 
GB,2020-11-18,A0304992,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,11/25/2020,12/3/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.320811,3288.81939,3000+ $
BR,2020-11-18,A0304900,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/26/2020,11/26/2020,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,South America,Free,0,0.0,2020-11,1.0,0.0,0 $
GB,2020-11-19,A0305425,Clinical,Charing Cross Hospital Medical Oncology Department,Susan Cleator,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/26/2020,12/3/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.320811,1644.409695,1500-2000$ 
GB,2020-11-19,A0305396,Clinical,The Christie Hospital,Matthew Krebs,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/28/2020,12/3/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-19,A0305159,Clinical,Charing Cross Hospital Medical Oncology Department,Robert Kitson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/26/2020,12/3/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.320811,3288.81939,3000+ $
GB,2020-11-19,A0305165,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Madeleine Hewish,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/26/2020,12/3/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.320811,1644.409695,1500-2000$ 
DE,2020-11-19,A0305281,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,11/26/2020,12/3/2020,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2990,2990.0,2020-11,1.184064,3540.35136,3000+ $
FR,2020-11-19,A0305402,Clinical,Clinique Clementville Centre de Cancerologie du Grand Montpellier,Herve Lauche,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/25/2020,12/4/2020,FRANCE,Commercial,Breast,FRANCE,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.184064,2948.31936,2000-3000$ 
GB,2020-11-19,A0305379,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/2/2020,12/2/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,,0.0,2020-11,1.320811,0.0,0 $
TR,2020-11-20,A0306270,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/3/2020,12/4/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-11,1.0,2100.0,2000-3000$ 
GB,2020-11-21,A0306339,Clinical,The Royal Preston Hospital NHS Foundation Trust,Saif Yousif,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/1/2020,12/1/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-21,A0306506,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/28/2020,12/3/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-11,1.320811,3041.827733,3000+ $
ES,2020-11-21,A0306368,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/2/2020,12/2/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-11,1.184064,2960.16,2000-3000$ 
GB,2020-11-21,A0306410,Clinical,The Christie Hospital,Natalie Cook,Guardant 360,2.11,GHI_01,Distributors : ROW,Sarcoma,11/28/2020,12/3/2020,UNITED KINGDOM,Commercial,Soft Tissue/Bone,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
ES,2020-11-21,A0306375,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,12/2/2020,12/2/2020,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-11,1.184064,2960.16,2000-3000$ 
GB,2020-11-23,A0306664,Clinical,Southampton General Hospital,Charlotte Rees,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,11/29/2020,1/9/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2300,2300.0,2020-11,1.320811,3037.8653,3000+ $
ES,2020-11-23,A0306652,Clinical,Hospital Quiron Barcelona,Alejandro Navarro,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/1/2020,12/1/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303,2303.0,2020-11,1.184064,2726.899392,2000-3000$ 
GB,2020-11-23,A0306639,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/29/2020,12/3/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.320811,1644.409695,1500-2000$ 
ES,2020-11-23,A0306654,Clinical,Fundacion Jimenez Diaz,Cristina Carames Sanchez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,12/1/2020,12/1/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.184064,1474.15968,0-1500$ 
FR,2020-11-23,A0306647,Clinical,Gustave Roussy Cancer Campus,Fabrice Barlesi,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/29/2020,12/3/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.184064,0.0,0 $
GB,2020-11-23,A0306631,Clinical,Charing Cross Hospital Medical Oncology Department,Michael Seckl,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,11/30/2020,12/3/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
FR,2020-11-23,A0306648,Clinical,Gustave Roussy Cancer Campus,Jean Charles Soria,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/29/2020,12/3/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.184064,0.0,0 $
GB,2020-11-23,A0306668,Clinical,Genesis Care Nottingham,Arvind Arora,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/30/2020,12/3/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1744,1744.0,2020-11,1.320811,2303.494384,2000-3000$ 
GB,2020-11-24,A0306855,Clinical,Care Oncology Clinic,Hariharan Kuhan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,12/2/2020,12/2/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.320811,3288.81939,3000+ $
GB,2020-11-24,A0306718,Clinical,The Royal Marsden NHS Foundation Trust,Maria Ifijen,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,12/1/2020,12/3/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.320811,3288.81939,3000+ $
GB,2020-11-24,A0306905,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/30/2020,12/3/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
MX,2020-11-24,A0306831,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/2/2020,12/2/2020,MEXICO,Commercial,Breast,MEXICO,1,non_AE,EUR,Americas,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,South America,Paid,1700,1700.0,2020-11,1.184064,2012.9088,2000-3000$ 
IE,2020-11-24,A0306752,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,12/2/2020,12/2/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.184064,1474.15968,0-1500$ 
GB,2020-11-25,A0307436,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/7/2020,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,1245,1245.0,2020-11,1.320811,1644.409695,1500-2000$ 
GB,2020-11-25,A0307570,Clinical,Synthesis Clinic,Nina Fuller-Shavel,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/2/2020,12/2/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-25,A0307348,Clinical,HCA at The Christie Clinic,David Woolf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/1/2020,12/1/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1745,1745.0,2020-11,1.320811,2304.815195,2000-3000$ 
IT,2020-11-25,A0307357,Clinical,ASST - Ospedale di Cremona,Margherita Ratti,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/2/2020,12/2/2020,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.184064,2948.31936,2000-3000$ 
GB,2020-11-25,A0307343,Clinical,The Christie Hospital,Fiona Thistlethwaite,Guardant 360,2.11,GHI_01,Distributors : ROW,Melanoma,12/2/2020,12/2/2020,UNITED KINGDOM,Commercial,Skin,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-27,A0307900,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,12/2/2020,12/2/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-11,1.320811,3041.827733,3000+ $
GB,2020-11-27,A0307692,Clinical,Coventry University Hospitals,Nawaz Walji,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/2/2020,12/2/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2300,2300.0,2020-11,1.320811,3037.8653,3000+ $
GB,2020-11-27,A0307731,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung cancer,12/2/2020,12/2/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.320811,1644.409695,1500-2000$ 
GB,2020-11-27,A0307839,Clinical,The Christie Hospital,Matthew Krebs,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),12/2/2020,12/2/2020,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-27,A0307819,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/3/2020,12/3/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.320811,1644.409695,1500-2000$ 
GB,2020-11-27,A0307927,Clinical,BMI Harbour Hospital,Amitabha Chakrabarti,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/3/2020,12/3/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.320811,3288.81939,3000+ $
GB,2020-11-27,A0307915,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/2/2020,1/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.320811,3288.81939,3000+ $
ES,2020-11-27,A0307908,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,12/2/2020,12/2/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-11,1.184064,2960.16,2000-3000$ 
ES,2020-11-27,A0307870,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/2/2020,12/2/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2200,2200.0,2020-11,1.184064,2604.9408,2000-3000$ 
ES,2020-11-27,A0307907,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/2/2020,12/17/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-11,1.184064,1474.15968,0-1500$ 
ES,2020-11-27,A0307817,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,,12/2/2020,12/2/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,0,0.0,2020-11,1.184064,0.0,0 $
ES,2020-11-27,A0307910,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/2/2020,12/2/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-11,1.184064,2960.16,2000-3000$ 
GB,2020-11-28,A0308030,Clinical,HCA Laboratories,Kefah Mokbel,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/3/2020,12/3/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-11,1.320811,3041.827733,3000+ $
GB,2020-11-28,A0307990,Clinical,HCA Laboratories,Martin Forster,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/3/2020,12/3/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-11,1.320811,3041.827733,3000+ $
GB,2020-11-28,A0308028,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/3/2020,1/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-11,1.320811,3288.81939,3000+ $
BR,2020-11-30,A0308093,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/10/2020,12/10/2020,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,South America,Paid,1350,1350.0,2020-11,1.0,1350.0,0-1500$ 
BR,2020-11-30,A0308118,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,12/7/2020,12/7/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,South America,Paid,1700,1700.0,2020-11,1.0,1700.0,1500-2000$ 
ES,2020-11-30,A0308117,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,12/5/2020,12/5/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-11,1.184064,2960.16,2000-3000$ 
ES,2020-11-30,A0308103,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Anal Carcinoma,12/7/2020,12/7/2020,SPAIN,Commercial,CRC,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-11,1.184064,2960.16,2000-3000$ 
ES,2020-11-30,A0308090,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/7/2020,12/7/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303,2303.0,2020-11,1.184064,2726.899392,2000-3000$ 
GB,2020-11-30,A0308123,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Appendix adenocarcinoma,12/14/2020,12/14/2020,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-30,A0308134,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/5/2020,12/5/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-11,1.320811,3041.827733,3000+ $
GB,2020-11-30,A0308130,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/11/2020,12/11/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-11,1.320811,0.0,0 $
GB,2020-11-30,A0308102,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sharadah Essapen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,12/12/2020,12/12/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2020,4,1,2020-11-01,2020-11,G360 CDx,2020Q4,Europe,Paid,,0.0,2020-11,1.320811,0.0,0 $
CL,2020-12-02,A0308875,Clinical,Clinica Las Condes,Alejandro Majlis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/7/2020,12/7/2020,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,South America,Paid,1550,1550.0,2020-12,1.0,1550.0,1500-2000$ 
FI,2020-12-03,A0309125,Clinical,Turku University Hospital,Eija Korkeila,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,12/9/2020,12/9/2020,FINLAND,Commercial,GI,FINLAND,1,non_AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.217602,3031.8289800000002,3000+ $
FI,2020-12-03,A0309172,Clinical,Turku University Hospital,Taneli Saariaho,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/8/2020,12/8/2020,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.217602,3031.8289800000002,3000+ $
LT,2020-12-03,A0309077,Clinical,Genomika,Mantas Simutis,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),12/10/2020,12/10/2020,LITHUANIA,Commercial,CUP,LITHUANIA,1,non_AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-12,1.217602,2556.9642000000003,2000-3000$ 
ES,2020-12-03,A0309326,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,12/8/2020,12/8/2020,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-12,1.217602,3044.005,3000+ $
TR,2020-12-03,A0309718,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/11/2020,12/31/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-12,1.0,2100.0,2000-3000$ 
ES,2020-12-03,A0309327,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian Serous Carcinoma,12/10/2020,12/10/2020,SPAIN,Commercial,Ovarian,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-12,1.217602,3044.005,3000+ $
CL,2020-12-04,A0309572,Clinical,Clinica Las Condes,Luis Cereceda,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/13/2020,12/22/2020,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,South America,Paid,1550,1550.0,2020-12,1.0,1550.0,1500-2000$ 
GB,2020-12-04,A0309430,Clinical,Cheltenham General Hospital,David Farrugia,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic neuroendocrine tumor,12/18/2020,12/23/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 Infinity,2020Q4,Europe,Free,0,0.0,2020-12,1.342835,0.0,0 $
GB,2020-12-04,A0309697,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,12/11/2020,12/11/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.342835,3343.65915,3000+ $
GB,2020-12-05,A0309999,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,12/12/2020,12/12/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2300,2300.0,2020-12,1.342835,3088.5205,3000+ $
TR,2020-12-05,A0310050,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/13/2020,12/21/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-12,1.0,2100.0,2000-3000$ 
GB,2020-12-07,A0310722,Clinical,Belfast City Hospital Cancer Center,Janusz Mezynski,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/14/2020,12/23/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-12,1.342835,1671.829575,1500-2000$ 
BR,2020-12-07,A0310696,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,12/11/2020,12/11/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,South America,Paid,1700,1700.0,2020-12,1.0,1700.0,1500-2000$ 
GB,2020-12-07,A0310701,Clinical,Bupa Cromwell Hospital,Robert Leonard,Guardant 360,2.11,GHI_01,Self-Pay Patient,Chordoma,12/11/2020,12/11/2020,UNITED KINGDOM,Commercial,Soft Tissue/Bone,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-12,1.342835,1671.829575,1500-2000$ 
GB,2020-12-08,A0310909,Clinical,HCA Laboratories,Laura Kenny,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/12/2020,12/12/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-12,1.342835,3092.549005,3000+ $
GB,2020-12-08,A0310895,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/12/2020,12/12/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-12,1.342835,3092.549005,3000+ $
GB,2020-12-08,A0311002,Clinical,The Royal Marsden NHS Foundation Trust,Daniela Kolarevic,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/14/2020,12/16/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.342835,3343.65915,3000+ $
GB,2020-12-08,A0310991,Clinical,The Royal Marsden Hospital,Alistair Ring,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,12/10/2020,12/10/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,0,0.0,2020-12,1.342835,0.0,0 $
GB,2020-12-08,A0310916,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),12/20/2020,12/20/2020,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2303.25,2303.0,2020-12,1.342835,3092.549005,3000+ $
GB,2020-12-09,A0311359,Clinical,Charing Cross Hospital Medical Oncology Department,Naveed Sarwar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),12/14/2020,12/14/2020,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-12,1.342835,0.0,0 $
GB,2020-12-09,A0311429,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung squamous cell carcinoma,12/14/2020,1/5/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2300,2300.0,2020-12,1.342835,3088.5205,3000+ $
BR,2020-12-09,A0311256,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/14/2020,12/14/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,South America,Paid,1350,1350.0,2020-12,1.0,1350.0,0-1500$ 
MK,2020-12-09,A0311430,Clinical,Dr. Biljana Ilkovska,Biljana Ilkovska,Guardant 360,2.11,GHI_01,Self-Pay Patient,Renal Cell Carcinoma,12/14/2020,1/27/2021,NORTH MACEDONIA,Commercial,Kidney,NORTH MACEDONIA,1,non_AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.217602,3031.8289800000002,3000+ $
GB,2020-12-09,A0311349,Clinical,The Christie Hospital,Donna Graham,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/14/2020,12/14/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-12,1.342835,0.0,0 $
TR,2020-12-09,A0311160,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/14/2020,12/31/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-12,1.0,2100.0,2000-3000$ 
GB,2020-12-09,A0311254,Clinical,The Royal Marsden NHS Foundation Trust,Maria Ifijen,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,12/14/2020,12/14/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.342835,3343.65915,3000+ $
GB,2020-12-09,A0311333,Clinical,BMI - The Princess Margaret Hospital,Harpreet Wasan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,12/15/2020,12/22/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2300,2300.0,2020-12,1.342835,3088.5205,3000+ $
GB,2020-12-10,A0311587,Clinical,HCA Laboratories,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/17/2020,12/17/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,"GBP 2,303.25",2303.0,2020-12,1.342835,3092.549005,3000+ $
GB,2020-12-10,A0311615,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/22/2020,12/22/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-12,1.342835,1671.829575,1500-2000$ 
GB,2020-12-10,A0311661,Clinical,Charing Cross Hospital Medical Oncology Department,Joanne Evans,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/16/2020,12/16/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-12,1.342835,0.0,0 $
GB,2020-12-10,A0311472,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/15/2020,12/15/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,"GBP 2,303.25",2303.0,2020-12,1.342835,3092.549005,3000+ $
GB,2020-12-10,A0311674,Clinical,The Royal Marsden Hospital,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,12/18/2020,12/18/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-12,1.342835,1671.829575,1500-2000$ 
TR,2020-12-11,A0311850,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,12/15/2020,12/31/2020,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-12,1.0,2100.0,2000-3000$ 
BR,2020-12-11,A0311805,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/17/2020,1/5/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,South America,Paid,1350,1350.0,2020-12,1.0,1350.0,0-1500$ 
GB,2020-12-11,A0311838,Clinical,The Royal Marsden NHS Foundation Trust,Alistair Ring,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/15/2020,12/16/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2300,2300.0,2020-12,1.342835,3088.5205,3000+ $
GB,2020-12-11,A0312001,Clinical,Charing Cross Hospital Medical Oncology Department,Danielle Power,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,12/17/2020,1/4/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.342835,3343.65915,3000+ $
IE,2020-12-12,A0312164,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,12/18/2020,12/18/2020,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-12,1.217602,1515.9144900000001,1500-2000$ 
GB,2020-12-12,A0312190,Clinical,Southampton General Hospital,Charlotte Rees,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,12/21/2020,12/21/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-12,1.342835,0.0,0 $
GB,2020-12-12,A0312320,Clinical,Charing Cross Hospital Medical Oncology Department,Danielle Power,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,12/19/2020,12/19/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.342835,3343.65915,3000+ $
GB,2020-12-12,A0312213,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/16/2020,12/16/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.342835,3343.65915,3000+ $
GB,2020-12-12,A0312292,Clinical,HCA Laboratories,Anne Rigg,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/19/2020,12/19/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,"GBP 2,303.25",2303.0,2020-12,1.342835,3092.549005,3000+ $
ES,2020-12-14,A0312389,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/21/2020,12/22/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2200,2200.0,2020-12,1.217602,2678.7244,2000-3000$ 
ES,2020-12-14,A0312390,Clinical,Hospital Clinico Provincial de Barcelona,Tamara Sauri,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,12/19/2020,12/19/2020,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2200,2200.0,2020-12,1.217602,2678.7244,2000-3000$ 
GB,2020-12-14,A0312391,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,12/24/2020,12/24/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-12,1.342835,1671.829575,1500-2000$ 
GB,2020-12-15,A0312572,Clinical,Coventry University Hospitals,Susan Lupton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/20/2020,12/20/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-12,1.342835,0.0,0 $
GB,2020-12-16,A0312917,Clinical,Southampton General Hospital,Hugo De La Pena,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/21/2020,12/21/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-12,1.342835,0.0,0 $
GB,2020-12-16,A0312834,Clinical,BMI Cavell Hospital,Stephen Karp,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/21/2020,12/21/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.342835,3343.65915,3000+ $
DE,2020-12-16,A0312909,Clinical,Deutsches Krebsforschungszentrum National Center for Tumor Diseases (NCT),Amir Abdollahi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/22/2020,12/23/2020,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2990,2990.0,2020-12,1.217602,3640.62998,3000+ $
GB,2020-12-17,A0313329,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,12/22/2020,1/11/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-12,1.342835,1671.829575,1500-2000$ 
CL,2020-12-17,A0313252,Clinical,Clinica Alemana,Conrado Vogel,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/26/2020,12/30/2020,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,South America,Paid,2500,2500.0,2020-12,1.0,2500.0,2000-3000$ 
GB,2020-12-17,A0313391,Clinical,The Royal Marsden Hospital,Merina Ahmed,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,12/22/2020,12/22/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-12,1.342835,1671.829575,1500-2000$ 
ES,2020-12-17,A0313284,Clinical,Hospital Clinico Provincial de Barcelona,Aleix Prat,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/22/2020,12/22/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2200,2200.0,2020-12,1.217602,2678.7244,2000-3000$ 
GB,2020-12-18,A0314330,Clinical,The Christie Hospital,Matthew Krebs,Guardant 360,2.11,GHI_01,Distributors : ROW,Soft tissue sarcoma,12/28/2020,12/28/2020,UNITED KINGDOM,Commercial,Soft Tissue/Bone,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-12,1.342835,0.0,0 $
GB,2020-12-18,A0314303,Clinical,The Christie Hospital,Natalie Cook,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),12/25/2020,12/25/2020,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-12,1.342835,0.0,0 $
ES,2020-12-18,A0313721,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/23/2020,12/23/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2200,2200.0,2020-12,1.217602,2678.7244,2000-3000$ 
GB,2020-12-19,A0314681,Clinical,Synthesis Clinic,Nina Fuller-Shavel,Guardant 360,2.11,GHI_01,Self-Pay Patient,Endometrial carcinoma,12/31/2020,12/31/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,????,0.0,2020-12,1.342835,0.0,0 $
ES,2020-12-19,A0314737,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/28/2020,12/28/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-12,1.217602,3044.005,3000+ $
GB,2020-12-19,A0314857,Clinical,HCA Laboratories,Peter Harper,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/26/2020,12/26/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,"GBP 2,303.25",2303.0,2020-12,1.342835,3092.549005,3000+ $
GB,2020-12-19,A0314805,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/25/2020,12/29/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.342835,3343.65915,3000+ $
GB,2020-12-21,A0314923,Clinical,Charing Cross Hospital Medical Oncology Department,Michael Seckl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,12/30/2020,12/30/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2490,2490.0,2020-12,1.342835,3343.65915,3000+ $
BR,2020-12-21,A0314905,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/28/2020,12/28/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,South America,Paid,1350,1350.0,2020-12,1.0,1350.0,0-1500$ 
FR,2020-12-21,A0314929,Clinical,Gustave Roussy Cancer Campus,Antoine Hollebecque,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/28/2020,12/28/2020,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-12,1.217602,0.0,0 $
GB,2020-12-21,A0314907,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Jonathan Dakin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,12/27/2020,12/27/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,,0.0,2020-12,1.342835,0.0,0 $
BR,2020-12-21,A0314939,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,12/25/2020,12/25/2020,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,South America,Paid,1700,1700.0,2020-12,1.0,1700.0,1500-2000$ 
ES,2020-12-21,A0314938,Clinical,Clinica Rotger Quironsalud,Teresa Acuna,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/25/2020,12/25/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-12,1.217602,1515.9144900000001,1500-2000$ 
GB,2020-12-21,A0314928,Clinical,The Royal Marsden NHS Foundation Trust,David Cunningham,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,12/28/2020,1/5/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2300 ????,2300.0,2020-12,1.342835,3088.5205,3000+ $
GB,2020-12-22,A0315151,Clinical,HCA Laboratories,Martin Forster,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,12/31/2020,12/31/2020,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,"GBP 2,303.25",2303.0,2020-12,1.342835,3092.549005,3000+ $
GB,2020-12-23,A0315229,Clinical,The Royal Marsden Hospital,Naureen Starling,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/31/2020,12/31/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-12,1.342835,0.0,0 $
GB,2020-12-23,A0315460,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,12/31/2020,12/31/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2300,2300.0,2020-12,1.342835,3088.5205,3000+ $
ES,2020-12-23,A0315355,Clinical,Hospital Parc Tauli,Laia Vila,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/29/2020,12/29/2020,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Free,0,0.0,2020-12,1.217602,0.0,0 $
GB,2020-12-23,A0315251,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/28/2020,12/28/2020,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-12,1.342835,1671.829575,1500-2000$ 
GB,2020-12-23,A0315274,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/28/2020,12/28/2020,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,"GBP 2,303.25",2303.0,2020-12,1.342835,3092.549005,3000+ $
ES,2020-12-24,A0315602,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/29/2020,12/29/2020,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,"EUR 2,303.00",2303.0,2020-12,1.217602,2804.1374060000003,2000-3000$ 
ES,2020-12-28,A0316040,Clinical,Hospital Universitario de Guadalajara,Isabel Fernandez,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,1/4/2021,1/4/2021,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,,0.0,2020-12,1.217602,0.0,0 $
TR,2020-12-28,A0316045,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/4/2021,1/4/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-12,1.0,2100.0,2000-3000$ 
TR,2020-12-28,A0316033,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/2/2021,1/2/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2100,2100.0,2020-12,1.0,2100.0,2000-3000$ 
ES,2020-12-28,A0316018,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,1/4/2021,1/4/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2500,2500.0,2020-12,1.217602,3044.005,3000+ $
GB,2020-12-31,A0316978,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/5/2021,1/5/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,2300,2300.0,2020-12,1.342835,3088.5205,3000+ $
GB,2020-12-31,A0316970,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,1/5/2021,1/5/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,1245,1245.0,2020-12,1.342835,1671.829575,1500-2000$ 
GB,2020-12-31,A0316887,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Prostate adenocarcinoma,1/7/2021,1/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2020,4,1,2020-12-01,2020-12,G360 CDx,2020Q4,Europe,Paid,0,0.0,2020-12,1.342835,0.0,0 $
GB,2021-01-02,A0317115,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/8/2021,1/28/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-01,1.364039,1698.228555,1500-2000$ 
GR,2021-01-02,A0317088,Clinical,Attikon University Hospital,Amanda Psyrri,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,1/7/2021,1/13/2021,GREECE,Commercial,Other,GREECE,1,non_AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.216347,3028.7040300000003,3000+ $
GB,2021-01-04,A0317229,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/11/2021,1/11/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-01,1.364039,3137.2897,3000+ $
MX,2021-01-05,A0317557,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,1/12/2021,1/14/2021,MEXICO,Commercial,GI,MEXICO,1,non_AE,EUR,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1700,1700.0,2021-01,1.216347,2067.7899,2000-3000$ 
ES,2021-01-05,A0317545,Clinical,Hospital Duran i Reynals-ICO Hospitalet,Ernest Nadal,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/9/2021,1/13/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-01,1.216347,1514.3520150000002,1500-2000$ 
GB,2021-01-05,A0317480,Clinical,The Nuffield Hospital Guildford,Robert Laing,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/11/2021,1/11/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-01,1.364039,3137.2897,3000+ $
ES,2021-01-07,A0318818,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/12/2021,1/12/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
GB,2021-01-07,A0318983,Clinical,Princess Elizabeth Hospital,Peter J Gomes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/13/2021,1/13/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.364039,3396.45711,3000+ $
ES,2021-01-07,A0318825,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Colorectal adenocarcinoma,1/14/2021,1/14/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,0,0.0,2021-01,1.216347,0.0,0 $
GB,2021-01-07,A0318758,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,1/12/2021,1/12/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
ES,2021-01-07,A0318772,Clinical,Centro de Salud Icod de los Vinos,Mercedes Sanchez Guiu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/12/2021,1/12/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.216347,3028.7040300000003,3000+ $
FI,2021-01-07,A0318902,Clinical,Turku University Hospital,Eija Korkeila,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,1/15/2021,1/15/2021,FINLAND,Commercial,GI,FINLAND,1,non_AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490 EUR,2490.0,2021-01,1.216347,3028.7040300000003,3000+ $
MX,2021-01-07,A0318648,Clinical,MileniaLabs,Andrea Castro Sanchez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,1/11/2021,2/1/2021,MEXICO,Commercial,Other,MEXICO,1,non_AE,EUR,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
GB,2021-01-07,A0318839,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/13/2021,3/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-01,1.364039,1698.228555,1500-2000$ 
CL,2021-01-07,A0318776,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/12/2021,1/12/2021,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1550,1550.0,2021-01,1.0,1550.0,1500-2000$ 
GB,2021-01-07,A0318836,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Large cell lung carcinoma,1/14/2021,2/3/2021,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-01,1.364039,1698.228555,1500-2000$ 
GB,2021-01-07,A0318762,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,1/13/2021,2/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,1244,1244.0,2021-01,1.364039,1696.864516,1500-2000$ 
MX,2021-01-08,A0319111,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/14/2021,1/14/2021,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1700,1700.0,2021-01,1.216347,2067.7899,2000-3000$ 
GB,2021-01-08,A0319064,Clinical,The Christie Hospital,Natalie Cook,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/13/2021,1/13/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
BE,2021-01-08,A0318985,Clinical,University Hospital Antwerp,Hans Prenen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,1/13/2021,1/13/2021,BELGIUM,Commercial,,BELGIUM,1,non_AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,,0.0,2021-01,1.216347,0.0,0 $
TR,2021-01-11,A0319621,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Small cell lung carcinoma,1/15/2021,2/16/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-01,1.0,2100.0,2000-3000$ 
GB,2021-01-11,A0319629,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/16/2021,1/16/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-01,1.364039,3137.2897,3000+ $
GB,2021-01-11,A0319641,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/17/2021,1/17/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.364039,3396.45711,3000+ $
GB,2021-01-11,A0319627,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/15/2021,1/15/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2303.25,2303.0,2021-01,1.364039,3141.381817,3000+ $
ES,2021-01-11,A0319674,Clinical,Hospital Quiron Barcelona,Victor Albarran,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/18/2021,1/18/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2241 EUR,2241.0,2021-01,1.216347,2725.833627,2000-3000$ 
GB,2021-01-11,A0319653,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/15/2021,6/1/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.364039,3396.45711,3000+ $
GB,2021-01-12,A0319864,Clinical,The Christie Hospital,Natalie Cook,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,1/28/2021,1/28/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
CA,2021-01-12,A0319823,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/17/2021,1/17/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Canada,Paid,1750,1750.0,2021-01,1.0,1750.0,1500-2000$ 
GB,2021-01-12,A0319863,Clinical,The Christie Hospital,Natalie Cook,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastroesophageal junction carcinoma,1/24/2021,1/24/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
BR,2021-01-13,A0320111,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/19/2021,3/4/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-01,1.0,1350.0,0-1500$ 
GB,2021-01-14,A0320395,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,1/23/2021,1/23/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.364039,3396.45711,3000+ $
GB,2021-01-14,A0320491,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/21/2021,2/26/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-01,1.364039,1698.228555,1500-2000$ 
DE,2021-01-14,A0320554,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Hepatocellular carcinoma,1/20/2021,1/20/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2990,2990.0,2021-01,1.216347,3636.87753,3000+ $
GB,2021-01-14,A0320503,Clinical,The Christie Hospital,Matthew Krebs,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,1/19/2021,1/19/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
CL,2021-01-14,A0320432,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/19/2021,2/1/2021,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1550,1550.0,2021-01,1.0,1550.0,1500-2000$ 
GB,2021-01-14,A0320291,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sharadah Essapen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/19/2021,1/19/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-01,1.364039,3137.2897,3000+ $
MX,2021-01-14,A0320519,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,1/19/2021,1/19/2021,MEXICO,Commercial,GI,MEXICO,1,non_AE,EUR,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1700,1700.0,2021-01,1.216347,2067.7899,2000-3000$ 
GB,2021-01-14,A0320434,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,1/19/2021,2/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-01,1.364039,1698.228555,1500-2000$ 
BR,2021-01-15,A0320631,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/20/2021,3/4/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-01,1.0,1350.0,0-1500$ 
GB,2021-01-15,A0320934,Clinical,Sussex Cancer Centre,Joanna Stokoe,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/21/2021,1/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
GB,2021-01-15,A0320928,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/21/2021,1/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
GB,2021-01-16,A0321240,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,1/22/2021,1/22/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.364039,3396.45711,3000+ $
GB,2021-01-16,A0321420,Clinical,The Christie Hospital,Louise Carter,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,1/23/2021,1/23/2021,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
GB,2021-01-16,A0321424,Clinical,The Christie Hospital,Natalie Cook,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,1/25/2021,1/25/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
ES,2021-01-16,A0321391,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,1/25/2021,1/25/2021,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
ES,2021-01-16,A0321390,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,1/23/2021,1/23/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
CA,2021-01-18,A0321439,Clinical,Dr. Rich Hsu,Rich Hsu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/22/2021,2/1/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Canada,Paid,3150,3150.0,2021-01,1.0,3150.0,3000+ $
ES,2021-01-18,A0321441,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/22/2021,1/22/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
ES,2021-01-18,A0321458,Clinical,Clinica Universidad de Navarra,Jose Luis Perez Gracia,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/22/2021,1/22/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
ES,2021-01-18,A0321427,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,1/25/2021,1/25/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
ES,2021-01-18,A0321457,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/22/2021,1/22/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
ES,2021-01-18,A0321419,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/22/2021,1/22/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
ES,2021-01-18,A0321414,Clinical,Hospital Ruber Internacional,Victor Albarran,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/23/2021,1/23/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2241 EUR,2241.0,2021-01,1.216347,2725.833627,2000-3000$ 
ES,2021-01-18,A0321472,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/23/2021,1/23/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.216347,3028.7040300000003,3000+ $
GB,2021-01-18,A0321471,Clinical,HCA at The Christie Clinic,Raffaele Califano,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,1/22/2021,2/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-01,1.364039,1698.228555,1500-2000$ 
ES,2021-01-18,A0321433,Clinical,Hospital Ruber Internacional,Francisco Javier Roman Garcia,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/25/2021,1/25/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,"EUR 2,303.00",2303.0,2021-01,1.216347,2801.2471410000003,2000-3000$ 
BR,2021-01-20,A0321937,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/25/2021,3/4/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-01,1.0,1350.0,0-1500$ 
GB,2021-01-20,A0321776,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/25/2021,2/26/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.364039,3396.45711,3000+ $
ES,2021-01-20,A0322043,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/26/2021,1/26/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.216347,3028.7040300000003,3000+ $
TR,2021-01-20,A0321977,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,1/22/2021,1/22/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,0,0.0,2021-01,1.0,0.0,0 $
GB,2021-01-21,A0322710,Clinical,The Christie Hospital,Matthew Krebs,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/28/2021,1/28/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
GB,2021-01-21,A0322644,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,1/28/2021,2/4/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-01,1.364039,1698.228555,1500-2000$ 
ES,2021-01-21,A0322437,Clinical,Hospital Quironsalud Sagrado Corazon,Juan Antonio Virizuela,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/26/2021,1/26/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.216347,3028.7040300000003,3000+ $
MX,2021-01-21,A0322630,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/27/2021,1/27/2021,MEXICO,Commercial,Breast,MEXICO,1,non_AE,EUR,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1700,1700.0,2021-01,1.216347,2067.7899,2000-3000$ 
ES,2021-01-22,A0322769,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/28/2021,1/28/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
ES,2021-01-22,A0322762,Clinical,Hospital Quiron Barcelona,Alejandro Navarro,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/26/2021,1/26/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2303,2303.0,2021-01,1.216347,2801.2471410000003,2000-3000$ 
BR,2021-01-22,A0322768,Clinical,Diagnosticos da America S.A.,Nise Yamaguchi,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/30/2021,3/4/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-01,1.0,1350.0,0-1500$ 
ES,2021-01-22,A0322890,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/31/2021,1/31/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
ES,2021-01-22,A0322765,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/28/2021,1/28/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
GB,2021-01-22,A0322763,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,1/28/2021,2/4/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.364039,3396.45711,3000+ $
ES,2021-01-22,A0322761,Clinical,Clinica Universidad de Navarra-Madrid,Antonio Gonzalez Martin,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/28/2021,1/28/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-01,1.216347,3040.8675000000003,3000+ $
GB,2021-01-25,A0323567,Clinical,The Christie Hospital,Donna Graham,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/1/2021,2/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
FI,2021-01-25,A0323549,Clinical,Turku University Hospital,Heikki Vilhonen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/1/2021,2/25/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490 EUR,2490.0,2021-01,1.216347,3028.7040300000003,3000+ $
TR,2021-01-25,A0323543,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,2/1/2021,2/16/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-01,1.0,2100.0,2000-3000$ 
TR,2021-01-25,A0323533,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,2/1/2021,2/16/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-01,1.0,2100.0,2000-3000$ 
ES,2021-01-25,A0323538,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/31/2021,1/31/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2303,2303.0,2021-01,1.216347,2801.2471410000003,2000-3000$ 
TR,2021-01-25,A0323539,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/1/2021,2/16/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-01,1.0,2100.0,2000-3000$ 
GB,2021-01-25,A0323546,Clinical,Bupa Cromwell Hospital,Robert Leonard,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/1/2021,2/1/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.364039,3396.45711,3000+ $
GB,2021-01-25,A0323552,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,2/2/2021,2/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.364039,3396.45711,3000+ $
GB,2021-01-25,A0323534,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal adenocarcinoma,2/2/2021,6/1/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-01,1.364039,3137.2897,3000+ $
TR,2021-01-25,A0323532,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/31/2021,2/16/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-01,1.0,2100.0,2000-3000$ 
GB,2021-01-27,A0324020,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/2/2021,2/4/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-01,1.364039,1698.228555,1500-2000$ 
ES,2021-01-28,A0324654,Clinical,HC Marbella International Hospital,Hernan Cortes Funes,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),2/5/2021,2/5/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.216347,3028.7040300000003,3000+ $
GB,2021-01-28,A0324646,Clinical,The Christie Hospital,Louise Carter,Guardant 360,2.11,GHI_01,Distributors : ROW,Fibrosarcoma,2/3/2021,2/3/2021,UNITED KINGDOM,Commercial,Soft Tissue/Bone,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-01,1.364039,0.0,0 $
BR,2021-01-28,A0324492,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,2/2/2021,3/4/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-01,1.0,1350.0,0-1500$ 
GB,2021-01-28,A0324381,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/3/2021,2/12/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-01,1.364039,1698.228555,1500-2000$ 
PE,2021-01-29,A0324851,Clinical,Oncosalud â€“ Oncocenter,Paola Montenegro Beltran,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,2/3/2021,3/2/2021,PERU,Commercial,Other,PERU,1,non_AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,2500,2500.0,2021-01,1.0,2500.0,2000-3000$ 
FI,2021-01-29,A0324760,Clinical,Turku University Hospital,Eija Korkeila,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,2/3/2021,2/3/2021,FINLAND,Commercial,GI,FINLAND,1,non_AE,EUR,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490 EUR,2490.0,2021-01,1.216347,3028.7040300000003,3000+ $
GB,2021-01-30,A0325462,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/5/2021,2/5/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.364039,3396.45711,3000+ $
CO,2021-01-30,A0325314,Clinical,OncoBiotecGen,Silvia Maradei,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Prostate adenocarcinoma,2/4/2021,4/1/2021,COLOMBIA,Commercial,,COLOMBIA,1,non_AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,3490,3490.0,2021-01,1.0,3490.0,3000+ $
GB,2021-01-30,A0325463,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/6/2021,2/6/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-01,1.364039,3396.45711,3000+ $
BR,2021-01-30,A0325304,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,2/5/2021,2/9/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2021,1,1,2021-01-01,2021-01,G360 CDx,2021Q1,South America,Paid,1700,1700.0,2021-01,1.0,1700.0,1500-2000$ 
MX,2021-02-01,A0325511,Clinical,MileniaLabs,Ivan Romarico Gonzalez Espinoza,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/9/2021,2/23/2021,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
ES,2021-02-01,A0325510,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/10/2021,2/10/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
ES,2021-02-01,A0325472,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/5/2021,2/5/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
ES,2021-02-01,A0325495,Clinical,Clinica Corachan,Miguel Hernandez Bronchud,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,2/7/2021,2/7/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-02,1.209424,3011.46576,3000+ $
GB,2021-02-01,A0325508,Clinical,Southampton General Hospital,Charlotte Rees,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/7/2021,2/12/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-02,1.387217,1727.085165,1500-2000$ 
GB,2021-02-01,A0325513,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/7/2021,2/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-02,1.387217,0.0,0 $
GB,2021-02-01,A0325558,Clinical,"NHS Highland, Raigmore Hospital, Inverness",Walter Mmeka,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/7/2021,7/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-02,1.387217,1727.085165,1500-2000$ 
GB,2021-02-02,A0325693,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/9/2021,2/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-02,1.387217,3108.7532969999997,3000+ $
FI,2021-02-02,A0325575,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/8/2021,2/8/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2490 EUR,2490.0,2021-02,1.209424,3011.46576,3000+ $
ES,2021-02-02,A0325742,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,2/11/2021,2/11/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
GB,2021-02-02,A0325678,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/6/2021,2/8/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-02,1.387217,1727.085165,1500-2000$ 
ES,2021-02-03,A0325888,Clinical,Clinica Universidad de Navarra-Madrid,Jesus Corral,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/7/2021,2/7/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
ES,2021-02-03,A0325887,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/8/2021,2/8/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2200,2200.0,2021-02,1.209424,2660.7328,2000-3000$ 
BR,2021-02-04,A0326135,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/15/2021,3/4/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-02,1.0,1350.0,0-1500$ 
BR,2021-02-04,A0326141,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,2/11/2021,3/4/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-02,1.0,1350.0,0-1500$ 
GB,2021-02-04,A0326100,Clinical,HCA Laboratories,Mark Harries,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/10/2021,2/10/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-02,1.387217,3108.7532969999997,3000+ $
GB,2021-02-04,A0326067,Clinical,The Nuffield Hospital Guildford,Robert Laing,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/8/2021,2/8/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-02,1.387217,3190.5991,3000+ $
GB,2021-02-04,A0326145,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/9/2021,2/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-02,1.387217,3108.7532969999997,3000+ $
AT,2021-02-04,A0326309,Clinical,Naturheilpraxis Dr. med. Baumert,Stefan Baumert,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,,2/11/2021,2/11/2021,AUSTRIA,Commercial,,AUSTRIA,1,non_AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,0,0.0,2021-02,1.209424,0.0,0 $
GB,2021-02-04,A0326282,Clinical,The Christie Hospital,Matthew Krebs,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/9/2021,2/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-02,1.387217,0.0,0 $
ES,2021-02-04,A0326069,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/19/2021,2/19/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
ES,2021-02-05,A0326503,Clinical,Clinica Universidad de Navarra-Madrid,Jesus Corral,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/11/2021,2/11/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
ES,2021-02-05,A0326616,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/15/2021,2/15/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
GB,2021-02-05,A0326609,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/10/2021,2/10/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-02,1.387217,1727.085165,1500-2000$ 
DE,2021-02-05,A0326467,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/10/2021,2/10/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2990,2990.0,2021-02,1.209424,3616.17776,3000+ $
MX,2021-02-05,A0326637,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),2/10/2021,2/10/2021,MEXICO,Commercial,CUP,MEXICO,1,non_AE,EUR,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1700,1700.0,2021-02,1.209424,2056.0208000000002,2000-3000$ 
GB,2021-02-05,A0326462,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/10/2021,2/10/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-02,1.387217,3190.5991,3000+ $
CL,2021-02-08,A0327337,Clinical,Clinica Las Condes,Luis Cereceda,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/17/2021,5/12/2021,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1550,1550.0,2021-02,1.0,1550.0,1500-2000$ 
IE,2021-02-08,A0327317,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/15/2021,2/25/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-02,1.209424,1505.73288,1500-2000$ 
ES,2021-02-08,A0327301,Clinical,CIMALab Diagnostics,Gorka Alkorta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/13/2021,2/16/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,,0.0,2021-02,1.209424,0.0,0 $
ES,2021-02-08,A0327326,Clinical,Genesiscare Hospital San Francisco de Asis,Lucrecia Ruiz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/15/2021,2/15/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-02,1.209424,3011.46576,3000+ $
ES,2021-02-08,A0327302,Clinical,Fundacion Jimenez Diaz,Cristina Carames Sanchez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,2/14/2021,2/14/2021,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-02,1.209424,1505.73288,1500-2000$ 
ES,2021-02-08,A0327348,Clinical,Fundacion Jimenez Diaz,Cristina Carames Sanchez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,2/13/2021,2/13/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-02,1.209424,1505.73288,1500-2000$ 
ES,2021-02-08,A0327335,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/14/2021,3/2/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-02,1.209424,3011.46576,3000+ $
ES,2021-02-08,A0327324,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/15/2021,2/15/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
ES,2021-02-08,A0327319,Clinical,Hospital Ruber Internacional,Cesar Mendiola,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastroesophageal junction carcinoma,2/17/2021,2/17/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2241 EUR,2241.0,2021-02,1.209424,2710.319184,2000-3000$ 
BR,2021-02-09,A0327423,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/14/2021,3/4/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-02,1.0,1350.0,0-1500$ 
BR,2021-02-09,A0327432,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/22/2021,3/4/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-02,1.0,1350.0,0-1500$ 
GB,2021-02-10,A0327844,Clinical,University Hospitals Of Leicester,Jan Mozny,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/15/2021,2/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-02,1.387217,1727.085165,1500-2000$ 
BR,2021-02-10,A0327742,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/14/2021,2/14/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1700,1700.0,2021-02,1.0,1700.0,1500-2000$ 
ES,2021-02-11,A0328098,Clinical,Clinica Universidad de Navarra-Madrid,Jesus Corral,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/17/2021,2/17/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
ES,2021-02-11,A0328049,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/16/2021,2/16/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
GB,2021-02-11,A0328058,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/16/2021,2/16/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-02,1.387217,3454.17033,3000+ $
GB,2021-02-11,A0328069,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/15/2021,2/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-02,1.387217,0.0,0 $
GB,2021-02-13,A0328782,Clinical,The Holly Private Hospital,Sherif Raouf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,2/19/2021,4/26/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-02,1.387217,3190.5991,3000+ $
GB,2021-02-13,A0328686,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/18/2021,2/18/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,"GBP 2,241.00",2241.0,2021-02,1.387217,3108.7532969999997,3000+ $
BR,2021-02-15,A0329065,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/23/2021,3/4/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-02,1.0,1350.0,0-1500$ 
BR,2021-02-15,A0329060,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,2/23/2021,3/4/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-02,1.0,1350.0,0-1500$ 
GB,2021-02-15,A0329035,Clinical,Western General Hospital - Edinburgh Cancer Centre,Olga Oikonomidou,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,2/23/2021,2/24/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-02,1.387217,1727.085165,1500-2000$ 
ES,2021-02-15,A0329072,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Large cell lung carcinoma,2/23/2021,2/23/2021,SPAIN,Commercial,Lung,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
GB,2021-02-15,A0329063,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/23/2021,2/23/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-02,1.387217,3108.7532969999997,3000+ $
ES,2021-02-17,A0329310,Clinical,Hospital Quiron Barcelona,Victor Albarran,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),2/24/2021,3/1/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2241 EUR,2241.0,2021-02,1.209424,2710.319184,2000-3000$ 
GB,2021-02-22,A0330145,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/27/2021,2/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-02,1.387217,0.0,0 $
FI,2021-02-22,A0330137,Clinical,Turku University Hospital,Eija Korkeila,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/27/2021,2/27/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2366 EUR,2366.0,2021-02,1.209424,2861.4971840000003,2000-3000$ 
TR,2021-02-22,A0330110,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/27/2021,3/16/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-02,1.0,2100.0,2000-3000$ 
TR,2021-02-22,A0330116,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/27/2021,3/16/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-02,1.0,2100.0,2000-3000$ 
CL,2021-02-22,A0330121,Clinical,Clinica Las Condes,Luis Cereceda,Guardant 360,2.11,GHI_01,Self-Pay Patient,Sarcoma,3/1/2021,5/20/2021,CHILE,Commercial,Soft Tissue/Bone,CHILE,1,non_AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1550,1550.0,2021-02,1.0,1550.0,1500-2000$ 
ES,2021-02-22,A0330072,Clinical,Hospital Quiron Barcelona,Victor Albarran,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/28/2021,2/28/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2241 EUR,2241.0,2021-02,1.209424,2710.319184,2000-3000$ 
FI,2021-02-22,A0330152,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/27/2021,2/27/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2490 EUR,2490.0,2021-02,1.209424,3011.46576,3000+ $
GB,2021-02-22,A0330125,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,3/3/2021,3/3/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-02,1.387217,3108.7532969999997,3000+ $
GB,2021-02-22,A0330108,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,2/28/2021,2/28/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-02,1.387217,0.0,0 $
GB,2021-02-23,A0330310,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Bernadette Lavery,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,3/2/2021,3/15/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-02,1.387217,3454.17033,3000+ $
BR,2021-02-23,A0330558,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,3/2/2021,3/2/2021,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1700,1700.0,2021-02,1.0,1700.0,1500-2000$ 
BR,2021-02-23,A0330390,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),2/27/2021,3/4/2021,BRAZIL,Commercial,CUP,BRAZIL,1,AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-02,1.0,1350.0,0-1500$ 
ES,2021-02-23,A0330505,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,3/2/2021,3/2/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
AT,2021-02-23,A0330556,Clinical,Naturheilpraxis Dr. med. Baumert,Stefan Baumert,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/3/2021,3/3/2021,AUSTRIA,Commercial,,AUSTRIA,1,non_AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,,0.0,2021-02,1.209424,0.0,0 $
ES,2021-02-24,A0330652,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Large cell lung carcinoma,3/3/2021,3/3/2021,SPAIN,Commercial,Lung,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
ES,2021-02-24,A0330644,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Pancreatic ductal adenocarcinoma,3/2/2021,3/2/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,0,0.0,2021-02,1.209424,0.0,0 $
ES,2021-02-24,A0330797,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/10/2021,3/10/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-02,1.209424,3023.56,3000+ $
GB,2021-02-24,A0330809,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,3/4/2021,3/4/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-02,1.387217,1727.085165,1500-2000$ 
GB,2021-02-24,A0330761,Clinical,Southend University Hospital,Hafiz Algurafi,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/4/2021,3/4/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-02,1.387217,0.0,0 $
GB,2021-02-25,A0331377,Clinical,GenesisCare,Georgios Antoniou,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,3/5/2021,3/8/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2409,2409.0,2021-02,1.387217,3341.8057529999996,3000+ $
TR,2021-02-25,A0331537,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/2/2021,3/16/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-02,1.0,2100.0,2000-3000$ 
GB,2021-02-25,A0331329,Clinical,The Nuffield Hospital Guildford,Robert Laing,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/5/2021,3/31/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-02,1.387217,3454.17033,3000+ $
BR,2021-02-26,A0331990,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/3/2021,3/3/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-02,1.0,1350.0,0-1500$ 
GB,2021-02-26,A0332260,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,3/2/2021,5/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-02,1.387217,3454.17033,3000+ $
DE,2021-02-26,A0332255,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Renal Cell Carcinoma,3/4/2021,3/4/2021,GERMANY,Commercial,Kidney,GERMANY,1,non_AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2990,2990.0,2021-02,1.209424,3616.17776,3000+ $
DE,2021-02-26,A0332265,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/2/2021,3/2/2021,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2990,2990.0,2021-02,1.209424,3616.17776,3000+ $
ES,2021-02-27,A0332451,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/8/2021,3/26/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2241 EUR,2241.0,2021-02,1.209424,2710.319184,2000-3000$ 
ES,2021-02-27,A0332631,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/9/2021,3/9/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1745,1745.0,2021-02,1.209424,2110.44488,2000-3000$ 
GB,2021-02-27,A0332558,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Shairoz Merchant,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/6/2021,3/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-02,1.387217,1727.085165,1500-2000$ 
GB,2021-02-27,A0332445,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung carcinoid,3/5/2021,3/26/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-02,1.387217,0.0,0 $
GB,2021-02-27,A0332605,Clinical,The Nuffield Hospital Guildford,Robert Laing,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/5/2021,3/12/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2021,1,1,2021-02-01,2021-02,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-02,1.387217,3454.17033,3000+ $
ES,2021-03-01,A0332672,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/9/2021,3/9/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-03,1.190316,2975.79,2000-3000$ 
ES,2021-03-01,A0332731,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/9/2021,3/9/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-03,1.190316,2975.79,2000-3000$ 
AR,2021-03-01,A0332674,Clinical,Laboratorio Genia,Andres Casella,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/9/2021,3/15/2021,ARGENTINA,Commercial,Breast,ARGENTINA,1,non_AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,2000,2000.0,2021-03,1.0,2000.0,1500-2000$ 
FI,2021-03-02,A0333261,Clinical,Turku University Hospital,Johanna Ruohola,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Other,3/10/2021,3/31/2021,FINLAND,Commercial,Other,FINLAND,1,non_AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2366 EUR,2366.0,2021-03,1.190316,2816.287656,2000-3000$ 
CH,2021-03-02,A0332880,Clinical,Lausanne University Hospital (CHUV),Nicolas Demartines,Guardant 360,2.12,GH2_12,Self-Pay Patient,Other,3/11/2021,3/11/2021,SWITZERLAND,Commercial,Other,SWITZERLAND,1,non_AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 Infinity,2021Q1,Europe,Paid,0,0.0,2021-03,1.190316,0.0,0 $
LT,2021-03-02,A0333099,Clinical,Genomika,Mantas Simutis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/10/2021,3/10/2021,LITHUANIA,Commercial,Breast,LITHUANIA,1,non_AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-03,1.190316,2499.6636,2000-3000$ 
GB,2021-03-02,A0332991,Clinical,Sussex Cancer Centre,Katie Wakeham,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/10/2021,3/10/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-03,1.385948,0.0,0 $
GB,2021-03-02,A0333107,Clinical,HCA Laboratories,Amen Sibtain,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/10/2021,3/10/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-03,1.385948,3105.909468,3000+ $
IE,2021-03-03,A0333586,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/10/2021,3/10/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.190316,1481.9434199999998,0-1500$ 
GB,2021-03-03,A0333645,Clinical,Sheffield Weston Park Cancer Centre,Nanditha Boindala,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/10/2021,3/10/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-03,1.385948,0.0,0 $
CO,2021-03-04,A0333871,Clinical,OncoBiotecGen,Silvia Maradei,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Prostate adenocarcinoma,3/10/2021,4/1/2021,COLOMBIA,Commercial,,COLOMBIA,1,non_AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,2100,2100.0,2021-03,1.0,2100.0,2000-3000$ 
BR,2021-03-04,A0333865,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/10/2021,3/10/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-03,1.0,1350.0,0-1500$ 
BR,2021-03-04,A0333859,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/11/2021,3/11/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-03,1.0,1350.0,0-1500$ 
GB,2021-03-04,A0334051,Clinical,Bristol Haematology and Oncology Centre,Jeremy Braybrooke,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/11/2021,3/11/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
ES,2021-03-04,A0333787,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/16/2021,3/16/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-03,1.190316,2975.79,2000-3000$ 
GB,2021-03-04,A0334080,Clinical,Charing Cross Hospital Medical Oncology Department,David Pinato,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,3/11/2021,3/11/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-03,1.385948,0.0,0 $
ES,2021-03-04,A0334062,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung carcinoid,3/11/2021,3/11/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-03,1.190316,2975.79,2000-3000$ 
GB,2021-03-04,A0333870,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,3/12/2021,3/12/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
ES,2021-03-04,A0333732,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,3/11/2021,3/11/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241 EUR,2241.0,2021-03,1.190316,2667.4981559999997,2000-3000$ 
GB,2021-03-05,A0334520,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),3/12/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
GB,2021-03-05,A0334551,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/12/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
GB,2021-03-05,A0334435,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/12/2021,3/12/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-03,1.385948,3105.909468,3000+ $
GB,2021-03-06,A0334985,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,,3/23/2021,3/23/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-03,1.385948,3105.909468,3000+ $
ES,2021-03-06,A0334994,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Large cell lung carcinoma,3/13/2021,3/13/2021,SPAIN,Commercial,Lung,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-03,1.190316,2975.79,2000-3000$ 
ES,2021-03-08,A0335205,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,3/16/2021,3/16/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-03,1.190316,2975.79,2000-3000$ 
TR,2021-03-08,A0335207,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),3/16/2021,4/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-03,1.0,2100.0,2000-3000$ 
ES,2021-03-08,A0335436,Clinical,INITIA Oncologia,Angel Luis Guerrero Zotano,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/16/2021,3/16/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,,0.0,2021-03,1.190316,0.0,0 $
TR,2021-03-08,A0335209,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,3/16/2021,4/15/2021,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-03,1.0,2100.0,2000-3000$ 
TR,2021-03-10,A0335996,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/18/2021,4/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2100,2100.0,2021-03,1.0,2100.0,2000-3000$ 
ES,2021-03-10,A0335929,Clinical,Hospital Quiron Barcelona,Iosune Baraibar,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/18/2021,3/18/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241 EUR,2241.0,2021-03,1.190316,2667.4981559999997,2000-3000$ 
CO,2021-03-11,A0336461,Clinical,OncoBiotecGen,Silvia Maradei,Guardant 360,2.11,GHI_01,Do Not Bill - ROW,Lung adenocarcinoma,3/19/2021,3/19/2021,COLOMBIA,Commercial,,COLOMBIA,1,non_AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,3490,3490.0,2021-03,1.0,3490.0,3000+ $
GB,2021-03-11,A0336419,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/19/2021,3/19/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-03,1.385948,3105.909468,3000+ $
GB,2021-03-11,A0336538,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/19/2021,1/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-03,1.385948,3105.909468,3000+ $
ES,2021-03-11,A0336558,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/19/2021,3/19/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2500,2500.0,2021-03,1.190316,2975.79,2000-3000$ 
GB,2021-03-11,A0336546,Clinical,HCA Laboratories,Mark Harries,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/19/2021,3/19/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-03,1.385948,3105.909468,3000+ $
GB,2021-03-12,A0336836,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/21/2021,3/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-03,1.385948,0.0,0 $
ES,2021-03-12,A0336767,Clinical,Vall D'Hebron University Hospital,Joan Carles,Guardant 360,2.11,GHI_01,Distributors : ROW,Renal Cell Carcinoma,3/22/2021,5/20/2021,SPAIN,Commercial,Kidney,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-03,1.190316,0.0,0 $
FI,2021-03-13,A0337282,Clinical,Turku University Hospital,Leena Lehmus,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Other,3/21/2021,3/31/2021,FINLAND,Commercial,Other,FINLAND,1,non_AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2366 EUR,2366.0,2021-03,1.190316,2816.287656,2000-3000$ 
FI,2021-03-13,A0337527,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/19/2021,3/19/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2366 EUR,2366.0,2021-03,1.190316,2816.287656,2000-3000$ 
GB,2021-03-13,A0337276,Clinical,GenesisCare Milton Keynes,Craig Macmillan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/21/2021,3/21/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-03,1.385948,3187.6803999999997,3000+ $
GB,2021-03-15,A0337559,Clinical,Poole Hospital NHS Foundation Trust,Mike Bayne,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/24/2021,3/24/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,0,0.0,2021-03,1.385948,0.0,0 $
GB,2021-03-15,A0337570,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/22/2021,3/22/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-03,1.385948,3187.6803999999997,3000+ $
GB,2021-03-15,A0337558,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/23/2021,3/23/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-03,1.385948,0.0,0 $
GB,2021-03-15,A0337571,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/22/2021,3/29/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-03,1.385948,3451.01052,3000+ $
TR,2021-03-15,A0337576,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/24/2021,4/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1943,1943.0,2021-03,1.0,1943.0,1500-2000$ 
GB,2021-03-16,A0337997,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/22/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
GB,2021-03-16,A0337973,Clinical,Genesis Care Nottingham,Santhanam Sundar,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Prostate adenocarcinoma,3/24/2021,3/29/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-03,1.385948,3187.6803999999997,3000+ $
GB,2021-03-16,A0337988,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,3/23/2021,3/31/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
GB,2021-03-16,A0338023,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/24/2021,3/24/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
GB,2021-03-16,A0338024,Clinical,University Hospitals Of Leicester,Kiran Kancherla,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,3/24/2021,3/31/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-03,1.385948,3451.01052,3000+ $
BR,2021-03-16,A0337980,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/23/2021,3/31/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1700,1700.0,2021-03,1.0,1700.0,1500-2000$ 
BR,2021-03-16,A0338070,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Leiomyosarcoma,3/23/2021,3/23/2021,BRAZIL,Commercial,Soft Tissue/Bone,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-03,1.0,1350.0,0-1500$ 
BR,2021-03-16,A0338085,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/23/2021,3/23/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-03,1.0,1350.0,0-1500$ 
BR,2021-03-16,A0338094,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Melanoma,3/23/2021,3/23/2021,BRAZIL,Commercial,Skin,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-03,1.0,1350.0,0-1500$ 
ES,2021-03-17,A0338394,Clinical,Instituto Oncology Rosell,Santiago Viteri,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,3/24/2021,4/6/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,,0.0,2021-03,1.190316,0.0,0 $
TR,2021-03-18,A0338815,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/24/2021,4/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1943,1943.0,2021-03,1.0,1943.0,1500-2000$ 
ES,2021-03-18,A0338881,Clinical,Hospital Quiron Barcelona,Aleix Prat,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/23/2021,3/23/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241 EUR,2241.0,2021-03,1.190316,2667.4981559999997,2000-3000$ 
GB,2021-03-18,A0338798,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,3/24/2021,3/30/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-03,1.385948,3187.6803999999997,3000+ $
GB,2021-03-18,A0338804,Clinical,Southampton General Hospital,Ellen Copson,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,3/24/2021,3/24/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2300,2300.0,2021-03,1.385948,3187.6803999999997,3000+ $
ES,2021-03-19,A0339152,Clinical,Hospital Universitario de Burgos,Enrique Lastra,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,3/25/2021,6/23/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.190316,1481.9434199999998,0-1500$ 
BR,2021-03-19,A0339460,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Head and neck carcinoma,3/26/2021,3/26/2021,BRAZIL,Commercial,Head and neck carcinoma,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-03,1.0,1350.0,0-1500$ 
GB,2021-03-19,A0339303,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,3/25/2021,3/25/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
BR,2021-03-19,A0339300,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastroesophageal junction carcinoma,3/30/2021,3/30/2021,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-03,1.0,1350.0,0-1500$ 
BR,2021-03-19,A0339318,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Hepatocellular carcinoma,3/25/2021,3/25/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-03,1.0,1350.0,0-1500$ 
GB,2021-03-19,A0339381,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,3/24/2021,3/24/2021,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-03,1.385948,0.0,0 $
GB,2021-03-19,A0339179,Clinical,The Royal Marsden Hospital,Anderley Gordon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,3/25/2021,4/6/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
BR,2021-03-22,A0339903,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/27/2021,3/27/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1350,1350.0,2021-03,1.0,1350.0,0-1500$ 
MX,2021-03-22,A0339923,Clinical,Labopat,Ivan Romarico Gonzalez-Espinoza,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/29/2021,3/29/2021,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,,0.0,2021-03,1.190316,0.0,0 $
TR,2021-03-22,A0339920,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,3/29/2021,4/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1943,1943.0,2021-03,1.0,1943.0,1500-2000$ 
GB,2021-03-22,A0339909,Clinical,Sussex Cancer Centre,Katie Wakeham,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/28/2021,3/28/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-03,1.385948,0.0,0 $
GB,2021-03-22,A0339921,Clinical,HCA Laboratories,Andrew Tutt,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/30/2021,3/30/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-03,1.385948,3105.909468,3000+ $
GB,2021-03-22,A0339928,Clinical,Sussex Cancer Centre,Katie Wakeham,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/28/2021,3/28/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-03,1.385948,0.0,0 $
GB,2021-03-22,A0339906,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/29/2021,4/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-03,1.385948,3451.01052,3000+ $
MK,2021-03-23,A0340239,Clinical,Dr. Biljana Ilkovska,Biljana Ilkovska,Guardant 360,2.11,GHI_01,Self-Pay Patient,Renal Cell Carcinoma,3/30/2021,4/13/2021,NORTH MACEDONIA,Commercial,Kidney,NORTH MACEDONIA,1,non_AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1745,1745.0,2021-03,1.190316,2077.10142,2000-3000$ 
GB,2021-03-23,A0340079,Clinical,Southampton General Hospital,Peter Simmonds,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),3/31/2021,3/31/2021,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Free,0,0.0,2021-03,1.385948,0.0,0 $
MX,2021-03-23,A0340196,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/30/2021,3/30/2021,MEXICO,Commercial,Breast,MEXICO,1,non_AE,EUR,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,,0.0,2021-03,1.190316,0.0,0 $
GB,2021-03-24,A0340474,Clinical,BMI - The Princess Margaret Hospital,Harpreet Wasan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,3/30/2021,3/30/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
ES,2021-03-24,A0340623,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/30/2021,3/30/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-03,1.190316,2963.8868399999997,2000-3000$ 
GB,2021-03-24,A0340561,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,3/30/2021,4/6/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
GB,2021-03-25,A0340866,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/30/2021,4/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
GB,2021-03-25,A0340976,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/30/2021,4/12/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
GB,2021-03-25,A0340780,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,4/1/2021,4/15/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2490,2490.0,2021-03,1.385948,3451.01052,3000+ $
RO,2021-03-25,A0340738,Clinical,Dr. Larger N. Monica,Larger Monica,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,3/30/2021,4/1/2021,ROMANIA,Commercial,,ROMANIA,1,non_AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2120,2120.0,2021-03,1.190316,2523.46992,2000-3000$ 
GB,2021-03-25,A0340888,Clinical,HCA Laboratories,Paul Ross,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/30/2021,3/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-03,1.385948,3105.909468,3000+ $
GB,2021-03-26,A0341297,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,4/6/2021,4/6/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
ES,2021-03-26,A0341097,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/30/2021,3/30/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1700,1700.0,2021-03,1.190316,2023.5372,2000-3000$ 
ES,2021-03-26,A0341329,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/31/2021,3/31/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241 EUR,2241.0,2021-03,1.190316,2667.4981559999997,2000-3000$ 
GB,2021-03-29,A0341832,Clinical,HCA Laboratories,Timothy Crook,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/3/2021,4/3/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-03,1.385948,3105.909468,3000+ $
GB,2021-03-29,A0341815,Clinical,HCA Laboratories,Kai-Keen Shiu,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,4/3/2021,4/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-03,1.385948,3105.909468,3000+ $
CO,2021-03-29,A0341810,Clinical,OncoBiotecGen,Silvia Maradei,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,4/4/2021,5/11/2021,COLOMBIA,Commercial,,COLOMBIA,1,non_AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,3490,3490.0,2021-03,1.0,3490.0,3000+ $
GB,2021-03-29,A0341809,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/9/2021,4/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
TR,2021-03-30,A0342472,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,4/6/2021,5/5/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1943,1943.0,2021-03,1.0,1943.0,1500-2000$ 
BR,2021-03-30,A0342218,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/4/2021,4/4/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1700,1700.0,2021-03,1.0,1700.0,1500-2000$ 
BR,2021-03-30,A0342219,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/6/2021,4/6/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,South America,Paid,1700,1700.0,2021-03,1.0,1700.0,1500-2000$ 
TR,2021-03-30,A0342478,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,4/4/2021,5/5/2021,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1943,1943.0,2021-03,1.0,1943.0,1500-2000$ 
TR,2021-03-30,A0342488,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,4/6/2021,5/5/2021,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1943,1943.0,2021-03,1.0,1943.0,1500-2000$ 
ES,2021-03-30,A0342248,Clinical,Hospital Universitario de Guadalajara,Javier Cassinello,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),4/5/2021,4/5/2021,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,EUR 1245,1245.0,2021-03,1.190316,1481.9434199999998,0-1500$ 
GB,2021-03-30,A0342217,Clinical,Synthesis Clinic,Nina Fuller-Shavel,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/7/2021,4/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
TR,2021-03-30,A0342491,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gurbuz Gorumlu,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Sarcoma,4/6/2021,5/5/2021,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1943,1943.0,2021-03,1.0,1943.0,1500-2000$ 
GB,2021-03-31,A0342544,Clinical,HCA Laboratories,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/6/2021,4/6/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,2241,2241.0,2021-03,1.385948,3105.909468,3000+ $
GB,2021-03-31,A0342539,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/6/2021,4/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2021,1,1,2021-03-01,2021-03,G360 CDx,2021Q1,Europe,Paid,1245,1245.0,2021-03,1.385948,1725.50526,1500-2000$ 
TR,2021-04-01,A0343088,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,4/6/2021,5/5/2021,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-04,1.0,1943.0,1500-2000$ 
GB,2021-04-01,A0343139,Clinical,Sussex Cancer Centre,Katie Wakeham,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,4/7/2021,4/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,0,0.0,2021-04,1.383379,0.0,0 $
GB,2021-04-01,A0343152,Clinical,Sarah Cannon Research Institute (SCRI),Elisa Fontana,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Prostate adenocarcinoma,4/7/2021,4/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2490,2490.0,2021-04,1.383379,3444.6137099999996,3000+ $
TR,2021-04-01,A0343117,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Sarcoma,4/9/2021,5/5/2021,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-04,1.0,1943.0,1500-2000$ 
GB,2021-04-01,A0343050,Clinical,Synthesis Clinic,Nina Fuller-Shavel,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/7/2021,4/12/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
ES,2021-04-01,A0343166,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/6/2021,4/6/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2500,2500.0,2021-04,1.196578,2991.4449999999997,2000-3000$ 
BR,2021-04-01,A0343101,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/5/2021,4/5/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-04,1.0,1350.0,0-1500$ 
TR,2021-04-01,A0343091,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,4/6/2021,5/5/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-04,1.0,1943.0,1500-2000$ 
BR,2021-04-02,A0343594,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,4/9/2021,4/9/2021,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-04,1.0,1350.0,0-1500$ 
BR,2021-04-02,A0343609,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,4/10/2021,4/10/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,1700,1700.0,2021-04,1.0,1700.0,1500-2000$ 
GB,2021-04-02,A0343477,Clinical,Charing Cross Hospital Medical Oncology Department,Harpreet Wasan,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,4/7/2021,4/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2300,2300.0,2021-04,1.383379,3181.7717,3000+ $
GB,2021-04-02,A0343447,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/7/2021,4/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-02,A0343621,Clinical,Cheltenham General Hospital,David Farrugia,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,4/9/2021,5/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2490,2490.0,2021-04,1.383379,3444.6137099999996,3000+ $
IE,2021-04-02,A0343675,Clinical,Bon Secours Hospital,Deirdre O'Mahony,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),4/9/2021,4/26/2021,IRELAND,Commercial,CUP,IRELAND,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
GB,2021-04-02,A0343616,Clinical,The Royal Marsden Hospital,Peter Barry,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/7/2021,4/30/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
FI,2021-04-02,A0343435,Clinical,Turku University Hospital,Eija Korkeila,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,4/11/2021,4/11/2021,FINLAND,Commercial,GI,FINLAND,1,non_AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 2366,2366.0,2021-04,1.196578,2831.1035479999996,2000-3000$ 
MX,2021-04-05,A0344126,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Cervical adenocarcinoma,4/7/2021,4/7/2021,MEXICO,Commercial,Cervical,MEXICO,1,non_AE,EUR,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,0,0.0,2021-04,1.196578,0.0,0 $
TR,2021-04-06,A0344344,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,4/14/2021,5/13/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-04,1.0,1943.0,1500-2000$ 
TR,2021-04-06,A0344302,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,4/12/2021,5/13/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-04,1.0,1943.0,1500-2000$ 
GB,2021-04-07,A0344574,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/14/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-07,A0344560,Clinical,Coventry University Hospitals,Nawaz Walji,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,4/13/2021,5/3/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2490,2490.0,2021-04,1.383379,3444.6137099999996,3000+ $
MX,2021-04-07,A0344625,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/13/2021,4/13/2021,MEXICO,Commercial,Breast,MEXICO,1,non_AE,EUR,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,3316,3316.0,2021-04,1.196578,3967.8526479999996,3000+ $
GB,2021-04-07,A0344722,Clinical,Southend University Hospital,Rafiqul Islam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/13/2021,5/4/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
MX,2021-04-07,A0344646,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Cervical adenocarcinoma,4/19/2021,4/19/2021,MEXICO,Commercial,Cervical,MEXICO,1,non_AE,EUR,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,1700,1700.0,2021-04,1.196578,2034.1825999999999,2000-3000$ 
GB,2021-04-08,A0345078,Clinical,Thatcham Health Centre,Rachel Sylvester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/16/2021,4/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-08,A0345393,Clinical,Charing Cross Hospital Medical Oncology Department,Rizvana Ahmad,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/15/2021,4/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-04,1.383379,0.0,0 $
GB,2021-04-08,A0344959,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Shairoz Merchant,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/13/2021,4/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-09,A0345437,Clinical,Cheltenham General Hospital,David Farrugia,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/17/2021,4/17/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2490,2490.0,2021-04,1.383379,3444.6137099999996,3000+ $
GB,2021-04-09,A0345419,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,4/14/2021,4/14/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
ES,2021-04-09,A0345414,Clinical,Hospital General Universitario Gregorio Maranon,Andres Munoz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,4/16/2021,4/16/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
GB,2021-04-09,A0345648,Clinical,Charing Cross Hospital Medical Oncology Department,Naveed Sarwar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),4/14/2021,4/14/2021,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,GBP 2300.00,2300.0,2021-04,1.383379,3181.7717,3000+ $
GB,2021-04-12,A0346140,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,4/19/2021,4/19/2021,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
IE,2021-04-12,A0346109,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/17/2021,4/17/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
GB,2021-04-12,A0346191,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/17/2021,4/17/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-04,1.383379,3100.1523389999998,3000+ $
FI,2021-04-12,A0346138,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/19/2021,4/19/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 2366,2366.0,2021-04,1.196578,2831.1035479999996,2000-3000$ 
GB,2021-04-12,A0346110,Clinical,The Royal Marsden NHS Foundation Trust,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,4/19/2021,5/4/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-12,A0346139,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/19/2021,4/19/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-12,A0346103,Clinical,St Bartholomews Hospital,Melissa Phillips,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/22/2021,4/27/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-12,A0346099,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/16/2021,4/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-12,A0346107,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/17/2021,4/19/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-14,A0346790,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/20/2021,4/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-14,A0346784,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,4/18/2021,4/18/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-04,1.383379,3100.1523389999998,3000+ $
GB,2021-04-15,A0347353,Clinical,The Rutherford Cancer Centre,Seema Arif,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,4/20/2021,4/20/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
ES,2021-04-15,A0347372,Clinical,Hospital Universitario de Guadalajara,Nicolas Mohedano Mohedano,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),4/21/2021,4/21/2021,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
GB,2021-04-15,A0347341,Clinical,Charing Cross Hospital Medical Oncology Department,Harpreet Wasan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/20/2021,4/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-04,1.383379,3181.7717,3000+ $
GB,2021-04-15,A0347203,Clinical,The Rutherford Cancer Centre,Seema Arif,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/20/2021,4/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
CH,2021-04-16,A0347527,Clinical,Lausanne University Hospital (CHUV),Nicolas Demartines,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,4/20/2021,4/20/2021,SWITZERLAND,Commercial,Other,SWITZERLAND,1,non_AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Free,0,0.0,2021-04,1.196578,0.0,0 $
GB,2021-04-16,A0347512,Clinical,Medway Maritime Hospital,Kolera Chengappa,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,4/22/2021,5/13/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-16,A0347604,Clinical,Eastbourne District General Hospital,Muawia Mohamed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/21/2021,5/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-16,A0347441,Clinical,The Royal Marsden NHS Foundation Trust,Ian Chau,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastroesophageal junction carcinoma,4/20/2021,1/7/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-16,A0347732,Clinical,Sussex Cancer Centre,Muawia Mohamed,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,4/20/2021,4/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,0,0.0,2021-04,1.383379,0.0,0 $
GB,2021-04-17,A0348066,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Appendix adenocarcinoma,4/23/2021,4/23/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-04,1.383379,3100.1523389999998,3000+ $
ES,2021-04-17,A0348120,Clinical,Hospital Universitario de Burgos,Ana Maria Lopez,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,4/23/2021,7/2/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
GB,2021-04-17,A0347819,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,4/19/2021,4/19/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,0,0.0,2021-04,1.383379,0.0,0 $
GB,2021-04-17,A0348108,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/24/2021,4/24/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
ES,2021-04-19,A0348195,Clinical,Hospital Universitario de Burgos,Sandra Lopez Peralta,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,4/23/2021,7/2/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
ES,2021-04-19,A0348187,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/23/2021,4/23/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
GB,2021-04-19,A0348189,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/26/2021,5/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
ES,2021-04-19,A0348190,Clinical,Hospital Universitario de Burgos,Ana Maria Lopez,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,4/23/2021,7/2/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
ES,2021-04-19,A0348199,Clinical,Hospital Universitario de Burgos,Ana Maria Lopez,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,4/28/2021,7/2/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
MX,2021-04-20,A0348530,Clinical,ABC Hospital,Christian Patricio Camacho Limas,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/24/2021,4/24/2021,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,3316,3316.0,2021-04,1.196578,3967.8526479999996,3000+ $
ES,2021-04-20,A0348330,Clinical,Hospital Universitario de Burgos,Ana Maria Lopez,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,4/27/2021,7/2/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
BR,2021-04-21,A0349031,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/27/2021,4/27/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-04,1.0,1350.0,0-1500$ 
ES,2021-04-21,A0349044,Clinical,Fundacion Jimenez Diaz,Jaime Rubio Perez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,4/27/2021,4/27/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
AR,2021-04-22,A0349206,Clinical,Laboratorio Genia,Andres Casella,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/27/2021,5/5/2021,ARGENTINA,Commercial,Breast,ARGENTINA,1,non_AE,USD,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,2000,2000.0,2021-04,1.0,2000.0,1500-2000$ 
GB,2021-04-22,A0349313,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,4/29/2021,4/29/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-22,A0349208,Clinical,North Middlesex University Hospital,George Nintos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/27/2021,4/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-04,1.383379,0.0,0 $
GB,2021-04-23,A0349515,Clinical,Charing Cross Hospital Medical Oncology Department,Olivia Hatcher,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/9/2021,5/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-04,1.383379,0.0,0 $
GB,2021-04-23,A0349680,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,4/30/2021,4/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2490,2490.0,2021-04,1.383379,3444.6137099999996,3000+ $
FI,2021-04-23,A0349729,Clinical,Turku University Hospital,Taneli Saariaho,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/29/2021,4/29/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 2366,2366.0,2021-04,1.196578,2831.1035479999996,2000-3000$ 
BR,2021-04-23,A0349641,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,4/28/2021,4/28/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-04,1.0,1350.0,0-1500$ 
BR,2021-04-23,A0349637,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/28/2021,1/7/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-04,1.0,1350.0,0-1500$ 
GB,2021-04-23,A0349686,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,4/30/2021,4/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-04,1.383379,3100.1523389999998,3000+ $
ES,2021-04-23,A0349568,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,4/29/2021,4/29/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2400 USD,2400.0,2021-04,1.196578,2871.7871999999998,2000-3000$ 
CL,2021-04-23,A0349668,Clinical,Clinica Santa Maria,Cristian Carvallo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/28/2021,4/28/2021,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,1550,1550.0,2021-04,1.0,1550.0,1500-2000$ 
GB,2021-04-23,A0349435,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/3/2021,5/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-23,A0349676,Clinical,Eastbourne District General Hospital,Muawia Mohamed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/28/2021,4/28/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Free,0,0.0,2021-04,1.383379,0.0,0 $
SI,2021-04-26,A0350137,Clinical,Luka Hauptman MD,Luka Hauptman,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/30/2021,5/3/2021,SLOVENIA,Commercial,,SLOVENIA,1,non_AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1745,1745.0,2021-04,1.196578,2088.02861,2000-3000$ 
ES,2021-04-26,A0350146,Clinical,Hospital Clinico Provincial de Barcelona,Lucio Ghiglione,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,5/1/2021,5/1/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 2200,2200.0,2021-04,1.196578,2632.4716,2000-3000$ 
GB,2021-04-26,A0350143,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/1/2021,5/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-26,A0350165,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/5/2021,5/5/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-04,1.383379,3181.7717,3000+ $
GB,2021-04-26,A0350144,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/1/2021,5/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-26,A0350140,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/1/2021,5/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-27,A0350512,Clinical,The Holly Private Hospital,John Conibear,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,5/4/2021,5/18/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2300,2300.0,2021-04,1.383379,3181.7717,3000+ $
GB,2021-04-28,A0351096,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/3/2021,5/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
BE,2021-04-28,A0350712,Clinical,Dr. Genevieve Petit,Genevieve Petit,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/5/2021,5/5/2021,BELGIUM,Commercial,,BELGIUM,1,non_AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 2990,2990.0,2021-04,1.196578,3577.76822,3000+ $
FR,2021-04-28,A0350809,Clinical,Institut de Cancerologie des Hospices Civils de Lyon,Michael Duruisseaux,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/2/2021,5/5/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1100,1100.0,2021-04,1.196578,1316.2358,0-1500$ 
MX,2021-04-29,A0351382,Clinical,MileniaLabs,Gerardo Rodriguez Abrajan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/4/2021,5/18/2021,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,2500,2500.0,2021-04,1.196578,2991.4449999999997,2000-3000$ 
ES,2021-04-29,A0351122,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),5/4/2021,5/4/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,,0.0,2021-04,1.196578,0.0,0 $
GB,2021-04-29,A0351104,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/4/2021,5/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
ES,2021-04-29,A0351317,Clinical,Hospital A Coruna,Maria Rosario Garcia Campelo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,5/4/2021,6/4/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
BR,2021-04-29,A0351138,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/4/2021,9/2/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,,0.0,2021-04,1.0,0.0,0 $
GB,2021-04-29,A0351108,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,5/4/2021,5/4/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-04,1.383379,3100.1523389999998,3000+ $
GB,2021-04-29,A0351135,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Jonathan Dakin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,5/4/2021,5/5/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-29,A0351438,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/4/2021,5/4/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
IE,2021-04-29,A0351117,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal adenocarcinoma,5/4/2021,5/20/2021,IRELAND,Commercial,GI,IRELAND,1,AE,EUR,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-04,1.196578,1489.7396099999999,0-1500$ 
GB,2021-04-30,A0351647,Clinical,HCA Laboratories,Sheeba Irshad,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/4/2021,5/4/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-04,1.383379,3100.1523389999998,3000+ $
CL,2021-04-30,A0351654,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/4/2021,5/4/2021,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,1550,1550.0,2021-04,1.0,1550.0,1500-2000$ 
CL,2021-04-30,A0351659,Clinical,Clinica Las Condes,Luis Cereceda,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),5/5/2021,5/5/2021,CHILE,Commercial,CUP,CHILE,1,non_AE,USD,Americas,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,South America,Paid,1550,1550.0,2021-04,1.0,1550.0,1500-2000$ 
GB,2021-04-30,A0351666,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/5/2021,5/5/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,1245,1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-30,A0351792,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,5/5/2021,5/10/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-30,A0351872,Clinical,Clatterbridge Cancer Centre,Rajaram Sripadam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/5/2021,5/10/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-04,1.383379,1722.3068549999998,1500-2000$ 
GB,2021-04-30,A0351784,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/4/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2021,2,1,2021-04-01,2021-04,G360 CDx,2021Q2,Europe,Paid,"GBP 2,490.00",2490.0,2021-04,1.383379,3444.6137099999996,3000+ $
GB,2021-05-01,A0351995,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/5/2021,5/5/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-05,1.406543,3235.0489000000002,3000+ $
ES,2021-05-01,A0352177,Clinical,Hospital Universitario de Guadalajara,Nicolas Mohedano Mohedano,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,,5/5/2021,5/5/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,-,0.0,2021-05,1.214649,0.0,0 $
GB,2021-05-03,A0352182,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/11/2021,5/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
GB,2021-05-03,A0352223,Clinical,Coventry University Hospitals,Susan Lupton,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,5/5/2021,5/5/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,,0.0,2021-05,1.406543,0.0,0 $
GB,2021-05-03,A0352221,Clinical,Sussex Cancer Centre,Angus Robinson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Renal pelvis urothelial carcinoma,5/8/2021,5/18/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.406543,0.0,0 $
BR,2021-05-03,A0352209,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/7/2021,5/7/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-05,1.0,1350.0,0-1500$ 
BR,2021-05-03,A0352211,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,5/11/2021,5/11/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-05,1.0,1350.0,0-1500$ 
GB,2021-05-03,A0352212,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/10/2021,5/10/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
DE,2021-05-04,A0352309,Clinical,University Hospital Frankfurt,Philipp Mandel,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,5/8/2021,5/18/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,0 EUR,0.0,2021-05,1.214649,0.0,0 $
LT,2021-05-04,A0352530,Clinical,Genomika,Mantas Simutis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Renal Cell Carcinoma,5/10/2021,5/20/2021,LITHUANIA,Commercial,Kidney,LITHUANIA,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2100,2100.0,2021-05,1.214649,2550.7629,2000-3000$ 
BR,2021-05-05,A0352717,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/10/2021,5/10/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-05,1.0,1350.0,0-1500$ 
ES,2021-05-06,A0352979,Clinical,Hospital Universitario de Guadalajara,Nicolas Mohedano Mohedano,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,5/10/2021,5/10/2021,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,1245 EUR,1245.0,2021-05,1.214649,1512.2380050000002,1500-2000$ 
GB,2021-05-06,A0353192,Clinical,Charing Cross Hospital Medical Oncology Department,Rohini Sharma,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pheochromocytoma,5/11/2021,5/18/2021,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.406543,0.0,0 $
GB,2021-05-06,A0353059,Clinical,The Royal Marsden Hospital,Sanjay Popat,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,5/11/2021,5/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
TR,2021-05-07,A0353559,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/12/2021,7/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-05,1.0,1943.0,1500-2000$ 
BR,2021-05-07,A0353368,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/13/2021,6/1/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-05,1.0,1350.0,0-1500$ 
BR,2021-05-07,A0353672,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/11/2021,5/19/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1700,1700.0,2021-05,1.0,1700.0,1500-2000$ 
GB,2021-05-07,A0353438,Clinical,HCA Laboratories,Fharat Raja,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/12/2021,5/12/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-05,1.406543,3152.062863,3000+ $
GB,2021-05-07,A0353543,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,5/11/2021,5/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-05,1.406543,3152.062863,3000+ $
GB,2021-05-07,A0353592,Clinical,The Rutherford Cancer Centre,Seema Arif,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/11/2021,5/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-05,1.406543,3235.0489000000002,3000+ $
GB,2021-05-07,A0353668,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/11/2021,5/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
GB,2021-05-07,A0353729,Clinical,Charing Cross Hospital Medical Oncology Department,Naveed Sarwar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),5/13/2021,5/13/2021,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.406543,0.0,0 $
GB,2021-05-07,A0353604,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,5/14/2021,5/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
GB,2021-05-07,A0353385,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/12/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
TR,2021-05-07,A0353564,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/11/2021,7/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-05,1.0,1943.0,1500-2000$ 
GB,2021-05-10,A0354126,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/16/2021,5/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.406543,0.0,0 $
GB,2021-05-10,A0354130,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/14/2021,5/14/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
ES,2021-05-10,A0354120,Clinical,Hospital Universitario de Burgos,Beatriz Llorente Ayala,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,5/17/2021,7/2/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,1245 EUR,1245.0,2021-05,1.214649,1512.2380050000002,1500-2000$ 
ES,2021-05-10,A0354144,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Appendix adenocarcinoma,5/16/2021,5/16/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2400 USD,2400.0,2021-05,1.214649,2915.1576,2000-3000$ 
AT,2021-05-10,A0354147,Clinical,Naturheilpraxis Dr. med. Baumert,Stefan Baumert,Guardant 360,2.11,GHI_01,Self-Pay Patient,Melanoma,5/14/2021,6/3/2021,AUSTRIA,Commercial,Skin,AUSTRIA,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,3490 EUR,3490.0,2021-05,1.214649,4239.125010000001,3000+ $
BR,2021-05-10,A0354132,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/14/2021,5/14/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-05,1.0,1350.0,0-1500$ 
ES,2021-05-10,A0354119,Clinical,Hospital Nuestra Senora de Sonsoles,Jose Enrique Ales,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),5/17/2021,5/17/2021,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,0 EUR,0.0,2021-05,1.214649,0.0,0 $
GB,2021-05-11,A0354424,Clinical,"Queenâ€™s Hospital, Barking, Havering, and Redbridge Univ Hosp NHS Trust",Mary Quigley,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/18/2021,5/19/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
TR,2021-05-12,A0354985,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,5/22/2021,7/15/2021,TURKEY,Commercial,Other,TURKEY,1,AE,USD,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-05,1.0,1943.0,1500-2000$ 
GB,2021-05-12,A0355053,Clinical,Southampton General Hospital,Andrew Bates,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,5/18/2021,5/18/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.406543,0.0,0 $
IE,2021-05-13,A0355323,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,5/21/2021,5/21/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-05,1.214649,1512.2380050000002,1500-2000$ 
GB,2021-05-13,A0355092,Clinical,Charing Cross Hospital Medical Oncology Department,Waleed Mohammed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/18/2021,5/18/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.406543,0.0,0 $
IE,2021-05-13,A0355314,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/18/2021,5/18/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-05,1.214649,1512.2380050000002,1500-2000$ 
GB,2021-05-13,A0355100,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,5/18/2021,5/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 2,490.00",2490.0,2021-05,1.406543,3502.2920700000004,3000+ $
GB,2021-05-13,A0355082,Clinical,North Middlesex University Hospital,George Nintos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/17/2021,5/17/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.406543,0.0,0 $
TR,2021-05-13,A0355093,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/18/2021,7/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-05,1.0,1943.0,1500-2000$ 
TR,2021-05-13,A0355094,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/18/2021,7/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-05,1.0,1943.0,1500-2000$ 
GB,2021-05-13,A0355076,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/19/2021,5/19/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
GB,2021-05-14,A0355782,Clinical,The Christie Hospital,Sacha Howell,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/19/2021,5/21/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
GB,2021-05-14,A0355711,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,5/21/2021,5/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 2,490.00",2490.0,2021-05,1.406543,3502.2920700000004,3000+ $
BR,2021-05-14,A0355523,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,5/19/2021,5/19/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-05,1.0,1350.0,0-1500$ 
GB,2021-05-14,A0355605,Clinical,Coventry University Hospitals,Susan Lupton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/19/2021,5/19/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.406543,0.0,0 $
GB,2021-05-14,A0355705,Clinical,HCA Laboratories,Paul Ross,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,5/19/2021,5/19/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-05,1.406543,3152.062863,3000+ $
ES,2021-05-14,A0355762,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/21/2021,5/21/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,0 EUR,0.0,2021-05,1.214649,0.0,0 $
GB,2021-05-14,A0355680,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/19/2021,5/19/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
ES,2021-05-14,A0355788,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/21/2021,5/21/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,0 EUR,0.0,2021-05,1.214649,0.0,0 $
GB,2021-05-14,A0355689,Clinical,Beatson West of Scotland Cancer Centre,Nicola Steele,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/20/2021,5/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.406543,0.0,0 $
LT,2021-05-14,A0355425,Clinical,Genomika,Mantas Simutis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/19/2021,5/20/2021,LITHUANIA,Commercial,Breast,LITHUANIA,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,2100,2100.0,2021-05,1.214649,2550.7629,2000-3000$ 
GB,2021-05-15,A0356017,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/21/2021,5/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-05,1.406543,3152.062863,3000+ $
DE,2021-05-17,A0356253,Clinical,University Hospital Frankfurt,Philipp Mandel,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,5/23/2021,5/23/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,0 EUR,0.0,2021-05,1.214649,0.0,0 $
CL,2021-05-17,A0356261,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/27/2021,5/27/2021,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1680,1680.0,2021-05,1.0,1680.0,1500-2000$ 
ES,2021-05-17,A0356254,Clinical,Hospital Duran i Reynals-ICO Hospitalet,Ernest Nadal,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/21/2021,5/21/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,0 EUR,0.0,2021-05,1.214649,0.0,0 $
ES,2021-05-17,A0356221,Clinical,Clinica Universidad de Navarra,Mariano Ponz-Sarvise,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,5/23/2021,5/23/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2400 USD,2400.0,2021-05,1.214649,2915.1576,2000-3000$ 
BR,2021-05-17,A0356265,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,5/22/2021,5/22/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-05,1.0,1350.0,0-1500$ 
BR,2021-05-17,A0356256,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/25/2021,5/25/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-05,1.0,1350.0,0-1500$ 
GB,2021-05-19,A0356905,Clinical,The Royal Marsden NHS Foundation Trust,Ian Chau,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,5/23/2021,6/17/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
GB,2021-05-19,A0356701,Clinical,HCA at The Christie Clinic,David Woolf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/24/2021,6/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
GB,2021-05-19,A0356775,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/23/2021,6/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
ES,2021-05-19,A0357060,Clinical,Hospital University La Paz,Javier de Castro Carpeno,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/24/2021,5/26/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2490 EUR,2490.0,2021-05,1.214649,3024.4760100000003,3000+ $
IT,2021-05-19,A0356881,Clinical,Ospedale San Martino,Alberto Sobrero,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/25/2021,5/25/2021,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.214649,0.0,0 $
GB,2021-05-19,A0356738,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,5/25/2021,5/25/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
BR,2021-05-19,A0356861,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Hepatocellular carcinoma,5/29/2021,5/29/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-05,1.0,1350.0,0-1500$ 
AT,2021-05-19,A0356845,Clinical,Naturheilpraxis Dr. med. Baumert,Stefan Baumert,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/26/2021,5/26/2021,AUSTRIA,Commercial,,AUSTRIA,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,3490 EUR,3490.0,2021-05,1.214649,4239.125010000001,3000+ $
ES,2021-05-20,A0357198,Clinical,Hospital Nuestra Senora de Sonsoles,Jose Enrique Ales,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/26/2021,5/26/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,0 EUR,0.0,2021-05,1.214649,0.0,0 $
ES,2021-05-20,A0357076,Clinical,Hospital University La Paz,Javier de Castro Carpeno,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,5/25/2021,5/25/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2490 EUR,2490.0,2021-05,1.214649,3024.4760100000003,3000+ $
IE,2021-05-20,A0357136,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal adenocarcinoma,5/24/2021,6/10/2021,IRELAND,Commercial,GI,IRELAND,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,EUR 1245,1245.0,2021-05,1.214649,1512.2380050000002,1500-2000$ 
ES,2021-05-20,A0357104,Clinical,Hospital Universitario de Burgos,Guillermo Crespo,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Renal pelvis urothelial carcinoma,5/25/2021,7/2/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,1245 EUR,1245.0,2021-05,1.214649,1512.2380050000002,1500-2000$ 
FR,2021-05-20,A0357485,Clinical,Institut Regional du Cancer Montpellier - ICM,Camille Travert,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/27/2021,5/27/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,0 EUR,0.0,2021-05,1.214649,0.0,0 $
GB,2021-05-21,A0357661,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Shairoz Merchant,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/26/2021,5/26/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
ES,2021-05-21,A0357514,Clinical,Hospital Universitario Insular de Gran Canaria,Gretel Benitez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/26/2021,6/3/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,1245 EUR,1245.0,2021-05,1.214649,1512.2380050000002,1500-2000$ 
BR,2021-05-21,A0357705,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/25/2021,5/25/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1700,1700.0,2021-05,1.0,1700.0,1500-2000$ 
GB,2021-05-22,A0358135,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric Carcinoma,6/2/2021,6/2/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-05,1.406543,3152.062863,3000+ $
DE,2021-05-24,A0358428,Clinical,Erlangen Universitaetsklinikum,Peter Fasching,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/29/2021,5/29/2021,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,0 EUR,0.0,2021-05,1.214649,0.0,0 $
GB,2021-05-24,A0358400,Clinical,Rutherford Cancer Centre North East,Seema Arif,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,5/28/2021,5/28/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-05,1.406543,3235.0489000000002,3000+ $
ES,2021-05-25,A0358839,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,5/30/2021,5/30/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2500 EUR,2500.0,2021-05,1.214649,3036.6225000000004,3000+ $
GB,2021-05-25,A0358553,Clinical,Genesis Care,Timothy Sevitt,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,5/31/2021,6/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 1,245.00",1245.0,2021-05,1.406543,1751.1460350000002,1500-2000$ 
GB,2021-05-26,A0359104,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,5/31/2021,5/31/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 2,490.00",2490.0,2021-05,1.406543,3502.2920700000004,3000+ $
GB,2021-05-26,A0358905,Clinical,Northampton General Hospital,Craig Knighton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/31/2021,5/31/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.406543,0.0,0 $
ES,2021-05-26,A0358900,Clinical,Hospital Vithas Castellon,Javier Garde Noguera,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/1/2021,6/1/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,0 EUR,0.0,2021-05,1.214649,0.0,0 $
IT,2021-05-27,A0359437,Clinical,Ospedale San Martino,Alberto Sobrero,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/2/2021,6/2/2021,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.214649,0.0,0 $
TR,2021-05-27,A0359519,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/1/2021,7/15/2021,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-05,1.0,1943.0,1500-2000$ 
CA,2021-05-27,A0359510,Clinical,Southlake Regional Health Centre,Farrah Kassam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),6/2/2021,6/2/2021,CANADA,Commercial,CUP,CANADA,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Canada,Free,0,0.0,2021-05,1.0,0.0,0 $
LU,2021-05-27,A0359284,Clinical,Hopitaux Robert Schuman,Boris Meuter,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,6/2/2021,6/2/2021,LUXEMBOURG,Commercial,Other,LUXEMBOURG,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,2990 EUR,2990.0,2021-05,1.214649,3631.8005100000005,3000+ $
GB,2021-05-27,A0359509,Clinical,GenesisCare Milton Keynes,Craig Macmillan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/2/2021,6/2/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 2,490.00",2490.0,2021-05,1.406543,3502.2920700000004,3000+ $
CA,2021-05-27,A0359524,Clinical,Cross Cancer Institute/University of Alberta,Quincy Chu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/2/2021,6/3/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Canada,Paid,1700,1700.0,2021-05,1.0,1700.0,1500-2000$ 
GB,2021-05-27,A0359708,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,6/2/2021,6/2/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-05,1.406543,3235.0489000000002,3000+ $
BR,2021-05-27,A0359278,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,5/29/2021,5/29/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-05,1.0,1350.0,0-1500$ 
GB,2021-05-28,A0360058,Clinical,Poole Hospital NHS Foundation Trust,Victoria Wells,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/2/2021,6/2/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-05,1.406543,0.0,0 $
FR,2021-05-29,A0360837,Clinical,Centre Hospitalier Departemental Vendee,Elise Redureau,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,6/3/2021,6/3/2021,FRANCE,Commercial,Other,FRANCE,1,non_AE,EUR,Europe,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Europe,Free,0 EUR,0.0,2021-05,1.214649,0.0,0 $
CA,2021-05-29,A0360776,Clinical,London Health Sciences Centre,Daniel Breadner,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/2/2021,6/2/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,5,2021,2,1,2021-05-01,2021-05,G360 CDx,2021Q2,Canada,Paid,1700,1700.0,2021-05,1.0,1700.0,1500-2000$ 
BR,2021-06-01,A0361037,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/6/2021,6/6/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-06,1.0,1350.0,0-1500$ 
BR,2021-06-01,A0361059,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,6/5/2021,6/5/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-06,1.0,1350.0,0-1500$ 
GB,2021-06-01,A0361070,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/6/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
IT,2021-06-01,A0361158,Clinical,Niguarda Cancer Center,Salvatore Siena,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/6/2021,6/28/2021,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2490 EUR,2490.0,2021-06,1.203926,2997.77574,2000-3000$ 
GB,2021-06-01,A0361075,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/8/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
GB,2021-06-01,A0361066,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,6/5/2021,6/10/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
ES,2021-06-01,A0361078,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/8/2021,6/8/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2490 EUR,2490.0,2021-06,1.203926,2997.77574,2000-3000$ 
GB,2021-06-01,A0361049,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/6/2021,6/6/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
BR,2021-06-01,A0361036,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/6/2021,6/6/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-06,1.0,1350.0,0-1500$ 
TR,2021-06-02,A0361426,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,6/8/2021,7/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-06,1.0,1943.0,1500-2000$ 
CA,2021-06-02,A0361422,Clinical,Thunder Bay Regional Cancer Center,Adrien Chan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/7/2021,6/7/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Canada,Paid,1700 USD,1700.0,2021-06,1.0,1700.0,1500-2000$ 
ES,2021-06-02,A0361686,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/8/2021,6/8/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241 EUR,2241.0,2021-06,1.203926,2697.9981660000003,2000-3000$ 
GB,2021-06-02,A0361525,Clinical,Basingstoke and North Hampshire Hospital,Marcus Remer,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/7/2021,6/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
GB,2021-06-02,A0361505,Clinical,Basingstoke and North Hampshire Hospital,Marcus Remer,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/7/2021,6/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
CL,2021-06-02,A0361509,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/8/2021,6/8/2021,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,1550 USD,1550.0,2021-06,1.0,1550.0,1500-2000$ 
GB,2021-06-03,A0362049,Clinical,Coventry University Hospitals,Nawaz Walji,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/10/2021,6/10/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
LT,2021-06-03,A0361816,Clinical,Genomika,Mantas Simutis,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,6/9/2021,6/9/2021,LITHUANIA,Commercial,Breast,LITHUANIA,1,non_AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,-,0.0,2021-06,1.203926,0.0,0 $
BR,2021-06-03,A0361930,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/7/2021,6/7/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-06,1.0,1350.0,0-1500$ 
GB,2021-06-03,A0362226,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Bladder carcinoma,6/9/2021,6/9/2021,UNITED KINGDOM,Commercial,Bladder,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
ES,2021-06-03,A0361833,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/7/2021,6/7/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,1745 EUR,1745.0,2021-06,1.203926,2100.85087,2000-3000$ 
FI,2021-06-03,A0362051,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/10/2021,6/10/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2366,2366.0,2021-06,1.203926,2848.4889160000002,2000-3000$ 
GB,2021-06-04,A0362519,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/9/2021,6/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-06,1.402254,3142.4512139999997,3000+ $
GB,2021-06-04,A0362414,Clinical,Southampton General Hospital,Sanjay Raj,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/9/2021,6/10/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-06,1.402254,3225.1841999999997,3000+ $
GB,2021-06-04,A0362325,Clinical,Bupa Cromwell Hospital,John Conibear,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/12/2021,6/12/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,"GBP 2,490.00",2490.0,2021-06,1.402254,3491.61246,3000+ $
TR,2021-06-04,A0362656,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/9/2021,7/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-06,1.0,1943.0,1500-2000$ 
GB,2021-06-05,A0362894,Clinical,HCA Laboratories,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/9/2021,6/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-06,1.402254,3142.4512139999997,3000+ $
FI,2021-06-05,A0362820,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/10/2021,6/10/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2366,2366.0,2021-06,1.203926,2848.4889160000002,2000-3000$ 
GB,2021-06-05,A0362865,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Robert Laing,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/10/2021,6/10/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-06,1.402254,3225.1841999999997,3000+ $
ES,2021-06-07,A0363122,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/12/2021,6/12/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2490 EUR,2490.0,2021-06,1.203926,2997.77574,2000-3000$ 
ES,2021-06-07,A0363116,Clinical,Hospital Nuestra Senora de Sonsoles,Jose Enrique Ales,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),6/12/2021,6/12/2021,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,EUR 0.00,0.0,2021-06,1.203926,0.0,0 $
GB,2021-06-08,A0363458,Clinical,Basingstoke and North Hampshire Hospital,Marcus Remer,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/12/2021,6/12/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
ES,2021-06-08,A0363383,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,6/14/2021,6/14/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241 EUR,2241.0,2021-06,1.203926,2697.9981660000003,2000-3000$ 
GB,2021-06-09,A0363819,Clinical,The Royal Marsden NHS Foundation Trust,David Watkins,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,6/15/2021,6/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
GB,2021-06-09,A0363765,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Sundus Yahya,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/14/2021,6/14/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
GB,2021-06-09,A0363871,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Robert Laing,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/16/2021,6/18/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
MX,2021-06-09,A0363890,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/15/2021,6/15/2021,MEXICO,Commercial,Breast,MEXICO,1,non_AE,EUR,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,3316 USD,3316.0,2021-06,1.203926,3992.218616,3000+ $
TR,2021-06-09,A0363803,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/14/2021,7/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,1943,1943.0,2021-06,1.0,1943.0,1500-2000$ 
GB,2021-06-11,A0365067,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/16/2021,6/16/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-06,1.402254,3142.4512139999997,3000+ $
GB,2021-06-11,A0364848,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/15/2021,6/17/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
ES,2021-06-11,A0364700,Clinical,Complexo Hospitalario Universitario De Orense,Jose Luis Firvida Perez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/17/2021,6/17/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,EUR 0.00,0.0,2021-06,1.203926,0.0,0 $
GB,2021-06-11,A0364840,Clinical,Barnet Hospital,Neha Chopra,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/16/2021,1/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
GB,2021-06-12,A0365189,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,6/17/2021,6/17/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-06,1.402254,3142.4512139999997,3000+ $
GB,2021-06-12,A0365210,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/17/2021,6/17/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-06,1.402254,3142.4512139999997,3000+ $
IE,2021-06-14,A0365549,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/19/2021,6/19/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,EUR 1245.00,1245.0,2021-06,1.203926,1498.88787,0-1500$ 
GB,2021-06-14,A0365569,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,6/22/2021,6/23/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
GB,2021-06-14,A0365551,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,6/22/2021,7/13/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
ES,2021-06-15,A0365700,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/21/2021,6/21/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2400 USD,2400.0,2021-06,1.203926,2889.4224,2000-3000$ 
GB,2021-06-16,A0366228,Clinical,Derriford University Hospitals Plymouth NHS Trust,Cyrus Daneshvar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/20/2021,6/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
GB,2021-06-16,A0366167,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/23/2021,6/23/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-06,1.402254,3142.4512139999997,3000+ $
GB,2021-06-16,A0366221,Clinical,Derriford University Hospitals Plymouth NHS Trust,Cyrus Daneshvar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/20/2021,6/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
ES,2021-06-17,A0366830,Clinical,Hospital Clinico San Carlos,Jose Angel Garcia-Saenz,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,6/22/2021,6/22/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,EUR 0.00,0.0,2021-06,1.203926,0.0,0 $
BR,2021-06-17,A0366511,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,6/22/2021,6/22/2021,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-06,1.0,1350.0,0-1500$ 
GB,2021-06-17,A0366586,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/22/2021,6/22/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-06,1.402254,3142.4512139999997,3000+ $
CL,2021-06-17,A0366801,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/30/2021,6/30/2021,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,1550 USD,1550.0,2021-06,1.0,1550.0,1500-2000$ 
BR,2021-06-17,A0366496,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,6/19/2021,6/19/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,-,0.0,2021-06,1.0,0.0,0 $
GB,2021-06-17,A0366811,Clinical,Bupa Cromwell Hospital,Andrew Gaya,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/22/2021,6/23/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 2490.00,2490.0,2021-06,1.402254,3491.61246,3000+ $
BR,2021-06-18,A0366976,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/22/2021,6/22/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-06,1.0,1350.0,0-1500$ 
GB,2021-06-18,A0367219,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/26/2021,6/29/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
GB,2021-06-18,A0367352,Clinical,BMI Harbour Hospital,Mike Bayne,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,6/23/2021,6/23/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
ES,2021-06-18,A0367112,Clinical,Hospital Clinico San Carlos,Santiago Cabezas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Other,6/23/2021,6/23/2021,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,EUR 0.00,0.0,2021-06,1.203926,0.0,0 $
GB,2021-06-19,A0367600,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/25/2021,6/25/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-06,1.402254,3142.4512139999997,3000+ $
GB,2021-06-19,A0367711,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/29/2021,6/29/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-06,1.402254,3225.1841999999997,3000+ $
GB,2021-06-21,A0367826,Clinical,North West Cancer Centre - Altnagelvin Area Hospital,Raafat Malek Abdelsayed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/25/2021,6/25/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
GB,2021-06-21,A0367851,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Gary Middleton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/28/2021,6/28/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
IT,2021-06-22,A0368119,Clinical,Policlinico Gemelli - Rome,Gennaro Iapicca,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/28/2021,6/28/2021,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2490 EUR,2490.0,2021-06,1.203926,2997.77574,2000-3000$ 
MX,2021-06-22,A0368127,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Squamous cell carcinoma,7/7/2021,7/7/2021,MEXICO,Commercial,Lung,MEXICO,1,non_AE,EUR,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,3316 USD,3316.0,2021-06,1.203926,3992.218616,3000+ $
GB,2021-06-23,A0368446,Clinical,Basingstoke and North Hampshire Hospital,Marcus Remer,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/29/2021,6/29/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
IE,2021-06-24,A0369010,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/29/2021,6/29/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,EUR 1245.00,1245.0,2021-06,1.203926,1498.88787,0-1500$ 
GB,2021-06-24,A0368939,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/29/2021,7/22/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
FR,2021-06-24,A0369229,Clinical,Institut Regional du Cancer Montpellier - ICM,Marie Viala,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/30/2021,6/30/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,EUR 0.00,0.0,2021-06,1.203926,0.0,0 $
FR,2021-06-24,A0369145,Clinical,Centre Leon Berard,Aurelie Swalduz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/29/2021,6/29/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,EUR 0.00,0.0,2021-06,1.203926,0.0,0 $
GB,2021-06-24,A0368821,Clinical,Western General Hospital - Edinburgh Cancer Centre,Melanie Mackean,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/30/2021,12/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free,GBP 0.00,0.0,2021-06,1.402254,0.0,0 $
GB,2021-06-25,A0369401,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/1/2021,7/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-06,1.402254,3225.1841999999997,3000+ $
GB,2021-06-25,A0369621,Clinical,The Royal Marsden NHS Foundation Trust,Rille Pihlak,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,6/30/2021,6/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
GB,2021-06-25,A0369640,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/30/2021,6/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
IT,2021-06-25,A0369497,Clinical,IEO - Istituto Europeo di Oncologia,Giuseppe Curigliano,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/29/2021,6/29/2021,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Free, 0.00 EUR,0.0,2021-06,1.203926,0.0,0 $
GB,2021-06-25,A0369675,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/29/2021,6/29/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-06,1.402254,3225.1841999999997,3000+ $
CA,2021-06-25,A0369393,Clinical,Durham Regional Cancer Centre,Kirsten Smerdon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,6/30/2021,6/30/2021,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Canada,Paid,2500 USD,2500.0,2021-06,1.0,2500.0,2000-3000$ 
IE,2021-06-25,A0369650,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/29/2021,7/7/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,EUR 1245.00,1245.0,2021-06,1.203926,1498.88787,0-1500$ 
ES,2021-06-25,A0369543,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/30/2021,6/30/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,1245 EUR,1245.0,2021-06,1.203926,1498.88787,0-1500$ 
GB,2021-06-25,A0369639,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Muthuveni Ezhil,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/30/2021,7/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
GB,2021-06-25,A0369656,Clinical,HCA Laboratories,Stephen Morris,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,6/30/2021,6/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-06,1.402254,3142.4512139999997,3000+ $
GB,2021-06-25,A0369646,Clinical,Cancer Centre London,Charlotte Rayner,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,7/4/2021,7/4/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-06,1.402254,3225.1841999999997,3000+ $
CA,2021-06-25,A0369592,Clinical,Princess Margaret Cancer Centre,Abha Gupta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,6/30/2021,6/30/2021,CANADA,Commercial,Other,CANADA,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Canada,Paid,2500 USD,2500.0,2021-06,1.0,2500.0,2000-3000$ 
BR,2021-06-26,A0369878,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,6/29/2021,6/29/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-06,1.0,1350.0,0-1500$ 
BR,2021-06-26,A0369895,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/1/2021,7/1/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,South America,Paid,1350,1350.0,2021-06,1.0,1350.0,0-1500$ 
GB,2021-06-26,A0369820,Clinical,HCA Laboratories,Jonathan Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/30/2021,6/30/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-06,1.402254,3142.4512139999997,3000+ $
GB,2021-06-28,A0370195,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Duodenal Adenocarcinoma,7/3/2021,7/3/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,"GBP 2,490.00",2490.0,2021-06,1.402254,3491.61246,3000+ $
CA,2021-06-28,A0370202,Clinical,Ottawa Hospital Cancer Centre,Tim Asmis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,7/4/2021,7/4/2021,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Canada,Free,EUR 0.00,0.0,2021-06,1.0,0.0,0 $
DE,2021-06-28,A0370216,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/4/2021,7/27/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2990 EUR,2990.0,2021-06,1.203926,3599.7387400000002,3000+ $
ES,2021-06-28,A0370207,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/4/2021,7/4/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2400 USD,2400.0,2021-06,1.203926,2889.4224,2000-3000$ 
GB,2021-06-28,A0370204,Clinical,Genesis Care Nottingham,Jamie Mills,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/3/2021,7/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,"GBP 2,300.00",2300.0,2021-06,1.402254,3225.1841999999997,3000+ $
GB,2021-06-29,A0370454,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/7/2021,7/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
GB,2021-06-29,A0370453,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/6/2021,7/6/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,2241,2241.0,2021-06,1.402254,3142.4512139999997,3000+ $
CA,2021-06-30,A0371053,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/8/2021,7/8/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Canada,Paid,1750 USD,1750.0,2021-06,1.0,1750.0,1500-2000$ 
GB,2021-06-30,A0371006,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/6/2021,7/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2021,2,1,2021-06-01,2021-06,G360 CDx,2021Q2,Europe,Paid,GBP 1245.00,1245.0,2021-06,1.402254,1745.80623,1500-2000$ 
ES,2021-07-01,A0372058,Clinical,Genesiscare Hospital San Francisco de Asis,Lucrecia Ruiz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/7/2021,7/7/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2490 EUR,2490.0,2021-07,1.182541,2944.52709,2000-3000$ 
ES,2021-07-01,A0371573,Clinical,MD Anderson Cancer Center-Spain,Isabel Burgueno,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/5/2021,7/5/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free, 0.00 EUR,0.0,2021-07,1.182541,0.0,0 $
BR,2021-07-01,A0372073,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/7/2021,7/7/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-07,1.0,1350.0,0-1500$ 
ES,2021-07-02,A0372236,Clinical,Clinica Universidad de Navarra-Madrid,Antonio Gonzalez Martin,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/8/2021,7/8/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2400 USD,2400.0,2021-07,1.182541,2838.0984000000003,2000-3000$ 
GB,2021-07-02,A0372263,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Appendix adenocarcinoma,7/7/2021,7/7/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-07,1.381184,3095.2333439999998,3000+ $
GB,2021-07-02,A0372629,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/7/2021,7/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-07,1.381184,3095.2333439999998,3000+ $
CL,2021-07-02,A0372600,Clinical,Clinica Las Condes,Luis Cereceda,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,7/7/2021,7/7/2021,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1550 USD,1550.0,2021-07,1.0,1550.0,1500-2000$ 
GB,2021-07-02,A0372595,Clinical,Basingstoke and North Hampshire Hospital,Marcus Remer,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/11/2021,7/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-07,1.381184,0.0,0 $
GB,2021-07-03,A0373087,Clinical,The Royal Marsden NHS Foundation Trust,Daniela Kolarevic,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/12/2021,7/12/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,"GBP 2,300.00",2300.0,2021-07,1.381184,3176.7232,3000+ $
GB,2021-07-03,A0372791,Clinical,BMI Harbour Hospital,Mike Bayne,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/9/2021,8/13/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,"GBP 2,490.00",2490.0,2021-07,1.381184,3439.1481599999997,3000+ $
GB,2021-07-03,A0373085,Clinical,Genesis Care Nottingham,Arvind Arora,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,7/10/2021,7/14/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,"GBP 2,490.00",2490.0,2021-07,1.381184,3439.1481599999997,3000+ $
GB,2021-07-03,A0373083,Clinical,Guys Hospital,Eleni Karapanagiotou,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/13/2021,7/13/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
TR,2021-07-06,A0373195,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung squamous cell carcinoma,7/12/2021,8/5/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-07,1.0,1943.0,1500-2000$ 
BR,2021-07-07,A0373412,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,7/14/2021,7/14/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-07,1.0,1350.0,0-1500$ 
GB,2021-07-07,A0373224,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/14/2021,7/14/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
CA,2021-07-07,A0373239,Clinical,Universite de Montreal - CHUM,Francine Aubin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,7/14/2021,7/14/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Canada,Paid,3500 USD,3500.0,2021-07,1.0,3500.0,3000+ $
GB,2021-07-07,A0373425,Clinical,The Royal Marsden NHS Foundation Trust,Alicia Okines,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/14/2021,7/14/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,"GBP 2,490.00",2490.0,2021-07,1.381184,3439.1481599999997,3000+ $
GB,2021-07-07,A0373295,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,7/16/2021,7/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-07,1.381184,3095.2333439999998,3000+ $
GB,2021-07-07,A0373290,Clinical,Bristol Haematology and Oncology Centre,Jeremy Braybrooke,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/14/2021,7/15/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,"GBP 2,490.00",2490.0,2021-07,1.381184,3439.1481599999997,3000+ $
GB,2021-07-07,A0373385,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,7/14/2021,7/14/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,"GBP 2,300.00",2300.0,2021-07,1.381184,3176.7232,3000+ $
GB,2021-07-07,A0373417,Clinical,The Royal Marsden NHS Foundation Trust,Nicholas Turner,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,7/14/2021,7/14/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,"GBP 2,490.00",2490.0,2021-07,1.381184,3439.1481599999997,3000+ $
GB,2021-07-08,A0373703,Clinical,North West Cancer Centre - Altnagelvin Area Hospital,Raafat Malek Abdelsayed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/16/2021,7/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-07,1.381184,0.0,0 $
GB,2021-07-08,A0373665,Clinical,Southend University Hospital,Gulshad Begum,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/16/2021,7/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-07,1.381184,0.0,0 $
GB,2021-07-08,A0373692,Clinical,Elstree Cancer Centre,David Miles,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/16/2021,7/16/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,"GBP 2,300.00",2300.0,2021-07,1.381184,3176.7232,3000+ $
ES,2021-07-08,A0373577,Clinical,Hospital Universitario HM Sanchinarro,Miriam Dorta,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/15/2021,8/20/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2490 EUR,2490.0,2021-07,1.182541,2944.52709,2000-3000$ 
ES,2021-07-09,A0374539,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,7/18/2021,7/18/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2400 USD,2400.0,2021-07,1.182541,2838.0984000000003,2000-3000$ 
ES,2021-07-09,A0374197,Clinical,Hospital Sanitas La Zarzuela,Pedro Salinas,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,7/13/2021,7/13/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free, 0.00 EUR,0.0,2021-07,1.182541,0.0,0 $
ES,2021-07-09,A0374390,Clinical,Hospital Sanitas La Zarzuela,Juan Jose Tafalla,Guardant 360,2.11,GHI_01,Self-Pay Patient,Thyroid carcinoma,7/16/2021,7/16/2021,SPAIN,Commercial,Thyroid,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free, 0.00 EUR,0.0,2021-07,1.182541,0.0,0 $
ES,2021-07-09,A0374629,Clinical,Hospital Universitario Miguel Servet,Elena Aguirre Ortega,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/15/2021,7/15/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free, 0.00 EUR,0.0,2021-07,1.182541,0.0,0 $
GB,2021-07-09,A0374476,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/15/2021,7/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
GB,2021-07-09,A0374630,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/15/2021,7/15/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,"GBP 2,300.00",2300.0,2021-07,1.381184,3176.7232,3000+ $
ES,2021-07-09,A0374473,Clinical,Hospital Sanitas La Zarzuela,Maria Concepion Fernandez-Chacon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/15/2021,7/15/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free, 0.00 EUR,0.0,2021-07,1.182541,0.0,0 $
GB,2021-07-09,A0374219,Clinical,Charing Cross Hospital Medical Oncology Department,Joanne Evans,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/17/2021,7/17/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-07,1.381184,0.0,0 $
GB,2021-07-09,A0374270,Clinical,Spire Harpenden Hospital,Nihal Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/16/2021,7/16/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,"GBP 2,300.00",2300.0,2021-07,1.381184,3176.7232,3000+ $
GB,2021-07-09,A0374485,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,7/20/2021,7/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-07,1.381184,3095.2333439999998,3000+ $
ES,2021-07-09,A0374289,Clinical,Genesiscare Hospital San Francisco de Asis,Lucrecia Ruiz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,7/15/2021,7/15/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid, 0.00 EUR,0.0,2021-07,1.182541,0.0,0 $
FI,2021-07-10,A0374666,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,7/17/2021,7/17/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2366,2366.0,2021-07,1.182541,2797.892006,2000-3000$ 
GB,2021-07-10,A0374979,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/16/2021,7/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-07,1.381184,0.0,0 $
ES,2021-07-12,A0375054,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,7/19/2021,7/19/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-07,1.182541,1472.263545,0-1500$ 
BR,2021-07-12,A0375055,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Small cell lung carcinoma,7/19/2021,7/19/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-07,1.0,1350.0,0-1500$ 
BR,2021-07-12,A0375058,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/19/2021,7/19/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-07,1.0,1350.0,0-1500$ 
GB,2021-07-13,A0375283,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/20/2021,7/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
TR,2021-07-13,A0375260,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,7/21/2021,8/5/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-07,1.0,1943.0,1500-2000$ 
GB,2021-07-13,A0375278,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,7/21/2021,7/21/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
FR,2021-07-13,A0375213,Clinical,Institut Regional du Cancer Montpellier - ICM,Camille Travert,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/21/2021,7/21/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free, 0.00 EUR,0.0,2021-07,1.182541,0.0,0 $
GB,2021-07-14,A0375939,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,7/21/2021,8/6/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
GB,2021-07-14,A0375713,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/21/2021,1/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
TR,2021-07-14,A0375925,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,7/21/2021,8/5/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-07,1.0,1943.0,1500-2000$ 
GB,2021-07-14,A0375929,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shivan Sivakumar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,7/21/2021,7/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
GB,2021-07-15,A0376262,Clinical,University Hospitals Of Leicester,David Lloyd,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/21/2021,7/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-07,1.381184,0.0,0 $
BR,2021-07-15,A0376345,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/22/2021,7/22/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1700 USD,1700.0,2021-07,1.0,1700.0,1500-2000$ 
BR,2021-07-15,A0376309,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/21/2021,7/21/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-07,1.0,1350.0,0-1500$ 
FI,2021-07-15,A0376301,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/22/2021,7/22/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2366,2366.0,2021-07,1.182541,2797.892006,2000-3000$ 
TR,2021-07-15,A0376346,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,7/22/2021,8/5/2021,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-07,1.0,1943.0,1500-2000$ 
IE,2021-07-16,A0376612,Clinical,Bon Secours Hospital,Deirdre O'Mahony,Guardant 360,2.11,GHI_01,Self-Pay Patient,Sarcoma,7/23/2021,7/23/2021,IRELAND,Commercial,Soft Tissue/Bone,IRELAND,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,EUR 1245.00,1245.0,2021-07,1.182541,1472.263545,0-1500$ 
BR,2021-07-17,A0377073,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/24/2021,7/24/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-07,1.0,1350.0,0-1500$ 
GB,2021-07-17,A0377061,Clinical,St James University Hospital,Dan Lee,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/22/2021,7/22/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-07,1.381184,0.0,0 $
DE,2021-07-19,A0377428,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/23/2021,7/23/2021,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2990 EUR,2990.0,2021-07,1.182541,3535.79759,3000+ $
ES,2021-07-19,A0377418,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,7/27/2021,7/27/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-07,1.182541,1472.263545,0-1500$ 
GB,2021-07-19,A0377440,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/25/2021,7/25/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
GB,2021-07-20,A0377614,Clinical,Mount Vernon Hospital Cancer Centre The Hillingdon Hospitals NHS Foundation Trust,Georgios Antoniou,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/27/2021,7/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
GB,2021-07-20,A0377588,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,8/1/2021,8/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-07,1.381184,3095.2333439999998,3000+ $
BR,2021-07-22,A0378992,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/28/2021,7/28/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-07,1.0,1350.0,0-1500$ 
BR,2021-07-22,A0378776,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/29/2021,7/29/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-07,1.0,1350.0,0-1500$ 
BR,2021-07-22,A0378767,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,7/29/2021,7/29/2021,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-07,1.0,1350.0,0-1500$ 
GB,2021-07-22,A0379082,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,7/28/2021,7/28/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,-,0.0,2021-07,1.381184,0.0,0 $
GB,2021-07-22,A0378681,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/29/2021,7/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
GB,2021-07-22,A0378563,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/29/2021,3/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
ES,2021-07-23,A0379478,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/29/2021,7/29/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-07,1.182541,1472.263545,0-1500$ 
GB,2021-07-24,A0379826,Clinical,HCA Laboratories,Martin Forster,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/31/2021,7/31/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-07,1.381184,3095.2333439999998,3000+ $
GB,2021-07-24,A0379906,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/31/2021,7/31/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-07,1.381184,3095.2333439999998,3000+ $
GB,2021-07-24,A0379932,Clinical,Elstree Cancer Centre,David Miles,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/28/2021,7/28/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,"GBP 2,300.00",2300.0,2021-07,1.381184,3176.7232,3000+ $
GB,2021-07-26,A0380151,Clinical,The Holly Private Hospital,Sherif Raouf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/2/2021,8/2/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-07,1.381184,0.0,0 $
BR,2021-07-26,A0380185,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/1/2021,8/1/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-07,1.0,1350.0,0-1500$ 
CA,2021-07-27,A0380239,Clinical,Sault Area Hospital,Mohammad Rassouli,Guardant 360,2.11,GHI_01,Self-Pay Patient,Sarcoma,8/3/2021,8/3/2021,CANADA,Commercial,Soft Tissue/Bone,CANADA,1,AE,USD,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Canada,Free, 0.00 USD,0.0,2021-07,1.0,0.0,0 $
GB,2021-07-27,A0380237,Clinical,Bronglais General Hospital,Elin Jones,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/3/2021,8/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
GB,2021-07-27,A0380244,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,8/4/2021,8/6/2021,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-07,1.381184,3095.2333439999998,3000+ $
GB,2021-07-28,A0380718,Clinical,Barnet Hospital,Neha Chopra,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/7/2021,8/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-07,1.381184,0.0,0 $
ES,2021-07-29,A0381547,Clinical,Hospital Universitario HM Sanchinarro,Antonio Cubillo Gracian,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,8/4/2021,8/20/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2500 USD,2500.0,2021-07,1.182541,2956.3525,2000-3000$ 
ES,2021-07-29,A0381312,Clinical,Complejo Hospitalario Ruber Juan Bravo,Victor Albarran,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/4/2021,8/7/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2241 EUR,2241.0,2021-07,1.182541,2650.0743810000004,2000-3000$ 
GB,2021-07-29,A0381301,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,8/4/2021,8/7/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-07,1.381184,3095.2333439999998,3000+ $
GB,2021-07-29,A0381451,Clinical,University College London Hospitals,Siow Ming Lee,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/4/2021,8/5/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
GB,2021-07-30,A0381870,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,8/2/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-07,1.381184,0.0,0 $
ES,2021-07-30,A0381695,Clinical,Hospital Universitario de Guadalajara,Javier Cassinello,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,8/5/2021,9/2/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-07,1.182541,1472.263545,0-1500$ 
GB,2021-07-30,A0381860,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/5/2021,8/5/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2300 GBP,2300.0,2021-07,1.381184,3176.7232,3000+ $
GB,2021-07-30,A0381705,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/5/2021,8/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-07,1.381184,1719.5740799999999,1500-2000$ 
GB,2021-07-30,A0381865,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,8/4/2021,8/4/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-07,1.381184,3095.2333439999998,3000+ $
TR,2021-07-31,A0382800,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,8/6/2021,9/2/2021,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-07,1.0,1943.0,1500-2000$ 
MX,2021-07-31,A0382681,Clinical,MileniaLabs,Gerardo Rodriguez Abrajan,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,8/7/2021,8/7/2021,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,South America,Paid,2500,2500.0,2021-07,1.182541,2956.3525,2000-3000$ 
ES,2021-07-31,A0382535,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/5/2021,8/5/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-07,1.182541,0.0,0 $
GB,2021-07-31,A0382802,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,8/6/2021,8/6/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,,0.0,2021-07,1.381184,0.0,0 $
TR,2021-07-31,A0382799,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,8/6/2021,8/6/2021,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,7,2021,3,1,2021-07-01,2021-07,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-07,1.0,1943.0,1500-2000$ 
GB,2021-08-02,A0382824,Clinical,Spire Hospital Portsmouth,Freddie Bartlett,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/6/2021,10/1/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,"GBP 2,490.00",2490.0,2021-08,1.379641,3435.3060899999996,3000+ $
IE,2021-08-02,A0382818,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/6/2021,3/20/2023,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-08,1.177023,1465.393635,0-1500$ 
GB,2021-08-02,A0382826,Clinical,Freeman Hospital,Alastair Greystoke,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/6/2021,8/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
ES,2021-08-02,A0382820,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/10/2021,8/10/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2200 EUR,2200.0,2021-08,1.177023,2589.4505999999997,2000-3000$ 
ES,2021-08-02,A0382819,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/7/2021,8/7/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2200 EUR,2200.0,2021-08,1.177023,2589.4505999999997,2000-3000$ 
BR,2021-08-03,A0383338,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,8/11/2021,8/11/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-08,1.0,1350.0,0-1500$ 
GB,2021-08-04,A0383611,Clinical,The Nuffield Hospital Guildford,Hardev Pandha,Guardant 360,2.11,GHI_01,Self-Pay Patient,Renal Cell Carcinoma,8/9/2021,8/9/2021,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,GBP 2300.00,2300.0,2021-08,1.379641,3173.1742999999997,3000+ $
GB,2021-08-04,A0383596,Clinical,The Rutherford Cancer Centre,Seema Arif,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/9/2021,8/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-08,1.379641,0.0,0 $
IE,2021-08-04,A0383745,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/10/2021,8/10/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-08,1.177023,1465.393635,0-1500$ 
GB,2021-08-04,A0383591,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shivan Sivakumar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/9/2021,8/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,0.00 GBP,0.0,2021-08,1.379641,0.0,0 $
BR,2021-08-05,A0383986,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/9/2021,8/9/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-08,1.0,1350.0,0-1500$ 
ES,2021-08-05,A0384336,Clinical,Clinica Universidad de Navarra,Alejandro Garcia-Consuegra Lopez Picazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,8/16/2021,8/16/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2400 USD,2400.0,2021-08,1.177023,2824.8552,2000-3000$ 
ES,2021-08-05,A0384018,Clinical,Complejo Hospitalario Ruber Juan Bravo,Victor Albarran,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/11/2021,8/11/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2241 EUR,2241.0,2021-08,1.177023,2637.7085429999997,2000-3000$ 
GB,2021-08-05,A0383975,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,8/9/2021,8/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-08,1.379641,3091.7754809999997,3000+ $
GB,2021-08-05,A0384032,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/9/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
GB,2021-08-06,A0384606,Clinical,The Royal Marsden NHS Foundation Trust,Geraldo Alves de Paula Neto,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/15/2021,8/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
ES,2021-08-06,A0384627,Clinical,Hospital De San Pau I Santa Tecla,Laia Capdevila,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/11/2021,8/11/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-08,1.177023,0.0,0 $
ES,2021-08-06,A0384619,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,8/12/2021,8/12/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2400 USD,2400.0,2021-08,1.177023,2824.8552,2000-3000$ 
ES,2021-08-06,A0384985,Clinical,Hospital Clinico San Carlos,Arancha Manzano,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),8/10/2021,8/10/2021,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-08,1.177023,0.0,0 $
ES,2021-08-06,A0384613,Clinical,Genesiscare Hospital San Francisco de Asis,Lucrecia Ruiz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/12/2021,8/16/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2490.00 EUR,2490.0,2021-08,1.177023,2930.78727,2000-3000$ 
ES,2021-08-06,A0384826,Clinical,Hospital Universitario Severo Ochoa,Maria Josefa Echarri Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/11/2021,8/12/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2490.00 EUR,2490.0,2021-08,1.177023,2930.78727,2000-3000$ 
ES,2021-08-06,A0384979,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/10/2021,8/10/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2400 USD,2400.0,2021-08,1.177023,2824.8552,2000-3000$ 
ES,2021-08-07,A0385300,Clinical,Complejo Hospitalario Ruber Juan Bravo,Victor Albarran,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/13/2021,8/13/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2241 EUR,2241.0,2021-08,1.177023,2637.7085429999997,2000-3000$ 
LT,2021-08-09,A0385388,Clinical,Genomika,Mantas Simutis,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,8/13/2021,9/2/2021,LITHUANIA,Commercial,Breast,LITHUANIA,1,non_AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,0,0.0,2021-08,1.177023,0.0,0 $
IE,2021-08-09,A0385384,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/13/2021,8/13/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-08,1.177023,1465.393635,0-1500$ 
ES,2021-08-09,A0385408,Clinical,INITIA Oncologia,Angel Luis Guerrero Zotano,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,8/18/2021,8/18/2021,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2490 EUR,2490.0,2021-08,1.177023,2930.78727,2000-3000$ 
ES,2021-08-09,A0385396,Clinical,"Institut Catala d'Oncologia Girona - ICO, Hospital Universitari De Girona Doctor Josep Trueta",Joaquim Bosch Barrera,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/13/2021,8/13/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-08,1.177023,0.0,0 $
ES,2021-08-10,A0385732,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/15/2021,8/15/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2400 USD,2400.0,2021-08,1.177023,2824.8552,2000-3000$ 
GB,2021-08-10,A0385708,Clinical,Worthing Hospital,Anna Britten,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,8/16/2021,8/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-08,1.379641,0.0,0 $
GB,2021-08-10,A0385727,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,8/18/2021,8/18/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-08,1.379641,3091.7754809999997,3000+ $
GB,2021-08-10,A0385770,Clinical,HCA Laboratories,Jeremy Peter Steele,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/16/2021,8/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-08,1.379641,3091.7754809999997,3000+ $
GB,2021-08-10,A0385685,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/15/2021,8/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
CA,2021-08-11,A0386241,Clinical,RCM Health Consultancy,Helena Dukic,Guardant 360,2.11,GHI_01,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),8/16/2021,9/7/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Canada,Paid,3500 USD,3500.0,2021-08,1.0,3500.0,3000+ $
GB,2021-08-11,A0385973,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shivan Sivakumar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/15/2021,8/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,"GBP 2,490.00",2490.0,2021-08,1.379641,3435.3060899999996,3000+ $
GB,2021-08-12,A0386637,Clinical,The Rutherford Cancer Centre,Russell Banner,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Head and neck carcinoma,8/17/2021,8/17/2021,UNITED KINGDOM,Commercial,Head and neck carcinoma,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
ES,2021-08-14,A0387529,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/18/2021,8/20/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2490.00 EUR,2490.0,2021-08,1.177023,2930.78727,2000-3000$ 
GB,2021-08-14,A0387515,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/18/2021,8/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
CA,2021-08-14,A0387522,Clinical,Sault Area Hospital,Mohammad Rassouli,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,8/18/2021,8/18/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Canada,Free,0.00 USD,0.0,2021-08,1.0,0.0,0 $
IE,2021-08-14,A0387619,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,8/18/2021,8/26/2021,IRELAND,Commercial,GI,IRELAND,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-08,1.177023,1465.393635,0-1500$ 
BR,2021-08-16,A0387853,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/22/2021,8/22/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-08,1.0,1350.0,0-1500$ 
GB,2021-08-16,A0387845,Clinical,Freeman Hospital,Alastair Greystoke,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/22/2021,8/24/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
DE,2021-08-16,A0387855,Clinical,Erlangen Universitaetsklinikum,Peter Fasching,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/21/2021,8/21/2021,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-08,1.177023,0.0,0 $
IE,2021-08-16,A0387858,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/22/2021,8/24/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-08,1.177023,1465.393635,0-1500$ 
ES,2021-08-16,A0387836,Clinical,Hospital Universitario de Guadalajara,Javier Cassinello,Guardant 360,2.11,GHI_01,Distributors : ROW,Thyroid carcinoma,8/21/2021,8/21/2021,SPAIN,Commercial,Thyroid,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-08,1.177023,1465.393635,0-1500$ 
ES,2021-08-16,A0387851,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,8/21/2021,8/21/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2500 USD,2500.0,2021-08,1.177023,2942.5575,2000-3000$ 
ES,2021-08-16,A0387837,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/22/2021,8/22/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2400 USD,2400.0,2021-08,1.177023,2824.8552,2000-3000$ 
TR,2021-08-17,A0388058,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,8/22/2021,9/27/2021,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-08,1.0,1943.0,1500-2000$ 
TR,2021-08-18,A0388705,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,8/24/2021,9/27/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-08,1.0,1943.0,1500-2000$ 
BR,2021-08-18,A0388822,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/22/2021,8/22/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-08,1.0,1350.0,0-1500$ 
TR,2021-08-18,A0388750,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,8/23/2021,9/27/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-08,1.0,1943.0,1500-2000$ 
GB,2021-08-19,A0389286,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,8/25/2021,8/25/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-08,1.379641,0.0,0 $
CA,2021-08-19,A0389325,Clinical,Cross Cancer Institute/University of Alberta,Randeep Sangha,Guardant 360,2.11,GHI_01,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),8/24/2021,8/24/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Canada,Paid,"1,700.00 USD",1700.0,2021-08,1.0,1700.0,1500-2000$ 
GB,2021-08-20,A0389783,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sharadah Essapen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/25/2021,9/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1245,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
BR,2021-08-20,A0389768,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/25/2021,8/25/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-08,1.0,1350.0,0-1500$ 
ES,2021-08-20,A0389714,Clinical,Fundacion Jimenez Diaz,Cristina Carames Sanchez,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Colorectal adenocarcinoma,8/25/2021,8/25/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-08,1.177023,0.0,0 $
ES,2021-08-20,A0389944,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,9/3/2021,9/3/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-08,1.177023,0.0,0 $
GB,2021-08-20,A0389772,Clinical,BMI Harbour Hospital,Lauren Gorf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/25/2021,8/26/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-08,1.379641,0.0,0 $
GB,2021-08-20,A0389775,Clinical,The Spire Hospital Hartswood,Eliot Sims,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/25/2021,8/30/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1245,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
GB,2021-08-21,A0390443,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,8/28/2021,8/28/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2300,2300.0,2021-08,1.379641,3173.1742999999997,3000+ $
GB,2021-08-21,A0390427,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/27/2021,8/27/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2300,2300.0,2021-08,1.379641,3173.1742999999997,3000+ $
DE,2021-08-23,A0390477,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,8/28/2021,2/23/2022,GERMANY,Commercial,GI,GERMANY,1,non_AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2990 EUR,2990.0,2021-08,1.177023,3519.29877,3000+ $
GB,2021-08-23,A0390491,Clinical,Freeman Hospital,Alastair Greystoke,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/28/2021,9/14/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-08,1.379641,0.0,0 $
BR,2021-08-23,A0390480,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/28/2021,8/28/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-08,1.0,1350.0,0-1500$ 
IT,2021-08-23,A0390517,Clinical,IEO - Istituto Europeo di Oncologia,Giuseppe Curigliano,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/28/2021,8/28/2021,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-08,1.177023,0.0,0 $
GB,2021-08-24,A0390956,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/30/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
GB,2021-08-24,A0390799,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Robert Laing,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/31/2021,8/31/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,"GBP 2,490.00",2490.0,2021-08,1.379641,3435.3060899999996,3000+ $
CA,2021-08-24,A0390789,Clinical,London Health Sciences Centre,Mark Vincent,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/29/2021,8/29/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Canada,Paid,"1,700.00 USD",1700.0,2021-08,1.0,1700.0,1500-2000$ 
SI,2021-08-25,A0391146,Clinical,Luka Hauptman MD,Luka Hauptman,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/30/2021,9/1/2021,SLOVENIA,Commercial,,SLOVENIA,1,non_AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1745 EUR,1745.0,2021-08,1.177023,2053.905135,2000-3000$ 
FR,2021-08-25,A0391227,Clinical,Centre Leon Berard,Aurelie Swalduz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/30/2021,8/30/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-08,1.177023,0.0,0 $
GB,2021-08-26,A0391674,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/30/2021,8/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-08,1.379641,3091.7754809999997,3000+ $
CA,2021-08-26,A0391632,Clinical,Southlake Regional Health Centre,Amira Rana,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/30/2021,8/30/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Canada,Free,0.00 USD,0.0,2021-08,1.0,0.0,0 $
TR,2021-08-26,A0391818,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung squamous cell carcinoma,9/2/2021,9/27/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-08,1.0,1943.0,1500-2000$ 
GB,2021-08-26,A0391758,Clinical,Princess Elizabeth Hospital,Peter J Gomes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/30/2021,9/2/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
GB,2021-08-27,A0392114,Clinical,The Royal Marsden NHS Foundation Trust,Alicia Okines,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/1/2021,9/1/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,2300 GBP,2300.0,2021-08,1.379641,3173.1742999999997,3000+ $
TR,2021-08-27,A0392434,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/1/2021,9/27/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-08,1.0,1943.0,1500-2000$ 
TR,2021-08-27,A0392435,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/1/2021,9/27/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-08,1.0,1943.0,1500-2000$ 
GB,2021-08-27,A0392105,Clinical,Poole Hospital NHS Foundation Trust,Amelie Harle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/1/2021,9/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-08,1.379641,0.0,0 $
GB,2021-08-27,A0392433,Clinical,Charing Cross Hospital Medical Oncology Department,Thomas Talbot,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,9/2/2021,9/2/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-08,1.379641,0.0,0 $
ES,2021-08-27,A0392249,Clinical,Hospital Nuestra Senora de Sonsoles,Lauren Condori,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),9/1/2021,10/5/2021,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1745 EUR,1745.0,2021-08,1.177023,2053.905135,2000-3000$ 
GB,2021-08-27,A0392144,Clinical,Spire Little Aston Hospital,Daniel Henderson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/1/2021,9/3/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,GBP 1245.00,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
BR,2021-08-28,A0392748,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/5/2021,9/5/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-08,1.0,1350.0,0-1500$ 
BR,2021-08-30,A0392951,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/5/2021,9/5/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-08,1.0,1350.0,0-1500$ 
GB,2021-08-30,A0392927,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/5/2021,9/5/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Free,GBP 0.00,0.0,2021-08,1.379641,0.0,0 $
BR,2021-08-30,A0392944,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/5/2021,9/5/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-08,1.0,1350.0,0-1500$ 
GB,2021-08-30,A0392946,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/5/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-08,1.379641,1717.6530449999998,1500-2000$ 
TR,2021-08-31,A0392999,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/5/2021,9/27/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2021,3,1,2021-08-01,2021-08,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-08,1.0,1943.0,1500-2000$ 
GB,2021-09-02,A0394427,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,9/8/2021,9/14/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-02,A0394091,Clinical,Medway Maritime Hospital,Fareen Rahman,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/6/2021,1/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
CA,2021-09-02,A0394385,Clinical,RCM Health Consultancy,Helena Dukic,Guardant 360,2.11,GHI_01,Self-Pay Patient,Fibrosarcoma,9/6/2021,9/14/2021,CANADA,Commercial,Soft Tissue/Bone,CANADA,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Canada,Paid,3500 USD,3500.0,2021-09,1.0,3500.0,3000+ $
GB,2021-09-03,A0394712,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/8/2021,9/8/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2490 GBP,2490.0,2021-09,1.374732,3423.08268,3000+ $
ES,2021-09-03,A0394641,Clinical,Fundacion Jimenez Diaz,Cristina Carames Sanchez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/11/2021,9/11/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-09,1.177358,1465.81071,0-1500$ 
GB,2021-09-03,A0394659,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/8/2021,9/14/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-03,A0394709,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/8/2021,9/8/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2490 GBP,2490.0,2021-09,1.374732,3423.08268,3000+ $
GB,2021-09-03,A0394683,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,9/9/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-03,A0394795,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/7/2021,9/7/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0.00 GBP,0.0,2021-09,1.374732,0.0,0 $
GB,2021-09-04,A0395272,Clinical,Beatson West of Scotland Cancer Centre,Janet Graham,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/9/2021,9/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
CA,2021-09-04,A0395091,Clinical,Cross Cancer Institute/University of Alberta,Quincy Chu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/9/2021,9/9/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Canada,Paid,1700 USD,1700.0,2021-09,1.0,1700.0,1500-2000$ 
TR,2021-09-07,A0395496,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/12/2021,10/14/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-09,1.0,1943.0,1500-2000$ 
BR,2021-09-07,A0395499,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/17/2021,9/17/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-09,1.0,1350.0,0-1500$ 
ES,2021-09-07,A0395492,Clinical,Hospital Clinico San Carlos,Jose Angel Garcia-Saenz,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/17/2021,9/17/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-09,1.177358,0.0,0 $
GB,2021-09-07,A0395470,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,9/11/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-07,A0395507,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/12/2021,9/14/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
BR,2021-09-07,A0395504,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/17/2021,9/17/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-09,1.0,1350.0,0-1500$ 
GB,2021-09-07,A0395491,Clinical,Western General Hospital - Edinburgh Cancer Centre,Melanie Mackean,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/13/2021,9/13/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0.00 GBP,0.0,2021-09,1.374732,0.0,0 $
ES,2021-09-08,A0396256,Clinical,Hospital Alvaro Cunqueiro,Martin Lazaro Quintela,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/14/2021,9/14/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-09,1.177358,0.0,0 $
GB,2021-09-08,A0396288,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/13/2021,9/13/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2490 GBP,2490.0,2021-09,1.374732,3423.08268,3000+ $
GB,2021-09-08,A0396398,Clinical,The Holly Private Hospital,Sherif Raouf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/18/2021,9/18/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2300 GBP,2300.0,2021-09,1.374732,3161.8836,3000+ $
FI,2021-09-08,A0396248,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/17/2021,9/17/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2366,2366.0,2021-09,1.177358,2785.629028,2000-3000$ 
GB,2021-09-08,A0396254,Clinical,Bupa Cromwell Hospital,Andrew Gaya,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/13/2021,9/13/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2300 GBP,2300.0,2021-09,1.374732,3161.8836,3000+ $
GB,2021-09-08,A0396251,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/15/2021,1/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-08,A0396382,Clinical,The Rutherford Cancer Centre,Emma Hudson,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Endometrial carcinoma,9/13/2021,9/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-09,A0396784,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/16/2021,9/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2300 GBP,2300.0,2021-09,1.374732,3161.8836,3000+ $
CA,2021-09-09,A0396990,Clinical,The Ottawa Hospital Cancer Centre - MP 911,Tim Asmis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/14/2021,9/14/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Canada,Free,0.00 USD,0.0,2021-09,1.0,0.0,0 $
GB,2021-09-09,A0397002,Clinical,HCA Laboratories,Richard Hubner,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/15/2021,9/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-09,1.374732,3080.774412,3000+ $
ES,2021-09-09,A0396847,Clinical,Hospital Universitario de Burgos,Beatriz Llorente Ayala,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,9/17/2021,9/17/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0.00 EUR,0.0,2021-09,1.177358,0.0,0 $
PL,2021-09-09,A0397508,Clinical,Narodowy Instytut Onkologii,Lucjan Wyrwicz,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,9/24/2021,10/11/2021,POLAND,Commercial,,POLAND,1,non_AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,Reveal,2021Q3,Europe,Paid,"3500 USD - 2957,97 EUR",3500.0,2021-09,1.177358,4120.753,3000+ $
GB,2021-09-09,A0396813,Clinical,Poole Hospital NHS Foundation Trust,Diane Laws,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/14/2021,9/14/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0.00 GBP,0.0,2021-09,1.374732,0.0,0 $
GB,2021-09-09,A0396788,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/14/2021,9/14/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-10,A0397706,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Anthony Neal,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/17/2021,9/21/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2490 GBP,2490.0,2021-09,1.374732,3423.08268,3000+ $
ES,2021-09-10,A0397663,Clinical,Hospital Universitario de Guadalajara,Luis Enrique Chara Velarde,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Non-small cell lung carcinoma (NSCLC),9/13/2021,9/13/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,0.00 EUR,0.0,2021-09,1.177358,0.0,0 $
CL,2021-09-10,A0397744,Clinical,Clinica Santa Maria,Cristian Carvallo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/21/2021,9/28/2021,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1550 USD,1550.0,2021-09,1.0,1550.0,1500-2000$ 
ES,2021-09-10,A0397856,Clinical,Hospital Universitario HM Sanchinarro,Antonio Cubillo Gracian,Guardant Reveal,1.0,GHI_10,Distributors : ROW,Colorectal adenocarcinoma,9/27/2021,10/11/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,Reveal,2021Q3,Europe,Paid,3500 USD,3500.0,2021-09,1.177358,4120.753,3000+ $
TR,2021-09-10,A0397621,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/17/2021,9/24/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0,0.0,2021-09,1.0,0.0,0 $
IT,2021-09-10,A0397624,Clinical,Niguarda Cancer Center,Salvatore Siena,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/16/2021,9/16/2021,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2490 EUR,2490.0,2021-09,1.177358,2931.62142,2000-3000$ 
GB,2021-09-11,A0398059,Clinical,The Royal Marsden NHS Foundation Trust,Amal Singh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/17/2021,10/14/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2490 GBP,2490.0,2021-09,1.374732,3423.08268,3000+ $
ES,2021-09-11,A0398173,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/19/2021,10/5/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1745 EUR,1745.0,2021-09,1.177358,2054.48971,2000-3000$ 
CA,2021-09-11,A0398232,Clinical,Cross Cancer Institute/University of Alberta,Hatim Karachiwala,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/17/2021,1/28/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Canada,Paid,1700 USD,1700.0,2021-09,1.0,1700.0,1500-2000$ 
GB,2021-09-11,A0398122,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sharadah Essapen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/15/2021,9/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2490 GBP,2490.0,2021-09,1.374732,3423.08268,3000+ $
BR,2021-09-13,A0398620,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/18/2021,9/22/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1700 USD,1700.0,2021-09,1.0,1700.0,1500-2000$ 
GB,2021-09-13,A0398485,Clinical,Coventry University Hospitals,Nawaz Walji,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/19/2021,9/19/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-13,A0398498,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,9/22/2021,9/22/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2490 GBP,2490.0,2021-09,1.374732,3423.08268,3000+ $
GB,2021-09-15,A0399955,Clinical,Peterborough City Hospital Dept of Oncology 18,Mohamed Mahgoub,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/24/2021,12/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-15,A0400248,Clinical,Spire Little Aston Hospital,Sundus Yahya,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/21/2021,9/21/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2490 GBP,2490.0,2021-09,1.374732,3423.08268,3000+ $
GB,2021-09-16,A0400916,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/22/2021,9/22/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
ES,2021-09-16,A0401014,Clinical,Complejo Hospitalario Ruber Juan Bravo,Victor Albarran,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenosquamous carcinoma,9/22/2021,9/22/2021,SPAIN,Commercial,Lung,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2241 EUR,2241.0,2021-09,1.177358,2638.459278,2000-3000$ 
BR,2021-09-16,A0400579,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),9/22/2021,9/22/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-09,1.0,1350.0,0-1500$ 
TR,2021-09-16,A0400555,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/20/2021,10/14/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-09,1.0,1943.0,1500-2000$ 
TR,2021-09-16,A0400548,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/22/2021,10/14/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-09,1.0,1943.0,1500-2000$ 
ES,2021-09-16,A0400575,Clinical,Hospital del Mar,Clara Montagut,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,9/23/2021,4/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-09,1.177358,1465.81071,0-1500$ 
TR,2021-09-16,A0400551,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/20/2021,9/24/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0,0.0,2021-09,1.0,0.0,0 $
ES,2021-09-16,A0400606,Clinical,Hospital Nuestra Senora de Sonsoles,Beatriz Barrios Collado,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung squamous cell carcinoma,9/21/2021,10/5/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1745 EUR,1745.0,2021-09,1.177358,2054.48971,2000-3000$ 
GB,2021-09-16,A0400578,Clinical,Kent Oncology Centre,Timothy Sevitt,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/22/2021,10/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-17,A0401359,Clinical,HCA Laboratories,Jonathan Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/22/2021,9/22/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-09,1.374732,3080.774412,3000+ $
GB,2021-09-17,A0401317,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/22/2021,9/22/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0.00 GBP,0.0,2021-09,1.374732,0.0,0 $
CA,2021-09-17,A0401330,Clinical,West Vancouver Wellness Centre,Justin Lafreniere,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,9/23/2021,10/1/2021,CANADA,Commercial,Other,CANADA,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Canada,Paid,1500 USD,1500.0,2021-09,1.0,1500.0,0-1500$ 
GB,2021-09-17,A0401363,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/23/2021,12/17/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-17,A0401092,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/25/2021,9/25/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-09,1.374732,3080.774412,3000+ $
GB,2021-09-17,A0401089,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung cancer,9/26/2021,9/26/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
GB,2021-09-18,A0401636,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/23/2021,9/23/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
BR,2021-09-18,A0401626,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,9/24/2021,9/24/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-09,1.0,1350.0,0-1500$ 
GB,2021-09-18,A0401633,Clinical,Sussex Cancer Centre,Juliet Brock,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/23/2021,9/23/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
FI,2021-09-20,A0401945,Clinical,Turku University Hospital,Jaana Kaunisto,Guardant 360,2.11,GHI_01,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),9/27/2021,9/27/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2366,2366.0,2021-09,1.177358,2785.629028,2000-3000$ 
BR,2021-09-20,A0401936,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/25/2021,9/25/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1700 USD,1700.0,2021-09,1.0,1700.0,1500-2000$ 
GB,2021-09-20,A0402175,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/25/2021,9/25/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2490 GBP,2490.0,2021-09,1.374732,3423.08268,3000+ $
TR,2021-09-21,A0402805,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung Large Cell Neuroendocrine Carcinoma,9/26/2021,10/14/2021,TURKEY,Commercial,Lung,TURKEY,1,AE,USD,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-09,1.0,1943.0,1500-2000$ 
GB,2021-09-21,A0402878,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/27/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
TR,2021-09-21,A0402799,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/26/2021,10/14/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-09,1.0,1943.0,1500-2000$ 
GB,2021-09-22,A0403522,Clinical,Beatson West of Scotland Cancer Centre,Fieke Froeling,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/27/2021,9/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2300 GBP,2300.0,2021-09,1.374732,3161.8836,3000+ $
ES,2021-09-23,A0403848,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/27/2021,9/27/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2500 USD,2500.0,2021-09,1.177358,2943.395,2000-3000$ 
MX,2021-09-23,A0403851,Clinical,MileniaLabs,Mauricio Kuri-Ayache,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,9/29/2021,9/29/2021,MEXICO,Commercial,Breast,MEXICO,1,non_AE,EUR,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,2500 USD,2500.0,2021-09,1.177358,2943.395,2000-3000$ 
GB,2021-09-23,A0403846,Clinical,Charing Cross Hospital Medical Oncology Department,Laura Kenny,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/28/2021,9/28/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0.00 GBP,0.0,2021-09,1.374732,0.0,0 $
ES,2021-09-23,A0403973,Clinical,Hospital Universitario de Guadalajara,Eduardo Roberts,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/27/2021,10/4/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-09,1.177358,1465.81071,0-1500$ 
CA,2021-09-23,A0403828,Clinical,Cross Cancer Institute/University of Alberta,Charles Butts,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/29/2021,9/29/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Canada,Paid,1700 USD,1700.0,2021-09,1.0,1700.0,1500-2000$ 
GB,2021-09-24,A0404338,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/28/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
TR,2021-09-24,A0404335,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung Large Cell Neuroendocrine Carcinoma,10/1/2021,10/14/2021,TURKEY,Commercial,Lung,TURKEY,1,AE,USD,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-09,1.0,1943.0,1500-2000$ 
GB,2021-09-24,A0404353,Clinical,HCA Laboratories,Jonathan Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/30/2021,9/30/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-09,1.374732,3080.774412,3000+ $
ES,2021-09-24,A0404331,Clinical,Hospital del Mar,Clara Montagut,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,9/28/2021,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-09,1.177358,1465.81071,0-1500$ 
ES,2021-09-24,A0404355,Clinical,Hospital Quiron Barcelona,Fabricio Racca,Guardant 360,2.11,GHI_01,Distributors : ROW,Renal pelvis urothelial carcinoma,9/29/2021,9/29/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2241 EUR,2241.0,2021-09,1.177358,2638.459278,2000-3000$ 
ES,2021-09-24,A0404258,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/29/2021,9/29/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2500 USD,2500.0,2021-09,1.177358,2943.395,2000-3000$ 
BR,2021-09-25,A0404912,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,9/30/2021,9/30/2021,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-09,1.0,1350.0,0-1500$ 
BR,2021-09-25,A0404907,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Sarcoma,9/29/2021,9/29/2021,BRAZIL,Commercial,Soft Tissue/Bone,BRAZIL,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-09,1.0,1350.0,0-1500$ 
ES,2021-09-25,A0404903,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/29/2021,9/29/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2490 EUR,2490.0,2021-09,1.177358,2931.62142,2000-3000$ 
TR,2021-09-27,A0405167,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/4/2021,10/4/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0,0.0,2021-09,1.0,0.0,0 $
DE,2021-09-27,A0405151,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/3/2021,10/12/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,3490 EUR,3490.0,2021-09,1.177358,4108.97942,3000+ $
TR,2021-09-27,A0405158,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/3/2021,10/14/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1943,1943.0,2021-09,1.0,1943.0,1500-2000$ 
GB,2021-09-27,A0405164,Clinical,Poole Hospital NHS Foundation Trust,Victoria Wells,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,10/3/2021,10/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0.00 GBP,0.0,2021-09,1.374732,0.0,0 $
BR,2021-09-27,A0405149,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),10/3/2021,10/3/2021,BRAZIL,Commercial,CUP,BRAZIL,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-09,1.0,1350.0,0-1500$ 
IE,2021-09-27,A0405166,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,10/3/2021,10/3/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 EUR,1245.0,2021-09,1.177358,1465.81071,0-1500$ 
CL,2021-09-27,A0405157,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/3/2021,10/3/2021,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1550 USD,1550.0,2021-09,1.0,1550.0,1500-2000$ 
LT,2021-09-27,A0405163,Clinical,Genomika,Mantas Simutis,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Ovarian carcinoma,10/3/2021,10/15/2021,LITHUANIA,Commercial,,LITHUANIA,1,non_AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2100,2100.0,2021-09,1.177358,2472.4518,2000-3000$ 
ES,2021-09-28,A0405577,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Cholangiocarcinoma,9/30/2021,9/30/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,0.00 EUR,0.0,2021-09,1.177358,0.0,0 $
GB,2021-09-28,A0405472,Clinical,Northampton General Hospital,Craig Knighton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Glioblastoma,10/3/2021,10/3/2021,UNITED KINGDOM,Commercial,Brain,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0.00 GBP,0.0,2021-09,1.374732,0.0,0 $
ES,2021-09-28,A0405581,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/3/2021,10/3/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2500 USD,2500.0,2021-09,1.177358,2943.395,2000-3000$ 
BR,2021-09-29,A0405962,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/4/2021,10/4/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-09,1.0,1350.0,0-1500$ 
BR,2021-09-29,A0405867,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,10/8/2021,10/8/2021,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,South America,Paid,1350 USD,1350.0,2021-09,1.0,1350.0,0-1500$ 
GB,2021-09-30,A0406647,Clinical,Charing Cross Hospital Medical Oncology Department,Pippa Riddle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/5/2021,10/5/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0.00 GBP,0.0,2021-09,1.374732,0.0,0 $
GB,2021-09-30,A0406619,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/6/2021,10/6/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2241,2241.0,2021-09,1.374732,3080.774412,3000+ $
GB,2021-09-30,A0406620,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,10/6/2021,11/2/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,1245 GBP,1245.0,2021-09,1.374732,1711.54134,1500-2000$ 
TR,2021-09-30,A0406511,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,10/6/2021,10/6/2021,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Free,0,0.0,2021-09,1.0,0.0,0 $
GB,2021-09-30,A0406700,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/6/2021,10/6/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2021,3,1,2021-09-01,2021-09,G360 CDx,2021Q3,Europe,Paid,2300 GBP,2300.0,2021-09,1.374732,3161.8836,3000+ $
GB,2021-10-01,A0407123,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/7/2021,10/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-10,1.3683,3147.09,3000+ $
GB,2021-10-01,A0407104,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,10/6/2021,10/6/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
GB,2021-10-01,A0407109,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,10/6/2021,2/23/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
ES,2021-10-01,A0407455,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/7/2021,10/7/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241 EUR,2241.0,2021-10,1.159,2597.319,2000-3000$ 
BR,2021-10-01,A0407099,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/6/2021,10/6/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-10,1.0,1350.0,0-1500$ 
BR,2021-10-01,A0407108,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,10/9/2021,10/9/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-10,1.0,1350.0,0-1500$ 
GB,2021-10-02,A0407745,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,10/7/2021,10/7/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
GB,2021-10-02,A0407632,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/7/2021,10/7/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
TR,2021-10-04,A0408013,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Ovarian carcinoma,10/11/2021,11/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-10,1.0,1943.0,1500-2000$ 
BR,2021-10-04,A0408008,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Bladder carcinoma,10/19/2021,10/19/2021,BRAZIL,Commercial,Bladder,BRAZIL,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1700 USD,1700.0,2021-10,1.0,1700.0,1500-2000$ 
FI,2021-10-04,A0408033,Clinical,Turku University Hospital,Olli Lyyra,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/9/2021,10/14/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2366,2366.0,2021-10,1.159,2742.194,2000-3000$ 
ES,2021-10-04,A0408015,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,10/9/2021,10/9/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-10,1.159,2022.4550000000002,2000-3000$ 
ES,2021-10-04,A0408005,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/9/2021,10/9/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-10,1.159,0.0,0 $
GB,2021-10-05,A0408389,Clinical,Guys Hospital,Eleni Karapanagiotou,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/10/2021,10/10/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0.00 GBP,0.0,2021-10,1.3683,0.0,0 $
GB,2021-10-05,A0408376,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,10/10/2021,10/10/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
ES,2021-10-05,A0408252,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/11/2021,10/29/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2490 EUR,2490.0,2021-10,1.159,2885.91,2000-3000$ 
GB,2021-10-05,A0408296,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/13/2021,10/25/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
MX,2021-10-06,A0408868,Clinical,MileniaLabs,Jose Ramon Villarreal Cardenas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,10/12/2021,10/14/2021,MEXICO,Commercial,Breast,MEXICO,1,non_AE,EUR,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,2500 USD,2500.0,2021-10,1.159,2897.5,2000-3000$ 
GB,2021-10-06,A0408970,Clinical,St Bartholomews Hospital,Peter Szlosarek,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,10/13/2021,11/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
TR,2021-10-07,A0409404,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/11/2021,11/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-10,1.0,1943.0,1500-2000$ 
GB,2021-10-07,A0409392,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/14/2021,11/11/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
ES,2021-10-07,A0409439,Clinical,Hospital del Mar,Clara Montagut,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,10/12/2021,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-10,1.159,1442.955,0-1500$ 
GB,2021-10-07,A0409388,Clinical,Western General Hospital - Edinburgh Cancer Centre,Olga Oikonomidou,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/14/2021,10/23/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
CL,2021-10-07,A0409433,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,10/19/2021,10/19/2021,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1550 USD,1550.0,2021-10,1.0,1550.0,1500-2000$ 
TR,2021-10-07,A0409403,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/12/2021,11/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-10,1.0,1943.0,1500-2000$ 
GB,2021-10-08,A0409966,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/14/2021,10/14/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
GB,2021-10-08,A0409951,Clinical,Genesis Care Nottingham,Jamie Mills,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,10/12/2021,11/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
TR,2021-10-08,A0410221,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/14/2021,11/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-10,1.0,1943.0,1500-2000$ 
BR,2021-10-08,A0409963,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Sarcoma,10/13/2021,10/13/2021,BRAZIL,Commercial,Soft Tissue/Bone,BRAZIL,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-10,1.0,1350.0,0-1500$ 
CL,2021-10-08,A0409971,Clinical,Clinica Las Condes,Luis Cereceda,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/16/2021,10/16/2021,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1550 USD,1550.0,2021-10,1.0,1550.0,1500-2000$ 
TR,2021-10-08,A0409968,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,10/14/2021,11/15/2021,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-10,1.0,1943.0,1500-2000$ 
GB,2021-10-08,A0409956,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sebastian Cummins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,10/15/2021,10/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-10,1.3683,3407.067,3000+ $
ES,2021-10-08,A0409953,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,10/14/2021,10/14/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-10,1.159,2022.4550000000002,2000-3000$ 
GB,2021-10-09,A0410365,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sebastian Cummins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,10/20/2021,10/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-10,1.3683,3147.09,3000+ $
GB,2021-10-09,A0410385,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/16/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
GB,2021-10-09,A0410371,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,10/16/2021,10/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-10,1.3683,3147.09,3000+ $
TR,2021-10-11,A0411119,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),10/16/2021,10/16/2021,TURKEY,Commercial,CUP,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-10,1.0,0.0,0 $
BR,2021-10-11,A0411140,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/23/2021,10/23/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-10,1.0,1350.0,0-1500$ 
ES,2021-10-11,A0411129,Clinical,Hospital del Mar,Clara Montagut,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,10/23/2021,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-10,1.159,1442.955,0-1500$ 
FI,2021-10-11,A0411127,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/18/2021,10/18/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2366,2366.0,2021-10,1.159,2742.194,2000-3000$ 
ES,2021-10-11,A0411149,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,10/16/2021,11/1/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-10,1.159,2022.4550000000002,2000-3000$ 
FI,2021-10-11,A0411132,Clinical,Turku University Hospital,Olli Lyyra,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/18/2021,10/18/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2366,2366.0,2021-10,1.159,2742.194,2000-3000$ 
GB,2021-10-11,A0411120,Clinical,Western General Hospital - Edinburgh Cancer Centre,Melanie Mackean,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/20/2021,10/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
ES,2021-10-11,A0411124,Clinical,Hospital Nuestra Senora de Sonsoles,Rosario Hernandez Garcia,Guardant 360,2.11,GHI_01,Self-Pay Patient,Large cell lung carcinoma,10/16/2021,10/16/2021,SPAIN,Commercial,Lung,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-10,1.159,2022.4550000000002,2000-3000$ 
IE,2021-10-11,A0411135,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/16/2021,10/19/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-10,1.159,1442.955,0-1500$ 
IE,2021-10-11,A0411121,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/16/2021,10/19/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-10,1.159,1442.955,0-1500$ 
GB,2021-10-12,A0411521,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Sundus Yahya,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,10/19/2021,10/19/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0.00 GBP,0.0,2021-10,1.3683,0.0,0 $
TR,2021-10-12,A0411685,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/17/2021,11/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-10,1.0,1943.0,1500-2000$ 
GB,2021-10-12,A0411541,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/17/2021,10/17/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
MX,2021-10-12,A0411530,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,10/19/2021,10/19/2021,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,3316 USD,3316.0,2021-10,1.159,3843.244,3000+ $
TR,2021-10-12,A0411679,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,10/18/2021,10/18/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-10,1.0,0.0,0 $
IE,2021-10-12,A0411690,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/17/2021,2/15/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-10,1.159,1442.955,0-1500$ 
GB,2021-10-12,A0411555,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,10/16/2021,10/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,0.00 GBP,0.0,2021-10,1.3683,0.0,0 $
ES,2021-10-12,A0411557,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/17/2021,10/17/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2500 USD,2500.0,2021-10,1.159,2897.5,2000-3000$ 
GB,2021-10-13,A0412241,Clinical,Princess Elizabeth Hospital,Peter J Gomes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/20/2021,10/20/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0.00 GBP,0.0,2021-10,1.3683,0.0,0 $
GB,2021-10-13,A0412003,Clinical,Worthing Hospital,Anna Britten,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,10/21/2021,10/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0.00 GBP,0.0,2021-10,1.3683,0.0,0 $
BR,2021-10-13,A0411994,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/20/2021,10/20/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-10,1.0,1350.0,0-1500$ 
ES,2021-10-13,A0412007,Clinical,Hospital Universitario HM Sanchinarro,Anabel Del Barrio,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/20/2021,11/3/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2490 EUR,2490.0,2021-10,1.159,2885.91,2000-3000$ 
GB,2021-10-14,A0412511,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),10/19/2021,10/19/2021,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-10,1.3683,3147.09,3000+ $
CR,2021-10-14,A0412566,Clinical,Hospital Cima,Enrique Munoz Hernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,10/22/2021,10/22/2021,COSTA RICA,Commercial,,COSTA RICA,1,non_AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,2500 USD,2500.0,2021-10,1.0,2500.0,2000-3000$ 
GB,2021-10-14,A0412783,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,10/20/2021,10/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
TR,2021-10-14,A0412776,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Melanoma,10/20/2021,11/15/2021,TURKEY,Commercial,Skin,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-10,1.0,1943.0,1500-2000$ 
BR,2021-10-14,A0412791,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/19/2021,10/19/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-10,1.0,1350.0,0-1500$ 
FR,2021-10-15,A0413178,Clinical,Centre Leon Berard,Aurelie Swalduz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/20/2021,10/20/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-10,1.159,0.0,0 $
GB,2021-10-15,A0413227,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/21/2021,11/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
GB,2021-10-15,A0413237,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Esophageal adenocarcinoma,10/20/2021,10/20/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
ES,2021-10-15,A0413192,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,10/20/2021,4/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-10,1.159,1442.955,0-1500$ 
GB,2021-10-15,A0413242,Clinical,HCA Laboratories,Neal Navani,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/27/2021,10/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
GB,2021-10-15,A0413267,Clinical,Freeman Hospital,Alastair Greystoke,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal squamous cell carcinoma,10/20/2021,10/20/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-10,1.3683,0.0,0 $
FI,2021-10-15,A0413199,Clinical,Turku University Hospital,Eija Korkeila,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal squamous cell carcinoma,10/20/2021,10/20/2021,FINLAND,Commercial,GI,FINLAND,1,non_AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2366,2366.0,2021-10,1.159,2742.194,2000-3000$ 
GB,2021-10-16,A0413601,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/21/2021,10/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
ES,2021-10-18,A0414223,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,10/20/2021,10/20/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2400 USD,2400.0,2021-10,1.159,2781.6,2000-3000$ 
ES,2021-10-18,A0414193,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/25/2021,10/25/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-10,1.159,1442.955,0-1500$ 
GB,2021-10-18,A0414233,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/22/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
GB,2021-10-18,A0414201,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/23/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
ES,2021-10-18,A0414220,Clinical,Fundacion Jimenez Diaz,Jaime Rubio Perez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/22/2021,10/22/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-10,1.159,0.0,0 $
GB,2021-10-18,A0414213,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sebastian Cummins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,10/22/2021,10/22/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-10,1.3683,3147.09,3000+ $
IE,2021-10-18,A0414255,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/22/2021,10/26/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-10,1.159,1442.955,0-1500$ 
GB,2021-10-18,A0414239,Clinical,HCA Laboratories,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/22/2021,10/22/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
GB,2021-10-18,A0414229,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/22/2021,10/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-10,1.3683,3407.067,3000+ $
TR,2021-10-18,A0414198,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/25/2021,11/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-10,1.0,1943.0,1500-2000$ 
FR,2021-10-19,A0414637,Clinical,Laboratoire Bio Ardâ€™Aisne,David Rossignol,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/23/2021,10/23/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2990 EUR,2990.0,2021-10,1.159,3465.4100000000003,3000+ $
CA,2021-10-19,A0414642,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/23/2021,10/23/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Canada,Paid,1750 USD,1750.0,2021-10,1.0,1750.0,1500-2000$ 
ES,2021-10-20,A0415347,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/26/2021,10/26/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,,0.0,2021-10,1.159,0.0,0 $
GB,2021-10-20,A0414967,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/26/2021,10/26/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-10,1.3683,0.0,0 $
GB,2021-10-21,A0415592,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/26/2021,10/26/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
ES,2021-10-21,A0415565,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,10/26/2021,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-10,1.159,1442.955,0-1500$ 
DE,2021-10-21,A0415568,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,GIST (Gastrointestinal stromal tumor),10/26/2021,10/26/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2990 EUR,2990.0,2021-10,1.159,3465.4100000000003,3000+ $
ES,2021-10-22,A0416209,Clinical,Hospital Clinico San Carlos,Monica Granja Ortega,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Appendix adenocarcinoma,10/27/2021,10/27/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-10,1.159,0.0,0 $
ES,2021-10-22,A0416439,Clinical,Hospital Clinico San Carlos,Santiago Cabezas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Other,10/28/2021,10/28/2021,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-10,1.159,0.0,0 $
ES,2021-10-22,A0416238,Clinical,Hospital Nuestra Senora de Sonsoles,Beatriz Barrios Collado,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/27/2021,10/27/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-10,1.159,2022.4550000000002,2000-3000$ 
ES,2021-10-22,A0416397,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,10/28/2021,10/28/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2500 USD,2500.0,2021-10,1.159,2897.5,2000-3000$ 
ES,2021-10-22,A0416266,Clinical,Hospital Nuestra Senora de Sonsoles,Beatriz Barrios Collado,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/27/2021,10/27/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-10,1.159,2022.4550000000002,2000-3000$ 
LT,2021-10-22,A0416236,Clinical,Genomika,Mantas Simutis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,10/27/2021,11/8/2021,LITHUANIA,Commercial,GI,LITHUANIA,1,non_AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-10,1.159,2022.4550000000002,2000-3000$ 
ES,2021-10-23,A0416790,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/28/2021,10/28/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2500 USD,2500.0,2021-10,1.159,2897.5,2000-3000$ 
ES,2021-10-23,A0417062,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/29/2021,10/29/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1735 EUR,1735.0,2021-10,1.159,2010.865,2000-3000$ 
GB,2021-10-25,A0417143,Clinical,HCA Laboratories,Khurum Khan,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/30/2021,10/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
GB,2021-10-25,A0417149,Clinical,St James University Hospital,Kevin Franks,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/31/2021,10/31/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-10,1.3683,3147.09,3000+ $
FR,2021-10-25,A0417154,Clinical,Institut Regional du Cancer Montpellier - ICM,Camille Travert,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,11/1/2021,11/1/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-10,1.159,0.0,0 $
GB,2021-10-25,A0417151,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,10/31/2021,10/31/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,GBP 1245,1245.0,2021-10,1.3683,1703.5335,1500-2000$ 
TR,2021-10-25,A0417145,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/31/2021,11/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-10,1.0,1943.0,1500-2000$ 
ES,2021-10-25,A0417125,Clinical,HC Marbella International Hospital,Jose Manuel Trigo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/1/2021,11/1/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2490,2490.0,2021-10,1.159,2885.91,2000-3000$ 
GB,2021-10-25,A0417133,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/30/2021,10/30/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
DE,2021-10-25,A0417134,Clinical,Dr. med. Kosta Schopow,Kosta Schopow,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,11/6/2021,11/8/2021,GERMANY,Commercial,Other,GERMANY,1,non_AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2443 EUR,2443.0,2021-10,1.159,2831.437,2000-3000$ 
BR,2021-10-26,A0417368,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Thyroid carcinoma,10/30/2021,10/30/2021,BRAZIL,Commercial,Thyroid,BRAZIL,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-10,1.0,1350.0,0-1500$ 
BR,2021-10-26,A0417365,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/3/2021,11/3/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-10,1.0,1350.0,0-1500$ 
TR,2021-10-26,A0417343,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/30/2021,10/30/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-10,1.0,0.0,0 $
BR,2021-10-28,A0418310,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,11/3/2021,11/3/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-10,1.0,1350.0,0-1500$ 
GB,2021-10-28,A0418471,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/2/2021,11/2/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-10,1.3683,3407.067,3000+ $
FI,2021-10-28,A0418211,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,11/1/2021,11/1/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-10,1.159,0.0,0 $
TR,2021-10-29,A0419204,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Sarcoma,11/4/2021,11/4/2021,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-10,1.0,0.0,0 $
GB,2021-10-29,A0419044,Clinical,St James University Hospital,Katy Clarke,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,11/5/2021,11/5/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-10,1.3683,0.0,0 $
TR,2021-10-29,A0419432,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,11/4/2021,11/15/2021,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-10,1.0,1943.0,1500-2000$ 
GB,2021-10-29,A0419008,Clinical,Nottingham City Hospital Campus,Jason Adhikaree,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/3/2021,11/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-10,1.3683,0.0,0 $
GB,2021-10-29,A0419083,Clinical,HCA Laboratories,Debashis Sarker,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,11/5/2021,11/5/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-10,1.3683,3066.3603000000003,3000+ $
BR,2021-10-29,A0419376,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/4/2021,11/4/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-10,1.0,1350.0,0-1500$ 
ES,2021-10-30,A0419912,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/4/2021,11/4/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2021,4,1,2021-10-01,2021-10,G360 CDx,2021Q4,Europe,Paid,2500 USD,2500.0,2021-10,1.159,2897.5,2000-3000$ 
TR,2021-11-01,A0419988,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,11/5/2021,11/5/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-11,1.0,0.0,0 $
ES,2021-11-01,A0419992,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,11/7/2021,4/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
ES,2021-11-01,A0420005,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/7/2021,11/7/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
ES,2021-11-01,A0420016,Clinical,Clinica Universidad de Navarra,Luis Alfonso Gurpide,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/9/2021,11/9/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2400 USD,2400.0,2021-11,1.139576,2734.9824,2000-3000$ 
GB,2021-11-01,A0420048,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/6/2021,11/8/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP ,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
GB,2021-11-01,A0420046,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/7/2021,11/8/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP ,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
ES,2021-11-01,A0419982,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/5/2021,11/5/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 EUR,2490.0,2021-11,1.139576,2837.5442399999997,2000-3000$ 
GB,2021-11-01,A0419996,Clinical,HCA Laboratories,Kai-Keen Shiu,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/6/2021,11/6/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-11,1.344387,3012.771267,3000+ $
BR,2021-11-01,A0420011,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/8/2021,11/8/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-11,1.0,1350.0,0-1500$ 
BR,2021-11-01,A0420014,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,11/7/2021,12/4/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Free,0,0.0,2021-11,1.0,0.0,0 $
GB,2021-11-01,A0419980,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/5/2021,11/8/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP ,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
ES,2021-11-01,A0420017,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,11/7/2021,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
IE,2021-11-01,A0419979,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Pancreatic ductal adenocarcinoma,11/5/2021,11/5/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-11,1.139576,0.0,0 $
GB,2021-11-01,A0420010,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Robert Laing,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/5/2021,11/13/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-11,1.344387,3347.52363,3000+ $
IE,2021-11-01,A0419977,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,11/5/2021,11/11/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
ES,2021-11-01,A0420013,Clinical,Hospital Universitario HM Monteprincipe,Carlos Millan Sanz-Lomana,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/7/2021,11/11/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 EUR,2490.0,2021-11,1.139576,2837.5442399999997,2000-3000$ 
PL,2021-11-02,A0420213,Clinical,Salve Medica,Piotr Okupski,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/8/2021,11/8/2021,POLAND,Commercial,Breast,POLAND,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 EUR,2490.0,2021-11,1.139576,2837.5442399999997,2000-3000$ 
GB,2021-11-02,A0420155,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/7/2021,11/7/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-11,1.344387,3092.0901,3000+ $
ES,2021-11-02,A0420330,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Esophageal adenocarcinoma,11/8/2021,4/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
DE,2021-11-03,A0421492,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/9/2021,11/9/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2990 EUR,2990.0,2021-11,1.139576,3407.3322399999997,3000+ $
TR,2021-11-04,A0422308,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/9/2021,12/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-11,1.0,1943.0,1500-2000$ 
ES,2021-11-04,A0422445,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,11/10/2021,4/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
TR,2021-11-05,A0423886,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/10/2021,11/10/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-11,1.0,0.0,0 $
DE,2021-11-05,A0423550,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/10/2021,2/7/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2990 EUR,2990.0,2021-11,1.139576,3407.3322399999997,3000+ $
IE,2021-11-05,A0423583,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/10/2021,11/13/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
GB,2021-11-05,A0423668,Clinical,Maidstone and Tunbridge Wells NHS Trust,Russell Burcombe,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/10/2021,12/1/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-11,1.344387,0.0,0 $
GB,2021-11-05,A0423889,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,11/10/2021,11/10/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-11,1.344387,0.0,0 $
GB,2021-11-06,A0424432,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/11/2021,11/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-11,1.344387,0.0,0 $
ES,2021-11-06,A0424426,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,11/16/2021,11/16/2021,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2500 USD,2500.0,2021-11,1.139576,2848.9399999999996,2000-3000$ 
GB,2021-11-06,A0424269,Clinical,St James University Hospital,Katy Clarke,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,11/11/2021,11/11/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-11,1.344387,0.0,0 $
BR,2021-11-08,A0424523,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/13/2021,11/13/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-11,1.0,1350.0,0-1500$ 
GB,2021-11-08,A0424531,Clinical,Beatson West of Scotland Cancer Centre,Rosie Harrand,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,11/10/2021,11/10/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-11,1.344387,0.0,0 $
ES,2021-11-08,A0424525,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/13/2021,11/13/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
ES,2021-11-08,A0424538,Clinical,Hospital Nuestra Senora de Sonsoles,Jose Enrique Ales,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/15/2021,11/15/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-11,1.139576,1988.5601199999999,1500-2000$ 
ES,2021-11-08,A0424560,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/12/2021,11/12/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
ES,2021-11-08,A0424524,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Do Not Bill - Promotional,Pancreatic ductal adenocarcinoma,11/14/2021,7/22/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-11,1.139576,0.0,0 $
GB,2021-11-08,A0424519,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,11/12/2021,1/5/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
ES,2021-11-08,A0424567,Clinical,Hospital Clinico San Carlos,Arancha Manzano,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,GIST (Gastrointestinal stromal tumor),11/12/2021,11/12/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
GB,2021-11-08,A0424534,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/12/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
BR,2021-11-08,A0424558,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/12/2021,11/12/2021,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-11,1.0,1350.0,0-1500$ 
GB,2021-11-08,A0424536,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/12/2021,11/12/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP ,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
BR,2021-11-08,A0424521,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/13/2021,11/13/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-11,1.0,1350.0,0-1500$ 
DE,2021-11-08,A0424528,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Hepatocellular carcinoma,11/13/2021,11/13/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2990 EUR,2990.0,2021-11,1.139576,3407.3322399999997,3000+ $
GB,2021-11-08,A0424543,Clinical,HCA Laboratories,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,11/12/2021,11/12/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-11,1.344387,3012.771267,3000+ $
MX,2021-11-08,A0424550,Clinical,MileniaLabs,Raquel Gerson,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/13/2021,11/15/2021,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,2500 USD,2500.0,2021-11,1.139576,2848.9399999999996,2000-3000$ 
GB,2021-11-08,A0424526,Clinical,HCA Laboratories,Khurum Khan,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,11/14/2021,11/14/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-11,1.344387,3012.771267,3000+ $
ES,2021-11-08,A0424514,Clinical,Complexo Hospitalario Universitario De Orense,Jose Luis Firvida Perez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/12/2021,11/12/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-11,1.139576,0.0,0 $
GB,2021-11-10,A0425511,Clinical,Royal United Hospitals Bath,Ashley Cox,Guardant 360,2.11,GHI_01,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),11/15/2021,11/15/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-11,1.344387,0.0,0 $
ES,2021-11-11,A0426857,Clinical,Hospital Universitario Lucus Augusti,Sergio Vazquez Estevez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/18/2021,11/18/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-11,1.139576,0.0,0 $
ES,2021-11-11,A0426865,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,11/16/2021,11/16/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2241 EUR,2241.0,2021-11,1.139576,2553.789816,2000-3000$ 
GB,2021-11-11,A0426793,Clinical,The Royal Marsden Hospital,Merina Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/16/2021,5/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-11,1.344387,3347.52363,3000+ $
GR,2021-11-11,A0426648,Clinical,Evangelismos Hospital,Theodore Tegos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,11/19/2021,11/19/2021,GREECE,Commercial,,GREECE,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 EUR,2490.0,2021-11,1.139576,2837.5442399999997,2000-3000$ 
GB,2021-11-11,A0426624,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Simon Grumett,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,11/20/2021,11/20/2021,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-11,1.344387,0.0,0 $
ES,2021-11-12,A0427422,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,11/18/2021,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
DE,2021-11-12,A0427368,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,12/3/2021,12/3/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,Reveal,2021Q4,Europe,Paid,3200 EUR,3200.0,2021-11,1.139576,3646.6431999999995,3000+ $
GB,2021-11-12,A0427401,Clinical,Sussex Cancer Centre,Joanna Stokoe,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/18/2021,11/18/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-11,1.344387,0.0,0 $
TR,2021-11-12,A0427384,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Other,11/19/2021,11/19/2021,TURKEY,Commercial,Other,TURKEY,1,AE,USD,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-11,1.0,0.0,0 $
GB,2021-11-12,A0427679,Clinical,Charing Cross Hospital Medical Oncology Department,Laura Kenny,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/19/2021,11/19/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
GB,2021-11-12,A0427419,Clinical,The Royal Marsden NHS Foundation Trust,Alicia Okines,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,11/18/2021,11/18/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-11,1.344387,3347.52363,3000+ $
GB,2021-11-12,A0427309,Clinical,Beatson West of Scotland Cancer Centre,Rosie Harrand,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/18/2021,11/18/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-11,1.344387,0.0,0 $
GB,2021-11-13,A0427991,Clinical,HCA Laboratories,Danielle Power,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastroesophageal junction carcinoma,11/19/2021,11/19/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-11,1.344387,3012.771267,3000+ $
GB,2021-11-13,A0428196,Clinical,GenesisCare Milton Keynes,Craig Macmillan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/20/2021,11/27/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-11,1.344387,3347.52363,3000+ $
GB,2021-11-13,A0428191,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/20/2021,11/20/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-11,1.344387,3347.52363,3000+ $
ES,2021-11-13,A0427962,Clinical,Hospital Nuestra Senora de Sonsoles,Jose Enrique Ales,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/19/2021,3/29/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-11,1.139576,1988.5601199999999,1500-2000$ 
GB,2021-11-13,A0428126,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/17/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
GB,2021-11-13,A0427996,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,11/18/2021,11/18/2021,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-11,1.344387,3012.771267,3000+ $
ES,2021-11-15,A0428240,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/21/2021,3/29/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-11,1.139576,1988.5601199999999,1500-2000$ 
FI,2021-11-15,A0428262,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/22/2021,11/22/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2366,2366.0,2021-11,1.139576,2696.2368159999996,2000-3000$ 
BR,2021-11-15,A0428226,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/23/2021,11/23/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-11,1.0,1350.0,0-1500$ 
IE,2021-11-15,A0428228,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/24/2021,11/24/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
TR,2021-11-15,A0428250,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,11/21/2021,12/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-11,1.0,1943.0,1500-2000$ 
IE,2021-11-15,A0428227,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Pancreatic ductal adenocarcinoma,11/17/2021,11/17/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-11,1.139576,0.0,0 $
ES,2021-11-17,A0430510,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/24/2021,11/24/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
ES,2021-11-18,A0431008,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,11/24/2021,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
TR,2021-11-18,A0431410,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,11/24/2021,12/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-11,1.0,1943.0,1500-2000$ 
CA,2021-11-18,A0430884,Clinical,Sault Area Hospital,Silvana Spadafora,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/23/2021,11/23/2021,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Canada,Free,0,0.0,2021-11,1.0,0.0,0 $
ES,2021-11-18,A0430900,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,11/23/2021,11/23/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2500 USD,2500.0,2021-11,1.139576,2848.9399999999996,2000-3000$ 
DE,2021-11-18,A0431972,Clinical,Reusrather Gemeinschaftspraxis,Michael Friedrich-Sander,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/23/2021,11/27/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,3490 EUR,3490.0,2021-11,1.139576,3977.1202399999997,3000+ $
ES,2021-11-18,A0432099,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,11/23/2021,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
ES,2021-11-18,A0432102,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,11/30/2021,4/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
ES,2021-11-18,A0431421,Clinical,Clinica Universidad de Navarra,Ignacio Gil Bazo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/24/2021,12/6/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1700 USD,1700.0,2021-11,1.139576,1937.2792,1500-2000$ 
BE,2021-11-18,A0431000,Clinical,Dr Justyna Surma,Justyna Surma,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,12/4/2021,12/4/2021,BELGIUM,Commercial,,BELGIUM,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-11,1.139576,0.0,0 $
TR,2021-11-19,A0433428,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),11/28/2021,11/28/2021,TURKEY,Commercial,CUP,TURKEY,1,AE,USD,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-11,1.0,0.0,0 $
GB,2021-11-19,A0432826,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,11/26/2021,11/26/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
ES,2021-11-19,A0432746,Clinical,"Institut Catala d'Oncologia Girona - ICO, Hospital Universitari De Girona Doctor Josep Trueta",Alejandro Hernandez Martinez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/24/2021,11/24/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-11,1.139576,0.0,0 $
GB,2021-11-19,A0433489,Clinical,Worcestershire Royal Hospital,David Farrugia,Guardant 360,2.11,GHI_01,Self-Pay Patient,Small cell lung carcinoma,11/25/2021,11/25/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-11,1.344387,3092.0901,3000+ $
TR,2021-11-19,A0432848,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,11/24/2021,11/24/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-11,1.0,0.0,0 $
SI,2021-11-19,A0433570,Clinical,Luka Hauptman MD,Luka Hauptman,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/26/2021,11/27/2021,SLOVENIA,Commercial,,SLOVENIA,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-11,1.139576,1988.5601199999999,1500-2000$ 
IE,2021-11-19,A0432668,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/24/2021,11/27/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
BR,2021-11-19,A0432738,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/29/2021,11/29/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-11,1.0,1350.0,0-1500$ 
ES,2021-11-19,A0432820,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/24/2021,11/24/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
GB,2021-11-19,A0433343,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,11/25/2021,11/25/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
AT,2021-11-19,A0432808,Clinical,Naturheilpraxis Dr. med. Baumert,Stefan Baumert,Guardant 360,2.11,GHI_01,Self-Pay Patient,Melanoma,12/8/2021,12/8/2021,AUSTRIA,Commercial,Skin,AUSTRIA,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2443 EUR,2443.0,2021-11,1.139576,2783.984168,2000-3000$ 
AT,2021-11-20,A0433980,Clinical,KABEG Management,Martin Stultschnig,Guardant 360,2.11,GHI_01,Self-Pay Patient,Glioblastoma,11/29/2021,11/29/2021,AUSTRIA,Commercial,Brain,AUSTRIA,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-11,1.139576,0.0,0 $
GB,2021-11-20,A0434013,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,11/29/2021,11/29/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-11,1.344387,3092.0901,3000+ $
GB,2021-11-20,A0433764,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/25/2021,11/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
GB,2021-11-22,A0434271,Clinical,Princess Elizabeth Hospital,Mohammad Butt,Guardant 360,2.11,GHI_01,Self-Pay Patient,Renal pelvis urothelial carcinoma,11/30/2021,11/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-11,1.344387,0.0,0 $
ES,2021-11-22,A0434206,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/30/2021,11/30/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2200 EUR,2200.0,2021-11,1.139576,2507.0672,2000-3000$ 
ES,2021-11-22,A0434187,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,11/29/2021,11/29/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2241 EUR,2241.0,2021-11,1.139576,2553.789816,2000-3000$ 
GB,2021-11-22,A0434208,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/29/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
TR,2021-11-22,A0434200,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,11/30/2021,12/15/2021,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-11,1.0,1943.0,1500-2000$ 
GB,2021-11-22,A0434228,Clinical,Charing Cross Hospital Medical Oncology Department,Waleed Mohammed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/29/2021,12/2/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
GB,2021-11-23,A0435061,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,11/30/2021,11/30/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,-,0.0,2021-11,1.344387,0.0,0 $
GB,2021-11-23,A0435104,Clinical,Princess Elizabeth Hospital,Mohammad Butt,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/1/2021,12/1/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-11,1.344387,3347.52363,3000+ $
GB,2021-11-23,A0435026,Clinical,The Royal Marsden NHS Foundation Trust,Alicia Okines,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,12/1/2021,12/7/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
BR,2021-11-24,A0435273,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/2/2021,12/2/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-11,1.0,1350.0,0-1500$ 
ES,2021-11-24,A0435180,Clinical,Hospital A Coruna,Maria Rosario Garcia Campelo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/3/2021,12/3/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,EUR 1245,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
ES,2021-11-26,A0435751,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,GIST (Gastrointestinal stromal tumor),12/2/2021,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
ES,2021-11-26,A0435650,Clinical,Hospital Clinico San Carlos,Natalia Vidal,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,11/30/2021,11/30/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,0 EUR,0.0,2021-11,1.139576,0.0,0 $
FI,2021-11-26,A0435950,Clinical,Turku University Hospital,Jaana Kaunisto,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/2/2021,12/2/2021,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2366,2366.0,2021-11,1.139576,2696.2368159999996,2000-3000$ 
ES,2021-11-26,A0436088,Clinical,Hospital Quiron Barcelona,Aleix Prat,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,12/5/2021,12/5/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 Infinity,2021Q4,Europe,Paid,3500 USD,3500.0,2021-11,1.139576,3988.5159999999996,3000+ $
IE,2021-11-26,A0435954,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/2/2021,12/2/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
GB,2021-11-26,A0435916,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Large cell lung carcinoma,12/6/2021,12/6/2021,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
GB,2021-11-26,A0435639,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,12/4/2021,12/4/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
ES,2021-11-26,A0436028,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/3/2021,12/3/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
CA,2021-11-26,A0435879,Clinical,RCM Health Consultancy,Helena Dukic,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,12/3/2021,12/3/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Canada,Paid,3500 USD,3500.0,2021-11,1.0,3500.0,3000+ $
ES,2021-11-26,A0435845,Clinical,Hospital Clinico San Carlos,Natalia Vidal,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/4/2021,12/4/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
ES,2021-11-27,A0436180,Clinical,Hospital Nuestra Senora de Sonsoles,Beatriz Barrios Collado,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),12/4/2021,3/29/2022,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-11,1.139576,1988.5601199999999,1500-2000$ 
TR,2021-11-27,A0436178,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Ovarian carcinoma,12/3/2021,12/15/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-11,1.0,1943.0,1500-2000$ 
GB,2021-11-27,A0436191,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/3/2021,12/3/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-11,1.344387,3012.771267,3000+ $
BR,2021-11-29,A0436516,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Renal Cell Carcinoma,12/7/2021,12/7/2021,BRAZIL,Commercial,Kidney,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-11,1.0,1350.0,0-1500$ 
BR,2021-11-29,A0436465,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/10/2021,12/10/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-11,1.0,1350.0,0-1500$ 
BR,2021-11-29,A0436513,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Head and neck carcinoma,12/5/2021,12/5/2021,BRAZIL,Commercial,Head and neck carcinoma,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-11,1.0,1350.0,0-1500$ 
GB,2021-11-29,A0436498,Clinical,The Holly Private Hospital,Sherif Raouf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/5/2021,12/5/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-11,1.344387,1673.761815,1500-2000$ 
BR,2021-11-29,A0436461,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/10/2021,12/10/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-11,1.0,1350.0,0-1500$ 
GB,2021-11-29,A0436511,Clinical,The Royal Marsden NHS Foundation Trust,Alicia Okines,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,12/5/2021,12/5/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-11,1.344387,3347.52363,3000+ $
IE,2021-11-30,A0436693,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/5/2021,12/8/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-11,1.139576,1418.7721199999999,0-1500$ 
TR,2021-11-30,A0436992,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,12/6/2021,12/15/2021,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-11,1.0,1943.0,1500-2000$ 
GB,2021-11-30,A0436815,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,12/9/2021,12/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-11,1.344387,3092.0901,3000+ $
GB,2021-11-30,A0436654,Clinical,The Rutherford Cancer Centre,Emma Hudson,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Ovarian carcinoma,12/6/2021,12/6/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-11,1.344387,3092.0901,3000+ $
ES,2021-11-30,A0436828,Clinical,Hospital La Luz,Esther Holgado Martin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/9/2021,12/9/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2021,4,1,2021-11-01,2021-11,G360 CDx,2021Q4,Europe,Paid,2490 EUR,2490.0,2021-11,1.139576,2837.5442399999997,2000-3000$ 
ES,2021-12-01,A0437241,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,2.11,GHI_01,Self-Pay Patient,GIST (Gastrointestinal stromal tumor),12/6/2021,12/6/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-12,1.130397,1972.5427650000001,1500-2000$ 
GB,2021-12-02,A0438576,Clinical,GenesisCare Milton Keynes,Craig Macmillan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/8/2021,12/8/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-12,1.330836,3060.9228,3000+ $
ES,2021-12-02,A0438163,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/8/2021,12/15/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-12,1.130397,1972.5427650000001,1500-2000$ 
GB,2021-12-03,A0439313,Clinical,Charing Cross Hospital Medical Oncology Department,Pippa Riddle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/9/2021,12/9/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
GB,2021-12-03,A0438726,Clinical,The Christie Hospital,Matthew Krebs,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/8/2021,12/8/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,"GBP 1,245.00",1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
TR,2021-12-03,A0438719,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,12/6/2021,12/6/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,0,0.0,2021-12,1.0,0.0,0 $
TR,2021-12-03,A0438810,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,12/8/2021,1/7/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-12,1.0,1943.0,1500-2000$ 
ES,2021-12-04,A0439628,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/9/2021,12/9/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-12,1.130397,1972.5427650000001,1500-2000$ 
ES,2021-12-04,A0439700,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,12/9/2021,4/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-12,1.130397,1407.3442650000002,0-1500$ 
ES,2021-12-04,A0439639,Clinical,Hospital Nuestra Senora de Sonsoles,Lauren Condori,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/10/2021,12/10/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-12,1.130397,1972.5427650000001,1500-2000$ 
ES,2021-12-04,A0439880,Clinical,Hospital Quiron Barcelona,Aleix Prat,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,12/15/2021,12/15/2021,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 Infinity,2021Q4,Europe,Paid,3500 USD,3500.0,2021-12,1.130397,3956.3895,3000+ $
ES,2021-12-04,A0439562,Clinical,Hospital Vithas Castellon,Javier Garde Noguera,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/9/2021,12/9/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-12,1.130397,0.0,0 $
GB,2021-12-04,A0439721,Clinical,Beatson West of Scotland Cancer Centre,Nicola Steele,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/9/2021,12/9/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
GB,2021-12-06,A0440086,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,12/16/2021,12/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-12,1.330836,3060.9228,3000+ $
IE,2021-12-06,A0440054,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/10/2021,12/15/2021,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-12,1.130397,1407.3442650000002,0-1500$ 
ES,2021-12-06,A0440057,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,12/11/2021,4/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-12,1.130397,1407.3442650000002,0-1500$ 
GB,2021-12-06,A0440073,Clinical,Belfast City Hospital Cancer Center,Adam Uprichard,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/14/2021,12/14/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
FR,2021-12-06,A0440066,Clinical,Institut Regional du Cancer Montpellier - ICM,Thomas Quentin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/10/2021,12/10/2021,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-12,1.130397,0.0,0 $
ES,2021-12-06,A0440094,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,12/16/2021,12/16/2021,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2400 USD,2400.0,2021-12,1.130397,2712.9528,2000-3000$ 
ES,2021-12-06,A0440083,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,12/16/2021,12/16/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-12,1.130397,1407.3442650000002,0-1500$ 
TR,2021-12-07,A0440644,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,12/15/2021,1/7/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-12,1.0,1943.0,1500-2000$ 
TR,2021-12-07,A0440646,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/15/2021,1/7/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-12,1.0,1943.0,1500-2000$ 
BR,2021-12-08,A0441259,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/14/2021,12/14/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
BR,2021-12-08,A0441265,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/14/2021,12/14/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
GB,2021-12-08,A0440924,Clinical,Sussex Cancer Centre,Juliet Brock,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/12/2021,12/12/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
TR,2021-12-08,A0441345,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,12/14/2021,12/14/2021,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-12,1.0,0.0,0 $
RO,2021-12-09,A0441948,Clinical,Amethyst Radiotherapy Clinic,Bogdan Mateies,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/16/2021,12/16/2021,ROMANIA,Commercial,Breast,ROMANIA,1,non_AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2490 EUR,2490.0,2021-12,1.130397,2814.6885300000004,2000-3000$ 
MX,2021-12-09,A0441795,Clinical,MileniaLabs,Osvaldo Hernandez,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Sarcoma,12/14/2021,12/22/2021,MEXICO,Commercial,Soft Tissue/Bone,MEXICO,1,non_AE,EUR,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,2500 USD,2500.0,2021-12,1.130397,2825.9925000000003,2000-3000$ 
GB,2021-12-09,A0441984,Clinical,Bronglais General Hospital,Elin Jones,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/16/2021,12/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-12,1.330836,3060.9228,3000+ $
GB,2021-12-09,A0441690,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,12/15/2021,12/15/2021,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,"GBP 1,245.00",1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
GB,2021-12-09,A0441608,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,12/16/2021,2/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,"GBP 1,245.00",1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
GB,2021-12-09,A0441976,Clinical,Peterborough City Hospital Dept of Oncology 18,Mohamed Mahgoub,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/16/2021,12/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,"GBP 1,245.00",1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
GB,2021-12-10,A0442376,Clinical,The Nuffield Hospital Guildford,Sebastian Cummins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/16/2021,12/16/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,"GBP 1,245.00",1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
GB,2021-12-10,A0442591,Clinical,St Bartholomews Hospital,Sherif Raouf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Head and neck carcinoma,12/16/2021,12/30/2021,UNITED KINGDOM,Commercial,Head and neck carcinoma,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,"GBP 1,245.00",1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
BR,2021-12-10,A0442229,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/16/2021,12/16/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
CA,2021-12-10,A0442138,Clinical,London Health Sciences Centre,Daniel Breadner,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastroesophageal junction carcinoma,12/16/2021,12/16/2021,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Canada,Paid,1700 USD,1700.0,2021-12,1.0,1700.0,1500-2000$ 
BR,2021-12-10,A0442232,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/16/2021,12/16/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
ES,2021-12-11,A0443025,Clinical,Hospital University La Paz,Javier de Castro Carpeno,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,12/15/2021,12/15/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-12,1.130397,0.0,0 $
TR,2021-12-11,A0443045,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,12/19/2021,1/7/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-12,1.0,1943.0,1500-2000$ 
GB,2021-12-11,A0443037,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Agnieszka Michael,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Ovarian carcinoma,12/19/2021,12/19/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
GB,2021-12-11,A0442780,Clinical,Worthing Hospital,Nick Adams,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/17/2021,12/17/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
BR,2021-12-11,A0442954,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/19/2021,12/19/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
DE,2021-12-13,A0443321,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Melanoma,12/21/2021,12/21/2021,GERMANY,Commercial,Skin,GERMANY,1,non_AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2990 EUR,2990.0,2021-12,1.130397,3379.8870300000003,3000+ $
TR,2021-12-13,A0443230,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/21/2021,1/7/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-12,1.0,1943.0,1500-2000$ 
GB,2021-12-13,A0443331,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,12/21/2021,12/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-12,1.330836,3060.9228,3000+ $
GB,2021-12-14,A0443706,Clinical,Bristol Haematology and Oncology Centre,Charles Comins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/21/2021,12/21/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
ES,2021-12-14,A0443804,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,12/22/2021,12/22/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2400 USD,2400.0,2021-12,1.130397,2712.9528,2000-3000$ 
GB,2021-12-14,A0443809,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/22/2021,12/22/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-12,1.330836,2982.403476,2000-3000$ 
ES,2021-12-14,A0443545,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,12/21/2021,12/21/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2400 USD,2400.0,2021-12,1.130397,2712.9528,2000-3000$ 
GB,2021-12-14,A0443782,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,12/22/2021,12/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,GBP 2490.00,2490.0,2021-12,1.330836,3313.7816399999997,3000+ $
CA,2021-12-14,A0443720,Clinical,Vernon Jubilee Hospital,Michael Humphreys,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,12/24/2021,12/24/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,Reveal,2021Q4,Canada,Paid,3500 USD,3500.0,2021-12,1.0,3500.0,3000+ $
GB,2021-12-15,A0444676,Clinical,St James University Hospital,Kevin Franks,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/23/2021,12/23/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
MX,2021-12-15,A0444668,Clinical,ABC Hospital,Gabriela Olivia Regalado Porras,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/22/2021,12/24/2021,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,3316 USD,3316.0,2021-12,1.130397,3748.3964520000004,3000+ $
GB,2021-12-15,A0444517,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/22/2021,2/11/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
GB,2021-12-15,A0444673,Clinical,Western General Hospital - Edinburgh Cancer Centre,Melanie Mackean,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/22/2021,12/22/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
DE,2021-12-15,A0444187,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,12/25/2021,12/25/2021,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,Reveal,2021Q4,Europe,Paid,3094 EUR,3094.0,2021-12,1.130397,3497.448318,3000+ $
TR,2021-12-16,A0444919,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,12/23/2021,1/7/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-12,1.0,1943.0,1500-2000$ 
GB,2021-12-16,A0444889,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,12/22/2021,12/22/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-12,1.330836,2982.403476,2000-3000$ 
BR,2021-12-16,A0444961,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Thyroid carcinoma,12/23/2021,12/23/2021,BRAZIL,Commercial,Thyroid,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
IE,2021-12-16,A0444894,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/22/2021,2/23/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-12,1.130397,1407.3442650000002,0-1500$ 
GB,2021-12-16,A0445315,Clinical,Belfast City Hospital Cancer Center,Jonathan McAleese,Guardant 360,2.11,GHI_01,Self-Pay Patient,Large cell lung carcinoma,12/23/2021,12/23/2021,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
GB,2021-12-17,A0445715,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/23/2021,12/23/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-12,1.330836,2982.403476,2000-3000$ 
GB,2021-12-17,A0445706,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/23/2021,12/30/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
ES,2021-12-17,A0445699,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/22/2021,12/22/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245,1245.0,2021-12,1.130397,1407.3442650000002,0-1500$ 
ES,2021-12-17,A0445950,Clinical,Hospital Nuestra Senora de Sonsoles,Rosario Hernandez Garcia,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),12/23/2021,12/23/2021,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-12,1.130397,1972.5427650000001,1500-2000$ 
DE,2021-12-17,A0445682,Clinical,Erlangen Universitaetsklinikum,Peter Fasching,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/22/2021,1/18/2022,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 EUR,0.0,2021-12,1.130397,0.0,0 $
ES,2021-12-18,A0446567,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),12/25/2021,12/25/2021,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-12,1.130397,1407.3442650000002,0-1500$ 
CA,2021-12-18,A0446357,Clinical,BC Cancer Agency - Surrey,Krista Noonan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/28/2021,12/28/2021,CANADA,Commercial,,CANADA,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Canada,Paid,3490 USD,3490.0,2021-12,1.0,3490.0,3000+ $
GB,2021-12-18,A0446502,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,12/25/2021,12/25/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,0,0.0,2021-12,1.330836,0.0,0 $
BR,2021-12-18,A0446294,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/27/2021,12/27/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1700 USD,1700.0,2021-12,1.0,1700.0,1500-2000$ 
ES,2021-12-20,A0446845,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/26/2021,12/26/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2400 USD,2400.0,2021-12,1.130397,2712.9528,2000-3000$ 
BR,2021-12-20,A0446824,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/27/2021,12/27/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
BR,2021-12-20,A0446830,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,12/28/2021,12/28/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
BR,2021-12-20,A0446832,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/27/2021,12/27/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
BR,2021-12-20,A0446837,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),12/29/2021,12/29/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
ES,2021-12-20,A0446840,Clinical,Clinica Rotger Quironsalud,Teresa Acuna,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/26/2021,12/26/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-12,1.130397,1407.3442650000002,0-1500$ 
GB,2021-12-21,A0447092,Clinical,Genesis Care Nottingham,Jamie Mills,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,12/31/2021,12/31/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-12,1.330836,3060.9228,3000+ $
GB,2021-12-21,A0447081,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,12/26/2021,12/27/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
MX,2021-12-21,A0447247,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,12/27/2021,12/27/2021,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,3316 USD,3316.0,2021-12,1.130397,3748.3964520000004,3000+ $
GB,2021-12-21,A0447147,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/27/2021,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
TR,2021-12-22,A0447333,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/27/2021,1/7/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-12,1.0,1943.0,1500-2000$ 
BR,2021-12-22,A0447726,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/28/2021,12/28/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
GB,2021-12-22,A0447462,Clinical,The Royal Marsden NHS Foundation Trust,Alicia Okines,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,12/28/2021,12/28/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-12,1.330836,3313.7816399999997,3000+ $
TR,2021-12-23,A0448269,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,12/30/2021,12/30/2021,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0,0.0,2021-12,1.0,0.0,0 $
MX,2021-12-23,A0448158,Clinical,ABC Hospital,Raquel Gerson,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/29/2021,12/30/2021,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,3316 USD,3316.0,2021-12,1.130397,3748.3964520000004,3000+ $
ES,2021-12-23,A0448032,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/31/2021,2/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2200 EUR,2200.0,2021-12,1.130397,2486.8734000000004,2000-3000$ 
GB,2021-12-23,A0448035,Clinical,GenesisCare Milton Keynes,Craig Macmillan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/28/2021,12/28/2021,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2300 GBP,2300.0,2021-12,1.330836,3060.9228,3000+ $
GB,2021-12-23,A0448400,Clinical,Belfast City Hospital Cancer Center,Jonathan McAleese,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/29/2021,12/29/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
GB,2021-12-23,A0448403,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/29/2021,1/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
ES,2021-12-23,A0448014,Clinical,Hospital La Luz,Esther Holgado Martin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/29/2021,12/29/2021,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2490 EUR,2490.0,2021-12,1.130397,2814.6885300000004,2000-3000$ 
ES,2021-12-23,A0448024,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/29/2021,2/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2200 EUR,2200.0,2021-12,1.130397,2486.8734000000004,2000-3000$ 
GB,2021-12-23,A0448139,Clinical,Peterborough City Hospital Dept of Oncology 18,Margaret Hutka,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,1/3/2022,1/3/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
TR,2021-12-24,A0448551,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,12/29/2021,1/7/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1943,1943.0,2021-12,1.0,1943.0,1500-2000$ 
ES,2021-12-24,A0448495,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,12/29/2021,4/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-12,1.130397,1407.3442650000002,0-1500$ 
BR,2021-12-24,A0448601,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/29/2021,12/29/2021,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
ES,2021-12-24,A0448545,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,GIST (Gastrointestinal stromal tumor),12/29/2021,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 EUR,1245.0,2021-12,1.130397,1407.3442650000002,0-1500$ 
GB,2021-12-27,A0448997,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,1/1/2022,1/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2490 GBP,2490.0,2021-12,1.330836,3313.7816399999997,3000+ $
GB,2021-12-27,A0449009,Clinical,Princess Elizabeth Hospital,Mohammad Butt,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,12/31/2021,12/31/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Free,0 GBP,0.0,2021-12,1.330836,0.0,0 $
GB,2021-12-27,A0448931,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/1/2022,1/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1245 GBP,1245.0,2021-12,1.330836,1656.8908199999998,1500-2000$ 
MX,2021-12-28,A0449087,Clinical,ABC Hospital,Raquel Gerson,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/1/2022,1/1/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,3316 USD,3316.0,2021-12,1.130397,3748.3964520000004,3000+ $
ES,2021-12-28,A0449245,Clinical,Hospital Nuestra Senora de Sonsoles,Jaime Ceballos Viro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/2/2022,1/2/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,1745 EUR,1745.0,2021-12,1.130397,1972.5427650000001,1500-2000$ 
BR,2021-12-28,A0449222,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,1/1/2022,1/1/2022,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
GB,2021-12-28,A0449170,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Prostate adenocarcinoma,12/29/2021,12/29/2021,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,0 GBP,0.0,2021-12,1.330836,0.0,0 $
BR,2021-12-29,A0449409,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/2/2022,1/2/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
ES,2021-12-29,A0449348,Clinical,Clinica Universidad de Navarra-Madrid,Antonio Gonzalez Martin,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,1/4/2022,1/4/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2400 USD,2400.0,2021-12,1.130397,2712.9528,2000-3000$ 
ES,2021-12-29,A0449534,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),1/2/2022,3/30/2022,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2200 EUR,2200.0,2021-12,1.130397,2486.8734000000004,2000-3000$ 
ES,2021-12-29,A0449339,Clinical,Instituto Oncology Rosell,Maria Gonzalez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/3/2022,1/3/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2490 EUR,2490.0,2021-12,1.130397,2814.6885300000004,2000-3000$ 
BR,2021-12-30,A0449808,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/5/2022,1/5/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,South America,Paid,1350 USD,1350.0,2021-12,1.0,1350.0,0-1500$ 
GB,2021-12-31,A0450260,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/5/2022,1/5/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,2241,2241.0,2021-12,1.330836,2982.403476,2000-3000$ 
GB,2021-12-31,A0450420,Clinical,Royal United Hospitals Bath,Ashley Cox,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Non-small cell lung carcinoma (NSCLC),1/4/2022,1/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2021,4,1,2021-12-01,2021-12,G360 CDx,2021Q4,Europe,Paid,0 GBP,0.0,2021-12,1.330836,0.0,0 $
CL,2022-01-03,A0450514,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/9/2022,1/9/2022,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,1550 USD,1550.0,2022-01,1.0,1550.0,1500-2000$ 
ES,2022-01-03,A0450498,Clinical,"GenesisCare Madrid, Hospital La Milagrosa",Lucrecia Ruiz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,1/10/2022,1/10/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-01,1.132211,2819.20539,2000-3000$ 
TR,2022-01-03,A0450505,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/7/2022,1/31/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-01,1.0,1943.0,1500-2000$ 
TR,2022-01-03,A0450503,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Melanoma,1/4/2022,1/4/2022,TURKEY,Commercial,Skin,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,0,0.0,2022-01,1.0,0.0,0 $
TR,2022-01-03,A0450492,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/7/2022,1/31/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-01,1.0,1943.0,1500-2000$ 
GB,2022-01-04,A0450701,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/8/2022,1/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-01,1.3556,3117.8799999999997,3000+ $
BR,2022-01-04,A0450718,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Carcinoma of unknown primary (CUP),1/11/2022,1/11/2022,BRAZIL,Commercial,CUP,BRAZIL,1,AE,USD,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,0 USD,0.0,2022-01,1.0,0.0,0 $
BR,2022-01-04,A0450662,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/8/2022,1/8/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,1700 USD,1700.0,2022-01,1.0,1700.0,1500-2000$ 
BR,2022-01-05,A0451202,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/12/2022,1/12/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-01,1.0,1350.0,0-1500$ 
ES,2022-01-06,A0451652,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/10/2022,1/10/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2500 USD,2500.0,2022-01,1.132211,2830.5275,2000-3000$ 
GB,2022-01-06,A0451433,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/10/2022,1/10/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-01,1.3556,3037.8995999999997,3000+ $
GR,2022-01-07,A0452147,Clinical,Metropolian Hospital,Epaminondas Samantas,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Pancreatic ductal adenocarcinoma,1/11/2022,1/11/2022,GREECE,Commercial,,GREECE,1,non_AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,0 EUR,0.0,2022-01,1.132211,0.0,0 $
ES,2022-01-07,A0452175,Clinical,Clinica Universidad de Navarra,Jose Maria Lopez-Picazo Gonzalez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,1/12/2022,1/12/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2400 USD,2400.0,2022-01,1.132211,2717.3064000000004,2000-3000$ 
ES,2022-01-07,A0452103,Clinical,Hospital La Luz,Esther Holgado Martin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/13/2022,3/29/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-01,1.132211,2819.20539,2000-3000$ 
GB,2022-01-07,A0452321,Clinical,The Royal Marsden NHS Foundation Trust,Mary O'Brien,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung cancer,1/12/2022,1/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-01,1.3556,3375.444,3000+ $
GB,2022-01-07,A0452195,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/12/2022,1/12/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-01,1.3556,3037.8995999999997,3000+ $
GB,2022-01-07,A0452131,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/11/2022,1/12/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-01,1.3556,3037.8995999999997,3000+ $
TR,2022-01-08,A0452749,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/16/2022,1/31/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-01,1.0,1943.0,1500-2000$ 
GB,2022-01-08,A0452636,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Daniel Henderson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/13/2022,1/13/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP ,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-10,A0453295,Clinical,Freeman Hospital,Alastair Greystoke,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/14/2022,1/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-01,1.3556,3117.8799999999997,3000+ $
TR,2022-01-10,A0453281,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/14/2022,1/31/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-01,1.0,1943.0,1500-2000$ 
GB,2022-01-10,A0453361,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,1/14/2022,1/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-01,1.3556,3375.444,3000+ $
GB,2022-01-10,A0453314,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/14/2022,1/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP ,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-10,A0453348,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/14/2022,1/14/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-01,1.3556,3037.8995999999997,3000+ $
TR,2022-01-11,A0453765,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/18/2022,1/31/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-01,1.0,1943.0,1500-2000$ 
IE,2022-01-11,A0453602,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal adenocarcinoma,1/21/2022,1/21/2022,IRELAND,Commercial,GI,IRELAND,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 EUR ,1245.0,2022-01,1.132211,1409.602695,0-1500$ 
GB,2022-01-12,A0453928,Clinical,Maidstone and Tunbridge Wells NHS Trust,Rosemeen Parkar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Appendix adenocarcinoma,1/21/2022,1/28/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-12,A0453967,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/18/2022,1/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-01,1.3556,1687.722,1500-2000$ 
GB,2022-01-12,A0454238,Clinical,The Nuffield Hospital Guildford,Sebastian Cummins,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Colorectal adenocarcinoma,2/1/2022,2/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,0 GBP,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-12,A0454178,Clinical,The Nuffield Hospital Guildford,Sebastian Cummins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/18/2022,1/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-01,1.3556,3375.444,3000+ $
RO,2022-01-12,A0454179,Clinical,Amethyst Radiotherapy Clinic,Bogdan Mateies,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/18/2022,1/18/2022,ROMANIA,Commercial,,ROMANIA,1,non_AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-01,1.132211,2819.20539,2000-3000$ 
TR,2022-01-12,A0454060,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,1/16/2022,1/31/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-01,1.0,1943.0,1500-2000$ 
BR,2022-01-12,A0454042,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/20/2022,1/20/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,1700 USD,1700.0,2022-01,1.0,1700.0,1500-2000$ 
TR,2022-01-12,A0454400,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Endometrial carcinoma,1/18/2022,1/31/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-01,1.0,1943.0,1500-2000$ 
GB,2022-01-13,A0454686,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/19/2022,1/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-01,1.3556,3037.8995999999997,3000+ $
GB,2022-01-13,A0454736,Clinical,Singleton Hospital,Alison Brewster,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,1/18/2022,1/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-13,A0454951,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/19/2022,1/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-01,1.3556,3037.8995999999997,3000+ $
GB,2022-01-13,A0454720,Clinical,Maidstone and Tunbridge Wells NHS Trust,Mark Hill,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,1/19/2022,1/19/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
FI,2022-01-13,A0455121,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/19/2022,1/19/2022,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2366,2366.0,2022-01,1.132211,2678.8112260000003,2000-3000$ 
ES,2022-01-13,A0454759,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/21/2022,2/3/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-01,1.132211,2819.20539,2000-3000$ 
GB,2022-01-13,A0454576,Clinical,The Rutherford Cancer Centre,Seema Arif,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/19/2022,1/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-01,1.3556,1687.722,1500-2000$ 
ES,2022-01-13,A0454748,Clinical,Hospital Sanitas La Zarzuela,Pedro Salinas,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,1/19/2022,1/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 EUR,0.0,2022-01,1.132211,0.0,0 $
GB,2022-01-13,A0455114,Clinical,Eastbourne District General Hospital,Muawia Mohamed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/19/2022,1/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP ,0.0,2022-01,1.3556,0.0,0 $
ES,2022-01-14,A0455508,Clinical,Hospital General Universitario De Toledo,Ruth Alvarez Cabellos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/20/2022,2/25/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-01,1.132211,2819.20539,2000-3000$ 
GB,2022-01-14,A0455562,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/19/2022,1/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-01,1.3556,3117.8799999999997,3000+ $
GB,2022-01-14,A0455208,Clinical,The Christie Hospital,Richard Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/19/2022,1/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-14,A0455489,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/21/2022,1/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-01,1.3556,1687.722,1500-2000$ 
IE,2022-01-14,A0455609,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/25/2022,1/25/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 EUR ,1245.0,2022-01,1.132211,1409.602695,0-1500$ 
GB,2022-01-14,A0455318,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/20/2022,1/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-01,1.3556,1687.722,1500-2000$ 
TR,2022-01-15,A0456167,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/25/2022,2/4/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-01,1.0,1943.0,1500-2000$ 
GB,2022-01-17,A0456284,Clinical,Royal United Hospitals Bath,Tania Tillett,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Carcinoma of unknown primary (CUP),1/20/2022,1/20/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
ES,2022-01-17,A0456265,Clinical,Fundacion Jimenez Diaz,Jaime Rubio Perez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/24/2022,1/24/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-01,1.132211,1409.602695,0-1500$ 
ES,2022-01-17,A0456268,Clinical,Hospital A Coruna,Maria Rosario Garcia Campelo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/25/2022,1/25/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,EUR 1245,1245.0,2022-01,1.132211,1409.602695,0-1500$ 
GB,2022-01-17,A0456270,Clinical,Coventry University Hospitals,Susan Lupton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/24/2022,1/24/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-17,A0456279,Clinical,Belfast City Hospital Cancer Center,Gerard Walls,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,1/24/2022,1/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-17,A0456257,Clinical,Poole Hospital NHS Foundation Trust,Lauren Gorf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/24/2022,1/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-17,A0456286,Clinical,University College London Hospitals,Mark Linch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,1/24/2022,5/31/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-01,1.3556,1687.722,1500-2000$ 
GB,2022-01-17,A0456261,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/24/2022,1/24/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-01,1.3556,3375.444,3000+ $
BR,2022-01-18,A0456582,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/22/2022,1/22/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-01,1.0,1350.0,0-1500$ 
ES,2022-01-18,A0456541,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/23/2022,2/3/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1745 EUR,1745.0,2022-01,1.132211,1975.7081950000002,1500-2000$ 
GB,2022-01-19,A0456690,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,1/23/2022,1/23/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-01,1.3556,3117.8799999999997,3000+ $
ES,2022-01-19,A0456977,Clinical,Hospital Nuestra Senora de Sonsoles,Lauren Condori,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,1/25/2022,3/29/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1745 EUR,1745.0,2022-01,1.132211,1975.7081950000002,1500-2000$ 
ES,2022-01-19,A0456938,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/24/2022,3/30/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2200 EUR,2200.0,2022-01,1.132211,2490.8642,2000-3000$ 
TR,2022-01-19,A0456956,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/24/2022,1/31/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-01,1.0,1943.0,1500-2000$ 
GB,2022-01-19,A0456786,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/25/2022,1/25/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-01,1.3556,3037.8995999999997,3000+ $
TR,2022-01-19,A0457653,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Ovarian carcinoma,1/28/2022,2/9/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 Infinity,2022Q1,Europe,Paid,3500 USD,3500.0,2022-01,1.0,3500.0,3000+ $
TR,2022-01-19,A0456994,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/28/2022,2/1/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-01,1.0,1943.0,1500-2000$ 
BR,2022-01-19,A0456969,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/23/2022,1/23/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-01,1.0,1350.0,0-1500$ 
GB,2022-01-20,A0457464,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/26/2022,1/26/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-01,1.3556,3037.8995999999997,3000+ $
ES,2022-01-20,A0457619,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/26/2022,3/29/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-01,1.132211,2819.20539,2000-3000$ 
FI,2022-01-20,A0457565,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/25/2022,1/25/2022,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,EUR 2303 ,2303.0,2022-01,1.132211,2607.481933,2000-3000$ 
GB,2022-01-20,A0457727,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,1/26/2022,7/15/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-01,1.3556,1687.722,1500-2000$ 
GB,2022-01-20,A0457670,Clinical,The Royal Marsden NHS Foundation Trust,Alistair Ring,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,1/26/2022,1/26/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-01,1.3556,3375.444,3000+ $
GB,2022-01-20,A0457733,Clinical,The Royal Marsden Hospital,Michael Davidson,Guardant 360,2.11,GHI_05,Self-Pay Patient,Lung adenocarcinoma,1/26/2022,1/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-01,1.3556,1687.722,1500-2000$ 
TR,2022-01-21,A0457874,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/26/2022,1/31/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-01,1.0,1943.0,1500-2000$ 
AT,2022-01-21,A0457769,Clinical,Naturheilpraxis Dr. med. Baumert,Stefan Baumert,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,1/27/2022,7/26/2022,AUSTRIA,Commercial,Other,AUSTRIA,1,non_AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,3490 EUR,3490.0,2022-01,1.132211,3951.4163900000003,3000+ $
GB,2022-01-21,A0457905,Clinical,St James University Hospital,Dan Lee,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,1/27/2022,1/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
ES,2022-01-21,A0458070,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/27/2022,1/27/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2400 USD,2400.0,2022-01,1.132211,2717.3064000000004,2000-3000$ 
TR,2022-01-21,A0457971,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Do Not Bill - Promotional,Lung adenocarcinoma,1/26/2022,1/26/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0,0.0,2022-01,1.0,0.0,0 $
GB,2022-01-22,A0458666,Clinical,The Nuffield Hospital Guildford,Sebastian Cummins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,1/29/2022,1/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-01,1.3556,3117.8799999999997,3000+ $
GB,2022-01-22,A0458581,Clinical,Cancer Centre London,Mary O'Brien,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/28/2022,1/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-01,1.3556,3117.8799999999997,3000+ $
GB,2022-01-22,A0458504,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,1/29/2022,1/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-01,1.3556,3375.444,3000+ $
IE,2022-01-24,A0458927,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/29/2022,1/29/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 EUR ,1245.0,2022-01,1.132211,1409.602695,0-1500$ 
ES,2022-01-24,A0458908,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,1/29/2022,3/29/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1745 EUR,1745.0,2022-01,1.132211,1975.7081950000002,1500-2000$ 
ES,2022-01-24,A0458906,Clinical,Hospital La Luz,Esther Holgado Martin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/29/2022,2/7/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 EUR - 2397 EUR,2490.0,2022-01,1.132211,2819.20539,2000-3000$ 
GB,2022-01-24,A0458722,Clinical,The Royal Marsden NHS Foundation Trust,David Cunningham,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/29/2022,1/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-01,1.3556,1687.722,1500-2000$ 
BR,2022-01-24,A0458761,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/29/2022,1/29/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-01,1.0,1350.0,0-1500$ 
BR,2022-01-24,A0458760,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),1/29/2022,1/29/2022,BRAZIL,Commercial,CUP,BRAZIL,1,AE,USD,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-01,1.0,1350.0,0-1500$ 
GB,2022-01-24,A0458884,Clinical,Charing Cross Hospital Medical Oncology Department,Victoria Harding,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/31/2022,1/31/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
ES,2022-01-24,A0458723,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenosquamous carcinoma,1/29/2022,2/14/2022,SPAIN,Commercial,Lung,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-01,1.132211,2819.20539,2000-3000$ 
TR,2022-01-24,A0458719,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Non-small cell lung carcinoma (NSCLC),1/29/2022,2/28/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,0,0.0,2022-01,1.0,0.0,0 $
GB,2022-01-24,A0458880,Clinical,St James University Hospital,Mark Teo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,1/29/2022,1/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-25,A0459035,Clinical,Eastbourne District General Hospital,Victoria Donovan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/2/2022,2/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
BR,2022-01-26,A0459732,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/31/2022,1/31/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-01,1.0,1350.0,0-1500$ 
GB,2022-01-26,A0459705,Clinical,Southampton General Hospital,Almurtadha Mula-Kh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,2/1/2022,2/1/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-26,A0459544,Clinical,The Colney Centre Oncology and Haematology Department,Zacharias Tasigiannopoulos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/30/2022,1/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
BR,2022-01-26,A0459790,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/4/2022,2/4/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-01,1.0,1350.0,0-1500$ 
GB,2022-01-26,A0459355,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/1/2022,2/1/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-01,1.3556,3375.444,3000+ $
GB,2022-01-27,A0460422,Clinical,Worthing Hospital,Nick Adams,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/2/2022,2/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-28,A0460786,Clinical,Huddersfield Royal Infirmary,Jo Dent,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/3/2022,2/3/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-01,1.3556,0.0,0 $
GB,2022-01-28,A0460499,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/3/2022,2/3/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-01,1.3556,3375.444,3000+ $
DE,2022-01-28,A0460782,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/3/2022,2/3/2022,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2990 EUR,2990.0,2022-01,1.132211,3385.31089,3000+ $
ES,2022-01-28,A0460481,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,2/2/2022,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-01,1.132211,1409.602695,0-1500$ 
MX,2022-01-28,A0460505,Clinical,ABC Hospital,Gabriela Olivia Regalado Porras,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/2/2022,2/2/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,South America,Paid,3316 USD,3316.0,2022-01,1.132211,3754.411676,3000+ $
GB,2022-01-29,A0461167,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,2/2/2022,2/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-01,1.3556,3375.444,3000+ $
ES,2022-01-31,A0461643,Clinical,Hospital Quiron Barcelona,Aleix Prat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,2/7/2022,2/11/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241 EUR,2241.0,2022-01,1.132211,2537.2848510000003,2000-3000$ 
GB,2022-01-31,A0461649,Clinical,HCA Laboratories,Carmel Coulter,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,2/8/2022,2/8/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,0 GBP,0.0,2022-01,1.3556,0.0,0 $
ES,2022-01-31,A0461606,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,2/5/2022,4/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-01,1.132211,1409.602695,0-1500$ 
GB,2022-01-31,A0461652,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/5/2022,2/18/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-01,1.3556,3037.8995999999997,3000+ $
ES,2022-01-31,A0461605,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/7/2022,2/7/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241 EUR,2241.0,2022-01,1.132211,2537.2848510000003,2000-3000$ 
ES,2022-01-31,A0461636,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/5/2022,2/5/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2022,1,1,2022-01-01,2022-01,G360 CDx,2022Q1,Europe,Paid,2241 EUR,2241.0,2022-01,1.132211,2537.2848510000003,2000-3000$ 
BR,2022-02-01,A0461898,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/5/2022,2/5/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-02,1.0,1350.0,0-1500$ 
TR,2022-02-02,A0462465,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/6/2022,2/6/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-02,1.0,1943.0,1500-2000$ 
GB,2022-02-02,A0462265,Clinical,HCA Laboratories,Nicholas Maisey,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/9/2022,5/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-02,1.353747,1685.415015,1500-2000$ 
GB,2022-02-02,A0462470,Clinical,Maidstone and Tunbridge Wells NHS Trust,Mark Hill,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/7/2022,2/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
GB,2022-02-03,A0462871,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,2/24/2022,2/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-02,1.353747,1685.415015,1500-2000$ 
MX,2022-02-03,A0463073,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),2/8/2022,2/8/2022,MEXICO,Commercial,CUP,MEXICO,1,non_AE,EUR,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,3316 USD,3316.0,2022-02,1.134813,3763.039908,3000+ $
GB,2022-02-03,A0463107,Clinical,The Holly Private Hospital,Sherif Raouf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/8/2022,3/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-02,1.353747,3370.83003,3000+ $
GB,2022-02-04,A0463601,Clinical,HCA Laboratories,Hartmut Kristeleit,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,2/10/2022,2/15/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-02,1.353747,3033.747027,3000+ $
GB,2022-02-04,A0463381,Clinical,HCA Laboratories,Jonathan Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/9/2022,2/9/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-02,1.353747,3033.747027,3000+ $
CL,2022-02-04,A0463327,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/9/2022,2/9/2022,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,1550 USD,1550.0,2022-02,1.0,1550.0,1500-2000$ 
GB,2022-02-04,A0463409,Clinical,Singleton Hospital,Alison Brewster,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/9/2022,2/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
TR,2022-02-04,A0463302,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/9/2022,2/9/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1943,1943.0,2022-02,1.0,1943.0,1500-2000$ 
GB,2022-02-04,A0463418,Clinical,The Montefiore Hospital,Richard Simcock,Guardant 360,2.11,GHI_01,Self-Pay Patient,Small cell lung carcinoma,2/10/2022,2/10/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-02,1.353747,3113.6181,3000+ $
GB,2022-02-04,A0463550,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/9/2022,2/9/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-02,1.353747,3033.747027,3000+ $
MX,2022-02-05,A0464134,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,2/11/2022,2/11/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,3316 USD,3316.0,2022-02,1.134813,3763.039908,3000+ $
ES,2022-02-07,A0464356,Clinical,Hospital Quiron Barcelona,Aleix Prat,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,2/16/2022,2/16/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 Infinity,2022Q1,Europe,Paid,3500 USD,3500.0,2022-02,1.134813,3971.8455000000004,3000+ $
CL,2022-02-07,A0464437,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/12/2022,2/12/2022,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,1550 USD,1550.0,2022-02,1.0,1550.0,1500-2000$ 
ES,2022-02-07,A0464378,Clinical,Hospital Clinico San Carlos,Natalia Vidal,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Bladder carcinoma,2/12/2022,2/21/2022,SPAIN,Commercial,Bladder,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-02,1.134813,1412.8421850000002,0-1500$ 
ES,2022-02-07,A0464375,Clinical,Hospital Clinico San Carlos,Arancha Manzano,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),2/12/2022,2/12/2022,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-02,1.134813,1412.8421850000002,0-1500$ 
GR,2022-02-07,A0464360,Clinical,Metropolian Hospital,Epaminondas Samantas,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/12/2022,2/12/2022,GREECE,Commercial,,GREECE,1,non_AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-02,1.134813,2825.6843700000004,2000-3000$ 
ES,2022-02-07,A0464365,Clinical,Hospital A Coruna,Maria Rosario Garcia Campelo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/12/2022,2/12/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,EUR 1245,1245.0,2022-02,1.134813,1412.8421850000002,0-1500$ 
ES,2022-02-07,A0464363,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/14/2022,2/18/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2200 EUR,2200.0,2022-02,1.134813,2496.5886,2000-3000$ 
ES,2022-02-07,A0464379,Clinical,Complejo Hospitalario Ruber Juan Bravo,Patricia Cortez Castedo,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/23/2022,2/23/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2241 EUR,2241.0,2022-02,1.134813,2543.115933,2000-3000$ 
GB,2022-02-07,A0464364,Clinical,The Holly Private Hospital,Sherif Raouf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/15/2022,2/15/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-02,1.353747,3370.83003,3000+ $
GB,2022-02-07,A0464367,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/12/2022,2/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-02,1.353747,3370.83003,3000+ $
GB,2022-02-07,A0464446,Clinical,HCA Laboratories,David Woolf,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/14/2022,2/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-02,1.353747,3033.747027,3000+ $
GB,2022-02-07,A0464382,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/12/2022,2/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-02,1.353747,3370.83003,3000+ $
BE,2022-02-07,A0464373,Clinical,Dr Justyna Surma,Justyna Surma,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/14/2022,2/14/2022,BELGIUM,Commercial,,BELGIUM,1,non_AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 EUR,0.0,2022-02,1.134813,0.0,0 $
ES,2022-02-08,A0464870,Clinical,Hospital Universitario HM Puerta Del Sur,Miriam Dorta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/12/2022,2/12/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-02,1.134813,2825.6843700000004,2000-3000$ 
GB,2022-02-08,A0464873,Clinical,HCA Laboratories,Khurum Khan,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Colorectal adenocarcinoma,2/23/2022,2/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,0 GBP,0.0,2022-02,1.353747,0.0,0 $
IE,2022-02-09,A0465661,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/15/2022,2/15/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 EUR ,1245.0,2022-02,1.134813,1412.8421850000002,0-1500$ 
GB,2022-02-09,A0465736,Clinical,HCA Laboratories,Hartmut Kristeleit,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/17/2022,2/17/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-02,1.353747,3033.747027,3000+ $
CA,2022-02-10,A0466453,Clinical,Rexdale Medical Centre,Katherine Dmetrichuk,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/16/2022,2/16/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Canada,Paid,3490 USD,3490.0,2022-02,1.0,3490.0,3000+ $
ES,2022-02-10,A0466360,Clinical,Complejo Hospitalario Ruber Juan Bravo,Araceli Priego Priego,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/19/2022,2/19/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2241 EUR,2241.0,2022-02,1.134813,2543.115933,2000-3000$ 
ES,2022-02-10,A0466273,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,2/16/2022,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 EUR ,1245.0,2022-02,1.134813,1412.8421850000002,0-1500$ 
BR,2022-02-10,A0466405,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/16/2022,2/16/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-02,1.0,1350.0,0-1500$ 
GB,2022-02-10,A0466047,Clinical,Maidstone and Tunbridge Wells NHS Trust,Julia Hall,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/16/2022,2/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
GB,2022-02-10,A0465990,Clinical,The Colney Centre Oncology and Haematology Department,Zacharias Tasigiannopoulos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/17/2022,2/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
GB,2022-02-10,A0465998,Clinical,HCA Laboratories,Khurum Khan,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/16/2022,2/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2241,2241.0,2022-02,1.353747,3033.747027,3000+ $
GB,2022-02-11,A0467088,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/22/2022,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-02,1.353747,1685.415015,1500-2000$ 
TR,2022-02-11,A0466923,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/16/2022,2/16/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
ES,2022-02-11,A0467092,Clinical,Hospital Nuestra Senora de Sonsoles,Lauren Condori,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,2/17/2022,3/29/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1745 EUR,1745.0,2022-02,1.134813,1980.248685,1500-2000$ 
TR,2022-02-11,A0466929,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/16/2022,2/16/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
GB,2022-02-11,A0467045,Clinical,HCA Laboratories,Hartmut Kristeleit,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/18/2022,3/10/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-02,1.353747,3370.83003,3000+ $
GB,2022-02-11,A0467057,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/17/2022,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,1245 GBP,1245.0,2022-02,1.353747,1685.415015,1500-2000$ 
GB,2022-02-12,A0467158,Clinical,HCA Laboratories,Carmel Coulter,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/18/2022,2/18/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
ES,2022-02-14,A0467743,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/18/2022,2/18/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-02,1.134813,2825.6843700000004,2000-3000$ 
BR,2022-02-14,A0467742,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,2/18/2022,2/18/2022,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-02,1.0,1350.0,0-1500$ 
ES,2022-02-14,A0467704,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/19/2022,4/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2200 EUR,2200.0,2022-02,1.134813,2496.5886,2000-3000$ 
ES,2022-02-14,A0467739,Clinical,Clinica Rotger Quironsalud,Teresa Acuna,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/19/2022,2/19/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-02,1.134813,1412.8421850000002,0-1500$ 
GB,2022-02-14,A0467717,Clinical,The Montefiore Hospital,Adrian Moss,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/19/2022,2/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-02,1.353747,3113.6181,3000+ $
GB,2022-02-14,A0467700,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sebastian Cummins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),2/20/2022,2/28/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-02,1.353747,3113.6181,3000+ $
GB,2022-02-14,A0467688,Clinical,West Suffolk Hospital,Daniel Patterson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/19/2022,2/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
FI,2022-02-15,A0468155,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/22/2022,2/22/2022,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2303 EUR,2303.0,2022-02,1.134813,2613.4743390000003,2000-3000$ 
GB,2022-02-16,A0468437,Clinical,The Royal Marsden NHS Foundation Trust,Ajita Joshi,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Esophageal squamous cell carcinoma,2/23/2022,7/26/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-02,1.353747,1685.415015,1500-2000$ 
GB,2022-02-16,A0468552,Clinical,HCA Laboratories,Khurum Khan,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,2/22/2022,3/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-02,1.353747,2948.460966,2000-3000$ 
GB,2022-02-16,A0468491,Clinical,Coventry University Hospitals,Susan Lupton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/22/2022,2/22/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-02,1.353747,1685.415015,1500-2000$ 
GB,2022-02-16,A0468873,Clinical,Sussex Cancer Centre,Jonathan Towler,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/24/2022,2/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
ES,2022-02-16,A0469020,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/23/2022,2/23/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-02,1.134813,2825.6843700000004,2000-3000$ 
TR,2022-02-17,A0469106,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/25/2022,2/25/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
IE,2022-02-17,A0469110,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/23/2022,2/23/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-02,1.134813,1412.8421850000002,0-1500$ 
GB,2022-02-17,A0469405,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/23/2022,2/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-02,1.353747,3370.83003,3000+ $
ES,2022-02-17,A0469412,Clinical,Hospital Quiron Barcelona,Teresa Macarulla,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,2/23/2022,2/23/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2241 EUR,2241.0,2022-02,1.134813,2543.115933,2000-3000$ 
GB,2022-02-17,A0469590,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/23/2022,2/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-02,1.353747,1685.415015,1500-2000$ 
GB,2022-02-18,A0470223,Clinical,Bupa Cromwell Hospital,Nick Plowman,Guardant 360,2.11,GHI_01,Self-Pay Patient,Small cell lung carcinoma,2/24/2022,2/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-02,1.353747,3113.6181,3000+ $
TR,2022-02-18,A0470210,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/24/2022,2/24/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
FI,2022-02-18,A0470131,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/25/2022,2/25/2022,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2303 EUR,2303.0,2022-02,1.134813,2613.4743390000003,2000-3000$ 
TR,2022-02-18,A0470207,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/27/2022,2/27/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
GB,2022-02-18,A0470241,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Shobhit Baijal,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal/Gastroesophageal junction Adenocarcinoma,2/25/2022,2/25/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
ES,2022-02-18,A0470218,Clinical,Hospital Clinico San Carlos,Arancha Manzano,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),2/24/2022,2/24/2022,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 EUR,0.0,2022-02,1.134813,0.0,0 $
GB,2022-02-18,A0470200,Clinical,Royal United Hospitals Bath,Tania Tillett,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),2/26/2022,2/26/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
CA,2022-02-19,A0470723,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/1/2022,3/10/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Canada,Free,0 GBP,0.0,2022-02,1.0,0.0,0 $
ES,2022-02-21,A0470774,Clinical,Hospital Quiron Barcelona,Aleix Prat,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,3/2/2022,3/2/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 Infinity,2022Q1,Europe,Paid,3500 USD -3100 EUR,3500.0,2022-02,1.134813,3971.8455000000004,3000+ $
GB,2022-02-21,A0470760,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/26/2022,2/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-02,1.353747,2948.460966,2000-3000$ 
TR,2022-02-21,A0470785,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/26/2022,2/26/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
BR,2022-02-21,A0470808,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/27/2022,2/27/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-02,1.0,1350.0,0-1500$ 
GB,2022-02-21,A0470788,Clinical,Beatson West of Scotland Cancer Centre,Cicely Cunningham,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,2/26/2022,2/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
GB,2022-02-21,A0470794,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,2/26/2022,2/26/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-02,1.353747,2948.460966,2000-3000$ 
GB,2022-02-21,A0470779,Clinical,Derriford University Hospitals Plymouth NHS Trust,Bojidar Goranov,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/26/2022,2/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
GB,2022-02-21,A0470798,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,2/26/2022,2/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-02,1.353747,3113.6181,3000+ $
GB,2022-02-22,A0470879,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Jenny Sherriff,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,2/27/2022,2/27/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
BR,2022-02-22,A0471061,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/1/2022,8/17/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-02,1.0,1350.0,0-1500$ 
GB,2022-02-22,A0470886,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Mariam Jafri,Guardant 360,2.11,GHI_01,Self-Pay Patient,Sarcoma,2/27/2022,2/27/2022,UNITED KINGDOM,Commercial,Soft Tissue/Bone,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
BR,2022-02-22,A0470998,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/27/2022,2/27/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,1700 USD,1700.0,2022-02,1.0,1700.0,1500-2000$ 
TR,2022-02-23,A0471412,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/1/2022,3/1/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
GB,2022-02-23,A0471357,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/1/2022,3/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-02,1.353747,3370.83003,3000+ $
GB,2022-02-23,A0471281,Clinical,Charing Cross Hospital Medical Oncology Department,Joanne Evans,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,3/1/2022,3/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
IE,2022-02-23,A0471706,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/1/2022,3/1/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-02,1.134813,1412.8421850000002,0-1500$ 
TR,2022-02-23,A0471709,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/1/2022,3/1/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
GB,2022-02-24,A0472514,Clinical,Castle Hill Hospital,Brendan Wooler,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,3/3/2022,3/3/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,0 GBP,0.0,2022-02,1.353747,0.0,0 $
GB,2022-02-24,A0472554,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/2/2022,3/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-02,1.353747,2948.460966,2000-3000$ 
GB,2022-02-24,A0472381,Clinical,HCA Laboratories,Hartmut Kristeleit,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,3/2/2022,6/21/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-02,1.353747,1685.415015,1500-2000$ 
TR,2022-02-24,A0472324,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,3/1/2022,3/29/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
MX,2022-02-24,A0472486,Clinical,MileniaLabs,Osvaldo Hernandez,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Ovarian carcinoma,3/3/2022,3/3/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,2500 USD,2500.0,2022-02,1.134813,2837.0325000000003,2000-3000$ 
TR,2022-02-24,A0472364,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/2/2022,3/2/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
TR,2022-02-24,A0472343,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),3/1/2022,3/1/2022,TURKEY,Commercial,CUP,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
ES,2022-02-25,A0472885,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/2/2022,3/2/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-02,1.134813,1412.8421850000002,0-1500$ 
IT,2022-02-25,A0473116,Clinical,San Raffaele Hospital,Olga Gribova,Guardant 360,2.11,GHI_01,Self-Pay Patient,Hepatocellular carcinoma,3/8/2022,3/14/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-02,1.134813,2825.6843700000004,2000-3000$ 
GB,2022-02-25,A0473318,Clinical,HCA Laboratories,Tim Mould,Guardant 360,2.11,GHI_01,Self-Pay Patient,Endometrial carcinoma,3/4/2022,3/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-02,1.353747,1685.415015,1500-2000$ 
GB,2022-02-25,A0472988,Clinical,Velindre Cancer Centre,Amy Quinton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,3/2/2022,3/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
TR,2022-02-25,A0473167,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/2/2022,3/2/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
TR,2022-02-28,A0474332,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,3/7/2022,3/7/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-02,1.0,1890.0,1500-2000$ 
GB,2022-02-28,A0474348,Clinical,Beatson West of Scotland Cancer Centre,Ben Fulton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Large cell lung carcinoma,3/7/2022,3/7/2022,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
GB,2022-02-28,A0474358,Clinical,The Royal Preston Hospital NHS Foundation Trust,Ruth Board,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/7/2022,3/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
GB,2022-02-28,A0474367,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/6/2022,3/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-02,1.353747,1685.415015,1500-2000$ 
GB,2022-02-28,A0474363,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/7/2022,3/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-02,1.353747,2948.460966,2000-3000$ 
GB,2022-02-28,A0474373,Clinical,Queen Alexandra Hospital,Sethupathi Ramalingam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/6/2022,3/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-02,1.353747,3113.6181,3000+ $
GB,2022-02-28,A0474360,Clinical,Queen Alexandra Hospital,Christopher Coyle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/7/2022,3/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
GB,2022-02-28,A0474369,Clinical,Velindre Cancer Centre,Amy Quinton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,3/6/2022,3/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
BR,2022-02-28,A0474376,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,3/6/2022,3/6/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,South America,Paid,,0.0,2022-02,1.0,0.0,0 $
GB,2022-02-28,A0474352,Clinical,Berkshire Cancer Centre,Richard Brown,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/6/2022,3/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2022,1,1,2022-02-01,2022-02,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-02,1.353747,0.0,0 $
ES,2022-03-01,A0475371,Clinical,Hospital Can Misses,Alicia Quilez Cutillas,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/8/2022,3/8/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-03,1.100694,1370.3640300000002,0-1500$ 
GB,2022-03-02,A0475955,Clinical,University College London Hospitals,Martin Forster,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/8/2022,3/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
CA,2022-03-02,A0475934,Clinical,London Health Sciences Centre,Daniel Breadner,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,3/8/2022,3/8/2022,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Canada,Free,0 USD,0.0,2022-03,1.0,0.0,0 $
MX,2022-03-02,A0475566,Clinical,ABC Hospital,Beatriz de Rienzo Madero,Guardant 360,2.11,GHI_01,Distributors : ROW,Endometrial carcinoma,3/15/2022,3/15/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,South America,Paid,3316 USD,3316.0,2022-03,1.100694,3649.901304,3000+ $
GB,2022-03-03,A0476383,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,3/9/2022,3/9/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
ES,2022-03-03,A0476176,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,3/8/2022,3/8/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 EUR ,1245.0,2022-03,1.100694,1370.3640300000002,0-1500$ 
GB,2022-03-03,A0476718,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/9/2022,3/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
DE,2022-03-03,A0476398,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/10/2022,3/30/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2990 EUR,2990.0,2022-03,1.100694,3291.07506,3000+ $
GB,2022-03-03,A0476348,Clinical,The Royal Marsden NHS Foundation Trust,Kazimierz Mochlinski,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,3/9/2022,5/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
GB,2022-03-03,A0476224,Clinical,West Suffolk Hospital,Daniel Patterson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/9/2022,3/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
TR,2022-03-04,A0477075,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/9/2022,3/9/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-03,1.0,1890.0,1500-2000$ 
GB,2022-03-04,A0477246,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/9/2022,3/10/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-04,A0477047,Clinical,"University Hospital Monklands, David Matthew Centre",Clinton Ali,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/9/2022,3/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
ES,2022-03-04,A0477036,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/9/2022,3/9/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-03,1.100694,1370.3640300000002,0-1500$ 
GB,2022-03-04,A0477037,Clinical,HCA Laboratories,Hartmut Kristeleit,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/9/2022,7/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
TR,2022-03-04,A0477033,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Cervical Squamous Cell Carcinoma,3/9/2022,3/9/2022,TURKEY,Commercial,Cervical,TURKEY,1,AE,USD,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-03,1.0,1890.0,1500-2000$ 
GB,2022-03-04,A0477319,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Shobhit Baijal,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,3/13/2022,3/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
ES,2022-03-04,A0477040,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,3/15/2022,3/15/2022,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2241 EUR,2241.0,2022-03,1.100694,2466.6552540000002,2000-3000$ 
GB,2022-03-04,A0477313,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,3/9/2022,3/21/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-04,A0477122,Clinical,Beatson West of Scotland Cancer Centre,Ben Fulton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/9/2022,3/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-04,A0477308,Clinical,Southampton General Hospital,Almurtadha Mula-Kh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,3/11/2022,3/11/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-07,A0478080,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/13/2022,3/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
GB,2022-03-07,A0478099,Clinical,HCA Laboratories,Khurum Khan,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/11/2022,3/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
BR,2022-03-07,A0478092,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/12/2022,3/12/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-03,1.0,1350.0,0-1500$ 
BR,2022-03-07,A0478095,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/12/2022,3/12/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-03,1.0,1350.0,0-1500$ 
GB,2022-03-07,A0478075,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/12/2022,3/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
IE,2022-03-07,A0478104,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,3/16/2022,3/16/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-03,1.100694,1370.3640300000002,0-1500$ 
ES,2022-03-07,A0478077,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/16/2022,3/16/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2400 USD,2400.0,2022-03,1.100694,2641.6656000000003,2000-3000$ 
GB,2022-03-07,A0478053,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/12/2022,3/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-08,A0478685,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/12/2022,3/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
GB,2022-03-08,A0478446,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/14/2022,3/14/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
GB,2022-03-08,A0478492,Clinical,Sussex Cancer Centre,Elizabeth Selvadurai,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/16/2022,3/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-09,A0479037,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/13/2022,3/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-09,A0479487,Clinical,Mount Vernon Hospital Cancer Centre The Hillingdon Hospitals NHS Foundation Trust,Arshi Denton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/16/2022,3/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-09,A0479172,Clinical,Guys Hospital,Elizabeth Harvey Jones,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/18/2022,3/21/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-10,A0480223,Clinical,University Hospitals Of Leicester,Jonathan Bennett,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/16/2022,3/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-10,A0479915,Clinical,The Rutherford Cancer Centre,Emma Hudson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Endometrial carcinoma,3/14/2022,3/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-10,A0479893,Clinical,Maidstone and Tunbridge Wells NHS Trust,Mark Hill,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/19/2022,3/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-10,A0480425,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/16/2022,3/16/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
GB,2022-03-10,A0480399,Clinical,University Hospitals Of Leicester,Jaseela Chiramel,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,3/15/2022,3/15/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-10,A0479939,Clinical,Freeman Hospital,Alastair Greystoke,Guardant 360,2.11,GHI_01,Self-Pay Patient,Anal squamous cell carcinoma,3/16/2022,3/16/2022,UNITED KINGDOM,Commercial,CRC,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-10,A0480407,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/15/2022,6/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-10,A0480166,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/14/2022,3/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-10,A0480392,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/16/2022,3/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
TR,2022-03-10,A0480077,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,3/14/2022,3/14/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-03,1.0,1890.0,1500-2000$ 
ES,2022-03-11,A0480797,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/16/2022,3/16/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2241 EUR,2241.0,2022-03,1.100694,2466.6552540000002,2000-3000$ 
GB,2022-03-11,A0480781,Clinical,The Royal Marsden NHS Foundation Trust,Nicholas Turner,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,3/17/2022,3/17/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,?,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-11,A0480900,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/16/2022,3/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-11,A0481677,Clinical,University Hospitals Of Leicester,Jaseela Chiramel,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/16/2022,3/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-11,A0480660,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/18/2022,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
ES,2022-03-14,A0481850,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/18/2022,3/18/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1745 EUR,1745.0,2022-03,1.100694,1920.7110300000002,1500-2000$ 
DE,2022-03-14,A0482079,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/19/2022,3/30/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2990 EUR,2990.0,2022-03,1.100694,3291.07506,3000+ $
GB,2022-03-14,A0482055,Clinical,Sheffield Weston Park Cancer Centre,Fiona Taylor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/19/2022,3/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-14,A0481944,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/18/2022,3/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
GB,2022-03-14,A0481840,Clinical,Guys Hospital,Elizabeth Harvey Jones,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/21/2022,3/21/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
BR,2022-03-14,A0482023,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/26/2022,3/26/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-03,1.0,1350.0,0-1500$ 
GB,2022-03-14,A0482059,Clinical,The Royal Marsden NHS Foundation Trust,Daniela Kolarevic,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/19/2022,3/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
GB,2022-03-14,A0481956,Clinical,Belfast City Hospital Cancer Center,Peter Gallagher,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/18/2022,3/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
TR,2022-03-14,A0481941,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/18/2022,3/18/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-03,1.0,1890.0,1500-2000$ 
TR,2022-03-14,A0481831,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,3/18/2022,3/18/2022,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-03,1.0,1890.0,1500-2000$ 
ES,2022-03-15,A0482526,Clinical,Hospital Universitario de Guadalajara,Luis Enrique Chara Velarde,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,3/24/2022,5/17/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-03,1.100694,1370.3640300000002,0-1500$ 
GB,2022-03-15,A0482456,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/21/2022,3/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
DE,2022-03-15,A0482515,Clinical,Charite Berlin,Sebastian Stintzing,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/20/2022,3/20/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,3490 EUR,3490.0,2022-03,1.100694,3841.4220600000003,3000+ $
GB,2022-03-15,A0482575,Clinical,Concierge Medicine,Helen Mitakidis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/20/2022,3/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
ES,2022-03-15,A0482682,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/20/2022,3/20/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2400 USD,2400.0,2022-03,1.100694,2641.6656000000003,2000-3000$ 
CA,2022-03-16,A0483299,Clinical,RCM Health Consultancy,Helena Dukic,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric adenocarcinoma,3/21/2022,3/22/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Canada,Paid,3500 USD,3500.0,2022-03,1.0,3500.0,3000+ $
CA,2022-03-16,A0483173,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/20/2022,3/20/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Canada,Free,0 USD,0.0,2022-03,1.0,0.0,0 $
ES,2022-03-16,A0483360,Clinical,Hospital Sanitas La Zarzuela,Juan Jose Tafalla,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,3/22/2022,3/22/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-03,1.100694,2740.7280600000004,2000-3000$ 
MX,2022-03-16,A0483126,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/21/2022,3/21/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,South America,Paid,3316 USD,3316.0,2022-03,1.100694,3649.901304,3000+ $
GB,2022-03-17,A0483785,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/22/2022,3/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
CL,2022-03-17,A0483485,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/22/2022,3/22/2022,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,South America,Paid,1550 USD,1550.0,2022-03,1.0,1550.0,1500-2000$ 
GB,2022-03-17,A0483816,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,3/22/2022,3/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-17,A0483818,Clinical,Charing Cross Hospital Medical Oncology Department,Naveed Sarwar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,3/23/2022,3/23/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
ES,2022-03-17,A0483449,Clinical,Clinica Tres Torres UOMI Cancer Center,Marta Suarez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/22/2022,3/22/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 EUR,0.0,2022-03,1.100694,0.0,0 $
GB,2022-03-17,A0483453,Clinical,HCA Laboratories,Amen Sibtain,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,3/22/2022,3/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
TR,2022-03-17,A0483798,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/22/2022,3/22/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-03,1.0,1890.0,1500-2000$ 
GB,2022-03-18,A0484086,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/22/2022,3/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
GB,2022-03-18,A0484225,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,3/22/2022,3/22/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
GB,2022-03-18,A0484089,Clinical,HCA Laboratories,Raffaele Califano,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/23/2022,3/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
ES,2022-03-18,A0484382,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/23/2022,4/5/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1745 EUR,1745.0,2022-03,1.100694,1920.7110300000002,1500-2000$ 
GB,2022-03-18,A0484078,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/26/2022,3/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-18,A0484345,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Duodenal Adenocarcinoma,3/26/2022,3/26/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
GB,2022-03-18,A0484613,Clinical,Queen Alexandra Hospital,Samuel Chan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/23/2022,3/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
TR,2022-03-19,A0485017,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,3/24/2022,3/24/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-03,1.0,1890.0,1500-2000$ 
CA,2022-03-19,A0485034,Clinical,Princess Margaret Cancer Centre,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/24/2022,3/24/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Canada,Paid,1750 USD,1750.0,2022-03,1.0,1750.0,1500-2000$ 
FI,2022-03-19,A0484746,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/5/2022,4/5/2022,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2303 EUR,2303.0,2022-03,1.100694,2534.898282,2000-3000$ 
ES,2022-03-21,A0485316,Clinical,Clinica Universidad de Navarra-Madrid,Julia Villamayor,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/26/2022,3/26/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2400 USD,2400.0,2022-03,1.100694,2641.6656000000003,2000-3000$ 
GB,2022-03-21,A0485248,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/25/2022,3/25/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
ES,2022-03-21,A0485242,Clinical,Hospital Nuestra Senora de Sonsoles,Rosario Hernandez Garcia,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,3/25/2022,3/25/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1745 EUR,1745.0,2022-03,1.100694,1920.7110300000002,1500-2000$ 
GB,2022-03-21,A0485258,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/25/2022,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-21,A0485352,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,3/23/2022,3/23/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,0 GBP,0.0,2022-03,1.316405,0.0,0 $
ES,2022-03-21,A0485274,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Esophageal squamous cell carcinoma,3/29/2022,3/29/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1745 EUR,1745.0,2022-03,1.100694,1920.7110300000002,1500-2000$ 
ES,2022-03-21,A0485238,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/26/2022,3/26/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2366 EUR,2366.0,2022-03,1.100694,2604.242004,2000-3000$ 
GB,2022-03-21,A0485285,Clinical,Southend University Hospital,Rafiqul Islam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Mesothelioma,3/26/2022,3/31/2022,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-21,A0485255,Clinical,Beatson West of Scotland Cancer Centre,Stephen McKay,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,3/28/2022,3/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-21,A0485281,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Non-small cell lung carcinoma (NSCLC),3/26/2022,3/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-21,A0485245,Clinical,The Royal Marsden NHS Foundation Trust,Jillian Noble,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,3/28/2022,3/28/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
ES,2022-03-21,A0485313,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/28/2022,3/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2500 USD,2500.0,2022-03,1.100694,2751.735,2000-3000$ 
GB,2022-03-22,A0485711,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/26/2022,3/31/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-22,A0485683,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),3/28/2022,3/28/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
IE,2022-03-23,A0486146,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/29/2022,8/2/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-03,1.100694,1370.3640300000002,0-1500$ 
GB,2022-03-23,A0486360,Clinical,Guys Hospital,Vasileios Angelis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/29/2022,3/29/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
ES,2022-03-24,A0486923,Clinical,Hospital Vithas Xanit Internacional,Pilar Cantizani Maillo,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Esophageal/Gastroesophageal junction Adenocarcinoma,4/6/2022,4/6/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,0 EUR,0.0,2022-03,1.100694,0.0,0 $
MX,2022-03-24,A0487255,Clinical,MileniaLabs,Luis Antonio Caned Trevino,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung squamous cell carcinoma,3/25/2022,4/7/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,South America,Paid,0 GBP,0.0,2022-03,1.100694,0.0,0 $
IE,2022-03-24,A0486869,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/30/2022,4/6/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 EUR,1245.0,2022-03,1.100694,1370.3640300000002,0-1500$ 
TR,2022-03-24,A0487162,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/29/2022,3/29/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-03,1.0,1890.0,1500-2000$ 
ES,2022-03-25,A0487485,Clinical,Hospital Nuestra Senora de Sonsoles,Jose Enrique Ales,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,3/30/2022,3/30/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1745 EUR,1745.0,2022-03,1.100694,1920.7110300000002,1500-2000$ 
BR,2022-03-25,A0487627,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/2/2022,8/18/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-03,1.0,1350.0,0-1500$ 
GB,2022-03-25,A0487542,Clinical,BMI - The Princess Margaret Hospital,Anthony Neal,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/3/2022,4/3/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-03,1.316405,3027.7315000000003,3000+ $
ES,2022-03-25,A0487415,Clinical,Hospital La Luz,Esther Holgado Martin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/30/2022,4/12/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 EUR,2490.0,2022-03,1.100694,2740.7280600000004,2000-3000$ 
GB,2022-03-25,A0487336,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/30/2022,3/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
CA,2022-03-25,A0487387,Clinical,Mount Sinai Hospital,Albert Kirshen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Glioblastoma,3/29/2022,3/29/2022,CANADA,Commercial,Brain,CANADA,1,AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Canada,Free,0 USD,0.0,2022-03,1.0,0.0,0 $
GB,2022-03-25,A0487351,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/30/2022,3/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-26,A0488128,Clinical,HCA Laboratories,Mark Nathan,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,3/31/2022,5/4/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2300 GBP,2300.0,2022-03,1.316405,3027.7315000000003,3000+ $
GB,2022-03-26,A0488301,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/5/2022,4/5/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
BR,2022-03-28,A0488591,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/2/2022,4/2/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-03,1.0,1350.0,0-1500$ 
TR,2022-03-28,A0488606,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Gastric adenocarcinoma,4/6/2022,4/6/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,0,0.0,2022-03,1.0,0.0,0 $
GB,2022-03-28,A0488596,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Christos Mikropoulos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,4/2/2022,4/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-28,A0488604,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/1/2022,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-28,A0488586,Clinical,Poole Hospital NHS Foundation Trust,Mike Bayne,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,4/2/2022,4/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-28,A0488546,Clinical,Queen Alexandra Hospital,Caroline Archer,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/2/2022,4/2/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP ,2490.0,2022-03,1.316405,3277.84845,3000+ $
ES,2022-03-28,A0488588,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/3/2022,4/3/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2241 EUR,2241.0,2022-03,1.100694,2466.6552540000002,2000-3000$ 
GB,2022-03-28,A0488582,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/2/2022,4/2/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
GB,2022-03-28,A0488537,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Shairoz Merchant,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,4/1/2022,4/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-28,A0488572,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/1/2022,4/1/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
GB,2022-03-29,A0488879,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,4/14/2022,4/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
GB,2022-03-29,A0488720,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/6/2022,4/6/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
GB,2022-03-29,A0488799,Clinical,HCA Laboratories,Martin Forster,Guardant 360,2.11,GHI_01,Distributors : ROW,Salivary gland carcinoma,4/12/2022,4/12/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
GB,2022-03-29,A0488796,Clinical,HCA Laboratories,Martin Forster,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/3/2022,4/3/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2178.75,2178.0,2022-03,1.316405,2867.13009,2000-3000$ 
GB,2022-03-30,A0489660,Clinical,Royal United Hospitals Bath,Tania Tillett,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/5/2022,5/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-30,A0489462,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/5/2022,4/5/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2490 GBP,2490.0,2022-03,1.316405,3277.84845,3000+ $
TR,2022-03-30,A0489745,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/5/2022,4/5/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1890,1890.0,2022-03,1.0,1890.0,1500-2000$ 
GB,2022-03-30,A0489538,Clinical,The Christie Hospital,Matthew Krebs,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,4/6/2022,4/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,0 GBP,0.0,2022-03,1.316405,0.0,0 $
BR,2022-03-31,A0490306,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/6/2022,4/6/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,South America,Paid,1350 USD,1350.0,2022-03,1.0,1350.0,0-1500$ 
DE,2022-03-31,A0490272,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal adenocarcinoma,4/6/2022,4/25/2022,GERMANY,Commercial,GI,GERMANY,1,non_AE,EUR,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,2990 EUR,2990.0,2022-03,1.100694,3291.07506,3000+ $
GB,2022-03-31,A0490222,Clinical,Poole Hospital NHS Foundation Trust,Mark Noble,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/5/2022,4/5/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-31,A0489988,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/5/2022,4/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
GB,2022-03-31,A0490245,Clinical,Sussex Cancer Centre,Katrine Steele,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,4/6/2022,4/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-31,A0490315,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/6/2022,4/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Free,0 GBP,0.0,2022-03,1.316405,0.0,0 $
GB,2022-03-31,A0489976,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,4/7/2022,4/7/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2022,1,1,2022-03-01,2022-03,G360 CDx,2022Q1,Europe,Paid,1245 GBP,1245.0,2022-03,1.316405,1638.924225,1500-2000$ 
ES,2022-04-01,A0490736,Clinical,Hospital Clinico San Carlos,Monica Antonanzas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung carcinoid,4/6/2022,4/12/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-04,1.080801,1345.597245,0-1500$ 
MX,2022-04-01,A0490908,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/6/2022,4/6/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,3316 USD,3316.0,2022-04,1.080801,3583.936116,3000+ $
GB,2022-04-01,A0490823,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,4/7/2022,4/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-04,1.293555,2975.1765,2000-3000$ 
BR,2022-04-01,A0490865,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/15/2022,4/15/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-04,1.0,1350.0,0-1500$ 
GB,2022-04-01,A0490441,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,4/6/2022,4/12/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
GB,2022-04-01,A0490671,Clinical,BMI Bishops Wood Hospital,Nicola Anyamene,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/6/2022,4/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2241 GBP,2241.0,2022-04,1.293555,2898.8567550000002,2000-3000$ 
GB,2022-04-02,A0491438,Clinical,HCA Laboratories,Jonathan Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/7/2022,4/7/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-04,1.293555,2817.36279,2000-3000$ 
GB,2022-04-02,A0491094,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/7/2022,4/7/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-04,1.293555,2817.36279,2000-3000$ 
GB,2022-04-04,A0491650,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/8/2022,4/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
ES,2022-04-04,A0491647,Clinical,Hospital University La Paz,Javier de Castro Carpeno,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/10/2022,4/10/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 EUR,0.0,2022-04,1.080801,0.0,0 $
GB,2022-04-04,A0491653,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Shobhit Baijal,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/10/2022,4/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
TR,2022-04-05,A0492075,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Head and neck carcinoma,4/12/2022,4/12/2022,TURKEY,Commercial,Head and neck carcinoma,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
GB,2022-04-05,A0492052,Clinical,Kent and Canterbury Hospital,Mathilda Cominos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/12/2022,4/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
ES,2022-04-06,A0492770,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,4/12/2022,7/29/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-04,1.080801,1345.597245,0-1500$ 
GB,2022-04-06,A0492776,Clinical,Worthing Hospital,Anna Britten,Guardant 360,2.11,GHI_01,Self-Pay Patient,Thymic carcinoma,4/13/2022,4/22/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
GB,2022-04-06,A0492731,Clinical,Nuffield Health Brighton Hospital,David Bloomfield,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/13/2022,4/13/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-04,1.293555,2975.1765,2000-3000$ 
GB,2022-04-06,A0492395,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Agnieszka Michael,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,4/13/2022,4/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
MX,2022-04-06,A0492851,Clinical,MileniaLabs,Luis Antonio Caned Trevino,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung squamous cell carcinoma,4/11/2022,4/11/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,2500 USD,2500.0,2022-04,1.080801,2702.0024999999996,2000-3000$ 
GB,2022-04-07,A0493555,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/13/2022,4/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-04,1.293555,3220.95195,3000+ $
GB,2022-04-07,A0493547,Clinical,The Nuffield Hospital Guildford,Sophie Otter,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,4/15/2022,4/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-04,1.293555,3220.95195,3000+ $
TR,2022-04-07,A0493133,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,4/13/2022,4/13/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
GB,2022-04-07,A0493548,Clinical,Queen Alexandra Hospital,Ann Oâ€™Callaghan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/13/2022,4/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-07,A0493549,Clinical,East Suffolk and North Essex NHS Foundation Trust,Sadaf Usman,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/13/2022,4/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
BR,2022-04-07,A0493265,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/20/2022,4/20/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-04,1.0,1350.0,0-1500$ 
GB,2022-04-07,A0493554,Clinical,The Rutherford Cancer Centre,Jason Lester,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,4/13/2022,4/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
BR,2022-04-07,A0493351,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/13/2022,4/13/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-04,1.0,1350.0,0-1500$ 
GB,2022-04-07,A0493312,Clinical,Guys Hospital,Elias Pintus,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/17/2022,4/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-07,A0493540,Clinical,Singleton Hospital,Steve Kihara,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/13/2022,4/13/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-07,A0493350,Clinical,Beatson West of Scotland Cancer Centre,Ishtiaq Zubairi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Large cell lung carcinoma,4/13/2022,4/13/2022,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
TR,2022-04-07,A0493553,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/12/2022,4/12/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
ES,2022-04-08,A0493813,Clinical,Fundacion Jimenez Diaz,Manuel Domine,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/12/2022,4/12/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 EUR,0.0,2022-04,1.080801,0.0,0 $
FI,2022-04-08,A0493713,Clinical,Turku University Hospital,Jaana Kaunisto,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/18/2022,4/18/2022,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2303 EUR,2303.0,2022-04,1.080801,2489.084703,2000-3000$ 
FI,2022-04-08,A0493628,Clinical,Turku University Hospital,Maria Silvoniemi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/13/2022,4/13/2022,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2303 EUR,2303.0,2022-04,1.080801,2489.084703,2000-3000$ 
GB,2022-04-09,A0494308,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,4/20/2022,4/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-04,1.293555,2817.36279,2000-3000$ 
BR,2022-04-09,A0494487,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/15/2022,4/15/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-04,1.0,1350.0,0-1500$ 
BR,2022-04-11,A0494792,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,4/12/2022,4/12/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-04,1.0,1350.0,0-1500$ 
ES,2022-04-11,A0494801,Clinical,Hospital Nuestra Senora de Sonsoles,Lauren Condori,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,4/17/2022,4/17/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1745 EUR,1745.0,2022-04,1.080801,1885.997745,1500-2000$ 
ES,2022-04-11,A0494810,Clinical,Hospital A Coruna,Maria Rosario Garcia Campelo,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,4/19/2022,4/19/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-04,1.080801,1345.597245,0-1500$ 
GB,2022-04-11,A0494804,Clinical,The Spire Hospital Hartswood,Sherif Raouf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/17/2022,5/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-04,1.293555,3220.95195,3000+ $
GB,2022-04-11,A0494773,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/15/2022,4/15/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-04,1.293555,2975.1765,2000-3000$ 
TR,2022-04-11,A0494765,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/15/2022,4/15/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
ES,2022-04-11,A0494800,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,4/17/2022,7/29/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-04,1.080801,1345.597245,0-1500$ 
GB,2022-04-11,A0494753,Clinical,Guys Hospital,Alexandros Georgiou,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/19/2022,4/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
TR,2022-04-11,A0494818,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,4/15/2022,4/15/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
GB,2022-04-11,A0494755,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/17/2022,4/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
GB,2022-04-11,A0494814,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/15/2022,4/15/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
TR,2022-04-13,A0496403,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/20/2022,4/20/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
ES,2022-04-13,A0496209,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/18/2022,4/28/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2940 EUR,2940.0,2022-04,1.080801,3177.5549399999995,3000+ $
TR,2022-04-13,A0496188,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,4/20/2022,4/20/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,0,0.0,2022-04,1.0,0.0,0 $
GB,2022-04-13,A0495405,Clinical,Kent and Canterbury Hospital,Mathilda Cominos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/20/2022,4/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-13,A0496256,Clinical,HCA Laboratories,John Conibear,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/19/2022,4/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-04,1.293555,2817.36279,2000-3000$ 
ES,2022-04-14,A0496661,Clinical,Fundacion Jimenez Diaz,Jaime Rubio Perez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/19/2022,4/21/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-04,1.080801,1345.597245,0-1500$ 
GB,2022-04-14,A0496811,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,4/19/2022,4/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
CA,2022-04-14,A0496759,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,4/22/2022,4/22/2022,CANADA,Commercial,Other,CANADA,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Canada,Free,0 EUR,0.0,2022-04,1.0,0.0,0 $
GB,2022-04-14,A0496819,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/19/2022,4/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
ES,2022-04-15,A0497522,Clinical,Clinica Corachan,Joaquin Bellmunt Molins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,4/21/2022,4/21/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2490 EUR,2490.0,2022-04,1.080801,2691.19449,2000-3000$ 
GB,2022-04-15,A0497802,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sharadah Essapen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/20/2022,4/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-04,1.293555,2975.1765,2000-3000$ 
GB,2022-04-15,A0497772,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/20/2022,4/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-04,1.293555,2975.1765,2000-3000$ 
BR,2022-04-15,A0497736,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/20/2022,4/20/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-04,1.0,1350.0,0-1500$ 
GB,2022-04-15,A0497612,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/20/2022,4/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-04,1.293555,2975.1765,2000-3000$ 
GB,2022-04-15,A0497574,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/25/2022,4/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
DE,2022-04-15,A0497356,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,4/20/2022,5/3/2022,GERMANY,Commercial,GI,GERMANY,1,non_AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2990 EUR,2990.0,2022-04,1.080801,3231.5949899999996,3000+ $
CA,2022-04-15,A0497345,Clinical,MacKenzie Richmond Hill Hospital,Suneil Khanna,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/19/2022,4/19/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Canada,Free,0 EUR,0.0,2022-04,1.0,0.0,0 $
ES,2022-04-18,A0499745,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,4/22/2022,11/25/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2500 USD,2500.0,2022-04,1.080801,2702.0024999999996,2000-3000$ 
GB,2022-04-18,A0499883,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/28/2022,6/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
GB,2022-04-18,A0499778,Clinical,HCA Laboratories,Anne Armstrong,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/22/2022,4/22/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-04,1.293555,2817.36279,2000-3000$ 
GB,2022-04-18,A0499792,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/22/2022,4/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-18,A0499762,Clinical,The Royal Preston Hospital NHS Foundation Trust,Lam Tai-Chung,Guardant 360,2.11,GHI_01,Self-Pay Patient,Thyroid carcinoma,4/22/2022,4/26/2022,UNITED KINGDOM,Commercial,Thyroid,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-18,A0499734,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sharadah Essapen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/24/2022,4/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-04,1.293555,3220.95195,3000+ $
GB,2022-04-18,A0499767,Clinical,HCA Laboratories,Debashis Sarker,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,4/22/2022,4/22/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-04,1.293555,2817.36279,2000-3000$ 
BR,2022-04-20,A0501711,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,4/24/2022,4/24/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-04,1.0,1350.0,0-1500$ 
GB,2022-04-21,A0502672,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,4/26/2022,4/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
GB,2022-04-21,A0502529,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Rachel Kerr,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/26/2022,4/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
TR,2022-04-21,A0502651,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,4/26/2022,4/26/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
ES,2022-04-22,A0503267,Clinical,Hospital Quiron Barcelona,Maria Ferrer Ciueira,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/3/2022,5/3/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2241 EUR,2241.0,2022-04,1.080801,2422.0750409999996,2000-3000$ 
TR,2022-04-22,A0503132,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/28/2022,4/28/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
GB,2022-04-22,A0503265,Clinical,St James University Hospital,Mark Teo,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Thymic carcinoma,4/27/2022,4/27/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,0 GBP,0.0,2022-04,1.293555,0.0,0 $
TR,2022-04-22,A0503141,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,4/28/2022,4/28/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
GB,2022-04-23,A0503775,Clinical,HCA Laboratories,Khurum Khan,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,4/29/2022,4/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-04,1.293555,2817.36279,2000-3000$ 
GB,2022-04-23,A0503754,Clinical,HCA Laboratories,Mark Harries,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,4/28/2022,4/28/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-04,1.293555,2817.36279,2000-3000$ 
GB,2022-04-23,A0503555,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/27/2022,7/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
GB,2022-04-23,A0503492,Clinical,Sussex Cancer Centre,Ed Chandy,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/29/2022,4/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-25,A0504032,Clinical,The Royal Wolverhampton NHS Trust,Sam Mannam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/30/2022,4/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
ES,2022-04-25,A0503985,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,4/30/2022,4/30/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2400 USD,2400.0,2022-04,1.080801,2593.9224,2000-3000$ 
GB,2022-04-25,A0503997,Clinical,Coventry University Hospitals,Clive Irwin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/6/2022,5/6/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
TR,2022-04-25,A0503927,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/30/2022,4/30/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
ES,2022-04-25,A0503983,Clinical,Hospital Clinico San Carlos,Arancha Manzano,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Sarcoma,4/30/2022,4/30/2022,SPAIN,Commercial,Soft Tissue/Bone,SPAIN,1,AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-04,1.080801,1345.597245,0-1500$ 
GB,2022-04-25,A0504030,Clinical,Musgrove Park Hospital,Sarah Foster,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,5/5/2022,5/5/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-25,A0504007,Clinical,Guys Hospital,Elinor Sawyer,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/9/2022,5/9/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-25,A0503971,Clinical,Singleton Hospital,Steve Kihara,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/30/2022,4/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
TR,2022-04-25,A0503951,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,4/30/2022,4/30/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
CA,2022-04-25,A0503958,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/30/2022,4/30/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Canada,Paid,1700 USD,1700.0,2022-04,1.0,1700.0,1500-2000$ 
GB,2022-04-25,A0503962,Clinical,St James University Hospital,Mark Teo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Thymic carcinoma,5/9/2022,5/9/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
BR,2022-04-25,A0503954,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/30/2022,4/30/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-04,1.0,1350.0,0-1500$ 
CA,2022-04-26,A0504248,Clinical,Markham Stouffville Hospital,Mateya Trinkaus,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/3/2022,5/3/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Canada,Free,0 EUR,0.0,2022-04,1.0,0.0,0 $
BR,2022-04-27,A0505191,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/3/2022,5/3/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-04,1.0,1350.0,0-1500$ 
TR,2022-04-27,A0504684,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/3/2022,5/4/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
GB,2022-04-27,A0504715,Clinical,Sussex Cancer Centre,Juliet Brock,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/4/2022,5/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-04,1.293555,2975.1765,2000-3000$ 
TR,2022-04-27,A0504813,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/3/2022,5/3/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
TR,2022-04-27,A0504866,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Head and neck carcinoma,5/4/2022,5/4/2022,TURKEY,Commercial,Head and neck carcinoma,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,0,0.0,2022-04,1.0,0.0,0 $
TR,2022-04-28,A0505446,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/3/2022,5/3/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
GB,2022-04-28,A0505442,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/10/2022,5/10/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-04,1.293555,2975.1765,2000-3000$ 
MX,2022-04-28,A0505697,Clinical,ABC Hospital,Erika Betzabe Ruiz Garcia,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,5/5/2022,5/5/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,3316 USD,3316.0,2022-04,1.080801,3583.936116,3000+ $
BR,2022-04-28,A0505726,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/4/2022,5/4/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-04,1.0,1350.0,0-1500$ 
GB,2022-04-28,A0505547,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/3/2022,5/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
BR,2022-04-28,A0505718,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,5/5/2022,5/5/2022,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-04,1.0,1350.0,0-1500$ 
TR,2022-04-28,A0505700,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/4/2022,5/4/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
GB,2022-04-28,A0505514,Clinical,The Royal Marsden NHS Foundation Trust,Geraldo Alves de Paula Neto,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,5/4/2022,5/5/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
GB,2022-04-29,A0506293,Clinical,Beatson West of Scotland Cancer Centre,Brian Clark,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,5/12/2022,5/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
DE,2022-04-29,A0506383,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,5/4/2022,5/9/2022,GERMANY,Commercial,Other,GERMANY,1,non_AE,EUR,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2990 EUR,2990.0,2022-04,1.080801,3231.5949899999996,3000+ $
TR,2022-04-29,A0505980,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Head and neck carcinoma,5/4/2022,5/4/2022,TURKEY,Commercial,Head and neck carcinoma,TURKEY,1,AE,USD,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-04,1.0,1890.0,1500-2000$ 
GB,2022-04-29,A0506474,Clinical,York Hospital,Angela Darby,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/4/2022,5/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-29,A0506182,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/5/2022,5/5/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-04,1.293555,2975.1765,2000-3000$ 
GB,2022-04-29,A0506175,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,5/4/2022,5/4/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-04,1.293555,2975.1765,2000-3000$ 
GB,2022-04-29,A0506422,Clinical,St James University Hospital,Katy Clarke,Guardant 360,2.11,GHI_01,Self-Pay Patient,Thymic carcinoma,5/4/2022,5/4/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-29,A0506512,Clinical,Charing Cross Hospital Medical Oncology Department,Rizvana Ahmad,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/4/2022,5/4/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-29,A0506454,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/4/2022,5/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
GB,2022-04-29,A0505983,Clinical,HCA Laboratories,Anne Rigg,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/5/2022,5/5/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-04,1.293555,2817.36279,2000-3000$ 
GB,2022-04-29,A0506330,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sharadah Essapen,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/4/2022,5/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-04,1.293555,3220.95195,3000+ $
GB,2022-04-30,A0507011,Clinical,Guys Hospital,Sharmistha Ghosh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/7/2022,5/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-04,1.293555,0.0,0 $
GB,2022-04-30,A0507056,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/7/2022,5/7/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-04,1.293555,3220.95195,3000+ $
GB,2022-04-30,A0506899,Clinical,Southampton General Hospital,Charlotte Rees,Guardant 360,2.11,GHI_01,Self-Pay Patient,Appendix adenocarcinoma,5/5/2022,5/23/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2022,2,1,2022-04-01,2022-04,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-04,1.293555,1610.475975,1500-2000$ 
GB,2022-05-02,A0507259,Clinical,Guys Hospital,Debra Josephs,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/6/2022,5/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-02,A0507253,Clinical,The Royal Preston Hospital NHS Foundation Trust,Ruth Board,Guardant 360,2.11,GHI_01,Self-Pay Patient,Melanoma,5/6/2022,5/6/2022,UNITED KINGDOM,Commercial,Skin,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-02,A0507265,Clinical,The Royal Preston Hospital NHS Foundation Trust,Catherine Mitchell,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),5/6/2022,5/6/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
TR,2022-05-02,A0507250,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/6/2022,5/6/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-05,1.0,1890.0,1500-2000$ 
ES,2022-05-02,A0507273,Clinical,Hospital Nuestra Senora de Sonsoles,Lauren Condori,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/6/2022,5/6/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1745 EUR,1745.0,2022-05,1.057227,1844.861115,1500-2000$ 
TR,2022-05-03,A0508171,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Bladder carcinoma,5/10/2022,5/10/2022,TURKEY,Commercial,Bladder,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-05,1.0,1890.0,1500-2000$ 
TR,2022-05-03,A0507547,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/8/2022,5/8/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-05,1.0,1890.0,1500-2000$ 
TR,2022-05-03,A0508163,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Gastric adenocarcinoma,5/13/2022,5/13/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 Infinity,2022Q2,Europe,Paid,3500,3500.0,2022-05,1.0,3500.0,3000+ $
TR,2022-05-03,A0508157,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,5/13/2022,5/13/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 Infinity,2022Q2,Europe,Paid,3500,3500.0,2022-05,1.0,3500.0,3000+ $
ES,2022-05-03,A0507902,Clinical,Hospital Nuestra Senora de Sonsoles,Lauren Condori,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,5/11/2022,5/11/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1745 EUR,1745.0,2022-05,1.057227,1844.861115,1500-2000$ 
GB,2022-05-04,A0508980,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/10/2022,5/10/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-05,1.244484,3098.76516,3000+ $
GB,2022-05-05,A0509478,Clinical,Guys Hospital,Mark Nathan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/11/2022,5/11/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-05,A0509397,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/10/2022,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
GB,2022-05-05,A0509522,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,5/10/2022,5/10/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-05,1.244484,2862.3131999999996,2000-3000$ 
GB,2022-05-05,A0509784,Clinical,Singleton Hospital,Craig Barrington,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/10/2022,5/10/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-05,A0509787,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/10/2022,5/10/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
GB,2022-05-06,A0510262,Clinical,Beatson West of Scotland Cancer Centre,Brian Clark,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/12/2022,5/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-05,1.244484,3098.76516,3000+ $
BR,2022-05-06,A0510672,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/19/2022,5/19/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-05,1.0,1350.0,0-1500$ 
GB,2022-05-06,A0510083,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/11/2022,5/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
BR,2022-05-06,A0510175,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/12/2022,5/12/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-05,1.0,1350.0,0-1500$ 
GB,2022-05-07,A0511084,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/12/2022,5/12/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
GB,2022-05-07,A0511261,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,5/12/2022,5/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
GB,2022-05-09,A0511559,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Qamar Ghafoor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),5/16/2022,5/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-09,A0511561,Clinical,Poole Hospital NHS Foundation Trust,Tom Geldart,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/14/2022,5/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-09,A0511585,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/13/2022,5/13/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-05,1.244484,2862.3131999999996,2000-3000$ 
CL,2022-05-09,A0511552,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/16/2022,5/16/2022,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,South America,Paid,1550 USD,1550.0,2022-05,1.0,1550.0,1500-2000$ 
TR,2022-05-09,A0511571,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/16/2022,5/16/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-05,1.0,1890.0,1500-2000$ 
GB,2022-05-09,A0511576,Clinical,HCA Laboratories,Neal Navani,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/14/2022,5/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
TR,2022-05-09,A0511593,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,5/17/2022,5/17/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-05,1.0,1890.0,1500-2000$ 
ES,2022-05-09,A0511589,Clinical,Hospital Nuestra Senora de Sonsoles,Rosario Hernandez Garcia,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/16/2022,5/16/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1745 EUR,1745.0,2022-05,1.057227,1844.861115,1500-2000$ 
TR,2022-05-09,A0511568,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/16/2022,5/16/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-05,1.0,1890.0,1500-2000$ 
BR,2022-05-09,A0511591,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/18/2022,5/18/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-05,1.0,1350.0,0-1500$ 
ES,2022-05-09,A0511555,Clinical,Hospital General Universitario Gregorio Maranon,Andres Munoz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/16/2022,5/16/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,EUR 1245,1245.0,2022-05,1.057227,1316.247615,0-1500$ 
GB,2022-05-10,A0511940,Clinical,Maidstone and Tunbridge Wells NHS Trust,Mark Hill,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/19/2022,6/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
GB,2022-05-10,A0512011,Clinical,Castle Hill Hospital,Iqtedar Muazzam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/18/2022,5/18/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
CA,2022-05-10,A0511805,Clinical,Sault Area Hospital,Mohammad Rassouli,Guardant 360,2.11,GHI_01,Self-Pay Patient,Hepatocellular carcinoma,5/17/2022,5/17/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Canada,Free,0 USD,0.0,2022-05,1.0,0.0,0 $
GB,2022-05-10,A0512033,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/14/2022,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
GB,2022-05-10,A0511719,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Jenny Sherriff,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,5/14/2022,5/14/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
CA,2022-05-10,A0511970,Clinical,Sault Area Hospital,Mohammad Rassouli,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,5/18/2022,5/18/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Canada,Free,0 USD,0.0,2022-05,1.0,0.0,0 $
GB,2022-05-11,A0512522,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Muthuveni Ezhil,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/18/2022,5/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-05,1.244484,3098.76516,3000+ $
GB,2022-05-12,A0513359,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/17/2022,5/17/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
GB,2022-05-12,A0513292,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,5/17/2022,5/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-05,1.244484,2862.3131999999996,2000-3000$ 
ES,2022-05-12,A0513289,Clinical,Hospital Universitario HM Sanchinarro,Pedro Pablo Lopez Casas,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,5/17/2022,12/30/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2500 USD,2500.0,2022-05,1.057227,2643.0674999999997,2000-3000$ 
GB,2022-05-12,A0512957,Clinical,HCA Laboratories,Khurum Khan,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,5/17/2022,5/17/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
CA,2022-05-13,A0513753,Clinical,London Health Sciences Centre,Paul Stewart,Guardant 360,2.11,GHI_01,Self-Pay Patient,Head and neck carcinoma,5/18/2022,5/18/2022,CANADA,Commercial,Head and neck carcinoma,CANADA,1,AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Canada,Free,0 USD,0.0,2022-05,1.0,0.0,0 $
GB,2022-05-13,A0513671,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,5/18/2022,5/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-05,1.244484,2862.3131999999996,2000-3000$ 
ES,2022-05-13,A0513623,Clinical,Hospital University La Paz,Javier de Castro Carpeno,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/18/2022,5/19/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2490 EUR,2490.0,2022-05,1.057227,2632.49523,2000-3000$ 
TR,2022-05-13,A0513656,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/19/2022,5/19/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-05,1.0,1890.0,1500-2000$ 
GB,2022-05-13,A0513588,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,5/25/2022,5/25/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
GB,2022-05-14,A0514454,Clinical,Queen Alexandra Hospital,Samuel Chan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/19/2022,5/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
TR,2022-05-16,A0514650,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/20/2022,5/20/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-05,1.0,1890.0,1500-2000$ 
GB,2022-05-16,A0514667,Clinical,Royal United Hospitals Bath,Ashley Cox,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/20/2022,5/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
TR,2022-05-16,A0514658,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/20/2022,5/20/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-05,1.0,1890.0,1500-2000$ 
GB,2022-05-16,A0514662,Clinical,Charing Cross Hospital Medical Oncology Department,Danielle Power,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/20/2022,5/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-05,1.244484,2862.3131999999996,2000-3000$ 
ES,2022-05-16,A0514669,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Esophageal/Gastroesophageal junction Adenocarcinoma,5/20/2022,5/20/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 EUR ,0.0,2022-05,1.057227,0.0,0 $
BR,2022-05-16,A0514680,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/25/2022,5/25/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-05,1.0,1350.0,0-1500$ 
GB,2022-05-17,A0515124,Clinical,HCA Laboratories,Amen Sibtain,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Renal Cell Carcinoma,5/21/2022,5/21/2022,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-05,1.244484,3098.76516,3000+ $
GB,2022-05-17,A0515248,Clinical,Spire Hospital Portsmouth,Freddie Bartlett,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,5/24/2022,5/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-05,1.244484,2862.3131999999996,2000-3000$ 
GB,2022-05-17,A0515378,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/21/2022,5/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-05,1.244484,2862.3131999999996,2000-3000$ 
GB,2022-05-17,A0515397,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,5/25/2022,5/25/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-05,1.244484,3098.76516,3000+ $
CA,2022-05-17,A0515180,Clinical,MacKenzie Richmond Hill Hospital,Francis Patafio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/21/2022,5/21/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Canada,Free,0 USD,0.0,2022-05,1.0,0.0,0 $
DE,2022-05-17,A0515129,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/30/2022,4/14/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 Infinity,2022Q2,Europe,Free,0 EUR,0.0,2022-05,1.057227,0.0,0 $
GB,2022-05-17,A0515453,Clinical,GenesisCare Milton Keynes,Gaural Patel,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/22/2022,5/22/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-05,1.244484,2862.3131999999996,2000-3000$ 
GB,2022-05-18,A0515899,Clinical,Maidstone and Tunbridge Wells NHS Trust,Mark Hill,Guardant360 CDx,2.12,GH2_12,Self-Pay Sponsored,Cholangiocarcinoma,6/2/2022,7/11/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 Infinity,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-05,1.244484,3098.76516,3000+ $
GB,2022-05-18,A0515588,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/24/2022,7/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
DE,2022-05-18,A0515625,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/22/2022,6/23/2022,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2990 EUR,2990.0,2022-05,1.057227,3161.10873,3000+ $
IE,2022-05-18,A0515656,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/22/2022,5/27/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-05,1.057227,1316.247615,0-1500$ 
GB,2022-05-18,A0515576,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/24/2022,5/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-05,1.244484,3098.76516,3000+ $
GB,2022-05-18,A0515717,Clinical,Musgrove Park Hospital,Petra Jankowska,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/22/2022,5/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-19,A0516988,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/24/2022,5/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
ES,2022-05-19,A0517208,Clinical,Hospital University La Paz,Javier de Castro Carpeno,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/24/2022,5/24/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 EUR ,0.0,2022-05,1.057227,0.0,0 $
GB,2022-05-20,A0517955,Clinical,Freeman Hospital,Timothy Simmons,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/25/2022,5/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
IE,2022-05-20,A0517907,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/25/2022,5/30/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-05,1.057227,1316.247615,0-1500$ 
GB,2022-05-20,A0517923,Clinical,HCA Laboratories,Mark Harries,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/25/2022,5/25/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
ES,2022-05-20,A0518004,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,5/27/2022,5/27/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-05,1.057227,1316.247615,0-1500$ 
GB,2022-05-20,A0517469,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,5/24/2022,5/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
GB,2022-05-20,A0517648,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,5/26/2022,5/26/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
GB,2022-05-20,A0517920,Clinical,Guys Hospital,Thomas Webb,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/26/2022,5/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-20,A0517957,Clinical,Belfast City Hospital Cancer Center,Sinead McCaffrey,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,5/29/2022,5/29/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-23,A0518629,Clinical,The Royal Marsden NHS Foundation Trust,Kazimierz Mochlinski,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,5/29/2022,5/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,?,0.0,2022-05,1.244484,0.0,0 $
CL,2022-05-23,A0518681,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/29/2022,6/2/2022,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,South America,Paid,1550 USD,1550.0,2022-05,1.0,1550.0,1500-2000$ 
GB,2022-05-23,A0518637,Clinical,Charing Cross Hospital Medical Oncology Department,Danielle Power,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/27/2022,5/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
BR,2022-05-23,A0518736,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/1/2022,6/1/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-05,1.0,1350.0,0-1500$ 
GB,2022-05-23,A0518611,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/2/2022,6/2/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
GB,2022-05-23,A0518642,Clinical,Southampton General Hospital,Sanjay Raj,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/28/2022,5/28/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-05,1.244484,3098.76516,3000+ $
ES,2022-05-23,A0518621,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Esophageal/Gastroesophageal junction Adenocarcinoma,5/31/2022,6/2/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1745 EUR,1745.0,2022-05,1.057227,1844.861115,1500-2000$ 
CL,2022-05-23,A0518673,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/29/2022,6/9/2022,CHILE,Commercial,,CHILE,1,non_AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,South America,Paid,1550 USD,1550.0,2022-05,1.0,1550.0,1500-2000$ 
GB,2022-05-24,A0519328,Clinical,The Royal Marsden NHS Foundation Trust,Daniela Kolarevic,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,5/31/2022,7/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
GB,2022-05-25,A0519723,Clinical,The Royal Marsden NHS Foundation Trust,David Watkins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,6/7/2022,6/7/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
ES,2022-05-25,A0520075,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,6/4/2022,10/27/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-05,1.057227,1316.247615,0-1500$ 
GB,2022-05-25,A0520030,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,6/1/2022,6/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
TR,2022-05-25,A0520017,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/1/2022,6/1/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-05,1.0,1890.0,1500-2000$ 
MX,2022-05-25,A0519860,Clinical,MileniaLabs,Luis Antonio Caned Trevino,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/2/2022,6/2/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,South America,Paid,2500 USD,2500.0,2022-05,1.057227,2643.0674999999997,2000-3000$ 
GB,2022-05-25,A0520170,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/1/2022,6/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
GB,2022-05-26,A0520788,Clinical,Eastbourne District General Hospital,Ed Chandy,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/2/2022,6/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
GB,2022-05-26,A0520651,Clinical,HCA Laboratories,Laura Kenny,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/2/2022,6/2/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
ES,2022-05-27,A0521742,Clinical,Hospital del Mar,Laura Visa,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Cholangiocarcinoma,6/2/2022,10/27/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-05,1.057227,1316.247615,0-1500$ 
ES,2022-05-27,A0521630,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,6/2/2022,6/2/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2400 USD,2400.0,2022-05,1.057227,2537.3448,2000-3000$ 
ES,2022-05-27,A0521719,Clinical,Hospital Nuestra Senora de Sonsoles,Jaime Ceballos Viro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Thyroid carcinoma,6/2/2022,6/2/2022,SPAIN,Commercial,Thyroid,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1745 EUR,1745.0,2022-05,1.057227,1844.861115,1500-2000$ 
GB,2022-05-27,A0521609,Clinical,Charing Cross Hospital Medical Oncology Department,Waleed Mohammed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/3/2022,6/3/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
ES,2022-05-27,A0521616,Clinical,Hospital Nuestra Senora de Sonsoles,Lauren Condori,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/2/2022,6/2/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1745 EUR,1745.0,2022-05,1.057227,1844.861115,1500-2000$ 
ES,2022-05-27,A0521625,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/2/2022,6/2/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-05,1.057227,1316.247615,0-1500$ 
GB,2022-05-27,A0521634,Clinical,Guys Hospital,Janine Mansi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/2/2022,6/2/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-27,A0521613,Clinical,Guys Hospital,Janine Mansi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/3/2022,6/3/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-27,A0521624,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/2/2022,6/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
GB,2022-05-31,A0522689,Clinical,The Royal Marsden NHS Foundation Trust,David Cunningham,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/6/2022,6/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
ES,2022-05-31,A0522751,Clinical,Hospital Puerta de Hierro,Ana Collazo Lorduy,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/9/2022,6/9/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-05,1.057227,1316.247615,0-1500$ 
ES,2022-05-31,A0522740,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/8/2022,6/8/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-05,1.057227,1316.247615,0-1500$ 
GB,2022-05-31,A0522729,Clinical,The Nuffield Hospital Guildford,Robert Laing,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,6/7/2022,6/8/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-05,1.244484,2862.3131999999996,2000-3000$ 
GB,2022-05-31,A0522715,Clinical,North West Cancer Treatment cantre Glan Clwyd Hospital,Duncan Wilkins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/6/2022,6/10/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
GB,2022-05-31,A0522776,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/6/2022,6/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-05,1.244484,1549.38258,1500-2000$ 
GB,2022-05-31,A0522730,Clinical,Beatson West of Scotland Cancer Centre,Tamsin Nash,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/5/2022,6/5/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-31,A0522702,Clinical,Beatson West of Scotland Cancer Centre,Tamsin Nash,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/4/2022,6/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-31,A0522712,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Esophageal squamous cell carcinoma,6/6/2022,6/6/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-05,1.244484,2710.486152,2000-3000$ 
BR,2022-05-31,A0522736,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/9/2022,6/9/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-05,1.0,1350.0,0-1500$ 
GB,2022-05-31,A0522856,Clinical,"Velindre University NHS Trust, Unit",Louise Hanna,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,6/7/2022,6/7/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-05-31,A0522763,Clinical,"Velindre University NHS Trust, Unit",Louise Hanna,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,6/6/2022,6/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2022,2,1,2022-05-01,2022-05,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-05,1.244484,0.0,0 $
GB,2022-06-01,A0523235,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,6/8/2022,6/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
GB,2022-06-01,A0523206,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Arshi Denton,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/7/2022,6/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
GB,2022-06-01,A0523190,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,6/7/2022,8/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
BR,2022-06-01,A0523225,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/7/2022,6/7/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-06,1.0,1350.0,0-1500$ 
BR,2022-06-01,A0523220,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/7/2022,6/7/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-06,1.0,1350.0,0-1500$ 
GB,2022-06-01,A0523232,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/7/2022,6/7/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
CA,2022-06-01,A0523202,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,6/7/2022,6/13/2022,CANADA,Commercial,Other,CANADA,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Canada,Paid,1700 USD,1700.0,2022-06,1.0,1700.0,1500-2000$ 
GB,2022-06-01,A0523201,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,6/8/2022,6/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
GB,2022-06-01,A0522990,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/6/2022,6/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-06,1.231882,2833.3286,2000-3000$ 
MX,2022-06-01,A0523349,Clinical,MileniaLabs,Guadalupe Evaristo Cedillo Salazar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,6/7/2022,6/7/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,2500 USD,2500.0,2022-06,1.056715,2641.7875000000004,2000-3000$ 
GB,2022-06-01,A0523219,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,6/10/2022,6/10/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
GB,2022-06-01,A0523134,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/7/2022,6/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
RO,2022-06-01,A0523205,Clinical,Amethyst Radiotherapy Clinic,Bogdan Mateies,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,6/6/2022,6/6/2022,ROMANIA,Commercial,,ROMANIA,1,non_AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 EUR,0.0,2022-06,1.056715,0.0,0 $
GB,2022-06-02,A0523918,Clinical,HCA Laboratories,Martin Forster,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,6/8/2022,6/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
TR,2022-06-03,A0526229,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,,GHI_19,Distributors : ROW,Carcinoma of unknown primary (CUP),6/10/2022,6/10/2022,TURKEY,Commercial,CUP,TURKEY,1,AE,USD,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-06,1.0,1890.0,1500-2000$ 
GB,2022-06-03,A0524286,Clinical,HCA Laboratories,Amen Sibtain,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/9/2022,6/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
TR,2022-06-03,A0526230,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,,GHI_19,Distributors : ROW,Thyroid carcinoma,6/10/2022,6/10/2022,TURKEY,Commercial,Thyroid,TURKEY,1,AE,USD,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-06,1.0,1890.0,1500-2000$ 
GB,2022-06-03,A0524302,Clinical,BMI Harbour Hospital,Amitabha Chakrabarti,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/8/2022,6/8/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
GB,2022-06-03,A0524310,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Daniel Rea,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/11/2022,6/11/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
GB,2022-06-03,A0524292,Clinical,Poole Hospital NHS Foundation Trust,Amelie Harle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/9/2022,6/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
ES,2022-06-04,A0524816,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/10/2022,6/14/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 EUR,2490.0,2022-06,1.056715,2631.22035,2000-3000$ 
BR,2022-06-06,A0525388,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/11/2022,6/11/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,1700 USD,1700.0,2022-06,1.0,1700.0,1500-2000$ 
ES,2022-06-06,A0525378,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/11/2022,7/19/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 EUR,2490.0,2022-06,1.056715,2631.22035,2000-3000$ 
BR,2022-06-06,A0526233,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/11/2022,6/11/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-06,1.0,1350.0,0-1500$ 
GB,2022-06-07,A0526422,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/13/2022,6/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
CA,2022-06-08,A0526830,Clinical,Integrated Health Clinic,Gurdev Parmar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/16/2022,6/30/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Canada,Free,0 USD,0.0,2022-06,1.0,0.0,0 $
IT,2022-06-08,A0526853,Clinical,IEO - Istituto Europeo di Oncologia,Giuseppe Curigliano,Guardant 360,2.11,GHI_19,Self-Pay Patient,Breast Carcinoma,6/14/2022,6/14/2022,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 EUR,2490.0,2022-06,1.056715,2631.22035,2000-3000$ 
ES,2022-06-08,A0526848,Clinical,Fundacion Jimenez Diaz,Jaime Rubio Perez,Guardant 360,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/1/2022,9/27/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 EUR,0.0,2022-06,1.056715,0.0,0 $
GB,2022-06-08,A0526846,Clinical,Maidstone and Tunbridge Wells NHS Trust,Ravish Mankragod,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/14/2022,6/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
GB,2022-06-08,A0526843,Clinical,HCA Laboratories,Alison Jones,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,6/16/2022,6/16/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
ES,2022-06-09,A0537263,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,7/1/2022,10/27/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
GB,2022-06-09,A0527614,Clinical,Coventry University Hospitals,Peter Correa,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/15/2022,6/15/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
GB,2022-06-09,A0527638,Clinical,Southampton General Hospital,Charlotte Rees,Guardant 360,2.11,GHI_01,Self-Pay Patient,Appendix adenocarcinoma,6/16/2022,6/16/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
TR,2022-06-09,A0527344,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/14/2022,6/14/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-06,1.0,1890.0,1500-2000$ 
IE,2022-06-09,A0527603,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/16/2022,6/16/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
ES,2022-06-09,A0527280,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/15/2022,6/15/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
GB,2022-06-10,A0528428,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/19/2022,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
GB,2022-06-10,A0528421,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/16/2022,8/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
RO,2022-06-10,A0528429,Clinical,Amethyst Radiotherapy Clinic,Bogdan Mateies,Guardant 360,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/21/2022,6/21/2022,ROMANIA,Commercial,,ROMANIA,1,non_AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 EUR,2490.0,2022-06,1.056715,2631.22035,2000-3000$ 
GB,2022-06-11,A0528633,Clinical,Singleton Hospital,Suprotim Basu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,6/16/2022,6/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
ES,2022-06-13,A0529683,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,2.11,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,6/21/2022,6/21/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2500 USD,2500.0,2022-06,1.056715,2641.7875000000004,2000-3000$ 
GB,2022-06-13,A0529216,Clinical,Castle Hill Hospital,Iqtedar Muazzam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/18/2022,6/18/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
GB,2022-06-13,A0529248,Clinical,Guys Hospital,Thomas Webb,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/18/2022,6/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
TR,2022-06-13,A0529212,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,,GHI_19,Distributors : ROW,Lung squamous cell carcinoma,6/17/2022,6/17/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-06,1.0,1890.0,1500-2000$ 
BR,2022-06-13,A0529200,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,6/20/2022,6/20/2022,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-06,1.0,1350.0,0-1500$ 
BR,2022-06-13,A0529222,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/17/2022,6/17/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,1700 USD,1700.0,2022-06,1.0,1700.0,1500-2000$ 
GB,2022-06-13,A0529204,Clinical,The Nuffield Hospital Guildford,Alexandra Stewart,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),6/19/2022,6/21/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
IE,2022-06-13,A0529247,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,6/30/2022,6/30/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
GB,2022-06-13,A0529221,Clinical,Eastbourne District General Hospital,Mary OBrien,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,6/17/2022,6/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
IE,2022-06-13,A0529223,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/17/2022,6/17/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
CA,2022-06-13,A0529197,Clinical,Integrated Health Clinic,Gurdev Parmar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Anal squamous cell carcinoma,6/19/2022,6/30/2022,CANADA,Commercial,CRC,CANADA,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Canada,Free,0 USD,0.0,2022-06,1.0,0.0,0 $
MX,2022-06-14,A0529575,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Melanoma,6/21/2022,6/21/2022,MEXICO,Commercial,Skin,MEXICO,1,non_AE,EUR,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,3316 USD,3316.0,2022-06,1.056715,3504.06694,3000+ $
GB,2022-06-14,A0529658,Clinical,Genesis Care,Mark Hill,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/29/2022,6/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-06,1.231882,2833.3286,2000-3000$ 
GB,2022-06-14,A0529691,Clinical,The Royal Marsden Hospital,Anna Minchom,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),6/22/2022,6/29/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,0 GBP,0.0,2022-06,1.231882,0.0,0 $
GB,2022-06-14,A0529604,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/25/2022,6/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
MX,2022-06-15,A0530345,Clinical,ABC Hospital,Arturo Gomez Gonzalez,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/23/2022,6/23/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,3316 USD,3316.0,2022-06,1.056715,3504.06694,3000+ $
GB,2022-06-15,A0529970,Clinical,The Royal Marsden Hospital,Anna Minchom,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/24/2022,6/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
ES,2022-06-15,A0530473,Clinical,Hospital A Coruna,Maria Rosario Garcia Campelo,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/23/2022,6/23/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
MX,2022-06-15,A0530344,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/21/2022,6/21/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,3316 USD,3316.0,2022-06,1.056715,3504.06694,3000+ $
GB,2022-06-16,A0531209,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,6/22/2022,6/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
GB,2022-06-16,A0530946,Clinical,Guys Hospital,Harris Gousis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),6/25/2022,6/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
IE,2022-06-16,A0531188,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,2.11,GHI_19,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),6/22/2022,6/22/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
GB,2022-06-16,A0530983,Clinical,The Royal Marsden NHS Foundation Trust,Sughra Yasmin,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,6/22/2022,6/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
TR,2022-06-16,A0533910,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kerim Kaban,Guardant 360,,GHI_19,Distributors : ROW,Ovarian carcinoma,6/27/2022,6/27/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-06,1.0,1890.0,1500-2000$ 
TR,2022-06-16,A0535369,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kerim Kaban,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/28/2022,6/28/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-06,1.0,1890.0,1500-2000$ 
ES,2022-06-16,A0531250,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,6/27/2022,6/27/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2500 USD,2500.0,2022-06,1.056715,2641.7875000000004,2000-3000$ 
ES,2022-06-16,A0531240,Clinical,Institute of Breast Cancer,Javier Cortes,UNKNOWN,2.11,GHI_19,Distributors : ROW,Breast Carcinoma,6/26/2022,6/26/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 EUR,0.0,2022-06,1.056715,0.0,0 $
GB,2022-06-16,A0531220,Clinical,The Royal Marsden NHS Foundation Trust,Ian Chau,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,6/23/2022,6/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
GB,2022-06-16,A0530935,Clinical,Castle Hill Hospital,Iqtedar Muazzam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,6/22/2022,6/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
IT,2022-06-17,A0533279,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/28/2022,6/28/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2000 EUR,2000.0,2022-06,1.056715,2113.4300000000003,2000-3000$ 
CA,2022-06-17,A0531716,Clinical,Markham Stouffville Hospital,Leena Hajra,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/23/2022,6/29/2022,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Canada,Free,0 USD,0.0,2022-06,1.0,0.0,0 $
GB,2022-06-17,A0531671,Clinical,HCA Laboratories,Jeremy Peter Steele,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/27/2022,6/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
GB,2022-06-17,A0531768,Clinical,Castle Hill Hospital,Iqtedar Muazzam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,6/23/2022,6/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
BR,2022-06-17,A0531770,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/23/2022,6/23/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,1350 USD,1350.0,2022-06,1.0,1350.0,0-1500$ 
GB,2022-06-17,A0531408,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,6/27/2022,6/27/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
GB,2022-06-17,A0531527,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,6/23/2022,6/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
GB,2022-06-20,A0533425,Clinical,HCA Laboratories,Martin Forster,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/25/2022,6/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
ES,2022-06-20,A0538207,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/4/2022,7/4/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
ES,2022-06-20,A0538177,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,,GHI_19,Self-Pay Patient,Other,7/4/2022,7/4/2022,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 EUR,2490.0,2022-06,1.056715,2631.22035,2000-3000$ 
ES,2022-06-20,A0538408,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,,GHI_19,Self-Pay Sponsored,Esophageal/Gastroesophageal junction Adenocarcinoma,7/7/2022,8/3/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1745 EUR,1745.0,2022-06,1.056715,1843.967675,1500-2000$ 
DE,2022-06-20,A0533398,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,6/29/2022,6/29/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 Infinity,2022Q2,Europe,Paid,2990 EUR,2990.0,2022-06,1.056715,3159.57785,3000+ $
GB,2022-06-20,A0533424,Clinical,Castle Hill Hospital,P Kneeshaw,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/27/2022,8/10/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
DE,2022-06-20,A0533394,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/29/2022,6/29/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 Infinity,2022Q2,Europe,Paid,2990 EUR,2990.0,2022-06,1.056715,3159.57785,3000+ $
GB,2022-06-20,A0533399,Clinical,Eastbourne District General Hospital,Victoria Donovan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/25/2022,6/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
IE,2022-06-20,A0538360,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/6/2022,7/6/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
GB,2022-06-21,A0533746,Clinical,The Royal Marsden NHS Foundation Trust,David Cunningham,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/28/2022,7/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
GB,2022-06-21,A0533661,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,6/28/2022,6/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
IT,2022-06-21,A0533859,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/28/2022,6/28/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2000 EUR,2000.0,2022-06,1.056715,2113.4300000000003,2000-3000$ 
GB,2022-06-22,A0534377,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/29/2022,6/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
GB,2022-06-22,A0534264,Clinical,The Holly Private Hospital,Sherif Raouf,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/30/2022,7/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
ES,2022-06-23,A0534794,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,6/28/2022,10/27/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
GB,2022-06-23,A0534748,Clinical,Castle Hill Hospital,Amandeep Dhadda,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/29/2022,7/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
GB,2022-06-23,A0535437,Clinical,Castle Hill Hospital,Amandeep Dhadda,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/4/2022,7/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
GB,2022-06-23,A0535138,Clinical,Genesis Care,Russell Burcombe,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/4/2022,9/9/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
ES,2022-06-23,A0534778,Clinical,HC Marbella International Hospital,Jose Manuel Trigo,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/28/2022,7/19/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490,2490.0,2022-06,1.056715,2631.22035,2000-3000$ 
ES,2022-06-23,A0534851,Clinical,HC Marbella International Hospital,Jose Manuel Trigo,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/28/2022,7/19/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490,2490.0,2022-06,1.056715,2631.22035,2000-3000$ 
ES,2022-06-24,A0536102,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung squamous cell carcinoma,6/30/2022,6/30/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
ES,2022-06-24,A0536055,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,,GHI_19,Self-Pay Sponsored,Other,6/30/2022,6/30/2022,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1745 EUR,1745.0,2022-06,1.056715,1843.967675,1500-2000$ 
GB,2022-06-24,A0536478,Clinical,The Royal Marsden NHS Foundation Trust,David Cunningham,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,7/4/2022,7/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
BR,2022-06-24,A0536395,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/29/2022,6/29/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,South America,Paid,1700 USD,1700.0,2022-06,1.0,1700.0,1500-2000$ 
ES,2022-06-24,A0536383,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/1/2022,7/1/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 EUR,2490.0,2022-06,1.056715,2631.22035,2000-3000$ 
IT,2022-06-24,A0536576,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/6/2022,7/6/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2000 EUR,2000.0,2022-06,1.056715,2113.4300000000003,2000-3000$ 
GB,2022-06-24,A0536564,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,7/11/2022,7/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
IT,2022-06-24,A0536107,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/4/2022,7/4/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2000 EUR,2000.0,2022-06,1.056715,2113.4300000000003,2000-3000$ 
GB,2022-06-24,A0535842,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/2/2022,7/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
GB,2022-06-25,A0537127,Clinical,The Royal Marsden NHS Foundation Trust,David Watkins,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,6/30/2022,6/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
GB,2022-06-25,A0536937,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sebastian Cummins,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/30/2022,6/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
ES,2022-06-27,A0537208,Clinical,Hospital La Luz,Esther Holgado Martin,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/7/2022,7/7/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 EUR,2490.0,2022-06,1.056715,2631.22035,2000-3000$ 
GB,2022-06-27,A0537252,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Appendix adenocarcinoma,7/4/2022,7/5/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
GB,2022-06-27,A0537199,Clinical,Clatterbridge cancer Center,Carles Escriu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/6/2022,7/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
ES,2022-06-27,A0537207,Clinical,Hospital Nuestra Senora de Sonsoles,Elena Filipovich Vegas,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,7/6/2022,7/6/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1745 EUR,1745.0,2022-06,1.056715,1843.967675,1500-2000$ 
ES,2022-06-27,A0537214,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/4/2022,7/4/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 EUR ,1245.0,2022-06,1.056715,1315.610175,0-1500$ 
CA,2022-06-28,A0537751,Clinical,BC Cancer centre - Vancouver,Sharlene Gill,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,7/11/2022,7/19/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,6,2022,2,1,2022-06-01,2022-06,Reveal,2022Q2,Canada,Free,0 USD,0.0,2022-06,1.0,0.0,0 $
GB,2022-06-28,A0537529,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,7/6/2022,7/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
ES,2022-06-29,A0538398,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,7/6/2022,12/30/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2500 USD,2500.0,2022-06,1.056715,2641.7875000000004,2000-3000$ 
GB,2022-06-29,A0538355,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,7/8/2022,7/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
GB,2022-06-29,A0538341,Clinical,Kent Oncology Centre,Timothy Sevitt,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenosquamous carcinoma,7/5/2022,7/8/2022,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
GB,2022-06-29,A0538406,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,7/5/2022,7/6/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
GB,2022-06-29,A0538404,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,7/26/2022,7/26/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1245 GBP,1245.0,2022-06,1.231882,1533.69309,1500-2000$ 
GB,2022-06-29,A0538450,Clinical,Guys Hospital,Sheeba Irshad,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/6/2022,7/6/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
GB,2022-06-29,A0538049,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/6/2022,7/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2178.75,2178.0,2022-06,1.231882,2683.0389959999998,2000-3000$ 
GB,2022-06-30,A0538866,Clinical,Queen Alexandra Hospital,Christopher Coyle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal/Gastroesophageal junction Adenocarcinoma,7/6/2022,7/6/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
GB,2022-06-30,A0538880,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,7/9/2022,7/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
ES,2022-06-30,A0538912,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,7/8/2022,1/2/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2500 USD,2500.0,2022-06,1.056715,2641.7875000000004,2000-3000$ 
GB,2022-06-30,A0538737,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/6/2022,7/6/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2300 GBP,2300.0,2022-06,1.231882,2833.3286,2000-3000$ 
GB,2022-06-30,A0538673,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/6/2022,7/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
TR,2022-06-30,A0538817,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,7/6/2022,7/6/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-06,1.0,1890.0,1500-2000$ 
DE,2022-06-30,A0538585,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.11,GHI_19,Self-Pay Patient,Breast Carcinoma,7/6/2022,5/22/2023,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2990 EUR,2990.0,2022-06,1.056715,3159.57785,3000+ $
ES,2022-06-30,A0538919,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,7/7/2022,7/22/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2500 USD,2500.0,2022-06,1.056715,2641.7875000000004,2000-3000$ 
GB,2022-06-30,A0538701,Clinical,Musgrove Park Hospital,Liz Toy,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/7/2022,7/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Free,0 GBP,0.0,2022-06,1.231882,0.0,0 $
TR,2022-06-30,A0538878,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,7/6/2022,7/6/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,1890,1890.0,2022-06,1.0,1890.0,1500-2000$ 
GB,2022-06-30,A0538709,Clinical,The Royal Marsden NHS Foundation Trust,Alicia Okines,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,7/6/2022,7/6/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 GBP,2490.0,2022-06,1.231882,3067.38618,3000+ $
ES,2022-06-30,A0538822,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,7/6/2022,7/6/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2241 EUR,2241.0,2022-06,1.056715,2368.098315,2000-3000$ 
ES,2022-06-30,A0538885,Clinical,Hospital Vithas Xanit Internacional,Pilar Cantizani Maillo,Guardant 360,2.11,GHI_19,Self-Pay Patient,Melanoma,7/6/2022,10/31/2022,SPAIN,Commercial,Skin,SPAIN,1,AE,EUR,Europe,6,2022,2,1,2022-06-01,2022-06,G360 CDx,2022Q2,Europe,Paid,2490 EUR,2490.0,2022-06,1.056715,2631.22035,2000-3000$ 
GB,2022-07-01,A0539698,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Large cell lung carcinoma,7/6/2022,9/27/2022,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
GB,2022-07-01,A0539607,Clinical,Sussex Cancer Centre,Kam Zaki,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/9/2022,7/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-01,A0539302,Clinical,University Hospitals Of Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,7/9/2022,7/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
GB,2022-07-01,A0539656,Clinical,HCA Laboratories,Susan Cleator,Guardant 360,2.11,GHI_01,Distributors : ROW,Anal squamous cell carcinoma,7/13/2022,7/13/2022,UNITED KINGDOM,Commercial,CRC,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
TR,2022-07-01,A0539452,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Glioma,7/15/2022,7/15/2022,TURKEY,Commercial,Brain,TURKEY,1,AE,USD,Europe,7,2022,3,1,2022-07-01,2022-07,G360 Infinity,2022Q3,Europe,Paid,1890,1890.0,2022-07,1.0,1890.0,1500-2000$ 
GB,2022-07-01,A0539707,Clinical,Medway Maritime Hospital,Afroditi Karathanasi,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/6/2022,7/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
CA,2022-07-01,A0539280,Clinical,London Health Sciences Centre,Mark Vincent,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),7/7/2022,7/7/2022,CANADA,Commercial,CUP,CANADA,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Canada,Paid,1700 USD,1700.0,2022-07,1.0,1700.0,1500-2000$ 
BR,2022-07-01,A0539714,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,7/8/2022,7/8/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-07,1.0,1750.0,1500-2000$ 
ES,2022-07-02,A0540677,Clinical,Complejo Hospitalario Ruber Juan Bravo,Araceli Priego Priego,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Lung squamous cell carcinoma,7/12/2022,7/12/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2241 EUR,2241.0,2022-07,1.019149,2283.912909,2000-3000$ 
ES,2022-07-02,A0540674,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Breast Carcinoma,7/11/2022,7/11/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2366 EUR,2366.0,2022-07,1.019149,2411.3065340000003,2000-3000$ 
GB,2022-07-02,A0540958,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Racha Kussaibati,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/12/2022,7/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-02,A0540680,Clinical,The Royal Marsden NHS Foundation Trust,Merina Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,7/13/2022,7/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
GB,2022-07-05,A0541158,Clinical,Poole Hospital NHS Foundation Trust,Mike Bayne,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/14/2022,7/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-07,1.200109,2760.2507,2000-3000$ 
ES,2022-07-05,A0541151,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),7/15/2022,7/15/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 EUR ,1245.0,2022-07,1.019149,1268.8405050000001,0-1500$ 
GB,2022-07-05,A0541129,Clinical,Guys Hospital,Alhasan AlAbdullah,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/14/2022,7/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
DE,2022-07-05,A0541154,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant360 CDx EU,,GHI_19,Do Not Bill - Cancelled,Breast Carcinoma,7/22/2022,7/22/2022,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-07,1.019149,0.0,0 $
GB,2022-07-05,A0541161,Clinical,Castle Hill Hospital,Amandeep Dhadda,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/15/2022,7/15/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-05,A0541127,Clinical,Guys Hospital,Alhasan AlAbdullah,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,7/12/2022,7/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-05,A0541181,Clinical,"Queenâ€™s Hospital, Barking, Havering, and Redbridge Univ Hosp NHS Trust",Eliot Sims,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/13/2022,8/1/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
GB,2022-07-05,A0541342,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/13/2022,7/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
TR,2022-07-05,A0541185,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,7/14/2022,7/14/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-07,1.0,1890.0,1500-2000$ 
GB,2022-07-06,A0541871,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,7/13/2022,7/13/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
GB,2022-07-06,A0541436,Clinical,Guys Hospital,Doaa Mohamed,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/13/2022,7/15/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-06,A0541713,Clinical,The Royal Marsden NHS Foundation Trust,Alicia Okines,Guardant360 CDx EU,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,7/19/2022,7/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
GB,2022-07-06,A0541629,Clinical,The Royal Marsden Hospital,Irene Chong,Guardant 360,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),7/13/2022,7/13/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
GB,2022-07-06,A0541493,Clinical,Nottingham City Hospital Campus,Jason Adhikaree,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/20/2022,7/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-06,A0541652,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/16/2022,7/16/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
GB,2022-07-06,A0541685,Clinical,The Royal Marsden Hospital,Michael Davidson,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,7/22/2022,7/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
TR,2022-07-06,A0541779,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/14/2022,7/14/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-07,1.0,1890.0,1500-2000$ 
GB,2022-07-06,A0541693,Clinical,HCA Laboratories,Mark Harries,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Breast Carcinoma,7/14/2022,7/14/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
GB,2022-07-06,A0541438,Clinical,Addenbrooke's Hospital,Elizabeth Smyth,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Esophageal adenocarcinoma,7/13/2022,7/13/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
GB,2022-07-06,A0541835,Clinical,Guys Hospital,Sheeba Irshad,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/27/2022,7/27/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-06,A0541758,Clinical,Royal United Hospitals Bath,Rebecca Bowen,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/1/2022,8/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-06,A0541815,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,7/13/2022,7/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-06,A0541743,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx EU,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,7/11/2022,7/11/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
ES,2022-07-07,A0542108,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,,GHI_19,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),7/13/2022,7/15/2022,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-07,1.019149,1268.8405050000001,0-1500$ 
GB,2022-07-07,A0542421,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,7/17/2022,7/17/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
GB,2022-07-07,A0542469,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant360 CDx EU,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,7/15/2022,8/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
GB,2022-07-07,A0542467,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,7/15/2022,7/15/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
IT,2022-07-07,A0542232,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Large cell lung carcinoma,7/12/2022,7/12/2022,ITALY,Commercial,Lung,ITALY,1,non_AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2000 EUR,2000.0,2022-07,1.019149,2038.2980000000002,2000-3000$ 
GB,2022-07-07,A0541968,Clinical,Musgrove Park Hospital,Julie Walther,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/14/2022,7/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
CA,2022-07-07,A0542225,Clinical,Princess Margaret Hospital,Miguel Garcia,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/17/2022,8/1/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Canada,Free,0 GBP,0.0,2022-07,1.0,0.0,0 $
IE,2022-07-07,A0542470,Clinical,Bon Secours Hospital,Brian Bird,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/15/2022,7/15/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-07,1.019149,1268.8405050000001,0-1500$ 
MX,2022-07-07,A0542302,Clinical,MileniaLabs,Ivan Romarico Gonzalez Espinoza,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Head and neck carcinoma,7/15/2022,7/15/2022,MEXICO,Commercial,Head and neck carcinoma,MEXICO,1,non_AE,EUR,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,South America,Paid,2500 USD,2500.0,2022-07,1.019149,2547.8725000000004,2000-3000$ 
TR,2022-07-07,A0542483,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx EU,,GHI_19,Do Not Bill - Cancelled,Melanoma,7/22/2022,7/22/2022,TURKEY,Commercial,Skin,TURKEY,1,AE,USD,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,0 USD,0.0,2022-07,1.0,0.0,0 $
GB,2022-07-08,A0543094,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/25/2022,7/25/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
BR,2022-07-08,A0543178,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/19/2022,7/19/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,South America,Paid,1700 USD,1700.0,2022-07,1.0,1700.0,1500-2000$ 
GB,2022-07-08,A0543251,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/20/2022,7/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
ES,2022-07-08,A0542756,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/1/2022,8/1/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 EUR,2490.0,2022-07,1.019149,2537.6810100000002,2000-3000$ 
GB,2022-07-11,A0544002,Clinical,Belfast City Hospital Cancer Center,Joanne Millar,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Ovarian carcinoma,7/20/2022,7/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
ES,2022-07-11,A0544459,Clinical,Hospital Nuestra Senora de Sonsoles,Lauren Condori,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/21/2022,7/21/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1745 EUR,1745.0,2022-07,1.019149,1778.415005,1500-2000$ 
BR,2022-07-11,A0543987,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/20/2022,7/20/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-07,1.0,1750.0,1500-2000$ 
GB,2022-07-11,A0543968,Clinical,The Nuffield Hospital Guildford,Sebastian Cummins,Guardant 360,2.11,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/21/2022,9/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
BR,2022-07-11,A0543993,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/20/2022,7/20/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-07,1.0,1750.0,1500-2000$ 
GB,2022-07-11,A0543979,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/20/2022,7/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-12,A0544621,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/21/2022,7/21/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2241 GBP,2241.0,2022-07,1.200109,2689.444269,2000-3000$ 
IT,2022-07-12,A0544629,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/21/2022,7/21/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2000 EUR,2000.0,2022-07,1.019149,2038.2980000000002,2000-3000$ 
GB,2022-07-13,A0544984,Clinical,The Holly Private Hospital,Sherif Raouf,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Other,7/27/2022,7/27/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
ES,2022-07-13,A0545058,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,7/21/2022,7/21/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2500 USD,2500.0,2022-07,1.019149,2547.8725000000004,2000-3000$ 
GB,2022-07-13,A0545086,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,7/21/2022,7/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
CA,2022-07-14,A0545924,Clinical,Integrated Health Clinic,Alanna Rinas,Guardant 360,2.11,GHI_01,Distributors : ROW,Glioblastoma,7/21/2022,7/21/2022,CANADA,Commercial,Brain,CANADA,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Canada,Free,0 GBP,0.0,2022-07,1.0,0.0,0 $
ES,2022-07-15,A0546239,Clinical,Hospital Universitario Insular de Gran Canaria,Alfonso Gomez de Liano,Guardant 360,2.11,GHI_19,Distributors : ROW,Prostate adenocarcinoma,7/25/2022,7/25/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-07,1.019149,1268.8405050000001,0-1500$ 
GB,2022-07-15,A0546490,Clinical,The Royal Marsden Hospital,Anna Minchom,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/25/2022,8/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
CA,2022-07-15,A0546388,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Endometrial carcinoma,7/25/2022,8/3/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Canada,Paid,1700 USD,1700.0,2022-07,1.0,1700.0,1500-2000$ 
GB,2022-07-15,A0546155,Clinical,Musgrove Park Hospital,Joanne Botten,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/23/2022,7/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-15,A0546559,Clinical,Singleton Hospital,Sing-Yu Moorcraft,Guardant 360,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),8/2/2022,8/2/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
GB,2022-07-15,A0546118,Clinical,Mount Vernon Hospital Cancer Centre The Hillingdon Hospitals NHS Foundation Trust,Georgios Antoniou,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/24/2022,7/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-07,1.200109,2760.2507,2000-3000$ 
GB,2022-07-15,A0546568,Clinical,Guys Hospital,Doaa Mohamed,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/28/2022,7/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
ES,2022-07-15,A0546486,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,7/25/2022,12/30/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2500 USD,2500.0,2022-07,1.019149,2547.8725000000004,2000-3000$ 
IT,2022-07-15,A0546349,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/25/2022,7/25/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2000 EUR,2000.0,2022-07,1.019149,2038.2980000000002,2000-3000$ 
CA,2022-07-16,A0547131,Clinical,Arbutus Family Medicine,Claire Block,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,7/27/2022,8/9/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Canada,Paid,1700 USD,1700.0,2022-07,1.0,1700.0,1500-2000$ 
CA,2022-07-16,A0551515,Clinical,London Health Sciences Centre,Mark Vincent,Guardant 360,2.12,GH2_12,Self-Pay Patient,Carcinoma of unknown primary (CUP),8/2/2022,8/2/2022,CANADA,Commercial,CUP,CANADA,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 Infinity,2022Q3,Canada,Free,0 GBP,0.0,2022-07,1.0,0.0,0 $
ES,2022-07-18,A0547294,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Breast Carcinoma,7/25/2022,7/25/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2366 EUR,2366.0,2022-07,1.019149,2411.3065340000003,2000-3000$ 
ES,2022-07-18,A0553066,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Gastric adenocarcinoma,8/2/2022,8/2/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-07,1.019149,1268.8405050000001,0-1500$ 
MX,2022-07-18,A0547280,Clinical,MileniaLabs,Jorge Urias,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Other,7/27/2022,7/28/2022,MEXICO,Commercial,Other,MEXICO,1,non_AE,EUR,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,South America,Paid,2500 USD,2500.0,2022-07,1.019149,2547.8725000000004,2000-3000$ 
GB,2022-07-18,A0547264,Clinical,HCA Laboratories,Daniel Krell,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,7/26/2022,7/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
GB,2022-07-18,A0547265,Clinical,HCA Laboratories,Jeremy Peter Steele,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/26/2022,7/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
GB,2022-07-18,A0547254,Clinical,HCA at The Christie Clinic,Jurjees Hasan,Guardant 360,,GHI_19,Self-Pay Patient,Endometrial carcinoma,7/26/2022,7/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
GB,2022-07-18,A0551218,Clinical,The Royal Wolverhampton NHS Trust,Ankit Jain,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,8/1/2022,8/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-18,A0547238,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/26/2022,7/26/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2241 GBP,2241.0,2022-07,1.200109,2689.444269,2000-3000$ 
GB,2022-07-18,A0547258,Clinical,The Royal Marsden NHS Foundation Trust,David Cunningham,Guardant360 CDx EU,,GHI_19,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,7/26/2022,7/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
IT,2022-07-20,A0548310,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/29/2022,7/29/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2000 EUR,2000.0,2022-07,1.019149,2038.2980000000002,2000-3000$ 
GB,2022-07-20,A0548177,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/28/2022,7/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
GB,2022-07-20,A0548141,Clinical,Maidstone and Tunbridge Wells NHS Trust,Julia Hall,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/29/2022,9/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-20,A0548185,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant360 CDx EU,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,8/1/2022,8/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
BR,2022-07-20,A0547834,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,8/2/2022,8/2/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-07,1.0,1750.0,1500-2000$ 
BR,2022-07-20,A0547839,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/28/2022,7/28/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-07,1.0,1750.0,1500-2000$ 
GB,2022-07-20,A0547837,Clinical,The Royal Marsden Hospital,Michael Davidson,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/29/2022,8/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
TR,2022-07-21,A0548700,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/1/2022,8/1/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-07,1.0,1890.0,1500-2000$ 
GB,2022-07-21,A0548621,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/1/2022,8/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
GB,2022-07-22,A0549234,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Daniel Rea,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/1/2022,8/1/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-22,A0549751,Clinical,Sussex Cancer Centre,Kam Zaki,Guardant360 CDx EU,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/1/2022,8/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
CA,2022-07-22,A0549758,Clinical,Sir Mortimer B Davis Jewish General Hosp,Michael Palumbo,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/4/2022,8/4/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Canada,Paid,1500 USD,1500.0,2022-07,1.0,1500.0,0-1500$ 
IT,2022-07-22,A0549739,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/1/2022,8/1/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2000 EUR,2000.0,2022-07,1.019149,2038.2980000000002,2000-3000$ 
GB,2022-07-23,A0550101,Clinical,HCA Laboratories,Daniel Krell,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,8/1/2022,8/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
FR,2022-07-25,A0550616,Clinical,Centre Leon Berard,Philippe Cassier,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/8/2022,8/8/2022,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-07,1.019149,0.0,0 $
ES,2022-07-25,A0550587,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,8/1/2022,8/1/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2241 EUR,2241.0,2022-07,1.019149,2283.912909,2000-3000$ 
IE,2022-07-25,A0550619,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/1/2022,8/4/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-07,1.019149,1268.8405050000001,0-1500$ 
IE,2022-07-25,A0550613,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/1/2022,8/3/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-07,1.019149,1268.8405050000001,0-1500$ 
TR,2022-07-25,A0550584,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/1/2022,8/1/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-07,1.0,1890.0,1500-2000$ 
DE,2022-07-25,A0550617,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/3/2022,8/3/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 Infinity,2022Q3,Europe,Free,0 EUR,0.0,2022-07,1.019149,0.0,0 $
TR,2022-07-25,A0550624,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,8/6/2022,8/6/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2022,3,1,2022-07-01,2022-07,G360 Infinity,2022Q3,Europe,Paid,2319,2319.0,2022-07,1.0,2319.0,2000-3000$ 
GB,2022-07-25,A0550612,Clinical,Southampton General Hospital,Andrew Bates,Guardant360 CDx EU,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,8/2/2022,8/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
TR,2022-07-25,A0550592,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,2.11,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/6/2022,8/6/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-07,1.0,1890.0,1500-2000$ 
BR,2022-07-25,A0550621,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,8/6/2022,8/6/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-07,1.0,1750.0,1500-2000$ 
GB,2022-07-25,A0550593,Clinical,HCA Laboratories,Suzy Cleator,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Breast Carcinoma,8/2/2022,8/2/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
GB,2022-07-25,A0550604,Clinical,GenesisCare Milton Keynes,Shahzeena Aslam,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/1/2022,8/1/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
GB,2022-07-26,A0557513,Clinical,The Royal Wolverhampton NHS Trust,Ankit Jain,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/9/2022,9/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-26,A0550849,Clinical,The Royal Marsden NHS Foundation Trust,Alicia Okines,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,8/9/2022,8/9/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-07,1.200109,2760.2507,2000-3000$ 
ES,2022-07-27,A0551704,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Small cell lung carcinoma,8/4/2022,8/4/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 EUR ,1245.0,2022-07,1.019149,1268.8405050000001,0-1500$ 
GB,2022-07-27,A0551872,Clinical,HCA Laboratories,Mark Harries,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Breast Carcinoma,8/8/2022,8/8/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
ES,2022-07-27,A0551709,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/4/2022,8/4/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 EUR ,1245.0,2022-07,1.019149,1268.8405050000001,0-1500$ 
GB,2022-07-27,A0551879,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant360 CDx EU,2.11,GHI_19,Distributors : ROW,Gastric adenocarcinoma,8/4/2022,8/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
GB,2022-07-27,A0551443,Clinical,HCA Laboratories,Elisa Fontana,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,8/9/2022,8/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
GB,2022-07-27,A0551877,Clinical,The Christie Hospital,Saifee Mullamitha,Guardant 360,2.11,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/11/2022,8/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
CA,2022-07-27,A0551489,Clinical,Marsden Centre,Kim Rovers,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/9/2022,8/9/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Canada,Free,0 USD,0.0,2022-07,1.0,0.0,0 $
GB,2022-07-27,A0551537,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant360 CDx EU,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/10/2022,8/11/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-27,A0551878,Clinical,The Royal Marsden NHS Foundation Trust,Sheela Rao,Guardant 360,2.11,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/11/2022,8/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
GB,2022-07-27,A0551855,Clinical,Sheffield Weston Park Cancer Centre,Fiona Taylor,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/6/2022,8/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-27,A0551588,Clinical,The Royal Marsden Hospital,Michael Davidson,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/3/2022,8/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
GB,2022-07-27,A0551524,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Other,8/8/2022,8/8/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
GB,2022-07-28,A0552524,Clinical,Musgrove Park Hospital,Liz Toy,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/5/2022,8/5/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
TR,2022-07-28,A0552460,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/5/2022,8/5/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-07,1.0,1890.0,1500-2000$ 
GB,2022-07-28,A0552316,Clinical,Freeman Hospital,Ajay Sudan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Small cell lung carcinoma,8/6/2022,8/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
TR,2022-07-28,A0553027,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,8/12/2022,8/12/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2022,3,1,2022-07-01,2022-07,G360 Infinity,2022Q3,Europe,Paid,2319,2319.0,2022-07,1.0,2319.0,2000-3000$ 
GB,2022-07-28,A0552448,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/4/2022,8/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-07,1.200109,2760.2507,2000-3000$ 
GB,2022-07-29,A0552884,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/6/2022,9/30/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-29,A0553192,Clinical,Coventry University Hospitals,Penny Kechagioglou,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/6/2022,8/6/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,2490 GBP,2490.0,2022-07,1.200109,2988.2714100000003,2000-3000$ 
GB,2022-07-29,A0553087,Clinical,Guys Hospital,Vasileios Angelis,Guardant360 CDx EU,,GHI_19,Do Not Bill - Cancelled,Breast Carcinoma,8/12/2022,8/12/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-29,A0553099,Clinical,Guys Hospital,Daniel Hughes,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,8/9/2022,8/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
CA,2022-07-29,A0553096,Clinical,RCM Health Consultancy,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/6/2022,8/9/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Canada,Paid,1700 USD,1700.0,2022-07,1.0,1700.0,1500-2000$ 
GB,2022-07-29,A0552831,Clinical,Guys Hospital,Isla Leslie,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/6/2022,8/6/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-07-29,A0553057,Clinical,Coventry University Hospitals,Penny Kechagioglou,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/7/2022,8/7/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,2300 GBP,2300.0,2022-07,1.200109,2760.2507,2000-3000$ 
GB,2022-07-29,A0552756,Clinical,HCA Laboratories,Mark Harries,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Breast Carcinoma,8/15/2022,8/15/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-07,1.200109,2613.837402,2000-3000$ 
GB,2022-07-29,A0552784,Clinical,Velindre Cancer Centre,Mick Button,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/6/2022,8/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
GB,2022-07-29,A0552731,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/9/2022,8/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-07,1.200109,1494.1357050000001,0-1500$ 
BR,2022-07-29,A0552991,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/7/2022,8/7/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-07,1.0,1750.0,1500-2000$ 
GB,2022-07-30,A0553462,Clinical,St Georges Hospital,Jason Chow,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),8/7/2022,8/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2022,3,1,2022-07-01,2022-07,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-07,1.200109,0.0,0 $
GB,2022-08-01,A0553767,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/12/2022,8/12/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-08,1.197291,2753.7693000000004,2000-3000$ 
GB,2022-08-01,A0553799,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Lalit Pallan,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/11/2022,8/11/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-01,A0553765,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/9/2022,8/9/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
ES,2022-08-01,A0553766,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,GIST (Gastrointestinal stromal tumor),8/9/2022,10/27/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-08,1.011835,1259.734575,0-1500$ 
GB,2022-08-01,A0553781,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,8/9/2022,8/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-08,1.197291,2607.699798,2000-3000$ 
TR,2022-08-01,A0553791,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,8/10/2022,8/10/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 Infinity,2022Q3,Europe,Paid,2319,2319.0,2022-08,1.0,2319.0,2000-3000$ 
GB,2022-08-01,A0553768,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Qamar Ghafoor,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/9/2022,8/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-02,A0554185,Clinical,Cancer Centre London,Anna-Mary Young,Guardant 360,2.11,GHI_19,Self-Pay Patient,Gastric adenocarcinoma,8/18/2022,8/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
GB,2022-08-02,A0554124,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Arnab Datta,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,8/11/2022,8/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-02,A0554384,Clinical,St Georges Hospital,Doraid Alrifai,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/10/2022,8/10/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-03,A0554964,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/10/2022,8/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
BR,2022-08-03,A0555457,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Gallbladder carcinoma,8/10/2022,8/10/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-08,1.0,1750.0,1500-2000$ 
GB,2022-08-03,A0554967,Clinical,The Royal Marsden NHS Foundation Trust,Alicia Okines,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,8/11/2022,8/11/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
MX,2022-08-04,A0556057,Clinical,MileniaLabs,Guadalupe Evaristo Cedillo Salazar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,8/11/2022,8/11/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,South America,Paid,2500 USD,2500.0,2022-08,1.011835,2529.5875,2000-3000$ 
GB,2022-08-04,A0555678,Clinical,North Middlesex University Hospital,Lucinda Melcher,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/18/2022,8/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
GB,2022-08-04,A0556060,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,,GHI_19,Self-Pay Patient,Other,8/12/2022,8/12/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-04,A0555721,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/11/2022,8/19/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
GB,2022-08-04,A0556029,Clinical,The Colney Centre Oncology and Haematology Department,Zacharias Tasigiannopoulos,Guardant 360,,GHI_19,Self-Pay Patient,Gastric adenocarcinoma,8/12/2022,8/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-08,1.197291,2753.7693000000004,2000-3000$ 
ES,2022-08-04,A0555653,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/11/2022,8/11/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 EUR,2490.0,2022-08,1.011835,2519.46915,2000-3000$ 
GB,2022-08-04,A0555668,Clinical,Maidstone and Tunbridge Wells NHS Trust,Grisma Patel,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/12/2022,8/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
ES,2022-08-04,A0556487,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Pancreatic ductal adenocarcinoma,8/12/2022,8/12/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-08,1.011835,0.0,0 $
BR,2022-08-04,A0555693,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/10/2022,8/10/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,South America,Paid,1700 USD,1700.0,2022-08,1.0,1700.0,1500-2000$ 
CA,2022-08-04,A0555682,Clinical,London Health Sciences Centre,Mark Vincent,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,8/12/2022,8/12/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 Infinity,2022Q3,Canada,Paid,1700 USD,1700.0,2022-08,1.0,1700.0,1500-2000$ 
BR,2022-08-04,A0555681,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/10/2022,8/10/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,South America,Paid,1700 USD,1700.0,2022-08,1.0,1700.0,1500-2000$ 
GB,2022-08-04,A0555629,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/9/2022,8/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
GB,2022-08-05,A0557530,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/11/2022,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
GB,2022-08-05,A0556794,Clinical,Addenbrooke's Hospital,Elizabeth Smyth,Guardant 360,,GHI_19,Self-Pay Patient,Esophageal/Gastroesophageal junction Adenocarcinoma,8/12/2022,8/12/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
CA,2022-08-05,A0557566,Clinical,Marsden Centre,Kim Rovers,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,8/14/2022,8/18/2022,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Canada,Free,0 USD,0.0,2022-08,1.0,0.0,0 $
TR,2022-08-05,A0564494,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,8/24/2022,9/22/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0,0.0,2022-08,1.0,0.0,0 $
GB,2022-08-05,A0556732,Clinical,Musgrove Park Hospital,Julie Walther,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/12/2022,8/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-05,A0556883,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/12/2022,8/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-08,1.197291,2753.7693000000004,2000-3000$ 
IT,2022-08-05,A0557545,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/12/2022,8/12/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2000 EUR,2000.0,2022-08,1.011835,2023.67,2000-3000$ 
GB,2022-08-05,A0557526,Clinical,Guys Hospital,Hannah Cheney Lowe,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/18/2022,8/18/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-06,A0557909,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,8/12/2022,8/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
GB,2022-08-06,A0557881,Clinical,Eastbourne District General Hospital,Mary OBrien,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/17/2022,8/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
ES,2022-08-08,A0558098,Clinical,Hospital Nuestra Senora de Sonsoles,Jose Enrique Ales,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/17/2022,8/17/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1745 EUR,1745.0,2022-08,1.011835,1765.652075,1500-2000$ 
TR,2022-08-08,A0558087,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,8/16/2022,8/16/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 Infinity,2022Q3,Europe,Paid,2319,2319.0,2022-08,1.0,2319.0,2000-3000$ 
GB,2022-08-08,A0558097,Clinical,The Royal Marsden NHS Foundation Trust,Sheela Rao,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/16/2022,8/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
DE,2022-08-08,A0558130,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Head and neck carcinoma,8/23/2022,8/23/2022,GERMANY,Commercial,Head and neck carcinoma,GERMANY,1,non_AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 Infinity,2022Q3,Europe,Paid,3341 EUR,3341.0,2022-08,1.011835,3380.540735,3000+ $
GB,2022-08-08,A0558077,Clinical,Poole Hospital NHS Foundation Trust,Mark Noble,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,8/18/2022,8/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-08,A0558106,Clinical,Cancer Centre London,Tim Benepal,74-Gene Panel,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/16/2022,8/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-08,1.197291,2753.7693000000004,2000-3000$ 
GB,2022-08-08,A0558091,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,8/16/2022,8/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
TR,2022-08-08,A0558114,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,8/16/2022,8/16/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-08,1.0,1890.0,1500-2000$ 
CA,2022-08-09,A0558476,Clinical,Marsden Centre,Kim Rovers,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,8/16/2022,8/18/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Canada,Free,0 USD,0.0,2022-08,1.0,0.0,0 $
BR,2022-08-10,A0559227,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,8/18/2022,8/18/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-08,1.0,1750.0,1500-2000$ 
GB,2022-08-10,A0559226,Clinical,Beatson West of Scotland Cancer Centre,Graeme Lumsden,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/19/2022,8/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-10,A0559207,Clinical,Maidstone and Tunbridge Wells NHS Trust,Grisma Patel,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/19/2022,8/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-10,A0559225,Clinical,The Royal Marsden NHS Foundation Trust,Sheela Rao,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,8/17/2022,8/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
GB,2022-08-10,A0559203,Clinical,Poole Hospital NHS Foundation Trust,Lauren Gorf,Guardant 360,,GHI_19,Self-Pay Patient,Gastric adenocarcinoma,8/17/2022,8/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
GB,2022-08-10,A0559230,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/18/2022,8/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
ES,2022-08-11,A0559849,Clinical,Fundacion Jimenez Diaz,Jaime Rubio Perez,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/17/2022,8/22/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-08,1.011835,1259.734575,0-1500$ 
GB,2022-08-11,A0559846,Clinical,Queen Alexandra Hospital,Samuel Chan,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/18/2022,8/18/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
GB,2022-08-11,A0559842,Clinical,Guys Hospital,Paul Kabuubi,Guardant 360,2.11,GHI_19,Self-Pay Patient,Breast Carcinoma,8/19/2022,9/29/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-11,A0559850,Clinical,Velindre Cancer Centre,Sahar Iqbal,Guardant 360,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/18/2022,9/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-11,A0559829,Clinical,HCA Laboratories,Susan Cleator,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,8/18/2022,8/18/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-08,1.197291,2607.699798,2000-3000$ 
GB,2022-08-11,A0559836,Clinical,St Georges Hospital,Doraid Alrifai,Guardant 360,,GHI_19,Self-Pay Patient,Other,8/18/2022,8/18/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-12,A0560136,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/23/2022,8/23/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
DE,2022-08-12,A0560116,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Renal Cell Carcinoma,8/22/2022,8/26/2022,GERMANY,Commercial,Kidney,GERMANY,1,non_AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 Infinity,2022Q3,Europe,Paid,2990 EUR,2990.0,2022-08,1.011835,3025.38665,3000+ $
TR,2022-08-12,A0560036,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,2.11,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/23/2022,8/23/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-08,1.0,1890.0,1500-2000$ 
GB,2022-08-12,A0560078,Clinical,St Bartholomews Hospital,Adam Januszewski,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/19/2022,8/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
TR,2022-08-12,A0560130,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/19/2022,8/19/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-08,1.0,1890.0,1500-2000$ 
GB,2022-08-12,A0560033,Clinical,Royal Free London NHS Foundation Trust,Alexandra Pender,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/21/2022,8/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
TR,2022-08-12,A0560089,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/19/2022,8/19/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-08,1.0,1890.0,1500-2000$ 
GB,2022-08-12,A0560132,Clinical,St Georges Hospital,Jason Chow,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/19/2022,8/19/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-12,A0560068,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/22/2022,8/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
ES,2022-08-12,A0560076,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,8/23/2022,8/31/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1745 EUR,1745.0,2022-08,1.011835,1765.652075,1500-2000$ 
TR,2022-08-15,A0561127,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GHI_19,Distributors : ROW,Carcinoma of unknown primary (CUP),8/23/2022,8/23/2022,TURKEY,Commercial,CUP,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-08,1.0,1890.0,1500-2000$ 
BR,2022-08-15,A0561198,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/23/2022,8/23/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-08,1.0,1750.0,1500-2000$ 
GB,2022-08-15,A0561125,Clinical,Castle Hill Hospital,Vikram Bansal,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/23/2022,9/27/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-15,A0561096,Clinical,Castle Hill Hospital,Vikram Bansal,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,8/26/2022,8/26/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-15,A0561095,Clinical,Castle Hill Hospital,Amandeep Dhadda,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/23/2022,8/23/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
TR,2022-08-15,A0561083,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/23/2022,8/23/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-08,1.0,1890.0,1500-2000$ 
CA,2022-08-15,A0561098,Clinical,RCM Health Consultancy,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/23/2022,8/24/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Canada,Paid,1700 USD,1700.0,2022-08,1.0,1700.0,1500-2000$ 
IE,2022-08-15,A0561101,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/24/2022,8/24/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-08,1.011835,1259.734575,0-1500$ 
ES,2022-08-15,A0561117,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,8/23/2022,9/27/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2400 USD,2400.0,2022-08,1.011835,2428.404,2000-3000$ 
GB,2022-08-16,A0561733,Clinical,Maidstone and Tunbridge Wells NHS Trust,Alicja Synowiec,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,8/24/2022,8/24/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-16,A0561732,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Arnab Datta,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/25/2022,8/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-16,A0561738,Clinical,Addenbrooke's Hospital,Elizabeth Smyth,Guardant 360,,GHI_19,Self-Pay Sponsored,Esophageal adenocarcinoma,8/24/2022,8/24/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
GB,2022-08-16,A0561735,Clinical,Genesis Care Nottingham,Santhanam Sundar,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,8/24/2022,8/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
GB,2022-08-16,A0561444,Clinical,The Nuffield Hospital Guildford,Sebastian Cummins,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/23/2022,8/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
GB,2022-08-16,A0561725,Clinical,Bupa Cromwell Hospital,Robert Leonard,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/24/2022,8/24/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-08,1.197291,2753.7693000000004,2000-3000$ 
GB,2022-08-17,A0562518,Clinical,Singleton Hospital,Craig Barrington,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/24/2022,8/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-17,A0562512,Clinical,HCA Laboratories,Mark Harries,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,8/25/2022,8/25/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-08,1.197291,2607.699798,2000-3000$ 
GB,2022-08-17,A0562536,Clinical,Poole Hospital NHS Foundation Trust,Khin-Ni Sann,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/25/2022,8/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
ES,2022-08-17,A0562646,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,8/25/2022,10/20/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2500 USD,2500.0,2022-08,1.011835,2529.5875,2000-3000$ 
MX,2022-08-17,A0562645,Clinical,ABC Hospital,Carlos Daniel Robles Vidal,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,8/25/2022,8/25/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,South America,Paid,3316 USD,3316.0,2022-08,1.011835,3355.2448600000002,3000+ $
CA,2022-08-17,A0562549,Clinical,London Health Sciences Centre,Daniel Breadner,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,9/9/2022,9/9/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,Reveal,2022Q3,Canada,Paid,1700 USD,1700.0,2022-08,1.0,1700.0,1500-2000$ 
GB,2022-08-17,A0562401,Clinical,Guys Hospital,Katherine Baines,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/24/2022,8/24/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-17,A0562531,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,8/25/2022,8/25/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-08,1.197291,2607.699798,2000-3000$ 
GB,2022-08-18,A0563414,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,8/25/2022,8/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-08,1.197291,2607.699798,2000-3000$ 
GB,2022-08-18,A0563430,Clinical,Guys Hospital,Daniel Hughes,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/25/2022,8/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-18,A0563479,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,8/29/2022,8/29/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-08,1.197291,2607.699798,2000-3000$ 
GB,2022-08-18,A0563382,Clinical,"Walsall Healthcare NHS Trust, Manor Hospital",Victoria Kunene,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/26/2022,8/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-08,1.197291,2753.7693000000004,2000-3000$ 
TR,2022-08-18,A0563428,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,8/26/2022,8/26/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 Infinity,2022Q3,Europe,Paid,2319,2319.0,2022-08,1.0,2319.0,2000-3000$ 
GB,2022-08-18,A0563431,Clinical,The Royal Wolverhampton NHS Trust,Qudsia Mujeeb,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/25/2022,8/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-19,A0564270,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,9/8/2022,3/1/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
GB,2022-08-19,A0564245,Clinical,Addenbrooke's Hospital,Elizabeth Smyth,Guardant 360,,GHI_19,Self-Pay Patient,Gastric adenocarcinoma,8/27/2022,8/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
GB,2022-08-19,A0564267,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Jonathan Dakin,Guardant 360,,GHI_19,Do Not Bill - Cancelled,,9/8/2022,9/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,0 GBP,0.0,2022-08,1.197291,0.0,0 $
ES,2022-08-19,A0564251,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/26/2022,8/26/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 EUR ,1245.0,2022-08,1.011835,1259.734575,0-1500$ 
GB,2022-08-19,A0564246,Clinical,Addenbrooke's Hospital,Elizabeth Smyth,Guardant 360,,GHI_19,Self-Pay Patient,Esophageal adenocarcinoma,8/26/2022,8/26/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
ES,2022-08-19,A0564253,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,8/27/2022,8/27/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 EUR ,1245.0,2022-08,1.011835,1259.734575,0-1500$ 
GB,2022-08-20,A0564745,Clinical,HCA Laboratories,Susan Cleator,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,8/29/2022,8/29/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-08,1.197291,2607.699798,2000-3000$ 
GB,2022-08-20,A0564761,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,8/29/2022,8/29/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-08,1.197291,2607.699798,2000-3000$ 
GB,2022-08-20,A0564633,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,2.12,GH2_12,Distributors : ROW,Prostate adenocarcinoma,8/30/2022,8/31/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 Infinity,2022Q3,Europe,Paid,0 GBP,0.0,2022-08,1.197291,0.0,0 $
CA,2022-08-20,A0564738,Clinical,London Health Sciences Centre,Daniel Breadner,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/29/2022,8/29/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Canada,Free,0 USD,0.0,2022-08,1.0,0.0,0 $
GB,2022-08-22,A0564860,Clinical,Beatson West of Scotland Cancer Centre,Brian Clark,Guardant 360,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),8/30/2022,8/30/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
BR,2022-08-22,A0564889,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,8/30/2022,8/30/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-08,1.0,1750.0,1500-2000$ 
TR,2022-08-22,A0564872,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,9/8/2022,9/8/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,0,0.0,2022-08,1.0,0.0,0 $
GB,2022-08-22,A0564844,Clinical,The James Cook University Hospital,Madhavi Adusumalli,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/30/2022,8/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-22,A0564828,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Shobhit Baijal,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/30/2022,8/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
ES,2022-08-22,A0564857,Clinical,Hospital Nuestra Senora de Sonsoles,Jose Enrique Ales,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Pancreatic ductal adenocarcinoma,9/8/2022,9/8/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 EUR ,0.0,2022-08,1.011835,0.0,0 $
ES,2022-08-22,A0564819,Clinical,Hospital Nuestra Senora de Sonsoles,Jose Enrique Ales,Guardant 360,,GHI_19,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,8/30/2022,9/6/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1745 EUR,1745.0,2022-08,1.011835,1765.652075,1500-2000$ 
GB,2022-08-23,A0565261,Clinical,Guys Hospital,Katherine Baines,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/31/2022,8/31/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
ES,2022-08-23,A0565430,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/31/2022,8/31/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 EUR ,1245.0,2022-08,1.011835,1259.734575,0-1500$ 
GB,2022-08-23,A0565267,Clinical,Velindre Cancer Centre,Sahar Iqbal,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/31/2022,8/31/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-24,A0565922,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,8/31/2022,9/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
ES,2022-08-24,A0565927,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/2/2022,9/2/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 EUR ,1245.0,2022-08,1.011835,1259.734575,0-1500$ 
GB,2022-08-25,A0566591,Clinical,HCA Laboratories,Alison Jones,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,8/31/2022,8/31/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-08,1.197291,2607.699798,2000-3000$ 
GB,2022-08-25,A0566644,Clinical,St Georges Hospital,Anna-Mary Young,Guardant 360,,GHI_19,Self-Pay Patient,Gastric Carcinoma,8/31/2022,8/31/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
ES,2022-08-25,A0566879,Clinical,Fundacion Jimenez Diaz,Jaime Rubio Perez,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/1/2022,9/1/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-08,1.011835,1259.734575,0-1500$ 
GB,2022-08-25,A0566671,Clinical,University Hospitals Of Leicester,Jaseela Chiramel,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/31/2022,8/31/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-25,A0566848,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Gastric adenocarcinoma,8/31/2022,9/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
TR,2022-08-25,A0566600,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Urothelial carcinoma,9/2/2022,9/2/2022,TURKEY,Commercial,Urothelial,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 Infinity,2022Q3,Europe,Paid,2319,2319.0,2022-08,1.0,2319.0,2000-3000$ 
GB,2022-08-25,A0566676,Clinical,Beatson West of Scotland Cancer Centre,John Maclay,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/31/2022,8/31/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-26,A0567484,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Ryan Dunchookchand,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,9/1/2022,9/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-26,A0567530,Clinical,Mount Vernon Hospital Cancer Centre The Hillingdon Hospitals NHS Foundation Trust,Alan Makepeace,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/1/2022,9/1/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-08,1.197291,2753.7693000000004,2000-3000$ 
ES,2022-08-26,A0567594,Clinical,Hospital Nuestra Senora de Sonsoles,Jose Enrique Ales,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/1/2022,9/1/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1745 EUR,1745.0,2022-08,1.011835,1765.652075,1500-2000$ 
GB,2022-08-26,A0567357,Clinical,Guys Hospital,Chin Lim,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,9/1/2022,9/1/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-26,A0567578,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,9/6/2022,9/6/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
TR,2022-08-26,A0568914,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/8/2022,9/8/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-08,1.0,1890.0,1500-2000$ 
GB,2022-08-26,A0567504,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,9/1/2022,9/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
GB,2022-08-27,A0568147,Clinical,Genesis Care,Russell Burcombe,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/7/2022,9/7/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
GB,2022-08-27,A0568149,Clinical,Singleton Hospital,Owen Nicholas,Guardant 360,,GHI_19,Self-Pay Patient,Other,9/2/2022,9/4/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-27,A0568143,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,9/4/2022,9/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-08,1.197291,2607.699798,2000-3000$ 
GB,2022-08-27,A0568141,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,9/4/2022,3/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-08,1.197291,1490.6272950000002,0-1500$ 
ES,2022-08-29,A0568263,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,9/4/2022,9/4/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1745 EUR,1745.0,2022-08,1.011835,1765.652075,1500-2000$ 
TR,2022-08-29,A0569643,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,9/5/2022,9/5/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 Infinity,2022Q3,Europe,Paid,2319,2319.0,2022-08,1.0,2319.0,2000-3000$ 
TR,2022-08-29,A0568260,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/7/2022,9/7/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-08,1.0,1890.0,1500-2000$ 
BR,2022-08-29,A0568306,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,9/4/2022,9/4/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-08,1.0,1750.0,1500-2000$ 
TR,2022-08-29,A0568280,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,9/5/2022,9/5/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-08,1.0,1890.0,1500-2000$ 
TR,2022-08-29,A0568249,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/2/2022,9/2/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-08,1.0,1890.0,1500-2000$ 
GB,2022-08-29,A0568238,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,9/9/2022,9/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-08,1.197291,2981.2545900000005,2000-3000$ 
IT,2022-08-29,A0568291,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/5/2022,9/5/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2000 EUR,2000.0,2022-08,1.011835,2023.67,2000-3000$ 
TR,2022-08-29,A0568287,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,9/6/2022,9/6/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 Infinity,2022Q3,Europe,Paid,2319,2319.0,2022-08,1.0,2319.0,2000-3000$ 
GB,2022-08-29,A0568283,Clinical,St Georges Hospital,Yee-Ean Ong,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,9/2/2022,10/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
GB,2022-08-31,A0569540,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Esophageal adenocarcinoma,9/6/2022,9/6/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-08,1.197291,2607.699798,2000-3000$ 
CA,2022-08-31,A0569571,Clinical,Brantford General Hospital,Brian Healy,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/8/2022,9/12/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Canada,Free,0 USD,0.0,2022-08,1.0,0.0,0 $
GB,2022-08-31,A0569591,Clinical,Musgrove Park Hospital,Joanne Botten,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/7/2022,9/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-08,1.197291,0.0,0 $
TR,2022-08-31,A0569515,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,9/10/2022,9/10/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-08,1.0,1890.0,1500-2000$ 
CA,2022-08-31,A0569484,Clinical,MacKenzie Richmond Hill Hospital,Francis Patafio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/5/2022,9/8/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2022,3,1,2022-08-01,2022-08,G360 CDx,2022Q3,Canada,Paid,1700 USD,1700.0,2022-08,1.0,1700.0,1500-2000$ 
ES,2022-09-01,A0570078,Clinical,Hospital Puerta de Hierro,Antonio Sanchez Ruiz,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Gastric adenocarcinoma,9/14/2022,9/23/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-09,0.9913,1234.1685,0-1500$ 
GB,2022-09-01,A0570089,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,9/6/2022,9/6/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
BR,2022-09-01,A0570097,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,9/8/2022,9/8/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-09,1.0,1750.0,1500-2000$ 
ES,2022-09-02,A0570629,Clinical,Hospital Arnau De Vilanova,Javier Garde Noguera,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/8/2022,9/8/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-09,0.9913,0.0,0 $
GB,2022-09-02,A0570645,Clinical,Maidstone and Tunbridge Wells NHS Trust,Mark Hill,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/8/2022,10/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-09,1.132387,2604.4901,2000-3000$ 
ES,2022-09-02,A0570704,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,9/7/2022,9/7/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2366 EUR,2366.0,2022-09,0.9913,2345.4157999999998,2000-3000$ 
CA,2022-09-02,A0570690,Clinical,MacKenzie Richmond Hill Hospital,Francis Patafio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/14/2022,9/27/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Canada,Free,0 USD,0.0,2022-09,1.0,0.0,0 $
GB,2022-09-02,A0570701,Clinical,St Bartholomews Hospital,Sarah Slater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/8/2022,9/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
GB,2022-09-02,A0570937,Clinical,Freeman Hospital,Sunita Kohli,Guardant 360,,GHI_19,Self-Pay Patient,Other,9/9/2022,9/9/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
GB,2022-09-02,A0574806,Clinical,St Paul's GP Surgery,Joanna Tunnicliffe,Guardant 360,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),9/14/2022,9/27/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
GB,2022-09-02,A0570941,Clinical,Addenbrooke's Hospital,Elizabeth Smyth,Guardant 360,,GHI_19,Self-Pay Patient,Esophageal adenocarcinoma,9/7/2022,9/7/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
GB,2022-09-02,A0570939,Clinical,"Primrose Unit, Bedford Hospital",Venkata Bulusu,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/7/2022,9/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
GB,2022-09-03,A0571547,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Other,9/11/2022,9/11/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
TR,2022-09-06,A0571685,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/11/2022,9/11/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-09,1.0,1890.0,1500-2000$ 
BR,2022-09-06,A0571807,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/20/2022,9/20/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-09,1.0,1750.0,1500-2000$ 
BR,2022-09-06,A0571841,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/12/2022,9/12/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-09,1.0,1750.0,1500-2000$ 
GB,2022-09-06,A0571748,Clinical,The Rutherford Cancer Centre,Seema Arif,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,9/13/2022,9/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2300 GBP,2300.0,2022-09,1.132387,2604.4901,2000-3000$ 
TR,2022-09-06,A0571690,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,9/15/2022,9/15/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 Infinity,2022Q3,Europe,Paid,0,0.0,2022-09,1.0,0.0,0 $
GB,2022-09-06,A0571670,Clinical,Musgrove Park Hospital,Petra Jankowska,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/11/2022,9/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
BR,2022-09-06,A0571840,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Duodenal Adenocarcinoma,9/12/2022,9/12/2022,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-09,1.0,1750.0,1500-2000$ 
ES,2022-09-06,A0571687,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,9/11/2022,9/11/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-09,0.9913,1234.1685,0-1500$ 
ES,2022-09-06,A0571736,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,9/13/2022,9/13/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-09,0.9913,1234.1685,0-1500$ 
GB,2022-09-06,A0571682,Clinical,Queen Alexandra Hospital,Victoria True,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),9/12/2022,9/12/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
IT,2022-09-06,A0571739,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/12/2022,9/12/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2000 EUR,2000.0,2022-09,0.9913,1982.6,1500-2000$ 
BR,2022-09-06,A0571843,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,9/12/2022,9/12/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-09,1.0,1750.0,1500-2000$ 
GB,2022-09-06,A0571733,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,9/17/2022,9/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
BR,2022-09-06,A0571842,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/12/2022,9/12/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-09,1.0,1750.0,1500-2000$ 
ES,2022-09-06,A0571777,Clinical,Clinica Tres Torres UOMI Cancer Center,Santiago Viteri,Guardant360 CDx,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,9/13/2022,9/13/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,0 EUR,0.0,2022-09,0.9913,0.0,0 $
BR,2022-09-06,A0571844,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/12/2022,9/12/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-09,1.0,1750.0,1500-2000$ 
GB,2022-09-07,A0572146,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/14/2022,9/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
PT,2022-09-07,A0572114,Clinical,Centro Hospitalar do Porto - Hospital Santo Antonio,Joana Simoes,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Breast Carcinoma,9/21/2022,10/4/2022,PORTUGAL,Commercial,Breast,PORTUGAL,1,non_AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-09,0.9913,0.0,0 $
TR,2022-09-07,A0572173,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/13/2022,9/13/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-09,1.0,1890.0,1500-2000$ 
GB,2022-09-07,A0572178,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shivan Sivakumar,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,9/13/2022,9/13/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
GB,2022-09-08,A0573065,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shivan Sivakumar,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,9/14/2022,9/14/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
FR,2022-09-08,A0573072,Clinical,Centre Leon Berard,Philippe Cassier,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/14/2022,9/14/2022,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-09,0.9913,0.0,0 $
GB,2022-09-08,A0573073,Clinical,HCA Laboratories,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/17/2022,9/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
TR,2022-09-08,A0573046,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,9/15/2022,9/15/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 Infinity,2022Q3,Europe,Paid,0,0.0,2022-09,1.0,0.0,0 $
GB,2022-09-08,A0573031,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,9/15/2022,9/15/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
ES,2022-09-08,A0573049,Clinical,Clinica Tres Torres UOMI Cancer Center,Santiago Viteri,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/15/2022,11/15/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 EUR,2490.0,2022-09,0.9913,2468.337,2000-3000$ 
GB,2022-09-08,A0572523,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,9/16/2022,9/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,Reveal,2022Q3,Europe,Free,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
GB,2022-09-09,A0574590,Clinical,HCA Laboratories,Paul Ross,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,9/23/2022,9/23/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
TR,2022-09-09,A0574599,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/20/2022,9/20/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-09,1.0,1890.0,1500-2000$ 
ES,2022-09-10,A0575010,Clinical,Clinica Universidad de Navarra-Madrid,Patricia Fuentes Bullejos,Guardant 360,2.11,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,9/23/2022,9/23/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2400 USD,2400.0,2022-09,0.9913,2379.12,2000-3000$ 
GB,2022-09-10,A0574993,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,9/14/2022,9/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
GB,2022-09-10,A0575000,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,9/14/2022,9/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
ES,2022-09-10,A0574980,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/19/2022,12/30/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2500 USD,2500.0,2022-09,0.9913,2478.25,2000-3000$ 
CA,2022-09-10,A0575003,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,9/15/2022,9/15/2022,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Canada,Paid,1700 USD,1700.0,2022-09,1.0,1700.0,1500-2000$ 
BR,2022-09-12,A0575472,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/16/2022,9/16/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-09,1.0,1750.0,1500-2000$ 
ES,2022-09-12,A0575426,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung squamous cell carcinoma,9/16/2022,5/4/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-09,0.9913,1234.1685,0-1500$ 
IE,2022-09-12,A0575444,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/20/2022,9/20/2022,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-09,0.9913,1234.1685,0-1500$ 
GB,2022-09-12,A0575463,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,9/16/2022,9/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
GB,2022-09-12,A0575425,Clinical,Singleton Hospital,Steve Kihara,Guardant 360,,GHI_19,Self-Pay Patient,Other,9/19/2022,10/4/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
IT,2022-09-12,A0575423,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/20/2022,9/20/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2000 EUR,2000.0,2022-09,0.9913,1982.6,1500-2000$ 
ES,2022-09-12,A0575440,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,9/20/2022,9/20/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-09,0.9913,1234.1685,0-1500$ 
GB,2022-09-12,A0575462,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/16/2022,3/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
GB,2022-09-12,A0575431,Clinical,The Nuffield Hospital Guildford,Sebastian Cummins,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/20/2022,9/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
GB,2022-09-12,A0575442,Clinical,York Hospital,Angela Darby,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/16/2022,9/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
GB,2022-09-13,A0575934,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,9/21/2022,9/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
GB,2022-09-13,A0576024,Clinical,Beatson West of Scotland Cancer Centre,Brian Clark,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/21/2022,9/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
GB,2022-09-14,A0576558,Clinical,Worthing Hospital,Anna Britten,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,9/22/2022,10/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
ES,2022-09-14,A0576541,Clinical,Clinica Tres Torres UOMI Cancer Center,Santiago Viteri,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/20/2022,10/4/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 EUR,2490.0,2022-09,0.9913,2468.337,2000-3000$ 
TR,2022-09-14,A0576547,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,9/22/2022,9/22/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 Infinity,2022Q3,Europe,Paid,0,0.0,2022-09,1.0,0.0,0 $
GB,2022-09-14,A0576540,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,,GHI_19,Distributors : ROW,Prostate adenocarcinoma,9/20/2022,9/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
TR,2022-09-14,A0576546,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Do Not Bill - Cancelled,Small cell lung carcinoma,10/1/2022,10/6/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,0,0.0,2022-09,1.0,0.0,0 $
GB,2022-09-15,A0577355,Clinical,Maidstone and Tunbridge Wells NHS Trust,Alexander Huddart,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/22/2022,10/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
GB,2022-09-15,A0577356,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,9/21/2022,9/21/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
GB,2022-09-15,A0577353,Clinical,Cancer Centre London,Tim Benepal,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/22/2022,9/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
TR,2022-09-15,A0577328,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/22/2022,9/22/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-09,1.0,1890.0,1500-2000$ 
TR,2022-09-15,A0577256,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/22/2022,9/22/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 Infinity,2022Q3,Europe,Paid,0,0.0,2022-09,1.0,0.0,0 $
GB,2022-09-15,A0577324,Clinical,The Royal Marsden NHS Foundation Trust,Jillian Noble,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,9/21/2022,9/21/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
ES,2022-09-15,A0577288,Clinical,Hospital Quiron Barcelona,Elvira Buxo Orra,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/28/2022,9/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2241 EUR,2241.0,2022-09,0.9913,2221.5033,2000-3000$ 
GB,2022-09-16,A0578020,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/22/2022,9/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
ES,2022-09-16,A0577992,Clinical,Instituto de Investigacion Sanitaria INCLIVA,Noelia Tarazona Llavero,Guardant 360,,GHI_19,Self-Pay Patient,Esophageal adenocarcinoma,9/22/2022,9/22/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-09,0.9913,0.0,0 $
GB,2022-09-16,A0577993,Clinical,HCA Laboratories,Fharat Raja,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,9/22/2022,9/22/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
GB,2022-09-16,A0578027,Clinical,Bupa Cromwell Hospital,John Conibear,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/22/2022,9/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
GB,2022-09-16,A0578028,Clinical,Derriford University Hospitals Plymouth NHS Trust,Frances Mark,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/22/2022,9/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
GB,2022-09-17,A0579138,Clinical,HCA Laboratories,Siow-Ming Lee,Guardant 360,2.11,GHI_01,Distributors : ROW,Large cell lung carcinoma,9/23/2022,9/23/2022,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
GB,2022-09-17,A0579145,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,9/23/2022,9/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
GB,2022-09-17,A0579201,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/24/2022,9/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
GB,2022-09-19,A0579294,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Carcinoma of unknown primary (CUP),9/23/2022,3/17/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
GB,2022-09-19,A0579307,Clinical,Queen Alexandra Hospital,Shyamika Acharige,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/24/2022,9/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
AR,2022-09-19,A0579328,Clinical,Mariano Dioca,Mariano Dioca,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/24/2022,9/27/2022,ARGENTINA,Commercial,,ARGENTINA,1,non_AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,2964 USD,2964.0,2022-09,1.0,2964.0,2000-3000$ 
GB,2022-09-19,A0579325,Clinical,Clatterbridge cancer Center,Carles Escriu,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/23/2022,9/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
GB,2022-09-20,A0579904,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,9/28/2022,9/28/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
GB,2022-09-20,A0579718,Clinical,St James University Hospital,Pooja Jain,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/30/2022,10/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
BR,2022-09-21,A0580545,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/27/2022,9/27/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-09,1.0,1750.0,1500-2000$ 
CA,2022-09-21,A0580559,Clinical,MacKenzie Richmond Hill Hospital,Francis Patafio,Guardant 360,2.11,GHI_01,Self-Pay Patient,Neuroendocrine carcinoma,9/30/2022,9/30/2022,CANADA,Commercial,Other,CANADA,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Canada,Paid,1700 USD,1700.0,2022-09,1.0,1700.0,1500-2000$ 
GB,2022-09-21,A0580539,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/27/2022,9/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
ES,2022-09-21,A0580540,Clinical,Hospital Arnau De Vilanova,Javier Garde Noguera,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,9/27/2022,10/4/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-09,0.9913,0.0,0 $
ES,2022-09-21,A0580518,Clinical,Clinica Tres Torres UOMI Cancer Center,Santiago Viteri,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/26/2022,9/26/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 EUR,2490.0,2022-09,0.9913,2468.337,2000-3000$ 
ES,2022-09-21,A0580239,Clinical,Centro Medico TEKNON IOB,Elvira Buxo Orra,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,9/28/2022,9/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2241 EUR,2241.0,2022-09,0.9913,2221.5033,2000-3000$ 
ES,2022-09-21,A0580531,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,9/28/2022,9/28/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-09,0.9913,0.0,0 $
CA,2022-09-22,A0581180,Clinical,Lions Gate Hospital,Ardashes Avanessian,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,9/30/2022,9/30/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Canada,Paid,0 USD,0.0,2022-09,1.0,0.0,0 $
GB,2022-09-22,A0581233,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/5/2022,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
ES,2022-09-22,A0580875,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/27/2022,9/27/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2366 EUR,2366.0,2022-09,0.9913,2345.4157999999998,2000-3000$ 
ES,2022-09-23,A0581871,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,10/4/2022,10/4/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2366 EUR,2366.0,2022-09,0.9913,2345.4157999999998,2000-3000$ 
GB,2022-09-23,A0581881,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenosquamous carcinoma,9/28/2022,9/28/2022,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
GB,2022-09-23,A0581866,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,2.11,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,9/28/2022,9/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
GB,2022-09-23,A0581868,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,9/28/2022,9/28/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
GB,2022-09-23,A0581886,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,9/28/2022,9/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
GB,2022-09-23,A0581873,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,9/28/2022,9/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
GB,2022-09-23,A0581920,Clinical,Guys Hospital,Boris Tocco,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,9/28/2022,9/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
GB,2022-09-23,A0581883,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,9/28/2022,9/28/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
ES,2022-09-23,A0581897,Clinical,Vall D'Hebron University Hospital,Enriqueta Felip,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/4/2022,10/4/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-09,0.9913,1234.1685,0-1500$ 
GB,2022-09-23,A0581862,Clinical,The Royal Marsden NHS Foundation Trust,Sheela Rao,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,10/4/2022,10/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
TR,2022-09-23,A0581863,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/28/2022,9/28/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1890,1890.0,2022-09,1.0,1890.0,1500-2000$ 
CA,2022-09-23,A0581896,Clinical,Sir Mortimer B Davis Jewish General Hosp,Petr Kavan,Guardant Reveal,1.0,GHI_10,Do Not Bill - Cancelled,Colorectal adenocarcinoma,11/3/2022,11/3/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,Reveal,2022Q3,Canada,Paid,0 USD,0.0,2022-09,1.0,0.0,0 $
TR,2022-09-23,A0581903,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,9/29/2022,9/29/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 Infinity,2022Q3,Europe,Paid,1890,1890.0,2022-09,1.0,1890.0,1500-2000$ 
GB,2022-09-24,A0582481,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Thyroid carcinoma,9/28/2022,9/28/2022,UNITED KINGDOM,Commercial,Thyroid,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
GB,2022-09-24,A0582514,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,9/30/2022,9/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
GB,2022-09-24,A0582570,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/4/2022,10/4/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
GB,2022-09-24,A0582582,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,9/29/2022,9/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
FR,2022-09-24,A0582539,Clinical,HEGP Hopital Europeen Georges Pompidou - AP-HP,Julien Taeib,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/3/2022,10/3/2022,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-09,0.9913,0.0,0 $
GB,2022-09-24,A0582488,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,9/28/2022,10/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
GB,2022-09-24,A0582498,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,9/28/2022,9/28/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
GB,2022-09-24,A0582587,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/30/2022,9/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
CA,2022-09-26,A0582720,Clinical,Lions Gate Hospital,Ardashes Avanessian,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/1/2022,10/1/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Canada,Free,0 USD,0.0,2022-09,1.0,0.0,0 $
GB,2022-09-26,A0582730,Clinical,The Holly Private Hospital,Eliot Sims,Guardant 360,2.11,GHI_19,Self-Pay Patient,Breast Carcinoma,10/4/2022,10/4/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2240 GBP,2240.0,2022-09,1.132387,2536.54688,2000-3000$ 
DE,2022-09-26,A0582725,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/1/2022,10/1/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2990 EUR,2990.0,2022-09,0.9913,2963.987,2000-3000$ 
GB,2022-09-26,A0582729,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant 360,2.11,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/4/2022,10/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2240 GBP,2240.0,2022-09,1.132387,2536.54688,2000-3000$ 
GB,2022-09-26,A0582741,Clinical,Western General Hospital - Edinburgh Cancer Centre,Stephen Harrow,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/5/2022,10/5/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
ES,2022-09-26,A0582739,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,10/4/2022,10/4/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-09,0.9913,1234.1685,0-1500$ 
GB,2022-09-27,A0583241,Clinical,Velindre Cancer Centre,Seema Arif,Guardant 360,2.11,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/2/2022,10/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2490 GBP,2490.0,2022-09,1.132387,2819.64363,2000-3000$ 
TR,2022-09-28,A0583824,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,10/6/2022,10/6/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 Infinity,2022Q3,Europe,Paid,2319,2319.0,2022-09,1.0,2319.0,2000-3000$ 
GB,2022-09-28,A0583845,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/5/2022,10/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
CA,2022-09-28,A0583933,Clinical,Neurvana Health,Ryan Best,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,10/7/2022,10/7/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,Reveal,2022Q3,Canada,Free,0 USD,0.0,2022-09,1.0,0.0,0 $
CA,2022-09-28,A0583834,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/5/2022,11/11/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Canada,Paid,1700 USD,1700.0,2022-09,1.0,1700.0,1500-2000$ 
GB,2022-09-28,A0583789,Clinical,The Royal Marsden NHS Foundation Trust,Penelope Edwards,Guardant 360,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/4/2022,10/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
CA,2022-09-28,A0583795,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/5/2022,11/21/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Canada,Paid,1700 USD,1700.0,2022-09,1.0,1700.0,1500-2000$ 
CA,2022-09-28,A0583934,Clinical,Neurvana Health,Ryan Best,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,10/7/2022,10/7/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,Reveal,2022Q3,Canada,Free,0 USD,0.0,2022-09,1.0,0.0,0 $
GB,2022-09-28,A0583722,Clinical,The Royal Marsden Hospital,Michael Davidson,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,9/30/2022,9/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,0 GBP,0.0,2022-09,1.132387,0.0,0 $
GB,2022-09-29,A0584379,Clinical,Guys Hospital,Sharmistha Ghosh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/12/2022,10/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
ES,2022-09-29,A0584400,Clinical,Instituto de Investigacion Sanitaria INCLIVA,Noelia Tarazona Llavero,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/15/2022,10/15/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-09,0.9913,0.0,0 $
GB,2022-09-29,A0584434,Clinical,Guys Hospital,Isla Leslie,Guardant 360,,GHI_19,Self-Pay Patient,Gallbladder carcinoma,10/5/2022,10/5/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
ES,2022-09-29,A0584430,Clinical,Hospital Ruber Internacional,Francisco Javier Roman Garcia,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/5/2022,10/5/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2241 EUR,2241.0,2022-09,0.9913,2221.5033,2000-3000$ 
TR,2022-09-30,A0585565,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung squamous cell carcinoma,10/11/2022,10/11/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 Infinity,2022Q3,Europe,Paid,0,0.0,2022-09,1.0,0.0,0 $
BR,2022-09-30,A0585575,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/8/2022,10/8/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-09,1.0,1750.0,1500-2000$ 
BR,2022-09-30,A0585563,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/8/2022,10/8/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1750 USD,1750.0,2022-09,1.0,1750.0,1500-2000$ 
TR,2022-09-30,A0585520,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,10/10/2022,10/10/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2022,3,1,2022-09-01,2022-09,G360 Infinity,2022Q3,Europe,Paid,0,0.0,2022-09,1.0,0.0,0 $
BR,2022-09-30,A0585510,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,10/6/2022,12/8/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,South America,Paid,1700 USD,1700.0,2022-09,1.0,1700.0,1500-2000$ 
ES,2022-09-30,A0585579,Clinical,Hospital Universitario 12 De Octubre,Luis Robles,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/10/2022,10/10/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 EUR,0.0,2022-09,0.9913,0.0,0 $
ES,2022-09-30,A0585592,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/8/2022,10/8/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 EUR,1245.0,2022-09,0.9913,1234.1685,0-1500$ 
GB,2022-09-30,A0585540,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,10/11/2022,10/12/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,1245 GBP,1245.0,2022-09,1.132387,1409.821815,0-1500$ 
GB,2022-09-30,A0585572,Clinical,HCA Laboratories,Thomas Richards,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,10/8/2022,10/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2178.75,2178.0,2022-09,1.132387,2466.338886,2000-3000$ 
DE,2022-09-30,A0585550,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/8/2022,10/8/2022,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Paid,2990 EUR,2990.0,2022-09,0.9913,2963.987,2000-3000$ 
GB,2022-09-30,A0585561,Clinical,Queen Alexandra Hospital,Shyamika Acharige,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/8/2022,10/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2022,3,1,2022-09-01,2022-09,G360 CDx,2022Q3,Europe,Free,0 GBP,0.0,2022-09,1.132387,0.0,0 $
GB,2022-10-01,A0586417,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Colorectal adenocarcinoma,11/9/2022,11/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,0 GBP,0.0,2022-10,1.1292,0.0,0 $
TR,2022-10-03,A0586577,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Sarcoma,10/11/2022,10/11/2022,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,0,0.0,2022-10,1.0,0.0,0 $
TR,2022-10-03,A0586548,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,2.11,GHI_19,Distributors : ROW,Other,10/11/2022,10/11/2022,TURKEY,Commercial,Other,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1890,1890.0,2022-10,1.0,1890.0,1500-2000$ 
GB,2022-10-03,A0586622,Clinical,Guys Hospital,Harris Gousis,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/10/2022,10/10/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
TR,2022-10-03,A0586623,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Sarcoma,10/11/2022,10/11/2022,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-10,1.0,2319.0,2000-3000$ 
GB,2022-10-03,A0586534,Clinical,Queen Alexandra Hospital,Sethupathi Ramalingam,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/10/2022,10/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
TR,2022-10-03,A0586535,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,2.11,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/10/2022,10/10/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1890,1890.0,2022-10,1.0,1890.0,1500-2000$ 
MX,2022-10-03,A0586595,Clinical,ABC Hospital,Gabriela Olivia Regalado Porras,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/9/2022,10/9/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,3316 USD,3316.0,2022-10,0.9833,3260.6227999999996,3000+ $
MX,2022-10-03,A0586604,Clinical,ABC Hospital,Gabriela Olivia Regalado Porras,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,10/11/2022,11/2/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,3316 USD,3316.0,2022-10,0.9833,3260.6227999999996,3000+ $
ES,2022-10-03,A0586616,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/11/2022,10/11/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-10,0.9833,1224.2085,0-1500$ 
BR,2022-10-03,A0586621,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Thymic carcinoma,10/11/2022,10/11/2022,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-10,1.0,1750.0,1500-2000$ 
GB,2022-10-03,A0586536,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/10/2022,10/10/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
GB,2022-10-04,A0587172,Clinical,Coventry University Hospitals,Mark Hocking,Guardant 360,,GHI_19,Self-Pay Patient,Ovarian carcinoma,10/12/2022,10/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-04,A0587448,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,10/11/2022,10/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-10,1.1292,2459.3976,2000-3000$ 
GB,2022-10-05,A0588294,Clinical,"Queenâ€™s Hospital, Barking, Havering, and Redbridge Univ Hosp NHS Trust",Eliot Sims,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/12/2022,10/12/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
CA,2022-10-05,A0588319,Clinical,MacKenzie Richmond Hill Hospital,Francis Patafio,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,10/14/2022,10/14/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,Reveal,2022Q4,Canada,Free,0 USD,0.0,2022-10,1.0,0.0,0 $
GB,2022-10-05,A0588279,Clinical,Queen Alexandra Hospital,Sethupathi Ramalingam,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/12/2022,10/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
BR,2022-10-05,A0588299,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/2/2022,11/2/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-10,1.0,1750.0,1500-2000$ 
GB,2022-10-05,A0588292,Clinical,Bristol Haematology and Oncology Centre,Vivek Mohan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/13/2022,10/17/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
TR,2022-10-06,A0588604,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,10/13/2022,10/13/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,0,0.0,2022-10,1.0,0.0,0 $
GB,2022-10-06,A0588692,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,10/13/2022,10/13/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-10,1.1292,2459.3976,2000-3000$ 
GB,2022-10-06,A0588632,Clinical,Clatterbridge Cancer Centre,Rajaram Sripadam,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/13/2022,10/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-10,1.1292,2529.408,2000-3000$ 
TR,2022-10-06,A0589002,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,10/14/2022,10/14/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-10,1.0,2319.0,2000-3000$ 
TR,2022-10-06,A0588622,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Gastric adenocarcinoma,10/13/2022,10/13/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,0,0.0,2022-10,1.0,0.0,0 $
GB,2022-10-06,A0588636,Clinical,HCA Laboratories,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/13/2022,10/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-10,1.1292,2459.3976,2000-3000$ 
GB,2022-10-06,A0588584,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Breast Carcinoma,11/9/2022,11/9/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-07,A0590562,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/13/2022,11/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-10,1.1292,2459.3976,2000-3000$ 
IT,2022-10-07,A0590194,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/13/2022,10/13/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2000 EUR,2000.0,2022-10,0.9833,1966.6,1500-2000$ 
FR,2022-10-07,A0590203,Clinical,"APHP, Tenon Hospital",Joseph Gligorv,Guardant 360,2.12,GH2_12,Self-Pay Patient,Leiomyosarcoma,10/13/2022,10/13/2022,FRANCE,Commercial,Soft Tissue/Bone,FRANCE,1,non_AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Free,0 EUR,0.0,2022-10,0.9833,0.0,0 $
GB,2022-10-07,A0590563,Clinical,East Suffolk and North Essex NHS Foundation Trust,Sadaf Usman,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/13/2022,10/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
BR,2022-10-10,A0591588,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/17/2022,10/17/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-10,1.0,1750.0,1500-2000$ 
BR,2022-10-10,A0591590,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/25/2022,10/25/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-10,1.0,1750.0,1500-2000$ 
BR,2022-10-10,A0591591,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/17/2022,10/17/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-10,1.0,1750.0,1500-2000$ 
GB,2022-10-10,A0591536,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic neuroendocrine tumor,10/16/2022,10/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
BR,2022-10-10,A0591550,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/18/2022,10/18/2022,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1700 USD,1700.0,2022-10,1.0,1700.0,1500-2000$ 
GB,2022-10-10,A0591501,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,10/25/2022,10/25/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-10,1.1292,2529.408,2000-3000$ 
GB,2022-10-10,A0591508,Clinical,The Nuffield Hospital Guildford,Sebastian Cummins,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/16/2022,10/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
TR,2022-10-10,A0591545,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,10/18/2022,10/18/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-10,1.0,2319.0,2000-3000$ 
GB,2022-10-11,A0592349,Clinical,"Primrose Unit, Bedford Hospital",Venkata Bulusu,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,10/19/2022,10/19/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
GB,2022-10-11,A0592340,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,11/8/2022,11/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,0 GBP,0.0,2022-10,1.1292,0.0,0 $
BR,2022-10-12,A0593008,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,10/22/2022,10/22/2022,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-10,1.0,1750.0,1500-2000$ 
MX,2022-10-12,A0592993,Clinical,ABC Hospital,Raquel Gerson,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,10/19/2022,10/19/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,3316 USD,3316.0,2022-10,0.9833,3260.6227999999996,3000+ $
BR,2022-10-12,A0593009,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,10/19/2022,10/19/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-10,1.0,1750.0,1500-2000$ 
FI,2022-10-12,A0592991,Clinical,Turku University Hospital,Heikki Vilhonen,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/20/2022,10/20/2022,FINLAND,Commercial,,FINLAND,1,non_AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2303 EUR,2303.0,2022-10,0.9833,2264.5398999999998,2000-3000$ 
GB,2022-10-12,A0592842,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/19/2022,10/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-12,A0592981,Clinical,Castle Hill Hospital,Alan Barreda,Guardant 360,2.11,GHI_19,Self-Pay Patient,Head and neck adenocarcinoma,10/20/2022,10/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-12,A0592958,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/19/2022,10/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-10,1.1292,2529.408,2000-3000$ 
GB,2022-10-12,A0592975,Clinical,Guys Hospital,Ailsa Lumsden,Guardant 360,,GHI_19,Self-Pay Patient,Gastric adenocarcinoma,10/25/2022,10/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-12,A0592997,Clinical,Guys Hospital,Hannah Cheney Lowe,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/19/2022,10/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-12,A0592990,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,10/19/2022,10/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-10,1.1292,2459.3976,2000-3000$ 
GB,2022-10-12,A0592846,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/19/2022,10/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
GB,2022-10-12,A0592995,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Arvind Tripathy,Guardant 360,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),10/26/2022,10/26/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-12,A0592996,Clinical,Queen Alexandra Hospital,Giuseppe Banna,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,10/19/2022,10/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-13,A0593678,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,10/19/2022,10/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-10,1.1292,2459.3976,2000-3000$ 
ES,2022-10-13,A0593657,Clinical,Hospital Vithas Xanit Internacional,Roberto Wolman,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/19/2022,11/4/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 EUR,2490.0,2022-10,0.9833,2448.417,2000-3000$ 
GB,2022-10-13,A0593711,Clinical,Berkshire Cancer Centre,Ruth Davis,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/26/2022,10/26/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-10,1.1292,2529.408,2000-3000$ 
ES,2022-10-13,A0593374,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,10/19/2022,10/19/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2366 EUR,2366.0,2022-10,0.9833,2326.4878,2000-3000$ 
TR,2022-10-13,A0593688,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,10/23/2022,10/23/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-10,1.0,2319.0,2000-3000$ 
GB,2022-10-13,A0593719,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,10/21/2022,10/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
ES,2022-10-13,A0593384,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,10/19/2022,10/19/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-10,0.9833,1224.2085,0-1500$ 
GB,2022-10-13,A0593355,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/26/2022,10/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-10,1.1292,2529.408,2000-3000$ 
GB,2022-10-13,A0593583,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,10/23/2022,10/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
GB,2022-10-14,A0594456,Clinical,Addenbrooke's Hospital,Elizabeth Smyth,Guardant 360,,GHI_19,Self-Pay Patient,Gastric adenocarcinoma,10/20/2022,10/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
GB,2022-10-14,A0594439,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/20/2022,10/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
GB,2022-10-14,A0594445,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/3/2022,11/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
GB,2022-10-14,A0594479,Clinical,The Christie Hospital,Alexander Lee,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,10/20/2022,10/27/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
GB,2022-10-14,A0594431,Clinical,St Georges Hospital,Yee-Ean Ong,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/20/2022,10/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
CA,2022-10-14,A0594375,Clinical,MacKenzie Richmond Hill Hospital,Francis Patafio,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,10/23/2022,10/23/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,Reveal,2022Q4,Canada,Free,0 USD,0.0,2022-10,1.0,0.0,0 $
TR,2022-10-14,A0594062,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,10/26/2022,10/26/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-10,1.0,2319.0,2000-3000$ 
MX,2022-10-14,A0594471,Clinical,MileniaLabs,Gabriela Olivia Regalado Porras,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,10/24/2022,11/2/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,2500 USD,2500.0,2022-10,0.9833,2458.25,2000-3000$ 
GB,2022-10-14,A0594427,Clinical,"Walsall Healthcare NHS Trust, Manor Hospital",Victoria Kunene,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/20/2022,10/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
IE,2022-10-14,A0594461,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/19/2022,3/14/2023,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-10,0.9833,1224.2085,0-1500$ 
GB,2022-10-14,A0594488,Clinical,St Georges Hospital,Sophie Barker,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,10/20/2022,10/20/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
TR,2022-10-14,A0594448,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sahin Lacin,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,10/25/2022,10/25/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,0,0.0,2022-10,1.0,0.0,0 $
CA,2022-10-15,A0594753,Clinical,Sir Mortimer B Davis Jewish General Hosp,Petr Kavan,Guardant Reveal,1.0,GHI_10,Do Not Bill - Cancelled,,11/9/2022,11/9/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,Reveal,2022Q4,Canada,Free,0 USD,0.0,2022-10,1.0,0.0,0 $
GB,2022-10-15,A0595301,Clinical,HCA Laboratories,Eleni Karapanagiotou,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/23/2022,10/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-10,1.1292,2459.3976,2000-3000$ 
GB,2022-10-17,A0595627,Clinical,Freeman Hospital,Alastair Greystoke,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/24/2022,10/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
ES,2022-10-17,A0595588,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/1/2022,11/1/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-10,0.9833,1224.2085,0-1500$ 
GB,2022-10-17,A0595563,Clinical,Musgrove Park Hospital,Simon Barnes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/2/2022,11/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-17,A0595622,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/23/2022,11/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
GB,2022-10-17,A0595580,Clinical,Beatson West of Scotland Cancer Centre,Aitzaz Qaisar,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/23/2022,10/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
BR,2022-10-17,A0595618,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Salivary gland carcinoma,10/23/2022,10/23/2022,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-10,1.0,1750.0,1500-2000$ 
BR,2022-10-17,A0595612,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/23/2022,10/23/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-10,1.0,1750.0,1500-2000$ 
GB,2022-10-17,A0595567,Clinical,Clatterbridge cancer Center,Carles Escriu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Large cell lung carcinoma,10/25/2022,10/25/2022,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
TR,2022-10-17,A0595519,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,10/25/2022,10/25/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1890,1890.0,2022-10,1.0,1890.0,1500-2000$ 
TR,2022-10-17,A0595581,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Do Not Bill - Cancelled,,11/8/2022,11/8/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,0,0.0,2022-10,1.0,0.0,0 $
GB,2022-10-18,A0596135,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,10/25/2022,10/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-10,1.1292,2459.3976,2000-3000$ 
GB,2022-10-18,A0596141,Clinical,Queen Alexandra Hospital,Sethupathi Ramalingam,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/7/2022,11/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
GB,2022-10-18,A0596158,Clinical,The Royal Marsden NHS Foundation Trust,David Watkins,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,10/25/2022,10/25/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
GB,2022-10-19,A0597004,Clinical,Southampton General Hospital,Almurtadha Mula-Kh,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Pancreatic ductal adenocarcinoma,11/9/2022,11/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-19,A0596990,Clinical,Huddersfield Royal Infirmary,Nick Brown,Guardant 360,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),10/26/2022,10/26/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
ES,2022-10-19,A0596986,Clinical,Hospital Universitario HM Sanchinarro,Carmen Martin Mesa,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,10/26/2022,10/26/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2240 EUR,2240.0,2022-10,0.9833,2202.592,2000-3000$ 
DE,2022-10-19,A0603487,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,11/2/2022,11/2/2022,GERMANY,Commercial,GI,GERMANY,1,non_AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Free,0 EUR,0.0,2022-10,0.9833,0.0,0 $
GB,2022-10-19,A0596962,Clinical,Spire Little Aston Hospital,Mojca Persic,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/26/2022,10/26/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-10,1.1292,2529.408,2000-3000$ 
GB,2022-10-19,A0596963,Clinical,The Royal Marsden NHS Foundation Trust,Ian Chau,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,11/1/2022,11/1/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
GB,2022-10-19,A0596992,Clinical,Singleton Hospital,Owen Nicholas,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/26/2022,10/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
DE,2022-10-19,A0596976,Clinical,Universitaetsklinikum Freiburg,Sonja Ganz,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Small cell lung carcinoma,10/24/2022,10/24/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 EUR,0.0,2022-10,0.9833,0.0,0 $
CA,2022-10-19,A0596956,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,10/28/2022,10/28/2022,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Canada,Paid,1700 USD,1700.0,2022-10,1.0,1700.0,1500-2000$ 
ES,2022-10-19,A0596982,Clinical,Hospital La Luz,Esther Holgado Martin,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/10/2022,11/10/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 EUR,2490.0,2022-10,0.9833,2448.417,2000-3000$ 
GB,2022-10-20,A0597747,Clinical,Guys Hospital,Angela Swampillai,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/28/2022,10/28/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
TR,2022-10-20,A0597736,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,10/31/2022,10/31/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-10,1.0,2319.0,2000-3000$ 
GB,2022-10-20,A0597723,Clinical,Genesis Care,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/26/2022,10/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
ES,2022-10-20,A0597820,Clinical,Hospital Quiron Barcelona,Aleix Prat,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,10/28/2022,10/28/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,2241 EUR,2241.0,2022-10,0.9833,2203.5753,2000-3000$ 
GB,2022-10-20,A0597843,Clinical,Addenbrooke's Hospital,Anna Shiarli,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/27/2022,11/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
FR,2022-10-20,A0597827,Clinical,"APHP, Tenon Hospital",Joseph Gligorv,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/26/2022,10/26/2022,FRANCE,Commercial,Breast,FRANCE,1,non_AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 EUR,0.0,2022-10,0.9833,0.0,0 $
CA,2022-10-20,A0597822,Clinical,Westglen Medical,Lisa Friedland,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/26/2022,10/26/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Canada,Free,0 USD,0.0,2022-10,1.0,0.0,0 $
GB,2022-10-21,A0598088,Clinical,The Royal Marsden NHS Foundation Trust,Sophie McGrath,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/29/2022,10/29/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
GB,2022-10-21,A0598358,Clinical,Charing Cross Hospital Medical Oncology Department,Laura Kenny,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/29/2022,10/29/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
CA,2022-10-21,A0598431,Clinical,Markham Stouffville Hospital,Sam Babak,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/31/2022,10/31/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Canada,Free,0 USD,0.0,2022-10,1.0,0.0,0 $
ES,2022-10-21,A0598025,Clinical,Hospital Universitario Puerta De Hierro,Juan Cristobal Sanchez Gonzalez,Guardant 360,,GHI_19,Self-Pay Patient,Other,10/29/2022,11/3/2022,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-10,0.9833,1224.2085,0-1500$ 
GB,2022-10-21,A0598363,Clinical,Guys Hospital,Danielle Crawley,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,10/29/2022,10/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
ES,2022-10-24,A0600309,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/2/2022,11/2/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2240 EUR,2240.0,2022-10,0.9833,2202.592,2000-3000$ 
MX,2022-10-24,A0600266,Clinical,MileniaLabs,Ivan Romarico Gonzalez Espinoza,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Colorectal adenocarcinoma,11/1/2022,11/1/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,2500 USD,2500.0,2022-10,0.9833,2458.25,2000-3000$ 
ES,2022-10-24,A0600255,Clinical,Hospital Universitario Insular de Gran Canaria,Delvys Rodriguez Abreu,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/1/2022,11/4/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-10,0.9833,1224.2085,0-1500$ 
GB,2022-10-24,A0600261,Clinical,Singleton Hospital,Sarah Gwynne,Guardant 360,,GHI_19,Self-Pay Patient,Esophageal adenocarcinoma,10/31/2022,10/31/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
TR,2022-10-24,A0600263,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,11/2/2022,11/2/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,0,0.0,2022-10,1.0,0.0,0 $
ES,2022-10-24,A0600305,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,10/31/2022,10/31/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2240 EUR,2240.0,2022-10,0.9833,2202.592,2000-3000$ 
TR,2022-10-24,A0600303,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,11/1/2022,11/1/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1890,1890.0,2022-10,1.0,1890.0,1500-2000$ 
TR,2022-10-24,A0600245,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,11/2/2022,11/2/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-10,1.0,2319.0,2000-3000$ 
GB,2022-10-24,A0600252,Clinical,The Holly Private Hospital,Sherif Raouf,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/1/2022,11/1/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
GB,2022-10-25,A0601124,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Katy Herring,Guardant 360,2.11,GHI_19,Self-Pay Patient,Breast Carcinoma,11/2/2022,11/2/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
CA,2022-10-25,A0601135,Clinical,Dr. Lori Coman-Wood's Office,Lori Coman-Wood,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,10/31/2022,10/31/2022,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Canada,Free,0 USD,0.0,2022-10,1.0,0.0,0 $
IT,2022-10-25,A0601127,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/2/2022,11/2/2022,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2000 EUR,2000.0,2022-10,0.9833,1966.6,1500-2000$ 
GB,2022-10-26,A0601923,Clinical,Maidstone and Tunbridge Wells NHS Trust,Mark Hill,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,11/8/2022,11/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
ES,2022-10-26,A0601878,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/2/2022,11/2/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-10,0.9833,1224.2085,0-1500$ 
GB,2022-10-26,A0601881,Clinical,HCA Laboratories,Mark Harries,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,11/2/2022,11/2/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-10,1.1292,2459.3976,2000-3000$ 
GB,2022-10-26,A0601931,Clinical,Maidstone and Tunbridge Wells NHS Trust,Julia Hall,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/2/2022,11/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
ES,2022-10-26,A0601880,Clinical,Clinica Universidad de Navarra-Madrid,Javier Rodriguez,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/11/2022,11/11/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2400 USD,2400.0,2022-10,0.9833,2359.92,2000-3000$ 
BR,2022-10-27,A0602305,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,11/7/2022,11/7/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-10,1.0,1750.0,1500-2000$ 
DE,2022-10-27,A0602403,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,11/3/2022,11/3/2022,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Free,0 EUR,0.0,2022-10,0.9833,0.0,0 $
MX,2022-10-27,A0602443,Clinical,ABC Hospital,Gabriela Olivia Regalado Porras,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,11/2/2022,11/2/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,3316 USD,3316.0,2022-10,0.9833,3260.6227999999996,3000+ $
GB,2022-10-27,A0603124,Clinical,Guys Hospital,Saoirse Dolly,Guardant 360,,GHI_19,Self-Pay Patient,Duodenal Adenocarcinoma,11/2/2022,11/2/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
ES,2022-10-27,A0602378,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant 360,2.12,GH2_12,Do Not Bill - Cancelled,,,8/25/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,0 EUR,0.0,2022-10,0.9833,0.0,0 $
GB,2022-10-27,A0602362,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/2/2022,11/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
MX,2022-10-27,A0602438,Clinical,MileniaLabs,Salvador Cardona,Guardant 360,2.11,GHI_01,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),11/4/2022,11/4/2022,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,2500 USD,2500.0,2022-10,0.9833,2458.25,2000-3000$ 
ES,2022-10-27,A0602383,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,11/2/2022,11/2/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 Infinity,2022Q4,Europe,Paid,2400 USD,2400.0,2022-10,0.9833,2359.92,2000-3000$ 
GB,2022-10-27,A0602211,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/2/2022,11/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
BR,2022-10-27,A0602291,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Head and neck carcinoma,11/2/2022,11/2/2022,BRAZIL,Commercial,Head and neck carcinoma,BRAZIL,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-10,1.0,1750.0,1500-2000$ 
CA,2022-10-27,A0602444,Clinical,London Health Sciences Centre,Paul Stewart,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,11/5/2022,11/5/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,Reveal,2022Q4,Canada,Free,0 USD,0.0,2022-10,1.0,0.0,0 $
GB,2022-10-27,A0602425,Clinical,Guys Hospital,Danielle Crawley,Guardant 360,,GHI_19,Self-Pay Patient,Renal Cell Carcinoma,11/2/2022,11/2/2022,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-28,A0603884,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,11/3/2022,11/3/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-10,1.1292,2811.708,2000-3000$ 
GB,2022-10-28,A0603867,Clinical,University Hospitals Of Leicester,Sabri Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/4/2022,11/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-28,A0603800,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,11/3/2022,11/3/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
GB,2022-10-28,A0603805,Clinical,Bristol Haematology and Oncology Centre,Vivek Mohan,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/3/2022,11/3/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
CA,2022-10-28,A0613763,Clinical,Sir Mortimer B Davis Jewish General Hosp,Petr Kavan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/22/2022,11/22/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Canada,Paid,1700 USD,1700.0,2022-10,1.0,1700.0,1500-2000$ 
GB,2022-10-28,A0603861,Clinical,Queen Alexandra Hospital,Mya Gyi,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/3/2022,11/3/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
GB,2022-10-28,A0603855,Clinical,Bupa Cromwell Hospital,Robert Leonard,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/3/2022,11/22/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-10,1.1292,1405.854,0-1500$ 
GB,2022-10-28,A0603794,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,,GHI_19,Distributors : ROW,Prostate adenocarcinoma,11/9/2022,11/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-10,1.1292,2459.3976,2000-3000$ 
GB,2022-10-28,A0603784,Clinical,Poole Hospital NHS Foundation Trust,Chris Davies,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,11/3/2022,11/3/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-10,1.1292,0.0,0 $
ES,2022-10-31,A0604621,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,11/4/2022,11/4/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2022,4,1,2022-10-01,2022-10,G360 CDx,2022Q4,Europe,Paid,2240 EUR,2240.0,2022-10,0.9833,2202.592,2000-3000$ 
IT,2022-11-01,A0605133,Clinical,Fondazione IRCCS Istituto Nazionale dei Tumori,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/6/2022,11/6/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 EUR,0.0,2022-11,0.979964,0.0,0 $
GB,2022-11-01,A0605178,Clinical,The Nuffield Hospital Guildford,Robert Laing,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/10/2022,11/10/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-11,1.173461,2628.5526400000003,2000-3000$ 
GB,2022-11-01,A0605165,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,11/13/2022,11/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-01,A0605176,Clinical,The Nuffield Hospital Guildford,Robert Laing,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/7/2022,11/8/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-02,A0605408,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,11/7/2022,11/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
GB,2022-11-02,A0605811,Clinical,St Bartholomews Hospital,Marco Gerlinger,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,11/7/2022,11/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
TR,2022-11-02,A0605814,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Osman Gokhan Demir,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung cancer,11/8/2022,11/8/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Paid,1838,1838.0,2022-11,1.0,1838.0,1500-2000$ 
DE,2022-11-02,A0605817,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,11/12/2022,4/14/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Paid,3341 EUR,3341.0,2022-11,0.979964,3274.0597239999997,3000+ $
GB,2022-11-03,A0606584,Clinical,Guys Hospital,James Spicer,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/9/2022,11/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-03,A0606563,Clinical,Sarah Cannon Research Institute-UK-CUPLB,Mario Uccello,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/9/2022,11/9/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
TR,2022-11-03,A0606586,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Nil Mandel,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,11/9/2022,11/10/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-11,1.0,2319.0,2000-3000$ 
TR,2022-11-03,A0606576,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Nezih Meydan,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,11/14/2022,12/6/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Free,0,0.0,2022-11,1.0,0.0,0 $
FR,2022-11-03,A0606607,Clinical,"APHP, Tenon Hospital",Joseph Gligorv,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/9/2022,11/9/2022,FRANCE,Commercial,Breast,FRANCE,1,non_AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0,0.0,2022-11,0.979964,0.0,0 $
GB,2022-11-03,A0606555,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/9/2022,11/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-11,1.173461,2628.5526400000003,2000-3000$ 
GB,2022-11-04,A0607512,Clinical,Guys Hospital,Daniel Hughes,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/11/2022,11/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-04,A0607481,Clinical,Guys Hospital,Sarah Rudman,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,11/9/2022,11/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-04,A0607394,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant 360,2.11,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,11/23/2022,11/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-04,A0607488,Clinical,United Lincolnshire Hospitals NHS Trust,Walter Mmeka,Guardant 360,,GHI_19,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),11/9/2022,11/9/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-11,1.173461,2921.91789,2000-3000$ 
CA,2022-11-04,A0607524,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,11/13/2022,11/13/2022,CANADA,Commercial,Other,CANADA,1,AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Canada,Free,0 USD,0.0,2022-11,1.0,0.0,0 $
IT,2022-11-04,A0607515,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/11/2022,11/11/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2000 EUR,2000.0,2022-11,0.979964,1959.9279999999999,1500-2000$ 
ES,2022-11-05,A0607995,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,11/13/2022,11/13/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-11,0.979964,1220.0551799999998,0-1500$ 
GB,2022-11-05,A0607979,Clinical,HCA Laboratories,Nikolaos Diamantis,Guardant360 CDx,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,11/17/2022,11/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
ES,2022-11-05,A0608031,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,11/11/2022,11/11/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-11,0.979964,1220.0551799999998,0-1500$ 
GB,2022-11-05,A0607992,Clinical,HCA Laboratories,Jonathan Waxman,Guardant360 CDx,,GHI_19,Distributors : ROW,Prostate adenocarcinoma,11/17/2022,11/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
GB,2022-11-05,A0608021,Clinical,HCA Laboratories,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/11/2022,11/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
GB,2022-11-07,A0608259,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,11/11/2022,11/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
TR,2022-11-07,A0608258,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Cholangiocarcinoma,11/11/2022,11/11/2022,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-11,1.0,1838.0,1500-2000$ 
ES,2022-11-07,A0608359,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,11/15/2022,11/15/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2240 EUR,2240.0,2022-11,0.979964,2195.1193599999997,2000-3000$ 
DE,2022-11-07,A0608328,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Endometrial carcinoma,11/16/2022,11/16/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Free,0 EUR,0.0,2022-11,0.979964,0.0,0 $
GB,2022-11-07,A0608248,Clinical,Castle Hill Hospital,Annet Pillai,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/11/2022,11/11/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
TR,2022-11-07,A0608296,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gul Basaran,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,11/11/2022,11/15/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-11,1.0,1838.0,1500-2000$ 
GB,2022-11-07,A0608278,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,11/11/2022,11/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-07,A0608294,Clinical,University Hospitals Of Leicester,Jaseela Chiramel,Guardant 360,,GHI_19,Do Not Bill - Cancelled,,11/10/2022,11/10/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-07,A0608320,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,11/13/2022,11/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-11,1.173461,2921.91789,2000-3000$ 
GB,2022-11-07,A0608352,Clinical,Queen Alexandra Hospital,Chit Cheng Yeoh,Guardant 360,,GHI_19,Self-Pay Patient,Melanoma,11/15/2022,11/15/2022,UNITED KINGDOM,Commercial,Skin,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-11,1.173461,2921.91789,2000-3000$ 
TR,2022-11-07,A0608339,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/13/2022,11/13/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-11,1.0,1838.0,1500-2000$ 
GB,2022-11-07,A0608242,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,11/11/2022,11/11/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-11,1.173461,2921.91789,2000-3000$ 
BR,2022-11-07,A0608244,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Head and neck carcinoma,11/13/2022,11/13/2022,BRAZIL,Commercial,Head and neck carcinoma,BRAZIL,1,AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-11,1.0,1750.0,1500-2000$ 
TR,2022-11-07,A0608344,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Papillary thyroid carcinoma,11/15/2022,12/7/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Free,0,0.0,2022-11,1.0,0.0,0 $
GB,2022-11-07,A0608275,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,11/12/2022,11/12/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
GB,2022-11-08,A0608835,Clinical,Southampton General Hospital,Almurtadha Mula-Kh,Guardant 360,,GHI_19,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,11/15/2022,11/15/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
PL,2022-11-09,A0609776,Clinical,Narodowy Instytut Onkologii,Lucjan Wyrwicz,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,11/17/2022,11/18/2022,POLAND,Commercial,,POLAND,1,non_AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Paid,2443 EUR,2443.0,2022-11,0.979964,2394.052052,2000-3000$ 
GB,2022-11-09,A0609691,Clinical,Guys Hospital,Sarah Rudman,Guardant 360,,GHI_19,Self-Pay Patient,Renal Cell Carcinoma,11/15/2022,11/15/2022,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-09,A0609818,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Tony Dhillon,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,11/16/2022,11/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-11,1.173461,2628.5526400000003,2000-3000$ 
GB,2022-11-09,A0609695,Clinical,The Holly Private Hospital,Eliot Sims,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/15/2022,11/15/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-11,1.173461,2628.5526400000003,2000-3000$ 
BR,2022-11-09,A0609805,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/16/2022,11/16/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-11,1.0,1750.0,1500-2000$ 
AR,2022-11-10,A0610555,Clinical,Oncologia Angel Roffo,Ana C. Adur,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/17/2022,11/17/2022,ARGENTINA,Commercial,,ARGENTINA,1,non_AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,South America,Paid,"USD 3,490.00",3490.0,2022-11,1.0,3490.0,3000+ $
GB,2022-11-10,A0610390,Clinical,Guys Hospital,Debra Josephs,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,11/16/2022,11/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-10,A0610415,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/16/2022,11/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
ES,2022-11-10,A0610512,Clinical,Hospital University La Paz,Javier de Castro Carpeno,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/17/2022,11/17/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 EUR,0.0,2022-11,0.979964,0.0,0 $
DE,2022-11-10,A0610475,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,11/18/2022,11/18/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Paid,3341 EUR,3341.0,2022-11,0.979964,3274.0597239999997,3000+ $
TR,2022-11-10,A0610571,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Bulent Karabulut,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/16/2022,11/17/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-11,1.0,1838.0,1500-2000$ 
GB,2022-11-10,A0610402,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/16/2022,11/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
GB,2022-11-10,A0610488,Clinical,"Queenâ€™s Hospital, Barking, Havering, and Redbridge Univ Hosp NHS Trust",Eliot Sims,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/19/2022,11/19/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-11,1.173461,2628.5526400000003,2000-3000$ 
GB,2022-11-10,A0610505,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,11/17/2022,11/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
GB,2022-11-10,A0610436,Clinical,The Royal Marsden NHS Foundation Trust,Hamzeh Kayhanian,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/16/2022,11/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-11,A0611164,Clinical,Freeman Hospital,John Frew,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,11/16/2022,11/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-11,A0610992,Clinical,Velindre Cancer Centre,Annabel Borley,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/18/2022,11/18/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-11,A0610922,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/17/2022,11/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-11,A0610996,Clinical,Clatterbridge Cancer Centre,Rajaram Sripadam,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/2/2022,12/2/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
ES,2022-11-12,A0611908,Clinical,Hospital General Universitario Gregorio Maranon,Andres Munoz,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,11/18/2022,11/18/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 EUR,0.0,2022-11,0.979964,0.0,0 $
ES,2022-11-12,A0611910,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/18/2022,11/18/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2400 USD,2400.0,2022-11,0.979964,2351.9136,2000-3000$ 
GB,2022-11-12,A0611913,Clinical,Clatterbridge Cancer Centre,Rajaram Sripadam,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,11/18/2022,11/18/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-14,A0612139,Clinical,GenesisCare Milton Keynes,Craig Macmillan,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/18/2022,7/20/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-11,1.173461,2921.91789,2000-3000$ 
BR,2022-11-14,A0612181,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,11/24/2022,11/24/2022,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,South America,Paid,1700 USD,1700.0,2022-11,1.0,1700.0,1500-2000$ 
TR,2022-11-14,A0612102,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,11/22/2022,11/22/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Free,0,0.0,2022-11,1.0,0.0,0 $
GB,2022-11-14,A0612024,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,11/21/2022,11/21/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-14,A0612165,Clinical,Bupa Cromwell Hospital,Robert Leonard,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/29/2022,11/29/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-14,A0612074,Clinical,North Middlesex University Hospital,Zaheer Mangera,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,11/20/2022,11/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-14,A0612154,Clinical,University Hospitals Of Leicester,Catherine Knox,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/21/2022,11/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-14,A0612186,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Other,11/28/2022,11/28/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-15,A0612699,Clinical,HCA Laboratories,Amen Sibtain,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,11/21/2022,11/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
GB,2022-11-16,A0613716,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,11/22/2022,11/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-16,A0613863,Clinical,Bupa Cromwell Hospital,Robert Leonard,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/22/2022,11/22/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-16,A0613875,Clinical,Castle Hill Hospital,Iqtedar Muazzam,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/22/2022,11/22/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-16,A0613705,Clinical,Maidstone and Tunbridge Wells NHS Trust,Thurkaa Shanmugalingam,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/22/2022,11/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-16,A0613799,Clinical,Guys Hospital,Julien De Naurois,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,11/22/2022,11/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
ES,2022-11-16,A0613804,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,2.11,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,12/12/2022,12/12/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2241 EUR,2241.0,2022-11,0.979964,2196.099324,2000-3000$ 
GB,2022-11-17,A0614651,Clinical,St Bartholomews Hospital,Farah Louise Lim,Guardant 360,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),11/24/2022,12/5/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-17,A0614109,Clinical,Clatterbridge cancer Center,Jonathan Heseltine,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/22/2022,11/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-17,A0614570,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/22/2022,11/22/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-11,1.173461,2628.5526400000003,2000-3000$ 
ES,2022-11-17,A0614266,Clinical,Fundacion Jimenez Diaz,Jaime Rubio Perez,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/22/2022,11/30/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-11,0.979964,1220.0551799999998,0-1500$ 
TR,2022-11-17,A0614333,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sinan Yavuz,Guardant 360,2.12,GH2_12,Distributors : ROW,Head and neck carcinoma,11/24/2022,11/24/2022,TURKEY,Commercial,Head and neck carcinoma,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-11,1.0,2319.0,2000-3000$ 
GB,2022-11-17,A0614603,Clinical,St Bartholomews Hospital,Adam Januszewski,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/24/2022,11/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-17,A0614564,Clinical,Guys Hospital,Boris Tocco,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/28/2022,11/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-17,A0614099,Clinical,Bronglais General Hospital,Elin Jones,Guardant 360,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),11/22/2022,11/22/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
ES,2022-11-17,A0614690,Clinical,Genesiscare Hospital San Francisco de Asis,Juan Pablo Fusco,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,11/24/2022,11/24/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 EUR,0.0,2022-11,0.979964,0.0,0 $
GB,2022-11-17,A0614320,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,11/23/2022,11/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
GB,2022-11-18,A0615740,Clinical,Clatterbridge cancer Center,Jonathan Heseltine,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,11/30/2022,11/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-18,A0615302,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,11/24/2022,11/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
BR,2022-11-18,A0615643,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,12/2/2022,12/2/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-11,1.0,1750.0,1500-2000$ 
CA,2022-11-18,A0615746,Clinical,Sault Area Hospital,Mohammad Rassouli,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,11/25/2022,11/25/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Canada,Free,0 USD,0.0,2022-11,1.0,0.0,0 $
GB,2022-11-18,A0615706,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Gastroesophageal junction carcinoma,11/29/2022,11/29/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
GB,2022-11-18,A0615734,Clinical,Singleton Hospital,Jason Lester,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,11/24/2022,5/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-11,1.173461,2628.5526400000003,2000-3000$ 
MX,2022-11-18,A0615633,Clinical,MileniaLabs,Gerardo Rodriguez Abrajan,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,11/27/2022,11/27/2022,MEXICO,Commercial,Breast,MEXICO,1,non_AE,EUR,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,South America,Paid,2500 USD,2500.0,2022-11,0.979964,2449.91,2000-3000$ 
ES,2022-11-18,A0615742,Clinical,Genesiscare Hospital San Francisco de Asis,Juan Diego Rodriguez,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/3/2022,12/3/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 EUR,0.0,2022-11,0.979964,0.0,0 $
GB,2022-11-18,A0615636,Clinical,Kettering General Hospital,George Tsaknis,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/24/2022,11/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-18,A0615313,Clinical,Guys Hospital,Harriet McGrath,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/27/2022,11/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-19,A0615945,Clinical,Guys Hospital,Maria Toki,Guardant 360,,GHI_19,Self-Pay Patient,Renal Cell Carcinoma,11/24/2022,11/24/2022,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-19,A0616176,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,11/24/2022,11/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
TR,2022-11-21,A0616662,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/29/2022,11/29/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-11,1.0,1838.0,1500-2000$ 
GB,2022-11-21,A0616615,Clinical,St Georges Hospital,Brian NG Cheng Hin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,12/5/2022,12/5/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-22,A0617062,Clinical,Genesis Care,Mark Hill,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,12/8/2022,12/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-11,1.173461,2921.91789,2000-3000$ 
GB,2022-11-22,A0617040,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/28/2022,3/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-23,A0617661,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,11/29/2022,11/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
ES,2022-11-23,A0617669,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/30/2022,11/30/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-11,0.979964,1220.0551799999998,0-1500$ 
GB,2022-11-23,A0617977,Clinical,Guys Hospital,Shabnam Rafiq,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,11/28/2022,11/28/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-23,A0618134,Clinical,The Royal Marsden Hospital,Merina Ahmed,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/30/2022,11/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-11,1.173461,2921.91789,2000-3000$ 
GB,2022-11-23,A0617992,Clinical,St Georges Hospital,Tim Benepal,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/13/2022,12/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-25,A0618811,Clinical,Eastbourne District General Hospital,Victoria Donovan,Guardant 360,,GHI_19,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),11/30/2022,11/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-25,A0618807,Clinical,Mount Alverina Hospital,Anthony Neal,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,12/8/2022,12/12/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
ES,2022-11-25,A0618853,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Other,12/5/2022,12/5/2022,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2240 EUR,2240.0,2022-11,0.979964,2195.1193599999997,2000-3000$ 
GB,2022-11-25,A0618841,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,11/30/2022,11/30/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-25,A0618783,Clinical,HCA Laboratories,Alison Jones,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,11/30/2022,11/30/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
CA,2022-11-25,A0618863,Clinical,BC Cancer centre - Vancouver,Sharlene Gill,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,12/3/2022,12/5/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,Reveal,2022Q4,Canada,Paid,3500 USD,3500.0,2022-11,1.0,3500.0,3000+ $
GB,2022-11-25,A0618778,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,11/30/2022,11/30/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
CL,2022-11-25,A0618818,Clinical,Clinica Las Condes,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,12/5/2022,12/5/2022,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,South America,Paid,1550 USD,1550.0,2022-11,1.0,1550.0,1500-2000$ 
GB,2022-11-25,A0618785,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,11/30/2022,11/30/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
ES,2022-11-25,A0618854,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,11/30/2022,11/30/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2400 USD,2400.0,2022-11,0.979964,2351.9136,2000-3000$ 
GB,2022-11-25,A0618855,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant360 CDx,,GHI_19,Distributors : ROW,Prostate adenocarcinoma,12/5/2022,12/5/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
BR,2022-11-25,A0618794,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,11/30/2022,11/30/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-11,1.0,1750.0,1500-2000$ 
BR,2022-11-25,A0618806,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/30/2022,11/30/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-11,1.0,1750.0,1500-2000$ 
GB,2022-11-28,A0619834,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Arshi Denton,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/3/2022,12/3/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
TR,2022-11-28,A0619840,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mehmet Ali Nahit Sehdur,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,12/6/2022,12/6/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Free,0,0.0,2022-11,1.0,0.0,0 $
TR,2022-11-28,A0619830,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sinan Yavuz,Guardant360 CDx,,GHI_19,Distributors : ROW,Testicular cancer,12/3/2022,12/3/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-11,1.0,1838.0,1500-2000$ 
GB,2022-11-28,A0619848,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/6/2022,12/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-11,1.173461,1460.958945,0-1500$ 
GB,2022-11-28,A0619849,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,12/3/2022,12/3/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
TR,2022-11-28,A0619877,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Bulent Karabulut,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/3/2022,12/3/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-11,1.0,1838.0,1500-2000$ 
GB,2022-11-28,A0619925,Clinical,Queen Alexandra Hospital,Sethupathi Ramalingam,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/4/2022,12/4/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-28,A0620000,Clinical,Poole Hospital NHS Foundation Trust,Diane Laws,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,12/6/2022,12/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
TR,2022-11-28,A0619829,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Aziz Karaoglu,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/3/2022,12/3/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-11,1.0,1838.0,1500-2000$ 
GB,2022-11-28,A0619824,Clinical,HCA Laboratories,Paul Ross,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,12/3/2022,12/3/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
GB,2022-11-29,A0621331,Clinical,The Lister Hospital,Thida Win,Guardant 360,,GHI_19,Self-Pay Patient,Other,12/6/2022,12/6/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-29,A0621314,Clinical,Eastbourne District General Hospital,Victoria Donovan,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,12/5/2022,12/5/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
GB,2022-11-29,A0621338,Clinical,The Royal Marsden Hospital,Paola Dâ€™arienzo,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/4/2022,12/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
CA,2022-11-29,A0621361,Clinical,RCM Health Consultancy,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/9/2022,12/9/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Canada,Paid,1700 USD,1700.0,2022-11,1.0,1700.0,1500-2000$ 
FR,2022-11-30,A0622064,Clinical,HEGP Hopital Europeen Georges Pompidou - AP-HP,Julien Taeib,Guardant 360,,GHI_19,Self-Pay Patient,Leiomyosarcoma,12/8/2022,12/8/2022,FRANCE,Commercial,Soft Tissue/Bone,FRANCE,1,non_AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0,0.0,2022-11,0.979964,0.0,0 $
DE,2022-11-30,A0622104,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,12/7/2022,12/7/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,11,2022,4,1,2022-11-01,2022-11,G360 Infinity,2022Q4,Europe,Paid,3341 EUR,3341.0,2022-11,0.979964,3274.0597239999997,3000+ $
GB,2022-11-30,A0622096,Clinical,Bupa Cromwell Hospital,Robert Leonard,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/6/2022,12/6/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-11,1.173461,0.0,0 $
TR,2022-11-30,A0622499,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Suna Cokmert,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/13/2022,12/13/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-11,1.0,1838.0,1500-2000$ 
GB,2022-11-30,A0622081,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,12/6/2022,12/6/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2022,4,1,2022-11-01,2022-11,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-11,1.173461,2555.7980580000003,2000-3000$ 
GB,2022-12-01,A0623312,Clinical,Charing Cross Hospital Medical Oncology Department,Tasnuma Haque,Guardant 360,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/8/2022,12/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
IT,2022-12-01,A0623033,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/6/2022,12/6/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2000 EUR,2000.0,2022-12,0.94477,1889.54,1500-2000$ 
IT,2022-12-01,A0622974,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/7/2022,12/7/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2000 EUR,2000.0,2022-12,0.94477,1889.54,1500-2000$ 
GB,2022-12-01,A0623339,Clinical,Guys Hospital,Maria Toki,Guardant 360,,GHI_19,Self-Pay Patient,Renal Cell Carcinoma,12/7/2022,12/7/2022,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-01,A0623340,Clinical,Guys Hospital,Kate Smith,Guardant 360,2.11,GHI_19,Self-Pay Patient,Chromophobe Renal Carcinoma,12/7/2022,12/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-01,A0623231,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/7/2022,12/7/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-12,1.217075,3030.51675,3000+ $
GB,2022-12-01,A0622822,Clinical,Bristol Haematology and Oncology Centre,Adam Dangoor,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,12/8/2022,12/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-01,A0623313,Clinical,Guys Hospital,Shabnam Rafiq,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/9/2022,12/9/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
TR,2022-12-02,A0623735,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Bulent Karabulut,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/8/2022,12/8/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
ES,2022-12-02,A0623682,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,12/8/2022,12/8/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-12,0.94477,1176.23865,0-1500$ 
ES,2022-12-02,A0623722,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,12/7/2022,12/7/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2240 EUR,2240.0,2022-12,0.94477,2116.2848,2000-3000$ 
TR,2022-12-02,A0623879,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kerem Okutur,Guardant360 CDx,2.12,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/9/2022,12/9/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
GB,2022-12-02,A0624023,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,12/7/2022,12/7/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
GB,2022-12-03,A0625039,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,12/9/2022,12/9/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
GB,2022-12-03,A0625122,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/8/2022,12/8/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
TR,2022-12-05,A0625307,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ahmet Sezer,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/9/2022,12/9/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
GB,2022-12-05,A0625325,Clinical,Clatterbridge Cancer Centre,Yvonne Blakemore,Guardant 360,,GHI_19,Self-Pay Patient,Large cell lung carcinoma,12/9/2022,12/9/2022,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-05,A0625366,Clinical,Guys Hospital,Angela Swampillai,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/10/2022,12/10/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
ES,2022-12-05,A0625348,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,12/9/2022,12/9/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 USD,0.0,2022-12,0.94477,0.0,0 $
GB,2022-12-05,A0625395,Clinical,HCA Laboratories,Nicholas Maisey,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/9/2022,12/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-12,1.217075,3030.51675,3000+ $
GB,2022-12-06,A0626187,Clinical,Whittington Hospital,Emma Spurrell,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/14/2022,12/14/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-06,A0626182,Clinical,The Royal Marsden NHS Foundation Trust,Karla Lee,Guardant 360,2.11,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/10/2022,12/12/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-07,A0626781,Clinical,Guys Hospital,Gehan Soosaipillai,Guardant 360,2.11,GHI_01,Self-Pay Patient,Appendix adenocarcinoma,12/12/2022,12/13/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-07,A0626955,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,12/12/2022,12/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
GB,2022-12-07,A0626808,Clinical,Guys Hospital,Gehan Soosaipillai,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/21/2022,12/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
IT,2022-12-07,A0626819,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/13/2022,12/13/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2000 EUR,2000.0,2022-12,0.94477,1889.54,1500-2000$ 
GB,2022-12-07,A0626585,Clinical,Genesis Care,Mark Hill,Guardant360 CDx EU,2.11,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,12/16/2022,12/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-12,1.217075,2726.2479999999996,2000-3000$ 
GB,2022-12-07,A0626956,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,12/12/2022,12/13/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
FR,2022-12-07,A0626791,Clinical,HEGP Hopital Europeen Georges Pompidou - AP-HP,Julien Taeib,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/12/2022,12/13/2022,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 EUR,0.0,2022-12,0.94477,0.0,0 $
TR,2022-12-07,A0626778,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Ovarian carcinoma,12/13/2022,12/14/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-12,1.0,2319.0,2000-3000$ 
ES,2022-12-07,A0626777,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/13/2022,12/13/2022,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2366 EUR,2366.0,2022-12,0.94477,2235.32582,2000-3000$ 
DE,2022-12-07,A0626786,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,12/14/2022,12/15/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,3341 EUR,3341.0,2022-12,0.94477,3156.47657,3000+ $
CA,2022-12-07,A0634745,Clinical,Sir Mortimer B Davis Jewish General Hosp,Petr Kavan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/25/2022,12/25/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Canada,Paid,1700 USD,1700.0,2022-12,1.0,1700.0,1500-2000$ 
GB,2022-12-07,A0626770,Clinical,HCA Laboratories,Susan Cleator,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,12/12/2022,12/13/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
GB,2022-12-07,A0626527,Clinical,Guys Hospital,Emma Beddowes,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/12/2022,12/12/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-08,A0627679,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sophie Otter,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/13/2022,12/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-12,1.217075,2726.2479999999996,2000-3000$ 
GB,2022-12-08,A0627681,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Arshi Denton,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/13/2022,12/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-08,A0627684,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,12/14/2022,12/24/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-08,A0627680,Clinical,St Georges Hospital,Tim Benepal,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/20/2022,12/20/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-12,1.217075,2726.2479999999996,2000-3000$ 
GB,2022-12-08,A0627554,Clinical,Southend University Hospital,Gulshad Begum,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/13/2022,12/13/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
BR,2022-12-08,A0627666,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/14/2022,12/14/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-12,1.0,1750.0,1500-2000$ 
BR,2022-12-08,A0627636,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/13/2022,12/13/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-12,1.0,1750.0,1500-2000$ 
GB,2022-12-08,A0627682,Clinical,Western General Hospital - Edinburgh Cancer Centre,Almudena Cascales,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/19/2022,12/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
BR,2022-12-08,A0627645,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/13/2022,12/13/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-12,1.0,1750.0,1500-2000$ 
GB,2022-12-09,A0628413,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,12/19/2022,12/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,Reveal,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-09,A0628388,Clinical,Charing Cross Hospital Medical Oncology Department,Waleed Mohammed,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/13/2022,12/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-09,A0628404,Clinical,Southampton General Hospital,Almurtadha Mula-Kh,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,12/23/2022,12/23/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-09,A0628364,Clinical,Queen Alexandra Hospital,Hannah Bainbridge,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/14/2022,12/14/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
CA,2022-12-09,A0628398,Clinical,Markham Stouffville Hospital,Mateya Trinkaus,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/13/2022,12/14/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Canada,Free,0 USD,0.0,2022-12,1.0,0.0,0 $
GB,2022-12-09,A0628393,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/15/2022,12/15/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
TR,2022-12-09,A0628394,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Urothelial carcinoma,12/18/2022,12/19/2022,TURKEY,Commercial,Urothelial,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-12,1.0,2319.0,2000-3000$ 
GB,2022-12-09,A0628368,Clinical,Velindre Cancer Centre,Samantha Cox,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,12/15/2022,12/15/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-10,A0630019,Clinical,Singleton Hospital,Nia Jackson,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/16/2022,12/16/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-10,A0630021,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,12/28/2022,1/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
GB,2022-12-10,A0630008,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Other,12/16/2022,12/17/2022,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
GB,2022-12-10,A0630040,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,12/17/2022,12/17/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
TR,2022-12-12,A0634115,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/23/2022,12/23/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
ES,2022-12-12,A0630220,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,,GHI_19,Distributors : ROW,Anal Carcinoma,12/16/2022,12/16/2022,SPAIN,Commercial,CRC,SPAIN,1,AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2400 USD,2400.0,2022-12,0.94477,2267.448,2000-3000$ 
GB,2022-12-12,A0630223,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,12/16/2022,12/16/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-12,1.217075,3030.51675,3000+ $
TR,2022-12-12,A0630199,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,74-Gene Panel,,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/23/2022,12/23/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
TR,2022-12-12,A0630201,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,74-Gene Panel,,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/16/2022,12/17/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
TR,2022-12-12,A0630222,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ozlem Yersal,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,12/19/2022,12/20/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,0,0.0,2022-12,1.0,0.0,0 $
GB,2022-12-13,A0630827,Clinical,The Royal Marsden Hospital,Naureen Starling,Guardant 360,,GHI_19,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),12/18/2022,12/18/2022,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-13,A0630962,Clinical,HCA Laboratories,Elisa Fontana,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,12/19/2022,12/19/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
GB,2022-12-13,A0630999,Clinical,Queen Alexandra Hospital,Mya Gyi,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/18/2022,12/18/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
CA,2022-12-14,A0631617,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,12/20/2022,12/30/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Canada,Paid,1700 USD,1700.0,2022-12,1.0,1700.0,1500-2000$ 
TR,2022-12-15,A0632436,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sinan Yavuz,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,12/21/2022,12/22/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-12,1.0,2319.0,2000-3000$ 
GB,2022-12-15,A0632461,Clinical,Clatterbridge cancer Center,Carles Escriu,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,12/28/2022,12/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,??,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-15,A0632364,Clinical,The Royal Marsden NHS Foundation Trust,David Cunningham,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,12/21/2022,12/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-15,A0632373,Clinical,Guys Hospital,Debra Josephs,Guardant 360,2.12,GH2_12,Self-Pay Patient,Prostate adenocarcinoma,12/25/2022,12/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
BR,2022-12-15,A0632388,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/22/2022,12/23/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-12,1.0,1750.0,1500-2000$ 
DE,2022-12-15,A0632393,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,12/26/2022,12/26/2022,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,3341 EUR,3341.0,2022-12,0.94477,3156.47657,3000+ $
GB,2022-12-15,A0632399,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,12/20/2022,12/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
GB,2022-12-15,A0632391,Clinical,St Georges Hospital,Krishnie Srikandarajah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/20/2022,12/21/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
TR,2022-12-16,A0633162,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ibrahim Yildiz,Guardant360 CDx,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,12/25/2022,12/25/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
ES,2022-12-16,A0633119,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,12/27/2022,12/28/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-12,0.94477,1176.23865,0-1500$ 
GB,2022-12-16,A0634757,Clinical,York Hospital,Mohieldin Mohamed,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/25/2022,12/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
IT,2022-12-16,A0633183,Clinical,Fondazione Poliambulanza Istituto Ospedaliero,Alberto Zaniboni,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/22/2022,12/22/2022,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 EUR,0.0,2022-12,0.94477,0.0,0 $
GB,2022-12-16,A0633145,Clinical,Poole Hospital NHS Foundation Trust,Kar Mun Ang,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,12/23/2022,12/23/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
ES,2022-12-16,A0633100,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,12/24/2022,12/24/2022,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-12,0.94477,1176.23865,0-1500$ 
CA,2022-12-17,A0633860,Clinical,Marsden Centre,Kim Rovers,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,12/24/2022,12/24/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,Reveal,2022Q4,Canada,Free,0 USD,0.0,2022-12,1.0,0.0,0 $
GB,2022-12-17,A0633791,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/24/2022,12/25/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-12,1.217075,3030.51675,3000+ $
CA,2022-12-17,A0633775,Clinical,Princess Margaret Cancer Centre,Robert Grant,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,12/23/2022,12/23/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Canada,Free,0 USD,0.0,2022-12,1.0,0.0,0 $
TR,2022-12-19,A0633962,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sinan Yavuz,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,12/25/2022,12/26/2022,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-12,1.0,2319.0,2000-3000$ 
BR,2022-12-19,A0634218,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/25/2022,12/25/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-12,1.0,1750.0,1500-2000$ 
GB,2022-12-19,A0633983,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/25/2022,3/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
TR,2022-12-19,A0633980,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Fatih Selcukbiricik,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,12/28/2022,12/28/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-12,1.0,2319.0,2000-3000$ 
GB,2022-12-20,A0634737,Clinical,Bradford Teaching Hospitals NHS Foundation Trust,Shazza Rehman,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/24/2022,12/25/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-12,1.217075,3030.51675,3000+ $
GB,2022-12-20,A0634653,Clinical,Guys Hospital,Danielle Crawley,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,12/25/2022,12/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-20,A0634696,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/25/2022,12/25/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-21,A0635602,Clinical,Aberdeen Royal Infirmary,Gordon Urquhart,74-Gene Panel,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/28/2022,12/29/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-21,A0635341,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sophie Otter,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,12/25/2022,12/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2240 GBP,2240.0,2022-12,1.217075,2726.2479999999996,2000-3000$ 
GB,2022-12-21,A0635587,Clinical,The Royal Marsden NHS Foundation Trust,Ian Chau,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,12/25/2022,12/26/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-12,1.217075,3030.51675,3000+ $
GB,2022-12-21,A0635287,Clinical,Guys Hospital,Debra Josephs,Guardant 360,2.12,GH2_12,Self-Pay Patient,Prostate adenocarcinoma,12/28/2022,12/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-21,A0635236,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,12/28/2022,12/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
BR,2022-12-21,A0635547,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,12/26/2022,12/26/2022,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-12,1.0,1750.0,1500-2000$ 
GB,2022-12-21,A0635298,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Non-small cell lung carcinoma (NSCLC),12/28/2022,12/28/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-12,1.217075,3030.51675,3000+ $
BR,2022-12-21,A0635552,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,12/25/2022,12/26/2022,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-12,1.0,1750.0,1500-2000$ 
ES,2022-12-21,A0635301,Clinical,Hospital Quiron Barcelona,Elvira Buxo Orra,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,12/28/2022,12/28/2022,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2241 EUR,2241.0,2022-12,0.94477,2117.22957,2000-3000$ 
BR,2022-12-21,A0635557,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Renal Cell Carcinoma,12/25/2022,12/26/2022,BRAZIL,Commercial,Kidney,BRAZIL,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-12,1.0,1750.0,1500-2000$ 
TR,2022-12-21,A0635278,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mehmet Akif Ozturk,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/25/2022,12/26/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
GB,2022-12-22,A0636351,Clinical,"Queenâ€™s Hospital, Barking, Havering, and Redbridge Univ Hosp NHS Trust",Eliot Sims,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/29/2022,12/29/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-12,1.217075,3030.51675,3000+ $
GB,2022-12-22,A0636306,Clinical,"NHS Highland, Raigmore Hospital, Inverness",Jane Barrett,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/27/2022,12/27/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
CA,2022-12-22,A0636350,Clinical,Princess Margaret Cancer Centre,Robert Grant,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,12/27/2022,12/28/2022,CANADA,Commercial,,CANADA,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Canada,Free,0 USD,0.0,2022-12,1.0,0.0,0 $
GB,2022-12-22,A0636326,Clinical,Singleton Hospital,Jason Lester,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,12/28/2022,5/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-22,A0636320,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,12/26/2022,5/11/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
TR,2022-12-22,A0636291,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kerem Okutur,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/27/2022,12/27/2022,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
GB,2022-12-22,A0636295,Clinical,Southend University Hospital,Mohammad Islam,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/28/2022,3/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-23,A0636713,Clinical,St James University Hospital,Kirsty Rodgers,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,1/7/2023,1/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-23,A0636739,Clinical,St James University Hospital,Martyn Kennedy,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/27/2022,12/27/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
ES,2022-12-23,A0636704,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,12/28/2022,7/3/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 EUR,1245.0,2022-12,0.94477,1176.23865,0-1500$ 
GB,2022-12-23,A0636751,Clinical,University Hospitals Coventry & Warwickshire NHS Trust,Michael Tilby,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,12/29/2022,1/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-24,A0637294,Clinical,Royal Free London NHS Foundation Trust,Amna Sheri,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,12/30/2022,1/4/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-24,A0637303,Clinical,Guys Hospital,Poppy Michoglou,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,12/29/2022,12/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
CA,2022-12-24,A0637354,Clinical,London Health Sciences Centre,Ana Lohman,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,1/9/2023,1/18/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Canada,Free,0 USD,0.0,2022-12,1.0,0.0,0 $
GB,2022-12-24,A0637291,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,12/29/2022,12/29/2022,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-24,A0637282,Clinical,The Royal Marsden Hospital,Jaishree Bhosle,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/5/2023,1/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-12,1.217075,3030.51675,3000+ $
GB,2022-12-24,A0637228,Clinical,St Bartholomews Hospital,Ami Mehta,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,12/28/2022,12/29/2022,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
GB,2022-12-24,A0637342,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,12/29/2022,12/29/2022,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2490 GBP,2490.0,2022-12,1.217075,3030.51675,3000+ $
GB,2022-12-24,A0637317,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,1/3/2023,1/3/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
GB,2022-12-27,A0637611,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,1/5/2023,3/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
TR,2022-12-28,A0638456,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sinan Yavuz,Guardant360 CDx,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,1/2/2023,1/2/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
GB,2022-12-28,A0638458,Clinical,HCA Laboratories,Mark Harries,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,1/15/2023,1/15/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,2178.75,2178.0,2022-12,1.217075,2650.78935,2000-3000$ 
IT,2022-12-28,A0638424,Clinical,Fondazione Poliambulanza Istituto Ospedaliero,Alberto Zaniboni,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,1/1/2023,1/1/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 EUR,0.0,2022-12,0.94477,0.0,0 $
GB,2022-12-28,A0638366,Clinical,University College London Hospitals,Martin Forster,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,1/3/2023,1/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1245 GBP,1245.0,2022-12,1.217075,1515.258375,1500-2000$ 
TR,2022-12-28,A0638439,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Goker Erdem,Guardant360 CDx,2.11,GHI_19,Distributors : ROW,Lung adenocarcinoma,1/8/2023,1/8/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
GB,2022-12-28,A0638361,Clinical,The Royal Marsden Hospital,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/1/2023,1/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Free,0 GBP,0.0,2022-12,1.217075,0.0,0 $
BR,2022-12-29,A0639133,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/3/2023,1/3/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-12,1.0,1750.0,1500-2000$ 
BR,2022-12-29,A0639082,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/3/2023,1/3/2023,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,South America,Paid,1700 USD,1700.0,2022-12,1.0,1700.0,1500-2000$ 
TR,2022-12-29,A0639629,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ertugrul Seyrek,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,1/3/2023,1/4/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Europe,Paid,1838,1838.0,2022-12,1.0,1838.0,1500-2000$ 
CA,2022-12-29,A0639128,Clinical,Hamilton Health Sciences Centre,Aly-Khan Lalani,Guardant 360,2.11,GHI_01,Self-Pay Patient,GIST (Gastrointestinal stromal tumor),1/5/2023,1/18/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,Canada,Free,0 USD,0.0,2022-12,1.0,0.0,0 $
TR,2022-12-30,A0639683,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ahmet Sezer,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,1/6/2023,1/6/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-12,1.0,2319.0,2000-3000$ 
DE,2022-12-30,A0639651,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,1/6/2023,4/14/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,3341 EUR,3341.0,2022-12,0.94477,3156.47657,3000+ $
TR,2022-12-30,A0639665,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulcan Bulut,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,1/7/2023,1/7/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,12,2022,4,1,2022-12-01,2022-12,G360 Infinity,2022Q4,Europe,Paid,2319,2319.0,2022-12,1.0,2319.0,2000-3000$ 
BR,2022-12-30,A0639697,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/8/2023,1/8/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,12,2022,4,1,2022-12-01,2022-12,G360 CDx,2022Q4,South America,Paid,1750 USD,1750.0,2022-12,1.0,1750.0,1500-2000$ 
GB,2023-01-03,A0640020,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,1/9/2023,1/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
CA,2023-01-03,A0640197,Clinical,RCM Health Consultancy,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/9/2023,2/27/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-01,1.0,1700.0,1500-2000$ 
GB,2023-01-04,A0640764,Clinical,The Royal Marsden NHS Foundation Trust,Stephen Johnston,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,1/13/2023,1/13/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2240 GBP,2240.0,2023-01,1.227075,2748.6479999999997,2000-3000$ 
BR,2023-01-04,A0640826,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,1/9/2023,1/10/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-01,1.0,1750.0,1500-2000$ 
BR,2023-01-04,A0640834,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/9/2023,1/10/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-01,1.0,1750.0,1500-2000$ 
GB,2023-01-04,A0640879,Clinical,St Bartholomews Hospital,Helen Killen,Guardant 360,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),1/9/2023,1/10/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-04,A0640752,Clinical,St Bartholomews Hospital,Ami Mehta,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,1/9/2023,1/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-04,A0640772,Clinical,York Hospital,Mohieldin Mohamed,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/17/2023,1/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
GB,2023-01-05,A0641543,Clinical,Genesis Care,Russell Burcombe,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,1/11/2023,1/11/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
GB,2023-01-05,A0641443,Clinical,St Bartholomews Hospital,Farah Louise Lim,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,1/20/2023,1/20/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-05,A0641528,Clinical,Queen Alexandra Hospital,Caroline Archer,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,1/13/2023,1/13/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2240 GBP,2240.0,2023-01,1.227075,2748.6479999999997,2000-3000$ 
TR,2023-01-05,A0641048,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Esat Namal,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,1/9/2023,1/9/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-01,1.0,1838.0,1500-2000$ 
GB,2023-01-05,A0641472,Clinical,St Bartholomews Hospital,Helen Killen,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/11/2023,1/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-05,A0641497,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,1/9/2023,1/10/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-05,A0641178,Clinical,Guys Hospital,Harriet McGrath,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/11/2023,1/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-06,A0642426,Clinical,Guys Hospital,Kaiser Anam,Guardant 360,,GHI_19,Self-Pay Patient,Gallbladder carcinoma,1/16/2023,1/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-06,A0642390,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,1/11/2023,1/11/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
TR,2023-01-06,A0642416,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Esin Oktay,Guardant360 CDx,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,1/10/2023,1/10/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-01,1.0,1838.0,1500-2000$ 
ES,2023-01-06,A0642406,Clinical,Hospital del Mar,Laura Visa,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,1/11/2023,2/6/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-01,1.078835,1343.149575,0-1500$ 
GB,2023-01-06,A0642370,Clinical,Charing Cross Hospital Medical Oncology Department,Olivia Hatcher,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,1/20/2023,1/20/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-07,A0642887,Clinical,Maidstone and Tunbridge Wells NHS Trust,Thurkaa Shanmugalingam,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/12/2023,1/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-07,A0642876,Clinical,Guys Hospital,Deborah Enting,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,1/11/2023,1/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-07,A0642845,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,1/12/2023,1/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2178.75,2178.0,2023-01,1.227075,2672.5693499999998,2000-3000$ 
IT,2023-01-09,A0643186,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/15/2023,1/15/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2000 EUR,2000.0,2023-01,1.078835,2157.67,2000-3000$ 
TR,2023-01-09,A0643193,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sinan Yavuz,Guardant 360,2.12,GH2_12,Distributors : ROW,Other,1/16/2023,1/17/2023,TURKEY,Commercial,Other,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
GB,2023-01-09,A0643161,Clinical,NHS - Wythenshawe Hospital,Jonathan Chung,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,1/13/2023,1/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
TR,2023-01-09,A0643181,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,1/16/2023,1/25/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
GB,2023-01-09,A0643153,Clinical,NHS - Wythenshawe Hospital,Jonathan Chung,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,1/16/2023,1/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
GB,2023-01-09,A0643168,Clinical,St James University Hospital,Martyn Kennedy,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/12/2023,3/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-09,A0643191,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,1/14/2023,1/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
BR,2023-01-10,A0643749,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,1/14/2023,1/14/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,South America,Paid,1700 USD,1700.0,2023-01,1.0,1700.0,1500-2000$ 
GB,2023-01-10,A0643775,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,,GHI_19,Self-Pay Sponsored,Gastric adenocarcinoma,1/14/2023,1/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
GB,2023-01-10,A0643776,Clinical,Guys Hospital,Elias Pintus,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,1/15/2023,1/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-10,A0643711,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,1/18/2023,1/18/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
GB,2023-01-10,A0643647,Clinical,HCA Laboratories,Martin Forster,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,1/14/2023,1/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2178.75,2178.0,2023-01,1.227075,2672.5693499999998,2000-3000$ 
GB,2023-01-10,A0643741,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,1/16/2023,1/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2178.75,2178.0,2023-01,1.227075,2672.5693499999998,2000-3000$ 
GB,2023-01-10,A0643676,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,1/20/2023,1/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,Reveal,2023Q1,Europe,Free,3490 GBP,3490.0,2023-01,1.227075,4282.49175,3000+ $
GB,2023-01-10,A0643755,Clinical,Synthesis Clinic,Nina Fuller-Shavel,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,1/16/2023,1/16/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
CA,2023-01-11,A0644665,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/17/2023,1/17/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-01,1.0,1700.0,1500-2000$ 
DE,2023-01-11,A0644669,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,1/26/2023,1/26/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,3341 EUR,3341.0,2023-01,1.078835,3604.387735,3000+ $
ES,2023-01-11,A0644718,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,1/24/2023,1/24/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2366 EUR,2366.0,2023-01,1.078835,2552.52361,2000-3000$ 
BR,2023-01-11,A0644711,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),1/17/2023,1/17/2023,BRAZIL,Commercial,CUP,BRAZIL,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-01,1.0,1750.0,1500-2000$ 
CA,2023-01-11,A0646153,Clinical,Neurvana Health,Ryan Best,Guardant Reveal,3.0,GHI_18,Self-Pay Patient,Breast Carcinoma,1/23/2023,1/24/2023,CANADA,,Breast,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,Reveal,2023Q1,Canada,Free,0 USD,0.0,2023-01,1.0,0.0,0 $
MX,2023-01-11,A0644723,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,1/26/2023,1/27/2023,MEXICO,Commercial,Breast,MEXICO,1,non_AE,EUR,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,South America,Paid,3228 USD,3228.0,2023-01,1.078835,3482.4793799999998,3000+ $
GB,2023-01-11,A0644713,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/17/2023,2/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
TR,2023-01-12,A0645305,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mehmet Akif Ozturk,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,1/18/2023,1/18/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
GB,2023-01-12,A0645646,Clinical,Southampton General Hospital,Andrew Bates,Guardant 360,2.12,GH2_12,Self-Pay Sponsored,Lung adenocarcinoma,1/20/2023,1/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
GB,2023-01-12,A0648060,Validation,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,,1/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
GB,2023-01-12,A0645643,Clinical,NHS - Wythenshawe Hospital,Jonathan Chung,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,1/18/2023,1/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
ES,2023-01-12,A0650341,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant360 CDx,,GHI_19,Distributors : ROW,Small cell lung carcinoma,1/25/2023,1/27/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2400 USD,2400.0,2023-01,1.078835,2589.204,2000-3000$ 
CA,2023-01-12,A0645132,Clinical,Mount Sinai Hospital,Ronald Burkes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/19/2023,1/20/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-01,1.0,1700.0,1500-2000$ 
GB,2023-01-12,A0645647,Clinical,The Nuffield Hospital Guildford,Alexandra Stewart,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Colorectal adenocarcinoma,1/26/2023,1/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-12,A0645645,Clinical,NHS - Wythenshawe Hospital,Jennifer Yung,Guardant 360,,GHI_19,Distributors : ROW,Mesothelioma,1/18/2023,1/18/2023,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
GB,2023-01-12,A0645244,Clinical,St Georges Hospital,Krishnie Srikandarajah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/17/2023,1/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
TR,2023-01-12,A0645321,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kerem Okutur,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,1/18/2023,1/18/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
GB,2023-01-13,A0646453,Clinical,St Georges Hospital,Tim Benepal,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/19/2023,1/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
CA,2023-01-13,A0646322,Clinical,"Blueguide, Inc.",Kate Barrett,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),1/19/2023,1/25/2023,CANADA,Commercial,CUP,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Canada,Free,0 USD,0.0,2023-01,1.0,0.0,0 $
CA,2023-01-13,A0646526,Clinical,London Health Sciences Centre,Elena Tsvetkova,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,1/19/2023,1/20/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Canada,Free,0 USD,0.0,2023-01,1.0,0.0,0 $
GB,2023-01-13,A0646458,Clinical,Guys Hospital,Alexandros Georgiou,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/19/2023,3/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
TR,2023-01-13,A0649980,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Hakan Sat Bozcuk,Guardant 360,2.12,GH2_12,Distributors : ROW,Ovarian carcinoma,1/25/2023,1/26/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
GB,2023-01-14,A0647196,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Prostate adenocarcinoma,1/26/2023,1/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-14,A0646878,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,1/19/2023,3/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
GB,2023-01-14,A0647216,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Arvind Tripathy,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/19/2023,1/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
DE,2023-01-16,A0647506,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,1/22/2023,1/23/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,3341 EUR,3341.0,2023-01,1.078835,3604.387735,3000+ $
TR,2023-01-16,A0647536,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant360 CDx,,GHI_19,Distributors : ROW,Ovarian carcinoma,1/23/2023,1/24/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-01,1.0,1838.0,1500-2000$ 
ES,2023-01-16,A0647560,Clinical,Hospital Universitario HM Sanchinarro,Carmen Martin Mesa,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,1/23/2023,1/23/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2240 EUR,2240.0,2023-01,1.078835,2416.5904,2000-3000$ 
GB,2023-01-16,A0647520,Clinical,Queen Alexandra Hospital,Victoria True,Guardant 360,,GHI_19,Self-Pay Patient,Hepatocellular carcinoma,1/25/2023,1/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
ES,2023-01-16,A0647490,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,1/26/2023,1/26/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-01,1.078835,1343.149575,0-1500$ 
MX,2023-01-16,A0647537,Clinical,ABC Hospital,Daniella Gomez Pue,Guardant 360,2.11,GHI_01,Distributors : ROW,Endometrial carcinoma,1/21/2023,1/22/2023,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,South America,Paid,3316 USD,3316.0,2023-01,1.078835,3577.41686,3000+ $
TR,2023-01-16,A0647519,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mehmet Akif Ozturk,Guardant 360,2.12,GH2_12,Distributors : ROW,Cholangiocarcinoma,1/24/2023,1/24/2023,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
DE,2023-01-16,A0647483,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Carcinoma of unknown primary (CUP),1/24/2023,1/24/2023,GERMANY,Commercial,CUP,GERMANY,1,non_AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,3341 EUR,3341.0,2023-01,1.078835,3604.387735,3000+ $
TR,2023-01-16,A0647482,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kayhan Erturk,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,1/22/2023,1/22/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
GB,2023-01-17,A0647971,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,1/23/2023,1/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
ES,2023-01-17,A0647891,Clinical,Hospital Universitario Infanta SofÃ­a,Gustavo Rubio Romero,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/25/2023,1/25/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 EUR,0.0,2023-01,1.078835,0.0,0 $
GB,2023-01-17,A0647878,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,1/22/2023,1/23/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
CA,2023-01-17,A0647860,Clinical,RCM Health Consultancy,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/24/2023,1/25/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-01,1.0,1700.0,1500-2000$ 
GB,2023-01-18,A0648762,Clinical,Cheltenham General Hospital,Nicholas Reed,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,1/24/2023,1/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-18,A0648229,Clinical,The Royal Marsden Hospital,Shelize Khakoo,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,1/23/2023,1/24/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
CA,2023-01-18,A0648751,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Appendix adenocarcinoma,1/24/2023,1/24/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-01,1.0,1700.0,1500-2000$ 
GB,2023-01-18,A0648178,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/27/2023,1/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
CA,2023-01-18,A0648668,Clinical,Integrated Health Clinic,Erin Rurak,Guardant Reveal,3.0,GHI_18,Do Not Bill - Cancelled,,1/26/2023,1/27/2023,CANADA,,,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,Reveal,2023Q1,Canada,Paid,0 USD ,0.0,2023-01,1.0,0.0,0 $
CA,2023-01-18,A0648697,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,1/23/2023,2/10/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-01,1.0,1700.0,1500-2000$ 
GB,2023-01-18,A0648185,Clinical,St Bartholomews Hospital,Peter Hall,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,1/24/2023,1/24/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
TR,2023-01-19,A0649539,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Osman Gokhan Demir,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,1/24/2023,1/25/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-01,1.0,1838.0,1500-2000$ 
ES,2023-01-19,A0648957,Clinical,HC Marbella International Hospital,Jose Manuel Trigo,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,1/24/2023,1/25/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490,2490.0,2023-01,1.078835,2686.29915,2000-3000$ 
TR,2023-01-19,A0649300,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Bulent Karabulut,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,1/25/2023,1/25/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
GB,2023-01-20,A0650325,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,1/26/2023,1/27/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
ES,2023-01-20,A0650339,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/2/2023,2/2/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-01,1.078835,1343.149575,0-1500$ 
CA,2023-01-20,A0650342,Clinical,RCM Health Consultancy,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/25/2023,1/25/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-01,1.0,1700.0,1500-2000$ 
CA,2023-01-20,A0650344,Clinical,Integrated Health Clinic,Erin Rurak,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/31/2023,2/3/2023,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Canada,Paid,0 USD ,0.0,2023-01,1.0,0.0,0 $
GB,2023-01-20,A0650392,Clinical,Kettering General Hospital,George Tsaknis,Guardant360 CDx,,GHI_19,Self-Pay Patient,Non-small cell lung carcinoma (NSCLC),1/25/2023,1/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-20,A0649733,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Appendix adenocarcinoma,1/27/2023,1/28/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
GB,2023-01-20,A0650329,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,1/26/2023,1/26/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
GB,2023-01-20,A0650362,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/25/2023,1/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
GB,2023-01-21,A0650701,Clinical,The Royal Marsden NHS Foundation Trust,David Cunningham,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,1/25/2023,1/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
GB,2023-01-21,A0650830,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,1/31/2023,1/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2178.75,2178.0,2023-01,1.227075,2672.5693499999998,2000-3000$ 
TR,2023-01-23,A0651186,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Tuncay Goksel,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,1/31/2023,1/31/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-01,1.0,1838.0,1500-2000$ 
ES,2023-01-23,A0651189,Clinical,Hospital Universitario HM Sanchinarro,Laura Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,1/29/2023,1/29/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2240 EUR,2240.0,2023-01,1.078835,2416.5904,2000-3000$ 
GB,2023-01-23,A0651175,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,1/29/2023,1/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
GB,2023-01-23,A0651167,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,1/29/2023,1/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
TR,2023-01-23,A0651197,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gurbuz Gorumlu,Guardant360 CDx,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,2/10/2023,2/10/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,0,0.0,2023-01,1.0,0.0,0 $
TR,2023-01-23,A0651177,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mehmet Akif Ozturk,Guardant 360,2.12,GH2_12,Distributors : ROW,Cholangiocarcinoma,1/30/2023,1/30/2023,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
GB,2023-01-23,A0652426,Clinical,University Hospital of Leicester - Glenfield Hospital,Muhammad Majid,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/29/2023,1/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
TR,2023-01-23,A0651199,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Prostate adenocarcinoma,1/31/2023,1/31/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
BR,2023-01-23,A0651929,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,1/31/2023,1/31/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-01,1.0,1750.0,1500-2000$ 
GB,2023-01-23,A0652471,Clinical,University Hospitals Of Leicester,Syed Mohammad,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/29/2023,1/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-23,A0652494,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,1/29/2023,1/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
GB,2023-01-24,A0651906,Clinical,NHS - Wythenshawe Hospital,Matthew Evison,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),1/30/2023,1/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
GB,2023-01-24,A0651921,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,1/30/2023,1/31/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
GB,2023-01-24,A0651691,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,1/31/2023,1/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
GB,2023-01-24,A0651889,Clinical,Kettering General Hospital,George Tsaknis,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,1/31/2023,1/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
BR,2023-01-25,A0652653,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Carcinoma of unknown primary (CUP),1/31/2023,3/21/2023,BRAZIL,Commercial,CUP,BRAZIL,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-01,1.0,1750.0,1500-2000$ 
BR,2023-01-25,A0652638,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,1/31/2023,1/31/2023,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-01,1.0,1750.0,1500-2000$ 
GB,2023-01-26,A0653250,Clinical,Genesis Care,Timothy Sevitt,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/31/2023,1/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
GB,2023-01-26,A0653451,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,1/31/2023,2/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
GB,2023-01-26,A0653206,Clinical,The Royal Marsden NHS Foundation Trust,Shahla Abu Naib,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,1/30/2023,1/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
GB,2023-01-26,A0653186,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,1/31/2023,1/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
GB,2023-01-26,A0653265,Clinical,Poole Hospital NHS Foundation Trust,Kar Mun Ang,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,2/1/2023,2/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
IT,2023-01-26,A0653255,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,1/31/2023,1/31/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2000 EUR,2000.0,2023-01,1.078835,2157.67,2000-3000$ 
GB,2023-01-26,A0683257,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,2.12,GH2_12,Distributors : ROW,Cholangiocarcinoma,3/14/2023,3/15/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
ES,2023-01-26,A0653192,Clinical,Hospital del Mar,Laura Visa,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Other,1/31/2023,1/31/2023,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-01,1.078835,1343.149575,0-1500$ 
GB,2023-01-26,A0653305,Clinical,NHS - Wythenshawe Hospital,Matthew Evison,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),1/31/2023,1/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
ES,2023-01-26,A0653450,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Other,1/31/2023,2/1/2023,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-01,1.078835,1343.149575,0-1500$ 
GB,2023-01-26,A0653190,Clinical,NHS - Wythenshawe Hospital,Christopher Craig,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,1/31/2023,1/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
GB,2023-01-26,A0652972,Clinical,The Nuffield Hospital Guildford,Alexandra Stewart,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,2/9/2023,2/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,Reveal,2023Q1,Europe,Paid,3490 GBP,3490.0,2023-01,1.227075,4282.49175,3000+ $
TR,2023-01-26,A0653261,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,2/1/2023,2/1/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
CA,2023-01-27,A0654055,Clinical,Dr Maged Salem,Maged Salem,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,1/31/2023,2/10/2023,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-01,1.0,1700.0,1500-2000$ 
GB,2023-01-27,A0654094,Clinical,Singleton Hospital,Steve Kihara,74-Gene Panel,,GHI_19,Self-Pay Patient,Gallbladder carcinoma,2/8/2023,2/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-01,1.227075,0.0,0 $
GB,2023-01-27,A0653986,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Victoria Kunene,Guardant 360,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,2/1/2023,2/1/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-01,1.227075,3055.41675,3000+ $
ES,2023-01-27,A0654184,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/1/2023,5/4/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-01,1.078835,1343.149575,0-1500$ 
ES,2023-01-27,A0654053,Clinical,Mutua de Terrassa,JosÃ© Mazarico,UNKNOWN,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,2/3/2023,2/4/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Free,0 EUR,0.0,2023-01,1.078835,0.0,0 $
GB,2023-01-28,A0654675,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,2/1/2023,2/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
GB,2023-01-28,A0654671,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,2/2/2023,2/2/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
GB,2023-01-28,A0654678,Clinical,HCA Laboratories,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/6/2023,2/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2178.75,2178.0,2023-01,1.227075,2672.5693499999998,2000-3000$ 
GB,2023-01-28,A0654715,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/3/2023,3/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
GB,2023-01-30,A0655045,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,2/5/2023,2/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-01,1.227075,1018.4722499999999,0-1500$ 
CA,2023-01-30,A0655012,Clinical,Dr Mark Brown,Mark Brown,Guardant Reveal,3.0,GHI_18,Do Not Bill - Cancelled,Breast Carcinoma,2/16/2023,2/17/2023,CANADA,,Breast,CANADA,1,AE,USD,Americas,1,2023,1,1,2023-01-01,2023-01,Reveal,2023Q1,Canada,Paid,0 USD,0.0,2023-01,1.0,0.0,0 $
GB,2023-01-30,A0654981,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/3/2023,3/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-01,1.227075,1527.708375,1500-2000$ 
ES,2023-01-30,A0654990,Clinical,Hospital Universitario HM Sanchinarro,Carmen Martin Mesa,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,2/6/2023,2/6/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2240 EUR,2240.0,2023-01,1.078835,2416.5904,2000-3000$ 
TR,2023-01-30,A0654986,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,2/3/2023,2/4/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,1,2023,1,1,2023-01-01,2023-01,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-01,1.0,2319.0,2000-3000$ 
GB,2023-01-31,A0655349,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,2.11,GHI_19,Distributors : ROW,Prostate adenocarcinoma,2/3/2023,2/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2178.75,2178.0,2023-01,1.227075,2672.5693499999998,2000-3000$ 
GB,2023-01-31,A0655356,Clinical,HCA Laboratories,Alison Jones,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,2/4/2023,2/4/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,1,2023,1,1,2023-01-01,2023-01,G360 CDx,2023Q1,Europe,Paid,2178.75,2178.0,2023-01,1.227075,2672.5693499999998,2000-3000$ 
TR,2023-02-01,A0656014,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Bulent Karabulut,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,2/5/2023,2/8/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-02,1.0,1838.0,1500-2000$ 
GB,2023-02-02,A0656349,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,2/7/2023,2/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-02,A0656292,Clinical,Queen Alexandra Hospital,Mario Uccello,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,2/6/2023,2/7/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-02,A0656656,Clinical,Bupa Cromwell Hospital,Crispin Hiley,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,2/6/2023,2/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2240 GBP,2240.0,2023-02,1.207064,2703.82336,2000-3000$ 
GB,2023-02-02,A0656721,Clinical,The Nuffield Hospital Guildford,Christos Mikropoulos,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,2/10/2023,2/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-02,A0656268,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,2/6/2023,3/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
ES,2023-02-02,A0656673,Clinical,Complejo Hospitalario Ruber Juan Bravo,Araceli Priego Priego,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,2/7/2023,2/7/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,0 EUR,0.0,2023-02,1.071835,0.0,0 $
GB,2023-02-02,A0656376,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sophie Otter,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,2/6/2023,2/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-02,A0656717,Clinical,Guys Hospital,Karen Harrison-Phipps,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/6/2023,2/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-02,A0656310,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,2/13/2023,2/14/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-02,1.207064,3005.58936,3000+ $
CA,2023-02-02,A0656755,Clinical,Cedars Cancer Centre,Nathaniel Bouganim,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,2/11/2023,2/12/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,Reveal,2023Q1,Canada,Free,0 USD,0.0,2023-02,1.0,0.0,0 $
TR,2023-02-03,A0662815,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Murat Akyol,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/16/2023,2/16/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-02,1.0,1838.0,1500-2000$ 
GB,2023-02-03,A0662854,Clinical,St Georges Hospital,YukChun Lam,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/16/2023,2/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
BR,2023-02-03,A0657171,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/7/2023,2/7/2023,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-02,1.0,1750.0,1500-2000$ 
GB,2023-02-03,A0657160,Clinical,The Colney Centre Oncology and Haematology Department,Zacharias Tasigiannopoulos,Guardant 360,,GHI_19,Self-Pay Patient,Thymic carcinoma,2/9/2023,2/27/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-02,1.207064,3005.58936,3000+ $
GB,2023-02-03,A0657166,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,2/7/2023,2/13/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
ES,2023-02-03,A0657295,Clinical,Hospital A Coruna,Manuel Fernandez Bruno,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,2/24/2023,2/24/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,0 EUR,0.0,2023-02,1.071835,0.0,0 $
ES,2023-02-03,A0657183,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/8/2023,2/11/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2400 USD,2400.0,2023-02,1.071835,2572.4040000000005,2000-3000$ 
GB,2023-02-03,A0662837,Clinical,St Georges Hospital,YukChun Lam,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/16/2023,2/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
ES,2023-02-03,A0657337,Clinical,Hospital Vithas Castellon,Javier Garde Noguera,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/10/2023,2/10/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 EUR,2490.0,2023-02,1.071835,2668.8691500000004,2000-3000$ 
GB,2023-02-03,A0657599,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,2/10/2023,2/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,Reveal,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
TR,2023-02-03,A0657268,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Adenocarcinoma of Unknown Primary,2/9/2023,2/10/2023,TURKEY,Commercial,CUP,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-02,1.0,2319.0,2000-3000$ 
CA,2023-02-04,A0658427,Clinical,Princess Margaret Cancer Centre,Erica Tsang,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/11/2023,2/11/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Canada,Free,0 USD,0.0,2023-02,1.0,0.0,0 $
CA,2023-02-04,A0658434,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/8/2023,2/9/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Canada,Free,0 USD,0.0,2023-02,1.0,0.0,0 $
GB,2023-02-04,A0658544,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant 360,,GHI_19,Self-Pay Patient,Appendix adenocarcinoma,2/10/2023,2/10/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2240 GBP,2240.0,2023-02,1.207064,2703.82336,2000-3000$ 
GB,2023-02-04,A0658476,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Gallbladder carcinoma,2/10/2023,2/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
TR,2023-02-06,A0659630,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gurbuz Gorumlu,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,2/11/2023,2/11/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-02,1.0,1838.0,1500-2000$ 
GB,2023-02-06,A0660436,Clinical,Sheffield Weston Park Cancer Centre,Richard Crossley,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,2/16/2023,2/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-06,A0660531,Clinical,HCA Laboratories,Crispin Hiley,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/17/2023,2/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-02,1.207064,2628.9853919999996,2000-3000$ 
UY,2023-02-06,A0660455,Clinical,Practice Dr Luis Ubillos,Luis Ubillos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/15/2023,2/16/2023,URUGUAY,Commercial,,URUGUAY,1,non_AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,South America,Free,0 USD,0.0,2023-02,1.0,0.0,0 $
ES,2023-02-06,A0660471,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,2.11,GHI_19,Distributors : ROW,Esophageal adenocarcinoma,2/14/2023,2/14/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2400 USD,2400.0,2023-02,1.071835,2572.4040000000005,2000-3000$ 
GB,2023-02-06,A0660312,Clinical,Queen Alexandra Hospital,Samuel Chan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Other,2/11/2023,2/11/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2240 GBP,2240.0,2023-02,1.207064,2703.82336,2000-3000$ 
GB,2023-02-06,A0660435,Clinical,St Georges Hospital,Anna-Mary Young,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/11/2023,2/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
CA,2023-02-06,A0658906,Clinical,Medical Centre,Rene Walker,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,2/11/2023,3/14/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Canada,Paid,1700 USD,1700.0,2023-02,1.0,1700.0,1500-2000$ 
GB,2023-02-06,A0660136,Clinical,Clatterbridge cancer Center,Carles Escriu,Guardant 360,,GHI_19,Self-Pay Patient,Adenocarcinoma of Unknown Primary,2/27/2023,2/27/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,??,0.0,2023-02,1.207064,0.0,0 $
ES,2023-02-06,A0660464,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/12/2023,2/12/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-02,1.071835,1334.4345750000002,0-1500$ 
GB,2023-02-06,A0660440,Clinical,Wirral University Teaching Hospital,Andrew Wight,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/13/2023,2/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-06,A0658959,Clinical,Wirral University Teaching Hospital,Andrew Wight,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,2/11/2023,2/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-07,A0661330,Clinical,Queen Alexandra Hospital,Hiba Al-Chamali,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/20/2023,2/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-07,A0661366,Clinical,University Hospitals Coventry & Warwickshire NHS Trust,Jane Worlding,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,2/12/2023,2/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-07,A0661354,Clinical,North Middlesex University Hospital,Lucinda Melcher,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,2/16/2023,3/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
TR,2023-02-07,A0661376,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kerim Kaban,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,2/13/2023,2/13/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-02,1.0,2319.0,2000-3000$ 
CA,2023-02-08,A0662875,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,2/23/2023,2/23/2023,CANADA,Commercial,Other,CANADA,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-02,1.0,1700.0,1500-2000$ 
BR,2023-02-08,A0662531,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,2/14/2023,2/15/2023,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-02,1.0,1750.0,1500-2000$ 
BR,2023-02-08,A0662520,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,2/14/2023,2/15/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-02,1.0,1750.0,1500-2000$ 
GB,2023-02-08,A0662338,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Mabel Teng,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,2/14/2023,2/15/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-08,A0662540,Clinical,Eastbourne District General Hospital,Victoria Donovan,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,2/17/2023,3/2/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-08,A0662518,Clinical,BMI Harbour Hospital,Amitabha Chakrabarti,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Breast Carcinoma,2/15/2023,2/15/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-02,1.207064,3005.58936,3000+ $
GB,2023-02-08,A0662867,Clinical,HCA Laboratories,Daniel Krell,Guardant360 CDx,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,2/13/2023,2/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-02,1.207064,2628.9853919999996,2000-3000$ 
GB,2023-02-08,A0662526,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,2/14/2023,2/15/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-02,1.207064,3005.58936,3000+ $
BR,2023-02-08,A0662491,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Small cell lung carcinoma,2/14/2023,2/14/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-02,1.0,1750.0,1500-2000$ 
ES,2023-02-09,A0663591,Clinical,Hospital Vithas Castellon,Javier Garde Noguera,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,2/15/2023,2/15/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 EUR,2490.0,2023-02,1.071835,2668.8691500000004,2000-3000$ 
GB,2023-02-09,A0663627,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Shairoz Merchant,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/15/2023,3/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
BR,2023-02-09,A0663702,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/14/2023,2/15/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-02,1.0,1750.0,1500-2000$ 
GB,2023-02-09,A0663534,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,2/15/2023,2/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-02,1.207064,3005.58936,3000+ $
GB,2023-02-09,A0663721,Clinical,The Rivers Hospital,Peter Szlosarek,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/15/2023,2/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-02,1.207064,3005.58936,3000+ $
ES,2023-02-09,A0663585,Clinical,Hospital Universitario Infanta SofÃ­a,Gustavo Rubio Romero,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/15/2023,2/15/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0,0.0,2023-02,1.071835,0.0,0 $
GB,2023-02-09,A0663456,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,2/15/2023,3/1/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-09,A0663630,Clinical,Guys Hospital,Danielle Crawley,Guardant 360,,GHI_19,Self-Pay Patient,Renal Cell Carcinoma,2/15/2023,2/22/2023,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-10,A0664529,Clinical,Genesis Care,Mark Hill,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,2/16/2023,2/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2240 GBP,2240.0,2023-02,1.207064,2703.82336,2000-3000$ 
TR,2023-02-10,A0664556,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mehmet Akif Ozturk,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,2/16/2023,2/16/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-02,1.0,2319.0,2000-3000$ 
GB,2023-02-10,A0666333,Clinical,St Georges Hospital,Stefania Redana,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,2/21/2023,2/21/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-10,A0664656,Clinical,Velindre Cancer Centre,Simon Waters,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,2/15/2023,2/16/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-10,A0664527,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,2/15/2023,2/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-10,A0664568,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,2/16/2023,2/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-10,A0664503,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Lung cancer,2/16/2023,2/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-11,A0665398,Clinical,The Royal Marsden NHS Foundation Trust,Alicia Okines,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Breast Carcinoma,3/8/2023,3/8/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-02,1.207064,3005.58936,3000+ $
GB,2023-02-11,A0665367,Clinical,HCA Laboratories,Mark Harries,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,2/16/2023,2/16/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-02,1.207064,2628.9853919999996,2000-3000$ 
GB,2023-02-11,A0665359,Clinical,Guys Hospital,Jonathon Olsburgh,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,2/16/2023,2/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
ES,2023-02-13,A0665680,Clinical,Institute of Breast Cancer,Javier Cortes,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,2/16/2023,2/17/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2366 EUR,2366.0,2023-02,1.071835,2535.9616100000003,2000-3000$ 
ES,2023-02-13,A0665686,Clinical,Complejo Hospitalario Ruber Juan Bravo,Araceli Priego Priego,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/20/2023,2/20/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2241 EUR,2241.0,2023-02,1.071835,2401.9822350000004,2000-3000$ 
GB,2023-02-13,A0665520,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Lung cancer,2/27/2023,2/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
ES,2023-02-13,A0665660,Clinical,Clinica Universidad de Navarra,Javier Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,2/17/2023,2/17/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2400 USD,2400.0,2023-02,1.071835,2572.4040000000005,2000-3000$ 
ES,2023-02-13,A0665601,Clinical,Mutua de Terrassa,JosÃ© Mazarico,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/16/2023,2/17/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0,0.0,2023-02,1.071835,0.0,0 $
GB,2023-02-13,A0665656,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/21/2023,2/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-13,A0665715,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,3/3/2023,3/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,Reveal,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-13,A0665650,Clinical,Queen Alexandra Hospital,Samuel Chan,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,2/16/2023,3/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
TR,2023-02-13,A0665687,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mehmet Akif Ozturk,Guardant 360,2.12,GH2_12,Distributors : ROW,Bladder carcinoma,2/21/2023,2/21/2023,TURKEY,Commercial,Bladder,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-02,1.0,2319.0,2000-3000$ 
GB,2023-02-13,A0665621,Clinical,HCA Laboratories,John Bridgewater,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Cholangiocarcinoma,2/17/2023,2/17/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-02,1.207064,2628.9853919999996,2000-3000$ 
GB,2023-02-13,A0665691,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Non-small cell lung carcinoma (NSCLC),2/17/2023,3/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-13,A0665681,Clinical,Beatson West of Scotland Cancer Centre,Brian Clark,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/16/2023,4/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-13,A0665607,Clinical,Queen Alexandra Hospital,Hiba Al-Chamali,Guardant 360,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),2/16/2023,2/17/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-13,A0665579,Clinical,Sheffield Weston Park Cancer Centre,Richard Crossley,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,2/17/2023,2/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-13,A0665665,Clinical,NHS - Wythenshawe Hospital,Nicola Sinnott,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Lung cancer,2/17/2023,2/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
TR,2023-02-13,A0665673,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic neuroendocrine tumor,2/21/2023,2/22/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-02,1.0,2319.0,2000-3000$ 
TR,2023-02-13,A0665670,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Cemil Bilir,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,2/25/2023,2/25/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-02,1.0,2319.0,2000-3000$ 
GB,2023-02-13,A0665605,Clinical,High Wycombe Hospital,Priya Joshi,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Breast Carcinoma,2/17/2023,2/17/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-13,A0665525,Clinical,Beatson West of Scotland Cancer Centre,Brian Clark,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/16/2023,2/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-13,A0665641,Clinical,Queen Alexandra Hospital,Ann Oâ€™Callaghan,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,2/16/2023,2/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-13,A0665617,Clinical,York Hospital,Mohieldin Mohamed,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,2/16/2023,3/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-13,A0665616,Clinical,Musgrove Park Hospital,Emma Barker,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/23/2023,2/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
BR,2023-02-13,A0665717,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/18/2023,2/19/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-02,1.0,1750.0,1500-2000$ 
GB,2023-02-14,A0666535,Clinical,HCA Laboratories,Alison Jones,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Breast Carcinoma,2/22/2023,2/22/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-02,1.207064,2628.9853919999996,2000-3000$ 
GB,2023-02-14,A0666450,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/3/2023,3/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-14,A0666485,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/20/2023,3/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
BR,2023-02-14,A0667185,Clinical,Hospital Israelita Albert Einstein,Pedro Uson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Gastric Carcinoma,2/27/2023,2/27/2023,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,South America,Free,0 USD,0.0,2023-02,1.0,0.0,0 $
GB,2023-02-15,A0667273,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,2/21/2023,2/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-02,1.207064,2628.9853919999996,2000-3000$ 
GB,2023-02-15,A0667272,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Ramon DeMello,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,2/21/2023,3/2/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-15,A0667251,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,2/22/2023,2/22/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-02,1.207064,3005.58936,3000+ $
ES,2023-02-16,A0668141,Clinical,Mutua de Terrassa,Carles Pericay,Guardant360 CDx,,GHI_19,Self-Pay Patient,Gastric adenocarcinoma,2/22/2023,2/22/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0,0.0,2023-02,1.071835,0.0,0 $
GB,2023-02-16,A0668102,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,2/22/2023,3/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-16,A0668094,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,2/22/2023,3/2/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-16,A0668235,Clinical,St Georges Hospital,Anna-Mary Young,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/22/2023,2/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-16,A0668136,Clinical,Queen Alexandra Hospital,Nishant Sundaresan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,2/22/2023,2/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
ES,2023-02-17,A0668790,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/22/2023,5/4/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-02,1.071835,1334.4345750000002,0-1500$ 
IT,2023-02-17,A0668792,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/23/2023,2/23/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2000 EUR,2000.0,2023-02,1.071835,2143.67,2000-3000$ 
RO,2023-02-17,A0668839,Clinical,Amethyst Radiotherapy Clinic,Bogdan Mateies,Guardant 360,,GHI_19,Self-Pay Patient,Ovarian carcinoma,2/24/2023,2/24/2023,ROMANIA,Commercial,,ROMANIA,1,non_AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 EUR,2490.0,2023-02,1.071835,2668.8691500000004,2000-3000$ 
GB,2023-02-17,A0668823,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Esophageal adenocarcinoma,2/22/2023,3/3/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-17,A0668800,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,2/22/2023,2/28/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-17,A0668753,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,2/27/2023,2/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,Reveal,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-17,A0668759,Clinical,Queen Alexandra Hospital,Nishant Sundaresan,74-Gene Panel,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/23/2023,7/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
TR,2023-02-17,A0669158,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gurbuz Gorumlu,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/21/2023,2/24/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0,0.0,2023-02,1.0,0.0,0 $
GB,2023-02-17,A0668694,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,3/1/2023,3/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,Reveal,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
CA,2023-02-17,A0668744,Clinical,Allan Blair Cancer Centre,Mirjana Zarkovic,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,2/28/2023,3/23/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,Reveal,2023Q1,Canada,Free,0 USD,0.0,2023-02,1.0,0.0,0 $
CA,2023-02-17,A0669295,Clinical,Cedars Cancer Centre,Nathaniel Bouganim,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/23/2023,3/2/2023,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-02,1.0,1700.0,1500-2000$ 
GB,2023-02-18,A0670056,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,2/24/2023,2/28/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-18,A0670123,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,2/24/2023,3/8/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-18,A0669973,Clinical,Guys Hospital,Elias Pintus,Guardant 360,2.12,GH2_12,Self-Pay Patient,Prostate adenocarcinoma,2/27/2023,2/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
ES,2023-02-20,A0670281,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,2/24/2023,2/27/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1745 EUR,1745.0,2023-02,1.071835,1870.3520750000002,1500-2000$ 
GB,2023-02-20,A0670270,Clinical,NHS - Wythenshawe Hospital,Jonathan Chung,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,2/27/2023,2/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
ES,2023-02-20,A0670361,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/24/2023,2/24/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-02,1.071835,1334.4345750000002,0-1500$ 
MX,2023-02-20,A0670236,Clinical,ABC Hospital,Jesus Miguel Lazaro de Leon,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,2/24/2023,2/24/2023,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,South America,Paid,3228 USD,3228.0,2023-02,1.071835,3459.88338,3000+ $
ES,2023-02-20,A0670359,Clinical,Genesiscare Hospital San Francisco de Asis,Juan Diego Rodriguez,Guardant 360,,GHI_19,Self-Pay Patient,Large cell lung carcinoma,3/9/2023,3/10/2023,SPAIN,Commercial,Lung,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0,0.0,2023-02,1.071835,0.0,0 $
BR,2023-02-20,A0670290,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/24/2023,3/3/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,South America,Paid,1700 USD,1700.0,2023-02,1.0,1700.0,1500-2000$ 
CA,2023-02-20,A0670253,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,2/24/2023,2/24/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-02,1.0,1700.0,1500-2000$ 
GB,2023-02-20,A0670374,Clinical,NHS - Wythenshawe Hospital,Matthew Evison,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,2/28/2023,2/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-20,A0670369,Clinical,University Hospitals Of Leicester,Joanna Wood,Guardant 360,,GHI_19,Self-Pay Patient,Ovarian carcinoma,2/24/2023,3/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
ES,2023-02-20,A0670371,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,2/24/2023,2/24/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-02,1.071835,1334.4345750000002,0-1500$ 
GB,2023-02-22,A0671807,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung cancer,2/27/2023,2/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-22,A0671542,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,2/27/2023,2/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-22,A0671682,Clinical,Guys Hospital,Giles Rottenberg,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,2/27/2023,2/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
ES,2023-02-22,A0677969,Clinical,Hospital A Coruna,Manuel Fernandez Bruno,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,3/9/2023,3/10/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Europe,Paid,1245 EUR ,1245.0,2023-02,1.071835,1334.4345750000002,0-1500$ 
GB,2023-02-22,A0671687,Clinical,Beatson West of Scotland Cancer Centre,Nabanita Bose,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/27/2023,2/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-22,A0671566,Clinical,Guys Hospital,Jonathon Olsburgh,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,2/28/2023,2/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
TR,2023-02-22,A0671715,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Cervical Squamous Cell Carcinoma,3/1/2023,3/7/2023,TURKEY,Commercial,Cervical,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-02,1.0,2319.0,2000-3000$ 
BR,2023-02-22,A0671555,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/7/2023,3/7/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-02,1.0,1750.0,1500-2000$ 
GB,2023-02-23,A0672657,Clinical,Genesis Care,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,2/28/2023,2/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2240 GBP,2240.0,2023-02,1.207064,2703.82336,2000-3000$ 
GB,2023-02-23,A0672601,Clinical,Queen Alexandra Hospital,Tharani Abeysekera,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,2/28/2023,3/1/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-23,A0672713,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx EU,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,2/28/2023,3/1/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-23,A0672608,Clinical,HCA Laboratories,John Bridgewater,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Cholangiocarcinoma,2/28/2023,3/9/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-02,1.207064,2628.9853919999996,2000-3000$ 
GB,2023-02-23,A0672688,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,2/28/2023,3/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-23,A0672668,Clinical,HCA Laboratories,Nicholas Maisey,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,2/28/2023,2/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-02,1.207064,2628.9853919999996,2000-3000$ 
GB,2023-02-23,A0672675,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,2/28/2023,3/1/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-23,A0672672,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,2/28/2023,2/28/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-23,A0672392,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,3/3/2023,3/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,Reveal,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-23,A0672676,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,2/28/2023,2/28/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-23,A0672602,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/1/2023,3/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-23,A0672681,Clinical,Singleton Hospital,Emma Christopher,Guardant 360,,GHI_19,Self-Pay Patient,Esophageal adenocarcinoma,2/28/2023,2/28/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-23,A0672520,Clinical,The Royal Marsden NHS Foundation Trust,Kroopa Joshi,Guardant 360,2.11,GHI_19,Self-Pay Patient,Other,3/2/2023,3/9/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-23,A0672589,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,2/28/2023,2/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-02,1.207064,2628.9853919999996,2000-3000$ 
GB,2023-02-23,A0672664,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung cancer,2/28/2023,3/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-23,A0672716,Clinical,The Rivers Hospital,Nihal Shah,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,2/28/2023,2/28/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-02,1.207064,3005.58936,3000+ $
GB,2023-02-23,A0672593,Clinical,Maidstone and Tunbridge Wells NHS Trust,Geraldo Alves de Paula Neto,74-Gene Panel,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,2/28/2023,3/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-24,A0673020,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Large cell lung carcinoma,3/1/2023,3/1/2023,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-24,A0673130,Clinical,NHS - Wythenshawe Hospital,Christopher Craig,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/1/2023,3/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-24,A0673108,Clinical,The Royal Marsden NHS Foundation Trust,Ian Chau,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,2/28/2023,2/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-02,1.207064,3005.58936,3000+ $
TR,2023-02-24,A0673174,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Fatih Selcukbiricik,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/2/2023,3/2/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-02,1.0,1838.0,1500-2000$ 
GB,2023-02-24,A0673123,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,,GHI_19,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,3/1/2023,6/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-24,A0673104,Clinical,Queen Alexandra Hospital,Samuel Chan,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/2/2023,3/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-24,A0673402,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,3/2/2023,3/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-24,A0673082,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Non-small cell lung carcinoma (NSCLC),2/28/2023,2/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
GB,2023-02-24,A0673524,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/3/2023,3/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-24,A0672979,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,3/1/2023,3/1/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-02,1.207064,2628.9853919999996,2000-3000$ 
GB,2023-02-24,A0673044,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/2/2023,3/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-24,A0673393,Clinical,NHS - Wythenshawe Hospital,Christopher Craig,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/2/2023,3/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
CA,2023-02-25,A0674081,Clinical,Salwa Saad Private Office,Salwa Saad,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/2/2023,3/2/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Canada,Free,0 USD,0.0,2023-02,1.0,0.0,0 $
ES,2023-02-25,A0674099,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/2/2023,3/2/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2400 USD,2400.0,2023-02,1.071835,2572.4040000000005,2000-3000$ 
GB,2023-02-27,A0674376,Clinical,Wirral University Teaching Hospital,Alison Hufton,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,3/6/2023,3/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
GB,2023-02-27,A0674417,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/5/2023,3/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
TR,2023-02-27,A0674403,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Small cell lung carcinoma,3/6/2023,3/6/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-02,1.0,2319.0,2000-3000$ 
GB,2023-02-27,A0674423,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/7/2023,3/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-27,A0674382,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,3/3/2023,3/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-02,1.207064,1502.79468,1500-2000$ 
TR,2023-02-27,A0674372,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sezer Saglam,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/4/2023,3/4/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-02,1.0,2319.0,2000-3000$ 
GB,2023-02-27,A0674350,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/2/2023,3/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-27,A0674357,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/4/2023,3/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-27,A0674396,Clinical,Maidstone and Tunbridge Wells NHS Trust,Safa Aykac,74-Gene Panel,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/2/2023,3/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-02,1.207064,0.0,0 $
CA,2023-02-27,A0674420,Clinical,London Health Sciences Centre,Daniel Breadner,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung squamous cell carcinoma,3/5/2023,3/6/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,2,2023,1,1,2023-02-01,2023-02,G360 Infinity,2023Q1,Canada,Paid,1700 USD,1700.0,2023-02,1.0,1700.0,1500-2000$ 
DE,2023-02-28,A0674959,Clinical,Universitat Ulm,Jochen (Joe) Lennerz,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,3/5/2023,3/9/2023,GERMANY,Commercial,GI,GERMANY,1,non_AE,EUR,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,3490 EUR,3490.0,2023-02,1.071835,3740.7041500000005,3000+ $
GB,2023-02-28,A0674970,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Large cell lung carcinoma,3/6/2023,3/6/2023,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-02,1.207064,1001.86312,0-1500$ 
GB,2023-02-28,A0674952,Clinical,Southampton General Hospital,Tim Iveson,Guardant 360,,GHI_19,Self-Pay Patient,Other,3/5/2023,3/5/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,2,2023,1,1,2023-02-01,2023-02,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-02,1.207064,3005.58936,3000+ $
GB,2023-03-01,A0677041,Clinical,NHS - University College London Hospital,Martin Forster,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/6/2023,3/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-01,A0677056,Clinical,HCA Laboratories,Elinor Sawyer,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,3/6/2023,3/6/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
GB,2023-03-01,A0676760,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/5/2023,3/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-01,A0676753,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/5/2023,3/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
TR,2023-03-01,A0676722,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/5/2023,3/16/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-03,1.0,1838.0,1500-2000$ 
BR,2023-03-01,A0677453,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/6/2023,3/6/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-03,1.0,1750.0,1500-2000$ 
ES,2023-03-01,A0677119,Clinical,Servico Medico Garrucha,Jose-Manuel Molina Montes,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,3/6/2023,3/7/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-03,1.0,1245.0,0-1500$ 
GB,2023-03-02,A0678258,Clinical,Beatson West of Scotland Cancer Centre,Brian Clark,Guardant 360,,GHI_19,Self-Pay Patient,Large cell lung carcinoma,3/8/2023,3/9/2023,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-02,A0678278,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,3/8/2023,3/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-02,A0678239,Clinical,The Royal Marsden NHS Foundation Trust,Sheela Rao,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,3/8/2023,3/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-03,1.18,2938.2,2000-3000$ 
GB,2023-03-02,A0678303,Clinical,Guys Hospital,Danielle Crawley,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,3/9/2023,3/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-03,A0678927,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,3/8/2023,3/8/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
IT,2023-03-03,A0679293,Clinical,Comprensorio sanitario di Bolzano,Luca Tondulli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/8/2023,3/9/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 EUR,0.0,2023-03,1.0,0.0,0 $
ES,2023-03-03,A0678805,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,3/8/2023,3/8/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2241 EUR,2241.0,2023-03,1.0,2241.0,2000-3000$ 
ES,2023-03-03,A0679002,Clinical,Hospital University La Paz,Javier de Castro Carpeno,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/14/2023,3/14/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 EUR,0.0,2023-03,1.0,0.0,0 $
GB,2023-03-03,A0678822,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/8/2023,3/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-03,A0678826,Clinical,Maidstone and Tunbridge Wells NHS Trust,Safa Aykac,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/8/2023,3/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-03,A0678824,Clinical,The Royal Marsden Kingston,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/15/2023,3/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-03,A0678912,Clinical,Nuffield Health Brighton Hospital,David Bloomfield,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,3/8/2023,3/9/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2240 GBP,2240.0,2023-03,1.18,2643.2,2000-3000$ 
GB,2023-03-03,A0678880,Clinical,Musgrove Park Hospital,Simon Barnes,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/8/2023,3/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-04,A0679926,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/10/2023,3/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-06,A0680169,Clinical,Queen Alexandra Hospital,Mya Gyi,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,3/12/2023,3/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-06,A0680199,Clinical,St Bartholomews Hospital,John Conibear,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,3/20/2023,3/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3490 GBP,3490.0,2023-03,1.18,4118.2,3000+ $
GB,2023-03-06,A0680166,Clinical,Queen Alexandra Hospital,Christopher Coyle,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/10/2023,3/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-06,A0680153,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,3/10/2023,3/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-06,A0680202,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,3/10/2023,3/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-06,A0680163,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/10/2023,3/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
GB,2023-03-06,A0680195,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,3/10/2023,3/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-06,A0680191,Clinical,Guys Hospital,Giles Rottenberg,74-Gene Panel,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,3/10/2023,3/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-06,A0680175,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/12/2023,3/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-06,A0680173,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/10/2023,3/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-06,A0680212,Clinical,Wirral University Teaching Hospital,Alison Hufton,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,3/13/2023,3/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-06,A0680186,Clinical,NHS - University College London Hospital,Ricky Thakrar,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,3/12/2023,3/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-06,A0680207,Clinical,Guys Hospital,Sugama Chicklore,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/12/2023,3/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
PT,2023-03-07,A0681510,Clinical,Institute CUF,Jorge Oliveira,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Prostate adenocarcinoma,3/31/2023,4/1/2023,PORTUGAL,Commercial,,PORTUGAL,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,0 EUR,0.0,2023-03,1.0,0.0,0 $
ES,2023-03-07,A0681588,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/13/2023,3/13/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-03,1.0,1245.0,0-1500$ 
GB,2023-03-07,A0681436,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/13/2023,3/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-08,A0682220,Clinical,HCA Laboratories,Eleni Karapanagiotou,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/16/2023,3/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
GB,2023-03-08,A0682100,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,3/16/2023,3/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,Reveal,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
TR,2023-03-08,A0682350,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Emre Sivrikoz,Guardant360 CDx,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,3/14/2023,3/14/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-03,1.0,1838.0,1500-2000$ 
AR,2023-03-08,A0682254,Clinical,Mariano Dioca,Mariano Dioca,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),3/13/2023,3/14/2023,ARGENTINA,Commercial,CUP,ARGENTINA,1,non_AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,South America,Paid,2964 USD,2964.0,2023-03,1.0,2964.0,2000-3000$ 
GB,2023-03-09,A0683653,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,3/21/2023,3/21/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
GB,2023-03-09,A0683597,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/14/2023,3/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
TR,2023-03-09,A0683714,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Saadettin Kilickap,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,3/15/2023,3/15/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-03,1.0,2319.0,2000-3000$ 
GB,2023-03-09,A0683740,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung cancer,3/15/2023,3/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-09,A0683682,Clinical,Musgrove Park Hospital,Janet Fallon,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/15/2023,3/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-09,A0683737,Clinical,HCA Laboratories,Andrew Wardley,Guardant360 CDx EU,,GHI_19,Distributors : ROW,Breast Carcinoma,3/15/2023,3/15/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
TR,2023-03-09,A0683735,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Esin Oktay,Guardant360 CDx,,GHI_19,Distributors : ROW,Carcinoma of unknown primary (CUP),3/18/2023,3/18/2023,TURKEY,Commercial,CUP,TURKEY,1,AE,USD,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-03,1.0,1838.0,1500-2000$ 
GB,2023-03-09,A0683576,Clinical,Velindre Cancer Centre,Simon Waters,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/14/2023,3/15/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-09,A0683703,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/15/2023,3/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
DE,2023-03-10,A0684149,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,3/17/2023,4/14/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3341 EUR,3341.0,2023-03,1.0,3341.0,3000+ $
GB,2023-03-10,A0684163,Clinical,The Royal Marsden NHS Foundation Trust,Naureen Starling,Guardant 360,,GHI_19,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,3/21/2023,3/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-10,A0684168,Clinical,HCA Laboratories,Daniel Hochhauser,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,3/15/2023,3/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
GB,2023-03-10,A0686262,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/19/2023,3/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-10,A0684137,Clinical,Guys Hospital,Leanne Ashrafian,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/20/2023,3/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-10,A0684154,Clinical,The Royal Marsden Hospital,Robert Huddart,Guardant360 CDx,,GHI_19,Self-Pay Patient,Urothelial carcinoma,3/15/2023,3/15/2023,UNITED KINGDOM,Commercial,Urothelial,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-10,A0684169,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,3/15/2023,3/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-03,1.18,2938.2,2000-3000$ 
GB,2023-03-10,A0684162,Clinical,University College London Hospitals,John Bridgewater,74-Gene Panel,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,3/17/2023,3/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-10,A0684180,Clinical,HCA Laboratories,Nicholas Maisey,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,3/15/2023,3/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
ES,2023-03-10,A0684337,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/16/2023,3/16/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2400 USD,2400.0,2023-03,1.0,2400.0,2000-3000$ 
CA,2023-03-10,A0686255,Clinical,Integrated Health Clinic,Gurdev Parmar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal squamous cell carcinoma,3/21/2023,3/21/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Canada,Free,0 USD,0.0,2023-03,1.0,0.0,0 $
GB,2023-03-10,A0684535,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/15/2023,3/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
ES,2023-03-10,A0684302,Clinical,Complejo Hospitalario Ruber Juan Bravo,Patricia Cortez Castedo,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,3/16/2023,3/16/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2241 EUR,2241.0,2023-03,1.0,2241.0,2000-3000$ 
ES,2023-03-11,A0685462,Clinical,Complejo Hospitalario Ruber Juan Bravo,Patricia Cortez Castedo,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,3/15/2023,3/15/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2241 EUR,2241.0,2023-03,1.0,2241.0,2000-3000$ 
GB,2023-03-11,A0685478,Clinical,The Royal Marsden NHS Foundation Trust,Ian Smith,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,3/16/2023,3/16/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-03,1.18,2938.2,2000-3000$ 
GB,2023-03-13,A0685715,Clinical,University Hospitals Of Leicester,Olubukola Ayodele,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/20/2023,3/20/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
BR,2023-03-13,A0685811,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/18/2023,3/18/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-03,1.0,1750.0,1500-2000$ 
GB,2023-03-13,A0685651,Clinical,Guys Hospital,Mona Salem,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,3/17/2023,4/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-13,A0685665,Clinical,Beatson West of Scotland Cancer Centre,Cicely Cunningham,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/20/2023,3/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
ES,2023-03-13,A0685685,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,3/17/2023,3/17/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2241 EUR,2241.0,2023-03,1.0,2241.0,2000-3000$ 
GB,2023-03-13,A0685717,Clinical,Queen Alexandra Hospital,Giuseppe Banna,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/21/2023,3/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
BR,2023-03-13,A0685814,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/20/2023,3/20/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-03,1.0,1750.0,1500-2000$ 
ES,2023-03-13,A0685736,Clinical,Hospital del Mar,Laura Visa,Guardant360 CDx,2.12,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,3/20/2023,3/23/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-03,1.0,1245.0,0-1500$ 
GB,2023-03-13,A0685704,Clinical,Guys Hospital,Leanne Ashrafian,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/23/2023,3/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-13,A0685708,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,3/19/2023,3/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,Reveal,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
PT,2023-03-13,A0685726,Clinical,Institute CUF,Jorge Oliveira,Guardant 360,2.12,GH2_12,Self-Pay Patient,Prostate adenocarcinoma,3/21/2023,3/21/2023,PORTUGAL,Commercial,,PORTUGAL,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3490 EUR,3490.0,2023-03,1.0,3490.0,3000+ $
BR,2023-03-13,A0685810,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,3/20/2023,3/20/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,South America,Paid,1750 USD,1750.0,2023-03,1.0,1750.0,1500-2000$ 
GB,2023-03-13,A0685691,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,3/22/2023,3/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-13,A0685701,Clinical,St Georges Hospital,Stefania Redana,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,3/20/2023,3/20/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-13,A0685720,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/20/2023,3/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
IT,2023-03-14,A0686256,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/20/2023,3/20/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2000 EUR,2000.0,2023-03,1.0,2000.0,1500-2000$ 
GB,2023-03-14,A0686279,Clinical,The Royal Marsden Hospital,Mary O'Brien,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,3/19/2023,5/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-14,A0686254,Clinical,Guys Hospital,Sugama Chicklore,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/21/2023,3/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-15,A0686956,Clinical,The Royal Marsden NHS Foundation Trust,Marina Parton,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,3/20/2023,3/23/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-03,1.18,2938.2,2000-3000$ 
GB,2023-03-15,A0686813,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung cancer,3/20/2023,3/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-15,A0686949,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,3/20/2023,3/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
GB,2023-03-16,A0688655,Clinical,NHS - University College London Hospital,Martin Forster,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/21/2023,3/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-16,A0688576,Clinical,NHS - Wythenshawe Hospital,Nicola Sinnott,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/22/2023,3/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-16,A0688610,Clinical,Sussex Cancer Centre,Kam Zaki,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/21/2023,3/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-16,A0688645,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/27/2023,3/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-16,A0688577,Clinical,NHS - Wythenshawe Hospital,Christopher Brockelsby,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/21/2023,3/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-16,A0688620,Clinical,NHS - University College London Hospital,Martin Forster,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/21/2023,3/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-16,A0688409,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,3/24/2023,3/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,Reveal,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-16,A0688736,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,,GHI_19,Distributors : ROW,Prostate adenocarcinoma,3/21/2023,3/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
GB,2023-03-16,A0690980,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung cancer,3/23/2023,3/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
ES,2023-03-16,A0688595,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung squamous cell carcinoma,3/21/2023,3/21/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-03,1.0,1245.0,0-1500$ 
GB,2023-03-16,A0688638,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/21/2023,3/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
CA,2023-03-16,A0688606,Clinical,London Health Sciences Centre,Daniel Breadner,Guardant 360,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,3/28/2023,3/28/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Canada,Free,0 USD,0.0,2023-03,1.0,0.0,0 $
ES,2023-03-16,A0688608,Clinical,Hospital University La Paz,Javier de Castro Carpeno,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,4/27/2023,4/27/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,0 EUR,0.0,2023-03,1.0,0.0,0 $
GB,2023-03-16,A0688640,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,3/21/2023,3/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
IT,2023-03-16,A0688657,Clinical,Comprensorio sanitario di Bolzano,Luca Tondulli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/21/2023,3/21/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 EUR,0.0,2023-03,1.0,0.0,0 $
IT,2023-03-17,A0689214,Clinical,Istituto Clinico Porta Sole Casa di Cura Srl,Antonio Rulli,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/22/2023,3/22/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2241 EUR,2241.0,2023-03,1.0,2241.0,2000-3000$ 
GB,2023-03-17,A0689271,Clinical,The Royal Marsden NHS Foundation Trust,Alistair Ring,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,3/22/2023,3/22/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-03,1.18,2938.2,2000-3000$ 
GB,2023-03-17,A0690982,Clinical,HCA Laboratories,Constantine Alifrangis,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Prostate adenocarcinoma,3/26/2023,3/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3490 GBP,3490.0,2023-03,1.18,4118.2,3000+ $
ES,2023-03-17,A0689339,Clinical,Fundacion Jimenez Diaz,Jaime Rubio Perez,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/22/2023,3/22/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-03,1.0,1245.0,0-1500$ 
GB,2023-03-17,A0690981,Clinical,Guys Hospital,Anthony Kong,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,Head and neck carcinoma,4/5/2023,4/5/2023,UNITED KINGDOM,Commercial,Head and neck carcinoma,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-17,A0690974,Clinical,The London Clinic,Nicholas Maisey,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,3/26/2023,3/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3490 GBP,3490.0,2023-03,1.18,4118.2,3000+ $
GB,2023-03-17,A0689200,Clinical,NHS - Wythenshawe Hospital,Richard Booton,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/22/2023,3/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
TR,2023-03-17,A0688995,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Suleyman Alici,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung squamous cell carcinoma,3/23/2023,3/23/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-03,1.0,2319.0,2000-3000$ 
GB,2023-03-17,A0689195,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/22/2023,3/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-17,A0688997,Clinical,Guys Hospital,Danielle Crawley,Guardant360 CDx,,GHI_19,Self-Pay Patient,Renal Cell Carcinoma,3/23/2023,3/28/2023,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-18,A0690597,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/22/2023,3/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
ES,2023-03-18,A0690608,Clinical,Hospital del Mar,Laura Visa,74-Gene Panel,,GHI_19,Self-Pay Sponsored,Other,3/22/2023,3/23/2023,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 EUR,1245.0,2023-03,1.0,1245.0,0-1500$ 
GB,2023-03-18,A0690527,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant360 CDx,2.11,GHI_19,Distributors : ROW,Lung cancer,3/24/2023,3/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-18,A0690624,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant360 CDx,2.11,GHI_19,Distributors : ROW,Lung cancer,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-18,A0690513,Clinical,The Christie Hospital,Saifee Mullamitha,Guardant 360,,GHI_19,Self-Pay Patient,Other,3/27/2023,3/30/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-18,A0690508,Clinical,NHS - University College London Hospital,Martin Forster,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/25/2023,3/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-18,A0690570,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-20,A0690858,Clinical,The Nuffield Hospital Guildford,Sebastian Cummins,Guardant 360,,GHI_19,Self-Pay Patient,Lung carcinoid,3/23/2023,3/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2240 GBP,2240.0,2023-03,1.18,2643.2,2000-3000$ 
GB,2023-03-20,A0690879,Clinical,Kent and Canterbury Hospital,Mathilda Cominos,74-Gene Panel,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/23/2023,4/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-20,A0690845,Clinical,Castle Hill Hospital,Lashitha Delpachithra,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,3/23/2023,3/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
TR,2023-03-20,A0690840,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Umut Demirci,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Sarcoma,3/26/2023,3/27/2023,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-03,1.0,2319.0,2000-3000$ 
GB,2023-03-20,A0690853,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/24/2023,3/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-20,A0690843,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/24/2023,3/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-20,A0690876,Clinical,Southampton General Hospital,Almurtadha Mula-Kh,Guardant 360,,GHI_19,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,3/23/2023,3/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-20,A0690869,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/23/2023,3/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
UY,2023-03-20,A0690872,Clinical,Practice Dr Luis Ubillos,Luis Ubillos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,3/24/2023,3/24/2023,URUGUAY,Commercial,Breast,URUGUAY,1,non_AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,South America,Paid,3490 USD,3490.0,2023-03,1.0,3490.0,3000+ $
GB,2023-03-20,A0690874,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung cancer,3/24/2023,3/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-20,A0690882,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,3/24/2023,3/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-20,A0690839,Clinical,Guys Hospital,Kate Smith,Guardant 360,,GHI_19,Self-Pay Patient,Renal Cell Carcinoma,3/24/2023,3/25/2023,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-21,A0691464,Clinical,Genesis Care,Timothy Sevitt,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,3/26/2023,3/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-03,1.18,2938.2,2000-3000$ 
IT,2023-03-21,A0691572,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/27/2023,3/27/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2000 EUR,2000.0,2023-03,1.0,2000.0,1500-2000$ 
CA,2023-03-21,A0691561,Clinical,Integrated Health Clinic,Gurdev Parmar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,3/27/2023,4/3/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Canada,Paid,0 USD,0.0,2023-03,1.0,0.0,0 $
GB,2023-03-22,A0692364,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
FR,2023-03-22,A0692446,Clinical,CLCC Institut Curie. 26 rue d'Ulm,Nicolas Girard,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/27/2023,3/27/2023,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 EUR,0.0,2023-03,1.0,0.0,0 $
GB,2023-03-23,A0693655,Clinical,Guys Hospital,Marios Hadjipavlou,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-23,A0693161,Clinical,NHS - University Hospitals Leicester,Claire Vella,Guardant 360,,GHI_19,Distributors : ROW,Carcinoma of unknown primary (CUP),3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-23,A0693345,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Other,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-23,A0693223,Clinical,Guys Hospital,Teresa Guerrero Urbano,Guardant 360,,GHI_19,Self-Pay Patient,Head and neck carcinoma,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,Head and neck carcinoma,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-23,A0693312,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-23,A0693310,Clinical,Guys Hospital,Mary Varia,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-23,A0693359,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,3/30/2023,3/30/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-23,A0693474,Clinical,NHS - University Hospitals Leicester,Asfandyar Yousuf,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/27/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-23,A0693455,Clinical,NHS - University Hospitals Leicester,Rajini Sudhir,Guardant 360,,GHI_19,Distributors : ROW,Lung squamous cell carcinoma,3/27/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-23,A0693299,Clinical,Guys Hospital,Saoirse Dolly,Guardant 360,,GHI_19,Self-Pay Patient,Other,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-23,A0693408,Clinical,The Blackheath Hospital,Nick Maisey,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3490 GBP,3490.0,2023-03,1.18,4118.2,3000+ $
GB,2023-03-23,A0693635,Clinical,HCA Laboratories,Amen Sibtain,Guardant360 CDx,2.11,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
TR,2023-03-23,A0693189,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Haci Ibrahim Petekaya,Guardant360 CDx,2.12,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),3/28/2023,3/28/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-03,1.0,1838.0,1500-2000$ 
GB,2023-03-23,A0693330,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-23,A0693266,Clinical,NHS - University Hospitals Leicester,Jonathan Bennett,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-23,A0693353,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,Cholangiocarcinoma,3/30/2023,3/30/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-23,A0693260,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,3/30/2023,4/4/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-23,A0693245,Clinical,NHS - Wythenshawe Hospital,Jonathan Chung,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-23,A0693371,Clinical,NHS - Wythenshawe Hospital,Christopher Craig,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/27/2023,3/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
MX,2023-03-24,A0694181,Clinical,MileniaLabs,Guadalupe Evaristo Cedillo Salazar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,3/28/2023,4/25/2023,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,South America,Paid,2500 USD,2500.0,2023-03,1.0,2500.0,2000-3000$ 
GB,2023-03-24,A0693967,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,3/28/2023,3/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-03,1.18,2938.2,2000-3000$ 
TR,2023-03-24,A0694150,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Elvina Almuradova,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,3/28/2023,3/29/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1838,1838.0,2023-03,1.0,1838.0,1500-2000$ 
GB,2023-03-24,A0693791,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/28/2023,3/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-24,A0694226,Clinical,Royal United Hospitals Bath,Mark Beresford,Guardant 360,2.12,GH2_12,Self-Pay Patient,Urothelial carcinoma,3/30/2023,3/30/2023,UNITED KINGDOM,Commercial,Urothelial,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-03,1.18,2938.2,2000-3000$ 
GB,2023-03-24,A0693816,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-24,A0693806,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Jonathan Dakin,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-03,1.18,2938.2,2000-3000$ 
GB,2023-03-24,A0693978,Clinical,Freeman Hospital,Sunita Kohli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Other,3/28/2023,3/28/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-24,A0694269,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/29/2023,3/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-24,A0693825,Clinical,Royal United Hospitals Bath,Tania Tillett,Guardant 360,2.12,GH2_12,Self-Pay Patient,Carcinoma of unknown primary (CUP),3/29/2023,3/29/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-03,1.18,2938.2,2000-3000$ 
GB,2023-03-25,A0695318,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/29/2023,3/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
ES,2023-03-25,A0695312,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,3/30/2023,3/31/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,2241 EUR,2241.0,2023-03,1.0,2241.0,2000-3000$ 
MX,2023-03-25,A0695240,Clinical,MileniaLabs,Luis Antonio Caned Trevino,Guardant 360,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,3/29/2023,4/25/2023,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,South America,Paid,2500 USD,2500.0,2023-03,1.0,2500.0,2000-3000$ 
ES,2023-03-27,A0695528,Clinical,HOSPITAL UNIV FUNDACION ALCORCON,XABIER MIELGO RUBIO,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/30/2023,3/31/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 EUR,0.0,2023-03,1.0,0.0,0 $
ES,2023-03-27,A0695500,Clinical,Hospital Quiron Barcelona,Jesus Soberino Garcia,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,4/3/2023,4/3/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,2241 EUR,2241.0,2023-03,1.0,2241.0,2000-3000$ 
GB,2023-03-27,A0695522,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/30/2023,3/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
DE,2023-03-27,A0695509,Clinical,SLK Kliniken GMBH,Uwe Martens,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,4/2/2023,4/3/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3341 EUR,3341.0,2023-03,1.0,3341.0,3000+ $
ES,2023-03-27,A0695510,Clinical,Hospital University La Paz,Javier de Castro Carpeno,Guardant 360,,GHI_19,Pharma : ROW,Lung adenocarcinoma,3/30/2023,10/26/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 EUR,0.0,2023-03,1.0,0.0,0 $
GB,2023-03-27,A0695555,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,4/3/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,Reveal,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-27,A0695492,Clinical,Sheffield Weston Park Cancer Centre,Shiyam Kumar,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,4/2/2023,4/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-27,A0695541,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung squamous cell carcinoma,3/30/2023,3/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-27,A0695518,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,3/30/2023,3/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
ES,2023-03-27,A0695501,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,4/2/2023,4/3/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2241 EUR,2241.0,2023-03,1.0,2241.0,2000-3000$ 
IT,2023-03-27,A0695543,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,3/31/2023,3/31/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2000 EUR,2000.0,2023-03,1.0,2000.0,1500-2000$ 
GB,2023-03-27,A0695506,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),3/31/2023,3/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-28,A0695901,Clinical,Guys Hospital,Karen Harrison-Phipps,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/2/2023,4/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-28,A0695992,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,,GHI_19,Distributors : ROW,Prostate adenocarcinoma,4/3/2023,4/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
GB,2023-03-28,A0695880,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/2/2023,4/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-28,A0695890,Clinical,Cancer Centre London,Anna-Mary Young,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic neuroendocrine tumor,4/4/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2240 GBP,2240.0,2023-03,1.18,2643.2,2000-3000$ 
GB,2023-03-29,A0696817,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/4/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-29,A0696964,Clinical,St Georges Hospital,Nicholas Brown,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,4/3/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-29,A0696598,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/4/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-29,A0696826,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/4/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-29,A0696837,Clinical,Guys Hospital,Deborah Enting,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,4/4/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-29,A0696955,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/4/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-29,A0696834,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/4/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-29,A0696848,Clinical,Great Western Hospitals,Omar Khan,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,4/4/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2240 GBP,2240.0,2023-03,1.18,2643.2,2000-3000$ 
GB,2023-03-29,A0696973,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/4/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-29,A0696963,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Madeleine Hewish,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/3/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2490 GBP,2490.0,2023-03,1.18,2938.2,2000-3000$ 
CA,2023-03-29,A0696842,Clinical,Integrated Health Clinic,Gurdev Parmar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,4/4/2023,4/21/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Canada,Paid,1700 USD,1700.0,2023-03,1.0,1700.0,1500-2000$ 
PE,2023-03-30,A0697985,Clinical,Carlos Carracedo Gonzalez,Carlos Carracedo Gonzalez,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,4/4/2023,4/4/2023,PERU,Commercial,,PERU,1,non_AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,South America,Paid,3490 USD,3490.0,2023-03,1.0,3490.0,3000+ $
DE,2023-03-30,A0698018,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,4/6/2023,4/6/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3341 EUR,3341.0,2023-03,1.0,3341.0,3000+ $
GB,2023-03-30,A0697899,Clinical,St Georges Hospital,Nicholas Brown,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/3/2023,4/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-30,A0697989,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/4/2023,4/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
ES,2023-03-30,A0697981,Clinical,Fundacion Jimenez Diaz,Jaime Rubio Perez,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,4/6/2023,4/6/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,0 EUR,0.0,2023-03,1.0,0.0,0 $
MX,2023-03-30,A0697917,Clinical,ABC Hospital,Gabriela Olivia Regalado Porras,Guardant 360,2.11,GHI_01,Distributors : ROW,Other,4/4/2023,4/21/2023,MEXICO,Commercial,Other,MEXICO,1,non_AE,EUR,Americas,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,South America,Paid,3228 USD,3228.0,2023-03,1.0,3228.0,3000+ $
GB,2023-03-30,A0697924,Clinical,NHS - Wythenshawe Hospital,Richard Booton,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/4/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-30,A0697390,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,4/4/2023,4/5/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-30,A0697975,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,4/4/2023,4/5/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,2178.75 GBP,2178.0,2023-03,1.18,2570.04,2000-3000$ 
GB,2023-03-30,A0697909,Clinical,Guys Hospital,Kaiser Anam,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,4/4/2023,4/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
TR,2023-03-30,A0698016,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Osman Gokhan Demir,Guardant 360,2.12,GH2_12,Distributors : ROW,Ovarian carcinoma,4/5/2023,4/5/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-03,1.0,2319.0,2000-3000$ 
DE,2023-03-30,A0698014,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/7/2023,4/7/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3341 EUR,3341.0,2023-03,1.0,3341.0,3000+ $
GB,2023-03-30,A0697701,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,4/3/2023,4/4/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
GB,2023-03-30,A0697992,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant 360,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,4/5/2023,4/5/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3490 GBP,3490.0,2023-03,1.18,4118.2,3000+ $
GB,2023-03-30,A0697869,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,4/3/2023,4/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-30,A0697875,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,4/5/2023,4/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3490 GBP,3490.0,2023-03,1.18,4118.2,3000+ $
GB,2023-03-30,A0698831,Clinical,Clatterbridge Cancer Centre,Carlo Palmieri,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Breast Carcinoma,4/27/2023,4/27/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-30,A0697919,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,4/3/2023,4/6/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,1245 GBP,1245.0,2023-03,1.18,1469.1,0-1500$ 
CA,2023-03-31,A0698473,Clinical,London Health Sciences Centre,Daniel Breadner,Guardant 360,2.12,GH2_12,Self-Pay Patient,Esophageal adenocarcinoma,4/10/2023,5/19/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Canada,Paid,2290 USD,2290.0,2023-03,1.0,2290.0,2000-3000$ 
GB,2023-03-31,A0698471,Clinical,Guys Hospital,Vishal Manik,74-Gene Panel,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,4/4/2023,4/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
GB,2023-03-31,A0698556,Clinical,NHS - University College London Hospital,Martin Forster,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/4/2023,4/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-31,A0698456,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shivan Sivakumar,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,4/9/2023,4/21/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,3490 GBP,3490.0,2023-03,1.18,4118.2,3000+ $
GB,2023-03-31,A0698491,Clinical,Guys Hospital,Mary Varia,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,4/5/2023,4/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
TR,2023-03-31,A0698608,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulcan Bulut,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,4/13/2023,4/13/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,3,2023,1,1,2023-03-01,2023-03,G360 Infinity,2023Q1,Europe,Paid,2319,2319.0,2023-03,1.0,2319.0,2000-3000$ 
GB,2023-03-31,A0698460,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/4/2023,4/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-31,A0698488,Clinical,NHS - University College London Hospital,Ricky Thakrar,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung cancer,4/5/2023,4/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Paid,830 GBP,830.0,2023-03,1.18,979.4,0-1500$ 
GB,2023-03-31,A0698587,Clinical,Guys Hospital,Alvin Lee,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Other,4/17/2023,4/19/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,3,2023,1,1,2023-03-01,2023-03,G360 CDx,2023Q1,Europe,Free,0 GBP,0.0,2023-03,1.18,0.0,0 $
ES,2023-04-01,A0699992,Clinical,Hospital Ruber Internacional,Araceli Priego Priego,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,4/7/2023,4/7/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2241 EUR,2241.0,2023-04,1.0,2241.0,2000-3000$ 
CA,2023-04-01,A0699347,Clinical,RCM Health Consultancy,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/5/2023,4/19/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Canada,Paid,1700 USD,1700.0,2023-04,1.0,1700.0,1500-2000$ 
GB,2023-04-03,A0699712,Clinical,Guys Hospital,Vishal Manik,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,4/9/2023,4/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
BR,2023-04-03,A0699827,Clinical,Hospital Israelita Albert Einstein,Maria Alzira Almeida,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/7/2023,4/7/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Free,0 USD,0.0,2023-04,1.0,0.0,0 $
GB,2023-04-03,A0699764,Clinical,The Montefiore Hospital,Richard Simcock,Guardant360 CDx EU,2.11,GHI_19,Self-Pay Sponsored,Breast Carcinoma,4/9/2023,4/9/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-04,1.18,2643.2,2000-3000$ 
GB,2023-04-03,A0699736,Clinical,Cancer Centre London,Muireann Kelleher,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,4/7/2023,4/7/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-04,1.18,2938.2,2000-3000$ 
ES,2023-04-03,A0699706,Clinical,Hospital Universitario de Guadalajara,Luis Enrique Chara Velarde,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,4/6/2023,4/21/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1245 EUR,1245.0,2023-04,1.0,1245.0,0-1500$ 
GB,2023-04-03,A0699777,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/6/2023,4/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-03,A0699700,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/6/2023,4/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
ES,2023-04-03,A0699752,Clinical,Hospital La Luz,Diego Alcaraz Nunes,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,4/7/2023,4/7/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-04,1.0,0.0,0 $
ES,2023-04-03,A0699739,Clinical,Hospital del Mar,Laura Visa,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Other,4/7/2023,4/21/2023,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1245 EUR,1245.0,2023-04,1.0,1245.0,0-1500$ 
GB,2023-04-03,A0699743,Clinical,BMI Bishops Wood Hospital,Andreas Polychronis,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,4/11/2023,4/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-04,1.18,4118.2,3000+ $
GB,2023-04-03,A0699854,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/6/2023,4/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-03,A0699769,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/6/2023,4/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
ES,2023-04-03,A0699691,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,4/6/2023,4/7/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2241 EUR,2241.0,2023-04,1.0,2241.0,2000-3000$ 
BR,2023-04-03,A0699848,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,4/11/2023,4/11/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-04,1.0,1750.0,1500-2000$ 
GB,2023-04-04,A0700410,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,4/12/2023,4/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,Reveal,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-04,1.18,4118.2,3000+ $
GB,2023-04-04,A0700374,Clinical,The Royal Marsden NHS Foundation Trust,David Cunningham,Guardant 360,,GHI_19,Self-Pay Sponsored,Duodenal Adenocarcinoma,4/11/2023,4/11/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-04,1.18,2938.2,2000-3000$ 
GB,2023-04-04,A0700397,Clinical,Maidstone and Tunbridge Wells NHS Trust,Saara Mohammed,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/9/2023,4/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-04,A0700417,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Non-small cell lung carcinoma (NSCLC),4/9/2023,4/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-04,1.18,1469.1,0-1500$ 
GB,2023-04-04,A0700634,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/10/2023,4/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-05,A0701639,Clinical,NHS - University Hospitals Leicester,Rajini Sudhir,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/10/2023,4/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-05,A0702030,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/17/2023,4/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-05,A0701201,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/11/2023,4/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
IT,2023-04-05,A0701264,Clinical,Casa di Cura Villa Donatello,Francesco Di Costanzo,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/11/2023,4/11/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2000 EUR,2000.0,2023-04,1.0,2000.0,1500-2000$ 
GB,2023-04-05,A0701349,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,4/12/2023,4/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,Reveal,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-04,1.18,4118.2,3000+ $
BR,2023-04-05,A0701568,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/10/2023,4/10/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-04,1.0,1750.0,1500-2000$ 
GB,2023-04-05,A0701615,Clinical,NHS - University Hospitals Leicester,Rajini Sudhir,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,4/10/2023,4/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-05,A0701600,Clinical,NHS - University College London Hospital,Samuel Janes,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/16/2023,4/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-05,A0701187,Clinical,The James Cook University Hospital,Darren Leaning,Guardant360 CDx,,GHI_19,Self-Pay Patient,Bladder carcinoma,4/9/2023,4/9/2023,UNITED KINGDOM,Commercial,Bladder,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-05,A0701379,Clinical,The Royal Marsden Hospital,Anderley Gordon,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/11/2023,4/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-04,1.18,1469.1,0-1500$ 
ES,2023-04-05,A0701529,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,4/12/2023,4/12/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2400 USD,2400.0,2023-04,1.0,2400.0,2000-3000$ 
CA,2023-04-05,A0701867,Clinical,London Health Sciences Centre,Daniel Breadner,Guardant 360,2.12,GH2_12,Self-Pay Patient,Esophageal/Gastroesophageal junction Adenocarcinoma,4/12/2023,8/29/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-04,1.0,2290.0,2000-3000$ 
TR,2023-04-06,A0702143,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Seyda Gunduz,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,4/12/2023,4/12/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-04,1.0,1838.0,1500-2000$ 
GB,2023-04-06,A0702209,Clinical,The Holly Private Hospital,Eliot Sims,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,4/12/2023,4/12/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-04,1.18,2938.2,2000-3000$ 
GB,2023-04-06,A0702068,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/11/2023,4/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-06,A0702141,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/11/2023,4/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-06,A0702200,Clinical,University College London Hospitals,John Bridgewater,74-Gene Panel,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,4/11/2023,4/20/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-04,1.18,1469.1,0-1500$ 
CA,2023-04-06,A0702096,Clinical,BC Cancer centre - Vancouver,Sharlene Gill,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,4/13/2023,4/19/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,Reveal,2023Q2,Canada,Paid,0 USD,0.0,2023-04,1.0,0.0,0 $
GB,2023-04-06,A0702153,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/12/2023,4/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
TR,2023-04-06,A0702077,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Goker Erdem,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,4/11/2023,4/17/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-04,1.0,1838.0,1500-2000$ 
GB,2023-04-06,A0702131,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,4/19/2023,4/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-07,A0703630,Clinical,NHS - Wythenshawe Hospital,Jonathan Chung,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/14/2023,4/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-07,A0703620,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Madeleine Hewish,Guardant360 CDx,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,4/14/2023,5/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-04,1.18,2643.2,2000-3000$ 
GB,2023-04-07,A0703639,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/12/2023,5/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-04,1.18,1469.1,0-1500$ 
GB,2023-04-07,A0703700,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/12/2023,4/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-08,A0704309,Clinical,Cancer Centre London,Muireann Kelleher,Guardant360 CDx,2.11,GHI_19,Self-Pay Sponsored,Breast Carcinoma,4/17/2023,4/17/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-04,1.18,2938.2,2000-3000$ 
GB,2023-04-08,A0704343,Clinical,The Royal Marsden Hospital,Robert Huddart,Guardant 360,,GHI_19,Self-Pay Sponsored,Other,4/13/2023,4/13/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-04,1.18,2938.2,2000-3000$ 
ES,2023-04-08,A0704291,Clinical,Hospital Universitario Infanta SofÃ­a,Gustavo Rubio Romero,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/12/2023,4/12/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-04,1.0,0.0,0 $
GB,2023-04-10,A0704633,Clinical,St Bartholomews Hospital,Marco Gerlinger,Guardant 360,,GHI_19,Self-Pay Patient,Gastroesophageal junction carcinoma,4/17/2023,4/17/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-10,A0705601,Clinical,High Wycombe Hospital,Prabir Chakraborti,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,4/16/2023,5/16/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-04,1.18,2938.2,2000-3000$ 
IT,2023-04-10,A0704602,Clinical,ASST Papa Giovanni XXIII,Denise Morotti,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,4/17/2023,4/17/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-04,1.0,0.0,0 $
IT,2023-04-10,A0704592,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/17/2023,4/17/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-04,1.0,0.0,0 $
GB,2023-04-10,A0704631,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/18/2023,4/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-10,A0704643,Clinical,"Northwick Park Hospital, London North West University Healthcare NHS Trust",Dan Ornadel,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/25/2023,4/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-10,A0704621,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Ajay Mehta,UNKNOWN,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,4/18/2023,4/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,0 GBP,0.0,2023-04,1.18,0.0,0 $
TR,2023-04-10,A0704616,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Berna Komurcuoglu,Guardant360 CDx,,GHI_19,Distributors : ROW,Carcinoma of unknown primary (CUP),4/21/2023,4/21/2023,TURKEY,Commercial,CUP,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-04,1.0,1838.0,1500-2000$ 
TR,2023-04-10,A0704597,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Osman Gokhan Demir,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,4/14/2023,4/15/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-04,1.0,2319.0,2000-3000$ 
GB,2023-04-10,A0704589,Clinical,Addenbrooke's Hospital,David Gilligan,Guardant 360,2.12,GH2_12,Self-Pay Patient,Carcinoma of unknown primary (CUP),4/14/2023,4/15/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-04,1.18,4118.2,3000+ $
CA,2023-04-11,A0706003,Clinical,Princess Margaret Cancer Centre,Jennifer Knox,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/17/2023,5/15/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-04,1.0,2290.0,2000-3000$ 
CA,2023-04-11,A0706059,Clinical,Princess Margaret Cancer Centre,Jennifer Knox,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,4/17/2023,4/17/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-04,1.0,2290.0,2000-3000$ 
GB,2023-04-12,A0706770,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,4/21/2023,5/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,Reveal,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-04,1.18,4118.2,3000+ $
GB,2023-04-12,A0707054,Clinical,East Suffolk and North Essex NHS Foundation Trust,Mukesh B Mukesh,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,4/18/2023,4/18/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-04,1.18,2643.2,2000-3000$ 
GB,2023-04-13,A0726123,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/18/2023,4/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-13,A0726085,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/19/2023,4/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-13,A0726089,Clinical,Freeman Hospital,Lindsay Hannah,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,4/27/2023,4/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-13,A0726337,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/19/2023,4/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-13,A0726116,Clinical,Guys Hospital,Anthony Kong,Guardant 360,2.11,GHI_01,Self-Pay Patient,Head and neck carcinoma,4/25/2023,4/25/2023,UNITED KINGDOM,Commercial,Head and neck carcinoma,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-14,A0726966,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/21/2023,4/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-14,A0727034,Clinical,Guys Hospital,Nirupa Murugaesu,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,4/19/2023,4/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-14,A0726929,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/19/2023,4/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-14,A0727049,Clinical,Guys Hospital,Debashis Sarker,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/19/2023,4/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-14,A0730722,Clinical,Kettering General Hospital,Muhammad Naeem,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/25/2023,4/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-14,A0726932,Clinical,Guys Hospital,Kasia Owczarczyk,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/21/2023,4/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-14,A0727118,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Jonathan Dakin,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,4/20/2023,4/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-04,1.18,2643.2,2000-3000$ 
GB,2023-04-14,A0727028,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/19/2023,4/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
ES,2023-04-15,A0728632,Clinical,Hospital University La Paz,CARLOS JIMENEZ MARTIN,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/25/2023,4/25/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-04,1.0,0.0,0 $
CA,2023-04-15,A0727615,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.12,GH2_12,Self-Pay Patient,Carcinoma of unknown primary (CUP),4/24/2023,4/24/2023,CANADA,Commercial,CUP,CANADA,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-04,1.0,2290.0,2000-3000$ 
ES,2023-04-17,A0728125,Clinical,Hospital Arnau De Vilanova,Javier Garde Noguera,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/24/2023,4/24/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1745 EUR,1745.0,2023-04,1.0,1745.0,1500-2000$ 
GB,2023-04-17,A0728138,Clinical,Poole Hospital NHS Foundation Trust,Joanna Hack,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-17,A0728095,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-17,A0728130,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-17,A0728142,Clinical,Glasgow Royal Infirmary,Claire Rooney,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-17,A0728102,Clinical,Glasgow Royal Infirmary,Claire Rooney,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-17,A0728720,Clinical,Southend University Hospital,Gairin Dancey,74-Gene Panel,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-17,A0728119,Clinical,NHS - Wythenshawe Hospital,Phil Crosbie,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-17,A0728079,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-17,A0728108,Clinical,Southend University Hospital,Gairin Dancey,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-17,A0728100,Clinical,Freeman Hospital,Lindsay Hannah,Guardant360 CDx,,GHI_19,Self-Pay Patient,Ovarian carcinoma,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
BR,2023-04-17,A0728157,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/22/2023,4/22/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-04,1.0,1750.0,1500-2000$ 
GB,2023-04-17,A0728146,Clinical,NHS - Wythenshawe Hospital,Phil Crosbie,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
TR,2023-04-17,A0728122,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Osman Gokhan Demir,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,4/24/2023,4/24/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-04,1.0,1838.0,1500-2000$ 
BR,2023-04-17,A0728148,Clinical,Hospital Israelita Albert Einstein,Pedro Uson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/22/2023,5/4/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,2241 USD,2241.0,2023-04,1.0,2241.0,2000-3000$ 
BR,2023-04-17,A0728110,Clinical,Hospital Israelita Albert Einstein,Rene Gansl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,4/22/2023,4/22/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,2490 USD,2490.0,2023-04,1.0,2490.0,2000-3000$ 
CL,2023-04-17,A0728066,Clinical,Clinica MEDS La Dehesa,Jose Miguel Reyes,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,4/24/2023,4/24/2023,CHILE,Commercial,Breast,CHILE,1,non_AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,1550 USD,1550.0,2023-04,1.0,1550.0,1500-2000$ 
BR,2023-04-17,A0728083,Clinical,Hospital Israelita Albert Einstein,Pedro Uson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/23/2023,4/25/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,2490 USD,2490.0,2023-04,1.0,2490.0,2000-3000$ 
TR,2023-04-17,A0728068,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Hilmi Ege,Guardant360 CDx,2.12,GHI_19,Distributors : ROW,Breast Carcinoma,4/24/2023,4/24/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-04,1.0,1838.0,1500-2000$ 
TR,2023-04-17,A0728062,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Umut Demirci,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,4/24/2023,4/24/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-04,1.0,2319.0,2000-3000$ 
TR,2023-04-17,A0728055,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ertugrul Seyrek,Guardant360 CDx,,GHI_19,Distributors : ROW,Thyroid medullary carcinoma,4/24/2023,4/24/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-04,1.0,1838.0,1500-2000$ 
BR,2023-04-17,A0728158,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/23/2023,4/23/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-04,1.0,1750.0,1500-2000$ 
ES,2023-04-17,A0728067,Clinical,Hospital Ruber Internacional,Javier Cortes Castan,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,4/25/2023,4/25/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0,0.0,2023-04,1.0,0.0,0 $
BR,2023-04-17,A0728058,Clinical,Hospital Israelita Albert Einstein,Pedro Uson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/23/2023,4/23/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,2490 USD,2490.0,2023-04,1.0,2490.0,2000-3000$ 
GB,2023-04-18,A0728551,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,4/27/2023,4/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-18,A0728705,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-04,1.18,2570.04,2000-3000$ 
GB,2023-04-18,A0728489,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-04,1.18,2570.04,2000-3000$ 
GB,2023-04-18,A0728614,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-18,A0728447,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/24/2023,4/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-18,A0728497,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,4/25/2023,4/25/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-04,1.18,2570.04,2000-3000$ 
GB,2023-04-18,A0728477,Clinical,Royal Free London NHS Foundation Trust,Anant Patel,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Lung cancer,4/28/2023,4/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-04,1.18,2938.2,2000-3000$ 
BR,2023-04-19,A0730124,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,4/25/2023,4/28/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,2500 USD,2500.0,2023-04,1.0,2500.0,2000-3000$ 
GB,2023-04-19,A0730388,Clinical,Queen Alexandra Hospital,Tharani Abeysekera,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,4/25/2023,4/25/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-19,A0730328,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/25/2023,4/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
BR,2023-04-19,A0726611,Clinical,AC Camargo Cancer Center,Helano Freitas,Guardant Reveal,3.0,GHI_18,Self-Pay Patient,Lung adenocarcinoma,5/2/2023,5/2/2023,BRAZIL,,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,Reveal,2023Q2,South America,Paid,3490 USD,3490.0,2023-04,1.0,3490.0,3000+ $
GB,2023-04-19,A0730294,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant 360,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,4/25/2023,4/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-04,1.18,2938.2,2000-3000$ 
BR,2023-04-19,A0730301,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,4/25/2023,4/25/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-04,1.0,1750.0,1500-2000$ 
GB,2023-04-20,A0733470,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/28/2023,4/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
CA,2023-04-20,A0731459,Clinical,London Health Sciences Centre,Mark Vincent,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,5/1/2023,5/1/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-04,1.0,2290.0,2000-3000$ 
GB,2023-04-20,A0731401,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/3/2023,5/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
ES,2023-04-21,A0732599,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,2.12,GH2_12,Distributors : ROW,Cholangiocarcinoma,5/1/2023,5/1/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Europe,Paid,2179 EUR,2179.0,2023-04,1.0,2179.0,2000-3000$ 
GB,2023-04-21,A0732630,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/1/2023,5/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-21,A0732614,Clinical,Singleton Hospital,Emma Christopher,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,4/26/2023,4/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
ES,2023-04-21,A0732615,Clinical,Hospital Quiron Barcelona,Josep Tabernero Caturla,Guardant 360,2.12,GH2_12,Distributors : ROW,Gastric adenocarcinoma,4/28/2023,4/28/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Europe,Paid,2241 EUR,2241.0,2023-04,1.0,2241.0,2000-3000$ 
TR,2023-04-22,A0732989,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Hilmi Ege,Guardant360 CDx,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,4/30/2023,4/30/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-04,1.0,1838.0,1500-2000$ 
GB,2023-04-24,A0734426,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/4/2023,5/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
DE,2023-04-24,A0733446,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Prostate adenocarcinoma,5/2/2023,5/2/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Europe,Paid,3341 EUR,3341.0,2023-04,1.0,3341.0,3000+ $
TR,2023-04-24,A0733410,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Melanoma,5/2/2023,5/2/2023,TURKEY,Commercial,Skin,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-04,1.0,2319.0,2000-3000$ 
IT,2023-04-24,A0733453,Clinical,ASST Papa Giovanni XXIII,Denise Morotti,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,4/28/2023,4/28/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-04,1.0,0.0,0 $
GB,2023-04-24,A0733447,Clinical,HCA Laboratories,Mark Harries,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,4/28/2023,4/28/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-04,1.18,2570.04,2000-3000$ 
ES,2023-04-24,A0733460,Clinical,Mutua de Terrassa,JosÃ© Mazarico,Guardant360 CDx,,GHI_19,Self-Pay Patient,Head and neck carcinoma,5/1/2023,5/1/2023,SPAIN,Commercial,Head and neck carcinoma,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-04,1.0,0.0,0 $
GB,2023-04-25,A0734209,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/3/2023,5/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-25,A0734221,Clinical,Clatterbridge cancer Center,Rachel Brooker,Guardant 360,2.11,GHI_01,Self-Pay Patient,Head and neck carcinoma,5/2/2023,5/3/2023,UNITED KINGDOM,Commercial,Head and neck carcinoma,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-25,A0734230,Clinical,NHS - Wythenshawe Hospital,Matthew Evison,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,4/30/2023,5/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
CA,2023-04-26,A0735711,Clinical,London Health Sciences Centre,Mark Vincent,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,5/8/2023,5/8/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,Reveal,2023Q2,Canada,Free,0 EUR,0.0,2023-04,1.0,0.0,0 $
GB,2023-04-26,A0735693,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/2/2023,5/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-04,1.18,2570.04,2000-3000$ 
BR,2023-04-26,A0735698,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,5/2/2023,5/5/2023,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-04,1.0,1750.0,1500-2000$ 
GB,2023-04-26,A0736076,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Other,5/2/2023,5/2/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-26,A0735679,Clinical,Queen Alexandra Hospital,Benjamin Smalley,Guardant 360,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),5/2/2023,5/2/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-26,A0735680,Clinical,Kent and Canterbury Hospital,Mathilda Cominos,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/2/2023,5/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-04,1.18,1469.1,0-1500$ 
ES,2023-04-27,A0736506,Clinical,Hospital Clinico San Carlos,Jorge Bartolome,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung squamous cell carcinoma,5/2/2023,5/2/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1245 EUR,1245.0,2023-04,1.0,1245.0,0-1500$ 
BR,2023-04-27,A0736512,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/2/2023,5/2/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-04,1.0,1750.0,1500-2000$ 
GB,2023-04-27,A0736496,Clinical,University Hospitals Coventry & Warwickshire NHS Trust,Jane Worlding,Guardant 360,2.11,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,5/8/2023,8/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-27,A0736500,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,5/6/2023,5/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-27,A0736484,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/2/2023,5/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-27,A0736498,Clinical,Guys Hospital,Muhammad Khan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,5/8/2023,8/31/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-27,A0736487,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,5/8/2023,8/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
CA,2023-04-27,A0736483,Clinical,St Catherines Regional Hospital,Adrian Ishkanian,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,5/8/2023,8/31/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-04,1.0,2290.0,2000-3000$ 
GB,2023-04-27,A0736502,Clinical,Beatson West of Scotland Cancer Centre,Carrie Featherstone,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/3/2023,5/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-27,A0736509,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,5/2/2023,5/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-27,A0736476,Clinical,Genesis Care,Riyaz Shah,Guardant 360,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/2/2023,5/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-04,1.18,2643.2,2000-3000$ 
GB,2023-04-27,A0736479,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/3/2023,5/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-27,A0736499,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/2/2023,5/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-04-27,A0736473,Clinical,HCA Laboratories,Rebecca Kristeleit,Guardant 360,2.11,GHI_19,Distributors : ROW,Ovarian carcinoma,5/2/2023,5/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-04,1.18,2570.04,2000-3000$ 
GB,2023-04-28,A0737427,Clinical,Cancer Centre London,Muireann Kelleher,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,5/3/2023,5/16/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-04,1.18,2938.2,2000-3000$ 
DE,2023-04-28,A0737430,Clinical,Universitaetsklinikum Freiburg,Justyna Rawluk,Guardant360 CDx,,GHI_19,Self-Pay Patient,Small cell lung carcinoma,5/3/2023,5/3/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-04,1.0,0.0,0 $
GB,2023-04-28,A0737440,Clinical,Singleton Hospital,Jason Lester,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,5/4/2023,5/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-04,1.18,1469.1,0-1500$ 
GB,2023-04-28,A0737437,Clinical,Singleton Hospital,Jason Lester,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,5/3/2023,5/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-04,1.18,2643.2,2000-3000$ 
ES,2023-04-28,A0737110,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/2/2023,5/2/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1245 EUR,1245.0,2023-04,1.0,1245.0,0-1500$ 
GB,2023-04-28,A0737439,Clinical,Mount Alverina Hospital,Sebastian Cummins,Guardant360 CDx,,GHI_19,Self-Pay Patient,GIST (Gastrointestinal stromal tumor),5/3/2023,5/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-04,1.18,2643.2,2000-3000$ 
GB,2023-04-28,A0737443,Clinical,Beatson West of Scotland Cancer Centre,Graeme Lumsden,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,5/3/2023,5/3/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
TR,2023-04-28,A0737433,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Hilmi Ege,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,5/3/2023,5/3/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-04,1.0,1838.0,1500-2000$ 
TR,2023-04-28,A0736887,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulcan Bulut,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,5/5/2023,5/5/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,4,2023,2,1,2023-04-01,2023-04,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-04,1.0,2319.0,2000-3000$ 
ES,2023-04-28,A0737441,Clinical,Clinica Tres Torres UOMI Cancer Center,Santiago Viteri,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/9/2023,7/21/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,2490 EUR,2490.0,2023-04,1.0,2490.0,2000-3000$ 
GB,2023-04-29,A0738192,Clinical,Guys Hospital,Alvin Lee,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Cholangiocarcinoma,5/9/2023,5/9/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-04,1.18,0.0,0 $
GB,2023-04-29,A0739007,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Other,5/8/2023,5/8/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,4,2023,2,1,2023-04-01,2023-04,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-04,1.18,979.4,0-1500$ 
GB,2023-05-01,A0738432,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/9/2023,5/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-05,1.18,2938.2,2000-3000$ 
GB,2023-05-01,A0738436,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/4/2023,5/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
ES,2023-05-01,A0738410,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/10/2023,5/10/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2400 USD,2400.0,2023-05,1.0,2400.0,2000-3000$ 
GB,2023-05-01,A0738449,Clinical,York Hospital,Mohieldin Mohamed,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/6/2023,5/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-01,A0738463,Clinical,NHS - University College London Hospital,Neal Navani,Guardant360 CDx,2.11,GHI_19,Distributors : ROW,Lung cancer,5/9/2023,5/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
BR,2023-05-01,A0738544,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/4/2023,5/4/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-05,1.0,1750.0,1500-2000$ 
GB,2023-05-01,A0738443,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/5/2023,5/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-01,A0738426,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/9/2023,5/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
BR,2023-05-01,A0738531,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/4/2023,5/4/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-05,1.0,1750.0,1500-2000$ 
GB,2023-05-01,A0738421,Clinical,BMI Bishops Wood Hospital,Andreas Polychronis,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,5/7/2023,5/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-05,1.18,4118.2,3000+ $
GB,2023-05-01,A0738391,Clinical,HCA Laboratories,Asad Qureshi,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,5/6/2023,5/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-05,1.18,2570.04,2000-3000$ 
GB,2023-05-01,A0738454,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/4/2023,5/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
DE,2023-05-01,A0738437,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/6/2023,5/6/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,3341 EUR,3341.0,2023-05,1.0,3341.0,3000+ $
BR,2023-05-01,A0738537,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Ovarian carcinoma,5/5/2023,5/5/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-05,1.0,1750.0,1500-2000$ 
GB,2023-05-01,A0738400,Clinical,Salisbury NHS Foundation Trust,Jenny Bradbury,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,5/6/2023,5/6/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-01,A0738453,Clinical,Singleton Hospital,Craig Barrington,Guardant360 CDx,,GHI_19,Self-Pay Patient,Appendix adenocarcinoma,5/4/2023,9/4/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-01,A0738412,Clinical,NHS - Wythenshawe Hospital,Richard Booton,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/9/2023,5/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
TR,2023-05-01,A0738492,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,5/8/2023,5/8/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-05,1.0,2319.0,2000-3000$ 
GB,2023-05-01,A0738448,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/4/2023,5/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
TR,2023-05-01,A0738450,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulcan Bulut,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/7/2023,5/7/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-05,1.0,1838.0,1500-2000$ 
GB,2023-05-01,A0738434,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/9/2023,5/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-02,A0739247,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/9/2023,5/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-03,A0740086,Clinical,University College London Hospitals,John Bridgewater,74-Gene Panel,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),5/10/2023,5/10/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-03,A0740101,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/8/2023,5/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
CA,2023-05-03,A0740049,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,5/11/2023,5/11/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-05,1.0,2290.0,2000-3000$ 
GB,2023-05-03,A0740072,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/8/2023,5/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-03,A0740067,Clinical,University College London Hospitals,John Bridgewater,74-Gene Panel,2.11,GHI_01,Self-Pay Patient,Other,5/8/2023,6/13/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-04,A0741150,Clinical,Positive IV,Thomas J Vogl,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-04,A0741125,Clinical,NHS - University Hospitals Leicester,Jonathan Bennett,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/9/2023,5/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-04,A0741132,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/9/2023,5/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
CA,2023-05-04,A0741214,Clinical,London Health Sciences Centre,Stephen Welch,Guardant 360,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,5/11/2023,5/11/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-05,1.0,2290.0,2000-3000$ 
GB,2023-05-04,A0741130,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/9/2023,5/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-04,A0741136,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/9/2023,5/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-05,A0742069,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,2.12,GHI_19,Distributors : ROW,Lung cancer,5/10/2023,5/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
TR,2023-05-05,A0742070,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Gastric adenocarcinoma,5/16/2023,5/16/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-05,1.0,2319.0,2000-3000$ 
GB,2023-05-05,A0742066,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/10/2023,5/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-05,A0742056,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/11/2023,5/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-05,A0742087,Clinical,NHS - Kettering General Hospital,George Tsaknis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/17/2023,5/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-05,A0742036,Clinical,Genesis Care,Mark Hill,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,5/10/2023,5/10/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-05,1.18,2938.2,2000-3000$ 
GB,2023-05-05,A0742060,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/14/2023,5/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
TR,2023-05-05,A0742086,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Abudullah Buyukcelik,Guardant 360,2.12,GH2_12,Do Not Bill - Cancelled,Lung adenocarcinoma,5/9/2023,5/22/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,0,0.0,2023-05,1.0,0.0,0 $
CA,2023-05-05,A0742057,Clinical,RCM Health Consultancy,Natasha Leighl,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,5/10/2023,6/21/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Canada,Paid,1700 USD,1700.0,2023-05,1.0,1700.0,1500-2000$ 
GB,2023-05-05,A0742050,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/10/2023,5/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-05,A0742075,Clinical,Queen Alexandra Hospital,Mya Gyi,74-Gene Panel,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/12/2023,5/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,0 GBP,0.0,2023-05,1.18,0.0,0 $
ES,2023-05-05,A0742042,Clinical,Hospital del Mar,Laura Visa,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,5/16/2023,5/16/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 EUR,1245.0,2023-05,1.0,1245.0,0-1500$ 
GB,2023-05-06,A0743314,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/12/2023,5/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-06,A0743326,Clinical,HCA Laboratories,Alison Jones,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,5/12/2023,5/12/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-05,1.18,2570.04,2000-3000$ 
GB,2023-05-06,A0743307,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/16/2023,5/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-09,A0751767,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/17/2023,5/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-05,1.18,2570.04,2000-3000$ 
GB,2023-05-09,A0752186,Clinical,Bupa Cromwell Hospital,John Conibear,UNKNOWN,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/18/2023,5/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-09,A0752205,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/15/2023,5/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-09,A0752181,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/15/2023,5/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-09,A0752184,Clinical,Charing Cross Hospital Medical Oncology Department,Danielle Power,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,5/15/2023,5/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-05,1.18,2643.2,2000-3000$ 
GB,2023-05-09,A0751748,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/18/2023,5/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
CA,2023-05-09,A0752199,Clinical,Markham Stouffville Hospital,Monali Ray,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,5/15/2023,5/15/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Canada,Free,0 USD,0.0,2023-05,1.0,0.0,0 $
GB,2023-05-09,A0751750,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/15/2023,5/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
DE,2023-05-09,A0751770,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/16/2023,5/16/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,3341 EUR,3341.0,2023-05,1.0,3341.0,3000+ $
TR,2023-05-09,A0752224,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Serkan Keskin,Guardant360 CDx,2.12,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/16/2023,5/16/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-05,1.0,1838.0,1500-2000$ 
GB,2023-05-09,A0751765,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/15/2023,5/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-09,A0751762,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,5/15/2023,5/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
DE,2023-05-09,A0752200,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,5/16/2023,5/16/2023,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,3341 EUR,3341.0,2023-05,1.0,3341.0,3000+ $
GB,2023-05-09,A0753139,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/17/2023,5/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-09,A0752178,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/15/2023,5/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-09,A0752182,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/15/2023,5/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-09,A0752208,Clinical,York Hospital,Mohieldin Mohamed,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/15/2023,5/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-09,A0751763,Clinical,The Royal Marsden Hospital,Robert Huddart,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Urothelial carcinoma,5/15/2023,5/15/2023,UNITED KINGDOM,Commercial,Urothelial,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-05,1.18,2938.2,2000-3000$ 
BR,2023-05-10,A0752634,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,5/16/2023,5/16/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-05,1.0,1750.0,1500-2000$ 
GB,2023-05-10,A0753126,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/17/2023,5/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-10,A0752622,Clinical,Guys Hospital,Mona Salem,Guardant 360,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,5/24/2023,5/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-10,A0753086,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/16/2023,5/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-10,A0752631,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Christos Mikropoulos,Guardant 360,2.11,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,5/17/2023,5/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
ES,2023-05-10,A0752657,Clinical,Clinica Universidad de Navarra-Madrid,Javier Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,5/15/2023,5/15/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2400 USD,2400.0,2023-05,1.0,2400.0,2000-3000$ 
GB,2023-05-11,A0754240,Clinical,Spire Leicester Hospital,Kiran Kancherla,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,5/16/2023,5/31/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-05,1.18,2643.2,2000-3000$ 
GB,2023-05-11,A0754236,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Jonathan Dakin,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,5/16/2023,5/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-05,1.18,2643.2,2000-3000$ 
GB,2023-05-11,A0754221,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant360 CDx,2.12,GHI_19,Distributors : ROW,Lung cancer,5/16/2023,5/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
DE,2023-05-11,A0754224,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,5/18/2023,5/18/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,3341 EUR,3341.0,2023-05,1.0,3341.0,3000+ $
GB,2023-05-11,A0754229,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/16/2023,5/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-11,A0754239,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/16/2023,5/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-11,A0754233,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/16/2023,5/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-11,A0754241,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/16/2023,5/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-12,A0754968,Clinical,Guys Hospital,Maia Aquino,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-12,A0755016,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/17/2023,5/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-12,A0755029,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/18/2023,5/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
TR,2023-05-12,A0755008,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Yasar Yildiz,Guardant360 CDx,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,5/23/2023,5/23/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-05,1.0,1838.0,1500-2000$ 
GB,2023-05-12,A0755040,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/17/2023,5/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-12,A0755034,Clinical,Singleton Hospital,Jason Lester,Guardant 360,,GHI_19,Self-Pay Patient,Large cell lung carcinoma,5/18/2023,5/18/2023,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-05,1.18,2643.2,2000-3000$ 
GB,2023-05-12,A0754945,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Panagiotis Koliou,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,5/22/2023,5/22/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-05,1.18,2643.2,2000-3000$ 
BR,2023-05-12,A0755024,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/17/2023,5/17/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-05,1.0,1750.0,1500-2000$ 
GB,2023-05-12,A0754967,Clinical,University Hospitals Coventry & Warwickshire NHS Trust,Vanessa Potter,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,5/18/2023,5/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
TR,2023-05-12,A0754959,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mehmet Ali Nahit Sehdur,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,5/19/2023,5/19/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-05,1.0,2319.0,2000-3000$ 
GB,2023-05-12,A0755023,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/22/2023,5/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-12,A0754965,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-12,A0755036,Clinical,HCA Laboratories,Paul Ross,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,5/18/2023,5/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-05,1.18,2570.04,2000-3000$ 
GB,2023-05-12,A0754953,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/17/2023,5/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-12,A0754955,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/22/2023,5/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-12,A0755045,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/18/2023,5/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
BR,2023-05-12,A0755010,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/16/2023,5/16/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-05,1.0,1750.0,1500-2000$ 
GB,2023-05-12,A0754941,Clinical,Clatterbridge Cancer Centre,Carlo Palmieri,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Breast Carcinoma,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-12,A0755032,Clinical,Southampton General Hospital,Andrew Bateman,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,5/19/2023,7/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-05,1.18,4118.2,3000+ $
GB,2023-05-13,A0755989,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,,GHI_19,Distributors : ROW,Prostate adenocarcinoma,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-05,1.18,2570.04,2000-3000$ 
ES,2023-05-13,A0755966,Clinical,Mutua de Terrassa,JosÃ© Mazarico,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/18/2023,5/18/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-05,1.0,0.0,0 $
ES,2023-05-13,A0755980,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,5/18/2023,6/7/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1745 EUR ,1745.0,2023-05,1.0,1745.0,1500-2000$ 
ES,2023-05-13,A0755981,Clinical,Complejo Hospitalario Ruber Juan Bravo,Araceli Priego Priego,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/19/2023,5/22/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2241 EUR,2241.0,2023-05,1.0,2241.0,2000-3000$ 
GB,2023-05-15,A0756205,Clinical,BMI Bishops Wood Hospital,Andreas Polychronis,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-05,1.18,2643.2,2000-3000$ 
GB,2023-05-15,A0756125,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/21/2023,5/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
TR,2023-05-15,A0756169,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ozcan Yildiz,Guardant 360,2.12,GH2_12,Distributors : ROW,Prostate adenocarcinoma,5/22/2023,5/22/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-05,1.0,2319.0,2000-3000$ 
GB,2023-05-15,A0756129,Clinical,Western General Hospital - Edinburgh Cancer Centre,Stephen Harrow,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-15,A0756178,Clinical,Positive IV,Thomas J Vogl,Guardant360 CDx,,GHI_19,Self-Pay Patient,Gastric adenocarcinoma,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-15,A0756118,Clinical,Velindre Cancer Centre,Ceri Powell,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-15,A0756112,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/21/2023,5/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-15,A0756181,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-15,A0756211,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-15,A0756206,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-15,A0756116,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-15,A0756168,Clinical,Poole Hospital NHS Foundation Trust,Chris Davies,Guardant360 CDx,2.11,GHI_19,Self-Pay Patient,Lung cancer,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-15,A0756109,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-15,A0756189,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/20/2023,5/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-15,A0756337,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
IT,2023-05-15,A0756128,Clinical,Casa di Cura Igea SpA,Antonio Ghidini,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,5/19/2023,5/19/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2000 EUR,2000.0,2023-05,1.0,2000.0,1500-2000$ 
GB,2023-05-15,A0756152,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
IT,2023-05-15,A0756202,Clinical,Casa di Cura Villa Donatello,Francesco Di Costanzo,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),5/27/2023,5/27/2023,ITALY,Commercial,CUP,ITALY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2000 EUR,2000.0,2023-05,1.0,2000.0,1500-2000$ 
IT,2023-05-15,A0756165,Clinical,Casa di Cura Villa Donatello,Francesco Di Costanzo,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,5/19/2023,5/19/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1800 EUR,1800.0,2023-05,1.0,1800.0,1500-2000$ 
GB,2023-05-15,A0756172,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-05,1.18,2643.2,2000-3000$ 
GB,2023-05-15,A0756196,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-15,A0756135,Clinical,Positive IV,Thomas J Vogl,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,5/19/2023,5/19/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
TR,2023-05-15,A0756195,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Osman Gokhan Demir,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,5/22/2023,5/22/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-05,1.0,2319.0,2000-3000$ 
CA,2023-05-16,A0757061,Clinical,London Health Sciences Centre,Paul Stewart,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Thyroid carcinoma,5/23/2023,5/23/2023,CANADA,Commercial,Thyroid,CANADA,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Canada,Free,0 USD,0.0,2023-05,1.0,0.0,0 $
GB,2023-05-16,A0757035,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/23/2023,5/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-17,A0758044,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/22/2023,5/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-17,A0758029,Clinical,NHS - University Hospitals Morecambe Bay,Timothy Gatheral,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,5/23/2023,5/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-17,A0758036,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/22/2023,5/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-17,A0758031,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/23/2023,5/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-18,A0758814,Clinical,Coventry University Hospitals,Peter Correa,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,5/24/2023,5/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-05,1.18,4118.2,3000+ $
IT,2023-05-18,A0758940,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/22/2023,5/22/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,FOC,0.0,2023-05,1.0,0.0,0 $
GB,2023-05-18,A0758929,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/23/2023,5/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-18,A0758906,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,5/24/2023,5/31/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-18,A0758917,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/23/2023,5/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-18,A0758797,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/22/2023,5/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
BR,2023-05-18,A0759056,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/23/2023,5/23/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-05,1.0,1750.0,1500-2000$ 
GB,2023-05-18,A0758801,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/24/2023,5/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-18,A0758861,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/23/2023,5/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-18,A0758880,Clinical,Barnet Hospital,Matthew Mee,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,5/24/2023,6/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-05,1.18,4118.2,3000+ $
GB,2023-05-18,A0758933,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/24/2023,5/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-18,A0758909,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/24/2023,5/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-18,A0758925,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/23/2023,5/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
TR,2023-05-18,A0758809,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kezban Nur Pilanci,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/22/2023,5/22/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-05,1.0,1838.0,1500-2000$ 
CA,2023-05-18,A0759014,Clinical,Credit Valley Hospital,Daniel Yokom,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Bladder carcinoma,5/24/2023,5/24/2023,CANADA,Commercial,Bladder,CANADA,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Canada,Free,0 USD,0.0,2023-05,1.0,0.0,0 $
GB,2023-05-19,A0759991,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,5/30/2023,5/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-19,A0760907,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,5/24/2023,5/31/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-19,A0760912,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/25/2023,5/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-19,A0760941,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
BR,2023-05-19,A0760944,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,5/25/2023,5/25/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-05,1.0,1750.0,1500-2000$ 
GB,2023-05-19,A0760120,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/25/2023,5/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-19,A0760910,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-19,A0760924,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/25/2023,5/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-19,A0760939,Clinical,Guys Hospital,Emma Mclean,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-19,A0760949,Clinical,HCA Laboratories,Susan Cleator,Guardant 360,,GHI_19,Distributors : ROW,Esophageal adenocarcinoma,5/25/2023,5/25/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-05,1.18,2570.04,2000-3000$ 
GB,2023-05-20,A0761609,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-20,A0761576,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-05,1.18,2938.2,2000-3000$ 
TR,2023-05-20,A0761602,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mehmet Akif Ozturk,Guardant 360,2.12,GH2_12,Distributors : ROW,Hepatocellular carcinoma,5/29/2023,5/29/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-05,1.0,2319.0,2000-3000$ 
CA,2023-05-20,A0761585,Clinical,Walker Family Cancer Centre,David Wasserman,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Other,5/29/2023,5/29/2023,CANADA,Commercial,Other,CANADA,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Canada,Free,0 USD,0.0,2023-05,1.0,0.0,0 $
GB,2023-05-22,A0761832,Clinical,Worthing Hospital,Richard Robinson,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-22,A0761880,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-22,A0761835,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/29/2023,5/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-22,A0761801,Clinical,The Royal Marsden NHS Foundation Trust,Sheela Rao,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,5/25/2023,5/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-05,1.18,2938.2,2000-3000$ 
GB,2023-05-22,A0761828,Clinical,University College London Hospitals,Palma Dileo,Guardant360 CDx,,GHI_19,Self-Pay Patient,Sarcoma,5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,Soft Tissue/Bone,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-22,A0761834,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-22,A0761833,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/5/2023,6/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-22,A0761843,Clinical,Torbay and South Devon Foundation Trust,Victoria Cope,Guardant360 CDx,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
DE,2023-05-22,A0761869,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Other,6/4/2023,6/4/2023,GERMANY,Commercial,Other,GERMANY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,3341 EUR,3341.0,2023-05,1.0,3341.0,3000+ $
GB,2023-05-22,A0761830,Clinical,Queen Alexandra Hospital,Sethupathi Ramalingam,74-Gene Panel,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/29/2023,5/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
TR,2023-05-22,A0761846,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Hilmi Ege,Guardant360 CDx,,GHI_19,Distributors : ROW,Ovarian carcinoma,5/26/2023,5/26/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-05,1.0,1838.0,1500-2000$ 
GB,2023-05-22,A0761838,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,5/25/2023,5/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
CA,2023-05-22,A0761847,Clinical,London Health Sciences Centre,Daniel Breadner,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,5/31/2023,6/6/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-05,1.0,2290.0,2000-3000$ 
GB,2023-05-22,A0761825,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Gastric adenocarcinoma,5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-22,A0761819,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-22,A0761815,Clinical,Singleton Hospital,Alison Brewster,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/26/2023,7/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-22,A0761837,Clinical,Guys Hospital,Justin Mencel,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,5/26/2023,5/31/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-22,A0761883,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-22,A0761872,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),5/26/2023,5/26/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
TR,2023-05-22,A0761803,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Esat Namal,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,5/29/2023,5/29/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-05,1.0,2319.0,2000-3000$ 
GB,2023-05-22,A0761821,Clinical,Royal Free London NHS Foundation Trust,Amna Sheri,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,5/29/2023,5/29/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
TR,2023-05-22,A0761823,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Cetin Ordu,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,5/30/2023,5/30/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-05,1.0,2319.0,2000-3000$ 
GB,2023-05-22,A0761876,Clinical,NHS - Wythenshawe Hospital,Nicola Sinnott,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/27/2023,5/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-23,A0762459,Clinical,HCA Laboratories,Kai-Keen Shiu,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,5/29/2023,5/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-05,1.18,2570.04,2000-3000$ 
GB,2023-05-23,A0762158,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/29/2023,5/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-23,A0762174,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/2/2023,6/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-23,A0762417,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/29/2023,5/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-24,A0763704,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/29/2023,5/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-24,A0763707,Clinical,NHS - Wythenshawe Hospital,Richard Booton,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/29/2023,5/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
ES,2023-05-24,A0762851,Clinical,Hospital del Mar,Laura Visa,Guardant360 CDx,2.11,GHI_01,Do Not Bill - Cancelled,Cholangiocarcinoma,6/2/2023,6/2/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-05,1.0,0.0,0 $
GB,2023-05-24,A0763548,Clinical,Singleton Hospital,Jason Lester,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,5/30/2023,5/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-05,1.18,2643.2,2000-3000$ 
GB,2023-05-24,A0763700,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/29/2023,7/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
BR,2023-05-24,A0763702,Clinical,Hospital Israelita Albert Einstein,Pedro Uson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/4/2023,6/8/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,South America,Paid,2490 USD,2490.0,2023-05,1.0,2490.0,2000-3000$ 
GB,2023-05-24,A0763061,Clinical,Guys Hospital,Mona Salem,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,5/30/2023,5/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-25,A0764441,Clinical,Clatterbridge cancer Center,Jonathan Heseltine,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,6/1/2023,6/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-25,A0764433,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,5/30/2023,6/9/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-25,A0764428,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),5/30/2023,5/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-25,A0764449,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/1/2023,6/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-25,A0764456,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/1/2023,6/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-25,A0764416,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/30/2023,5/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-25,A0764463,Clinical,Eastbourne District General Hospital,Eleanor Giddings,Guardant 360,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/1/2023,6/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
TR,2023-05-26,A0765274,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Nilufer Guler,Guardant 360,2.12,GH2_12,Distributors : ROW,Sarcoma,6/1/2023,6/1/2023,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-05,1.0,2319.0,2000-3000$ 
CA,2023-05-26,A0765338,Clinical,London Health Sciences Centre,Elena Tsvetkova,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,6/1/2023,6/12/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-05,1.0,2290.0,2000-3000$ 
TR,2023-05-26,A0764624,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,5/31/2023,5/31/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-05,1.0,2319.0,2000-3000$ 
GB,2023-05-26,A0765239,Clinical,NHS - University Hospitals Morecambe Bay,Gilbert Jifon,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung cancer,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-26,A0765240,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/31/2023,5/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-26,A0765377,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/31/2023,5/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
IT,2023-05-26,A0765272,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,5/31/2023,5/31/2023,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2000 EUR,2000.0,2023-05,1.0,2000.0,1500-2000$ 
GB,2023-05-26,A0765207,Clinical,Western General Hospital - Edinburgh Cancer Centre,Stephen Harrow,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/5/2023,6/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-26,A0765271,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/31/2023,5/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-26,A0765186,Clinical,The Royal Marsden Hospital,Robert Huddart,Guardant 360,,GHI_19,Self-Pay Sponsored,Bladder carcinoma,5/31/2023,5/31/2023,UNITED KINGDOM,Commercial,Bladder,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-05,1.18,2938.2,2000-3000$ 
GB,2023-05-26,A0765264,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/31/2023,5/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-26,A0765286,Clinical,Guys Hospital,Debashis Sarker,Guardant 360,,GHI_19,Self-Pay Patient,Other,6/1/2023,6/1/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-05,1.18,0.0,0 $
GB,2023-05-26,A0765266,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/31/2023,5/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-26,A0765213,Clinical,HCA at The Christie Clinic,Gregory Wilson,Guardant 360,2.12,GH2_12,Self-Pay Sponsored,Breast Carcinoma,6/2/2023,6/2/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-05,1.18,4118.2,3000+ $
GB,2023-05-26,A0765216,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/1/2023,6/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-26,A0765253,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,5/31/2023,5/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-26,A0765249,Clinical,NHS - University Hospitals Morecambe Bay,Gilbert Jifon,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/31/2023,5/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
IT,2023-05-26,A0765244,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/31/2023,5/31/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,FOC,0.0,2023-05,1.0,0.0,0 $
IT,2023-05-26,A0765252,Clinical,Istituto Clinico Porta Sole Casa di Cura Srl,Antonio Rulli,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,5/31/2023,5/31/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2241 EUR,2241.0,2023-05,1.0,2241.0,2000-3000$ 
GB,2023-05-26,A0765222,Clinical,NHS - University Hospitals Morecambe Bay,Gilbert Jifon,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/1/2023,6/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-26,A0765235,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,5/31/2023,5/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-27,A0765779,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/1/2023,6/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
ES,2023-05-30,A0766299,Clinical,Hospital Universitario HM Sanchinarro,Carmen Martin Mesa,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/6/2023,7/4/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2240 EUR,2240.0,2023-05,1.0,2240.0,2000-3000$ 
GB,2023-05-30,A0766293,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/4/2023,6/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-30,A0766283,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/5/2023,6/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
TR,2023-05-30,A0766332,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Ovarian carcinoma,6/5/2023,6/5/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,5,2023,2,1,2023-05-01,2023-05,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-05,1.0,2319.0,2000-3000$ 
GB,2023-05-30,A0766278,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/6/2023,6/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-30,A0766305,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,6/4/2023,6/4/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-05,1.18,2938.2,2000-3000$ 
IT,2023-05-30,A0766277,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/2/2023,6/2/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Free,FOC,0.0,2023-05,1.0,0.0,0 $
GB,2023-05-30,A0766324,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/2/2023,6/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-30,A0766295,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/7/2023,6/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-30,A0766285,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/4/2023,6/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-30,A0766275,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/4/2023,6/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-30,A0766287,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/2/2023,6/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-30,A0766279,Clinical,The Nuffield Hospital Guildford,Sebastian Cummins,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,6/4/2023,6/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-05,1.18,2938.2,2000-3000$ 
GB,2023-05-31,A0767014,Clinical,Positive IV,Thomas J Vogl,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,6/5/2023,6/5/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-05,1.18,1469.1,0-1500$ 
GB,2023-05-31,A0766984,Clinical,Genesis Care,Justin Waters,Guardant360 CDx,2.12,GHI_19,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),6/5/2023,6/5/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-05,1.18,2643.2,2000-3000$ 
BR,2023-05-31,A0767048,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,6/5/2023,6/15/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,South America,Paid,2500 USD,2500.0,2023-05,1.0,2500.0,2000-3000$ 
GB,2023-05-31,A0766943,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/5/2023,6/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-31,A0767180,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung squamous cell carcinoma,6/5/2023,6/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-31,A0767164,Clinical,HCA Laboratories,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Carcinoma of unknown primary (CUP),6/6/2023,6/6/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-05,1.18,2570.04,2000-3000$ 
GB,2023-05-31,A0767176,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/6/2023,6/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-31,A0767178,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/11/2023,6/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-05,1.18,979.4,0-1500$ 
GB,2023-05-31,A0767146,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Jonathan Dakin,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,6/6/2023,6/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,5,2023,2,1,2023-05-01,2023-05,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-05,1.18,2643.2,2000-3000$ 
GB,2023-06-01,A0768934,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/6/2023,6/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-01,A0769610,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/6/2023,6/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-01,A0769597,Clinical,Guys Hospital,Saoirse Dolly,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Cholangiocarcinoma,6/29/2023,6/29/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-01,A0769539,Clinical,St Georges Hospital,Anna-Mary Young,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,6/5/2023,6/5/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-06,1.18,1469.1,0-1500$ 
GB,2023-06-01,A0769546,Clinical,East Suffolk and North Essex NHS Foundation Trust,Mukesh B Mukesh,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,6/8/2023,6/8/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-01,A0769584,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/5/2023,6/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-01,A0768946,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/5/2023,6/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
CA,2023-06-01,A0769578,Clinical,London Health Sciences Centre,Elena Tsvetkova,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Other,6/8/2023,6/8/2023,CANADA,Commercial,Other,CANADA,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-06,1.0,2290.0,2000-3000$ 
RO,2023-06-01,A0769563,Clinical,Amethyst Radiotherapy Clinic,Bogdan Mateies,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/6/2023,6/7/2023,ROMANIA,Commercial,,ROMANIA,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 EUR,2490.0,2023-06,1.0,2490.0,2000-3000$ 
GB,2023-06-01,A0769577,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/5/2023,6/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
TR,2023-06-02,A0770618,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kerim Kaban,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,6/11/2023,6/11/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-06,1.0,2319.0,2000-3000$ 
GB,2023-06-02,A0770696,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),6/8/2023,6/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-02,A0770680,Clinical,University Hospitals Of Leicester,Olubukola Ayodele,Guardant 360,,GHI_19,Self-Pay Patient,Head and neck carcinoma,6/8/2023,6/8/2023,UNITED KINGDOM,Commercial,Head and neck carcinoma,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
TR,2023-06-02,A0770682,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ruchan Uslu,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,6/9/2023,6/9/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-06,1.0,1838.0,1500-2000$ 
GB,2023-06-02,A0770647,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Panagiotis Koliou,Guardant 360,2.11,GHI_19,Self-Pay Patient,Breast Carcinoma,6/9/2023,7/25/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
BR,2023-06-02,A0770220,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,6/8/2023,6/8/2023,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
BR,2023-06-02,A0770172,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/14/2023,6/14/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
GB,2023-06-02,A0770689,Clinical,HCA Laboratories,Dionysis Papadatos-Pastos,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
BR,2023-06-02,A0770183,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/7/2023,6/7/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
GB,2023-06-02,A0770651,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
BR,2023-06-02,A0770199,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,6/7/2023,6/7/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
GB,2023-06-02,A0770650,Clinical,NHS - Wythenshawe Hospital,Balata Haval,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
IT,2023-06-02,A0770697,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/12/2023,6/12/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1745 EUR ,1745.0,2023-06,1.0,1745.0,1500-2000$ 
IT,2023-06-02,A0770692,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/8/2023,6/8/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2000 EUR,2000.0,2023-06,1.0,2000.0,1500-2000$ 
TR,2023-06-02,A0770661,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sahin Lacin,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,6/9/2023,6/9/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-06,1.0,2319.0,2000-3000$ 
TR,2023-06-02,A0770688,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ece Esin,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,6/8/2023,6/8/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-06,1.0,2319.0,2000-3000$ 
GB,2023-06-02,A0770660,Clinical,Guys Hospital,Sindu Vivekanandan,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/8/2023,6/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
ES,2023-06-02,A0770637,Clinical,Hospital University La Paz,Laura Gutierrez,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/8/2023,6/8/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-06,1.0,0.0,0 $
GB,2023-06-02,A0770630,Clinical,Cancer Centre London,Vincent Khoo,74-Gene Panel,2.11,GHI_19,Self-Pay Sponsored,Prostate adenocarcinoma,6/6/2023,6/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
ES,2023-06-02,A0770645,Clinical,Complejo Hospitalario Ruber Juan Bravo,Araceli Priego Priego,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,6/20/2023,6/20/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,0 EUR,0.0,2023-06,1.0,0.0,0 $
GB,2023-06-02,A0770641,Clinical,Queen Alexandra Hospital,Sethupathi Ramalingam,Guardant360 CDx,2.11,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,6/9/2023,8/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-02,A0770662,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Jonathan Dakin,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,6/7/2023,6/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-02,A0770679,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/7/2023,6/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
ES,2023-06-03,A0771276,Clinical,Clinica Tres Torres UOMI Cancer Center,Santiago Viteri,Guardant360 CDx,,GHI_19,Self-Pay Patient,Urothelial carcinoma,6/9/2023,7/21/2023,SPAIN,Commercial,Urothelial,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 EUR,2490.0,2023-06,1.0,2490.0,2000-3000$ 
GB,2023-06-03,A0771261,Clinical,The Royal Marsden NHS Foundation Trust,Sheela Rao,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,6/8/2023,6/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-03,A0770811,Clinical,Worthing Hospital,Numbere Numbere,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,6/8/2023,6/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-05,A0771457,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-05,A0771442,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-05,A0771461,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
TR,2023-06-05,A0771479,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Serkan Keskin,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,6/13/2023,6/13/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-06,1.0,2319.0,2000-3000$ 
GB,2023-06-05,A0771441,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1245 GBP,1245.0,2023-06,1.18,1469.1,0-1500$ 
GB,2023-06-05,A0771462,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-05,A0771449,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-05,A0771494,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-05,A0771475,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/12/2023,6/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-05,A0771460,Clinical,University College London Hospitals,Mahbubl Ahmed,Guardant360 CDx,,GHI_19,Self-Pay Patient,Sarcoma,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,Soft Tissue/Bone,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
ES,2023-06-05,A0771477,Clinical,Hospital del Mar,Laura Visa,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,6/9/2023,6/9/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1245 EUR,1245.0,2023-06,1.0,1245.0,0-1500$ 
DE,2023-06-05,A0771466,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,6/13/2023,6/13/2023,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,3341 EUR,3341.0,2023-06,1.0,3341.0,3000+ $
GB,2023-06-05,A0771499,Clinical,St Georges Hospital,Tim Benepal,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-06,1.18,2643.2,2000-3000$ 
GB,2023-06-05,A0771459,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/13/2023,6/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-05,A0771450,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-05,A0771486,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-05,A0771451,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/9/2023,6/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-06,A0771928,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/12/2023,6/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-06,A0771947,Clinical,Princess Alexandra Hospital,Apostolos Konstantis,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,6/22/2023,6/22/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-07,A0772992,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/13/2023,6/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-07,A0773004,Clinical,The Nuffield Hospital Guildford,Robert Laing,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,6/12/2023,6/12/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-07,A0772745,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,,GHI_19,Distributors : ROW,Prostate adenocarcinoma,6/12/2023,6/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
GB,2023-06-07,A0773000,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/12/2023,6/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-07,A0773007,Clinical,Genesis Care,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/12/2023,6/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
BR,2023-06-07,A0772687,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/13/2023,6/13/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
GB,2023-06-07,A0774939,Clinical,University College London Hospitals,Lucinda Melcher,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,6/14/2023,8/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
GB,2023-06-07,A0772890,Clinical,Sussex Cancer Centre,Kam Zaki,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/12/2023,6/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
CA,2023-06-08,A0774610,Clinical,London Health Sciences Centre,Elena Tsvetkova,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,6/20/2023,6/20/2023,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-06,1.0,2290.0,2000-3000$ 
GB,2023-06-08,A0773506,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/12/2023,6/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-08,A0774614,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/13/2023,6/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-08,A0774605,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),6/13/2023,6/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-08,A0773519,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/13/2023,6/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-08,A0774613,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/13/2023,6/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
IT,2023-06-09,A0775408,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cutaneous squamous cell carcinoma,6/14/2023,6/14/2023,ITALY,Commercial,Skin,ITALY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2000 EUR,2000.0,2023-06,1.0,2000.0,1500-2000$ 
GB,2023-06-09,A0775511,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/14/2023,6/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-09,A0775452,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/14/2023,6/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
TR,2023-06-09,A0775427,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ozlem Yersal,Guardant360 CDx,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/15/2023,6/15/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-06,1.0,1838.0,1500-2000$ 
GB,2023-06-09,A0775505,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/14/2023,6/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-09,A0775428,Clinical,Hammersmith Hospital,Harpreet Wasan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,6/14/2023,6/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
CA,2023-06-09,A0775442,Clinical,London Health Sciences Centre,Stephen Welch,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Carcinoma of unknown primary (CUP),6/15/2023,6/15/2023,CANADA,Commercial,CUP,CANADA,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Canada,Paid,2290 USD,2290.0,2023-06,1.0,2290.0,2000-3000$ 
GB,2023-06-09,A0775420,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/15/2023,6/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
IT,2023-06-09,A0775418,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,6/14/2023,6/14/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2000 EUR,2000.0,2023-06,1.0,2000.0,1500-2000$ 
IT,2023-06-09,A0775449,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Squamous cell carcinoma,6/14/2023,6/14/2023,ITALY,Commercial,Lung,ITALY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2000 EUR,2000.0,2023-06,1.0,2000.0,1500-2000$ 
GB,2023-06-09,A0775456,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/15/2023,6/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-09,A0775454,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,6/15/2023,6/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-09,A0775409,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/14/2023,6/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-10,A0776190,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/15/2023,6/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
ES,2023-06-10,A0776207,Clinical,Hospital Quiron Barcelona,Enriqueta Felip,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/15/2023,6/15/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2179 EUR,2179.0,2023-06,1.0,2179.0,2000-3000$ 
ES,2023-06-10,A0775802,Clinical,Hospital Clinico San Carlos,Jorge Bartolome,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,6/14/2023,6/14/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1245 EUR,1245.0,2023-06,1.0,1245.0,0-1500$ 
GB,2023-06-10,A0776222,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/15/2023,6/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-10,A0776168,Clinical,Princess Alexandra Hospital,Apostolos Konstantis,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,6/15/2023,6/15/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-12,A0776372,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/19/2023,6/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-12,A0776357,Clinical,NHS - Wythenshawe Hospital,Phil Crosbie,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/19/2023,6/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-12,A0776407,Clinical,EDX Medical Ltd,Thomas Bailward,Guardant360 CDx,,GHI_19,Self-Pay Patient,Other,6/19/2023,6/19/2023,UNITED KINGDOM,Commercial,Other,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-12,A0776346,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/19/2023,6/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-12,A0776349,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/19/2023,6/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-12,A0776424,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/19/2023,6/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
TR,2023-06-12,A0776408,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ahmet Dirican,Guardant360 CDx,2.12,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/18/2023,6/18/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-06,1.0,1838.0,1500-2000$ 
GB,2023-06-12,A0776361,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/19/2023,6/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-12,A0776419,Clinical,Musgrove Park Hospital,Justin Pepperell,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,6/18/2023,6/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-13,A0777159,Clinical,Widcombe Surgery,Rebecca Hodson,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,6/19/2023,7/4/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
GB,2023-06-13,A0777085,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/21/2023,6/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-13,A0777096,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/19/2023,6/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
IT,2023-06-13,A0777140,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Melanoma,6/21/2023,6/21/2023,ITALY,Commercial,Skin,ITALY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 EUR,0.0,2023-06,1.0,0.0,0 $
GB,2023-06-13,A0777160,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-14,A0778219,Clinical,HCA Laboratories,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
GB,2023-06-14,A0778265,Clinical,NHS - Wythenshawe Hospital,Richard Booton,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/21/2023,6/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-14,A0778252,Clinical,Genesis Care,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-06,1.18,2643.2,2000-3000$ 
GB,2023-06-14,A0778202,Clinical,Elstree Cancer Centre,Neel Bhuva,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,6/19/2023,6/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-14,A0778216,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/21/2023,6/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-14,A0778228,Clinical,Bristol Haematology and Oncology Centre,Thomas Bird,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,6/19/2023,6/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
BR,2023-06-14,A0778199,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Hepatocellular carcinoma,6/20/2023,6/27/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,2500 USD,2500.0,2023-06,1.0,2500.0,2000-3000$ 
GB,2023-06-14,A0778204,Clinical,HCA at The Christie Clinic,Gregory Wilson,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,6/27/2023,7/4/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-06,1.18,4118.2,3000+ $
GB,2023-06-14,A0778197,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
ES,2023-06-14,A0778198,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,7/31/2023,7/31/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,0 EUR,0.0,2023-06,1.0,0.0,0 $
GB,2023-06-15,A0778689,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
GB,2023-06-15,A0778677,Clinical,HCA Laboratories,Eleni Karapanagiotou,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
GB,2023-06-15,A0778865,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,6/27/2023,6/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,Reveal,2023Q2,Europe,Paid,3490 GBP,3490.0,2023-06,1.18,4118.2,3000+ $
GB,2023-06-15,A0778638,Clinical,NHS - University Hospitals Leicester,Dean Fennell,Guardant 360,2.12,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-15,A0778566,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-15,A0778592,Clinical,Glasgow Royal Infirmary,John Farley,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-15,A0778620,Clinical,Beatson West of Scotland Cancer Centre,Vivienne MacLaren,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-15,A0778558,Clinical,Eastbourne District General Hospital,Arun Jeevagan,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
ES,2023-06-15,A0779082,Clinical,Complejo Hospitalario Ruber Juan Bravo,Araceli Priego Priego,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/21/2023,6/21/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2241 EUR,2241.0,2023-06,1.0,2241.0,2000-3000$ 
ES,2023-06-16,A0780535,Clinical,Clinica Universidad de Navarra,Jose Maria Lopez-Picazo Gonzalez,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/22/2023,6/22/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2400 USD,2400.0,2023-06,1.0,2400.0,2000-3000$ 
GB,2023-06-16,A0780509,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/22/2023,6/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-16,A0779965,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/22/2023,6/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-16,A0780522,Clinical,Clatterbridge cancer Center,Ehab Ibrahim,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/22/2023,6/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-16,A0780653,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/23/2023,8/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-16,A0779675,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,6/20/2023,6/20/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
GB,2023-06-16,A0779665,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/22/2023,6/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-16,A0780661,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/23/2023,6/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-16,A0779725,Clinical,NHS - University Hospitals Morecambe Bay,Shahedal Bari,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/21/2023,6/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-16,A0779677,Clinical,NHS - University Hospitals Morecambe Bay,Urmi Gupta,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/22/2023,6/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-16,A0780281,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,6/22/2023,6/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-16,A0780437,Clinical,NHS - University Hospitals Morecambe Bay,Urmi Gupta,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung cancer,7/24/2023,7/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-16,A0780668,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/23/2023,6/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-17,A0782963,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),6/23/2023,6/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-17,A0782953,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/23/2023,6/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-17,A0782936,Clinical,NHS - University Hospitals Morecambe Bay,Urmi Gupta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/23/2023,6/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
BR,2023-06-17,A0782167,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/27/2023,6/27/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
TR,2023-06-17,A0782928,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Bilgin Demir,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/23/2023,6/23/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-06,1.0,1838.0,1500-2000$ 
TR,2023-06-17,A0782954,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ali Ayberk Besen,Guardant 360,2.12,GH2_12,Distributors : ROW,Bladder carcinoma,6/27/2023,6/27/2023,TURKEY,Commercial,Bladder,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-06,1.0,2319.0,2000-3000$ 
TR,2023-06-17,A0782952,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gurbuz Gorumlu,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/23/2023,6/23/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-06,1.0,1838.0,1500-2000$ 
GB,2023-06-17,A0782956,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/23/2023,6/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
RO,2023-06-19,A0783153,Clinical,Amethyst Radiotherapy Clinic,Bogdan Mateies,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/23/2023,6/23/2023,ROMANIA,Commercial,,ROMANIA,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 EUR,2490.0,2023-06,1.0,2490.0,2000-3000$ 
BR,2023-06-19,A0783163,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/23/2023,6/23/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
GB,2023-06-19,A0783138,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,6/23/2023,6/23/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-06,1.18,2643.2,2000-3000$ 
GB,2023-06-20,A0785663,Clinical,Guys Hospital,Sindu Vivekanandan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/27/2023,6/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-20,A0783967,Clinical,HCA Laboratories,Asad Qureshi,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,6/26/2023,6/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
GB,2023-06-20,A0783957,Clinical,The Royal Marsden NHS Foundation Trust,Sheela Rao,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,6/26/2023,6/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-20,A0783981,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/26/2023,6/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-20,A0783973,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/28/2023,6/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-21,A0785245,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/27/2023,6/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-21,A0785006,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/26/2023,6/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-21,A0785261,Clinical,Guys Hospital,Kiruthikah Thillai,Guardant 360,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,6/26/2023,6/26/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-21,A0784842,Clinical,NHS - Barts Health,Lianne Castle,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/26/2023,6/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-21,A0785274,Clinical,Guys Hospital,Van Sim,Guardant360 CDx,,GHI_19,Self-Pay Patient,Renal Cell Carcinoma,6/27/2023,6/27/2023,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-21,A0785062,Clinical,Southend University Hospital,Yejide Odedina,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/26/2023,6/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-21,A0785285,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/26/2023,6/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-21,A0784995,Clinical,HCA Laboratories,Alison Jones,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,7/9/2023,7/9/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
GB,2023-06-21,A0785252,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/26/2023,6/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
CA,2023-06-21,A0785058,Clinical,William Osler Health System,Brandon Sheffield,74-Gene Panel,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/27/2023,6/27/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Canada,Free,0 USD,0.0,2023-06,1.0,0.0,0 $
ES,2023-06-21,A0784843,Clinical,Hospital Puerta de Hierro,Mariano Provencio,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/27/2023,6/27/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1245 EUR,1245.0,2023-06,1.0,1245.0,0-1500$ 
BR,2023-06-21,A0785253,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Cholangiocarcinoma,6/26/2023,6/26/2023,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
GB,2023-06-21,A0785007,Clinical,Addenbrooke's Hospital,David Gilligan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/27/2023,6/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2240 GBP,2240.0,2023-06,1.18,2643.2,2000-3000$ 
BR,2023-06-21,A0785084,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/26/2023,6/26/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
GB,2023-06-22,A0785748,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/30/2023,6/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-22,A0785590,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),6/27/2023,6/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-22,A0786258,Clinical,Guys Hospital,Stephanie Fraser,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,6/27/2023,6/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
DE,2023-06-22,A0785564,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung squamous cell carcinoma,7/3/2023,7/3/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,3341 EUR,3341.0,2023-06,1.0,3341.0,3000+ $
GB,2023-06-22,A0786297,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,6/27/2023,7/4/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
GB,2023-06-22,A0786255,Clinical,HCA Laboratories,John Conibear,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,6/29/2023,6/29/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
GB,2023-06-22,A0786296,Clinical,NHS - University Hospitals Leicester,Rajini Sudhir,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/2/2023,7/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
CA,2023-06-22,A0786120,Clinical,Sunnybrook Health Sciences Centre,Anthony Lott,Guardant Reveal,1.0,GHI_10,Do Not Bill - Cancelled,Cholangiocarcinoma,6/30/2023,6/30/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,Reveal,2023Q2,Canada,Paid,0 USD,0.0,2023-06,1.0,0.0,0 $
GB,2023-06-22,A0786298,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),6/27/2023,6/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-22,A0787012,Clinical,Torbay and South Devon Foundation Trust,Louise Medley,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/27/2023,6/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
UY,2023-06-22,A0786309,Clinical,Practice Dr Luis Ubillos,Luis Ubillos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),7/6/2023,7/6/2023,URUGUAY,Commercial,CUP,URUGUAY,1,non_AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,3490 USD,3490.0,2023-06,1.0,3490.0,3000+ $
GB,2023-06-23,A0787403,Clinical,NHS - Wythenshawe Hospital,Richard Booton,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/29/2023,6/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
IT,2023-06-23,A0786809,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Do Not Bill - Cancelled,Sarcoma,7/24/2023,7/24/2023,ITALY,Commercial,Soft Tissue/Bone,ITALY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,0 EUR,0.0,2023-06,1.0,0.0,0 $
TR,2023-06-23,A0786689,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Nil Mandel,Guardant 360,2.12,GH2_12,Distributors : ROW,Gastric adenocarcinoma,6/29/2023,6/29/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-06,1.0,2319.0,2000-3000$ 
TR,2023-06-23,A0786744,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mustafa Ozdogan,Guardant 360,2.12,GH2_12,Do Not Bill - Cancelled,Ovarian carcinoma,6/30/2023,6/30/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,0,0.0,2023-06,1.0,0.0,0 $
CA,2023-06-23,A0786620,Clinical,Bluewater Health,Julie Lebert,74-Gene Panel,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/28/2023,7/6/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Canada,Free,0 USD,0.0,2023-06,1.0,0.0,0 $
CA,2023-06-23,A0786581,Clinical,Bluewater Health,Julie Lebert,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Prostate adenocarcinoma,6/30/2023,7/3/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Canada,Free,0 USD,0.0,2023-06,1.0,0.0,0 $
CA,2023-06-23,A0786576,Clinical,Bluewater Health,Julie Lebert,74-Gene Panel,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,6/28/2023,7/3/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Canada,Free,0 USD,0.0,2023-06,1.0,0.0,0 $
BR,2023-06-23,A0786670,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,6/29/2023,6/29/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
TR,2023-06-23,A0786796,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ahmet Dirican,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung squamous cell carcinoma,6/29/2023,6/29/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-06,1.0,1838.0,1500-2000$ 
IT,2023-06-23,A0786790,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Sarcoma,6/28/2023,6/28/2023,ITALY,Commercial,Soft Tissue/Bone,ITALY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2000 EUR,2000.0,2023-06,1.0,2000.0,1500-2000$ 
GB,2023-06-23,A0786840,Clinical,NHS - Barts Health,Adam Januszewski,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/29/2023,6/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-23,A0786734,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/27/2023,6/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-23,A0786753,Clinical,Beatson West of Scotland Cancer Centre,Hilary Glen,Guardant 360,,GHI_19,Self-Pay Patient,Renal pelvis urothelial carcinoma,6/30/2023,6/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-23,A0786835,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/28/2023,6/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-23,A0786711,Clinical,Western General Hospital - Edinburgh Cancer Centre,Melanie Mackean,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/27/2023,7/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
GB,2023-06-23,A0786736,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),6/27/2023,6/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-23,A0787433,Clinical,NHS - Wythenshawe Hospital,Richard Booton,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/28/2023,6/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
ES,2023-06-24,A0787873,Clinical,Hospital Quiron Barcelona,Jesus Soberino Garcia,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,6/30/2023,6/30/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2241 EUR,2241.0,2023-06,1.0,2241.0,2000-3000$ 
ES,2023-06-24,A0787902,Clinical,Hospital Quiron Barcelona,Jesus Soberino Garcia,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,7/3/2023,7/3/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2241 EUR,2241.0,2023-06,1.0,2241.0,2000-3000$ 
GB,2023-06-24,A0787875,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/3/2023,7/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-24,A0787996,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,6/30/2023,6/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-24,A0788032,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,6/29/2023,6/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
ES,2023-06-24,A0787907,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/28/2023,6/28/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2400 USD,2400.0,2023-06,1.0,2400.0,2000-3000$ 
GB,2023-06-26,A0788245,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/5/2023,7/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-26,A0788272,Clinical,Poole Hospital NHS Foundation Trust,Ravi Punwani,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,6/30/2023,6/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-26,A0788232,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/2/2023,7/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-26,A0788289,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/2/2023,7/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
TR,2023-06-26,A0788258,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Haci Ibrahim Petekaya,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/29/2023,6/29/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1838,1838.0,2023-06,1.0,1838.0,1500-2000$ 
GB,2023-06-26,A0788278,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,6/29/2023,6/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-26,A0788282,Clinical,Singleton Hospital,Laura Jones,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,7/2/2023,7/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-26,A0788251,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,6/29/2023,6/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
BR,2023-06-26,A0788328,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),7/9/2023,7/9/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
GB,2023-06-26,A0788284,Clinical,HCA Laboratories,Sheeba Irshad,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,6/29/2023,6/29/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
GB,2023-06-26,A0788261,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,6/30/2023,6/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-26,A0788332,Clinical,Freeman Hospital,Mark Verrill,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/9/2023,7/9/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
TR,2023-06-26,A0788269,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulcan Bulut,Guardant 360,2.12,GH2_12,Distributors : ROW,Carcinoma of unknown primary (CUP),7/6/2023,7/6/2023,TURKEY,Commercial,CUP,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-06,1.0,2319.0,2000-3000$ 
GB,2023-06-26,A0788275,Clinical,St Bartholomews Hospital,Peter Hall,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,6/29/2023,6/29/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-27,A0788988,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/2/2023,7/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-27,A0788971,Clinical,The Royal Marsden NHS Foundation Trust,David Cunningham,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,7/2/2023,7/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-27,A0788978,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sheel Mehta,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,7/5/2023,7/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
GB,2023-06-27,A0788956,Clinical,Sussex Cancer Centre,Kate Lankester,Guardant360 CDx,,GHI_19,Self-Pay Patient,Ovarian carcinoma,7/19/2023,7/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-28,A0790035,Clinical,Elstree Cancer Centre,Andreas Polychronis,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/9/2023,7/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-28,A0789981,Clinical,HCA Laboratories,Sheeba Irshad,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,7/6/2023,7/6/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
IT,2023-06-28,A0797605,Clinical,"Magna Graecia"" University of Catanzaro",Lucia Fiorillo,Guardant360 CDx,,GHI_19,Self-Pay Patient,Leiomyosarcoma,7/14/2023,7/14/2023,ITALY,Commercial,Soft Tissue/Bone,ITALY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,0 EUR,0.0,2023-06,1.0,0.0,0 $
CA,2023-06-28,A0790415,Clinical,Sir Mortimer B Davis Jewish General Hosp,Petr Kavan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,7/3/2023,7/3/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Canada,Paid,1700 USD,1700.0,2023-06,1.0,1700.0,1500-2000$ 
ES,2023-06-28,A0790405,Clinical,Hospital del Mar,Laura Visa,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,7/3/2023,7/4/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1500 EUR,1500.0,2023-06,1.0,1500.0,0-1500$ 
CA,2023-06-28,A0789769,Clinical,Dr McKnight - Private Practice,Arlene McKnight,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,7/11/2023,7/14/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,Reveal,2023Q2,Canada,Free,0 USD,0.0,2023-06,1.0,0.0,0 $
CA,2023-06-28,A0790013,Clinical,Hamilton Health Sciences Centre,Richard Tozer,74-Gene Panel,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/3/2023,9/13/2023,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Canada,Paid,1700 USD,1700.0,2023-06,1.0,1700.0,1500-2000$ 
GB,2023-06-28,A0790394,Clinical,Southampton General Hospital,Charlotte Rees,Guardant360 CDx,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),7/3/2023,7/13/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
TR,2023-06-29,A0790910,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sinem Akbas,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,7/6/2023,7/6/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-06,1.0,2319.0,2000-3000$ 
DE,2023-06-29,A0790886,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,7/6/2023,7/6/2023,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,3341 EUR,3341.0,2023-06,1.0,3341.0,3000+ $
GB,2023-06-29,A0791302,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/4/2023,7/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-29,A0791021,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,1.0,GHI_10,Self-Pay Patient,Colorectal adenocarcinoma,7/11/2023,7/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,Reveal,2023Q2,Europe,Paid,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-29,A0791316,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/4/2023,7/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
TR,2023-06-29,A0790865,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gokhan Karakaya,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,7/7/2023,7/7/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,2319,2319.0,2023-06,1.0,2319.0,2000-3000$ 
GB,2023-06-29,A0791327,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/4/2023,7/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-29,A0791336,Clinical,Musgrove Park Hospital,Justin Pepperell,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/4/2023,7/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Free,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-29,A0791334,Clinical,Princess Elizabeth Hospital,Mohammad Butt,Guardant 360,2.12,GH2_12,Do Not Bill - Cancelled,Prostate adenocarcinoma,6/30/2023,6/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 Infinity,2023Q2,Europe,Paid,0 GBP,0.0,2023-06,1.18,0.0,0 $
GB,2023-06-29,A0791329,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,,GHI_19,Self-Pay Patient,Large cell lung carcinoma,7/4/2023,7/4/2023,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
GB,2023-06-30,A0791755,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/5/2023,7/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-30,A0792234,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/5/2023,7/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-30,A0792272,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/9/2023,7/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-30,A0792286,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/7/2023,7/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-30,A0791765,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),7/6/2023,7/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-30,A0791723,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/5/2023,7/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
ES,2023-06-30,A0792227,Clinical,Clinica Universidad de Navarra-Madrid,Antonio Gonzalez Martin,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,7/6/2023,7/6/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2400 USD,2400.0,2023-06,1.0,2400.0,2000-3000$ 
GB,2023-06-30,A0791753,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/5/2023,7/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
BR,2023-06-30,A0792299,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Esophageal squamous cell carcinoma,7/7/2023,7/7/2023,BRAZIL,Commercial,GI,BRAZIL,1,AE,USD,Americas,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,South America,Paid,1750 USD,1750.0,2023-06,1.0,1750.0,1500-2000$ 
GB,2023-06-30,A0791759,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,,GHI_19,Distributors : ROW,Bladder carcinoma,7/6/2023,7/6/2023,UNITED KINGDOM,Commercial,Bladder,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
GB,2023-06-30,A0792262,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/8/2023,7/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-30,A0791739,Clinical,The Spire Hospital Hartswood,Eliot Sims,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/5/2023,7/6/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2490 GBP,2490.0,2023-06,1.18,2938.2,2000-3000$ 
GB,2023-06-30,A0791724,Clinical,The James Cook University Hospital,Nick Wadd,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,7/5/2023,7/5/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,1450 GBP,1450.0,2023-06,1.18,1711.0,1500-2000$ 
GB,2023-06-30,A0791786,Clinical,HCA Laboratories,Nicholas Maisey,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,7/5/2023,7/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,2178.75 GBP,2178.0,2023-06,1.18,2570.04,2000-3000$ 
GB,2023-06-30,A0791776,Clinical,NHS - Wythenshawe Hospital,Phil Crosbie,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/6/2023,7/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-30,A0791740,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/5/2023,7/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-30,A0791710,Clinical,NHS - Barts Health,Adam Januszewski,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/6/2023,7/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-06-30,A0792295,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/6/2023,7/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,6,2023,2,1,2023-06-01,2023-06,G360 CDx,2023Q2,Europe,Paid,830 GBP,830.0,2023-06,1.18,979.4,0-1500$ 
GB,2023-07-01,A0792653,Clinical,Bupa Cromwell Hospital,John Conibear,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-07,1.18,4118.2,3000+ $
GB,2023-07-03,A0793058,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung cancer,7/24/2023,7/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-03,A0793067,Clinical,NHS - University Hospitals Morecambe Bay,Gilbert Jifon,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-03,A0793046,Clinical,HCA Laboratories,Martin Forster,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/11/2023,7/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-07,1.18,2570.04,2000-3000$ 
GB,2023-07-03,A0793106,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Christos Mikropoulos,Guardant360 CDx,2.11,GHI_01,Do Not Bill - Cancelled,Prostate adenocarcinoma,7/24/2023,7/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-03,A0793101,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-03,A0793065,Clinical,Sussex Cancer Centre,Kam Zaki,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-07,1.18,2938.2,2000-3000$ 
GB,2023-07-03,A0793089,Clinical,Mount Alverina Hospital,Christos Mikropoulos,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-07,1.18,2643.2,2000-3000$ 
GB,2023-07-03,A0793077,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-03,A0793068,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-03,A0793055,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Jonathan Dakin,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/11/2023,7/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-07,1.18,2643.2,2000-3000$ 
GB,2023-07-03,A0793056,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-03,A0793064,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,7/15/2023,7/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-03,A0793051,Clinical,Maidstone and Tunbridge Wells NHS Trust,Russell Burcombe,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/11/2023,7/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-03,A0793082,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-03,A0793080,Clinical,NHS - University Hospitals Morecambe Bay,Gilbert Jifon,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-03,A0793043,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
ES,2023-07-03,A0793038,Clinical,Hospital Universitario Infanta SofÃ­a,Maria Sereno,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/11/2023,7/11/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 EUR,0.0,2023-07,1.0,0.0,0 $
IT,2023-07-03,A0793075,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,7/11/2023,7/11/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
ES,2023-07-03,A0793062,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,7/7/2023,7/7/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-07,1.0,1500.0,0-1500$ 
ES,2023-07-03,A0793074,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/14/2023,7/14/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-07,1.0,1500.0,0-1500$ 
GB,2023-07-03,A0793042,Clinical,NHS - University Hospitals Morecambe Bay,Gilbert Jifon,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/11/2023,7/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-03,A0793040,Clinical,Genesis Care,Nicholas Rowell,Guardant 360,2.12,GH2_12,Self-Pay Patient,Thyroid carcinoma,7/11/2023,9/21/2023,UNITED KINGDOM,Commercial,Thyroid,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-07,1.18,4118.2,3000+ $
IT,2023-07-03,A0793097,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Glioblastoma,7/11/2023,7/11/2023,ITALY,Commercial,Brain,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1745 EUR ,1745.0,2023-07,1.0,1745.0,1500-2000$ 
GB,2023-07-03,A0793071,Clinical,HCA Laboratories,Alison Jones,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,7/11/2023,7/11/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-07,1.18,2570.04,2000-3000$ 
GB,2023-07-03,A0793041,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/10/2023,7/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
IT,2023-07-03,A0793102,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Glioblastoma,7/11/2023,7/11/2023,ITALY,Commercial,Brain,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
GB,2023-07-05,A0794365,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-05,A0794266,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,7/11/2023,7/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-05,A0794248,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-05,A0794280,Clinical,Guys Hospital,Sarah Hunter,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,7/10/2023,8/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-05,A0794252,Clinical,Northampton General Hospital,Aleksandar Aleksic,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-05,A0794347,Clinical,Guys Hospital,Sarah Hunter,Guardant360 CDx,,GHI_19,Self-Pay Patient,Renal Cell Carcinoma,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
IT,2023-07-05,A0794294,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/10/2023,7/10/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
GB,2023-07-06,A0795449,Clinical,NHS - University Hospitals Sussex,Kam Zaki,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/11/2023,7/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-06,A0795512,Clinical,University Hospital of Leicester - Glenfield Hospital,Lucy Faulkner,Guardant 360,2.11,GHI_01,Self-Pay Patient,Head and neck carcinoma,7/12/2023,7/12/2023,UNITED KINGDOM,Commercial,Head and neck carcinoma,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
BR,2023-07-06,A0795520,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Gastric adenocarcinoma,7/11/2023,7/11/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-07,1.0,1750.0,1500-2000$ 
GB,2023-07-06,A0795519,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/12/2023,7/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
TR,2023-07-06,A0795147,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gurbuz Gorumlu,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/11/2023,7/11/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1838,1838.0,2023-07,1.0,1838.0,1500-2000$ 
GB,2023-07-06,A0795150,Clinical,Barnet Hospital,Matthew Mee,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/13/2023,7/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-06,A0795468,Clinical,Worthing Hospital,Richard Robinson,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/10/2023,7/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-06,A0795515,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/12/2023,7/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
CA,2023-07-06,A0795524,Clinical,Bluewater Health,Julie Lebert,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Prostate adenocarcinoma,7/12/2023,10/25/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Canada,Paid,2290 USD,2290.0,2023-07,1.0,2290.0,2000-3000$ 
GB,2023-07-06,A0795532,Clinical,NHS - Barts Health,Adam Januszewski,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/11/2023,7/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
TR,2023-07-06,A0795521,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Cetin Ordu,Guardant 360,2.12,GH2_12,Distributors : ROW,Other,7/20/2023,7/20/2023,TURKEY,Commercial,Other,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-07,1.0,2319.0,2000-3000$ 
ES,2023-07-06,A0795529,Clinical,Hospital Quiron Barcelona,Jesus Soberino Garcia,Guardant 360,2.12,GH2_12,Do Not Bill - Cancelled,Breast Carcinoma,7/7/2023,7/7/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,0 EUR,0.0,2023-07,1.0,0.0,0 $
GB,2023-07-06,A0795545,Clinical,University College London Hospitals,Sandra Strauss,Guardant360 CDx,,GHI_19,Self-Pay Patient,Sarcoma,7/11/2023,7/11/2023,UNITED KINGDOM,Commercial,Soft Tissue/Bone,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-07,A0796009,Clinical,NHS - Barts Health,William Ricketts,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/11/2023,7/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
TR,2023-07-07,A0796222,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Abudullah Buyukcelik,Guardant360 CDx,2.12,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/12/2023,7/12/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1838,1838.0,2023-07,1.0,1838.0,1500-2000$ 
GB,2023-07-07,A0795995,Clinical,Poole Hospital NHS Foundation Trust,Khin-Ni Sann,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/12/2023,7/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
IT,2023-07-07,A0796010,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Do Not Bill - Cancelled,Breast Carcinoma,8/7/2023,8/7/2023,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 EUR,0.0,2023-07,1.0,0.0,0 $
GB,2023-07-07,A0796019,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/12/2023,7/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
ES,2023-07-07,A0796345,Clinical,Hospital Clinico San Carlos,Jorge Bartolome,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,7/18/2023,7/18/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-07,1.0,1500.0,0-1500$ 
GB,2023-07-07,A0796017,Clinical,NHS - University Hospitals Morecambe Bay,Shahedal Bari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/12/2023,7/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-07,A0796358,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant360 CDx,2.11,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,7/13/2023,7/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-07,1.18,2570.04,2000-3000$ 
GB,2023-07-07,A0796002,Clinical,Eastbourne District General Hospital,Arun Jeevagan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,7/11/2023,8/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-07,A0796331,Clinical,NHS - University Hospitals Morecambe Bay,Shahedal Bari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/13/2023,7/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-08,A0796757,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/13/2023,7/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-08,A0796694,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/13/2023,7/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-10,A0797561,Clinical,University Hospitals Of Leicester,Olubukola Ayodele,Guardant 360,2.11,GHI_01,Self-Pay Patient,Bladder carcinoma,7/17/2023,7/17/2023,UNITED KINGDOM,Commercial,Bladder,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-10,A0797414,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/13/2023,7/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-10,A0797404,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,7/13/2023,7/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-10,A0797409,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/17/2023,7/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
TR,2023-07-10,A0797559,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Fatih Selcukbiricik,Guardant 360,2.12,GH2_12,Distributors : ROW,Gastric adenocarcinoma,7/20/2023,7/20/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-07,1.0,2319.0,2000-3000$ 
GB,2023-07-10,A0797410,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,7/14/2023,7/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-10,A0797583,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/19/2023,7/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-10,A0797335,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/19/2023,7/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-10,A0797356,Clinical,York Hospital,Kathryn Humphries,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/14/2023,7/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
TR,2023-07-10,A0797354,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/13/2023,7/13/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1838,1838.0,2023-07,1.0,1838.0,1500-2000$ 
GB,2023-07-10,A0797337,Clinical,NHS - University Hospitals Leicester,Olubukola Ayodele,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/13/2023,7/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-10,A0797353,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,7/13/2023,7/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
TR,2023-07-10,A0797423,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Gastric adenocarcinoma,7/20/2023,7/20/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-07,1.0,2319.0,2000-3000$ 
GB,2023-07-10,A0797417,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/14/2023,7/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
CA,2023-07-11,A0798482,Clinical,"Blueguide, Inc.",Kankesan Janarthanan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Renal Cell Carcinoma,7/16/2023,7/16/2023,CANADA,Commercial,Kidney,CANADA,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Canada,Free,0 USD,0.0,2023-07,1.0,0.0,0 $
GB,2023-07-11,A0798493,Clinical,HCA Laboratories,Crispin Hiley,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/16/2023,7/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-07,1.18,2570.04,2000-3000$ 
GB,2023-07-11,A0798500,Clinical,HCA Laboratories,Mark Harries,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,7/16/2023,7/16/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-07,1.18,2570.04,2000-3000$ 
GB,2023-07-11,A0798130,Clinical,BMI The Chaucer Hospital,Rakesh Raman,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,7/20/2023,7/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-07,1.18,4118.2,3000+ $
GB,2023-07-11,A0798469,Clinical,Mount Alverina Hospital,Mazhar Ajaz,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,Melanoma,7/16/2023,7/16/2023,UNITED KINGDOM,Commercial,Skin,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-07,1.18,2643.2,2000-3000$ 
GB,2023-07-12,A0799529,Clinical,NHS - Charing Cross Hospital,Susannah Bloch,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,7/17/2023,7/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
CA,2023-07-12,A0800300,Clinical,Markham Stouffville Hospital,Mateya Trinkaus,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,7/31/2023,7/31/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Canada,Free,0 USD,0.0,2023-07,1.0,0.0,0 $
GB,2023-07-12,A0799615,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.12,GHI_19,Distributors : ROW,Lung cancer,7/18/2023,7/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
BR,2023-07-12,A0799612,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Prostate adenocarcinoma,7/21/2023,7/27/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,South America,Paid,2500 USD,2500.0,2023-07,1.0,2500.0,2000-3000$ 
GB,2023-07-12,A0799610,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/17/2023,7/17/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
TR,2023-07-12,A0799501,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ahmet Demirkazik,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,7/23/2023,7/23/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-07,1.0,2319.0,2000-3000$ 
GB,2023-07-12,A0799602,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/18/2023,7/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-13,A0800622,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,7/18/2023,7/18/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-07,1.18,2570.04,2000-3000$ 
GB,2023-07-13,A0800647,Clinical,Coventry University Hospitals,Peter Correa,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/19/2023,7/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-07,1.18,2643.2,2000-3000$ 
ES,2023-07-13,A0800661,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,7/25/2023,7/25/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-07,1.0,1500.0,0-1500$ 
GB,2023-07-13,A0800613,Clinical,The Nuffield Hospital Guildford,Ajay Mehta,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,7/18/2023,7/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-07,1.18,2643.2,2000-3000$ 
GB,2023-07-13,A0800620,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/19/2023,7/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
BR,2023-07-13,A0799971,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,7/18/2023,7/18/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-07,1.0,1750.0,1500-2000$ 
BR,2023-07-13,A0799959,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/18/2023,7/18/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-07,1.0,1750.0,1500-2000$ 
GB,2023-07-13,A0800625,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/18/2023,7/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-13,A0800051,Clinical,NHS - Wythenshawe Hospital,Avik Ghoshal,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,7/20/2023,7/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-13,A0800672,Clinical,Genesis Care Nottingham,Sarah Khan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/18/2023,8/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-07,1.18,2938.2,2000-3000$ 
GB,2023-07-13,A0800639,Clinical,Guys Hospital,Emma Mclean,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/18/2023,7/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
TR,2023-07-14,A0801110,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Haci Ibrahim Petekaya,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/18/2023,7/18/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1838,1838.0,2023-07,1.0,1838.0,1500-2000$ 
GB,2023-07-14,A0801635,Clinical,Elstree Cancer Centre,Andreas Polychronis,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/18/2023,7/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-07,1.18,2643.2,2000-3000$ 
GB,2023-07-14,A0801391,Clinical,Southampton General Hospital,Andrew Bates,Guardant360 CDx,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,7/19/2023,7/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-07,1.18,2938.2,2000-3000$ 
GB,2023-07-14,A0801388,Clinical,Singleton Hospital,David Watkins,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/18/2023,7/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
IT,2023-07-14,A0801368,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Other,7/18/2023,7/18/2023,ITALY,Commercial,Other,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
GB,2023-07-14,A0801308,Clinical,Musgrove Park Hospital,Janet Fallon,Guardant 360,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,7/20/2023,7/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-14,A0801408,Clinical,Genesis Care,Riyaz Shah,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,7/20/2023,7/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-07,1.18,2938.2,2000-3000$ 
GB,2023-07-14,A0801359,Clinical,HCA Laboratories,Alison Jones,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,7/18/2023,7/18/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-07,1.18,2570.04,2000-3000$ 
GB,2023-07-14,A0801708,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/20/2023,7/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
IT,2023-07-14,A0801354,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,7/19/2023,7/19/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
ES,2023-07-14,A0801452,Clinical,Hospital Universitario de Guadalajara,Javier Cassinello,Guardant 360,,GHI_19,Self-Pay Sponsored,Thyroid carcinoma,7/18/2023,8/1/2023,SPAIN,Commercial,Thyroid,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-07,1.0,1500.0,0-1500$ 
IT,2023-07-14,A0801355,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Other,7/18/2023,7/18/2023,ITALY,Commercial,Other,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1745 EUR ,1745.0,2023-07,1.0,1745.0,1500-2000$ 
IT,2023-07-14,A0801334,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/24/2023,7/24/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
GB,2023-07-14,A0801384,Clinical,St Bartholomews Hospital,Michael Grant,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/18/2023,7/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-15,A0802440,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/19/2023,7/19/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-17,A0802681,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/25/2023,7/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-17,A0802694,Clinical,NHS - Wythenshawe Hospital,Christopher Craig,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/25/2023,7/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-17,A0802741,Clinical,The Nuffield Hospital Guildford,Sebastian Cummins,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/25/2023,7/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-17,A0802744,Clinical,Worcestershire Royal Hospital,Nishanth Murukesh,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/21/2023,8/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
TR,2023-07-17,A0802705,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kubra Hasimoglu Gurun,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Gastric adenocarcinoma,7/25/2023,7/25/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-07,1.0,2319.0,2000-3000$ 
GB,2023-07-17,A0802749,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-07,1.18,2570.04,2000-3000$ 
GB,2023-07-17,A0802738,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-17,A0802690,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-17,A0802710,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/21/2023,8/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-17,A0802699,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-17,A0802742,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
ES,2023-07-17,A0802758,Clinical,Clinica Universidad de Navarra,Miguel FernÃ¡ndez de Sanmamed GutiÃ©rrez,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/21/2023,7/21/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2400 USD,2400.0,2023-07,1.0,2400.0,2000-3000$ 
GB,2023-07-17,A0802711,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-17,A0802756,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-17,A0802752,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-17,A0802764,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-17,A0802730,Clinical,NHS - Arrowe Park,Andrew Wight,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/24/2023,7/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
ES,2023-07-17,A0802722,Clinical,Hospital Clinico San Carlos,Jorge Bartolome,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,7/25/2023,7/25/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-07,1.0,1500.0,0-1500$ 
GB,2023-07-17,A0802762,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-07,1.18,2938.2,2000-3000$ 
GB,2023-07-17,A0802701,Clinical,Beatson West of Scotland Cancer Centre,Gregory Naylor,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/21/2023,7/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-17,A0802686,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung cancer,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-17,A0802761,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/21/2023,7/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
BR,2023-07-17,A0802770,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,7/21/2023,7/21/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-07,1.0,1750.0,1500-2000$ 
GB,2023-07-18,A0803810,Clinical,The London Clinic,Peter Szlosarek,Guardant360 CDx,2.12,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,7/24/2023,7/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-07,1.18,2643.2,2000-3000$ 
GB,2023-07-19,A0804847,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/24/2023,7/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
BR,2023-07-19,A0804915,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Salivary gland adenoid cystic carcinoma,7/24/2023,7/24/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-07,1.0,1750.0,1500-2000$ 
GB,2023-07-19,A0804857,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/24/2023,7/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-19,A0804473,Clinical,NHS - Wythenshawe Hospital,Matthew Evison,Guardant 360,,GHI_19,Distributors : ROW,Lung adenosquamous carcinoma,7/24/2023,7/24/2023,UNITED KINGDOM,Commercial,Lung,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
UY,2023-07-20,A0805900,Clinical,Practice Dr Luis Ubillos,Luis Ubillos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,7/25/2023,7/25/2023,URUGUAY,Commercial,Breast,URUGUAY,1,non_AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,South America,Paid,3490 USD,3490.0,2023-07,1.0,3490.0,3000+ $
ES,2023-07-20,A0805907,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Other,7/29/2023,7/29/2023,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-07,1.0,1500.0,0-1500$ 
ES,2023-07-20,A0805897,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,7/25/2023,7/25/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-07,1.0,1500.0,0-1500$ 
RO,2023-07-20,A0805410,Clinical,Amethyst Radiotherapy Clinic,Bogdan Mateies,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/25/2023,7/28/2023,ROMANIA,Commercial,,ROMANIA,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2490 EUR,2490.0,2023-07,1.0,2490.0,2000-3000$ 
DE,2023-07-20,A0805311,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,7/27/2023,7/27/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,3341 EUR,3341.0,2023-07,1.0,3341.0,3000+ $
IT,2023-07-20,A0816372,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,8/7/2023,8/7/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
GB,2023-07-20,A0805455,Clinical,NHS - Wythenshawe Hospital,Gaurav Ahuja,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/28/2023,7/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-21,A0808048,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,8/1/2023,8/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-21,A0807009,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/26/2023,7/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-21,A0806925,Clinical,Cancer Centre London,Muireann Kelleher,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/28/2023,7/28/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-07,1.18,2938.2,2000-3000$ 
GB,2023-07-21,A0807000,Clinical,NHS - Kingston Hospital,Farid Bazari,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/26/2023,7/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-21,A0807118,Clinical,The Spire Hospital Hartswood,Rafiqul Islam,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,7/26/2023,7/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-07,1.18,2643.2,2000-3000$ 
GB,2023-07-21,A0806993,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Christos Mikropoulos,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,7/26/2023,7/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-21,A0807062,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/26/2023,7/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-21,A0807061,Clinical,Musgrove Park Hospital,Emma Barker,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,7/26/2023,7/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-21,A0806996,Clinical,Cancer Centre London,Muireann Kelleher,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/26/2023,7/26/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-07,1.18,2938.2,2000-3000$ 
GB,2023-07-21,A0807004,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/26/2023,8/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-21,A0807109,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung cancer,7/25/2023,7/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,0 GBP,0.0,2023-07,1.18,0.0,0 $
BR,2023-07-21,A0807111,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic ductal adenocarcinoma,7/28/2023,8/2/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-07,1.0,1750.0,1500-2000$ 
DE,2023-07-21,A0806914,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,7/28/2023,7/28/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,3341 EUR,3341.0,2023-07,1.0,3341.0,3000+ $
GB,2023-07-21,A0807001,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/26/2023,7/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
ES,2023-07-22,A0807492,Clinical,Hospital Clinico San Carlos,Jorge Bartolome,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,7/27/2023,7/27/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-07,1.0,1500.0,0-1500$ 
CA,2023-07-22,A0807571,Clinical,London Health Sciences Centre,Daniel Breadner,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,7/31/2023,8/3/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Canada,Paid,2290 USD,2290.0,2023-07,1.0,2290.0,2000-3000$ 
CA,2023-07-22,A0807705,Clinical,Princess Margaret Cancer Centre,Jennifer Knox,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,7/31/2023,9/4/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Canada,Paid,2290 USD,2290.0,2023-07,1.0,2290.0,2000-3000$ 
TR,2023-07-24,A0807908,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ahmet Dirican,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung cancer,7/28/2023,7/28/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1838,1838.0,2023-07,1.0,1838.0,1500-2000$ 
GB,2023-07-24,A0807975,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/2/2023,8/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
IT,2023-07-24,A0808000,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/1/2023,8/1/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
GB,2023-07-24,A0807911,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/30/2023,7/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-24,A0807956,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/28/2023,7/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-24,A0807919,Clinical,Cancer Centre London,Muireann Kelleher,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/30/2023,7/30/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-07,1.18,2938.2,2000-3000$ 
IT,2023-07-24,A0807920,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/1/2023,8/1/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
GB,2023-07-24,A0807921,Clinical,Poole Hospital NHS Foundation Trust,Tom Geldart,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/28/2023,7/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-24,A0807984,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Gastric adenocarcinoma,7/29/2023,7/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-07,1.18,2570.04,2000-3000$ 
GB,2023-07-24,A0807983,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/28/2023,7/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-24,A0807999,Clinical,NHS - University Hospitals Morecambe Bay,Gilbert Jifon,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/28/2023,7/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
IT,2023-07-24,A0807912,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,8/2/2023,8/2/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
ES,2023-07-24,A0807897,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,,GHI_19,Distributors : ROW,Basal cell carcinoma,7/27/2023,7/27/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2179 EUR,2179.0,2023-07,1.0,2179.0,2000-3000$ 
ES,2023-07-24,A0807990,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,7/30/2023,7/30/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2400 USD,2400.0,2023-07,1.0,2400.0,2000-3000$ 
GB,2023-07-24,A0807903,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/28/2023,7/28/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-24,A0807965,Clinical,Singleton Hospital,Steve Kihara,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/1/2023,10/25/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-24,A0807988,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Rebecca Muirhead,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,7/30/2023,7/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-24,A0807997,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,8/2/2023,8/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-24,A0807977,Clinical,NHS - Aintree University Hospital,Mohammed Ahmed,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,8/1/2023,8/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
CA,2023-07-25,A0808951,Clinical,Bluewater Health,Julie Lebert,74-Gene Panel,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/29/2023,7/31/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Canada,Paid,1700 USD,1700.0,2023-07,1.0,1700.0,1500-2000$ 
GB,2023-07-26,A0810393,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,8/2/2023,8/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-26,A0810405,Clinical,Cancer Centre London,Mary O'Brien,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,7/31/2023,7/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-07,1.18,2643.2,2000-3000$ 
GB,2023-07-26,A0809908,Clinical,NHS - University Hospitals Leicester,Syed Ajmal,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/1/2023,8/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
CA,2023-07-26,A0810378,Clinical,Stronach Regional Cancer Centre,Labib Zibdawi,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/1/2023,8/1/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Canada,Free,0 USD,0.0,2023-07,1.0,0.0,0 $
GB,2023-07-26,A0810401,Clinical,GenesisCare Milton Keynes,Craig Macmillan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,7/31/2023,7/31/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-07,1.18,2643.2,2000-3000$ 
UY,2023-07-26,A0809880,Clinical,Practice Dr Luis Ubillos,Luis Ubillos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,7/31/2023,7/31/2023,URUGUAY,Commercial,,URUGUAY,1,non_AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,South America,Paid,3490 USD,3490.0,2023-07,1.0,3490.0,3000+ $
GB,2023-07-26,A0810404,Clinical,NHS - Chelsea & Westminster Hospital,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/31/2023,7/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-26,A0810382,Clinical,NHS - Royal Surrey,Ajay Mehta,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/2/2023,8/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-26,A0810163,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,8/2/2023,8/2/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
CA,2023-07-26,A0809815,Clinical,BC Cancer centre - Vancouver,Sharlene Gill,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Colorectal adenocarcinoma,8/8/2023,8/8/2023,CANADA,,,CANADA,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,Reveal,2023Q3,Canada,Paid,0 USD,0.0,2023-07,1.0,0.0,0 $
GB,2023-07-26,A0809956,Clinical,NHS - Wythenshawe Hospital,Richard Booton,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,7/31/2023,7/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-27,A0811141,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Colorectal adenocarcinoma,8/8/2023,8/8/2023,UNITED KINGDOM,,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,Reveal,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-07,1.18,4118.2,3000+ $
GB,2023-07-27,A0811146,Clinical,Kent and Canterbury Hospital,Mathilda Cominos,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/2/2023,8/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-27,A0811070,Clinical,Stoke Mandeville Hospital,Andrew Eichholz,Guardant360 CDx,,GHI_19,Do Not Bill - Cancelled,Breast Carcinoma,8/8/2023,8/8/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-27,A0811023,Clinical,Maidstone and Tunbridge Wells NHS Trust,Jane Brown,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung squamous cell carcinoma,8/3/2023,8/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-27,A0811134,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,8/1/2023,8/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-27,A0811166,Clinical,Musgrove Park Hospital,Emma Cattell,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/2/2023,8/2/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-27,A0811172,Clinical,HCA Laboratories,Mark Harries,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,8/2/2023,8/2/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-07,1.18,2570.04,2000-3000$ 
TR,2023-07-28,A0812551,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ozcan Yildiz,Guardant360 CDx,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,7/31/2023,7/31/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,0,0.0,2023-07,1.0,0.0,0 $
GB,2023-07-28,A0812112,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Paul Miller,Guardant360 CDx,,GHI_19,Self-Pay Patient,Esophageal/Gastroesophageal junction Adenocarcinoma,8/2/2023,8/2/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-28,A0812537,Clinical,NHS - West Suffolk,Thomas Pulimood,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,8/1/2023,8/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-28,A0812086,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,8/3/2023,8/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-28,A0812510,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/1/2023,8/1/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-28,A0812144,Clinical,NHS - Wythenshawe Hospital,Christopher Craig,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,8/2/2023,8/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-28,A0812249,Clinical,NHS - Royal Free Hospital,Anant Patel,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,8/1/2023,8/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-28,A0812131,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Ramon DeMello,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/4/2023,8/4/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-28,A0812224,Clinical,St Bartholomews Hospital,Marco Gerlinger,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/2/2023,8/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-28,A0812066,Clinical,Guys Hospital,Justin Mencel,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/5/2023,8/5/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
DE,2023-07-28,A0812484,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,8/4/2023,8/4/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,3341 EUR,3341.0,2023-07,1.0,3341.0,3000+ $
GB,2023-07-28,A0812538,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,8/1/2023,8/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-31,A0813342,Clinical,Eastbourne District General Hospital,Victoria Donovan,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/8/2023,8/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-31,A0813399,Clinical,St Bartholomews Hospital,Vasileios Angelis,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/7/2023,8/7/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
TR,2023-07-31,A0813422,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,8/7/2023,8/7/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-07,1.0,2319.0,2000-3000$ 
IT,2023-07-31,A0813406,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,8/7/2023,8/7/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
TR,2023-07-31,A0813391,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,8/7/2023,8/7/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-07,1.0,2319.0,2000-3000$ 
GB,2023-07-31,A0813366,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Distributors : ROW,Lung squamous cell carcinoma,8/4/2023,8/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
GB,2023-07-31,A0813407,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Colorectal adenocarcinoma,8/9/2023,8/9/2023,UNITED KINGDOM,,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,Reveal,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-07,1.18,4118.2,3000+ $
GB,2023-07-31,A0813362,Clinical,Freeman Hospital,Lindsay Hannah,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,Ovarian Epithelial Carcinoma,8/7/2023,8/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
GB,2023-07-31,A0813380,Clinical,The Christie Hospital,Francisca Marti Marti,Guardant360 CDx,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,8/4/2023,8/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-07,1.18,1711.0,1500-2000$ 
GB,2023-07-31,A0813374,Clinical,St Bartholomews Hospital,Alison Berner,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/4/2023,8/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-07,1.18,0.0,0 $
DE,2023-07-31,A0813314,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/9/2023,8/9/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,3341 EUR,3341.0,2023-07,1.0,3341.0,3000+ $
GB,2023-07-31,A0813311,Clinical,NHS - Salford Royal  Hospital,Seamus Grundy,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,8/7/2023,8/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-07,1.18,979.4,0-1500$ 
IT,2023-07-31,A0813300,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Glioblastoma,8/7/2023,8/7/2023,ITALY,Commercial,Brain,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1745 EUR ,1745.0,2023-07,1.0,1745.0,1500-2000$ 
ES,2023-07-31,A0813330,Clinical,Hospital Clinico San Carlos,Jorge Bartolome,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,8/4/2023,8/4/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-07,1.0,1500.0,0-1500$ 
IT,2023-07-31,A0813412,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,8/7/2023,8/7/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
IT,2023-07-31,A0813285,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/14/2023,8/14/2023,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1745 EUR ,1745.0,2023-07,1.0,1745.0,1500-2000$ 
IT,2023-07-31,A0813290,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/7/2023,8/7/2023,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
IT,2023-07-31,A0813303,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Glioblastoma,8/7/2023,8/7/2023,ITALY,Commercial,Brain,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
TR,2023-07-31,A0813355,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Leyla Ozer,Guardant360 CDx,2.12,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/4/2023,8/18/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,1838,1838.0,2023-07,1.0,1838.0,1500-2000$ 
TR,2023-07-31,A0813384,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kerem Okutur,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,8/7/2023,8/7/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-07,1.0,2319.0,2000-3000$ 
CA,2023-07-31,A0813371,Clinical,Cedars Cancer Centre,Ramy Saleh,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ewing sarcoma,8/4/2023,8/4/2023,CANADA,Commercial,Soft Tissue/Bone,CANADA,1,AE,USD,Americas,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Canada,Paid,1700 USD,1700.0,2023-07,1.0,1700.0,1500-2000$ 
IT,2023-07-31,A0813324,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,8/7/2023,8/7/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,7,2023,3,1,2023-07-01,2023-07,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-07,1.0,2000.0,1500-2000$ 
TR,2023-07-31,A0813345,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mehmet Akif Ozturk,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,8/7/2023,8/7/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,7,2023,3,1,2023-07-01,2023-07,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-07,1.0,2319.0,2000-3000$ 
GB,2023-08-01,A0815856,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Distributors : ROW,Lung cancer,8/7/2023,8/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-08,1.18,979.4,0-1500$ 
GB,2023-08-01,A0816352,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Christos Mikropoulos,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,8/7/2023,8/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-01,A0815832,Clinical,NHS - Kettering General Hospital,George Tsaknis,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung cancer,8/7/2023,8/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-08,1.18,979.4,0-1500$ 
GB,2023-08-01,A0816319,Clinical,NHS - Wythenshawe Hospital,Jonathan Chung,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung cancer,8/3/2023,8/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,0 GBP,0.0,2023-08,1.18,0.0,0 $
GB,2023-08-01,A0813774,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Colorectal adenocarcinoma,8/10/2023,8/10/2023,UNITED KINGDOM,,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,Reveal,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-08,1.18,4118.2,3000+ $
GB,2023-08-01,A0816313,Clinical,St Bartholomews Hospital,Michael Grant,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,8/7/2023,8/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-08,1.18,0.0,0 $
TR,2023-08-01,A0814956,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ece Esin,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Hepatocellular carcinoma,8/8/2023,8/8/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-08,1.0,2319.0,2000-3000$ 
CA,2023-08-02,A0816803,Clinical,Tom Baker Cancer Center,Safiya Karim,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Other,8/9/2023,8/9/2023,CANADA,Commercial,Other,CANADA,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Canada,Paid,2290 USD,2290.0,2023-08,1.0,2290.0,2000-3000$ 
CA,2023-08-02,A0816651,Clinical,London Health Sciences Centre,Stephen Welch,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,8/9/2023,8/9/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Canada,Paid,2290 USD,2290.0,2023-08,1.0,2290.0,2000-3000$ 
BR,2023-08-02,A0817170,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/8/2023,8/8/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-08,1.0,1750.0,1500-2000$ 
GB,2023-08-02,A0816810,Clinical,NHS - University College London Hospital,Neal Navani,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung cancer,8/8/2023,8/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,0 GBP,0.0,2023-08,1.18,0.0,0 $
GB,2023-08-02,A0817158,Clinical,NHS - Kettering General Hospital,George Tsaknis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/8/2023,8/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-08,1.18,979.4,0-1500$ 
GB,2023-08-02,A0816806,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,8/7/2023,8/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-08,1.18,979.4,0-1500$ 
GB,2023-08-02,A0816797,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,2.11,GHI_19,Distributors : ROW,Lung cancer,8/8/2023,8/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,830 GBP,830.0,2023-08,1.18,979.4,0-1500$ 
GB,2023-08-02,A0816764,Clinical,NHS - Cambridge University Hospitals,Frank Mccaughan,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung cancer,8/14/2023,8/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,0 GBP,0.0,2023-08,1.18,0.0,0 $
GB,2023-08-02,A0816819,Clinical,NHS - Maidstone Hospital,Riyaz Shah,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung cancer,8/8/2023,8/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,0 GBP,0.0,2023-08,1.18,0.0,0 $
GB,2023-08-02,A0816805,Clinical,HCA at The Christie Clinic,Gregory Wilson,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,8/9/2023,8/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-08,1.18,2570.04,2000-3000$ 
GB,2023-08-02,A0816741,Clinical,Guys Hospital,Saoirse Dolly,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Pancreatic neuroendocrine tumor,8/10/2023,8/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-03,A0820149,Clinical,Positive IV,Thomas J Vogl,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/12/2023,8/15/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
TR,2023-08-03,A0818087,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Haci Ibrahim Petekaya,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/7/2023,8/7/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1838,1838.0,2023-08,1.0,1838.0,1500-2000$ 
GB,2023-08-03,A0817736,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/8/2023,8/14/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-03,A0818081,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/7/2023,8/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
BR,2023-08-03,A0817997,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/8/2023,8/11/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-08,1.0,1750.0,1500-2000$ 
GB,2023-08-03,A0817646,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,8/11/2023,8/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-08,1.18,2570.04,2000-3000$ 
GB,2023-08-03,A0817572,Clinical,The Nuffield Hospital Guildford,Mazhar Ajaz,Guardant 360,,GHI_19,Self-Pay Sponsored,Melanoma,8/13/2023,8/13/2023,UNITED KINGDOM,Commercial,Skin,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2490 GB,2490.0,2023-08,1.18,2938.2,2000-3000$ 
GB,2023-08-04,A0818750,Clinical,Clatterbridge cancer Center,Roopa Kurup,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/9/2023,8/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
BR,2023-08-04,A0819103,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/9/2023,8/9/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-08,1.0,1750.0,1500-2000$ 
RO,2023-08-05,A0819758,Clinical,Amethyst Radiotherapy Clinic,Bogdan Mateies,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/11/2023,9/13/2023,ROMANIA,Commercial,,ROMANIA,1,non_AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2490 EUR,2490.0,2023-08,1.0,2490.0,2000-3000$ 
GB,2023-08-07,A0820066,Clinical,BMI Bishops Wood Hospital,Andreas Polychronis,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/11/2023,8/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2490 GB,2490.0,2023-08,1.18,2938.2,2000-3000$ 
GB,2023-08-07,A0819902,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/15/2023,8/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-08,1.18,2570.04,2000-3000$ 
ES,2023-08-07,A0820076,Clinical,HC Marbella International Hospital,Jose Manuel Trigo,UNKNOWN,2.12,GH2_12,Do Not Bill - Cancelled,Lung adenocarcinoma,8/8/2023,8/8/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,0 EUR,0.0,2023-08,1.0,0.0,0 $
ES,2023-08-07,A0820047,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,8/22/2023,8/22/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-08,1.0,1500.0,0-1500$ 
GB,2023-08-07,A0820061,Clinical,NHS - Fairfield Hospital,Rehan Naseer,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung cancer,8/8/2023,8/8/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,0 GBP,0.0,2023-08,1.18,0.0,0 $
GB,2023-08-07,A0819897,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,8/11/2023,8/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-08,1.18,2570.04,2000-3000$ 
GB,2023-08-07,A0820020,Clinical,HCA Laboratories,Constantine Alifrangis,Guardant 360,,GHI_19,Distributors : ROW,Prostate adenocarcinoma,8/11/2023,8/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-08,1.18,2570.04,2000-3000$ 
GB,2023-08-07,A0820062,Clinical,The Royal Wolverhampton NHS Trust,Sam Mannam,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,8/11/2023,8/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-07,A0820049,Clinical,Beatson West of Scotland Cancer Centre,Brian Clark,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/11/2023,8/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-08,1.18,2643.2,2000-3000$ 
TR,2023-08-07,A0819920,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Umut Disel,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,8/15/2023,8/15/2023,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Free,0,0.0,2023-08,1.0,0.0,0 $
BR,2023-08-09,A0822132,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Non-small cell lung carcinoma (NSCLC),8/14/2023,8/17/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-08,1.0,1750.0,1500-2000$ 
GB,2023-08-09,A0822066,Clinical,Guys Hospital,Kasia Owczarczyk,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/14/2023,8/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
CA,2023-08-10,A0823546,Clinical,London Health Sciences Centre,Daniel Breadner,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Colorectal adenocarcinoma,8/17/2023,8/17/2023,CANADA,,,CANADA,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,Reveal,2023Q3,Canada,Free,0 USD,0.0,2023-08,1.0,0.0,0 $
CA,2023-08-10,A0824280,Clinical,Marsden Centre,Kim Rovers,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Breast Carcinoma,8/17/2023,8/17/2023,CANADA,,Breast,CANADA,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,Reveal,2023Q3,Canada,Free,0 USD,0.0,2023-08,1.0,0.0,0 $
TR,2023-08-10,A0823613,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Haci Ibrahim Petekaya,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,8/17/2023,8/17/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-08,1.0,2319.0,2000-3000$ 
GB,2023-08-10,A0823569,Clinical,Poole Hospital NHS Foundation Trust,Rachel Plant,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/14/2023,8/14/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-10,A0823571,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sophie Otter,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,8/14/2023,8/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
ES,2023-08-10,A0824116,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Other,8/21/2023,8/21/2023,SPAIN,Commercial,Other,SPAIN,1,AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-08,1.0,1500.0,0-1500$ 
GB,2023-08-10,A0823490,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/17/2023,8/17/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-10,A0823336,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,8/14/2023,8/14/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-08,1.18,2570.04,2000-3000$ 
GB,2023-08-10,A0823589,Clinical,Sheffield Weston Park Cancer Centre,Richard Crossley,Guardant360 CDx,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),8/15/2023,8/29/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-11,A0825516,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Sheel Mehta,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,8/16/2023,8/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-08,1.18,2643.2,2000-3000$ 
GB,2023-08-11,A0830877,Clinical,BMI Cavell Hospital,Girija Anand,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,8/23/2023,8/23/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-11,A0825007,Clinical,The Spire Hospital Hartswood,Eliot Sims,Guardant 360,,GHI_19,Self-Pay Sponsored,Breast Carcinoma,8/19/2023,8/19/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-08,1.18,2643.2,2000-3000$ 
IT,2023-08-11,A0825498,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/16/2023,8/16/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-08,1.0,2000.0,1500-2000$ 
ES,2023-08-11,A0825101,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/17/2023,8/17/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-08,1.0,1500.0,0-1500$ 
CO,2023-08-12,A0826106,Clinical,Biotecnologia y Genetica S.A.S,Silvia Maradei,74-Gene Panel,2.11,GHI_01,Do Not Bill - Cancelled,Glioma,8/18/2023,8/18/2023,COLOMBIA,Commercial,Brain,COLOMBIA,1,non_AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,0 USD,0.0,2023-08,1.0,0.0,0 $
GB,2023-08-14,A0826520,Clinical,Poole Hospital NHS Foundation Trust,David Morgan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/18/2023,8/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-08,1.18,0.0,0 $
GB,2023-08-14,A0826518,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/18/2023,8/22/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-14,A0826489,Clinical,GenesisCare,Muthuveni Ezhil,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,8/18/2023,8/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-08,1.18,2643.2,2000-3000$ 
GB,2023-08-14,A0826475,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Paul Miller,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/18/2023,8/21/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
TR,2023-08-14,A0826498,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ozkan Alan,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,8/23/2023,8/23/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-08,1.0,2319.0,2000-3000$ 
IT,2023-08-14,A0826467,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenosquamous carcinoma,8/18/2023,8/18/2023,ITALY,Commercial,Lung,ITALY,1,non_AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-08,1.0,2000.0,1500-2000$ 
BR,2023-08-14,A0826513,Clinical,Hospital Israelita Albert Einstein,Pedro Uson,Guardant 360,2.11,GHI_01,Self-Pay Patient,Other,8/18/2023,8/18/2023,BRAZIL,Commercial,Other,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Free,0 USD,0.0,2023-08,1.0,0.0,0 $
TR,2023-08-14,A0826455,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sinan Yavuz,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,8/22/2023,8/22/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-08,1.0,2319.0,2000-3000$ 
BR,2023-08-15,A0826999,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Small cell lung carcinoma,8/21/2023,8/21/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-08,1.0,1750.0,1500-2000$ 
BR,2023-08-15,A0827011,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/20/2023,8/20/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-08,1.0,1750.0,1500-2000$ 
GB,2023-08-15,A0826924,Clinical,Maidstone and Tunbridge Wells NHS Trust,Mark Hill,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/21/2023,8/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-15,A0827605,Clinical,Mount Alverina Hospital,Sebastian Cummins,Guardant 360,2.12,GH2_12,Self-Pay Patient,Goblet cell carcinoid (GCC),8/21/2023,8/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-08,1.18,4118.2,3000+ $
GB,2023-08-16,A0828669,Clinical,Positive IV,Thomas J Vogl,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/22/2023,8/22/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
TR,2023-08-16,A0828661,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Fatih Selcukbiricik,Guardant 360,2.12,GH2_12,Distributors : ROW,Other,8/23/2023,8/23/2023,TURKEY,Commercial,Other,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-08,1.0,2319.0,2000-3000$ 
BR,2023-08-16,A0828668,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/21/2023,8/21/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-08,1.0,1750.0,1500-2000$ 
GB,2023-08-16,A0828679,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,8/22/2023,8/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-08,1.18,2570.04,2000-3000$ 
GB,2023-08-16,A0828691,Clinical,Poole Hospital NHS Foundation Trust,Lauren Gorf,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/21/2023,8/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-08,1.18,0.0,0 $
GB,2023-08-17,A0830100,Clinical,Genesis Care,Mark Hill,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,8/23/2023,8/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-08,1.18,2938.2,2000-3000$ 
GB,2023-08-17,A0829973,Clinical,Singleton Hospital,Nida Hassan,74-Gene Panel,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/23/2023,8/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-08,1.18,0.0,0 $
MX,2023-08-17,A0829276,Clinical,MileniaLabs,Lucia Tellez,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Urothelial carcinoma,8/23/2023,8/23/2023,MEXICO,Commercial,Urothelial,MEXICO,1,non_AE,EUR,Americas,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,South America,Paid,2990 USD ,2990.0,2023-08,1.0,2990.0,2000-3000$ 
GB,2023-08-17,A0830048,Clinical,Royal Hampshire County Hospital,Sanjay Raj,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,8/22/2023,8/22/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-08,1.18,2643.2,2000-3000$ 
GB,2023-08-17,A0830051,Clinical,Royal Free London NHS Foundation Trust,Daniel Krell,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,8/25/2023,8/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-17,A0830068,Clinical,Clatterbridge cancer Center,Ehab Ibrahim,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/22/2023,8/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-08,1.18,0.0,0 $
GB,2023-08-17,A0829980,Clinical,Guys Hospital,Marios Hadjipavlou,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Prostate adenocarcinoma,8/18/2023,8/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,0 GBP,0.0,2023-08,1.18,0.0,0 $
GB,2023-08-17,A0829257,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Paul Miller,Guardant360 CDx,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),8/21/2023,8/21/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-18,A0830621,Clinical,Musgrove Park Hospital,Sarah Foster,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/23/2023,8/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-08,1.18,0.0,0 $
DE,2023-08-18,A0830984,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,8/28/2023,8/28/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,3341 EUR,3341.0,2023-08,1.0,3341.0,3000+ $
GB,2023-08-18,A0830496,Clinical,Crosshouse Hospital,Catherine Anderson,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/23/2023,8/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-08,1.18,0.0,0 $
GB,2023-08-18,A0830898,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,8/23/2023,8/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-08,1.18,2570.04,2000-3000$ 
GB,2023-08-18,A0830946,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/27/2023,8/27/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-19,A0831433,Clinical,The Royal Marsden NHS Foundation Trust,Sheela Rao,Guardant 360,,GHI_19,Self-Pay Sponsored,Colorectal adenocarcinoma,8/25/2023,8/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
FR,2023-08-21,A0832048,Clinical,Institut de Cancerologie de Lorraine,Jean-Louis Merlin,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,8/29/2023,8/29/2023,FRANCE,Commercial,,FRANCE,1,non_AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Free,0 EUR,0.0,2023-08,1.0,0.0,0 $
GB,2023-08-21,A0832119,Clinical,Spire Harpenden Hospital,Nihal Shah,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Breast Carcinoma,8/28/2023,8/28/2023,UNITED KINGDOM,,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,Reveal,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-08,1.18,4118.2,3000+ $
UY,2023-08-21,A0832101,Clinical,Practice Dr Luis Ubillos,Luis Ubillos,Guardant 360,2.11,GHI_01,Self-Pay Patient,Ovarian carcinoma,8/25/2023,8/25/2023,URUGUAY,Commercial,,URUGUAY,1,non_AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,3490 USD,3490.0,2023-08,1.0,3490.0,3000+ $
BR,2023-08-21,A0832140,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung squamous cell carcinoma,8/24/2023,8/29/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-08,1.0,1750.0,1500-2000$ 
TR,2023-08-21,A0832090,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Nil Mandel,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung squamous cell carcinoma,8/25/2023,8/25/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1838,1838.0,2023-08,1.0,1838.0,1500-2000$ 
GB,2023-08-21,A0832055,Clinical,HCA Laboratories,Nikolaos Diamantis,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/29/2023,10/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-08,1.18,2938.2,2000-3000$ 
GB,2023-08-21,A0832016,Clinical,Beatson West of Scotland Cancer Centre,Carrie Featherstone,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,8/24/2023,8/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-08,1.18,0.0,0 $
CA,2023-08-21,A0832029,Clinical,Walker Family Cancer Centre,Radhika Yelamanchili,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Pancreatic adenocarcinoma,8/29/2023,8/29/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Canada,Free,0 USD,0.0,2023-08,1.0,0.0,0 $
BR,2023-08-21,A0832139,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,8/25/2023,8/25/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-08,1.0,1750.0,1500-2000$ 
ES,2023-08-22,A0832848,Clinical,Hospital Clinico San Carlos,Jorge Bartolome,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Carcinoma of unknown primary (CUP),8/29/2023,8/29/2023,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-08,1.0,1500.0,0-1500$ 
GB,2023-08-22,A0832825,Clinical,Mount Alverina Hospital,Mazhar Ajaz,Guardant360 CDx,,GHI_19,Self-Pay Patient,Melanoma,9/2/2023,9/2/2023,UNITED KINGDOM,Commercial,Skin,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-08,1.18,2643.2,2000-3000$ 
GB,2023-08-22,A0832736,Clinical,Jersey General Hospital St. Helier,Rabinder Singh Soomal,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/28/2023,8/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-08,1.18,2938.2,2000-3000$ 
CA,2023-08-22,A0832626,Clinical,Tom Baker Cancer Center,Gerald Lim,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Glioblastoma,8/28/2023,8/29/2023,CANADA,Commercial,Brain,CANADA,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Canada,Paid,2290 USD,2290.0,2023-08,1.0,2290.0,2000-3000$ 
CA,2023-08-22,A0832962,Clinical,Princess Margaret Cancer Centre,Jennifer Knox,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,8/28/2023,8/31/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Canada,Paid,2290 USD,2290.0,2023-08,1.0,2290.0,2000-3000$ 
BR,2023-08-23,A0833416,Clinical,"Murad, Casali E Carneiro Ltda",Bruna Mattioly Valente,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/28/2023,8/29/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,2500 USD,2500.0,2023-08,1.0,2500.0,2000-3000$ 
BR,2023-08-23,A0833425,Clinical,"Murad, Casali E Carneiro Ltda",Bruna Mattioly Valente,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,8/30/2023,8/30/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,2500 USD,2500.0,2023-08,1.0,2500.0,2000-3000$ 
CA,2023-08-23,A0833374,Clinical,Integrated Health Clinic,Gurdev Parmar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Esophageal squamous cell carcinoma,8/28/2023,8/28/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Canada,Free,0 USD,0.0,2023-08,1.0,0.0,0 $
NL,2023-08-23,A0833424,Clinical,Erasmus MC Kanker Institute,Sophie Gerritse,Guardant360 CDx,2.12,GH2_12,Self-Pay Patient,Carcinoma of unknown primary (CUP),8/30/2023,8/30/2023,NETHERLANDS,Commercial,CUP,NETHERLANDS,1,non_AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Free,0 USD,0.0,2023-08,1.0,0.0,0 $
GB,2023-08-23,A0834156,Clinical,Poole Hospital NHS Foundation Trust,Rachel Plant,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,8/27/2023,8/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-24,A0835454,Clinical,St Georges Hospital,Anna-Mary Young,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,8/30/2023,8/30/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
GB,2023-08-25,A0835903,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,8/29/2023,8/29/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-08,1.18,2570.04,2000-3000$ 
ES,2023-08-25,A0835703,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,8/30/2023,8/30/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2400 USD,2400.0,2023-08,1.0,2400.0,2000-3000$ 
GB,2023-08-25,A0836640,Clinical,Guys Hospital,Elias Pintus,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,8/30/2023,10/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
ES,2023-08-25,A0835770,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,8/29/2023,8/29/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-08,1.0,1500.0,0-1500$ 
CA,2023-08-25,A0835764,Clinical,Integrated Health Clinic,Gurdev Parmar,Guardant 360,2.11,GHI_01,Self-Pay Patient,Glioblastoma,8/29/2023,8/29/2023,CANADA,Commercial,Brain,CANADA,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Canada,Paid,??,0.0,2023-08,1.0,0.0,0 $
GB,2023-08-28,A0837590,Clinical,Genesis Care,Catherine Harper-Wynne,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,9/3/2023,9/3/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-08,1.18,4118.2,3000+ $
GB,2023-08-28,A0837594,Clinical,Genesis Care,Mark Hill,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/3/2023,9/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-08,1.18,4118.2,3000+ $
TR,2023-08-28,A0837584,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Nil Mandel,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,9/3/2023,9/3/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-08,1.0,2319.0,2000-3000$ 
TR,2023-08-28,A0837643,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,9/5/2023,9/5/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-08,1.0,2319.0,2000-3000$ 
GB,2023-08-28,A0837585,Clinical,Beatson West of Scotland Cancer Centre,Robert Jones,Guardant360 CDx,,GHI_19,Self-Pay Patient,Urothelial carcinoma,9/5/2023,9/5/2023,UNITED KINGDOM,Commercial,Urothelial,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-08,1.18,0.0,0 $
BR,2023-08-28,A0837656,Clinical,"Murad, Casali E Carneiro Ltda",Juliana Garcia Carneiro,Guardant 360,2.11,GHI_01,Self-Pay Patient,Colorectal carcinoma,8/31/2023,9/1/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,South America,Paid,2500 USD,2500.0,2023-08,1.0,2500.0,2000-3000$ 
GB,2023-08-28,A0837582,Clinical,University College London Hospitals,Lucinda Melcher,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/6/2023,9/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
DE,2023-08-28,A0837633,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Carcinoma of unknown primary (CUP),9/3/2023,9/4/2023,GERMANY,Commercial,CUP,GERMANY,1,non_AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,3341 EUR,3341.0,2023-08,1.0,3341.0,3000+ $
GB,2023-08-28,A0837609,Clinical,Peterborough City Hospital Dept of Oncology 18,Abigail Hollingdale,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/4/2023,9/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-08,1.18,1711.0,1500-2000$ 
ES,2023-08-28,A0837639,Clinical,HC Marbella International Hospital,Jose Manuel Trigo,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/1/2023,9/1/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2490 EUR,2490.0,2023-08,1.0,2490.0,2000-3000$ 
GB,2023-08-29,A0839268,Clinical,Singleton Hospital,Jason Lester,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/9/2023,9/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-08,1.18,2643.2,2000-3000$ 
TR,2023-08-29,A0838437,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Umut Demirci,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,9/5/2023,9/5/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-08,1.0,2319.0,2000-3000$ 
GB,2023-08-29,A0838552,Clinical,Queen Alexandra Hospital,Samuel Chan,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/4/2023,10/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-08,1.18,2938.2,2000-3000$ 
CA,2023-08-30,A0839375,Clinical,London Health Sciences Centre,Stephen Welch,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,9/6/2023,9/6/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Canada,Paid,2290 USD,2290.0,2023-08,1.0,2290.0,2000-3000$ 
GB,2023-08-31,A0840220,Clinical,Clatterbridge cancer Center,Tariq Noor-ul-Ain,Guardant 360,2.11,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/7/2023,9/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-08,1.18,0.0,0 $
CA,2023-08-31,A0839771,Clinical,Neurvana Health,Ryan Best,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Rectal adenocarcinoma,9/5/2023,9/5/2023,CANADA,,,CANADA,1,AE,USD,Americas,8,2023,3,1,2023-08-01,2023-08,Reveal,2023Q3,Canada,Free,0 USD,0.0,2023-08,1.0,0.0,0 $
TR,2023-08-31,A0839943,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung Large Cell Neuroendocrine Carcinoma,9/6/2023,9/6/2023,TURKEY,Commercial,Lung,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-08,1.0,2319.0,2000-3000$ 
TR,2023-08-31,A0840360,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Hakan Sat Bozcuk,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/6/2023,9/6/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 CDx,2023Q3,Europe,Paid,1838,1838.0,2023-08,1.0,1838.0,1500-2000$ 
TR,2023-08-31,A0839828,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sahin Lacin,Guardant 360,2.12,GH2_12,Distributors : ROW,Extrahepatic cholangiocarcinoma,9/7/2023,9/7/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,8,2023,3,1,2023-08-01,2023-08,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-08,1.0,2319.0,2000-3000$ 
GB,2023-09-01,A0840832,Clinical,St James University Hospital,Adel Samson,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,9/7/2023,9/7/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
ES,2023-09-01,A0841183,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,9/6/2023,9/6/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1745 EUR,1745.0,2023-09,1.0,1745.0,1500-2000$ 
GB,2023-09-01,A0840657,Clinical,Guys Hospital,Sarah Ngan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),9/7/2023,11/6/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
GB,2023-09-01,A0840806,Clinical,HCA Laboratories,Siow-Ming Lee,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/15/2023,9/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-09,1.18,2570.04,2000-3000$ 
GB,2023-09-01,A0841173,Clinical,Guys Hospital,Nirupa Murugaesu,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/7/2023,9/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
GB,2023-09-01,A0841168,Clinical,Spire Leicester Hospital,Samreen Ahmed,Guardant 360,,GHI_19,Self-Pay Patient,Breast carcinoma (triple negative),9/6/2023,9/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-09,1.18,2643.2,2000-3000$ 
GB,2023-09-01,A0840864,Clinical,Poole Hospital NHS Foundation Trust,Charlotte Davies,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/7/2023,9/7/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
GB,2023-09-02,A0841481,Clinical,Guys Hospital,Ali Mahmoud,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,9/12/2023,9/12/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
GB,2023-09-02,A0841497,Clinical,Cancer Centre at the Queen Elizabeth Hospital,David Peake,Guardant360 CDx,,GHI_19,Self-Pay Patient,Sarcoma,9/7/2023,9/7/2023,UNITED KINGDOM,Commercial,Soft Tissue/Bone,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-09,1.18,2938.2,2000-3000$ 
BR,2023-09-05,A0842320,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/10/2023,9/10/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-09,1.0,1750.0,1500-2000$ 
GB,2023-09-05,A0842266,Clinical,The Royal Marsden NHS Foundation Trust,Sanjay Popat,Guardant360 CDx,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,9/10/2023,10/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-05,A0842282,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,9/13/2023,10/13/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
TR,2023-09-05,A0842268,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Cengiz Yakicier,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,9/12/2023,9/12/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
GB,2023-09-05,A0842260,Clinical,Queen Alexandra Hospital,Anne Suovuori,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/10/2023,9/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
TR,2023-09-05,A0842224,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,9/11/2023,9/11/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
GB,2023-09-05,A0842228,Clinical,Addenbrooke's Hospital,David Gilligan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/18/2023,9/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
TR,2023-09-05,A0842278,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ibrahim Yildiz,Guardant 360,2.12,GH2_12,Distributors : ROW,Cholangiocarcinoma,9/12/2023,9/12/2023,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
GB,2023-09-05,A0842324,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Breast Carcinoma,9/10/2023,9/10/2023,UNITED KINGDOM,,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,Reveal,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-09,1.18,4118.2,3000+ $
BR,2023-09-05,A0842325,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/13/2023,9/13/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-09,1.0,1750.0,1500-2000$ 
GB,2023-09-06,A0842766,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,9/13/2023,9/13/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-06,A0842661,Clinical,Genesis Care Nottingham,Santhanam Sundar,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/11/2023,9/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-09,1.18,2938.2,2000-3000$ 
TR,2023-09-06,A0843316,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,9/12/2023,9/12/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
GB,2023-09-06,A0842748,Clinical,Eastbourne District General Hospital,Victoria Donovan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/12/2023,9/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
TR,2023-09-06,A0843255,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Umut Demirci,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/18/2023,9/18/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
GB,2023-09-07,A0844418,Clinical,Eastbourne District General Hospital,Victoria Donovan,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,9/12/2023,9/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-07,A0844612,Clinical,NHS - University Hospitals Leicester,Samreen Ahmed,Guardant 360,2.11,GHI_01,Do Not Bill - Cancelled,Lung adenocarcinoma,9/12/2023,9/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
GB,2023-09-07,A0844278,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/12/2023,10/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-09,1.18,2570.04,2000-3000$ 
ES,2023-09-07,A0844668,Clinical,Hospital Quiron Barcelona,Jesus Soberino Garcia,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,9/15/2023,9/15/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2179 EUR ,2179.0,2023-09,1.0,2179.0,2000-3000$ 
GB,2023-09-07,A0844095,Clinical,HCA Laboratories,Hartmut Kristeleit,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,9/12/2023,9/12/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-09,1.18,2570.04,2000-3000$ 
GB,2023-09-07,A0844469,Clinical,Royal Hampshire County Hospital,Andrew Miles,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Colorectal adenocarcinoma,9/18/2023,9/18/2023,UNITED KINGDOM,,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,Reveal,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-09,1.18,4118.2,3000+ $
GB,2023-09-07,A0844656,Clinical,Singleton Hospital,Jason Lester,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/12/2023,9/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-09,1.18,2938.2,2000-3000$ 
TR,2023-09-07,A0844364,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/13/2023,9/13/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
IT,2023-09-08,A0845608,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Glioblastoma,9/13/2023,9/13/2023,ITALY,Commercial,Brain,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
GB,2023-09-08,A0845882,Clinical,Genesis Care,Nicholas Rowell,Guardant 360,2.12,GH2_12,Self-Pay Patient,Tonsil Squamous cell carcinoma,9/15/2023,9/15/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-09,1.18,2643.2,2000-3000$ 
IT,2023-09-08,A0845626,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Glioblastoma,9/13/2023,9/13/2023,ITALY,Commercial,Brain,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1745 EUR ,1745.0,2023-09,1.0,1745.0,1500-2000$ 
GB,2023-09-08,A0845019,Clinical,Guys Hospital,Ailsa Lumsden,Guardant360 CDx,,GHI_19,Self-Pay Patient,GIST (Gastrointestinal stromal tumor),9/12/2023,9/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
GB,2023-09-08,A0844991,Clinical,Singleton Hospital,David Watkins,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/12/2023,9/12/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
IT,2023-09-08,A0845066,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,9/12/2023,9/12/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
IT,2023-09-08,A0845015,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Glioblastoma,9/14/2023,9/14/2023,ITALY,Commercial,Brain,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
CA,2023-09-08,A0844984,Clinical,London Health Sciences Centre,Jacques Raphael,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,9/14/2023,9/14/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Canada,Free,0 USD,0.0,2023-09,1.0,0.0,0 $
GB,2023-09-08,A0846019,Clinical,HCA Laboratories,Mark Harries,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,9/13/2023,10/11/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-09,1.18,2570.04,2000-3000$ 
CA,2023-09-08,A0845211,Clinical,"Blueguide, Inc.",Kate Barrett,Guardant 360,2.11,GHI_01,Self-Pay Patient,Carcinoma of unknown primary (CUP),9/14/2023,9/14/2023,CANADA,Commercial,CUP,CANADA,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Canada,Paid,1700 USD,1700.0,2023-09,1.0,1700.0,1500-2000$ 
CL,2023-09-08,A0845001,Clinical,Clinica Universidad de los Andes,Ricardo Silva Munoz,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Renal Cell Carcinoma,9/14/2023,9/14/2023,CHILE,Commercial,Kidney,CHILE,1,non_AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,South America,Paid,3990 USD,3990.0,2023-09,1.0,3990.0,3000+ $
IT,2023-09-08,A0844927,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Glioblastoma,9/14/2023,9/14/2023,ITALY,Commercial,Brain,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1745 EUR ,1745.0,2023-09,1.0,1745.0,1500-2000$ 
IT,2023-09-08,A0845052,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,9/12/2023,9/12/2023,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
GB,2023-09-09,A0846623,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/16/2023,9/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-09,1.18,2570.04,2000-3000$ 
TR,2023-09-09,A0846657,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Umut Demirci,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,9/14/2023,9/14/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
GB,2023-09-09,A0846753,Clinical,HCA Laboratories,Alison Jones,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,9/14/2023,10/17/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-09,1.18,2570.04,2000-3000$ 
TR,2023-09-11,A0847165,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,9/19/2023,9/19/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
GB,2023-09-11,A0847125,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant360 CDx,,GHI_19,Self-Pay Patient,Esophageal/Gastroesophageal junction Adenocarcinoma,9/17/2023,10/30/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
UY,2023-09-11,A0847077,Clinical,Practice Dr Luis Ubillos,Luis Ubillos,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,9/18/2023,9/18/2023,URUGUAY,Commercial,GI,URUGUAY,1,non_AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,South America,Free,0 USD,0.0,2023-09,1.0,0.0,0 $
TR,2023-09-11,A0847121,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Fulden Yumuk,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,9/18/2023,9/18/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
GB,2023-09-11,A0847127,Clinical,Mount Alverina Hospital,Sebastian Cummins,Guardant 360,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,9/18/2023,11/2/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-09,1.18,2938.2,2000-3000$ 
GB,2023-09-11,A0847134,Clinical,East Suffolk and North Essex NHS Foundation Trust,Mukesh B Mukesh,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,9/19/2023,9/19/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-09,1.18,2938.2,2000-3000$ 
IT,2023-09-11,A0847123,Clinical,"Magna Graecia"" University of Catanzaro",Simona Gualtieri,Guardant 360,,GHI_19,Self-Pay Patient,Sarcoma,9/14/2023,9/14/2023,ITALY,Commercial,Soft Tissue/Bone,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 EUR,0.0,2023-09,1.0,0.0,0 $
GB,2023-09-11,A0847187,Clinical,Mount Vernon Hospital Cancer Centre The Hillingdon Hospitals NHS Foundation Trust,Saira Khalique,Guardant360 CDx,,GHI_19,Self-Pay Patient,Ovarian carcinoma,9/14/2023,9/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
CA,2023-09-12,A0848084,Clinical,Tom Baker Cancer Center,Gavin Reynolds,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Glioblastoma,9/19/2023,9/26/2023,CANADA,Commercial,Brain,CANADA,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Canada,Free,0 USD,0.0,2023-09,1.0,0.0,0 $
CA,2023-09-12,A0847881,Clinical,Marsden Centre,Mandana Kamyar,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Rectal adenocarcinoma,9/20/2023,9/20/2023,CANADA,,,CANADA,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,Reveal,2023Q3,Canada,Free,0 USD,0.0,2023-09,1.0,0.0,0 $
CA,2023-09-12,A0847821,Clinical,Marsden Centre,Kim Rovers,74-Gene Panel,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/19/2023,9/19/2023,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Canada,Paid,??,0.0,2023-09,1.0,0.0,0 $
TR,2023-09-13,A0848580,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Houseyin Martsoylu,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,9/20/2023,9/20/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
IT,2023-09-13,A0848617,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/18/2023,9/18/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
GB,2023-09-13,A0848435,Clinical,Positive IV,Thomas J Vogl,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,9/19/2023,9/19/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-13,A0848737,Clinical,Southend University Hospital,Sophie Tisi,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/20/2023,9/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
ES,2023-09-14,A0849836,Clinical,Clinica Universidad de Navarra-Madrid,Gonzalo Fernandez Hinojal,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/19/2023,9/19/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2400 USD,2400.0,2023-09,1.0,2400.0,2000-3000$ 
GB,2023-09-14,A0850022,Clinical,Singleton Hospital,Sing-Yu Moorcraft,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/20/2023,9/20/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
MX,2023-09-14,A0849671,Clinical,MileniaLabs,Ignacio Miguel Funtes Mendez,74-Gene Panel,2.11,GHI_01,Do Not Bill - Cancelled,Pancreatic adenocarcinoma,,9/15/2023,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,South America,Paid,0,0.0,2023-09,1.0,0.0,0 $
BR,2023-09-14,A0850311,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/20/2023,9/27/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-09,1.0,1750.0,1500-2000$ 
GB,2023-09-14,A0849569,Clinical,Nuffield Health Warwickshire,Peter Correa,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/20/2023,10/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-14,A0849668,Clinical,Royal United Hospitals Bath,Sharath Gangadhara,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Pancreatic carcinoma,9/21/2023,9/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-09,1.18,2938.2,2000-3000$ 
GB,2023-09-14,A0850176,Clinical,Guys Hospital,Imran Petkar,Guardant 360,,GHI_19,Self-Pay Patient,Head and neck carcinoma,9/26/2023,9/26/2023,UNITED KINGDOM,Commercial,Head and neck carcinoma,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
GB,2023-09-15,A0851474,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,9/21/2023,9/21/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-09,1.18,2570.04,2000-3000$ 
IT,2023-09-15,A0851378,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/21/2023,9/21/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
IT,2023-09-15,A0851457,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Anaplastic astrocytoma,9/21/2023,9/21/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
IT,2023-09-15,A0851323,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,9/21/2023,9/21/2023,ITALY,Commercial,GI,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
DE,2023-09-15,A0851249,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,9/21/2023,9/21/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,3341 EUR,3341.0,2023-09,1.0,3341.0,3000+ $
MX,2023-09-15,A0851252,Clinical,ABC Hospital,Raquel Mendoza,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,9/21/2023,9/21/2023,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,South America,Paid,3228 USD,3228.0,2023-09,1.0,3228.0,3000+ $
IT,2023-09-15,A0851467,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Anaplastic astrocytoma,9/21/2023,9/21/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1745 EUR ,1745.0,2023-09,1.0,1745.0,1500-2000$ 
GB,2023-09-15,A0851563,Clinical,HCA Laboratories,Mark Harries,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,9/20/2023,9/20/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-09,1.18,2570.04,2000-3000$ 
IT,2023-09-15,A0851367,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,9/18/2023,10/2/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,0 EUR,0.0,2023-09,1.0,0.0,0 $
GB,2023-09-16,A0852273,Clinical,Guys Hospital,Jonathan Noel,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,9/21/2023,9/21/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
CA,2023-09-16,A0852256,Clinical,"Blueguide, Inc.",Anita Agrawal,Guardant 360,2.11,GHI_01,Self-Pay Patient,Squamous cell carcinoma,9/21/2023,9/26/2023,CANADA,Commercial,Lung,CANADA,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Canada,Free,0 USD,0.0,2023-09,1.0,0.0,0 $
TR,2023-09-18,A0852810,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ruchan Uslu,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,9/24/2023,9/24/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
GB,2023-09-18,A0852802,Clinical,York Hospital,Mohieldin Mohamed,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/22/2023,9/22/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
CA,2023-09-18,A0852877,Clinical,"Blueguide, Inc.",Scott Bentley,Guardant 360,2.11,GHI_01,Self-Pay Patient,Breast Carcinoma,9/25/2023,9/25/2023,CANADA,Commercial,Breast,CANADA,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Canada,Paid,??,0.0,2023-09,1.0,0.0,0 $
GB,2023-09-19,A0853737,Clinical,University College London Hospitals,John Bridgewater,Guardant 360,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,9/27/2023,9/27/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-19,A0853774,Clinical,Dr George Buyanovskyâ€™s clinic,George Buyanovsky,Guardant 360,2.12,GH2_12,Self-Pay Patient,Cervical Squamous Cell Carcinoma,9/30/2023,9/30/2023,UNITED KINGDOM,Commercial,Cervical,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-09,1.18,4118.2,3000+ $
GB,2023-09-19,A0854024,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/24/2023,9/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
CA,2023-09-19,A0854044,Clinical,St Michaelâ€™s Hospital,Kieran McIntyre,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung cancer,9/25/2023,9/25/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Canada,Paid,??,0.0,2023-09,1.0,0.0,0 $
GB,2023-09-19,A0853778,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/23/2023,9/23/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-20,A0854528,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Jonathan Dakin,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,9/26/2023,10/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-09,1.18,2938.2,2000-3000$ 
DE,2023-09-20,A0854451,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,9/26/2023,9/26/2023,GERMANY,Commercial,GI,GERMANY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,3341 EUR,3341.0,2023-09,1.0,3341.0,3000+ $
ES,2023-09-21,A0856351,Clinical,Hospital A Coruna,Maria Rosario Garcia Campelo,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/7/2023,10/7/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1500 EUR,1500.0,2023-09,1.0,1500.0,0-1500$ 
GB,2023-09-21,A0855982,Clinical,Freeman Hospital,Alastair Greystoke,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/26/2023,9/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-21,A0859215,Clinical,Genesis Care Nottingham,Santhanam Sundar,Guardant360 CDx,,GHI_19,Self-Pay Patient,Bladder carcinoma,10/3/2023,10/3/2023,UNITED KINGDOM,Commercial,Bladder,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-09,1.18,2643.2,2000-3000$ 
CA,2023-09-21,A0856079,Clinical,Princess Margaret Cancer Centre,Jennifer Knox,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,9/29/2023,9/29/2023,CANADA,Commercial,GI,CANADA,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Canada,Paid,2290 USD,2290.0,2023-09,1.0,2290.0,2000-3000$ 
GB,2023-09-21,A0856094,Clinical,GenesisCare Milton Keynes,Sarah Smith,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,9/27/2023,9/27/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-21,A0856358,Clinical,Maidstone and Tunbridge Wells NHS Trust,Riyaz Shah,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/26/2023,9/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-21,A0856348,Clinical,Southampton General Hospital,Jenny Bradbury,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,9/27/2023,9/27/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-21,A0855820,Clinical,The Royal Marsden NHS Foundation Trust,David Cunningham,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,9/26/2023,9/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-09,1.18,2938.2,2000-3000$ 
IT,2023-09-22,A0856714,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,9/26/2023,9/26/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,0 EUR,0.0,2023-09,1.0,0.0,0 $
IT,2023-09-22,A0857278,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Do Not Bill - Cancelled,Breast Carcinoma,10/5/2023,10/5/2023,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,0 EUR,0.0,2023-09,1.0,0.0,0 $
GB,2023-09-22,A0856633,Clinical,HCA Laboratories,Simon Hughes,Guardant 360,,GHI_19,Distributors : ROW,Prostate adenocarcinoma,9/26/2023,10/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-09,1.18,2570.04,2000-3000$ 
IT,2023-09-22,A0856596,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Do Not Bill - Cancelled,Colorectal adenocarcinoma,9/26/2023,10/5/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,0 EUR,0.0,2023-09,1.0,0.0,0 $
DE,2023-09-22,A0856746,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Carcinoma of unknown primary (CUP),9/28/2023,9/28/2023,GERMANY,Commercial,CUP,GERMANY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,3341 EUR,3341.0,2023-09,1.0,3341.0,3000+ $
IT,2023-09-22,A0857266,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cutaneous squamous cell carcinoma,9/27/2023,9/27/2023,ITALY,Commercial,Skin,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
BR,2023-09-22,A0856493,Clinical,Hospital Alemao Oswaldo Cruz,Cheng Tzu Yen,74-Gene Panel,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,9/26/2023,9/26/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,South America,Paid,2490 USD,2490.0,2023-09,1.0,2490.0,2000-3000$ 
IT,2023-09-22,A0856606,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,9/26/2023,9/26/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
ES,2023-09-23,A0857746,Clinical,Clinica Universidad de Navarra-Madrid,Javier Rodriguez,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,9/27/2023,9/27/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2400 USD,2400.0,2023-09,1.0,2400.0,2000-3000$ 
GB,2023-09-25,A0858521,Clinical,Freeman Hospital,Jill Gardiner,Guardant360 CDx,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),9/29/2023,9/29/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
TR,2023-09-25,A0858533,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ece Esin,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Gastric adenocarcinoma,10/2/2023,10/2/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
UY,2023-09-25,A0858523,Clinical,Practice Dr Luis Ubillos,Luis Ubillos,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Prostate adenocarcinoma,10/2/2023,10/2/2023,URUGUAY,Commercial,,URUGUAY,1,non_AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,South America,Paid,3990 USD,3990.0,2023-09,1.0,3990.0,3000+ $
IT,2023-09-25,A0858584,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/28/2023,9/28/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
DE,2023-09-25,A0858609,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,10/1/2023,10/1/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,3341 EUR,3341.0,2023-09,1.0,3341.0,3000+ $
GB,2023-09-25,A0858543,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/4/2023,10/4/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-09,1.18,2938.2,2000-3000$ 
GB,2023-09-25,A0858616,Clinical,Castle Hill Hospital,Iqtedar Muazzam,Guardant 360,,GHI_19,Self-Pay Patient,Renal Cell Carcinoma,9/28/2023,10/30/2023,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
IT,2023-09-25,A0858611,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,9/28/2023,9/28/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
GB,2023-09-25,A0858595,Clinical,Department of Oncology Chelsea and Westminster Hospital,Thomas Newsom-Davis,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/28/2023,9/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-25,A0858588,Clinical,Royal Stoke University Hospital,Apurna Jegannathen,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/5/2023,10/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-26,A0859271,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,10/4/2023,10/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-09,1.18,2570.04,2000-3000$ 
GB,2023-09-26,A0859009,Clinical,HCA Laboratories,John Conibear,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,9/30/2023,9/30/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2178.75 GBP,2178.0,2023-09,1.18,2570.04,2000-3000$ 
CA,2023-09-26,A0859243,Clinical,Marsden Centre,Mandana Kamyar,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Colorectal adenocarcinoma,10/3/2023,10/3/2023,CANADA,,,CANADA,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,Reveal,2023Q3,Canada,Free,0 USD,0.0,2023-09,1.0,0.0,0 $
DE,2023-09-26,A0858987,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Cholangiocarcinoma,10/6/2023,10/6/2023,GERMANY,Commercial,GI,GERMANY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,3341 EUR,3341.0,2023-09,1.0,3341.0,3000+ $
ES,2023-09-27,A0860527,Clinical,Centro de Patologia de la Mama-Fundacion Tejerina,Ana de Lara Gonzalez,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/1/2023,10/15/2023,SPAIN,Commercial,Breast,SPAIN,1,AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1745 EUR,1745.0,2023-09,1.0,1745.0,1500-2000$ 
CA,2023-09-27,A0859935,Clinical,Marsden Centre,Kim Rovers,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Breast Carcinoma,10/3/2023,10/3/2023,CANADA,,Breast,CANADA,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,Reveal,2023Q3,Canada,Free,0 USD,0.0,2023-09,1.0,0.0,0 $
BR,2023-09-27,A0860516,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/6/2023,10/6/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-09,1.0,1750.0,1500-2000$ 
BR,2023-09-27,A0860507,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/3/2023,10/3/2023,BRAZIL,Commercial,Breast,BRAZIL,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-09,1.0,1750.0,1500-2000$ 
RO,2023-09-27,A0860093,Clinical,Amethyst Radiotherapy Clinic,Bogdan Mateies,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/11/2023,10/11/2023,ROMANIA,Commercial,,ROMANIA,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 EUR,0.0,2023-09,1.0,0.0,0 $
BR,2023-09-27,A0860493,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal carcinoma,10/3/2023,10/3/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,South America,Paid,1750 USD,1750.0,2023-09,1.0,1750.0,1500-2000$ 
GB,2023-09-28,A0860937,Clinical,EDX Medical Ltd,Hendrik-Tobias Arkenau,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,10/2/2023,10/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2490 GBP,2490.0,2023-09,1.18,2938.2,2000-3000$ 
TR,2023-09-28,A0861005,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ertugrul Seyrek,83-Gene Panel,2.12,GH2_12,Distributors : ROW,Large cell carcinoma,10/5/2023,10/5/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,9,2023,3,1,2023-09-01,2023-09,G360 Infinity,2023Q3,Europe,Paid,2319,2319.0,2023-09,1.0,2319.0,2000-3000$ 
GB,2023-09-28,A0860720,Clinical,Eastbourne District General Hospital,Osei Kankam,Guardant360 CDx,,GHI_19,Self-Pay Patient,Adenoid cystic carcinoma,10/3/2023,10/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Free,0 GBP,0.0,2023-09,1.18,0.0,0 $
MX,2023-09-28,A0862548,Clinical,MileniaLabs,Ignacio Miguel Funtes Mendez,74-Gene Panel,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/2/2023,10/2/2023,MEXICO,Commercial,,MEXICO,1,non_AE,EUR,Americas,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,South America,Paid,2500 USD,2500.0,2023-09,1.0,2500.0,2000-3000$ 
GB,2023-09-29,A0863407,Clinical,The Nuffield Hospital Guildford,Tony Dhillon,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Colorectal adenocarcinoma,10/9/2023,10/11/2023,UNITED KINGDOM,,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,Reveal,2023Q3,Europe,Paid,3490 GBP,3490.0,2023-09,1.18,4118.2,3000+ $
GB,2023-09-29,A0862949,Clinical,Guys Hospital,Justin Mencel,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/4/2023,10/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-29,A0863526,Clinical,The Nuffield Hospital Guildford,Mazhar Ajaz,Guardant 360,2.11,GHI_01,Self-Pay Patient,Melanoma,10/5/2023,10/5/2023,UNITED KINGDOM,Commercial,Skin,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2240 GBP,2240.0,2023-09,1.18,2643.2,2000-3000$ 
GB,2023-09-29,A0863398,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Carcinoma of unknown primary (CUP),10/3/2023,10/16/2023,UNITED KINGDOM,Commercial,CUP,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-29,A0863430,Clinical,Barnet Hospital,Matthew Mee,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/9/2023,10/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
ES,2023-09-29,A0863518,Clinical,Clinica IMQ Zorrotzaurre,Francisco Fernandez Ruz,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/4/2023,11/6/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2490 EUR,2490.0,2023-09,1.0,2490.0,2000-3000$ 
GB,2023-09-29,A0863388,Clinical,Coventry University Hospitals,Peter Correa,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/5/2023,10/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
GB,2023-09-29,A0863382,Clinical,Cancer Centre at the Queen Elizabeth Hospital,Victoria Kunene,Guardant 360,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/3/2023,10/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,1450 GBP,1450.0,2023-09,1.18,1711.0,1500-2000$ 
IT,2023-09-29,A0863107,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/4/2023,10/4/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,9,2023,3,1,2023-09-01,2023-09,G360 CDx,2023Q3,Europe,Paid,2000 EUR,2000.0,2023-09,1.0,2000.0,1500-2000$ 
TR,2023-10-02,A0864696,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Gastric adenocarcinoma,10/9/2023,10/9/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
GB,2023-10-02,A0864692,Clinical,Worcestershire Royal Hospital,Mark Churn,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Colorectal adenocarcinoma,10/9/2023,10/10/2023,UNITED KINGDOM,,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,Reveal,2023Q4,Europe,Paid,3490 GBP,3490.0,2023-10,1.18,4118.2,3000+ $
GB,2023-10-02,A0864713,Clinical,Addenbrooke's Hospital,Ramesh Bulusu,Guardant360 CDx,2.12,GHI_19,Self-Pay Patient,GIST (Gastrointestinal stromal tumor),10/6/2023,10/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
TR,2023-10-02,A0864756,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Umut Demirci,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,10/9/2023,10/9/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
IT,2023-10-02,A0864677,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung cancer,10/7/2023,10/7/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
TR,2023-10-02,A0868759,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gungor Utkan,Guardant360 CDx,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,10/11/2023,10/11/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1838,1838.0,2023-10,1.0,1838.0,1500-2000$ 
GB,2023-10-02,A0864726,Clinical,HCA Laboratories,Alison Jones,Guardant 360,,GHI_19,Distributors : ROW,Bladder carcinoma,10/6/2023,10/6/2023,UNITED KINGDOM,Commercial,Bladder,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
GB,2023-10-02,A0864706,Clinical,Charing Cross Hospital Medical Oncology Department,Farah Rehman,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/9/2023,10/10/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
ES,2023-10-02,A0864687,Clinical,Hospital Clinico San Carlos,Jorge Bartolome,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,10/6/2023,10/6/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1500 EUR,1500.0,2023-10,1.0,1500.0,0-1500$ 
BR,2023-10-02,A0864759,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/6/2023,10/16/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
GB,2023-10-02,A0864702,Clinical,Singleton Hospital,Ali Hussnain,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,10/6/2023,10/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-10,1.18,0.0,0 $
GB,2023-10-02,A0864691,Clinical,Medway Maritime Hospital,Harman Saman,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/6/2023,10/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-10,1.18,0.0,0 $
GB,2023-10-03,A0865389,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,10/9/2023,10/9/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
GB,2023-10-03,A0865426,Clinical,University Hospitals Of Leicester,Meera Chauhan,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung adenocarcinoma,10/11/2023,10/11/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-10,1.18,0.0,0 $
GB,2023-10-04,A0866524,Clinical,HCA Laboratories,Mary Mccormack,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,10/10/2023,10/10/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
IT,2023-10-04,A0866057,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/11/2023,10/11/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
IT,2023-10-04,A0866397,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/10/2023,10/10/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
CA,2023-10-04,A0866360,Clinical,Marsden Centre,Kim Rovers,Guardant Reveal,3.0,GH_Reveal_3_0,Self-Pay Patient,Breast Carcinoma,10/12/2023,10/12/2023,CANADA,,Breast,CANADA,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,Reveal,2023Q4,Canada,Free,0 USD,0.0,2023-10,1.0,0.0,0 $
GB,2023-10-04,A0866153,Clinical,Royal Free London NHS Foundation Trust,Jackie Newby,Guardant 360,2.11,GHI_01,Distributors : ROW,Breast Carcinoma,10/18/2023,10/18/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-10,1.18,0.0,0 $
IE,2023-10-05,A0867157,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,10/11/2023,10/11/2023,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,0 EUR,0.0,2023-10,1.0,0.0,0 $
IT,2023-10-05,A0867204,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/11/2023,10/11/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
TR,2023-10-05,A0867270,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Prostate adenocarcinoma,10/10/2023,10/11/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
TR,2023-10-05,A0867234,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Yuksel Urun,Guardant 360,2.12,GH2_12,Distributors : ROW,Prostate adenocarcinoma,10/12/2023,10/12/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
GB,2023-10-05,A0867031,Clinical,Worcestershire Royal Hospital,Mark Churn,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/10/2023,10/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
GB,2023-10-05,A0867278,Clinical,HCA Laboratories,Martin Forster,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/10/2023,10/10/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
GB,2023-10-06,A0868576,Clinical,HCA Laboratories,Mark Harries,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,10/12/2023,10/12/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
CA,2023-10-06,A0868501,Clinical,Markham Stouffville Hospital,Sam Babak,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,10/13/2023,10/13/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Canada,Paid,2290 USD,2290.0,2023-10,1.0,2290.0,2000-3000$ 
IT,2023-10-06,A0868385,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Melanoma,10/11/2023,10/11/2023,ITALY,Commercial,Skin,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
IT,2023-10-06,A0868321,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Bladder carcinoma,10/11/2023,10/11/2023,ITALY,Commercial,Bladder,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
IT,2023-10-06,A0868389,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,10/12/2023,10/12/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
IT,2023-10-06,A0868365,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Do Not Bill - Cancelled,Melanoma,10/21/2023,10/21/2023,ITALY,Commercial,Skin,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,0 EUR,0.0,2023-10,1.0,0.0,0 $
IT,2023-10-06,A0868305,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Bladder carcinoma,10/11/2023,10/11/2023,ITALY,Commercial,Bladder,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1745 EUR ,1745.0,2023-10,1.0,1745.0,1500-2000$ 
GB,2023-10-07,A0868826,Clinical,EDX Medical Ltd,Hendrik-Tobias Arkenau,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/13/2023,10/13/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,??,0.0,2023-10,1.18,0.0,0 $
GB,2023-10-09,A0869553,Clinical,Castle Hill Hospital,Iqtedar Muazzam,Guardant 360,,GHI_19,Self-Pay Patient,Renal Cell Carcinoma,10/15/2023,10/15/2023,UNITED KINGDOM,Commercial,Kidney,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
GB,2023-10-09,A0872336,Clinical,The Holly Private Hospital,Eliot Sims,Guardant360 CDx,,GHI_19,Distributors : ROW,Breast Carcinoma,10/17/2023,10/17/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2490 GBP,2490.0,2023-10,1.18,2938.2,2000-3000$ 
ES,2023-10-09,A0869673,Clinical,Quironsalud Bizkaia Hospital,Guillermo Lopez Vivanco,Guardant 360,,GHI_19,Self-Pay Patient,Lung mucinous adenocarcinoma,10/14/2023,10/14/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,??,0.0,2023-10,1.0,0.0,0 $
GB,2023-10-09,A0869556,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Shiroma De Silva-Minor,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/14/2023,10/14/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2490 GBP,2490.0,2023-10,1.18,2938.2,2000-3000$ 
TR,2023-10-09,A0869587,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Emel Sezer,Guardant 360,2.12,GH2_12,Distributors : ROW,Gastric Carcinoma,10/17/2023,10/19/2023,TURKEY,Commercial,GI,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
TR,2023-10-09,A0869576,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Selami Bayram,Guardant 360,2.12,GH2_12,Distributors : ROW,Ovarian carcinoma,10/16/2023,10/16/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
GB,2023-10-09,A0869653,Clinical,HCA Laboratories,Martin Forster,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/16/2023,10/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
TR,2023-10-09,A0869605,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Nil Mandel,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,10/16/2023,10/16/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
GB,2023-10-09,A0869568,Clinical,Bradford Teaching Hospitals NHS Foundation Trust,Chidi Molokwu,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,10/16/2023,10/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-10,1.18,0.0,0 $
TR,2023-10-09,A0869594,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Haci Ibrahim Petekaya,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,10/17/2023,10/17/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
ES,2023-10-09,A0869595,Clinical,Clinica Universidad de Navarra-Madrid,Lucia Ceniceros,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,10/16/2023,10/16/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2400 USD,2400.0,2023-10,1.0,2400.0,2000-3000$ 
GB,2023-10-09,A0869662,Clinical,HCA Laboratories,Daniel Krell,Guardant 360,,GHI_19,Distributors : ROW,Small bowel adenocarcinoma,10/16/2023,10/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
TR,2023-10-09,A0869548,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Pancreatic ductal adenocarcinoma,10/16/2023,10/16/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
BR,2023-10-10,A0871033,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/14/2023,10/14/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
BR,2023-10-10,A0871025,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/18/2023,10/18/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
BR,2023-10-10,A0870972,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Small cell lung carcinoma,10/16/2023,10/16/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
BR,2023-10-10,A0870990,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/16/2023,10/19/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
GB,2023-10-10,A0870860,Clinical,Marsden360 Lab,Mikel Valganonpetrizan,Guardant360 CDx,2.11,GHI_01,Do Not Bill - Cancelled,Lung cancer,10/24/2023,10/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,0 GBP,0.0,2023-10,1.18,0.0,0 $
GB,2023-10-10,A0870992,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/14/2023,10/14/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
BR,2023-10-11,A0871546,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/16/2023,10/16/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
IE,2023-10-11,A0871958,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/17/2023,11/6/2023,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.0,1450.0,0-1500$ 
ES,2023-10-11,A0871471,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,10/24/2023,10/24/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1500 EUR,1500.0,2023-10,1.0,1500.0,0-1500$ 
GB,2023-10-11,A0871951,Clinical,HCA Laboratories,Mark Harries,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,10/17/2023,10/17/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
GB,2023-10-11,A0871495,Clinical,Sussex Cancer Centre,Kam Zaki,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/16/2023,10/16/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
CO,2023-10-12,A0872978,Clinical,Biotecnologia y Genetica S.A.S,Silvia Maradei,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Lung cancer,10/22/2023,10/22/2023,COLOMBIA,Commercial,,COLOMBIA,1,non_AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,South America,Paid,3990 USD,3990.0,2023-10,1.0,3990.0,3000+ $
CA,2023-10-12,A0872353,Clinical,Integrated Health Clinic,Gurdev Parmar,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/16/2023,10/16/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Canada,Free,0 USD,0.0,2023-10,1.0,0.0,0 $
ES,2023-10-12,A0873095,Clinical,Hospital Clinico San Carlos,Jorge Bartolome,Guardant360 CDx,2.11,GHI_01,Self-Pay Sponsored,Lung adenocarcinoma,10/19/2023,10/19/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1500 EUR,1500.0,2023-10,1.0,1500.0,0-1500$ 
ES,2023-10-12,A0872491,Clinical,Clinica IMQ Zorrotzaurre,Francisco Fernandez Ruz,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/17/2023,10/17/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2490 EUR,2490.0,2023-10,1.0,2490.0,2000-3000$ 
GB,2023-10-12,A0873097,Clinical,Nuffield Health Warwickshire,Peter Correa,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,10/18/2023,10/18/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2240 GBP,2240.0,2023-10,1.18,2643.2,2000-3000$ 
GB,2023-10-13,A0873296,Clinical,Sheffield Weston Park Cancer Centre,Sabbagh Ahmad,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,10/21/2023,10/21/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
IT,2023-10-13,A0873419,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Do Not Bill - Cancelled,Lung adenocarcinoma,11/2/2023,11/2/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,0 EUR,0.0,2023-10,1.0,0.0,0 $
GB,2023-10-13,A0873307,Clinical,BMI Bishops Wood Hospital,Nihal Shah,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/18/2023,10/18/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2240 GBP,2240.0,2023-10,1.18,2643.2,2000-3000$ 
TR,2023-10-13,A0873302,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Zuleyha Calikusu,Guardant 360,2.12,GH2_12,Distributors : ROW,Small cell lung carcinoma,10/20/2023,10/20/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
GB,2023-10-13,A0873527,Clinical,Spire Leicester Hospital,Kiran Kancherla,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/18/2023,10/18/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2240 GBP,2240.0,2023-10,1.18,2643.2,2000-3000$ 
ES,2023-10-13,A0873552,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,10/18/2023,10/18/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2179 EUR ,2179.0,2023-10,1.0,2179.0,2000-3000$ 
TR,2023-10-14,A0874139,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Kezban Nur Pilanci,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,10/20/2023,10/20/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
TR,2023-10-14,A0874238,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Zuleyha Calikusu,Guardant360 CDx,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,10/26/2023,10/26/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1838,1838.0,2023-10,1.0,1838.0,1500-2000$ 
GB,2023-10-16,A0874970,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,10/24/2023,10/24/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
IT,2023-10-16,A0874961,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/21/2023,10/21/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 EUR,0.0,2023-10,1.0,0.0,0 $
IT,2023-10-16,A0874975,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/22/2023,10/22/2023,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
TR,2023-10-16,A0875037,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,10/24/2023,10/24/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
BR,2023-10-16,A0874984,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/21/2023,10/21/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
GB,2023-10-17,A0875414,Clinical,HCA Laboratories,Paul Ellis,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,10/22/2023,10/22/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
GB,2023-10-17,A0875488,Clinical,Marsden360 Lab,Mikel Valganonpetrizan,Guardant360 CDx,2.11,GHI_01,Distributors : ROW,Lung cancer,10/22/2023,10/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-10,1.18,0.0,0 $
GB,2023-10-17,A0875436,Clinical,Marsden360 Lab,Mikel Valganonpetrizan,Guardant360 CDx,2.11,GHI_01,Distributors : ROW,Lung cancer,10/22/2023,10/26/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-10,1.18,0.0,0 $
GB,2023-10-17,A0875530,Clinical,Jersey General Hospital St. Helier,Rabinder Singh Soomal,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/22/2023,11/1/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
GB,2023-10-18,A0876814,Clinical,Bupa Cromwell Hospital,Riyaz Shah,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/24/2023,10/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2240 GBP,2240.0,2023-10,1.18,2643.2,2000-3000$ 
GB,2023-10-18,A0876717,Clinical,Singleton Hospital,Steve Kihara,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,10/24/2023,10/24/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-10,1.18,0.0,0 $
TR,2023-10-18,A0876628,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,10/25/2023,10/25/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
TR,2023-10-18,A0876712,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Yuksel Urun,Guardant 360,2.12,GH2_12,Distributors : ROW,Urothelial carcinoma,11/3/2023,11/3/2023,TURKEY,Commercial,Urothelial,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
GB,2023-10-18,A0876381,Clinical,Sussex Cancer Centre,Kam Zaki,UNKNOWN,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/24/2023,10/24/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2490 GBP,2490.0,2023-10,1.18,2938.2,2000-3000$ 
TR,2023-10-18,A0876685,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Sualp Tansan,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,10/25/2023,10/25/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
BR,2023-10-18,A0876283,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Prostate adenocarcinoma,10/24/2023,10/24/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
CA,2023-10-19,A0877384,Clinical,Princess Margaret Cancer Centre,Frances Shepherd,Guardant 360,2.11,GHI_01,Self-Pay Patient,Lung squamous cell carcinoma,10/24/2023,10/24/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Canada,Paid,1700 USD,1700.0,2023-10,1.0,1700.0,1500-2000$ 
GB,2023-10-19,A0878235,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Carla Pema,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,10/25/2023,10/25/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2490 GBP,2490.0,2023-10,1.18,2938.2,2000-3000$ 
IT,2023-10-20,A0878509,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Squamous cell carcinoma of the tongue,10/25/2023,10/25/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
IT,2023-10-20,A0878582,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Uterine Carcinoma,10/25/2023,10/25/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
IT,2023-10-20,A0878968,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/26/2023,10/26/2023,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
IT,2023-10-20,A0878984,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,10/25/2023,10/25/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
IT,2023-10-20,A0878525,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Squamous cell carcinoma of the tongue,10/25/2023,10/25/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1745 EUR ,1745.0,2023-10,1.0,1745.0,1500-2000$ 
GB,2023-10-20,A0878892,Clinical,HCA Laboratories,Mary Mccormack,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,10/28/2023,10/28/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
ES,2023-10-20,A0879256,Clinical,Hospital Clinico San Carlos,Jorge Bartolome,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,10/25/2023,10/25/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1500 EUR,1500.0,2023-10,1.0,1500.0,0-1500$ 
IT,2023-10-20,A0878590,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,10/26/2023,10/26/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
IT,2023-10-20,A0878975,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/25/2023,10/25/2023,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1745 EUR ,1745.0,2023-10,1.0,1745.0,1500-2000$ 
IT,2023-10-20,A0878995,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Glioblastoma,10/27/2023,10/27/2023,ITALY,Commercial,Brain,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
ES,2023-10-21,A0879932,Clinical,Hospital Quiron Barcelona,Jose Luis Cuadra,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,10/26/2023,10/26/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2179 EUR ,2179.0,2023-10,1.0,2179.0,2000-3000$ 
GB,2023-10-21,A0879623,Clinical,Guys Hospital,Mary Lei,Guardant 360,,GHI_19,Self-Pay Patient,Head and neck carcinoma,10/26/2023,10/26/2023,UNITED KINGDOM,Commercial,Head and neck carcinoma,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-10,1.18,0.0,0 $
GB,2023-10-21,A0879925,Clinical,Bupa Cromwell Hospital,Charles Lowdell,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/26/2023,10/26/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2490 GBP,2490.0,2023-10,1.18,2938.2,2000-3000$ 
ES,2023-10-23,A0880196,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Cholangiocarcinoma,10/28/2023,10/28/2023,SPAIN,Commercial,GI,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1500 EUR,1500.0,2023-10,1.0,1500.0,0-1500$ 
TR,2023-10-23,A0880142,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Fatih Selcukbiricik,Guardant 360,2.12,GH2_12,Distributors : ROW,Breast Carcinoma,11/1/2023,11/1/2023,TURKEY,Commercial,Breast,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
IE,2023-10-23,A0880180,Clinical,Bon Secours Hospital,Brian Bird,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,10/29/2023,10/29/2023,IRELAND,Commercial,,IRELAND,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.0,1450.0,0-1500$ 
DE,2023-10-23,A0880260,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,11/1/2023,11/1/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,3341 EUR,3341.0,2023-10,1.0,3341.0,3000+ $
GB,2023-10-23,A0880247,Clinical,HCA Laboratories,Martin Forster,Guardant 360,,GHI_19,Distributors : ROW,Head and neck carcinoma,11/2/2023,11/2/2023,UNITED KINGDOM,Commercial,Head and neck carcinoma,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
TR,2023-10-23,A0880133,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Gulay Ozgon,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/28/2023,10/28/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1838,1838.0,2023-10,1.0,1838.0,1500-2000$ 
GB,2023-10-23,A0880155,Clinical,Velindre Cancer Centre,Simon Waters,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,10/30/2023,10/30/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2490 GBP,2490.0,2023-10,1.18,2938.2,2000-3000$ 
BR,2023-10-23,A0880246,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,10/29/2023,10/29/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
TR,2023-10-23,A0880269,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,,11/4/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
ES,2023-10-23,A0880168,Clinical,Hospital Universitario HM Sanchinarro,Beatriz Paumard,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,10/29/2023,10/29/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2240 EUR,2240.0,2023-10,1.0,2240.0,2000-3000$ 
GB,2023-10-24,A0880627,Clinical,HCA Laboratories,Paul Ross,Guardant 360,,GHI_19,Distributors : ROW,Colorectal adenocarcinoma,10/28/2023,10/28/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
TR,2023-10-25,A0881623,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Hakan Sat Bozcuk,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/31/2023,10/31/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1838,1838.0,2023-10,1.0,1838.0,1500-2000$ 
GB,2023-10-26,A0883416,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Cholangiocarcinoma,11/1/2023,11/1/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
BR,2023-10-26,A0883365,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Adenoid cystic carcinoma,10/31/2023,11/2/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
GB,2023-10-26,A0883411,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/2/2023,11/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
IT,2023-10-26,A0882552,Clinical,Istituto Nazionale dei Tumori di Milano,Andrea Vingiani,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,,11/5/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
GB,2023-10-26,A0883419,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Pancreatic ductal adenocarcinoma,11/2/2023,11/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
BR,2023-10-26,A0883379,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/1/2023,11/1/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
ES,2023-10-26,A0882769,Clinical,Hospital A Coruna,Maria Rosario Garcia Campelo,Guardant 360,,GHI_19,Self-Pay Patient,Adenocarcinoma of Unknown Primary,11/1/2023,11/1/2023,SPAIN,Commercial,CUP,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1500 EUR,1500.0,2023-10,1.0,1500.0,0-1500$ 
ES,2023-10-26,A0883397,Clinical,Clinica IMQ Zorrotzaurre,Ricardo Fernandez,Guardant 360,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,11/1/2023,11/1/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 EUR,1450.0,2023-10,1.0,1450.0,0-1500$ 
ES,2023-10-26,A0882770,Clinical,Hospital del Mar,Laura Visa,Guardant 360,,GHI_19,Self-Pay Sponsored,Pancreatic ductal adenocarcinoma,11/1/2023,11/1/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 EUR,0.0,2023-10,1.0,0.0,0 $
BR,2023-10-26,A0883384,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,11/1/2023,11/1/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
GB,2023-10-26,A0883421,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,2.11,GHI_01,Self-Pay Patient,Colorectal adenocarcinoma,11/2/2023,11/2/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
GB,2023-10-26,A0883271,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/31/2023,10/31/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
ES,2023-10-26,A0882653,Clinical,HC Marbella International Hospital,Jose Manuel Trigo,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,10/31/2023,10/31/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2490 EUR,2490.0,2023-10,1.0,2490.0,2000-3000$ 
TR,2023-10-26,A0882465,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mehmet Akif Ozturk,Guardant 360,2.12,GH2_12,Distributors : ROW,Colorectal adenocarcinoma,11/2/2023,11/2/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
BR,2023-10-26,A0883373,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Colorectal adenocarcinoma,10/31/2023,11/2/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-10,1.0,1750.0,1500-2000$ 
CA,2023-10-26,A0885321,Clinical,"Blueguide, Inc.",Marc Vincent Langill,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic ductal adenocarcinoma,,11/5/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Canada,Paid,2290 USD,2290.0,2023-10,1.0,2290.0,2000-3000$ 
TR,2023-10-26,A0882616,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Berna Komurcuoglu,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,11/1/2023,11/1/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-10,1.0,2319.0,2000-3000$ 
CA,2023-10-26,A0882505,Clinical,Markham Stouffville Hospital,Monali Ray,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Lung adenocarcinoma,11/2/2023,11/2/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Canada,Paid,2290 USD,2290.0,2023-10,1.0,2290.0,2000-3000$ 
TR,2023-10-26,A0882542,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ahmet Sezer,Guardant360 CDx,,GHI_19,Distributors : ROW,Sarcoma,11/1/2023,11/1/2023,TURKEY,Commercial,Soft Tissue/Bone,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1838,1838.0,2023-10,1.0,1838.0,1500-2000$ 
ES,2023-10-27,A0884101,Clinical,Hospital University La Paz,Oliver Higuera,Guardant360 CDx,,GHI_19,Private Insurance/Employee Health Plan,Lung adenocarcinoma,11/3/2023,11/3/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1500 EUR,1500.0,2023-10,1.0,1500.0,0-1500$ 
GB,2023-10-27,A0883842,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,11/1/2023,11/1/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-10,1.18,0.0,0 $
GB,2023-10-27,A0884050,Clinical,Mount Alverina Hospital,Sebastian Cummins,Guardant360 CDx,,GHI_19,Self-Pay Patient,Esophageal/Gastroesophageal junction Adenocarcinoma,11/2/2023,11/2/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2240 GBP,2240.0,2023-10,1.18,2643.2,2000-3000$ 
GB,2023-10-27,A0883873,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Christopher Cunningham,Guardant 360,2.12,GH2_12,Self-Pay Patient,Rectal Cancer,,11/1/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,3490 GBP,3490.0,2023-10,1.18,4118.2,3000+ $
DE,2023-10-27,A0883701,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Colorectal adenocarcinoma,11/2/2023,11/2/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,3341 EUR,3341.0,2023-10,1.0,3341.0,3000+ $
GB,2023-10-28,A0884763,Clinical,Guys Hospital,Elias Pintus,Guardant 360,2.11,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,11/3/2023,11/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
IT,2023-10-30,A0885185,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,GIST (Gastrointestinal stromal tumor),11/5/2023,11/5/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
DE,2023-10-30,A0885198,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,,11/4/2023,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,3341 EUR,3341.0,2023-10,1.0,3341.0,3000+ $
GB,2023-10-30,A0885140,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,11/3/2023,11/3/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
IT,2023-10-30,A0885175,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,GIST (Gastrointestinal stromal tumor),11/6/2023,11/6/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1745 EUR ,1745.0,2023-10,1.0,1745.0,1500-2000$ 
ES,2023-10-30,A0885183,Clinical,HOSPITAL UNIV FUNDACION ALCORCON,Elisabeth Jimenez,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,,11/4/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 EUR,0.0,2023-10,1.0,0.0,0 $
ES,2023-10-30,A0885168,Clinical,Hospital University La Paz,Oliver Higuera,Guardant360 CDx,,GHI_19,Private Insurance/Employee Health Plan,Lung adenocarcinoma,11/6/2023,11/6/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1500 EUR,1500.0,2023-10,1.0,1500.0,0-1500$ 
GB,2023-10-30,A0885199,Clinical,Royal Surrey County Hospital - St Luke's Cancer Centre,Philip Turner,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,11/3/2023,11/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
GB,2023-10-30,A0885153,Clinical,St Marys Hospital Isle of Wight,Andrew Woolley,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,11/5/2023,11/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-10,1.18,0.0,0 $
GB,2023-10-30,A0885149,Clinical,HCA Laboratories,Suzy Cleator,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,11/3/2023,11/3/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
IT,2023-10-30,A0885147,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Glioblastoma,11/2/2023,11/2/2023,ITALY,Commercial,Brain,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
TR,2023-10-30,A0885159,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Ertugrul Seyrek,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,11/3/2023,11/3/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1838,1838.0,2023-10,1.0,1838.0,1500-2000$ 
IT,2023-10-30,A0885151,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung cancer,11/3/2023,11/3/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
GB,2023-10-30,A0885176,Clinical,HCA Laboratories,Peter Schmid,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,11/3/2023,11/3/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
IT,2023-10-30,A0885135,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,11/3/2023,11/3/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-10,1.0,2000.0,1500-2000$ 
GB,2023-10-30,A0885143,Clinical,BMI The Chaucer Hospital,Carys Thomas,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,11/3/2023,11/3/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2490 GBP,2490.0,2023-10,1.18,2938.2,2000-3000$ 
DE,2023-10-30,A0885112,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Pancreatic cystic tumor,,11/4/2023,GERMANY,Commercial,,GERMANY,1,non_AE,EUR,Europe,10,2023,4,1,2023-10-01,2023-10,G360 Infinity,2023Q4,Europe,Paid,3341 EUR,3341.0,2023-10,1.0,3341.0,3000+ $
GB,2023-10-31,A0885853,Clinical,HCA Laboratories,Hendrik-Tobias Arkenau,Guardant 360,,GHI_19,Distributors : ROW,Pancreatic ductal adenocarcinoma,,11/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
GB,2023-10-31,A0885784,Clinical,Kent Oncology Centre,Geraldo Alves de Paula Neto,Guardant360 CDx,,GHI_19,Self-Pay Patient,Colorectal adenocarcinoma,,11/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-10,1.18,1711.0,1500-2000$ 
GB,2023-10-31,A0885768,Clinical,HCA Laboratories,Khurum Khan,Guardant 360,,GHI_19,Distributors : ROW,Cholangiocarcinoma,,11/4/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,10,2023,4,1,2023-10-01,2023-10,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-10,1.18,2570.04,2000-3000$ 
ES,2023-11-01,A0886995,Clinical,Hospital Clinico San Carlos,Jorge Bartolome,Guardant360 CDx,,GHI_19,Self-Pay Sponsored,Lung adenocarcinoma,,11/5/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,1500 EUR,1500.0,2023-11,1.0,1500.0,0-1500$ 
GB,2023-11-01,A0889083,Clinical,Wellington Hospital,Martyn Caplin,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic neuroendocrine tumor,,11/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,2240 GBP,2240.0,2023-11,1.18,2643.2,2000-3000$ 
IT,2023-11-01,A0886924,Clinical,Paola Hospital - ASP of Cosenza,Gianfranco Filippelli,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,,11/5/2023,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Free,0 EUR,0.0,2023-11,1.0,0.0,0 $
GB,2023-11-01,A0886522,Clinical,HCA Laboratories,John Bridgewater,Guardant 360,,GHI_19,Distributors : ROW,"Primary liver cancer, unspecified",,11/4/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-11,1.18,2570.04,2000-3000$ 
TR,2023-11-01,A0886986,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,,11/6/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2023,4,1,2023-11-01,2023-11,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-11,1.0,2319.0,2000-3000$ 
GB,2023-11-01,A0887036,Clinical,St Bartholomews Hospital,Alison Berner,UNKNOWN,,GHI_19,Self-Pay Patient,Breast Carcinoma,,11/6/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Free,0 GBP,0.0,2023-11,1.18,0.0,0 $
GB,2023-11-01,A0886550,Clinical,Oxford University Hospitals NHS Foundation Trust Churchill Hospital,Paul Miller,Guardant360 CDx,,GHI_19,Self-Pay Patient,Pancreatic ductal adenocarcinoma,,11/5/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-11,1.18,1711.0,1500-2000$ 
DE,2023-11-02,A0888231,Clinical,SLK Kliniken GMBH,Uwe Martens,Guardant 360,2.12,GH2_12,Self-Pay Patient,Breast Carcinoma,,11/3/2023,GERMANY,Commercial,Breast,GERMANY,1,non_AE,EUR,Europe,11,2023,4,1,2023-11-01,2023-11,G360 Infinity,2023Q4,Europe,Paid,3341 EUR,3341.0,2023-11,1.0,3341.0,3000+ $
IT,2023-11-02,A0887439,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Thyroid carcinoma,,11/6/2023,ITALY,Commercial,Thyroid,ITALY,1,non_AE,EUR,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,1745 EUR ,1745.0,2023-11,1.0,1745.0,1500-2000$ 
IT,2023-11-02,A0887503,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Prostate adenocarcinoma,,11/6/2023,ITALY,Commercial,,ITALY,1,non_AE,EUR,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-11,1.0,2000.0,1500-2000$ 
IT,2023-11-02,A0887512,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,,11/6/2023,ITALY,Commercial,Breast,ITALY,1,non_AE,EUR,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-11,1.0,2000.0,1500-2000$ 
ES,2023-11-02,A0887957,Clinical,Hospital Clinico Provincial de Barcelona,Noemi Reguart,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,,11/3/2023,SPAIN,Commercial,,SPAIN,1,AE,EUR,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,1500 EUR,1500.0,2023-11,1.0,1500.0,0-1500$ 
IT,2023-11-02,A0887499,Clinical,Fondazione Falciani Onlus,Bruno Damascelli,Guardant360 CDx,,GHI_19,Self-Pay Patient,Thyroid carcinoma,,11/6/2023,ITALY,Commercial,Thyroid,ITALY,1,non_AE,EUR,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,2000 EUR,2000.0,2023-11,1.0,2000.0,1500-2000$ 
GB,2023-11-02,A0887487,Clinical,St Georges Hospital,Anna-Mary Young,Guardant360 CDx,,GHI_19,Self-Pay Patient,Esophageal/Gastroesophageal junction Adenocarcinoma,,11/6/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-11,1.18,1711.0,1500-2000$ 
GB,2023-11-02,A0888216,Clinical,HCA Laboratories,Thomas Newsom-Davis,Guardant 360,,GHI_19,Distributors : ROW,Lung adenocarcinoma,,11/3/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-11,1.18,2570.04,2000-3000$ 
CA,2023-11-02,A0888166,Clinical,London Health Sciences Centre,Stephen Welch,83-Gene Panel,2.12,GH2_12,Self-Pay Patient,Ovarian carcinosarcoma,,11/3/2023,CANADA,Commercial,,CANADA,1,AE,USD,Americas,11,2023,4,1,2023-11-01,2023-11,G360 Infinity,2023Q4,Canada,Paid,??,0.0,2023-11,1.0,0.0,0 $
BR,2023-11-02,A0888316,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,,11/3/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-11,1.0,1750.0,1500-2000$ 
AT,2023-11-02,A0887931,Clinical,MedVienna Arztezentrum,Martin Luzbetak,Guardant360 CDx,,GHI_19,Self-Pay Patient,Breast Carcinoma,,11/3/2023,AUSTRIA,Commercial,Breast,AUSTRIA,1,non_AE,EUR,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,2490 EUR,2490.0,2023-11,1.0,2490.0,2000-3000$ 
BR,2023-11-02,A0888327,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Lung adenocarcinoma,,11/3/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-11,1.0,1750.0,1500-2000$ 
GB,2023-11-03,A0888723,Clinical,GenesisCare Milton Keynes,Craig Macmillan,Guardant 360,,GHI_19,Self-Pay Patient,Breast Carcinoma,,11/6/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,,0.0,2023-11,1.18,0.0,0 $
GB,2023-11-03,A0888672,Clinical,Mount Vernon Hospital Cancer Centre The Hillingdon Hospitals NHS Foundation Trust,Suraiya Dubash,Guardant360 CDx,,GHI_19,Self-Pay Patient,Lung adenocarcinoma,,11/6/2023,UNITED KINGDOM,Commercial,,UNITED KINGDOM,1,AE,GBP,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-11,1.18,1711.0,1500-2000$ 
GB,2023-11-03,A0888583,Clinical,HCA Laboratories,Alison Jones,Guardant 360,,GHI_19,Distributors : ROW,Breast Carcinoma,,11/6/2023,UNITED KINGDOM,Commercial,Breast,UNITED KINGDOM,1,AE,GBP,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,2178.75 GBP,2178.0,2023-11,1.18,2570.04,2000-3000$ 
TR,2023-11-03,A0888482,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Mutlu Demiray,Guardant 360,2.12,GH2_12,Distributors : ROW,Lung adenocarcinoma,,11/3/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2023,4,1,2023-11-01,2023-11,G360 Infinity,2023Q4,Europe,Paid,2319,2319.0,2023-11,1.0,2319.0,2000-3000$ 
TR,2023-11-03,A0889244,Clinical,Valentis Saglik Hizmetleri ve Danismanlik AS,Fatih Selcukbiricik,Guardant360 CDx,,GHI_19,Distributors : ROW,Lung adenocarcinoma,,11/6/2023,TURKEY,Commercial,,TURKEY,1,AE,USD,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,1838,1838.0,2023-11,1.0,1838.0,1500-2000$ 
BR,2023-11-03,A0888593,Clinical,Diagnosticos da America S.A.,Cristovam Scapulatempo Neto,Guardant 360,2.11,GHI_01,Distributors : ROW,Pancreatic adenocarcinoma,,11/6/2023,BRAZIL,Commercial,,BRAZIL,1,AE,USD,Americas,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,South America,Paid,1750 USD,1750.0,2023-11,1.0,1750.0,1500-2000$ 
GB,2023-11-04,A0889836,Clinical,University College London Hospitals,John Bridgewater,Guardant360 CDx,,GHI_19,Self-Pay Patient,Cholangiocarcinoma,,11/4/2023,UNITED KINGDOM,Commercial,GI,UNITED KINGDOM,1,AE,GBP,Europe,11,2023,4,1,2023-11-01,2023-11,G360 CDx,2023Q4,Europe,Paid,1450 GBP,1450.0,2023-11,1.18,1711.0,1500-2000$ 
